*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 86 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 250 ALA A 81 ALA.? 10.40 C3 PG4 B 350 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 1.29 52.42 33.85 0.45 52.31 32.60 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 86 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 250 ALA D 201 ALA~? 12.42 C7 PG4 C 350 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -50.29 13.95 54.51 -49.45 12.81 55.00 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 86 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 250 ALA C 81 ALA.? 9.82 C5 PG4 D 350 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -51.31 8.31 29.27 -50.61 9.39 30.07 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 3 hits 2wwt_o00 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 64 SER~? 26.25 O3 PG4 B 350 A 524 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 556 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 1.46 56.04 50.07 2.12 55.38 52.31 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 1.74 60.96 43.57 3.36 61.47 42.28 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 A 445 SER A 64 SER~? 26.25 O3 PG4 B 350 A 524 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 556 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 1.46 56.04 50.07 2.12 55.38 52.31 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 8.08 50.44 43.84 7.48 51.26 41.98 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 A 445 SER A 241 SER.? 9.98 O3 PO4 A 349 A 524 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 556 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -1.16 62.88 18.52 0.68 62.16 19.33 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 A 445 SER B 64 SER~? 26.98 C5 PG4 A 350 A 524 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 556 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 5 3 # 5 A 445 SER B 241 SER.? 10.02 O1 PO4 B 349 A 524 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 556 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 6 3 # 6 A 445 SER C 64 SER~? 25.88 C5 PG4 D 350 A 524 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 556 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 7 3 # 7 A 445 SER C 241 SER.? 9.97 O3 PO4 C 349 A 524 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 556 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 8 3 # 8 A 445 SER D 64 SER~? 27.50 C6 PG4 C 350 A 524 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 556 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 9 3 # 9 A 445 SER D 241 SER.? 10.08 O3 PO4 D 349 A 524 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 556 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -38.74 26.41 54.26 -37.48 24.84 54.87 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 9 hits 3o4g_o00 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 64 SER~? 26.25 O3 PG4 B 350 A 123 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 172 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 45.74 29.80 42.79 47.58 31.06 41.64 1.46 56.04 50.07 2.12 55.38 52.31 coo 44.17 25.61 37.60 45.21 25.56 35.81 3.61 55.89 43.73 3.10 55.52 45.73 coo 39.85 24.35 34.94 41.12 25.58 33.83 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER A 241 SER.? 9.98 O3 PO4 A 349 A 123 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 172 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 45.74 29.80 42.79 47.58 31.06 41.64 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 44.17 25.61 37.60 45.21 25.56 35.81 1.50 56.90 17.79 2.83 56.38 19.33 coo 39.85 24.35 34.94 41.12 25.58 33.83 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 3 3 # 3 A 98 SER B 241 SER.? 10.02 O1 PO4 B 349 A 123 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 172 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 45.74 29.80 42.79 47.58 31.06 41.64 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 44.17 25.61 37.60 45.21 25.56 35.81 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 39.85 24.35 34.94 41.12 25.58 33.83 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 4 3 # 4 A 98 SER C 241 SER.? 9.97 O3 PO4 C 349 A 123 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 172 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 45.74 29.80 42.79 47.58 31.06 41.64 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 44.17 25.61 37.60 45.21 25.56 35.81 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 39.85 24.35 34.94 41.12 25.58 33.83 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 5 3 # 5 A 98 SER D 241 SER.? 10.08 O3 PO4 D 349 A 123 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 172 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 45.74 29.80 42.79 47.58 31.06 41.64 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 44.17 25.61 37.60 45.21 25.56 35.81 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 39.85 24.35 34.94 41.12 25.58 33.83 -41.09 30.11 59.34 -39.33 28.92 59.24 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 5 hits 3qwd_o00 naa= 3 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 226 ASP.? 25.19 O1 PO4 A 349 A 117 LYS A 184 LYS^? 18.49 O1 PO4 A 349 A 150 CYH A 151 CYH.? 21.29 O1 PO4 A 349 coo 37.97 47.82 5.46 38.65 48.02 7.40 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 41.02 51.33 13.36 40.18 47.06 9.99 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 39.17 42.30 8.54 40.94 44.26 7.78 -28.58 54.43 14.94 -26.94 52.63 16.24 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 117 LYS B 184 LYS^? 17.27 O2 PO4 B 349 A 150 CYH B 151 CYH.? 20.90 O2 PO4 B 349 coo 37.97 47.82 5.46 38.65 48.02 7.40 20.38 42.79 0.27 22.43 42.38 0.23 coo 41.02 51.33 13.36 40.18 47.06 9.99 15.36 36.70 4.47 15.17 34.16 8.91 coo 39.17 42.30 8.54 40.94 44.26 7.78 17.77 46.72 3.80 16.28 45.67 5.92 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 3 3 # 3 A 29 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 117 LYS B 316 LYS~? 24.20 O3 PO4 B 349 A 150 CYH B 330 CYH^? 15.61 O4 PO4 B 349 coo 37.97 47.82 5.46 38.65 48.02 7.40 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 41.02 51.33 13.36 40.18 47.06 9.99 -2.04 35.41 -19.34 2.27 31.66 -22.14 coo 39.17 42.30 8.54 40.94 44.26 7.78 2.17 41.99 -12.90 -0.49 41.01 -12.76 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 4 3 # 4 A 29 ASP C 226 ASP.? 11.40 C1 PG4 A 350 A 117 LYS C 184 LYS^? 18.13 O2 PO4 C 349 A 150 CYH C 151 CYH.? 19.97 C1 PG4 A 350 coo 37.97 47.82 5.46 38.65 48.02 7.40 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 41.02 51.33 13.36 40.18 47.06 9.99 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 39.17 42.30 8.54 40.94 44.26 7.78 -23.43 29.67 36.17 -24.68 27.35 36.97 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 5 3 # 5 A 29 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 117 LYS C 316 LYS~? 23.27 O4 PO4 C 349 A 150 CYH C 330 CYH^? 15.66 O1 PO4 C 349 coo 37.97 47.82 5.46 38.65 48.02 7.40 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 41.02 51.33 13.36 40.18 47.06 9.99 -44.69 38.73 13.31 -40.21 38.10 9.89 coo 39.17 42.30 8.54 40.94 44.26 7.78 -39.83 38.74 22.16 -42.53 38.02 21.91 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 6 3 # 6 A 29 ASP D 226 ASP.? 25.08 O1 PO4 D 349 A 117 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 150 CYH D 151 CYH.? 21.19 O1 PO4 D 349 coo 37.97 47.82 5.46 38.65 48.02 7.40 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 41.02 51.33 13.36 40.18 47.06 9.99 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 39.17 42.30 8.54 40.94 44.26 7.78 -68.87 26.89 52.59 -67.21 24.68 51.99 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 7 3 # 7 A 29 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 117 LYS D 316 LYS~? 24.37 O2 PO4 D 349 A 150 CYH D 330 CYH^? 15.59 O4 PO4 D 349 coo 37.97 47.82 5.46 38.65 48.02 7.40 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 41.02 51.33 13.36 40.18 47.06 9.99 -49.65 42.56 73.75 -53.64 42.38 78.67 coo 39.17 42.30 8.54 40.94 44.26 7.78 -54.33 40.49 65.01 -51.55 40.30 65.47 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 7 hits 3uao_o00 naa= 3 ULMN 4 1a0j_c08 TRYPSIN user 1 4 # 1 A 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 195 SER A 241 SER.? 9.98 O3 PO4 A 349 A 196 GLY A 234 GLY.? 7.10 O3 PO4 A 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 1.50 56.90 17.79 2.83 56.38 19.33 coo 22.33 45.48 59.73 23.35 43.67 60.06 -1.16 62.88 18.52 0.68 62.16 19.33 coo 20.90 36.72 61.65 22.18 37.53 63.52 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 20.40 37.63 58.06 19.79 37.28 58.50 -4.72 55.63 18.83 -5.29 56.17 18.78 ULMN 4 1a0j_c08 TRYPSIN user 2 4 # 2 A 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 195 SER B 241 SER.? 10.02 O1 PO4 B 349 A 196 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 22.33 45.48 59.73 23.35 43.67 60.06 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 20.90 36.72 61.65 22.18 37.53 63.52 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 20.40 37.63 58.06 19.79 37.28 58.50 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1a0j_c08 TRYPSIN user 3 4 # 3 A 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 195 SER C 241 SER.? 9.97 O3 PO4 C 349 A 196 GLY C 234 GLY.? 6.98 O3 PO4 C 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 22.33 45.48 59.73 23.35 43.67 60.06 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 20.90 36.72 61.65 22.18 37.53 63.52 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 20.40 37.63 58.06 19.79 37.28 58.50 -46.93 23.60 34.75 -46.44 24.03 34.33 ULMN 4 1a0j_c08 TRYPSIN user 4 4 # 4 A 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 195 SER D 241 SER.? 10.08 O3 PO4 D 349 A 196 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 20.90 36.72 61.65 22.18 37.53 63.52 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 20.40 37.63 58.06 19.79 37.28 58.50 -44.87 24.99 54.53 -45.43 25.38 54.91 1a0j_c08 source 1a0j TRYPSIN : 4 hits 1a0j_c08 naa= 4 ULMN 4 1a0j_c09 TRYPSIN user 1 4 # 1 B 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 195 SER A 241 SER.? 9.98 O3 PO4 A 349 B 196 GLY A 234 GLY.? 7.10 O3 PO4 A 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 1.50 56.90 17.79 2.83 56.38 19.33 coo 43.04 44.75 47.18 43.31 45.51 49.13 -1.16 62.88 18.52 0.68 62.16 19.33 coo 48.11 50.52 52.24 48.62 48.46 53.13 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 45.44 52.17 50.15 46.23 52.37 50.05 -4.72 55.63 18.83 -5.29 56.17 18.78 ULMN 4 1a0j_c09 TRYPSIN user 2 4 # 2 B 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 195 SER B 241 SER.? 10.02 O1 PO4 B 349 B 196 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 43.04 44.75 47.18 43.31 45.51 49.13 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 48.11 50.52 52.24 48.62 48.46 53.13 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 45.44 52.17 50.15 46.23 52.37 50.05 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1a0j_c09 TRYPSIN user 3 4 # 3 B 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 195 SER C 241 SER.? 9.97 O3 PO4 C 349 B 196 GLY C 234 GLY.? 6.98 O3 PO4 C 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 43.04 44.75 47.18 43.31 45.51 49.13 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 48.11 50.52 52.24 48.62 48.46 53.13 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 45.44 52.17 50.15 46.23 52.37 50.05 -46.93 23.60 34.75 -46.44 24.03 34.33 ULMN 4 1a0j_c09 TRYPSIN user 4 4 # 4 B 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 195 SER D 241 SER.? 10.08 O3 PO4 D 349 B 196 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 48.11 50.52 52.24 48.62 48.46 53.13 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 45.44 52.17 50.15 46.23 52.37 50.05 -44.87 24.99 54.53 -45.43 25.38 54.91 1a0j_c09 source 1a0j TRYPSIN : 4 hits 1a0j_c09 naa= 4 ULMN 4 1a0j_c10 TRYPSIN user 1 4 # 1 C 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 195 SER A 241 SER.? 9.98 O3 PO4 A 349 C 196 GLY A 234 GLY.? 7.10 O3 PO4 A 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 1.50 56.90 17.79 2.83 56.38 19.33 coo 34.89 38.34 78.12 35.11 39.59 76.42 -1.16 62.88 18.52 0.68 62.16 19.33 coo 36.16 46.87 75.66 34.01 46.43 74.59 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 39.34 45.13 76.73 39.04 45.77 77.16 -4.72 55.63 18.83 -5.29 56.17 18.78 ULMN 4 1a0j_c10 TRYPSIN user 2 4 # 2 C 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 195 SER B 241 SER.? 10.02 O1 PO4 B 349 C 196 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 34.89 38.34 78.12 35.11 39.59 76.42 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 36.16 46.87 75.66 34.01 46.43 74.59 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 39.34 45.13 76.73 39.04 45.77 77.16 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1a0j_c10 TRYPSIN user 3 4 # 3 C 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 C 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 195 SER C 241 SER.? 9.97 O3 PO4 C 349 C 196 GLY C 234 GLY.? 6.98 O3 PO4 C 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 34.89 38.34 78.12 35.11 39.59 76.42 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 36.16 46.87 75.66 34.01 46.43 74.59 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 39.34 45.13 76.73 39.04 45.77 77.16 -46.93 23.60 34.75 -46.44 24.03 34.33 ULMN 4 1a0j_c10 TRYPSIN user 4 4 # 4 C 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 195 SER D 241 SER.? 10.08 O3 PO4 D 349 C 196 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 36.16 46.87 75.66 34.01 46.43 74.59 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 39.34 45.13 76.73 39.04 45.77 77.16 -44.87 24.99 54.53 -45.43 25.38 54.91 1a0j_c10 source 1a0j TRYPSIN : 4 hits 1a0j_c10 naa= 4 ULMN 4 1a0j_c11 TRYPSIN user 1 4 # 1 D 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 D 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 195 SER A 241 SER.? 9.98 O3 PO4 A 349 D 196 GLY A 234 GLY.? 7.10 O3 PO4 A 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 1.50 56.90 17.79 2.83 56.38 19.33 coo 13.53 16.28 93.98 11.45 16.21 94.40 -1.16 62.88 18.52 0.68 62.16 19.33 coo 6.63 21.03 97.42 6.71 19.20 98.95 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 7.63 22.04 93.90 7.66 22.58 94.52 -4.72 55.63 18.83 -5.29 56.17 18.78 ULMN 4 1a0j_c11 TRYPSIN user 2 4 # 2 D 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 195 SER B 241 SER.? 10.02 O1 PO4 B 349 D 196 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 13.53 16.28 93.98 11.45 16.21 94.40 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 6.63 21.03 97.42 6.71 19.20 98.95 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 7.63 22.04 93.90 7.66 22.58 94.52 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1a0j_c11 TRYPSIN user 3 4 # 3 D 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 D 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 195 SER C 241 SER.? 9.97 O3 PO4 C 349 D 196 GLY C 234 GLY.? 6.98 O3 PO4 C 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 13.53 16.28 93.98 11.45 16.21 94.40 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 6.63 21.03 97.42 6.71 19.20 98.95 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 7.63 22.04 93.90 7.66 22.58 94.52 -46.93 23.60 34.75 -46.44 24.03 34.33 ULMN 4 1a0j_c11 TRYPSIN user 4 4 # 4 D 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 195 SER D 241 SER.? 10.08 O3 PO4 D 349 D 196 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 6.63 21.03 97.42 6.71 19.20 98.95 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 7.63 22.04 93.90 7.66 22.58 94.52 -44.87 24.99 54.53 -45.43 25.38 54.91 1a0j_c11 source 1a0j TRYPSIN : 4 hits 1a0j_c11 naa= 4 ULMN 4 1a4l_c00 ADENOSINE DEAMINASE user 1 4 # 1 A 217 GLU A 94 GLU~? 21.51 O3 PG4 B 350 A 238 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 240 TYR A 91 TYR~? 12.90 C4 PG4 B 350 A 295 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 43.34 23.35 58.83 42.51 22.61 57.01 2.26 51.25 46.83 2.00 52.68 48.40 coo 42.05 26.66 57.34 40.70 25.38 56.36 3.61 55.89 43.73 3.10 55.52 45.73 coo 41.81 28.15 62.72 40.19 27.93 60.45 3.23 49.01 40.90 3.18 50.90 38.82 coo 36.14 24.70 53.70 38.21 24.19 53.50 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 4 1a4l_c00 ADENOSINE DEAMINASE user 2 4 # 2 A 217 GLU C 94 GLU~? 21.12 C5 PG4 D 350 A 238 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 240 TYR C 91 TYR~? 12.18 C5 PG4 D 350 A 295 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 43.34 23.35 58.83 42.51 22.61 57.01 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 42.05 26.66 57.34 40.70 25.38 56.36 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 41.81 28.15 62.72 40.19 27.93 60.45 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 36.14 24.70 53.70 38.21 24.19 53.50 -52.23 5.22 16.50 -53.97 6.36 17.05 1a4l_c00 source 1a4l ADENOSINE DEAMINASE : 2 hits 1a4l_c00 naa= 4 ULMN 4 1a4l_c01 ADENOSINE DEAMINASE user 1 4 # 1 B 717 GLU A 94 GLU~? 21.51 O3 PG4 B 350 B 738 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 740 TYR A 91 TYR~? 12.90 C4 PG4 B 350 B 795 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 32.32 71.08 108.35 31.58 70.14 106.58 2.26 51.25 46.83 2.00 52.68 48.40 coo 31.04 74.39 106.98 29.75 73.04 106.02 3.61 55.89 43.73 3.10 55.52 45.73 coo 30.81 75.93 112.31 29.09 75.53 110.14 3.23 49.01 40.90 3.18 50.90 38.82 coo 25.01 72.35 103.36 27.06 71.87 103.09 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 4 1a4l_c01 ADENOSINE DEAMINASE user 2 4 # 2 B 717 GLU C 94 GLU~? 21.12 C5 PG4 D 350 B 738 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 740 TYR C 91 TYR~? 12.18 C5 PG4 D 350 B 795 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 32.32 71.08 108.35 31.58 70.14 106.58 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 31.04 74.39 106.98 29.75 73.04 106.02 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 30.81 75.93 112.31 29.09 75.53 110.14 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 25.01 72.35 103.36 27.06 71.87 103.09 -52.23 5.22 16.50 -53.97 6.36 17.05 1a4l_c01 source 1a4l ADENOSINE DEAMINASE : 2 hits 1a4l_c01 naa= 4 ULMN 4 1a4l_c03 ADENOSINE DEAMINASE user 1 4 # 1 D1717 GLU A 94 GLU~? 21.51 O3 PG4 B 350 D1738 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D1740 TYR A 91 TYR~? 12.90 C4 PG4 B 350 D1795 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 79.46 66.71 96.16 78.02 67.53 97.49 2.26 51.25 46.83 2.00 52.68 48.40 coo 77.62 63.23 97.06 75.99 64.55 97.16 3.61 55.89 43.73 3.10 55.52 45.73 coo 79.86 61.53 92.34 77.28 61.88 93.36 3.23 49.01 40.90 3.18 50.90 38.82 coo 70.75 65.08 97.32 72.46 65.59 98.49 1.74 60.96 43.57 3.36 61.47 42.28 1a4l_c03 source 1a4l ADENOSINE DEAMINASE : 1 hits 1a4l_c03 naa= 4 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 1 4 # 1 A 142 ALA A 187 ALA.? 10.63 O1 PO4 A 349 A 144 GLY A 199 GLY.? 14.09 O1 PG4 A 350 A 280 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 414 GLU A 196 GLU~? 14.14 O1 PO4 A 349 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -15.70 52.98 26.26 -15.60 52.72 27.75 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -17.17 48.70 27.51 -16.96 48.00 27.99 coo -3.84 22.59 11.63 -6.55 23.25 11.72 19.22 39.10 5.74 19.70 36.67 7.05 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -18.66 54.90 30.43 -20.55 55.76 30.68 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 2 4 # 2 A 142 ALA B 187 ALA.? 10.53 O2 PO4 B 349 A 144 GLY B 199 GLY.? 13.71 O1 PG4 B 350 A 280 TYR A 225 TYR.? 21.13 O1 PO4 A 349 A 414 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 6.84 34.76 9.15 6.94 33.32 9.66 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 8.71 34.57 13.67 8.56 34.17 14.43 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 3 4 # 3 A 142 ALA C 187 ALA.? 10.66 O2 PO4 C 349 A 144 GLY C 199 GLY.? 14.01 O1 PG4 C 350 A 280 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 414 GLU C 196 GLU~? 13.61 O2 PO4 C 349 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -34.89 17.65 31.97 -34.86 16.31 31.26 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -32.88 14.56 34.60 -33.00 13.70 34.89 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -32.17 15.85 27.58 -30.80 16.36 26.07 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 4 4 # 4 A 142 ALA C 213 ALA~? 8.04 O1 PG4 C 350 A 144 GLY C 212 GLY~? 9.26 C2 PG4 C 350 A 280 TYR A 225 TYR.? 21.13 O1 PO4 A 349 A 414 GLU C 135 GLU.? -3.67 O1 PG4 C 350s coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -34.93 17.01 43.45 -36.20 16.37 42.93 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -34.69 19.16 46.59 -35.10 19.11 45.88 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -38.59 10.74 44.23 -39.39 10.87 46.20 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 5 4 # 5 A 142 ALA D 187 ALA.? 10.52 O1 PO4 D 349 A 144 GLY D 199 GLY.? 13.68 O5 PG4 D 350 A 280 TYR C 225 TYR~? 18.05 C6 PG4 A 350 A 414 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -55.68 17.82 58.37 -55.49 16.55 59.17 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -57.03 13.69 56.19 -56.77 12.88 56.00 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -22.42 22.90 31.89 -22.15 20.23 31.17 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -58.16 15.98 62.44 -59.80 16.71 63.55 1b8f_c00 source 1b8f HISTIDINE AMMONIA-LYASE : 5 hits 1b8f_c00 naa= 4 ULMN 4 1ca0_c02 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 1 4 # 1 B 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 195 SER A 241 SER.? 9.98 O3 PO4 A 349 C 196 GLY A 234 GLY.? 7.10 O3 PO4 A 349 coo 9.31 59.87 4.78 10.85 60.06 6.19 1.50 56.90 17.79 2.83 56.38 19.33 coo 5.59 57.53 8.57 7.14 58.09 7.29 -1.16 62.88 18.52 0.68 62.16 19.33 coo 14.55 58.92 8.37 13.10 60.57 7.33 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 13.67 55.27 8.79 14.08 55.70 9.37 -4.72 55.63 18.83 -5.29 56.17 18.78 ULMN 4 1ca0_c02 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 2 4 # 2 B 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 195 SER B 241 SER.? 10.02 O1 PO4 B 349 C 196 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo 9.31 59.87 4.78 10.85 60.06 6.19 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 5.59 57.53 8.57 7.14 58.09 7.29 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 14.55 58.92 8.37 13.10 60.57 7.33 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 13.67 55.27 8.79 14.08 55.70 9.37 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1ca0_c02 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 3 4 # 3 B 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 195 SER C 241 SER.? 9.97 O3 PO4 C 349 C 196 GLY C 234 GLY.? 6.98 O3 PO4 C 349 coo 9.31 59.87 4.78 10.85 60.06 6.19 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 5.59 57.53 8.57 7.14 58.09 7.29 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 14.55 58.92 8.37 13.10 60.57 7.33 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 13.67 55.27 8.79 14.08 55.70 9.37 -46.93 23.60 34.75 -46.44 24.03 34.33 ULMN 4 1ca0_c02 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 4 4 # 4 B 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 195 SER D 241 SER.? 10.08 O3 PO4 D 349 C 196 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo 9.31 59.87 4.78 10.85 60.06 6.19 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 5.59 57.53 8.57 7.14 58.09 7.29 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 14.55 58.92 8.37 13.10 60.57 7.33 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 13.67 55.27 8.79 14.08 55.70 9.37 -44.87 24.99 54.53 -45.43 25.38 54.91 1ca0_c02 source 1ca0 PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLO: 4 hits 1ca0_c02 naa= 4 ULMN 4 1ca0_c03 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 1 4 # 1 G 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 G 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 H 195 SER A 241 SER.? 9.98 O3 PO4 A 349 H 196 GLY A 234 GLY.? 7.10 O3 PO4 A 349 coo 55.62 80.38 34.57 53.54 80.49 34.33 1.50 56.90 17.79 2.83 56.38 19.33 coo 55.92 77.51 29.55 55.59 78.35 31.47 -1.16 62.88 18.52 0.68 62.16 19.33 coo 49.36 79.22 35.31 50.95 80.97 34.93 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 49.96 75.54 34.73 49.24 75.92 34.45 -4.72 55.63 18.83 -5.29 56.17 18.78 ULMN 4 1ca0_c03 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 2 4 # 2 G 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 G 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 H 195 SER B 241 SER.? 10.02 O1 PO4 B 349 H 196 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo 55.62 80.38 34.57 53.54 80.49 34.33 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 55.92 77.51 29.55 55.59 78.35 31.47 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 49.36 79.22 35.31 50.95 80.97 34.93 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 49.96 75.54 34.73 49.24 75.92 34.45 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1ca0_c03 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 3 4 # 3 G 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 G 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 H 195 SER C 241 SER.? 9.97 O3 PO4 C 349 H 196 GLY C 234 GLY.? 6.98 O3 PO4 C 349 coo 55.62 80.38 34.57 53.54 80.49 34.33 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 55.92 77.51 29.55 55.59 78.35 31.47 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 49.36 79.22 35.31 50.95 80.97 34.93 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 49.96 75.54 34.73 49.24 75.92 34.45 -46.93 23.60 34.75 -46.44 24.03 34.33 ULMN 4 1ca0_c03 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 4 4 # 4 G 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 G 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 H 195 SER D 241 SER.? 10.08 O3 PO4 D 349 H 196 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo 55.62 80.38 34.57 53.54 80.49 34.33 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 55.92 77.51 29.55 55.59 78.35 31.47 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 49.36 79.22 35.31 50.95 80.97 34.93 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 49.96 75.54 34.73 49.24 75.92 34.45 -44.87 24.99 54.53 -45.43 25.38 54.91 1ca0_c03 source 1ca0 PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLO: 4 hits 1ca0_c03 naa= 4 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 1 4 # 1 A 72 ASP A 89 ASP~? 13.93 C4 PG4 B 350 A 141 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 143 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 148 GLU A 15 GLU.? 17.86 C3 PG4 B 350 coo 86.21 51.78 11.27 86.87 50.27 12.61 10.16 45.65 42.38 11.05 44.28 40.99 coo 77.92 48.13 25.32 78.70 49.17 23.61 1.74 60.96 43.57 3.36 61.47 42.28 coo 79.83 48.98 19.95 81.76 49.72 20.33 3.61 55.89 43.73 3.10 55.52 45.73 coo 76.11 54.71 19.44 77.75 55.81 18.59 7.25 58.10 39.87 8.59 56.71 39.00 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 2 4 # 2 A 72 ASP C 89 ASP.? 13.45 C5 PG4 D 350 A 141 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 143 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 148 GLU C 15 GLU.? 17.45 C5 PG4 D 350 coo 86.21 51.78 11.27 86.87 50.27 12.61 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 77.92 48.13 25.32 78.70 49.17 23.61 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 79.83 48.98 19.95 81.76 49.72 20.33 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 76.11 54.71 19.44 77.75 55.81 18.59 -57.75 5.96 21.41 -58.79 5.43 23.18 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 3 4 # 3 A 72 ASP D 89 ASP.? 16.35 C5 PG4 C 350 A 141 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 143 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 148 GLU D 15 GLU.? 19.32 C4 PG4 C 350 coo 86.21 51.78 11.27 86.87 50.27 12.61 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 77.92 48.13 25.32 78.70 49.17 23.61 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 79.83 48.98 19.95 81.76 49.72 20.33 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 76.11 54.71 19.44 77.75 55.81 18.59 -33.73 9.80 72.63 -32.07 9.73 71.31 1cd5_c00 source 1cd5 GLUCOSAMINE 6-PHOSPHATE DEAMINASE : 3 hits 1cd5_c00 naa= 4 ULMN 4 1d8h_c00 MRNA TRIPHOSPHATASE CET1 user 1 4 # 1 A 393 ARG B 206 ARG~? -3.06 O4 PG4 B 350s A 433 GLU A 135 GLU.? -3.98 O1 PG4 A 350s A 456 LYS B 134 LYS.? 7.94 O5 PG4 B 350 A 458 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo 8.61 51.76 73.74 9.78 51.49 70.80 -2.22 41.47 25.55 0.33 41.32 27.30 coo 14.59 54.44 69.55 14.31 53.05 67.99 -10.19 39.37 24.45 -9.09 38.16 23.13 coo 1.72 46.30 68.29 5.79 48.68 67.64 1.49 32.28 22.12 4.07 30.52 27.68 coo 6.20 47.59 62.97 6.73 49.77 65.20 -3.22 31.42 16.60 -5.11 31.22 14.14 1d8h_c00 source 1d8h MRNA TRIPHOSPHATASE CET1 : 1 hits 1d8h_c00 naa= 4 ULMN 4 1d8h_c01 MRNA TRIPHOSPHATASE CET1 user 1 4 # 1 B 393 ARG B 206 ARG~? -3.06 O4 PG4 B 350s B 433 GLU A 135 GLU.? -3.98 O1 PG4 A 350s B 456 LYS B 134 LYS.? 7.94 O5 PG4 B 350 B 458 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo -1.83 99.06 29.59 -0.10 96.84 28.90 -2.22 41.47 25.55 0.33 41.32 27.30 coo -1.96 91.25 27.47 0.16 91.64 27.05 -10.19 39.37 24.45 -9.09 38.16 23.13 coo 7.52 102.36 32.33 4.96 99.05 30.60 1.49 32.28 22.12 4.07 30.52 27.68 coo 9.47 95.54 30.17 6.44 95.66 31.22 -3.22 31.42 16.60 -5.11 31.22 14.14 1d8h_c01 source 1d8h MRNA TRIPHOSPHATASE CET1 : 1 hits 1d8h_c01 naa= 4 ULMN 4 1d8h_c02 MRNA TRIPHOSPHATASE CET1 user 1 4 # 1 C 393 ARG B 206 ARG~? -3.06 O4 PG4 B 350s C 433 GLU A 135 GLU.? -3.98 O1 PG4 A 350s C 456 LYS B 134 LYS.? 7.94 O5 PG4 B 350 C 458 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo 5.89 19.72 74.11 3.89 22.05 73.98 -2.22 41.47 25.55 0.33 41.32 27.30 coo 2.64 24.82 79.60 2.66 26.04 77.84 -10.19 39.37 24.45 -9.09 38.16 23.13 coo 2.79 21.47 64.30 3.04 22.87 68.57 1.49 32.28 22.12 4.07 30.52 27.68 coo -0.70 27.77 67.44 -0.05 25.34 69.46 -3.22 31.42 16.60 -5.11 31.22 14.14 1d8h_c02 source 1d8h MRNA TRIPHOSPHATASE CET1 : 1 hits 1d8h_c02 naa= 4 ULMN 4 1ddj_c03 PLASMINOGEN user 1 4 # 1 D 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 D 646 ASP B 208 ASP~? 8.88 C3 PG4 B 350 D 739 GLY A 192 GLY~? 8.82 O1 PO4 A 349 D 741 ALA A 201 ALA~? 12.43 O1 PG4 A 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -13.34 54.92 29.80 -13.05 54.30 30.24 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -10.23 47.67 26.68 -9.44 47.25 27.90 ULMN 4 1ddj_c03 PLASMINOGEN user 2 4 # 2 D 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 739 GLY B 192 GLY~? 8.75 O2 PO4 B 349 D 741 ALA B 201 ALA~? 11.68 O5 PG4 A 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -27.66 47.32 40.66 -27.81 47.01 41.41 4.63 30.70 8.46 4.46 30.28 9.17 coo -29.58 40.72 40.37 -30.29 39.69 41.25 1.77 34.76 14.91 1.15 33.57 15.58 ULMN 4 1ddj_c03 PLASMINOGEN user 3 4 # 3 D 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 D 646 ASP D 208 ASP~? 8.41 C6 PG4 D 350 D 739 GLY C 192 GLY~? 8.67 O2 PO4 C 349 D 741 ALA C 201 ALA~? 12.26 O1 PG4 C 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -37.38 15.60 28.56 -37.54 14.80 28.74 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -39.60 13.45 36.30 -40.20 12.08 36.02 ULMN 4 1ddj_c03 PLASMINOGEN user 4 4 # 4 D 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 739 GLY D 192 GLY~? 8.57 O1 PO4 D 349 D 741 ALA D 201 ALA~? 12.42 C7 PG4 C 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -52.91 16.56 61.94 -52.62 15.79 61.81 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -50.29 13.95 54.51 -49.45 12.81 55.00 ULMN 4 1ddj_c03 PLASMINOGEN user 5 4 # 5 D 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 739 GLY D 199 GLY.? 13.68 O5 PG4 D 350 D 741 ALA D 201 ALA~? 12.42 C7 PG4 C 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -57.03 13.69 56.19 -56.77 12.88 56.00 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -50.29 13.95 54.51 -49.45 12.81 55.00 1ddj_c03 source 1ddj PLASMINOGEN : 5 hits 1ddj_c03 naa= 4 ULMN 4 1dwo_c02 HYDROXYNITRILE LYASE user 1 4 # 1 A 11 THR A 242 THR.? 14.16 O1 PG4 B 350 A 80 SER A 241 SER.? 9.98 O3 PO4 A 349 A 208 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 236 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 47.13 41.31 120.49 48.87 42.53 120.85 -3.11 49.78 15.72 -2.58 47.68 15.65 coo 49.19 42.85 125.39 50.92 43.54 123.63 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 57.80 42.94 129.59 56.47 43.28 127.93 -1.16 62.88 18.52 0.68 62.16 19.33 coo 55.54 41.70 125.00 53.71 42.50 124.53 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 4 1dwo_c02 HYDROXYNITRILE LYASE user 2 4 # 2 A 11 THR B 242 THR.? 14.01 C2 PG4 A 350 A 80 SER B 241 SER.? 10.02 O1 PO4 B 349 A 208 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 236 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 47.13 41.31 120.49 48.87 42.53 120.85 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 49.19 42.85 125.39 50.92 43.54 123.63 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 57.80 42.94 129.59 56.47 43.28 127.93 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 55.54 41.70 125.00 53.71 42.50 124.53 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 4 1dwo_c02 HYDROXYNITRILE LYASE user 3 4 # 3 A 11 THR C 242 THR.? 14.00 O5 PG4 D 350 A 80 SER C 241 SER.? 9.97 O3 PO4 C 349 A 208 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 236 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 47.13 41.31 120.49 48.87 42.53 120.85 -47.88 22.66 41.54 -48.06 21.40 43.36 coo 49.19 42.85 125.39 50.92 43.54 123.63 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 57.80 42.94 129.59 56.47 43.28 127.93 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 55.54 41.70 125.00 53.71 42.50 124.53 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 4 1dwo_c02 HYDROXYNITRILE LYASE user 4 4 # 4 A 11 THR D 242 THR.? 14.33 O2 PG4 C 350 A 80 SER D 241 SER.? 10.08 O3 PO4 D 349 A 208 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 236 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 47.13 41.31 120.49 48.87 42.53 120.85 -43.74 23.47 47.95 -43.28 22.17 46.24 coo 49.19 42.85 125.39 50.92 43.54 123.63 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 57.80 42.94 129.59 56.47 43.28 127.93 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 55.54 41.70 125.00 53.71 42.50 124.53 -38.74 26.41 54.26 -37.48 24.84 54.87 1dwo_c02 source 1dwo HYDROXYNITRILE LYASE : 4 hits 1dwo_c02 naa= 4 ULMN 4 1dwo_c03 HYDROXYNITRILE LYASE user 1 4 # 1 B 11 THR A 242 THR.? 14.16 O1 PG4 B 350 B 80 SER A 241 SER.? 9.98 O3 PO4 A 349 B 208 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 236 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 52.85 24.36 98.72 52.23 22.37 99.26 -3.11 49.78 15.72 -2.58 47.68 15.65 coo 55.25 19.46 97.60 53.04 19.32 98.76 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 57.34 11.46 102.30 56.11 13.10 101.70 -1.16 62.88 18.52 0.68 62.16 19.33 coo 55.03 16.17 103.08 54.39 17.23 101.45 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 4 1dwo_c03 HYDROXYNITRILE LYASE user 2 4 # 2 B 11 THR A 244 THR~? 10.12 O4 PO4 A 349 B 80 SER A 241 SER.? 9.98 O3 PO4 A 349 B 208 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 236 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 52.85 24.36 98.72 52.23 22.37 99.26 -8.00 52.96 15.18 -7.58 55.05 14.79 coo 55.25 19.46 97.60 53.04 19.32 98.76 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 57.34 11.46 102.30 56.11 13.10 101.70 -1.16 62.88 18.52 0.68 62.16 19.33 coo 55.03 16.17 103.08 54.39 17.23 101.45 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 4 1dwo_c03 HYDROXYNITRILE LYASE user 3 4 # 3 B 11 THR B 242 THR.? 14.01 C2 PG4 A 350 B 80 SER B 241 SER.? 10.02 O1 PO4 B 349 B 208 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 236 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 52.85 24.36 98.72 52.23 22.37 99.26 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 55.25 19.46 97.60 53.04 19.32 98.76 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 57.34 11.46 102.30 56.11 13.10 101.70 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 55.03 16.17 103.08 54.39 17.23 101.45 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 4 1dwo_c03 HYDROXYNITRILE LYASE user 4 4 # 4 B 11 THR B 244 THR~? 10.49 O4 PO4 B 349 B 80 SER B 241 SER.? 10.02 O1 PO4 B 349 B 208 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 236 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 52.85 24.36 98.72 52.23 22.37 99.26 -2.27 44.71 7.93 -2.99 44.80 5.89 coo 55.25 19.46 97.60 53.04 19.32 98.76 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 57.34 11.46 102.30 56.11 13.10 101.70 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 55.03 16.17 103.08 54.39 17.23 101.45 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 4 1dwo_c03 HYDROXYNITRILE LYASE user 5 4 # 5 B 11 THR C 242 THR.? 14.00 O5 PG4 D 350 B 80 SER C 241 SER.? 9.97 O3 PO4 C 349 B 208 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 236 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 52.85 24.36 98.72 52.23 22.37 99.26 -47.88 22.66 41.54 -48.06 21.40 43.36 coo 55.25 19.46 97.60 53.04 19.32 98.76 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 57.34 11.46 102.30 56.11 13.10 101.70 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 55.03 16.17 103.08 54.39 17.23 101.45 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 4 1dwo_c03 HYDROXYNITRILE LYASE user 6 4 # 6 B 11 THR C 244 THR~? 10.31 O1 PO4 C 349 B 80 SER C 241 SER.? 9.97 O3 PO4 C 349 B 208 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 236 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 52.85 24.36 98.72 52.23 22.37 99.26 -43.52 25.65 38.88 -44.31 27.18 37.52 coo 55.25 19.46 97.60 53.04 19.32 98.76 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 57.34 11.46 102.30 56.11 13.10 101.70 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 55.03 16.17 103.08 54.39 17.23 101.45 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 4 1dwo_c03 HYDROXYNITRILE LYASE user 7 4 # 7 B 11 THR D 242 THR.? 14.33 O2 PG4 C 350 B 80 SER D 241 SER.? 10.08 O3 PO4 D 349 B 208 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 236 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 52.85 24.36 98.72 52.23 22.37 99.26 -43.74 23.47 47.95 -43.28 22.17 46.24 coo 55.25 19.46 97.60 53.04 19.32 98.76 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 57.34 11.46 102.30 56.11 13.10 101.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 55.03 16.17 103.08 54.39 17.23 101.45 -38.74 26.41 54.26 -37.48 24.84 54.87 ULMN 4 1dwo_c03 HYDROXYNITRILE LYASE user 8 4 # 8 B 11 THR D 244 THR~? 10.60 O4 PO4 D 349 B 80 SER D 241 SER.? 10.08 O3 PO4 D 349 B 208 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 236 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 52.85 24.36 98.72 52.23 22.37 99.26 -48.51 26.01 50.22 -48.02 27.82 51.30 coo 55.25 19.46 97.60 53.04 19.32 98.76 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 57.34 11.46 102.30 56.11 13.10 101.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 55.03 16.17 103.08 54.39 17.23 101.45 -38.74 26.41 54.26 -37.48 24.84 54.87 1dwo_c03 source 1dwo HYDROXYNITRILE LYASE : 8 hits 1dwo_c03 naa= 4 ULMN 4 1e6e_c00 ADRENODOXIN user 1 4 # 1 A 55 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 159 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 376 ILE A 21 ILE.? 14.60 C3 PG4 B 350 A 377 THR A 20 THR.? 13.58 O3 PO4 A 349 coo 17.95 58.52 112.81 17.29 59.41 111.03 3.61 55.89 43.73 3.10 55.52 45.73 coo 11.32 57.46 110.35 12.85 58.48 111.39 8.08 50.44 43.84 7.48 51.26 41.98 coo 15.00 65.23 121.40 15.42 63.95 122.00 3.71 56.69 34.01 4.81 56.28 34.79 coo 15.65 69.77 121.40 17.38 70.64 120.41 3.89 61.16 32.01 5.74 61.19 30.84 ULMN 4 1e6e_c00 ADRENODOXIN user 2 4 # 2 A 55 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 159 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 376 ILE B 21 ILE.? 14.94 O1 PO4 B 349 A 377 THR B 20 THR.? 14.13 O1 PO4 B 349 coo 17.95 58.52 112.81 17.29 59.41 111.03 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 11.32 57.46 110.35 12.85 58.48 111.39 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 15.00 65.23 121.40 15.42 63.95 122.00 -11.35 23.00 7.86 -12.39 22.10 8.35 coo 15.65 69.77 121.40 17.38 70.64 120.41 -11.82 24.00 3.10 -13.90 24.62 2.83 ULMN 4 1e6e_c00 ADRENODOXIN user 3 4 # 3 A 55 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 159 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 376 ILE C 21 ILE.? 14.37 C5 PG4 D 350 A 377 THR C 20 THR.? 14.12 O3 PO4 C 349 coo 17.95 58.52 112.81 17.29 59.41 111.03 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 11.32 57.46 110.35 12.85 58.48 111.39 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 15.00 65.23 121.40 15.42 63.95 122.00 -54.26 10.44 25.68 -55.39 9.48 25.57 coo 15.65 69.77 121.40 17.38 70.64 120.41 -55.27 14.55 23.34 -57.23 15.15 23.98 ULMN 4 1e6e_c00 ADRENODOXIN user 4 4 # 4 A 55 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 159 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 376 ILE D 21 ILE.? 15.54 C4 PG4 C 350 A 377 THR D 20 THR.? 14.77 O2 PO4 D 349 coo 17.95 58.52 112.81 17.29 59.41 111.03 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 11.32 57.46 110.35 12.85 58.48 111.39 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 15.00 65.23 121.40 15.42 63.95 122.00 -36.63 13.70 67.46 -35.61 12.77 67.75 coo 15.65 69.77 121.40 17.38 70.64 120.41 -36.38 18.01 69.72 -34.45 18.87 69.35 1e6e_c00 source 1e6e ADRENODOXIN : 4 hits 1e6e_c00 naa= 4 ULMN 4 1e6e_c01 ADRENODOXIN user 1 4 # 1 C 55 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 159 ASP A 90 ASP~? 15.98 C4 PG4 B 350 C 376 ILE A 21 ILE.? 14.60 C3 PG4 B 350 C 377 THR A 20 THR.? 13.58 O3 PO4 A 349 coo -29.07 40.56 142.27 -27.79 41.91 141.29 3.61 55.89 43.73 3.10 55.52 45.73 coo -23.44 38.39 138.46 -25.44 39.03 138.64 8.08 50.44 43.84 7.48 51.26 41.98 coo -37.08 37.01 134.95 -37.09 36.11 136.10 3.71 56.69 34.01 4.81 56.28 34.79 coo -39.65 39.67 132.35 -40.33 41.62 133.03 3.89 61.16 32.01 5.74 61.19 30.84 ULMN 4 1e6e_c01 ADRENODOXIN user 2 4 # 2 C 55 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 159 ASP B 90 ASP~? 17.21 C5 PG4 A 350 C 376 ILE B 21 ILE.? 14.94 O1 PO4 B 349 C 377 THR B 20 THR.? 14.13 O1 PO4 B 349 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -11.35 23.00 7.86 -12.39 22.10 8.35 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -11.82 24.00 3.10 -13.90 24.62 2.83 ULMN 4 1e6e_c01 ADRENODOXIN user 3 4 # 3 C 55 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 159 ASP C 90 ASP~? 15.56 C5 PG4 D 350 C 376 ILE C 21 ILE.? 14.37 C5 PG4 D 350 C 377 THR C 20 THR.? 14.12 O3 PO4 C 349 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -54.26 10.44 25.68 -55.39 9.48 25.57 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -55.27 14.55 23.34 -57.23 15.15 23.98 ULMN 4 1e6e_c01 ADRENODOXIN user 4 4 # 4 C 55 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 159 ASP D 90 ASP~? 17.03 C4 PG4 C 350 C 376 ILE D 21 ILE.? 15.54 C4 PG4 C 350 C 377 THR D 20 THR.? 14.77 O2 PO4 D 349 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -36.63 13.70 67.46 -35.61 12.77 67.75 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -36.38 18.01 69.72 -34.45 18.87 69.35 1e6e_c01 source 1e6e ADRENODOXIN : 4 hits 1e6e_c01 naa= 4 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 1 4 # 1 A 7 TYR A 91 TYR~? 12.90 C4 PG4 B 350 A 72 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 92 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 98 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 3.23 49.01 40.90 3.18 50.90 38.82 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 8.08 50.44 43.84 7.48 51.26 41.98 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 1.74 60.96 43.57 3.36 61.47 42.28 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 2 4 # 2 A 7 TYR A 313 TYR~? 26.58 O2 PO4 A 349 A 72 ASP A 311 ASP~? 22.72 O2 PO4 A 349 A 92 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 98 GLU A 312 GLU~? 22.67 O2 PO4 A 349 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 -7.13 87.01 20.69 -6.82 88.46 18.34 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 -4.84 83.29 26.02 -4.08 84.26 24.26 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 -11.55 82.77 24.82 -13.13 83.67 25.87 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 3 4 # 3 A 7 TYR B 91 TYR~? 13.43 C5 PG4 A 350 A 72 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 92 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 98 GLU B 94 GLU~? 22.11 C5 PG4 A 350 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 -9.83 18.57 16.69 -10.13 20.18 14.41 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 -7.91 12.10 15.72 -7.33 10.19 14.89 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 4 4 # 4 A 7 TYR B 313 TYR~? 26.96 O3 PO4 B 349 A 72 ASP B 311 ASP~? 22.86 O3 PO4 B 349 A 92 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 98 GLU B 312 GLU~? 22.88 O3 PO4 B 349 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 -5.51 31.63 -24.11 -6.16 33.31 -26.25 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 -0.30 29.09 -19.54 1.27 27.97 -20.48 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 5 4 # 5 A 7 TYR C 91 TYR~? 12.18 C5 PG4 D 350 A 72 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 92 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 98 GLU C 94 GLU~? 21.12 C5 PG4 D 350 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 -51.22 -2.72 22.56 -51.13 -3.21 20.49 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 6 4 # 6 A 7 TYR C 313 TYR~? 27.17 O4 PO4 C 349 A 72 ASP C 311 ASP~? 22.87 O4 PO4 C 349 A 92 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 98 GLU C 312 GLU~? 22.95 O4 PO4 C 349 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 -48.51 39.37 7.07 -48.60 42.05 6.33 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 -43.40 34.54 8.60 -41.92 34.59 7.07 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 7 4 # 7 A 7 TYR D 91 TYR~? 13.46 C4 PG4 C 350 A 72 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 92 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 98 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 8 4 # 8 A 7 TYR D 313 TYR~? 26.83 O2 PO4 D 349 A 72 ASP D 311 ASP~? 22.85 O2 PO4 D 349 A 92 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 98 GLU D 312 GLU~? 22.27 O2 PO4 D 349 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 -45.78 44.87 79.28 -45.52 47.64 79.09 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 -43.35 38.70 79.64 -42.93 40.74 79.14 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 -50.13 39.19 79.01 -51.63 38.45 80.28 1f8x_c00 source 1f8x NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE : 8 hits 1f8x_c00 naa= 4 ULMN 4 1f8x_c01 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 1 4 # 1 B 207 TYR A 91 TYR~? 12.90 C4 PG4 B 350 B 272 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 292 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 298 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo 65.34 -9.96 -1.84 62.54 -9.98 -1.80 3.23 49.01 40.90 3.18 50.90 38.82 coo 59.10 -7.54 -0.32 58.10 -9.33 0.15 8.08 50.44 43.84 7.48 51.26 41.98 coo 57.21 -14.68 -11.04 55.94 -13.90 -9.53 1.74 60.96 43.57 3.36 61.47 42.28 coo 60.44 -8.22 -6.20 60.22 -10.11 -5.29 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 4 1f8x_c01 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 2 4 # 2 B 207 TYR A 313 TYR~? 26.58 O2 PO4 A 349 B 272 ASP A 311 ASP~? 22.72 O2 PO4 A 349 B 292 ASP A 332 ASP~? 12.07 O2 PO4 A 349 B 298 GLU A 312 GLU~? 22.67 O2 PO4 A 349 coo 65.34 -9.96 -1.84 62.54 -9.98 -1.80 -7.13 87.01 20.69 -6.82 88.46 18.34 coo 59.10 -7.54 -0.32 58.10 -9.33 0.15 -4.84 83.29 26.02 -4.08 84.26 24.26 coo 57.21 -14.68 -11.04 55.94 -13.90 -9.53 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 60.44 -8.22 -6.20 60.22 -10.11 -5.29 -11.55 82.77 24.82 -13.13 83.67 25.87 ULMN 4 1f8x_c01 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 3 4 # 3 B 207 TYR B 91 TYR~? 13.43 C5 PG4 A 350 B 272 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 292 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 298 GLU B 94 GLU~? 22.11 C5 PG4 A 350 coo 65.34 -9.96 -1.84 62.54 -9.98 -1.80 -9.83 18.57 16.69 -10.13 20.18 14.41 coo 59.10 -7.54 -0.32 58.10 -9.33 0.15 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 57.21 -14.68 -11.04 55.94 -13.90 -9.53 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 60.44 -8.22 -6.20 60.22 -10.11 -5.29 -7.91 12.10 15.72 -7.33 10.19 14.89 ULMN 4 1f8x_c01 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 4 4 # 4 B 207 TYR B 313 TYR~? 26.96 O3 PO4 B 349 B 272 ASP B 311 ASP~? 22.86 O3 PO4 B 349 B 292 ASP B 332 ASP~? 12.13 O3 PO4 B 349 B 298 GLU B 312 GLU~? 22.88 O3 PO4 B 349 coo 65.34 -9.96 -1.84 62.54 -9.98 -1.80 -5.51 31.63 -24.11 -6.16 33.31 -26.25 coo 59.10 -7.54 -0.32 58.10 -9.33 0.15 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 57.21 -14.68 -11.04 55.94 -13.90 -9.53 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 60.44 -8.22 -6.20 60.22 -10.11 -5.29 -0.30 29.09 -19.54 1.27 27.97 -20.48 ULMN 4 1f8x_c01 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 5 4 # 5 B 207 TYR C 91 TYR~? 12.18 C5 PG4 D 350 B 272 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 292 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 298 GLU C 94 GLU~? 21.12 C5 PG4 D 350 coo 65.34 -9.96 -1.84 62.54 -9.98 -1.80 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 59.10 -7.54 -0.32 58.10 -9.33 0.15 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 57.21 -14.68 -11.04 55.94 -13.90 -9.53 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 60.44 -8.22 -6.20 60.22 -10.11 -5.29 -51.22 -2.72 22.56 -51.13 -3.21 20.49 ULMN 4 1f8x_c01 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 6 4 # 6 B 207 TYR C 313 TYR~? 27.17 O4 PO4 C 349 B 272 ASP C 311 ASP~? 22.87 O4 PO4 C 349 B 292 ASP C 332 ASP~? 12.18 O4 PO4 C 349 B 298 GLU C 312 GLU~? 22.95 O4 PO4 C 349 coo 65.34 -9.96 -1.84 62.54 -9.98 -1.80 -48.51 39.37 7.07 -48.60 42.05 6.33 coo 59.10 -7.54 -0.32 58.10 -9.33 0.15 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 57.21 -14.68 -11.04 55.94 -13.90 -9.53 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 60.44 -8.22 -6.20 60.22 -10.11 -5.29 -43.40 34.54 8.60 -41.92 34.59 7.07 ULMN 4 1f8x_c01 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 7 4 # 7 B 207 TYR D 91 TYR~? 13.46 C4 PG4 C 350 B 272 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 292 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 298 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo 65.34 -9.96 -1.84 62.54 -9.98 -1.80 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 59.10 -7.54 -0.32 58.10 -9.33 0.15 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 57.21 -14.68 -11.04 55.94 -13.90 -9.53 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 60.44 -8.22 -6.20 60.22 -10.11 -5.29 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 4 1f8x_c01 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 8 4 # 8 B 207 TYR D 313 TYR~? 26.83 O2 PO4 D 349 B 272 ASP D 311 ASP~? 22.85 O2 PO4 D 349 B 292 ASP D 332 ASP~? 12.02 O2 PO4 D 349 B 298 GLU D 312 GLU~? 22.27 O2 PO4 D 349 coo 65.34 -9.96 -1.84 62.54 -9.98 -1.80 -45.78 44.87 79.28 -45.52 47.64 79.09 coo 59.10 -7.54 -0.32 58.10 -9.33 0.15 -43.35 38.70 79.64 -42.93 40.74 79.14 coo 57.21 -14.68 -11.04 55.94 -13.90 -9.53 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 60.44 -8.22 -6.20 60.22 -10.11 -5.29 -50.13 39.19 79.01 -51.63 38.45 80.28 1f8x_c01 source 1f8x NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE : 8 hits 1f8x_c01 naa= 4 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 4 # 1 A 106 ASN A 267 ASN.? 11.93 O4 PO4 A 349 A 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 135 SER A 241 SER.? 9.98 O3 PO4 A 349 A 144 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 4.37 61.77 16.42 3.54 60.20 17.57 coo 52.62 57.63 23.12 50.77 57.51 22.26 1.50 56.90 17.79 2.83 56.38 19.33 coo 58.09 56.12 21.20 55.66 55.15 21.36 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 46.65 56.95 20.09 48.42 58.17 20.01 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 4 # 2 A 106 ASN A 267 ASN.? 11.93 O4 PO4 A 349 A 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 135 SER B 143 SER.? 15.37 C2 PG4 B 350 A 144 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 4.37 61.77 16.42 3.54 60.20 17.57 coo 52.62 57.63 23.12 50.77 57.51 22.26 1.50 56.90 17.79 2.83 56.38 19.33 coo 58.09 56.12 21.20 55.66 55.15 21.36 8.40 53.62 17.31 10.72 53.32 17.95 coo 46.65 56.95 20.09 48.42 58.17 20.01 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 4 # 3 A 106 ASN A 269 ASN.? 10.42 O3 PO4 A 349 A 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 135 SER A 241 SER.? 9.98 O3 PO4 A 349 A 144 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 5.56 58.73 21.48 4.09 58.66 22.99 coo 52.62 57.63 23.12 50.77 57.51 22.26 1.50 56.90 17.79 2.83 56.38 19.33 coo 58.09 56.12 21.20 55.66 55.15 21.36 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 46.65 56.95 20.09 48.42 58.17 20.01 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 4 # 4 A 106 ASN A 269 ASN.? 10.42 O3 PO4 A 349 A 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 135 SER B 143 SER.? 15.37 C2 PG4 B 350 A 144 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 5.56 58.73 21.48 4.09 58.66 22.99 coo 52.62 57.63 23.12 50.77 57.51 22.26 1.50 56.90 17.79 2.83 56.38 19.33 coo 58.09 56.12 21.20 55.66 55.15 21.36 8.40 53.62 17.31 10.72 53.32 17.95 coo 46.65 56.95 20.09 48.42 58.17 20.01 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 4 # 5 A 106 ASN B 267 ASN.? 11.96 O4 PO4 B 349 A 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 135 SER A 143 SER.? 14.48 C2 PG4 A 350 A 144 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -15.10 40.08 1.51 -14.03 39.29 3.16 coo 52.62 57.63 23.12 50.77 57.51 22.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 58.09 56.12 21.20 55.66 55.15 21.36 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 46.65 56.95 20.09 48.42 58.17 20.01 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 4 # 6 A 106 ASN B 267 ASN.? 11.96 O4 PO4 B 349 A 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 135 SER B 241 SER.? 10.02 O1 PO4 B 349 A 144 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -15.10 40.08 1.51 -14.03 39.29 3.16 coo 52.62 57.63 23.12 50.77 57.51 22.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 58.09 56.12 21.20 55.66 55.15 21.36 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 46.65 56.95 20.09 48.42 58.17 20.01 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 7 4 # 7 A 106 ASN B 269 ASN.? 10.41 O1 PO4 B 349 A 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 135 SER A 143 SER.? 14.48 C2 PG4 A 350 A 144 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 52.62 57.63 23.12 50.77 57.51 22.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 58.09 56.12 21.20 55.66 55.15 21.36 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 46.65 56.95 20.09 48.42 58.17 20.01 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 8 4 # 8 A 106 ASN B 269 ASN.? 10.41 O1 PO4 B 349 A 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 135 SER B 241 SER.? 10.02 O1 PO4 B 349 A 144 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 52.62 57.63 23.12 50.77 57.51 22.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 58.09 56.12 21.20 55.66 55.15 21.36 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 46.65 56.95 20.09 48.42 58.17 20.01 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 9 4 # 9 A 106 ASN C 267 ASN.? 11.87 O1 PO4 C 349 A 108 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 135 SER C 241 SER.? 9.97 O3 PO4 C 349 A 144 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -56.89 27.38 32.00 -55.68 25.71 32.54 coo 52.62 57.63 23.12 50.77 57.51 22.26 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 58.09 56.12 21.20 55.66 55.15 21.36 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 46.65 56.95 20.09 48.42 58.17 20.01 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 10 4 # 10 A 106 ASN C 267 ASN.? 11.87 O1 PO4 C 349 A 108 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 135 SER D 143 SER.? 14.73 O4 PG4 D 350 A 144 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -56.89 27.38 32.00 -55.68 25.71 32.54 coo 52.62 57.63 23.12 50.77 57.51 22.26 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 58.09 56.12 21.20 55.66 55.15 21.36 -59.66 21.71 38.39 -61.59 20.24 38.67 coo 46.65 56.95 20.09 48.42 58.17 20.01 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 11 4 # 11 A 106 ASN C 269 ASN.? 10.45 O3 PO4 C 349 A 108 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 135 SER C 241 SER.? 9.97 O3 PO4 C 349 A 144 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -57.17 21.55 31.51 -55.49 20.56 30.60 coo 52.62 57.63 23.12 50.77 57.51 22.26 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 58.09 56.12 21.20 55.66 55.15 21.36 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 46.65 56.95 20.09 48.42 58.17 20.01 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 12 4 # 12 A 106 ASN C 269 ASN.? 10.45 O3 PO4 C 349 A 108 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 135 SER D 143 SER.? 14.73 O4 PG4 D 350 A 144 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -57.17 21.55 31.51 -55.49 20.56 30.60 coo 52.62 57.63 23.12 50.77 57.51 22.26 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 58.09 56.12 21.20 55.66 55.15 21.36 -59.66 21.71 38.39 -61.59 20.24 38.67 coo 46.65 56.95 20.09 48.42 58.17 20.01 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 13 4 # 13 A 106 ASN D 267 ASN.? 11.74 O3 PO4 D 349 A 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 135 SER C 143 SER.? 14.49 C2 PG4 C 350 A 144 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -35.75 30.56 56.76 -36.75 28.68 56.44 coo 52.62 57.63 23.12 50.77 57.51 22.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 58.09 56.12 21.20 55.66 55.15 21.36 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 46.65 56.95 20.09 48.42 58.17 20.01 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 14 4 # 14 A 106 ASN D 267 ASN.? 11.74 O3 PO4 D 349 A 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 135 SER D 241 SER.? 10.08 O3 PO4 D 349 A 144 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -35.75 30.56 56.76 -36.75 28.68 56.44 coo 52.62 57.63 23.12 50.77 57.51 22.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 58.09 56.12 21.20 55.66 55.15 21.36 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 46.65 56.95 20.09 48.42 58.17 20.01 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 15 4 # 15 A 106 ASN D 269 ASN.? 10.24 O3 PO4 D 349 A 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 135 SER C 143 SER.? 14.49 C2 PG4 C 350 A 144 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -34.61 24.72 58.03 -36.14 23.70 59.12 coo 52.62 57.63 23.12 50.77 57.51 22.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 58.09 56.12 21.20 55.66 55.15 21.36 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 46.65 56.95 20.09 48.42 58.17 20.01 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 4 1grc_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 16 4 # 16 A 106 ASN D 269 ASN.? 10.24 O3 PO4 D 349 A 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 135 SER D 241 SER.? 10.08 O3 PO4 D 349 A 144 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -34.61 24.72 58.03 -36.14 23.70 59.12 coo 52.62 57.63 23.12 50.77 57.51 22.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 58.09 56.12 21.20 55.66 55.15 21.36 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 46.65 56.95 20.09 48.42 58.17 20.01 -41.09 30.11 59.34 -39.33 28.92 59.24 1grc_c00 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 16 hits 1grc_c00 naa= 4 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 4 # 1 B 106 ASN A 269 ASN.? 10.42 O3 PO4 A 349 B 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 135 SER A 241 SER.? 9.98 O3 PO4 A 349 B 144 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 5.56 58.73 21.48 4.09 58.66 22.99 coo 41.00 107.18 12.86 42.70 107.82 11.96 1.50 56.90 17.79 2.83 56.38 19.33 coo 36.51 108.90 17.50 37.10 110.80 16.19 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 31.60 110.69 6.14 29.69 109.74 5.94 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 4 # 2 B 106 ASN A 269 ASN.? 10.42 O3 PO4 A 349 B 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 135 SER B 143 SER.? 15.37 C2 PG4 B 350 B 144 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 5.56 58.73 21.48 4.09 58.66 22.99 coo 41.00 107.18 12.86 42.70 107.82 11.96 1.50 56.90 17.79 2.83 56.38 19.33 coo 36.51 108.90 17.50 37.10 110.80 16.19 8.40 53.62 17.31 10.72 53.32 17.95 coo 31.60 110.69 6.14 29.69 109.74 5.94 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 4 # 3 B 106 ASN A 270 ASN.? 15.06 O3 PO4 A 349 B 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 135 SER A 241 SER.? 9.98 O3 PO4 A 349 B 144 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 7.80 59.00 17.23 7.36 57.24 18.34 coo 41.00 107.18 12.86 42.70 107.82 11.96 1.50 56.90 17.79 2.83 56.38 19.33 coo 36.51 108.90 17.50 37.10 110.80 16.19 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 31.60 110.69 6.14 29.69 109.74 5.94 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 4 # 4 B 106 ASN B 269 ASN.? 10.41 O1 PO4 B 349 B 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 135 SER A 143 SER.? 14.48 C2 PG4 A 350 B 144 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 36.51 108.90 17.50 37.10 110.80 16.19 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 31.60 110.69 6.14 29.69 109.74 5.94 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 4 # 5 B 106 ASN B 269 ASN.? 10.41 O1 PO4 B 349 B 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 135 SER B 241 SER.? 10.02 O1 PO4 B 349 B 144 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 36.51 108.90 17.50 37.10 110.80 16.19 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 31.60 110.69 6.14 29.69 109.74 5.94 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 4 # 6 B 106 ASN B 270 ASN.? 15.02 O1 PO4 B 349 B 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 135 SER B 241 SER.? 10.02 O1 PO4 B 349 B 144 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -17.98 39.50 4.84 -17.14 38.86 6.70 coo 41.00 107.18 12.86 42.70 107.82 11.96 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 36.51 108.90 17.50 37.10 110.80 16.19 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 31.60 110.69 6.14 29.69 109.74 5.94 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 7 4 # 7 B 106 ASN C 269 ASN.? 10.45 O3 PO4 C 349 B 108 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 135 SER D 143 SER.? 14.73 O4 PG4 D 350 B 144 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -57.17 21.55 31.51 -55.49 20.56 30.60 coo 41.00 107.18 12.86 42.70 107.82 11.96 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 36.51 108.90 17.50 37.10 110.80 16.19 -59.66 21.71 38.39 -61.59 20.24 38.67 coo 31.60 110.69 6.14 29.69 109.74 5.94 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 8 4 # 8 B 106 ASN D 269 ASN.? 10.24 O3 PO4 D 349 B 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 135 SER C 143 SER.? 14.49 C2 PG4 C 350 B 144 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.61 24.72 58.03 -36.14 23.70 59.12 coo 41.00 107.18 12.86 42.70 107.82 11.96 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 36.51 108.90 17.50 37.10 110.80 16.19 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 31.60 110.69 6.14 29.69 109.74 5.94 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 9 4 # 9 B 106 ASN D 270 ASN.? 14.75 O3 PO4 D 349 B 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 135 SER D 241 SER.? 10.08 O3 PO4 D 349 B 144 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -32.60 27.92 55.07 -33.22 25.92 54.63 coo 41.00 107.18 12.86 42.70 107.82 11.96 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 36.51 108.90 17.50 37.10 110.80 16.19 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 31.60 110.69 6.14 29.69 109.74 5.94 -31.75 16.85 51.07 -30.38 15.61 52.00 1grc_c01 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 9 hits 1grc_c01 naa= 4 ULMN 4 1hzd_c01 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 B 141 ALA B 201 ALA~? 11.68 O5 PG4 A 350 B 186 GLY B 192 GLY~? 8.75 O2 PO4 B 349 B 189 GLU B 196 GLU~? 13.82 O2 PO4 B 349 B 209 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo -8.13 -16.22 36.72 -8.40 -15.53 35.38 1.77 34.76 14.91 1.15 33.57 15.58 coo -1.96 -15.64 35.87 -1.68 -16.38 36.08 4.63 30.70 8.46 4.46 30.28 9.17 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 10.06 30.74 8.04 11.63 30.24 6.70 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 3.23 35.71 5.73 3.00 33.97 6.89 1hzd_c01 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 1 hits 1hzd_c01 naa= 4 ULMN 4 1hzd_c03 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 D 141 ALA B 201 ALA~? 11.68 O5 PG4 A 350 D 186 GLY B 192 GLY~? 8.75 O2 PO4 B 349 D 189 GLU B 196 GLU~? 13.82 O2 PO4 B 349 D 209 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo -9.83 -0.92 -1.27 -9.83 -1.74 0.02 1.77 34.76 14.91 1.15 33.57 15.58 coo -5.10 2.47 0.73 -5.35 3.21 0.47 4.63 30.70 8.46 4.46 30.28 9.17 coo -2.98 4.12 3.98 -4.11 2.53 4.76 10.06 30.74 8.04 11.63 30.24 6.70 coo -9.98 2.96 6.77 -8.83 4.39 5.71 3.23 35.71 5.73 3.00 33.97 6.89 1hzd_c03 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 1 hits 1hzd_c03 naa= 4 ULMN 4 1j00_c00 THIOESTERASE I user 1 4 # 1 A 44 GLY A 108 GLY.? 11.36 O3 PG4 B 350 A 73 ASN A 107 ASN^? 9.64 C5 PG4 B 350 A 154 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 157 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo 5.31 35.31 46.19 5.56 34.58 46.17 -5.80 48.81 34.39 -5.17 48.42 34.72 coo 1.82 33.37 49.33 3.83 34.09 49.37 -5.73 45.70 37.96 -3.97 45.35 36.84 coo 8.45 43.15 56.37 9.67 41.50 55.89 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 9.95 38.09 54.06 8.12 38.46 53.08 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 4 1j00_c00 THIOESTERASE I user 2 4 # 2 A 44 GLY B 108 GLY.? 11.44 C5 PG4 A 350 A 73 ASN B 107 ASN^? 9.43 C5 PG4 A 350 A 154 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 157 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo 5.31 35.31 46.19 5.56 34.58 46.17 -1.45 26.58 15.61 -2.07 26.26 16.03 coo 1.82 33.37 49.33 3.83 34.09 49.37 -1.39 23.50 19.22 -3.25 24.51 19.38 coo 8.45 43.15 56.37 9.67 41.50 55.89 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 9.95 38.09 54.06 8.12 38.46 53.08 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 4 1j00_c00 THIOESTERASE I user 3 4 # 3 A 44 GLY C 108 GLY.? 11.29 O3 PG4 D 350 A 73 ASN C 107 ASN^? 9.61 C3 PG4 D 350 A 154 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 157 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo 5.31 35.31 46.19 5.56 34.58 46.17 -43.60 7.14 31.15 -44.12 6.54 31.35 coo 1.82 33.37 49.33 3.83 34.09 49.37 -42.97 2.46 31.63 -44.77 2.90 32.68 coo 8.45 43.15 56.37 9.67 41.50 55.89 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 9.95 38.09 54.06 8.12 38.46 53.08 -48.06 9.35 37.56 -47.54 11.38 37.75 1j00_c00 source 1j00 THIOESTERASE I : 3 hits 1j00_c00 naa= 4 ULMN 4 1j00_c01 THIOESTERASE I user 1 4 # 1 A 44 GLY A 108 GLY.? 11.36 O3 PG4 B 350 A 73 ASN A 107 ASN^? 9.64 C5 PG4 B 350 A 154 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 157 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo 5.31 35.31 46.19 5.56 34.58 46.17 -5.80 48.81 34.39 -5.17 48.42 34.72 coo 1.82 33.37 49.33 3.83 34.09 49.37 -5.73 45.70 37.96 -3.97 45.35 36.84 coo 8.45 43.15 56.37 9.67 41.50 55.89 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 9.95 38.09 54.06 8.12 38.46 53.08 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 4 1j00_c01 THIOESTERASE I user 2 4 # 2 A 44 GLY B 108 GLY.? 11.44 C5 PG4 A 350 A 73 ASN B 107 ASN^? 9.43 C5 PG4 A 350 A 154 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 157 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo 5.31 35.31 46.19 5.56 34.58 46.17 -1.45 26.58 15.61 -2.07 26.26 16.03 coo 1.82 33.37 49.33 3.83 34.09 49.37 -1.39 23.50 19.22 -3.25 24.51 19.38 coo 8.45 43.15 56.37 9.67 41.50 55.89 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 9.95 38.09 54.06 8.12 38.46 53.08 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 4 1j00_c01 THIOESTERASE I user 3 4 # 3 A 44 GLY C 108 GLY.? 11.29 O3 PG4 D 350 A 73 ASN C 107 ASN^? 9.61 C3 PG4 D 350 A 154 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 157 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo 5.31 35.31 46.19 5.56 34.58 46.17 -43.60 7.14 31.15 -44.12 6.54 31.35 coo 1.82 33.37 49.33 3.83 34.09 49.37 -42.97 2.46 31.63 -44.77 2.90 32.68 coo 8.45 43.15 56.37 9.67 41.50 55.89 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 9.95 38.09 54.06 8.12 38.46 53.08 -48.06 9.35 37.56 -47.54 11.38 37.75 1j00_c01 source 1j00 THIOESTERASE I : 3 hits 1j00_c01 naa= 4 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 4 # 1 A 50 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 55 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 84 LYS B 177 LYS~? 21.19 O2 PO4 B 349 A 117 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo 11.09 42.89 24.44 11.32 42.06 22.49 20.38 42.79 0.27 22.43 42.38 0.23 coo 4.60 40.33 20.42 7.25 39.50 20.05 19.22 39.10 5.74 19.70 36.67 7.05 coo 9.71 44.83 15.47 10.13 41.43 19.93 18.35 34.41 -3.27 19.41 29.18 0.25 coo 9.34 39.83 14.67 8.39 39.19 16.43 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 4 # 2 A 50 ASP D 226 ASP.? 25.08 O1 PO4 D 349 A 55 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 84 LYS D 177 LYS~? 20.36 O1 PO4 D 349 A 117 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo 11.09 42.89 24.44 11.32 42.06 22.49 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 4.60 40.33 20.42 7.25 39.50 20.05 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 9.71 44.83 15.47 10.13 41.43 19.93 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 9.34 39.83 14.67 8.39 39.19 16.43 -62.51 23.18 64.17 -63.84 21.56 64.29 1mrq_c00 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 2 hits 1mrq_c00 naa= 4 ULMN 4 1n8o_c01 CHYMOTRYPSIN A, B CHAIN user 1 4 # 1 B 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 195 SER A 241 SER.? 9.98 O3 PO4 A 349 C 196 GLY A 234 GLY.? 7.10 O3 PO4 A 349 coo 31.98 -6.99 19.44 30.75 -5.55 18.68 1.50 56.90 17.79 2.83 56.38 19.33 coo 36.93 -4.10 19.45 35.15 -5.13 19.05 -1.16 62.88 18.52 0.68 62.16 19.33 coo 28.33 -3.35 15.58 28.24 -4.45 17.63 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 31.25 -3.44 13.14 30.79 -2.74 13.19 -4.72 55.63 18.83 -5.29 56.17 18.78 ULMN 4 1n8o_c01 CHYMOTRYPSIN A, B CHAIN user 2 4 # 2 B 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 195 SER B 241 SER.? 10.02 O1 PO4 B 349 C 196 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo 31.98 -6.99 19.44 30.75 -5.55 18.68 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 36.93 -4.10 19.45 35.15 -5.13 19.05 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 28.33 -3.35 15.58 28.24 -4.45 17.63 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 31.25 -3.44 13.14 30.79 -2.74 13.19 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1n8o_c01 CHYMOTRYPSIN A, B CHAIN user 3 4 # 3 B 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 195 SER C 241 SER.? 9.97 O3 PO4 C 349 C 196 GLY C 234 GLY.? 6.98 O3 PO4 C 349 coo 31.98 -6.99 19.44 30.75 -5.55 18.68 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 36.93 -4.10 19.45 35.15 -5.13 19.05 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 28.33 -3.35 15.58 28.24 -4.45 17.63 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 31.25 -3.44 13.14 30.79 -2.74 13.19 -46.93 23.60 34.75 -46.44 24.03 34.33 ULMN 4 1n8o_c01 CHYMOTRYPSIN A, B CHAIN user 4 4 # 4 B 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 195 SER D 241 SER.? 10.08 O3 PO4 D 349 C 196 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo 31.98 -6.99 19.44 30.75 -5.55 18.68 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 36.93 -4.10 19.45 35.15 -5.13 19.05 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 28.33 -3.35 15.58 28.24 -4.45 17.63 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 31.25 -3.44 13.14 30.79 -2.74 13.19 -44.87 24.99 54.53 -45.43 25.38 54.91 1n8o_c01 source 1n8o CHYMOTRYPSIN A, B CHAIN : 4 hits 1n8o_c01 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL A 281 VAL~? 14.54 O4 PO4 A 349 A 194 GLY B 293 GLY~? 20.43 O4 PO4 A 349 A 417 ILE B 78 ILE^? 13.34 C5 PG4 A 350 A 457 ALA B 81 ALA.? 10.90 C4 PG4 A 350 coo 60.43 93.31 8.03 62.16 94.30 8.93 -5.43 63.60 7.64 -4.70 63.98 9.68 coo 59.34 89.99 13.88 59.24 89.18 13.73 2.42 62.24 4.78 2.23 61.74 5.37 coo 39.61 128.90 22.54 40.04 128.24 23.80 -3.37 20.99 14.93 -4.42 21.03 15.99 coo 43.27 124.32 20.47 43.79 125.29 21.53 -9.22 24.44 12.09 -8.53 25.77 12.01 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL A 281 VAL~? 14.54 O4 PO4 A 349 A 194 GLY B 293 GLY~? 20.43 O4 PO4 A 349 A 417 ILE B 80 ILE.? 16.18 C4 PG4 A 350 A 457 ALA B 81 ALA.? 10.90 C4 PG4 A 350 coo 60.43 93.31 8.03 62.16 94.30 8.93 -5.43 63.60 7.64 -4.70 63.98 9.68 coo 59.34 89.99 13.88 59.24 89.18 13.73 2.42 62.24 4.78 2.23 61.74 5.37 coo 39.61 128.90 22.54 40.04 128.24 23.80 -8.04 20.62 10.30 -8.33 19.20 10.24 coo 43.27 124.32 20.47 43.79 125.29 21.53 -9.22 24.44 12.09 -8.53 25.77 12.01 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 151 VAL B 77 VAL^? 18.07 O1 PO4 B 349 A 194 GLY B 79 GLY.? 14.35 O1 PO4 B 349 A 417 ILE A 21 ILE.? 14.60 C3 PG4 B 350 A 457 ALA A 81 ALA.? 10.40 C3 PG4 B 350 coo 60.43 93.31 8.03 62.16 94.30 8.93 0.92 18.88 13.75 2.48 19.98 12.65 coo 59.34 89.99 13.88 59.24 89.18 13.73 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 39.61 128.90 22.54 40.04 128.24 23.80 3.71 56.69 34.01 4.81 56.28 34.79 coo 43.27 124.32 20.47 43.79 125.29 21.53 1.29 52.42 33.85 0.45 52.31 32.60 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 151 VAL B 77 VAL^? 18.07 O1 PO4 B 349 A 194 GLY B 79 GLY.? 14.35 O1 PO4 B 349 A 417 ILE A 80 ILE.? 15.35 C3 PG4 B 350 A 457 ALA A 81 ALA.? 10.40 C3 PG4 B 350 coo 60.43 93.31 8.03 62.16 94.30 8.93 0.92 18.88 13.75 2.48 19.98 12.65 coo 59.34 89.99 13.88 59.24 89.18 13.73 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 39.61 128.90 22.54 40.04 128.24 23.80 0.88 54.97 37.41 1.44 55.29 38.70 coo 43.27 124.32 20.47 43.79 125.29 21.53 1.29 52.42 33.85 0.45 52.31 32.60 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 151 VAL B 77 VAL^? 18.07 O1 PO4 B 349 A 194 GLY B 108 GLY.? 11.44 C5 PG4 A 350 A 417 ILE C 36 ILE^? 18.54 O4 PO4 C 349 A 457 ALA C 34 ALA.? 19.28 O2 PO4 C 349 coo 60.43 93.31 8.03 62.16 94.30 8.93 0.92 18.88 13.75 2.48 19.98 12.65 coo 59.34 89.99 13.88 59.24 89.18 13.73 -1.45 26.58 15.61 -2.07 26.26 16.03 coo 39.61 128.90 22.54 40.04 128.24 23.80 -39.24 6.90 15.57 -39.97 7.67 16.46 coo 43.27 124.32 20.47 43.79 125.29 21.53 -33.62 7.75 17.77 -34.37 7.21 18.99 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 151 VAL B 106 VAL^? 16.38 O4 PG4 A 350 A 194 GLY B 108 GLY.? 11.44 C5 PG4 A 350 A 417 ILE C 36 ILE^? 18.54 O4 PO4 C 349 A 457 ALA C 34 ALA.? 19.28 O2 PO4 C 349 coo 60.43 93.31 8.03 62.16 94.30 8.93 2.26 21.28 17.40 3.92 21.88 16.12 coo 59.34 89.99 13.88 59.24 89.18 13.73 -1.45 26.58 15.61 -2.07 26.26 16.03 coo 39.61 128.90 22.54 40.04 128.24 23.80 -39.24 6.90 15.57 -39.97 7.67 16.46 coo 43.27 124.32 20.47 43.79 125.29 21.53 -33.62 7.75 17.77 -34.37 7.21 18.99 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 151 VAL B 281 VAL~? 14.69 O4 PO4 B 349 A 194 GLY A 293 GLY.? 20.64 O4 PO4 B 349 A 417 ILE A 78 ILE^? 13.32 O3 PG4 B 350 A 457 ALA A 81 ALA.? 10.40 C3 PG4 B 350 coo 60.43 93.31 8.03 62.16 94.30 8.93 -7.14 49.37 -3.63 -7.60 47.19 -3.44 coo 59.34 89.99 13.88 59.24 89.18 13.73 -15.25 51.43 -1.86 -14.91 51.02 -1.25 coo 39.61 128.90 22.54 40.04 128.24 23.80 -3.53 50.51 39.07 -2.48 49.42 39.24 coo 43.27 124.32 20.47 43.79 125.29 21.53 1.29 52.42 33.85 0.45 52.31 32.60 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 A 151 VAL B 281 VAL~? 14.69 O4 PO4 B 349 A 194 GLY A 293 GLY.? 20.64 O4 PO4 B 349 A 417 ILE A 80 ILE.? 15.35 C3 PG4 B 350 A 457 ALA A 81 ALA.? 10.40 C3 PG4 B 350 coo 60.43 93.31 8.03 62.16 94.30 8.93 -7.14 49.37 -3.63 -7.60 47.19 -3.44 coo 59.34 89.99 13.88 59.24 89.18 13.73 -15.25 51.43 -1.86 -14.91 51.02 -1.25 coo 39.61 128.90 22.54 40.04 128.24 23.80 0.88 54.97 37.41 1.44 55.29 38.70 coo 43.27 124.32 20.47 43.79 125.29 21.53 1.29 52.42 33.85 0.45 52.31 32.60 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 A 151 VAL C 218 VAL~? 16.70 O1 PG4 C 350 A 194 GLY C 250 GLY~? 15.20 C2 PG4 C 350 A 417 ILE A 36 ILE^? 18.49 O2 PO4 A 349 A 457 ALA A 34 ALA.? 19.56 O1 PO4 A 349 coo 60.43 93.31 8.03 62.16 94.30 8.93 -28.78 21.64 39.37 -29.76 23.61 39.33 coo 59.34 89.99 13.88 59.24 89.18 13.73 -34.85 24.44 43.72 -34.85 25.15 43.35 coo 39.61 128.90 22.54 40.04 128.24 23.80 -11.35 60.80 43.89 -10.68 60.59 42.66 coo 43.27 124.32 20.47 43.79 125.29 21.53 -17.06 58.68 42.33 -16.23 57.41 42.15 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 10 4 # 10 A 151 VAL C 300 VAL^? 15.63 O1 PO4 C 349 A 194 GLY C 302 GLY^? 15.82 O1 PO4 C 349 A 417 ILE A 40 ILE^? 22.69 O3 PG4 B 350 A 457 ALA A 10 ALA^? 23.10 O2 PO4 A 349 coo 60.43 93.31 8.03 62.16 94.30 8.93 -38.52 37.72 33.24 -40.61 37.11 32.94 coo 59.34 89.99 13.88 59.24 89.18 13.73 -38.20 38.03 27.59 -38.48 37.54 28.20 coo 39.61 128.90 22.54 40.04 128.24 23.80 -1.30 57.07 46.35 -1.49 55.97 47.14 coo 43.27 124.32 20.47 43.79 125.29 21.53 -7.72 56.24 46.31 -7.04 55.58 47.47 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 11 4 # 11 A 151 VAL D 77 VAL^? 18.45 O1 PO4 D 349 A 194 GLY D 79 GLY.? 15.17 O2 PO4 D 349 A 417 ILE C 21 ILE.? 14.37 C5 PG4 D 350 A 457 ALA C 81 ALA.? 9.82 C5 PG4 D 350 coo 60.43 93.31 8.03 62.16 94.30 8.93 -48.31 5.62 67.72 -49.86 7.16 67.64 coo 59.34 89.99 13.88 59.24 89.18 13.73 -44.38 10.12 68.07 -43.71 9.75 67.85 coo 39.61 128.90 22.54 40.04 128.24 23.80 -54.26 10.44 25.68 -55.39 9.48 25.57 coo 43.27 124.32 20.47 43.79 125.29 21.53 -51.31 8.31 29.27 -50.61 9.39 30.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 12 4 # 12 A 151 VAL D 77 VAL^? 18.45 O1 PO4 D 349 A 194 GLY D 79 GLY.? 15.17 O2 PO4 D 349 A 417 ILE C 80 ILE.? 14.76 C5 PG4 D 350 A 457 ALA C 81 ALA.? 9.82 C5 PG4 D 350 coo 60.43 93.31 8.03 62.16 94.30 8.93 -48.31 5.62 67.72 -49.86 7.16 67.64 coo 59.34 89.99 13.88 59.24 89.18 13.73 -44.38 10.12 68.07 -43.71 9.75 67.85 coo 39.61 128.90 22.54 40.04 128.24 23.80 -50.92 7.07 25.05 -51.42 6.14 24.06 coo 43.27 124.32 20.47 43.79 125.29 21.53 -51.31 8.31 29.27 -50.61 9.39 30.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 13 4 # 13 A 151 VAL D 281 VAL~? 14.65 O4 PO4 D 349 A 194 GLY C 293 GLY~? 20.66 O4 PO4 D 349 A 417 ILE C 78 ILE^? 13.09 O3 PG4 D 350 A 457 ALA C 81 ALA.? 9.82 C5 PG4 D 350 coo 60.43 93.31 8.03 62.16 94.30 8.93 -45.53 38.66 52.84 -44.75 37.36 54.45 coo 59.34 89.99 13.88 59.24 89.18 13.73 -37.76 39.68 49.36 -37.98 38.91 49.39 coo 39.61 128.90 22.54 40.04 128.24 23.80 -45.84 3.81 27.27 -46.71 2.92 28.12 coo 43.27 124.32 20.47 43.79 125.29 21.53 -51.31 8.31 29.27 -50.61 9.39 30.07 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 14 4 # 14 A 151 VAL D 281 VAL~? 14.65 O4 PO4 D 349 A 194 GLY C 293 GLY~? 20.66 O4 PO4 D 349 A 417 ILE C 80 ILE.? 14.76 C5 PG4 D 350 A 457 ALA C 81 ALA.? 9.82 C5 PG4 D 350 coo 60.43 93.31 8.03 62.16 94.30 8.93 -45.53 38.66 52.84 -44.75 37.36 54.45 coo 59.34 89.99 13.88 59.24 89.18 13.73 -37.76 39.68 49.36 -37.98 38.91 49.39 coo 39.61 128.90 22.54 40.04 128.24 23.80 -50.92 7.07 25.05 -51.42 6.14 24.06 coo 43.27 124.32 20.47 43.79 125.29 21.53 -51.31 8.31 29.27 -50.61 9.39 30.07 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 14 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL A 132 VAL.? 13.34 C6 PG4 B 350 B 194 GLY A 189 GLY~? 8.76 O1 PO4 A 349 B 417 ILE B 55 ILE.? 14.16 O3 PO4 B 349 B 457 ALA B 27 ALA~? 7.73 O3 PO4 B 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -10.07 45.98 33.36 -10.51 48.12 33.74 coo 50.40 126.23 20.48 50.46 127.00 20.75 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 68.38 85.45 19.33 67.41 85.52 20.41 0.89 19.37 -2.99 0.96 19.96 -1.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 0.57 24.81 3.25 0.35 26.08 4.04 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL A 132 VAL.? 13.34 C6 PG4 B 350 B 194 GLY A 199 GLY.? 14.09 O1 PG4 A 350 B 417 ILE B 55 ILE.? 14.16 O3 PO4 B 349 B 457 ALA B 27 ALA~? 7.73 O3 PO4 B 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -10.07 45.98 33.36 -10.51 48.12 33.74 coo 50.40 126.23 20.48 50.46 127.00 20.75 -17.17 48.70 27.51 -16.96 48.00 27.99 coo 68.38 85.45 19.33 67.41 85.52 20.41 0.89 19.37 -2.99 0.96 19.96 -1.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 0.57 24.81 3.25 0.35 26.08 4.04 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 B 151 VAL A 218 VAL~? 16.35 O1 PG4 A 350 B 194 GLY A 199 GLY.? 14.09 O1 PG4 A 350 B 417 ILE B 55 ILE.? 14.16 O3 PO4 B 349 B 457 ALA B 27 ALA~? 7.73 O3 PO4 B 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -21.92 48.09 19.23 -21.19 49.38 17.59 coo 50.40 126.23 20.48 50.46 127.00 20.75 -17.17 48.70 27.51 -16.96 48.00 27.99 coo 68.38 85.45 19.33 67.41 85.52 20.41 0.89 19.37 -2.99 0.96 19.96 -1.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 0.57 24.81 3.25 0.35 26.08 4.04 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 B 151 VAL A 273 VAL.? 17.09 O4 PO4 A 349 B 194 GLY B 293 GLY~? 20.43 O4 PO4 A 349 B 417 ILE B 55 ILE.? 14.16 O3 PO4 B 349 B 457 ALA B 27 ALA~? 7.73 O3 PO4 B 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 7.08 61.83 12.64 6.21 59.81 12.76 coo 50.40 126.23 20.48 50.46 127.00 20.75 2.42 62.24 4.78 2.23 61.74 5.37 coo 68.38 85.45 19.33 67.41 85.52 20.41 0.89 19.37 -2.99 0.96 19.96 -1.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 0.57 24.81 3.25 0.35 26.08 4.04 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 B 151 VAL A 281 VAL~? 14.54 O4 PO4 A 349 B 194 GLY B 293 GLY~? 20.43 O4 PO4 A 349 B 417 ILE B 55 ILE.? 14.16 O3 PO4 B 349 B 457 ALA B 27 ALA~? 7.73 O3 PO4 B 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -5.43 63.60 7.64 -4.70 63.98 9.68 coo 50.40 126.23 20.48 50.46 127.00 20.75 2.42 62.24 4.78 2.23 61.74 5.37 coo 68.38 85.45 19.33 67.41 85.52 20.41 0.89 19.37 -2.99 0.96 19.96 -1.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 0.57 24.81 3.25 0.35 26.08 4.04 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 B 151 VAL A 281 VAL~? 14.54 O4 PO4 A 349 B 194 GLY B 293 GLY~? 20.43 O4 PO4 A 349 B 417 ILE B 78 ILE^? 13.34 C5 PG4 A 350 B 457 ALA B 81 ALA.? 10.90 C4 PG4 A 350 coo 52.95 126.71 13.21 51.34 125.24 13.19 -5.43 63.60 7.64 -4.70 63.98 9.68 coo 50.40 126.23 20.48 50.46 127.00 20.75 2.42 62.24 4.78 2.23 61.74 5.37 coo 68.38 85.45 19.33 67.41 85.52 20.41 -3.37 20.99 14.93 -4.42 21.03 15.99 coo 65.50 91.13 17.77 64.65 89.88 18.00 -9.22 24.44 12.09 -8.53 25.77 12.01 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 B 151 VAL B 75 VAL^? 22.07 O4 PG4 A 350 B 194 GLY B 102 GLY.? 25.81 O4 PG4 A 350 B 417 ILE C 36 ILE^? 18.54 O4 PO4 C 349 B 457 ALA C 34 ALA.? 19.28 O2 PO4 C 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 5.16 14.94 16.13 6.27 16.82 16.26 coo 50.40 126.23 20.48 50.46 127.00 20.75 5.13 9.24 22.93 4.64 9.48 22.34 coo 68.38 85.45 19.33 67.41 85.52 20.41 -39.24 6.90 15.57 -39.97 7.67 16.46 coo 65.50 91.13 17.77 64.65 89.88 18.00 -33.62 7.75 17.77 -34.37 7.21 18.99 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 B 151 VAL B 77 VAL^? 18.07 O1 PO4 B 349 B 194 GLY B 79 GLY.? 14.35 O1 PO4 B 349 B 417 ILE A 21 ILE.? 14.60 C3 PG4 B 350 B 457 ALA A 81 ALA.? 10.40 C3 PG4 B 350 coo 52.95 126.71 13.21 51.34 125.24 13.19 0.92 18.88 13.75 2.48 19.98 12.65 coo 50.40 126.23 20.48 50.46 127.00 20.75 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 68.38 85.45 19.33 67.41 85.52 20.41 3.71 56.69 34.01 4.81 56.28 34.79 coo 65.50 91.13 17.77 64.65 89.88 18.00 1.29 52.42 33.85 0.45 52.31 32.60 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 B 151 VAL B 106 VAL^? 16.38 O4 PG4 A 350 B 194 GLY B 108 GLY.? 11.44 C5 PG4 A 350 B 417 ILE C 36 ILE^? 18.54 O4 PO4 C 349 B 457 ALA C 34 ALA.? 19.28 O2 PO4 C 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 2.26 21.28 17.40 3.92 21.88 16.12 coo 50.40 126.23 20.48 50.46 127.00 20.75 -1.45 26.58 15.61 -2.07 26.26 16.03 coo 68.38 85.45 19.33 67.41 85.52 20.41 -39.24 6.90 15.57 -39.97 7.67 16.46 coo 65.50 91.13 17.77 64.65 89.88 18.00 -33.62 7.75 17.77 -34.37 7.21 18.99 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 10 4 # 10 B 151 VAL B 132 VAL.? 12.49 C8 PG4 A 350 B 194 GLY B 189 GLY~? 8.50 O2 PO4 B 349 B 417 ILE A 55 ILE.? 14.03 O2 PO4 A 349 B 457 ALA A 27 ALA~? 7.49 O2 PO4 A 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 2.43 28.48 18.14 2.79 27.81 16.06 coo 50.40 126.23 20.48 50.46 127.00 20.75 1.22 33.78 11.00 2.03 33.50 11.09 coo 68.38 85.45 19.33 67.41 85.52 20.41 -7.50 68.60 37.99 -7.75 67.19 37.66 coo 65.50 91.13 17.77 64.65 89.88 18.00 -8.59 61.44 33.66 -8.54 60.49 32.47 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 11 4 # 11 B 151 VAL B 273 VAL.? 17.21 O4 PO4 B 349 B 194 GLY A 293 GLY.? 20.64 O4 PO4 B 349 B 417 ILE A 55 ILE.? 14.03 O2 PO4 A 349 B 457 ALA A 27 ALA~? 7.49 O2 PO4 A 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -18.50 43.50 0.88 -17.27 43.86 2.67 coo 50.40 126.23 20.48 50.46 127.00 20.75 -15.25 51.43 -1.86 -14.91 51.02 -1.25 coo 68.38 85.45 19.33 67.41 85.52 20.41 -7.50 68.60 37.99 -7.75 67.19 37.66 coo 65.50 91.13 17.77 64.65 89.88 18.00 -8.59 61.44 33.66 -8.54 60.49 32.47 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 12 4 # 12 B 151 VAL B 281 VAL~? 14.69 O4 PO4 B 349 B 194 GLY A 293 GLY.? 20.64 O4 PO4 B 349 B 417 ILE A 55 ILE.? 14.03 O2 PO4 A 349 B 457 ALA A 27 ALA~? 7.49 O2 PO4 A 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -7.14 49.37 -3.63 -7.60 47.19 -3.44 coo 50.40 126.23 20.48 50.46 127.00 20.75 -15.25 51.43 -1.86 -14.91 51.02 -1.25 coo 68.38 85.45 19.33 67.41 85.52 20.41 -7.50 68.60 37.99 -7.75 67.19 37.66 coo 65.50 91.13 17.77 64.65 89.88 18.00 -8.59 61.44 33.66 -8.54 60.49 32.47 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 13 4 # 13 B 151 VAL C 218 VAL~? 16.70 O1 PG4 C 350 B 194 GLY C 199 GLY.? 14.01 O1 PG4 C 350 B 417 ILE D 55 ILE.? 15.06 O2 PO4 D 349 B 457 ALA D 27 ALA~? 8.25 O2 PO4 D 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -28.78 21.64 39.37 -29.76 23.61 39.33 coo 50.40 126.23 20.48 50.46 127.00 20.75 -32.88 14.56 34.60 -33.00 13.70 34.89 coo 68.38 85.45 19.33 67.41 85.52 20.41 -48.60 18.74 78.07 -48.68 18.23 76.71 coo 65.50 91.13 17.77 64.65 89.88 18.00 -48.66 17.60 69.69 -48.49 17.70 68.18 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 14 4 # 14 B 151 VAL C 218 VAL~? 16.70 O1 PG4 C 350 B 194 GLY C 250 GLY~? 15.20 C2 PG4 C 350 B 417 ILE A 36 ILE^? 18.49 O2 PO4 A 349 B 457 ALA A 34 ALA.? 19.56 O1 PO4 A 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -28.78 21.64 39.37 -29.76 23.61 39.33 coo 50.40 126.23 20.48 50.46 127.00 20.75 -34.85 24.44 43.72 -34.85 25.15 43.35 coo 68.38 85.45 19.33 67.41 85.52 20.41 -11.35 60.80 43.89 -10.68 60.59 42.66 coo 65.50 91.13 17.77 64.65 89.88 18.00 -17.06 58.68 42.33 -16.23 57.41 42.15 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 15 4 # 15 B 151 VAL C 340 VAL~? 19.51 O1 PO4 C 349 B 194 GLY C 302 GLY^? 15.82 O1 PO4 C 349 B 417 ILE A 55 ILE.? 14.03 O2 PO4 A 349 B 457 ALA A 27 ALA~? 7.49 O2 PO4 A 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -33.29 37.43 20.49 -35.01 38.51 19.58 coo 50.40 126.23 20.48 50.46 127.00 20.75 -38.20 38.03 27.59 -38.48 37.54 28.20 coo 68.38 85.45 19.33 67.41 85.52 20.41 -7.50 68.60 37.99 -7.75 67.19 37.66 coo 65.50 91.13 17.77 64.65 89.88 18.00 -8.59 61.44 33.66 -8.54 60.49 32.47 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 16 4 # 16 B 151 VAL D 77 VAL^? 18.45 O1 PO4 D 349 B 194 GLY D 79 GLY.? 15.17 O2 PO4 D 349 B 417 ILE C 21 ILE.? 14.37 C5 PG4 D 350 B 457 ALA C 81 ALA.? 9.82 C5 PG4 D 350 coo 52.95 126.71 13.21 51.34 125.24 13.19 -48.31 5.62 67.72 -49.86 7.16 67.64 coo 50.40 126.23 20.48 50.46 127.00 20.75 -44.38 10.12 68.07 -43.71 9.75 67.85 coo 68.38 85.45 19.33 67.41 85.52 20.41 -54.26 10.44 25.68 -55.39 9.48 25.57 coo 65.50 91.13 17.77 64.65 89.88 18.00 -51.31 8.31 29.27 -50.61 9.39 30.07 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 17 4 # 17 B 151 VAL D 132 VAL.? 13.27 C6 PG4 C 350 B 194 GLY D 189 GLY~? 8.43 O1 PO4 D 349 B 417 ILE C 55 ILE.? 13.72 O4 PO4 C 349 B 457 ALA C 27 ALA~? 7.42 O4 PO4 C 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -50.38 7.90 57.55 -50.66 9.13 59.37 coo 50.40 126.23 20.48 50.46 127.00 20.75 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 68.38 85.45 19.33 67.41 85.52 20.41 -44.93 15.77 13.26 -44.55 15.34 14.57 coo 65.50 91.13 17.77 64.65 89.88 18.00 -43.00 15.18 21.21 -42.97 15.63 22.69 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 18 4 # 18 B 151 VAL D 132 VAL.? 13.27 C6 PG4 C 350 B 194 GLY D 199 GLY.? 13.68 O5 PG4 D 350 B 417 ILE C 55 ILE.? 13.72 O4 PO4 C 349 B 457 ALA C 27 ALA~? 7.42 O4 PO4 C 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -50.38 7.90 57.55 -50.66 9.13 59.37 coo 50.40 126.23 20.48 50.46 127.00 20.75 -57.03 13.69 56.19 -56.77 12.88 56.00 coo 68.38 85.45 19.33 67.41 85.52 20.41 -44.93 15.77 13.26 -44.55 15.34 14.57 coo 65.50 91.13 17.77 64.65 89.88 18.00 -43.00 15.18 21.21 -42.97 15.63 22.69 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 19 4 # 19 B 151 VAL D 273 VAL.? 17.16 O4 PO4 D 349 B 194 GLY C 293 GLY~? 20.66 O4 PO4 D 349 B 417 ILE A 61 ILE^? 22.05 O2 PO4 A 349 B 457 ALA A 38 ALA^? 24.00 O2 PO4 A 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -33.05 33.35 54.03 -34.09 31.93 52.71 coo 50.40 126.23 20.48 50.46 127.00 20.75 -37.76 39.68 49.36 -37.98 38.91 49.39 coo 68.38 85.45 19.33 67.41 85.52 20.41 -1.11 64.78 46.73 -0.65 65.19 45.43 coo 65.50 91.13 17.77 64.65 89.88 18.00 -6.82 60.44 47.96 -6.30 59.52 49.08 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 20 4 # 20 B 151 VAL D 273 VAL.? 17.16 O4 PO4 D 349 B 194 GLY C 293 GLY~? 20.66 O4 PO4 D 349 B 417 ILE C 55 ILE.? 13.72 O4 PO4 C 349 B 457 ALA C 27 ALA~? 7.42 O4 PO4 C 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -33.05 33.35 54.03 -34.09 31.93 52.71 coo 50.40 126.23 20.48 50.46 127.00 20.75 -37.76 39.68 49.36 -37.98 38.91 49.39 coo 68.38 85.45 19.33 67.41 85.52 20.41 -44.93 15.77 13.26 -44.55 15.34 14.57 coo 65.50 91.13 17.77 64.65 89.88 18.00 -43.00 15.18 21.21 -42.97 15.63 22.69 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 21 4 # 21 B 151 VAL D 281 VAL~? 14.65 O4 PO4 D 349 B 194 GLY C 293 GLY~? 20.66 O4 PO4 D 349 B 417 ILE C 55 ILE.? 13.72 O4 PO4 C 349 B 457 ALA C 27 ALA~? 7.42 O4 PO4 C 349 coo 52.95 126.71 13.21 51.34 125.24 13.19 -45.53 38.66 52.84 -44.75 37.36 54.45 coo 50.40 126.23 20.48 50.46 127.00 20.75 -37.76 39.68 49.36 -37.98 38.91 49.39 coo 68.38 85.45 19.33 67.41 85.52 20.41 -44.93 15.77 13.26 -44.55 15.34 14.57 coo 65.50 91.13 17.77 64.65 89.88 18.00 -43.00 15.18 21.21 -42.97 15.63 22.69 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 22 4 # 22 B 151 VAL D 281 VAL~? 14.65 O4 PO4 D 349 B 194 GLY C 293 GLY~? 20.66 O4 PO4 D 349 B 417 ILE C 78 ILE^? 13.09 O3 PG4 D 350 B 457 ALA C 81 ALA.? 9.82 C5 PG4 D 350 coo 52.95 126.71 13.21 51.34 125.24 13.19 -45.53 38.66 52.84 -44.75 37.36 54.45 coo 50.40 126.23 20.48 50.46 127.00 20.75 -37.76 39.68 49.36 -37.98 38.91 49.39 coo 68.38 85.45 19.33 67.41 85.52 20.41 -45.84 3.81 27.27 -46.71 2.92 28.12 coo 65.50 91.13 17.77 64.65 89.88 18.00 -51.31 8.31 29.27 -50.61 9.39 30.07 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 22 hits 1pix_c01 naa= 4 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 457 ALA A 175 ALA~? 17.35 O1 PO4 A 349 A 458 ALA A 176 ALA~? 18.28 O1 PO4 A 349 B 193 ALA A 338 ALA~? 14.94 O1 PO4 A 349 B 194 GLY A 337 GLY~? 17.24 O2 PO4 A 349 coo 43.27 124.32 20.47 43.79 125.29 21.53 -24.81 67.41 24.63 -24.01 68.06 23.54 coo 39.57 123.53 20.89 38.42 124.25 20.20 -27.00 64.71 23.01 -26.51 63.43 22.36 coo 47.95 129.15 20.31 47.81 128.95 18.79 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 50.40 126.23 20.48 50.46 127.00 20.75 -19.69 73.64 23.95 -19.01 73.56 23.47 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 457 ALA A 318 ALA~? 17.89 O4 PO4 A 349 A 458 ALA A 320 ALA~? 23.05 O4 PO4 A 349 B 193 ALA A 262 ALA.? 14.15 O4 PO4 A 349 B 194 GLY A 263 GLY.? 15.67 O4 PO4 A 349 coo 43.27 124.32 20.47 43.79 125.29 21.53 -6.76 78.87 15.90 -6.16 78.10 17.06 coo 39.57 123.53 20.89 38.42 124.25 20.20 -10.88 80.11 12.63 -10.83 81.63 12.81 coo 47.95 129.15 20.31 47.81 128.95 18.79 -3.81 73.23 18.07 -4.57 74.45 18.58 coo 50.40 126.23 20.48 50.46 127.00 20.75 -0.26 73.98 16.89 -0.52 73.23 16.93 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 457 ALA B 175 ALA~? 17.30 O2 PO4 B 349 A 458 ALA B 176 ALA~? 18.30 O2 PO4 B 349 B 193 ALA B 338 ALA~? 14.85 O2 PO4 B 349 B 194 GLY B 337 GLY~? 16.94 O3 PO4 B 349 coo 43.27 124.32 20.47 43.79 125.29 21.53 14.10 34.75 -6.58 13.02 35.55 -7.27 coo 39.57 123.53 20.89 38.42 124.25 20.20 16.22 37.28 -4.66 15.77 38.11 -3.49 coo 47.95 129.15 20.31 47.81 128.95 18.79 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 50.40 126.23 20.48 50.46 127.00 20.75 8.09 33.07 -11.69 7.39 33.52 -11.68 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 457 ALA B 318 ALA~? 17.72 O4 PO4 B 349 A 458 ALA B 315 ALA~? 17.89 O3 PO4 B 349 B 193 ALA B 262 ALA.? 14.24 O4 PO4 B 349 B 194 GLY B 263 GLY.? 15.67 O4 PO4 B 349 coo 43.27 124.32 20.47 43.79 125.29 21.53 -5.89 38.26 -16.81 -6.24 37.24 -15.74 coo 39.57 123.53 20.89 38.42 124.25 20.20 -4.15 33.50 -16.84 -3.20 32.43 -16.31 coo 47.95 129.15 20.31 47.81 128.95 18.79 -8.15 37.18 -10.66 -7.46 36.53 -11.87 coo 50.40 126.23 20.48 50.46 127.00 20.75 -11.92 37.68 -11.02 -11.58 37.84 -10.33 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 457 ALA C 175 ALA~? 17.02 O2 PG4 A 350 A 458 ALA C 176 ALA~? 15.03 O2 PG4 A 350 B 193 ALA C 338 ALA~? 14.81 O2 PO4 C 349 B 194 GLY C 337 GLY~? 17.12 O2 PO4 C 349 coo 43.27 124.32 20.47 43.79 125.29 21.53 -28.16 28.46 20.32 -29.18 29.57 20.45 coo 39.57 123.53 20.89 38.42 124.25 20.20 -25.95 28.73 23.42 -26.39 28.45 24.83 coo 47.95 129.15 20.31 47.81 128.95 18.79 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 50.40 126.23 20.48 50.46 127.00 20.75 -34.47 31.36 16.09 -35.14 31.66 16.46 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 457 ALA C 318 ALA~? 17.77 O1 PO4 C 349 A 458 ALA C 315 ALA~? 17.93 O4 PO4 C 349 B 193 ALA C 262 ALA.? 14.18 O1 PO4 C 349 B 194 GLY C 263 GLY.? 15.64 O1 PO4 C 349 coo 43.27 124.32 20.47 43.79 125.29 21.53 -48.31 39.11 17.38 -48.73 37.65 17.44 coo 39.57 123.53 20.89 38.42 124.25 20.20 -46.99 35.68 13.73 -46.10 34.53 13.27 coo 47.95 129.15 20.31 47.81 128.95 18.79 -50.44 33.90 21.10 -49.80 34.39 19.83 coo 50.40 126.23 20.48 50.46 127.00 20.75 -54.20 34.53 21.28 -53.83 34.17 21.88 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 457 ALA D 175 ALA~? 17.45 O1 PO4 D 349 A 458 ALA D 176 ALA~? 18.20 O1 PO4 D 349 B 193 ALA D 338 ALA~? 15.02 O1 PO4 D 349 B 194 GLY D 337 GLY~? 16.88 O2 PO4 D 349 coo 43.27 124.32 20.47 43.79 125.29 21.53 -64.41 28.74 68.50 -63.57 30.01 68.35 coo 39.57 123.53 20.89 38.42 124.25 20.20 -66.56 28.54 65.37 -66.10 28.17 63.98 coo 47.95 129.15 20.31 47.81 128.95 18.79 -59.57 33.12 68.34 -59.94 31.78 67.75 coo 50.40 126.23 20.48 50.46 127.00 20.75 -58.47 33.44 71.99 -57.91 33.83 71.55 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 A 457 ALA D 318 ALA~? 17.72 O4 PO4 D 349 A 458 ALA D 315 ALA~? 17.83 O2 PO4 D 349 B 193 ALA D 262 ALA.? 14.16 O4 PO4 D 349 B 194 GLY D 263 GLY.? 15.57 O4 PO4 D 349 coo 43.27 124.32 20.47 43.79 125.29 21.53 -46.09 42.95 69.61 -45.44 41.57 69.77 coo 39.57 123.53 20.89 38.42 124.25 20.20 -46.93 39.91 73.63 -47.63 38.72 74.27 coo 47.95 129.15 20.31 47.81 128.95 18.79 -43.19 37.69 66.65 -43.90 38.22 67.91 coo 50.40 126.23 20.48 50.46 127.00 20.75 -39.54 38.74 66.34 -39.84 38.31 65.76 1pix_c02 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 8 hits 1pix_c02 naa= 4 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 193 ALA A 262 ALA.? 14.15 O4 PO4 A 349 A 194 GLY A 263 GLY.? 15.67 O4 PO4 A 349 B 457 ALA A 318 ALA~? 17.89 O4 PO4 A 349 B 458 ALA A 320 ALA~? 23.05 O4 PO4 A 349 coo 61.89 87.20 13.50 62.59 88.00 12.38 -3.81 73.23 18.07 -4.57 74.45 18.58 coo 59.34 89.99 13.88 59.24 89.18 13.73 -0.26 73.98 16.89 -0.52 73.23 16.93 coo 65.50 91.13 17.77 64.65 89.88 18.00 -6.76 78.87 15.90 -6.16 78.10 17.06 coo 68.56 91.15 20.03 69.95 90.68 19.64 -10.88 80.11 12.63 -10.83 81.63 12.81 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 193 ALA A 338 ALA~? 14.94 O1 PO4 A 349 A 194 GLY A 337 GLY~? 17.24 O2 PO4 A 349 B 457 ALA A 175 ALA~? 17.35 O1 PO4 A 349 B 458 ALA A 176 ALA~? 18.28 O1 PO4 A 349 coo 61.89 87.20 13.50 62.59 88.00 12.38 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 59.34 89.99 13.88 59.24 89.18 13.73 -19.69 73.64 23.95 -19.01 73.56 23.47 coo 65.50 91.13 17.77 64.65 89.88 18.00 -24.81 67.41 24.63 -24.01 68.06 23.54 coo 68.56 91.15 20.03 69.95 90.68 19.64 -27.00 64.71 23.01 -26.51 63.43 22.36 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 193 ALA B 262 ALA.? 14.24 O4 PO4 B 349 A 194 GLY B 263 GLY.? 15.67 O4 PO4 B 349 B 457 ALA B 318 ALA~? 17.72 O4 PO4 B 349 B 458 ALA B 315 ALA~? 17.89 O3 PO4 B 349 coo 61.89 87.20 13.50 62.59 88.00 12.38 -8.15 37.18 -10.66 -7.46 36.53 -11.87 coo 59.34 89.99 13.88 59.24 89.18 13.73 -11.92 37.68 -11.02 -11.58 37.84 -10.33 coo 65.50 91.13 17.77 64.65 89.88 18.00 -5.89 38.26 -16.81 -6.24 37.24 -15.74 coo 68.56 91.15 20.03 69.95 90.68 19.64 -4.15 33.50 -16.84 -3.20 32.43 -16.31 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 193 ALA B 338 ALA~? 14.85 O2 PO4 B 349 A 194 GLY B 337 GLY~? 16.94 O3 PO4 B 349 B 457 ALA B 175 ALA~? 17.30 O2 PO4 B 349 B 458 ALA B 176 ALA~? 18.30 O2 PO4 B 349 coo 61.89 87.20 13.50 62.59 88.00 12.38 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 59.34 89.99 13.88 59.24 89.18 13.73 8.09 33.07 -11.69 7.39 33.52 -11.68 coo 65.50 91.13 17.77 64.65 89.88 18.00 14.10 34.75 -6.58 13.02 35.55 -7.27 coo 68.56 91.15 20.03 69.95 90.68 19.64 16.22 37.28 -4.66 15.77 38.11 -3.49 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 193 ALA C 262 ALA.? 14.18 O1 PO4 C 349 A 194 GLY C 263 GLY.? 15.64 O1 PO4 C 349 B 457 ALA C 318 ALA~? 17.77 O1 PO4 C 349 B 458 ALA C 315 ALA~? 17.93 O4 PO4 C 349 coo 61.89 87.20 13.50 62.59 88.00 12.38 -50.44 33.90 21.10 -49.80 34.39 19.83 coo 59.34 89.99 13.88 59.24 89.18 13.73 -54.20 34.53 21.28 -53.83 34.17 21.88 coo 65.50 91.13 17.77 64.65 89.88 18.00 -48.31 39.11 17.38 -48.73 37.65 17.44 coo 68.56 91.15 20.03 69.95 90.68 19.64 -46.99 35.68 13.73 -46.10 34.53 13.27 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 193 ALA C 338 ALA~? 14.81 O2 PO4 C 349 A 194 GLY C 337 GLY~? 17.12 O2 PO4 C 349 B 457 ALA C 175 ALA~? 17.02 O2 PG4 A 350 B 458 ALA C 176 ALA~? 15.03 O2 PG4 A 350 coo 61.89 87.20 13.50 62.59 88.00 12.38 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 59.34 89.99 13.88 59.24 89.18 13.73 -34.47 31.36 16.09 -35.14 31.66 16.46 coo 65.50 91.13 17.77 64.65 89.88 18.00 -28.16 28.46 20.32 -29.18 29.57 20.45 coo 68.56 91.15 20.03 69.95 90.68 19.64 -25.95 28.73 23.42 -26.39 28.45 24.83 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 193 ALA D 262 ALA.? 14.16 O4 PO4 D 349 A 194 GLY D 263 GLY.? 15.57 O4 PO4 D 349 B 457 ALA D 318 ALA~? 17.72 O4 PO4 D 349 B 458 ALA D 315 ALA~? 17.83 O2 PO4 D 349 coo 61.89 87.20 13.50 62.59 88.00 12.38 -43.19 37.69 66.65 -43.90 38.22 67.91 coo 59.34 89.99 13.88 59.24 89.18 13.73 -39.54 38.74 66.34 -39.84 38.31 65.76 coo 65.50 91.13 17.77 64.65 89.88 18.00 -46.09 42.95 69.61 -45.44 41.57 69.77 coo 68.56 91.15 20.03 69.95 90.68 19.64 -46.93 39.91 73.63 -47.63 38.72 74.27 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 A 193 ALA D 338 ALA~? 15.02 O1 PO4 D 349 A 194 GLY D 337 GLY~? 16.88 O2 PO4 D 349 B 457 ALA D 175 ALA~? 17.45 O1 PO4 D 349 B 458 ALA D 176 ALA~? 18.20 O1 PO4 D 349 coo 61.89 87.20 13.50 62.59 88.00 12.38 -59.57 33.12 68.34 -59.94 31.78 67.75 coo 59.34 89.99 13.88 59.24 89.18 13.73 -58.47 33.44 71.99 -57.91 33.83 71.55 coo 65.50 91.13 17.77 64.65 89.88 18.00 -64.41 28.74 68.50 -63.57 30.01 68.35 coo 68.56 91.15 20.03 69.95 90.68 19.64 -66.56 28.54 65.37 -66.10 28.17 63.98 1pix_c03 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 8 hits 1pix_c03 naa= 4 ULMN 4 1qj4_c01 HYDROXYNITRILE LYASE user 1 4 # 1 A 11 THR A 242 THR.? 14.16 O1 PG4 B 350 A 80 SER A 241 SER.? 9.98 O3 PO4 A 349 A 207 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 235 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 12.22 47.74 12.94 13.22 49.24 14.10 -3.11 49.78 15.72 -2.58 47.68 15.65 coo 15.54 46.73 17.13 17.06 48.44 16.17 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 23.60 50.31 20.82 21.66 50.51 20.06 -1.16 62.88 18.52 0.68 62.16 19.33 coo 20.17 51.16 17.08 18.31 50.28 17.44 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 4 1qj4_c01 HYDROXYNITRILE LYASE user 2 4 # 2 A 11 THR B 242 THR.? 14.01 C2 PG4 A 350 A 80 SER B 241 SER.? 10.02 O1 PO4 B 349 A 207 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 235 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 12.22 47.74 12.94 13.22 49.24 14.10 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 15.54 46.73 17.13 17.06 48.44 16.17 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 23.60 50.31 20.82 21.66 50.51 20.06 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 20.17 51.16 17.08 18.31 50.28 17.44 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 4 1qj4_c01 HYDROXYNITRILE LYASE user 3 4 # 3 A 11 THR C 242 THR.? 14.00 O5 PG4 D 350 A 80 SER C 241 SER.? 9.97 O3 PO4 C 349 A 207 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 235 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 12.22 47.74 12.94 13.22 49.24 14.10 -47.88 22.66 41.54 -48.06 21.40 43.36 coo 15.54 46.73 17.13 17.06 48.44 16.17 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 23.60 50.31 20.82 21.66 50.51 20.06 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 20.17 51.16 17.08 18.31 50.28 17.44 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 4 1qj4_c01 HYDROXYNITRILE LYASE user 4 4 # 4 A 11 THR D 242 THR.? 14.33 O2 PG4 C 350 A 80 SER D 241 SER.? 10.08 O3 PO4 D 349 A 207 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 235 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 12.22 47.74 12.94 13.22 49.24 14.10 -43.74 23.47 47.95 -43.28 22.17 46.24 coo 15.54 46.73 17.13 17.06 48.44 16.17 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 23.60 50.31 20.82 21.66 50.51 20.06 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 20.17 51.16 17.08 18.31 50.28 17.44 -38.74 26.41 54.26 -37.48 24.84 54.87 1qj4_c01 source 1qj4 HYDROXYNITRILE LYASE : 4 hits 1qj4_c01 naa= 4 ULMN 4 1qrz_c04 PLASMINOGEN user 1 4 # 1 A 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 741 SER B 235 SER.? 9.35 O4 PO4 B 349 A 742 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -6.73 42.81 4.19 -8.03 43.03 2.17 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1qrz_c04 PLASMINOGEN user 2 4 # 2 A 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 741 SER D 235 SER.? 9.32 O4 PO4 D 349 A 742 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -44.15 28.59 53.58 -43.17 30.60 54.60 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -44.87 24.99 54.53 -45.43 25.38 54.91 1qrz_c04 source 1qrz PLASMINOGEN : 2 hits 1qrz_c04 naa= 4 ULMN 4 1qrz_c05 PLASMINOGEN user 1 4 # 1 B 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 741 SER B 235 SER.? 9.35 O4 PO4 B 349 B 742 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -6.73 42.81 4.19 -8.03 43.03 2.17 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 -5.34 40.16 6.49 -4.85 40.15 5.88 1qrz_c05 source 1qrz PLASMINOGEN : 1 hits 1qrz_c05 naa= 4 ULMN 4 1qrz_c06 PLASMINOGEN user 1 4 # 1 C 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 C 741 SER B 235 SER.? 9.35 O4 PO4 B 349 C 742 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -6.73 42.81 4.19 -8.03 43.03 2.17 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1qrz_c06 PLASMINOGEN user 2 4 # 2 C 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 C 741 SER D 235 SER.? 9.32 O4 PO4 D 349 C 742 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -44.15 28.59 53.58 -43.17 30.60 54.60 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 -44.87 24.99 54.53 -45.43 25.38 54.91 1qrz_c06 source 1qrz PLASMINOGEN : 2 hits 1qrz_c06 naa= 4 ULMN 4 1qrz_c07 PLASMINOGEN user 1 4 # 1 D 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 741 SER B 235 SER.? 9.35 O4 PO4 B 349 D 742 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -6.73 42.81 4.19 -8.03 43.03 2.17 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1qrz_c07 PLASMINOGEN user 2 4 # 2 D 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 741 SER D 235 SER.? 9.32 O4 PO4 D 349 D 742 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -44.15 28.59 53.58 -43.17 30.60 54.60 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 -44.87 24.99 54.53 -45.43 25.38 54.91 1qrz_c07 source 1qrz PLASMINOGEN : 2 hits 1qrz_c07 naa= 4 ULMN 4 1r1j_c00 NEPRILYSIN user 1 4 # 1 A 584 GLU A 135 GLU.? -3.98 O1 PG4 A 350s A 650 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 711 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 717 ARG A 133 ARG.? 8.90 C3 PG4 B 350 coo 29.33 48.80 29.17 29.00 46.74 29.48 -10.19 39.37 24.45 -9.09 38.16 23.13 coo 38.62 44.38 31.99 36.86 43.62 32.96 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 31.96 38.97 33.59 30.29 39.94 32.77 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 36.26 41.03 36.49 33.98 42.25 34.87 -4.79 46.92 29.78 -3.00 49.36 29.13 ULMN 4 1r1j_c00 NEPRILYSIN user 2 4 # 2 A 584 GLU A 135 GLU.? -3.98 O1 PG4 A 350s A 650 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 711 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 717 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo 29.33 48.80 29.17 29.00 46.74 29.48 -10.19 39.37 24.45 -9.09 38.16 23.13 coo 38.62 44.38 31.99 36.86 43.62 32.96 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 31.96 38.97 33.59 30.29 39.94 32.77 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 36.26 41.03 36.49 33.98 42.25 34.87 -3.22 31.42 16.60 -5.11 31.22 14.14 ULMN 4 1r1j_c00 NEPRILYSIN user 3 4 # 3 A 584 GLU B 135 GLU.? -3.99 O5 PG4 B 350s A 650 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 711 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 717 ARG A 133 ARG.? 8.90 C3 PG4 B 350 coo 29.33 48.80 29.17 29.00 46.74 29.48 2.30 38.46 22.67 1.14 39.98 23.57 coo 38.62 44.38 31.99 36.86 43.62 32.96 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 31.96 38.97 33.59 30.29 39.94 32.77 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 36.26 41.03 36.49 33.98 42.25 34.87 -4.79 46.92 29.78 -3.00 49.36 29.13 ULMN 4 1r1j_c00 NEPRILYSIN user 4 4 # 4 A 584 GLU B 135 GLU.? -3.99 O5 PG4 B 350s A 650 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 711 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 717 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo 29.33 48.80 29.17 29.00 46.74 29.48 2.30 38.46 22.67 1.14 39.98 23.57 coo 38.62 44.38 31.99 36.86 43.62 32.96 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 31.96 38.97 33.59 30.29 39.94 32.77 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 36.26 41.03 36.49 33.98 42.25 34.87 -3.22 31.42 16.60 -5.11 31.22 14.14 ULMN 4 1r1j_c00 NEPRILYSIN user 5 4 # 5 A 584 GLU C 135 GLU.? -3.67 O1 PG4 C 350s A 650 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 711 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 717 ARG C 133 ARG.? 8.69 C6 PG4 D 350 coo 29.33 48.80 29.17 29.00 46.74 29.48 -38.59 10.74 44.23 -39.39 10.87 46.20 coo 38.62 44.38 31.99 36.86 43.62 32.96 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 31.96 38.97 33.59 30.29 39.94 32.77 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 36.26 41.03 36.49 33.98 42.25 34.87 -44.64 9.69 35.41 -46.86 11.41 34.11 ULMN 4 1r1j_c00 NEPRILYSIN user 6 4 # 6 A 584 GLU C 135 GLU.? -3.67 O1 PG4 C 350s A 650 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 711 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 717 ARG D 133 ARG.? 8.84 C4 PG4 C 350 coo 29.33 48.80 29.17 29.00 46.74 29.48 -38.59 10.74 44.23 -39.39 10.87 46.20 coo 38.62 44.38 31.99 36.86 43.62 32.96 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 31.96 38.97 33.59 30.29 39.94 32.77 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 36.26 41.03 36.49 33.98 42.25 34.87 -45.06 11.05 55.96 -43.37 13.22 57.41 ULMN 4 1r1j_c00 NEPRILYSIN user 7 4 # 7 A 584 GLU D 135 GLU.? -4.27 C8 PG4 D 350s A 650 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 711 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 717 ARG C 133 ARG.? 8.69 C6 PG4 D 350 coo 29.33 48.80 29.17 29.00 46.74 29.48 -50.80 9.98 46.92 -49.80 10.03 45.07 coo 38.62 44.38 31.99 36.86 43.62 32.96 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 31.96 38.97 33.59 30.29 39.94 32.77 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 36.26 41.03 36.49 33.98 42.25 34.87 -44.64 9.69 35.41 -46.86 11.41 34.11 ULMN 4 1r1j_c00 NEPRILYSIN user 8 4 # 8 A 584 GLU D 135 GLU.? -4.27 C8 PG4 D 350s A 650 ASP D 131 ASP^? 9.77 C6 PG4 C 350 A 711 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 717 ARG D 133 ARG.? 8.84 C4 PG4 C 350 coo 29.33 48.80 29.17 29.00 46.74 29.48 -50.80 9.98 46.92 -49.80 10.03 45.07 coo 38.62 44.38 31.99 36.86 43.62 32.96 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 31.96 38.97 33.59 30.29 39.94 32.77 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 36.26 41.03 36.49 33.98 42.25 34.87 -45.06 11.05 55.96 -43.37 13.22 57.41 ULMN 4 1r1j_c00 NEPRILYSIN user 9 4 # 9 A 584 GLU D 135 GLU.? -4.27 C8 PG4 D 350s A 650 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 711 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 717 ARG D 133 ARG.? 8.84 C4 PG4 C 350 coo 29.33 48.80 29.17 29.00 46.74 29.48 -50.80 9.98 46.92 -49.80 10.03 45.07 coo 38.62 44.38 31.99 36.86 43.62 32.96 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 31.96 38.97 33.59 30.29 39.94 32.77 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 36.26 41.03 36.49 33.98 42.25 34.87 -45.06 11.05 55.96 -43.37 13.22 57.41 1r1j_c00 source 1r1j NEPRILYSIN : 9 hits 1r1j_c00 naa= 4 ULMN 4 1rtf_c04 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 4 # 1 B 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 195 SER A 241 SER.? 9.98 O3 PO4 A 349 B 196 GLY A 234 GLY.? 7.10 O3 PO4 A 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 1.50 56.90 17.79 2.83 56.38 19.33 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -1.16 62.88 18.52 0.68 62.16 19.33 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 0.64 25.09 37.94 0.51 25.31 37.16 -4.72 55.63 18.83 -5.29 56.17 18.78 ULMN 4 1rtf_c04 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 4 # 2 B 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 195 SER B 241 SER.? 10.02 O1 PO4 B 349 B 196 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 0.64 25.09 37.94 0.51 25.31 37.16 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 4 1rtf_c04 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 4 # 3 B 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 195 SER C 241 SER.? 9.97 O3 PO4 C 349 B 196 GLY C 234 GLY.? 6.98 O3 PO4 C 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 0.64 25.09 37.94 0.51 25.31 37.16 -46.93 23.60 34.75 -46.44 24.03 34.33 ULMN 4 1rtf_c04 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 4 # 4 B 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 195 SER D 241 SER.? 10.08 O3 PO4 D 349 B 196 GLY D 234 GLY.? 7.11 O3 PO4 D 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 0.64 25.09 37.94 0.51 25.31 37.16 -44.87 24.99 54.53 -45.43 25.38 54.91 1rtf_c04 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 4 hits 1rtf_c04 naa= 4 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 1 4 # 1 44 ASP B 226 ASP.? 24.90 O2 PO4 B 349 49 TYR B 225 TYR~? 21.07 O2 PO4 B 349 79 LYS B 177 LYS~? 21.19 O2 PO4 B 349 112 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo 6.17 -0.98 36.99 6.36 -2.08 35.21 20.38 42.79 0.27 22.43 42.38 0.23 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 19.22 39.10 5.74 19.70 36.67 7.05 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 18.35 34.41 -3.27 19.41 29.18 0.25 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 2 4 # 2 44 ASP D 226 ASP.? 25.08 O1 PO4 D 349 49 TYR D 225 TYR.? 21.05 O1 PO4 D 349 79 LYS D 177 LYS~? 20.36 O1 PO4 D 349 112 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -62.51 23.18 64.17 -63.84 21.56 64.29 2alr_c00 source 2alr ALDEHYDE REDUCTASE : 2 hits 2alr_c00 naa= 4 ULMN 4 3csm_c00 CHORISMATE MUTASE user 1 4 # 1 A 16 ARG A 30 ARG~? 10.33 O2 PO4 A 349 A 157 ARG A 335 ARG~? 17.04 O2 PO4 A 349 A 168 LYS A 165 LYS~? -2.78 O4 PO4 A 349s A 246 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo 37.85 22.13 39.07 35.08 21.72 40.26 -9.85 66.58 32.39 -7.32 68.13 33.36 coo 42.53 17.43 30.59 39.80 18.74 31.20 -10.94 77.02 25.36 -8.46 78.77 25.78 coo 36.10 13.35 45.30 34.36 14.97 39.48 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 36.95 11.32 36.89 36.00 13.20 36.97 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 4 3csm_c00 CHORISMATE MUTASE user 2 4 # 2 A 16 ARG C 30 ARG~? 10.19 O4 PO4 C 349 A 157 ARG C 335 ARG~? 16.94 O4 PO4 C 349 A 168 LYS C 165 LYS~? -2.77 O1 PO4 C 349s A 246 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo 37.85 22.13 39.07 35.08 21.72 40.26 -42.41 19.48 17.74 -45.10 19.59 16.14 coo 42.53 17.43 30.59 39.80 18.74 31.20 -43.40 31.02 13.21 -46.07 30.90 11.67 coo 36.10 13.35 45.30 34.36 14.97 39.48 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 36.95 11.32 36.89 36.00 13.20 36.97 -35.81 26.11 19.98 -35.09 25.51 18.09 3csm_c00 source 3csm CHORISMATE MUTASE : 2 hits 3csm_c00 naa= 4 ULMN 4 3csm_c01 CHORISMATE MUTASE user 1 4 # 1 B 16 ARG A 30 ARG~? 10.33 O2 PO4 A 349 B 157 ARG A 335 ARG~? 17.04 O2 PO4 A 349 B 168 LYS A 165 LYS~? -2.78 O4 PO4 A 349s B 246 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo 36.39 28.16 -15.11 39.30 27.67 -15.87 -9.85 66.58 32.39 -7.32 68.13 33.36 coo 30.58 24.11 -7.00 33.37 25.38 -7.33 -10.94 77.02 25.36 -8.46 78.77 25.78 coo 38.96 18.92 -20.31 39.88 21.02 -14.46 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 36.95 17.56 -11.96 37.91 19.44 -12.06 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 4 3csm_c01 CHORISMATE MUTASE user 2 4 # 2 B 16 ARG C 30 ARG~? 10.19 O4 PO4 C 349 B 157 ARG C 335 ARG~? 16.94 O4 PO4 C 349 B 168 LYS C 165 LYS~? -2.77 O1 PO4 C 349s B 246 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo 36.39 28.16 -15.11 39.30 27.67 -15.87 -42.41 19.48 17.74 -45.10 19.59 16.14 coo 30.58 24.11 -7.00 33.37 25.38 -7.33 -43.40 31.02 13.21 -46.07 30.90 11.67 coo 38.96 18.92 -20.31 39.88 21.02 -14.46 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 36.95 17.56 -11.96 37.91 19.44 -12.06 -35.81 26.11 19.98 -35.09 25.51 18.09 3csm_c01 source 3csm CHORISMATE MUTASE : 2 hits 3csm_c01 naa= 4 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 1 4 # 1 A 283 GLU A 286 GLU~? 19.74 O4 PO4 A 349 C 12 THR A 287 THR~? 22.00 O4 PO4 A 349 C 25 TYR A 285 TYR~? 11.91 O4 PO4 A 349 C 89 THR B 287 THR~? 22.03 O4 PO4 A 349 coo 60.56 18.92 0.90 61.14 20.52 2.16 -13.11 61.08 5.26 -13.84 62.85 4.34 coo 55.95 25.18 2.21 55.69 23.16 3.11 -10.13 56.48 2.76 -8.53 56.78 1.32 coo 55.67 19.31 -0.41 56.70 20.51 1.90 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 59.81 26.53 8.25 58.00 25.30 8.32 -2.38 56.31 1.67 -4.17 57.52 1.30 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 2 4 # 2 A 283 GLU B 286 GLU~? 20.04 O4 PO4 B 349 C 12 THR B 287 THR~? 22.03 O4 PO4 A 349 C 25 TYR B 285 TYR~? 12.05 O4 PO4 B 349 C 89 THR A 287 THR~? 22.00 O4 PO4 A 349 coo 60.56 18.92 0.90 61.14 20.52 2.16 0.48 53.28 -2.68 0.79 53.94 -4.67 coo 55.95 25.18 2.21 55.69 23.16 3.11 -2.38 56.31 1.67 -4.17 57.52 1.30 coo 55.67 19.31 -0.41 56.70 20.51 1.90 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 59.81 26.53 8.25 58.00 25.30 8.32 -10.13 56.48 2.76 -8.53 56.78 1.32 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 3 4 # 3 A 283 GLU C 286 GLU~? 19.95 O1 PO4 C 349 C 12 THR C 287 THR~? 22.18 O1 PO4 C 349 C 25 TYR C 285 TYR~? 11.99 O1 PO4 C 349 C 89 THR D 287 THR~? 22.05 O1 PO4 C 349 coo 60.56 18.92 0.90 61.14 20.52 2.16 -40.61 39.13 37.58 -40.31 41.01 36.65 coo 55.95 25.18 2.21 55.69 23.16 3.11 -43.08 38.07 43.05 -44.80 39.16 43.76 coo 55.67 19.31 -0.41 56.70 20.51 1.90 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 59.81 26.53 8.25 58.00 25.30 8.32 -50.86 37.45 44.52 -49.17 38.53 43.62 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 4 4 # 4 A 283 GLU D 286 GLU~? 19.90 O4 PO4 D 349 C 12 THR D 287 THR~? 22.05 O1 PO4 C 349 C 25 TYR D 285 TYR~? 12.08 O4 PO4 D 349 C 89 THR C 287 THR~? 22.18 O1 PO4 C 349 coo 60.56 18.92 0.90 61.14 20.52 2.16 -53.47 38.80 49.84 -54.10 40.73 50.49 coo 55.95 25.18 2.21 55.69 23.16 3.11 -50.86 37.45 44.52 -49.17 38.53 43.62 coo 55.67 19.31 -0.41 56.70 20.51 1.90 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 59.81 26.53 8.25 58.00 25.30 8.32 -43.08 38.07 43.05 -44.80 39.16 43.76 3eca_c04 source 3eca ASPARAGINASE TYPE II : 4 hits 3eca_c04 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP C 198 ASP.? 14.11 O1 PG4 C 350 A 100 ARG C 220 ARG~? 11.31 O1 PG4 C 350 A 116 GLN C 216 GLN~? 7.49 O1 PG4 C 350 coo 32.24 20.09 5.34 30.38 19.04 5.27 -29.82 11.85 32.90 -29.50 11.63 35.01 coo 26.40 25.34 6.28 26.15 22.33 7.25 -25.78 14.58 38.60 -28.17 14.03 40.55 coo 26.74 21.94 13.78 27.57 20.97 12.08 -29.55 15.50 43.86 -30.62 13.67 44.21 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP C 343 ASP~? 16.17 O1 PG4 A 350 A 100 ARG C 179 ARG~? 14.85 O2 PG4 A 350 A 116 GLN A 216 GLN~? 7.36 O1 PG4 A 350 coo 32.24 20.09 5.34 30.38 19.04 5.27 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 26.40 25.34 6.28 26.15 22.33 7.25 -24.98 33.12 21.00 -27.25 35.17 20.85 coo 26.74 21.94 13.78 27.57 20.97 12.08 -19.93 41.08 21.62 -18.69 39.99 22.97 12as_c00 source 12as ASPARAGINE SYNTHETASE : 2 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP C 198 ASP.? 14.11 O1 PG4 C 350 B 100 ARG C 220 ARG~? 11.31 O1 PG4 C 350 B 116 GLN C 216 GLN~? 7.49 O1 PG4 C 350 coo 32.18 48.37 12.48 33.96 49.46 12.97 -29.82 11.85 32.90 -29.50 11.63 35.01 coo 39.04 43.25 11.37 38.30 45.35 13.56 -25.78 14.58 38.60 -28.17 14.03 40.55 coo 37.43 42.63 19.41 36.76 44.08 17.97 -29.55 15.50 43.86 -30.62 13.67 44.21 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP C 343 ASP~? 16.17 O1 PG4 A 350 B 100 ARG C 179 ARG~? 14.85 O2 PG4 A 350 B 116 GLN A 216 GLN~? 7.36 O1 PG4 A 350 coo 32.18 48.37 12.48 33.96 49.46 12.97 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 39.04 43.25 11.37 38.30 45.35 13.56 -24.98 33.12 21.00 -27.25 35.17 20.85 coo 37.43 42.63 19.41 36.76 44.08 17.97 -19.93 41.08 21.62 -18.69 39.99 22.97 12as_c01 source 12as ASPARAGINE SYNTHETASE : 2 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR B 221 TYR~? 17.66 O1 PG4 B 350 B 190 LYS B 223 LYS~? 20.96 O1 PG4 B 350 B 222 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 7.17 16.59 41.26 8.01 19.20 40.73 16.24 38.44 11.23 15.50 36.34 12.94 coo 13.38 20.00 35.06 11.43 22.49 39.53 21.08 44.90 9.51 21.11 48.16 14.97 coo 9.76 26.58 38.10 11.63 25.78 38.76 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR C 221 TYR~? 17.74 O1 PG4 C 350 B 190 LYS C 223 LYS~? 21.04 C2 PG4 C 350 B 222 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 7.17 16.59 41.26 8.01 19.20 40.73 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 13.38 20.00 35.06 11.43 22.49 39.53 -19.98 24.16 38.56 -19.29 22.78 44.77 coo 9.76 26.58 38.10 11.63 25.78 38.76 -21.22 29.31 30.63 -19.17 29.03 30.27 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 2 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS B 223 LYS~? 20.96 O1 PG4 B 350 A 222 ASP B 226 ASP.? 24.90 O2 PO4 B 349 B 140 TYR B 221 TYR~? 17.66 O1 PG4 B 350 coo -4.61 20.12 30.34 -2.74 22.65 25.95 21.08 44.90 9.51 21.11 48.16 14.97 coo -1.04 26.60 27.37 -2.94 25.93 26.69 20.38 42.79 0.27 22.43 42.38 0.23 coo 1.51 16.60 24.17 0.82 19.23 24.79 16.24 38.44 11.23 15.50 36.34 12.94 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS C 223 LYS~? 21.04 C2 PG4 C 350 A 222 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 140 TYR C 221 TYR~? 17.74 O1 PG4 C 350 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -19.98 24.16 38.56 -19.29 22.78 44.77 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 1.51 16.60 24.17 0.82 19.23 24.79 -25.26 18.68 35.52 -25.91 16.01 35.07 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 2 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 195 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 3.61 55.89 43.73 3.10 55.52 45.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 1.74 60.96 43.57 3.36 61.47 42.28 coo 20.90 36.72 61.65 22.18 37.53 63.52 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1a0j_c00 TRYPSIN user 2 3 # 2 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 195 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 3.61 55.89 43.73 3.10 55.52 45.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 8.08 50.44 43.84 7.48 51.26 41.98 coo 20.90 36.72 61.65 22.18 37.53 63.52 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1a0j_c00 TRYPSIN user 3 3 # 3 A 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 195 SER A 241 SER.? 9.98 O3 PO4 A 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 1.50 56.90 17.79 2.83 56.38 19.33 coo 22.33 45.48 59.73 23.35 43.67 60.06 -1.16 62.88 18.52 0.68 62.16 19.33 coo 20.90 36.72 61.65 22.18 37.53 63.52 -0.69 52.51 16.88 -2.72 53.79 17.21 ULMN 3 1a0j_c00 TRYPSIN user 4 3 # 4 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 195 SER B 64 SER~? 26.98 C5 PG4 A 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 22.33 45.48 59.73 23.35 43.67 60.06 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 20.90 36.72 61.65 22.18 37.53 63.52 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1a0j_c00 TRYPSIN user 5 3 # 5 A 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 195 SER B 241 SER.? 10.02 O1 PO4 B 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 22.33 45.48 59.73 23.35 43.67 60.06 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 20.90 36.72 61.65 22.18 37.53 63.52 -9.21 42.20 9.74 -7.29 41.83 8.32 ULMN 3 1a0j_c00 TRYPSIN user 6 3 # 6 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 195 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 20.90 36.72 61.65 22.18 37.53 63.52 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1a0j_c00 TRYPSIN user 7 3 # 7 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 195 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 20.90 36.72 61.65 22.18 37.53 63.52 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1a0j_c00 TRYPSIN user 8 3 # 8 A 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 195 SER C 241 SER.? 9.97 O3 PO4 C 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 22.33 45.48 59.73 23.35 43.67 60.06 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 20.90 36.72 61.65 22.18 37.53 63.52 -50.53 22.77 38.79 -48.65 23.56 37.48 ULMN 3 1a0j_c00 TRYPSIN user 9 3 # 9 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 195 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 22.33 45.48 59.73 23.35 43.67 60.06 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 20.90 36.72 61.65 22.18 37.53 63.52 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1a0j_c00 TRYPSIN user 10 3 # 10 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 195 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 22.33 45.48 59.73 23.35 43.67 60.06 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 20.90 36.72 61.65 22.18 37.53 63.52 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1a0j_c00 TRYPSIN user 11 3 # 11 A 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 195 SER D 241 SER.? 10.08 O3 PO4 D 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 20.90 36.72 61.65 22.18 37.53 63.52 -41.15 24.23 50.62 -43.08 24.97 51.88 1a0j_c00 source 1a0j TRYPSIN : 11 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 195 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 3.61 55.89 43.73 3.10 55.52 45.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 1.74 60.96 43.57 3.36 61.47 42.28 coo 48.11 50.52 52.24 48.62 48.46 53.13 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1a0j_c01 TRYPSIN user 2 3 # 2 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 195 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 3.61 55.89 43.73 3.10 55.52 45.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 8.08 50.44 43.84 7.48 51.26 41.98 coo 48.11 50.52 52.24 48.62 48.46 53.13 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1a0j_c01 TRYPSIN user 3 3 # 3 B 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 195 SER A 241 SER.? 9.98 O3 PO4 A 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 1.50 56.90 17.79 2.83 56.38 19.33 coo 43.04 44.75 47.18 43.31 45.51 49.13 -1.16 62.88 18.52 0.68 62.16 19.33 coo 48.11 50.52 52.24 48.62 48.46 53.13 -0.69 52.51 16.88 -2.72 53.79 17.21 ULMN 3 1a0j_c01 TRYPSIN user 4 3 # 4 B 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 102 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 195 SER B 64 SER~? 26.98 C5 PG4 A 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 43.04 44.75 47.18 43.31 45.51 49.13 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 48.11 50.52 52.24 48.62 48.46 53.13 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1a0j_c01 TRYPSIN user 5 3 # 5 B 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 195 SER B 241 SER.? 10.02 O1 PO4 B 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 43.04 44.75 47.18 43.31 45.51 49.13 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 48.11 50.52 52.24 48.62 48.46 53.13 -9.21 42.20 9.74 -7.29 41.83 8.32 ULMN 3 1a0j_c01 TRYPSIN user 6 3 # 6 B 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 102 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 195 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 43.04 44.75 47.18 43.31 45.51 49.13 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 48.11 50.52 52.24 48.62 48.46 53.13 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1a0j_c01 TRYPSIN user 7 3 # 7 B 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 195 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 43.04 44.75 47.18 43.31 45.51 49.13 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 48.11 50.52 52.24 48.62 48.46 53.13 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1a0j_c01 TRYPSIN user 8 3 # 8 B 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 195 SER C 241 SER.? 9.97 O3 PO4 C 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 43.04 44.75 47.18 43.31 45.51 49.13 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 48.11 50.52 52.24 48.62 48.46 53.13 -50.53 22.77 38.79 -48.65 23.56 37.48 ULMN 3 1a0j_c01 TRYPSIN user 9 3 # 9 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 195 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 43.04 44.75 47.18 43.31 45.51 49.13 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 48.11 50.52 52.24 48.62 48.46 53.13 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1a0j_c01 TRYPSIN user 10 3 # 10 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 195 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 43.04 44.75 47.18 43.31 45.51 49.13 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 48.11 50.52 52.24 48.62 48.46 53.13 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1a0j_c01 TRYPSIN user 11 3 # 11 B 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 195 SER D 241 SER.? 10.08 O3 PO4 D 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 48.11 50.52 52.24 48.62 48.46 53.13 -41.15 24.23 50.62 -43.08 24.97 51.88 1a0j_c01 source 1a0j TRYPSIN : 11 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 102 ASP A 41 ASP.? 20.10 O2 PO4 A 349 C 195 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 3.61 55.89 43.73 3.10 55.52 45.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 1.74 60.96 43.57 3.36 61.47 42.28 coo 36.16 46.87 75.66 34.01 46.43 74.59 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1a0j_c02 TRYPSIN user 2 3 # 2 C 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 C 195 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 3.61 55.89 43.73 3.10 55.52 45.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 8.08 50.44 43.84 7.48 51.26 41.98 coo 36.16 46.87 75.66 34.01 46.43 74.59 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1a0j_c02 TRYPSIN user 3 3 # 3 C 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 195 SER A 241 SER.? 9.98 O3 PO4 A 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 1.50 56.90 17.79 2.83 56.38 19.33 coo 34.89 38.34 78.12 35.11 39.59 76.42 -1.16 62.88 18.52 0.68 62.16 19.33 coo 36.16 46.87 75.66 34.01 46.43 74.59 -0.69 52.51 16.88 -2.72 53.79 17.21 ULMN 3 1a0j_c02 TRYPSIN user 4 3 # 4 C 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 102 ASP B 41 ASP.? 20.21 O3 PO4 B 349 C 195 SER B 64 SER~? 26.98 C5 PG4 A 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 34.89 38.34 78.12 35.11 39.59 76.42 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 36.16 46.87 75.66 34.01 46.43 74.59 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1a0j_c02 TRYPSIN user 5 3 # 5 C 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 195 SER B 241 SER.? 10.02 O1 PO4 B 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 34.89 38.34 78.12 35.11 39.59 76.42 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 36.16 46.87 75.66 34.01 46.43 74.59 -9.21 42.20 9.74 -7.29 41.83 8.32 ULMN 3 1a0j_c02 TRYPSIN user 6 3 # 6 C 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 102 ASP C 41 ASP.? 20.22 O4 PO4 C 349 C 195 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 34.89 38.34 78.12 35.11 39.59 76.42 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 36.16 46.87 75.66 34.01 46.43 74.59 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1a0j_c02 TRYPSIN user 7 3 # 7 C 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 C 195 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 34.89 38.34 78.12 35.11 39.59 76.42 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 36.16 46.87 75.66 34.01 46.43 74.59 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1a0j_c02 TRYPSIN user 8 3 # 8 C 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 C 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 195 SER C 241 SER.? 9.97 O3 PO4 C 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 34.89 38.34 78.12 35.11 39.59 76.42 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 36.16 46.87 75.66 34.01 46.43 74.59 -50.53 22.77 38.79 -48.65 23.56 37.48 ULMN 3 1a0j_c02 TRYPSIN user 9 3 # 9 C 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 102 ASP D 41 ASP.? 20.92 O2 PO4 D 349 C 195 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 34.89 38.34 78.12 35.11 39.59 76.42 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 36.16 46.87 75.66 34.01 46.43 74.59 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1a0j_c02 TRYPSIN user 10 3 # 10 C 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 C 195 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 34.89 38.34 78.12 35.11 39.59 76.42 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 36.16 46.87 75.66 34.01 46.43 74.59 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1a0j_c02 TRYPSIN user 11 3 # 11 C 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 195 SER D 241 SER.? 10.08 O3 PO4 D 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 36.16 46.87 75.66 34.01 46.43 74.59 -41.15 24.23 50.62 -43.08 24.97 51.88 1a0j_c02 source 1a0j TRYPSIN : 11 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 102 ASP A 41 ASP.? 20.10 O2 PO4 A 349 D 195 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 3.61 55.89 43.73 3.10 55.52 45.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 1.74 60.96 43.57 3.36 61.47 42.28 coo 6.63 21.03 97.42 6.71 19.20 98.95 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1a0j_c03 TRYPSIN user 2 3 # 2 D 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 D 195 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 3.61 55.89 43.73 3.10 55.52 45.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 8.08 50.44 43.84 7.48 51.26 41.98 coo 6.63 21.03 97.42 6.71 19.20 98.95 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1a0j_c03 TRYPSIN user 3 3 # 3 D 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 D 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 195 SER A 241 SER.? 9.98 O3 PO4 A 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 1.50 56.90 17.79 2.83 56.38 19.33 coo 13.53 16.28 93.98 11.45 16.21 94.40 -1.16 62.88 18.52 0.68 62.16 19.33 coo 6.63 21.03 97.42 6.71 19.20 98.95 -0.69 52.51 16.88 -2.72 53.79 17.21 ULMN 3 1a0j_c03 TRYPSIN user 4 3 # 4 D 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 D 102 ASP B 41 ASP.? 20.21 O3 PO4 B 349 D 195 SER B 64 SER~? 26.98 C5 PG4 A 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 13.53 16.28 93.98 11.45 16.21 94.40 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 6.63 21.03 97.42 6.71 19.20 98.95 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1a0j_c03 TRYPSIN user 5 3 # 5 D 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 195 SER B 241 SER.? 10.02 O1 PO4 B 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 13.53 16.28 93.98 11.45 16.21 94.40 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 6.63 21.03 97.42 6.71 19.20 98.95 -9.21 42.20 9.74 -7.29 41.83 8.32 ULMN 3 1a0j_c03 TRYPSIN user 6 3 # 6 D 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 102 ASP C 41 ASP.? 20.22 O4 PO4 C 349 D 195 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 13.53 16.28 93.98 11.45 16.21 94.40 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 6.63 21.03 97.42 6.71 19.20 98.95 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1a0j_c03 TRYPSIN user 7 3 # 7 D 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 D 195 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 13.53 16.28 93.98 11.45 16.21 94.40 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 6.63 21.03 97.42 6.71 19.20 98.95 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1a0j_c03 TRYPSIN user 8 3 # 8 D 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 D 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 195 SER C 241 SER.? 9.97 O3 PO4 C 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 13.53 16.28 93.98 11.45 16.21 94.40 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 6.63 21.03 97.42 6.71 19.20 98.95 -50.53 22.77 38.79 -48.65 23.56 37.48 ULMN 3 1a0j_c03 TRYPSIN user 9 3 # 9 D 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 D 102 ASP D 41 ASP.? 20.92 O2 PO4 D 349 D 195 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 13.53 16.28 93.98 11.45 16.21 94.40 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 6.63 21.03 97.42 6.71 19.20 98.95 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1a0j_c03 TRYPSIN user 10 3 # 10 D 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 D 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 D 195 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 13.53 16.28 93.98 11.45 16.21 94.40 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 6.63 21.03 97.42 6.71 19.20 98.95 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1a0j_c03 TRYPSIN user 11 3 # 11 D 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 195 SER D 241 SER.? 10.08 O3 PO4 D 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 6.63 21.03 97.42 6.71 19.20 98.95 -41.15 24.23 50.62 -43.08 24.97 51.88 1a0j_c03 source 1a0j TRYPSIN : 11 hits 1a0j_c03 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 16 GLY.? 15.23 O3 PO4 A 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 3.61 55.89 43.73 3.10 55.52 45.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 8.08 50.44 43.84 7.48 51.26 41.98 coo 22.57 32.23 64.13 21.98 32.82 64.22 2.07 60.33 37.29 2.12 60.80 37.90 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 3.61 55.89 43.73 3.10 55.52 45.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 8.08 50.44 43.84 7.48 51.26 41.98 coo 22.57 32.23 64.13 21.98 32.82 64.22 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 3.61 55.89 43.73 3.10 55.52 45.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 8.08 50.44 43.84 7.48 51.26 41.98 coo 22.57 32.23 64.13 21.98 32.82 64.22 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1a0j_c12 TRYPSIN user 4 3 # 4 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 3.61 55.89 43.73 3.10 55.52 45.73 coo 22.33 45.48 59.73 23.35 43.67 60.06 8.08 50.44 43.84 7.48 51.26 41.98 coo 22.57 32.23 64.13 21.98 32.82 64.22 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1a0j_c12 TRYPSIN user 5 3 # 5 A 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 102 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 193 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 22.33 45.48 59.73 23.35 43.67 60.06 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 22.57 32.23 64.13 21.98 32.82 64.22 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 1a0j_c12 TRYPSIN user 6 3 # 6 A 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 193 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 1.50 56.90 17.79 2.83 56.38 19.33 coo 22.33 45.48 59.73 23.35 43.67 60.06 -1.16 62.88 18.52 0.68 62.16 19.33 coo 22.57 32.23 64.13 21.98 32.82 64.22 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1a0j_c12 TRYPSIN user 7 3 # 7 A 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 193 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 1.50 56.90 17.79 2.83 56.38 19.33 coo 22.33 45.48 59.73 23.35 43.67 60.06 -1.16 62.88 18.52 0.68 62.16 19.33 coo 22.57 32.23 64.13 21.98 32.82 64.22 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1a0j_c12 TRYPSIN user 8 3 # 8 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 16 GLY.? 15.34 O3 PO4 B 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 22.57 32.23 64.13 21.98 32.82 64.22 -8.99 19.43 5.14 -8.92 18.73 4.81 ULMN 3 1a0j_c12 TRYPSIN user 9 3 # 9 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 22.57 32.23 64.13 21.98 32.82 64.22 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1a0j_c12 TRYPSIN user 10 3 # 10 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 22.57 32.23 64.13 21.98 32.82 64.22 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1a0j_c12 TRYPSIN user 11 3 # 11 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 22.57 32.23 64.13 21.98 32.82 64.22 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1a0j_c12 TRYPSIN user 12 3 # 12 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 22.33 45.48 59.73 23.35 43.67 60.06 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 22.57 32.23 64.13 21.98 32.82 64.22 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1a0j_c12 TRYPSIN user 13 3 # 13 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 22.33 45.48 59.73 23.35 43.67 60.06 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 22.57 32.23 64.13 21.98 32.82 64.22 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1a0j_c12 TRYPSIN user 14 3 # 14 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 193 GLY B 108 GLY.? 11.44 C5 PG4 A 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 22.33 45.48 59.73 23.35 43.67 60.06 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 22.57 32.23 64.13 21.98 32.82 64.22 -1.45 26.58 15.61 -2.07 26.26 16.03 ULMN 3 1a0j_c12 TRYPSIN user 15 3 # 15 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 193 GLY B 84 GLY.? 7.18 C3 PG4 A 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 22.33 45.48 59.73 23.35 43.67 60.06 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 22.57 32.23 64.13 21.98 32.82 64.22 -14.58 29.73 14.21 -14.80 28.98 14.10 ULMN 3 1a0j_c12 TRYPSIN user 16 3 # 16 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 22.33 45.48 59.73 23.35 43.67 60.06 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 22.57 32.23 64.13 21.98 32.82 64.22 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1a0j_c12 TRYPSIN user 17 3 # 17 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 22.33 45.48 59.73 23.35 43.67 60.06 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 22.57 32.23 64.13 21.98 32.82 64.22 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1a0j_c12 TRYPSIN user 18 3 # 18 A 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 193 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 22.33 45.48 59.73 23.35 43.67 60.06 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 22.57 32.23 64.13 21.98 32.82 64.22 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1a0j_c12 TRYPSIN user 19 3 # 19 A 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 193 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 22.33 45.48 59.73 23.35 43.67 60.06 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 22.57 32.23 64.13 21.98 32.82 64.22 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1a0j_c12 TRYPSIN user 20 3 # 20 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 193 GLY C 16 GLY.? 15.48 O4 PO4 C 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 22.57 32.23 64.13 21.98 32.82 64.22 -52.98 9.90 20.86 -53.06 9.69 20.11 ULMN 3 1a0j_c12 TRYPSIN user 21 3 # 21 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 193 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 22.57 32.23 64.13 21.98 32.82 64.22 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1a0j_c12 TRYPSIN user 22 3 # 22 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 193 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 22.57 32.23 64.13 21.98 32.82 64.22 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1a0j_c12 TRYPSIN user 23 3 # 23 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 193 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 22.57 32.23 64.13 21.98 32.82 64.22 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1a0j_c12 TRYPSIN user 24 3 # 24 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 193 GLY C 84 GLY.? 7.31 O4 PG4 D 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 22.33 45.48 59.73 23.35 43.67 60.06 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 22.57 32.23 64.13 21.98 32.82 64.22 -56.51 10.28 34.21 -56.90 9.83 33.65 ULMN 3 1a0j_c12 TRYPSIN user 25 3 # 25 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 193 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 22.33 45.48 59.73 23.35 43.67 60.06 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 22.57 32.23 64.13 21.98 32.82 64.22 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 1a0j_c12 TRYPSIN user 26 3 # 26 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 193 GLY C 108 GLY.? 11.29 O3 PG4 D 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 22.33 45.48 59.73 23.35 43.67 60.06 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 22.57 32.23 64.13 21.98 32.82 64.22 -43.60 7.14 31.15 -44.12 6.54 31.35 ULMN 3 1a0j_c12 TRYPSIN user 27 3 # 27 A 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 193 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 22.33 45.48 59.73 23.35 43.67 60.06 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 22.57 32.23 64.13 21.98 32.82 64.22 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1a0j_c12 TRYPSIN user 28 3 # 28 A 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 193 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 22.33 45.48 59.73 23.35 43.67 60.06 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 22.57 32.23 64.13 21.98 32.82 64.22 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1a0j_c12 TRYPSIN user 29 3 # 29 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 16 GLY.? 16.14 O2 PO4 D 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 22.33 45.48 59.73 23.35 43.67 60.06 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.65 13.48 72.21 -38.70 13.32 72.96 ULMN 3 1a0j_c12 TRYPSIN user 30 3 # 30 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 22.33 45.48 59.73 23.35 43.67 60.06 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 22.57 32.23 64.13 21.98 32.82 64.22 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1a0j_c12 TRYPSIN user 31 3 # 31 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 22.33 45.48 59.73 23.35 43.67 60.06 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 22.57 32.23 64.13 21.98 32.82 64.22 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1a0j_c12 TRYPSIN user 32 3 # 32 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 22.33 45.48 59.73 23.35 43.67 60.06 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 22.57 32.23 64.13 21.98 32.82 64.22 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1a0j_c12 TRYPSIN user 33 3 # 33 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 22.57 32.23 64.13 21.98 32.82 64.22 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1a0j_c12 TRYPSIN user 34 3 # 34 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 22.57 32.23 64.13 21.98 32.82 64.22 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1a0j_c12 TRYPSIN user 35 3 # 35 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 22.57 32.23 64.13 21.98 32.82 64.22 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1a0j_c12 TRYPSIN user 36 3 # 36 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 108 GLY.? 11.50 C6 PG4 C 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 22.57 32.23 64.13 21.98 32.82 64.22 -46.34 8.93 60.42 -45.67 8.48 60.39 ULMN 3 1a0j_c12 TRYPSIN user 37 3 # 37 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 22.33 45.48 59.73 23.35 43.67 60.06 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 22.57 32.23 64.13 21.98 32.82 64.22 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1a0j_c12 TRYPSIN user 38 3 # 38 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 22.33 45.48 59.73 23.35 43.67 60.06 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 22.57 32.23 64.13 21.98 32.82 64.22 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1a0j_c12 TRYPSIN user 39 3 # 39 A 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 193 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 22.57 32.23 64.13 21.98 32.82 64.22 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1a0j_c12 TRYPSIN user 40 3 # 40 A 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 193 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 22.57 32.23 64.13 21.98 32.82 64.22 -40.50 35.55 47.63 -40.37 36.37 47.40 1a0j_c12 source 1a0j TRYPSIN : 40 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 193 GLY A 16 GLY.? 15.23 O3 PO4 A 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 3.61 55.89 43.73 3.10 55.52 45.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 8.08 50.44 43.84 7.48 51.26 41.98 coo 50.46 51.91 56.90 50.65 51.62 56.14 2.07 60.33 37.29 2.12 60.80 37.90 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 193 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 3.61 55.89 43.73 3.10 55.52 45.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 8.08 50.44 43.84 7.48 51.26 41.98 coo 50.46 51.91 56.90 50.65 51.62 56.14 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 193 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 3.61 55.89 43.73 3.10 55.52 45.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 8.08 50.44 43.84 7.48 51.26 41.98 coo 50.46 51.91 56.90 50.65 51.62 56.14 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1a0j_c13 TRYPSIN user 4 3 # 4 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 193 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 3.61 55.89 43.73 3.10 55.52 45.73 coo 43.04 44.75 47.18 43.31 45.51 49.13 8.08 50.44 43.84 7.48 51.26 41.98 coo 50.46 51.91 56.90 50.65 51.62 56.14 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1a0j_c13 TRYPSIN user 5 3 # 5 B 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 102 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 193 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 43.04 44.75 47.18 43.31 45.51 49.13 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 50.46 51.91 56.90 50.65 51.62 56.14 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 1a0j_c13 TRYPSIN user 6 3 # 6 B 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 193 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 1.50 56.90 17.79 2.83 56.38 19.33 coo 43.04 44.75 47.18 43.31 45.51 49.13 -1.16 62.88 18.52 0.68 62.16 19.33 coo 50.46 51.91 56.90 50.65 51.62 56.14 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1a0j_c13 TRYPSIN user 7 3 # 7 B 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 193 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 1.50 56.90 17.79 2.83 56.38 19.33 coo 43.04 44.75 47.18 43.31 45.51 49.13 -1.16 62.88 18.52 0.68 62.16 19.33 coo 50.46 51.91 56.90 50.65 51.62 56.14 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1a0j_c13 TRYPSIN user 8 3 # 8 B 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 193 GLY B 16 GLY.? 15.34 O3 PO4 B 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 50.46 51.91 56.90 50.65 51.62 56.14 -8.99 19.43 5.14 -8.92 18.73 4.81 ULMN 3 1a0j_c13 TRYPSIN user 9 3 # 9 B 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 193 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 50.46 51.91 56.90 50.65 51.62 56.14 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1a0j_c13 TRYPSIN user 10 3 # 10 B 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 193 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 50.46 51.91 56.90 50.65 51.62 56.14 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1a0j_c13 TRYPSIN user 11 3 # 11 B 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 193 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 50.46 51.91 56.90 50.65 51.62 56.14 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1a0j_c13 TRYPSIN user 12 3 # 12 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 43.04 44.75 47.18 43.31 45.51 49.13 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 50.46 51.91 56.90 50.65 51.62 56.14 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1a0j_c13 TRYPSIN user 13 3 # 13 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 43.04 44.75 47.18 43.31 45.51 49.13 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 50.46 51.91 56.90 50.65 51.62 56.14 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1a0j_c13 TRYPSIN user 14 3 # 14 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 193 GLY B 84 GLY.? 7.18 C3 PG4 A 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 43.04 44.75 47.18 43.31 45.51 49.13 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 50.46 51.91 56.90 50.65 51.62 56.14 -14.58 29.73 14.21 -14.80 28.98 14.10 ULMN 3 1a0j_c13 TRYPSIN user 15 3 # 15 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 43.04 44.75 47.18 43.31 45.51 49.13 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 50.46 51.91 56.90 50.65 51.62 56.14 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1a0j_c13 TRYPSIN user 16 3 # 16 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 43.04 44.75 47.18 43.31 45.51 49.13 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 50.46 51.91 56.90 50.65 51.62 56.14 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1a0j_c13 TRYPSIN user 17 3 # 17 B 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 193 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 43.04 44.75 47.18 43.31 45.51 49.13 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 50.46 51.91 56.90 50.65 51.62 56.14 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1a0j_c13 TRYPSIN user 18 3 # 18 B 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 193 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 43.04 44.75 47.18 43.31 45.51 49.13 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 50.46 51.91 56.90 50.65 51.62 56.14 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1a0j_c13 TRYPSIN user 19 3 # 19 B 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 193 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 43.04 44.75 47.18 43.31 45.51 49.13 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 50.46 51.91 56.90 50.65 51.62 56.14 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1a0j_c13 TRYPSIN user 20 3 # 20 B 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 193 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 43.04 44.75 47.18 43.31 45.51 49.13 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 50.46 51.91 56.90 50.65 51.62 56.14 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1a0j_c13 TRYPSIN user 21 3 # 21 B 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 193 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 43.04 44.75 47.18 43.31 45.51 49.13 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 50.46 51.91 56.90 50.65 51.62 56.14 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1a0j_c13 TRYPSIN user 22 3 # 22 B 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 193 GLY C 84 GLY.? 7.31 O4 PG4 D 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 43.04 44.75 47.18 43.31 45.51 49.13 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 50.46 51.91 56.90 50.65 51.62 56.14 -56.51 10.28 34.21 -56.90 9.83 33.65 ULMN 3 1a0j_c13 TRYPSIN user 23 3 # 23 B 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 193 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 43.04 44.75 47.18 43.31 45.51 49.13 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 50.46 51.91 56.90 50.65 51.62 56.14 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 1a0j_c13 TRYPSIN user 24 3 # 24 B 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 193 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 43.04 44.75 47.18 43.31 45.51 49.13 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 50.46 51.91 56.90 50.65 51.62 56.14 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1a0j_c13 TRYPSIN user 25 3 # 25 B 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 193 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 43.04 44.75 47.18 43.31 45.51 49.13 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 50.46 51.91 56.90 50.65 51.62 56.14 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1a0j_c13 TRYPSIN user 26 3 # 26 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 193 GLY D 16 GLY.? 16.14 O2 PO4 D 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 43.04 44.75 47.18 43.31 45.51 49.13 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 50.46 51.91 56.90 50.65 51.62 56.14 -38.65 13.48 72.21 -38.70 13.32 72.96 ULMN 3 1a0j_c13 TRYPSIN user 27 3 # 27 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 193 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 43.04 44.75 47.18 43.31 45.51 49.13 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 50.46 51.91 56.90 50.65 51.62 56.14 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1a0j_c13 TRYPSIN user 28 3 # 28 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 193 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 43.04 44.75 47.18 43.31 45.51 49.13 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 50.46 51.91 56.90 50.65 51.62 56.14 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1a0j_c13 TRYPSIN user 29 3 # 29 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 193 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 43.04 44.75 47.18 43.31 45.51 49.13 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 50.46 51.91 56.90 50.65 51.62 56.14 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1a0j_c13 TRYPSIN user 30 3 # 30 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 50.46 51.91 56.90 50.65 51.62 56.14 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1a0j_c13 TRYPSIN user 31 3 # 31 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 50.46 51.91 56.90 50.65 51.62 56.14 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1a0j_c13 TRYPSIN user 32 3 # 32 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 50.46 51.91 56.90 50.65 51.62 56.14 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1a0j_c13 TRYPSIN user 33 3 # 33 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 193 GLY D 108 GLY.? 11.50 C6 PG4 C 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 50.46 51.91 56.90 50.65 51.62 56.14 -46.34 8.93 60.42 -45.67 8.48 60.39 ULMN 3 1a0j_c13 TRYPSIN user 34 3 # 34 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 43.04 44.75 47.18 43.31 45.51 49.13 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 50.46 51.91 56.90 50.65 51.62 56.14 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1a0j_c13 TRYPSIN user 35 3 # 35 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 43.04 44.75 47.18 43.31 45.51 49.13 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 50.46 51.91 56.90 50.65 51.62 56.14 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1a0j_c13 TRYPSIN user 36 3 # 36 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 43.04 44.75 47.18 43.31 45.51 49.13 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 50.46 51.91 56.90 50.65 51.62 56.14 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1a0j_c13 TRYPSIN user 37 3 # 37 B 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 193 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 50.46 51.91 56.90 50.65 51.62 56.14 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1a0j_c13 TRYPSIN user 38 3 # 38 B 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 193 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 50.46 51.91 56.90 50.65 51.62 56.14 -40.50 35.55 47.63 -40.37 36.37 47.40 1a0j_c13 source 1a0j TRYPSIN : 38 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 C 193 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 3.61 55.89 43.73 3.10 55.52 45.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 8.08 50.44 43.84 7.48 51.26 41.98 coo 35.43 51.03 72.12 35.20 50.72 72.87 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 C 193 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 3.61 55.89 43.73 3.10 55.52 45.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 8.08 50.44 43.84 7.48 51.26 41.98 coo 35.43 51.03 72.12 35.20 50.72 72.87 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 C 193 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 3.61 55.89 43.73 3.10 55.52 45.73 coo 34.89 38.34 78.12 35.11 39.59 76.42 8.08 50.44 43.84 7.48 51.26 41.98 coo 35.43 51.03 72.12 35.20 50.72 72.87 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1a0j_c14 TRYPSIN user 4 3 # 4 C 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 102 ASP A 203 ASP~? 10.68 C3 PG4 B 350 C 193 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 34.89 38.34 78.12 35.11 39.59 76.42 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 35.43 51.03 72.12 35.20 50.72 72.87 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 1a0j_c14 TRYPSIN user 5 3 # 5 C 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 193 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 1.50 56.90 17.79 2.83 56.38 19.33 coo 34.89 38.34 78.12 35.11 39.59 76.42 -1.16 62.88 18.52 0.68 62.16 19.33 coo 35.43 51.03 72.12 35.20 50.72 72.87 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1a0j_c14 TRYPSIN user 6 3 # 6 C 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 193 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 1.50 56.90 17.79 2.83 56.38 19.33 coo 34.89 38.34 78.12 35.11 39.59 76.42 -1.16 62.88 18.52 0.68 62.16 19.33 coo 35.43 51.03 72.12 35.20 50.72 72.87 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1a0j_c14 TRYPSIN user 7 3 # 7 C 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 C 193 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 35.43 51.03 72.12 35.20 50.72 72.87 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1a0j_c14 TRYPSIN user 8 3 # 8 C 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 C 193 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 35.43 51.03 72.12 35.20 50.72 72.87 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1a0j_c14 TRYPSIN user 9 3 # 9 C 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 C 193 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 35.43 51.03 72.12 35.20 50.72 72.87 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1a0j_c14 TRYPSIN user 10 3 # 10 C 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 C 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 34.89 38.34 78.12 35.11 39.59 76.42 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 35.43 51.03 72.12 35.20 50.72 72.87 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1a0j_c14 TRYPSIN user 11 3 # 11 C 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 C 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 34.89 38.34 78.12 35.11 39.59 76.42 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 35.43 51.03 72.12 35.20 50.72 72.87 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1a0j_c14 TRYPSIN user 12 3 # 12 C 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 C 193 GLY B 108 GLY.? 11.44 C5 PG4 A 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 34.89 38.34 78.12 35.11 39.59 76.42 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 35.43 51.03 72.12 35.20 50.72 72.87 -1.45 26.58 15.61 -2.07 26.26 16.03 ULMN 3 1a0j_c14 TRYPSIN user 13 3 # 13 C 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 C 193 GLY B 84 GLY.? 7.18 C3 PG4 A 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 34.89 38.34 78.12 35.11 39.59 76.42 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 35.43 51.03 72.12 35.20 50.72 72.87 -14.58 29.73 14.21 -14.80 28.98 14.10 ULMN 3 1a0j_c14 TRYPSIN user 14 3 # 14 C 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 C 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 34.89 38.34 78.12 35.11 39.59 76.42 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 35.43 51.03 72.12 35.20 50.72 72.87 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1a0j_c14 TRYPSIN user 15 3 # 15 C 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 C 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 34.89 38.34 78.12 35.11 39.59 76.42 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 35.43 51.03 72.12 35.20 50.72 72.87 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1a0j_c14 TRYPSIN user 16 3 # 16 C 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 193 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 34.89 38.34 78.12 35.11 39.59 76.42 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 35.43 51.03 72.12 35.20 50.72 72.87 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1a0j_c14 TRYPSIN user 17 3 # 17 C 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 193 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 34.89 38.34 78.12 35.11 39.59 76.42 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 35.43 51.03 72.12 35.20 50.72 72.87 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1a0j_c14 TRYPSIN user 18 3 # 18 C 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 C 193 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 34.89 38.34 78.12 35.11 39.59 76.42 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 35.43 51.03 72.12 35.20 50.72 72.87 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1a0j_c14 TRYPSIN user 19 3 # 19 C 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 C 193 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 34.89 38.34 78.12 35.11 39.59 76.42 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 35.43 51.03 72.12 35.20 50.72 72.87 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1a0j_c14 TRYPSIN user 20 3 # 20 C 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 C 193 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 34.89 38.34 78.12 35.11 39.59 76.42 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 35.43 51.03 72.12 35.20 50.72 72.87 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1a0j_c14 TRYPSIN user 21 3 # 21 C 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 C 193 GLY C 84 GLY.? 7.31 O4 PG4 D 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 34.89 38.34 78.12 35.11 39.59 76.42 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 35.43 51.03 72.12 35.20 50.72 72.87 -56.51 10.28 34.21 -56.90 9.83 33.65 ULMN 3 1a0j_c14 TRYPSIN user 22 3 # 22 C 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 C 193 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 34.89 38.34 78.12 35.11 39.59 76.42 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 35.43 51.03 72.12 35.20 50.72 72.87 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 1a0j_c14 TRYPSIN user 23 3 # 23 C 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 102 ASP D 208 ASP~? 8.41 C6 PG4 D 350 C 193 GLY C 108 GLY.? 11.29 O3 PG4 D 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 34.89 38.34 78.12 35.11 39.59 76.42 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 35.43 51.03 72.12 35.20 50.72 72.87 -43.60 7.14 31.15 -44.12 6.54 31.35 ULMN 3 1a0j_c14 TRYPSIN user 24 3 # 24 C 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 C 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 193 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 34.89 38.34 78.12 35.11 39.59 76.42 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 35.43 51.03 72.12 35.20 50.72 72.87 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1a0j_c14 TRYPSIN user 25 3 # 25 C 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 C 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 193 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 34.89 38.34 78.12 35.11 39.59 76.42 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 35.43 51.03 72.12 35.20 50.72 72.87 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1a0j_c14 TRYPSIN user 26 3 # 26 C 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 C 193 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 34.89 38.34 78.12 35.11 39.59 76.42 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 35.43 51.03 72.12 35.20 50.72 72.87 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1a0j_c14 TRYPSIN user 27 3 # 27 C 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 C 193 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 34.89 38.34 78.12 35.11 39.59 76.42 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 35.43 51.03 72.12 35.20 50.72 72.87 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1a0j_c14 TRYPSIN user 28 3 # 28 C 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 C 193 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 34.89 38.34 78.12 35.11 39.59 76.42 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 35.43 51.03 72.12 35.20 50.72 72.87 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1a0j_c14 TRYPSIN user 29 3 # 29 C 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 C 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 35.43 51.03 72.12 35.20 50.72 72.87 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1a0j_c14 TRYPSIN user 30 3 # 30 C 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 C 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 35.43 51.03 72.12 35.20 50.72 72.87 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1a0j_c14 TRYPSIN user 31 3 # 31 C 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 C 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 35.43 51.03 72.12 35.20 50.72 72.87 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1a0j_c14 TRYPSIN user 32 3 # 32 C 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 C 193 GLY D 108 GLY.? 11.50 C6 PG4 C 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 35.43 51.03 72.12 35.20 50.72 72.87 -46.34 8.93 60.42 -45.67 8.48 60.39 ULMN 3 1a0j_c14 TRYPSIN user 33 3 # 33 C 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 C 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 34.89 38.34 78.12 35.11 39.59 76.42 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 35.43 51.03 72.12 35.20 50.72 72.87 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1a0j_c14 TRYPSIN user 34 3 # 34 C 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 C 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 34.89 38.34 78.12 35.11 39.59 76.42 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 35.43 51.03 72.12 35.20 50.72 72.87 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1a0j_c14 TRYPSIN user 35 3 # 35 C 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 193 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 35.43 51.03 72.12 35.20 50.72 72.87 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1a0j_c14 TRYPSIN user 36 3 # 36 C 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 193 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 35.43 51.03 72.12 35.20 50.72 72.87 -40.50 35.55 47.63 -40.37 36.37 47.40 1a0j_c14 source 1a0j TRYPSIN : 36 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 D 193 GLY A 16 GLY.? 15.23 O3 PO4 A 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 3.61 55.89 43.73 3.10 55.52 45.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 8.08 50.44 43.84 7.48 51.26 41.98 coo 1.80 21.25 100.04 2.61 21.42 100.18 2.07 60.33 37.29 2.12 60.80 37.90 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 D 193 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 3.61 55.89 43.73 3.10 55.52 45.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 8.08 50.44 43.84 7.48 51.26 41.98 coo 1.80 21.25 100.04 2.61 21.42 100.18 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 D 193 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 3.61 55.89 43.73 3.10 55.52 45.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 8.08 50.44 43.84 7.48 51.26 41.98 coo 1.80 21.25 100.04 2.61 21.42 100.18 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1a0j_c15 TRYPSIN user 4 3 # 4 D 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 D 193 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 3.61 55.89 43.73 3.10 55.52 45.73 coo 13.53 16.28 93.98 11.45 16.21 94.40 8.08 50.44 43.84 7.48 51.26 41.98 coo 1.80 21.25 100.04 2.61 21.42 100.18 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1a0j_c15 TRYPSIN user 5 3 # 5 D 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 D 102 ASP A 203 ASP~? 10.68 C3 PG4 B 350 D 193 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 13.53 16.28 93.98 11.45 16.21 94.40 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 1.80 21.25 100.04 2.61 21.42 100.18 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 1a0j_c15 TRYPSIN user 6 3 # 6 D 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 D 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 193 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 1.50 56.90 17.79 2.83 56.38 19.33 coo 13.53 16.28 93.98 11.45 16.21 94.40 -1.16 62.88 18.52 0.68 62.16 19.33 coo 1.80 21.25 100.04 2.61 21.42 100.18 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1a0j_c15 TRYPSIN user 7 3 # 7 D 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 D 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 193 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 1.50 56.90 17.79 2.83 56.38 19.33 coo 13.53 16.28 93.98 11.45 16.21 94.40 -1.16 62.88 18.52 0.68 62.16 19.33 coo 1.80 21.25 100.04 2.61 21.42 100.18 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1a0j_c15 TRYPSIN user 8 3 # 8 D 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 D 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 D 193 GLY B 16 GLY.? 15.34 O3 PO4 B 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 1.80 21.25 100.04 2.61 21.42 100.18 -8.99 19.43 5.14 -8.92 18.73 4.81 ULMN 3 1a0j_c15 TRYPSIN user 9 3 # 9 D 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 D 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 D 193 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 1.80 21.25 100.04 2.61 21.42 100.18 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1a0j_c15 TRYPSIN user 10 3 # 10 D 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 D 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 D 193 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 1.80 21.25 100.04 2.61 21.42 100.18 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1a0j_c15 TRYPSIN user 11 3 # 11 D 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 D 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 D 193 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 1.80 21.25 100.04 2.61 21.42 100.18 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1a0j_c15 TRYPSIN user 12 3 # 12 D 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 13.53 16.28 93.98 11.45 16.21 94.40 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 1.80 21.25 100.04 2.61 21.42 100.18 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1a0j_c15 TRYPSIN user 13 3 # 13 D 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 13.53 16.28 93.98 11.45 16.21 94.40 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 1.80 21.25 100.04 2.61 21.42 100.18 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1a0j_c15 TRYPSIN user 14 3 # 14 D 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 193 GLY B 108 GLY.? 11.44 C5 PG4 A 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 13.53 16.28 93.98 11.45 16.21 94.40 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 1.80 21.25 100.04 2.61 21.42 100.18 -1.45 26.58 15.61 -2.07 26.26 16.03 ULMN 3 1a0j_c15 TRYPSIN user 15 3 # 15 D 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 D 193 GLY B 84 GLY.? 7.18 C3 PG4 A 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 13.53 16.28 93.98 11.45 16.21 94.40 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 1.80 21.25 100.04 2.61 21.42 100.18 -14.58 29.73 14.21 -14.80 28.98 14.10 ULMN 3 1a0j_c15 TRYPSIN user 16 3 # 16 D 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 D 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 13.53 16.28 93.98 11.45 16.21 94.40 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 1.80 21.25 100.04 2.61 21.42 100.18 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1a0j_c15 TRYPSIN user 17 3 # 17 D 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 D 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 13.53 16.28 93.98 11.45 16.21 94.40 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 1.80 21.25 100.04 2.61 21.42 100.18 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1a0j_c15 TRYPSIN user 18 3 # 18 D 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 193 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 13.53 16.28 93.98 11.45 16.21 94.40 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 1.80 21.25 100.04 2.61 21.42 100.18 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1a0j_c15 TRYPSIN user 19 3 # 19 D 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 193 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 13.53 16.28 93.98 11.45 16.21 94.40 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 1.80 21.25 100.04 2.61 21.42 100.18 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1a0j_c15 TRYPSIN user 20 3 # 20 D 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 D 193 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 13.53 16.28 93.98 11.45 16.21 94.40 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 1.80 21.25 100.04 2.61 21.42 100.18 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1a0j_c15 TRYPSIN user 21 3 # 21 D 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 D 193 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 13.53 16.28 93.98 11.45 16.21 94.40 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 1.80 21.25 100.04 2.61 21.42 100.18 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1a0j_c15 TRYPSIN user 22 3 # 22 D 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 D 193 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 13.53 16.28 93.98 11.45 16.21 94.40 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 1.80 21.25 100.04 2.61 21.42 100.18 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1a0j_c15 TRYPSIN user 23 3 # 23 D 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 D 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 D 193 GLY C 84 GLY.? 7.31 O4 PG4 D 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 13.53 16.28 93.98 11.45 16.21 94.40 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 1.80 21.25 100.04 2.61 21.42 100.18 -56.51 10.28 34.21 -56.90 9.83 33.65 ULMN 3 1a0j_c15 TRYPSIN user 24 3 # 24 D 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 D 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 D 193 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 13.53 16.28 93.98 11.45 16.21 94.40 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 1.80 21.25 100.04 2.61 21.42 100.18 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 1a0j_c15 TRYPSIN user 25 3 # 25 D 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 D 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 193 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 13.53 16.28 93.98 11.45 16.21 94.40 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 1.80 21.25 100.04 2.61 21.42 100.18 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1a0j_c15 TRYPSIN user 26 3 # 26 D 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 D 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 193 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 13.53 16.28 93.98 11.45 16.21 94.40 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 1.80 21.25 100.04 2.61 21.42 100.18 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1a0j_c15 TRYPSIN user 27 3 # 27 D 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 D 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 D 193 GLY D 16 GLY.? 16.14 O2 PO4 D 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 13.53 16.28 93.98 11.45 16.21 94.40 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 1.80 21.25 100.04 2.61 21.42 100.18 -38.65 13.48 72.21 -38.70 13.32 72.96 ULMN 3 1a0j_c15 TRYPSIN user 28 3 # 28 D 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 D 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 D 193 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 13.53 16.28 93.98 11.45 16.21 94.40 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 1.80 21.25 100.04 2.61 21.42 100.18 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1a0j_c15 TRYPSIN user 29 3 # 29 D 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 D 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 D 193 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 13.53 16.28 93.98 11.45 16.21 94.40 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 1.80 21.25 100.04 2.61 21.42 100.18 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1a0j_c15 TRYPSIN user 30 3 # 30 D 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 D 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 D 193 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 13.53 16.28 93.98 11.45 16.21 94.40 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 1.80 21.25 100.04 2.61 21.42 100.18 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1a0j_c15 TRYPSIN user 31 3 # 31 D 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 1.80 21.25 100.04 2.61 21.42 100.18 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1a0j_c15 TRYPSIN user 32 3 # 32 D 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 1.80 21.25 100.04 2.61 21.42 100.18 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1a0j_c15 TRYPSIN user 33 3 # 33 D 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 1.80 21.25 100.04 2.61 21.42 100.18 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1a0j_c15 TRYPSIN user 34 3 # 34 D 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 193 GLY D 108 GLY.? 11.50 C6 PG4 C 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 1.80 21.25 100.04 2.61 21.42 100.18 -46.34 8.93 60.42 -45.67 8.48 60.39 ULMN 3 1a0j_c15 TRYPSIN user 35 3 # 35 D 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 D 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 13.53 16.28 93.98 11.45 16.21 94.40 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 1.80 21.25 100.04 2.61 21.42 100.18 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1a0j_c15 TRYPSIN user 36 3 # 36 D 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 D 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 13.53 16.28 93.98 11.45 16.21 94.40 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 1.80 21.25 100.04 2.61 21.42 100.18 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1a0j_c15 TRYPSIN user 37 3 # 37 D 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 D 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 13.53 16.28 93.98 11.45 16.21 94.40 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 1.80 21.25 100.04 2.61 21.42 100.18 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1a0j_c15 TRYPSIN user 38 3 # 38 D 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 193 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 1.80 21.25 100.04 2.61 21.42 100.18 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1a0j_c15 TRYPSIN user 39 3 # 39 D 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 193 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 1.80 21.25 100.04 2.61 21.42 100.18 -40.50 35.55 47.63 -40.37 36.37 47.40 1a0j_c15 source 1a0j TRYPSIN : 39 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 152 ARG^? 23.60 O1 PO4 A 349 265 HIS A 229 HIS^? 14.13 O1 PO4 A 349 274 TYR A 285 TYR~? 11.91 O4 PO4 A 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -26.26 60.60 13.36 -28.56 61.89 11.76 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 0.94 52.26 9.16 1.95 54.78 9.91 -8.78 59.29 10.05 -7.08 58.89 12.20 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 153 ARG^? 21.78 O1 PO4 A 349 265 HIS A 229 HIS^? 14.13 O1 PO4 A 349 274 TYR A 285 TYR~? 11.91 O4 PO4 A 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -23.08 51.89 14.34 -24.46 52.07 11.57 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 0.94 52.26 9.16 1.95 54.78 9.91 -8.78 59.29 10.05 -7.08 58.89 12.20 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG A 261 ARG^? 7.73 O2 PO4 A 349 265 HIS A 266 HIS.? 18.54 O4 PO4 A 349 274 TYR A 285 TYR~? 11.91 O4 PO4 A 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -1.53 69.75 22.21 -1.72 66.84 23.28 coo -14.48 45.59 11.18 -14.02 47.49 10.42 6.94 67.18 14.08 7.86 68.38 12.63 coo 0.94 52.26 9.16 1.95 54.78 9.91 -8.78 59.29 10.05 -7.08 58.89 12.20 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG A 335 ARG~? 17.04 O2 PO4 A 349 265 HIS A 309 HIS.? 13.93 O2 PO4 A 349 274 TYR A 31 TYR~? 9.01 O2 PO4 A 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -10.94 77.02 25.36 -8.46 78.77 25.78 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 0.94 52.26 9.16 1.95 54.78 9.91 -13.67 63.12 32.54 -12.97 64.78 30.45 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG B 152 ARG^? 23.80 O2 PO4 B 349 265 HIS B 229 HIS^? 14.08 O2 PO4 B 349 274 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 14.94 46.89 -2.30 16.61 48.81 -4.04 coo -14.48 45.59 11.18 -14.02 47.49 10.42 11.38 38.70 0.79 12.71 38.99 -0.80 coo 0.94 52.26 9.16 1.95 54.78 9.91 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1a41_c01 TOPOISOMERASE I user 6 3 # 6 223 ARG B 153 ARG^? 21.71 O2 PO4 B 349 265 HIS B 229 HIS^? 14.08 O2 PO4 B 349 274 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 12.56 47.43 6.76 13.42 50.26 5.86 coo -14.48 45.59 11.18 -14.02 47.49 10.42 11.38 38.70 0.79 12.71 38.99 -0.80 coo 0.94 52.26 9.16 1.95 54.78 9.91 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1a41_c01 TOPOISOMERASE I user 7 3 # 7 223 ARG B 261 ARG^? 7.86 O3 PO4 B 349 265 HIS B 266 HIS.? 18.54 O4 PO4 B 349 274 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo 0.94 52.26 9.16 1.95 54.78 9.91 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1a41_c01 TOPOISOMERASE I user 8 3 # 8 223 ARG C 152 ARG^? 15.32 O1 PG4 A 350 265 HIS C 229 HIS^? 14.09 O2 PO4 C 349 274 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -26.55 34.01 32.08 -24.98 36.67 32.18 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 0.94 52.26 9.16 1.95 54.78 9.91 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1a41_c01 TOPOISOMERASE I user 9 3 # 9 223 ARG C 153 ARG^? 21.82 O2 PO4 C 349 265 HIS C 229 HIS^? 14.09 O2 PO4 C 349 274 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -28.52 27.96 39.05 -27.50 30.55 40.41 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 0.94 52.26 9.16 1.95 54.78 9.91 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1a41_c01 TOPOISOMERASE I user 10 3 # 10 223 ARG C 261 ARG^? 7.89 O4 PO4 C 349 265 HIS C 266 HIS.? 18.53 O1 PO4 C 349 274 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -51.94 28.25 21.63 -51.22 25.74 23.33 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -60.48 31.92 28.90 -61.75 33.58 29.06 coo 0.94 52.26 9.16 1.95 54.78 9.91 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1a41_c01 TOPOISOMERASE I user 11 3 # 11 223 ARG C 335 ARG~? 16.94 O4 PO4 C 349 265 HIS C 309 HIS.? 14.15 O4 PO4 C 349 274 TYR C 31 TYR~? 9.00 O4 PO4 C 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -43.40 31.02 13.21 -46.07 30.90 11.67 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 0.94 52.26 9.16 1.95 54.78 9.91 -38.22 17.89 20.09 -39.26 20.46 19.95 ULMN 3 1a41_c01 TOPOISOMERASE I user 12 3 # 12 223 ARG C 335 ARG~? 16.94 O4 PO4 C 349 265 HIS C 309 HIS.? 14.15 O4 PO4 C 349 274 TYR C 56 TYR.? 20.70 O4 PO4 C 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -43.40 31.02 13.21 -46.07 30.90 11.67 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 0.94 52.26 9.16 1.95 54.78 9.91 -41.24 17.60 7.53 -40.11 17.22 5.03 ULMN 3 1a41_c01 TOPOISOMERASE I user 13 3 # 13 223 ARG D 152 ARG^? 23.56 O1 PO4 D 349 265 HIS D 229 HIS^? 14.18 O1 PO4 D 349 274 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -66.62 32.34 56.11 -68.43 34.76 55.54 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 0.94 52.26 9.16 1.95 54.78 9.91 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1a41_c01 TOPOISOMERASE I user 14 3 # 14 223 ARG D 153 ARG^? 21.95 O1 PO4 D 349 265 HIS D 229 HIS^? 14.18 O1 PO4 D 349 274 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -63.61 25.82 49.88 -65.26 27.93 48.32 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 0.94 52.26 9.16 1.95 54.78 9.91 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1a41_c01 TOPOISOMERASE I user 15 3 # 15 223 ARG D 261 ARG^? 8.01 O2 PO4 D 349 265 HIS D 266 HIS.? 18.55 O4 PO4 D 349 274 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -41.02 32.36 67.18 -41.18 29.51 65.99 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -32.64 35.78 59.13 -31.61 37.59 58.96 coo 0.94 52.26 9.16 1.95 54.78 9.91 -49.07 33.98 51.47 -47.27 32.17 52.61 1a41_c01 source 1a41 TOPOISOMERASE I : 15 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 94 GLU~? 21.51 O3 PG4 B 350 A 60 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 175 TYR A 91 TYR~? 12.90 C4 PG4 B 350 coo 46.10 28.27 19.27 45.48 26.99 20.84 2.26 51.25 46.83 2.00 52.68 48.40 coo 56.42 28.06 12.93 55.01 27.92 14.50 1.74 60.96 43.57 3.36 61.47 42.28 coo 45.02 22.04 15.38 46.16 24.00 13.76 3.23 49.01 40.90 3.18 50.90 38.82 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 317 GLU~? 25.40 O4 PO4 A 349 A 60 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 175 TYR A 313 TYR~? 26.58 O2 PO4 A 349 coo 46.10 28.27 19.27 45.48 26.99 20.84 -6.54 84.03 15.10 -5.06 85.44 15.56 coo 56.42 28.06 12.93 55.01 27.92 14.50 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 45.02 22.04 15.38 46.16 24.00 13.76 -7.13 87.01 20.69 -6.82 88.46 18.34 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU B 94 GLU~? 22.11 C5 PG4 A 350 A 60 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 175 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 46.10 28.27 19.27 45.48 26.99 20.84 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 56.42 28.06 12.93 55.01 27.92 14.50 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 45.02 22.04 15.38 46.16 24.00 13.76 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU D 94 GLU~? 22.39 C6 PG4 C 350 A 60 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 175 TYR D 91 TYR~? 13.46 C4 PG4 C 350 coo 46.10 28.27 19.27 45.48 26.99 20.84 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 56.42 28.06 12.93 55.01 27.92 14.50 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 45.02 22.04 15.38 46.16 24.00 13.76 -37.64 3.76 65.52 -37.58 6.56 65.66 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU D 317 GLU~? 25.08 O4 PO4 D 349 A 60 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 175 TYR D 313 TYR~? 26.83 O2 PO4 D 349 coo 46.10 28.27 19.27 45.48 26.99 20.84 -45.36 46.85 72.91 -43.76 47.38 74.18 coo 56.42 28.06 12.93 55.01 27.92 14.50 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 45.02 22.04 15.38 46.16 24.00 13.76 -45.78 44.87 79.28 -45.52 47.64 79.09 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 5 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 125 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 156 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 19.22 39.10 5.74 19.70 36.67 7.05 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 11.38 38.70 0.79 12.71 38.99 -0.80 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 125 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 156 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -68.08 25.33 66.69 -67.75 19.10 66.60 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR B 225 TYR~? 21.07 O2 PO4 B 349 B 125 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 156 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 19.22 39.10 5.74 19.70 36.67 7.05 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 11.38 38.70 0.79 12.71 38.99 -0.80 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR D 225 TYR.? 21.05 O1 PO4 D 349 B 125 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 156 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -68.08 25.33 66.69 -67.75 19.10 66.60 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR B 225 TYR~? 21.07 O2 PO4 B 349 C 125 HIS B 229 HIS^? 14.08 O2 PO4 B 349 C 156 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 19.22 39.10 5.74 19.70 36.67 7.05 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 11.38 38.70 0.79 12.71 38.99 -0.80 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR D 225 TYR.? 21.05 O1 PO4 D 349 C 125 HIS D 229 HIS^? 14.18 O1 PO4 D 349 C 156 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -68.08 25.33 66.69 -67.75 19.10 66.60 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR B 225 TYR~? 21.07 O2 PO4 B 349 D 125 HIS B 229 HIS^? 14.08 O2 PO4 B 349 D 156 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 54.10 1.42 85.16 54.14 4.17 85.62 19.22 39.10 5.74 19.70 36.67 7.05 coo 61.27 5.43 85.32 62.73 6.38 86.49 11.38 38.70 0.79 12.71 38.99 -0.80 coo 60.28 4.62 76.00 58.35 6.41 80.65 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR D 225 TYR.? 21.05 O1 PO4 D 349 D 125 HIS D 229 HIS^? 14.18 O1 PO4 D 349 D 156 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 54.10 1.42 85.16 54.14 4.17 85.62 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 61.27 5.43 85.32 62.73 6.38 86.49 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 60.28 4.62 76.00 58.35 6.41 80.65 -68.08 25.33 66.69 -67.75 19.10 66.60 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c03 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER A 64 SER~? 26.25 O3 PG4 B 350 A 228 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 257 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 9.47 41.64 34.15 9.10 39.28 33.93 1.46 56.04 50.07 2.12 55.38 52.31 coo 2.03 38.95 28.44 3.60 38.60 29.83 1.74 60.96 43.57 3.36 61.47 42.28 coo 6.85 37.62 29.99 7.50 38.47 31.78 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 2 3 # 2 A 98 SER A 64 SER~? 26.25 O3 PG4 B 350 A 228 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 257 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 9.47 41.64 34.15 9.10 39.28 33.93 1.46 56.04 50.07 2.12 55.38 52.31 coo 2.03 38.95 28.44 3.60 38.60 29.83 8.08 50.44 43.84 7.48 51.26 41.98 coo 6.85 37.62 29.99 7.50 38.47 31.78 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 3 3 # 3 A 98 SER A 241 SER.? 9.98 O3 PO4 A 349 A 228 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 257 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 9.47 41.64 34.15 9.10 39.28 33.93 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 2.03 38.95 28.44 3.60 38.60 29.83 -1.16 62.88 18.52 0.68 62.16 19.33 coo 6.85 37.62 29.99 7.50 38.47 31.78 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 4 3 # 4 A 98 SER B 64 SER~? 26.98 C5 PG4 A 350 A 228 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 257 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 9.47 41.64 34.15 9.10 39.28 33.93 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 2.03 38.95 28.44 3.60 38.60 29.83 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 6.85 37.62 29.99 7.50 38.47 31.78 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 5 3 # 5 A 98 SER B 241 SER.? 10.02 O1 PO4 B 349 A 228 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 257 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 9.47 41.64 34.15 9.10 39.28 33.93 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 2.03 38.95 28.44 3.60 38.60 29.83 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 6.85 37.62 29.99 7.50 38.47 31.78 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 6 3 # 6 A 98 SER C 64 SER~? 25.88 C5 PG4 D 350 A 228 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 257 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 9.47 41.64 34.15 9.10 39.28 33.93 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 2.03 38.95 28.44 3.60 38.60 29.83 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 6.85 37.62 29.99 7.50 38.47 31.78 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 7 3 # 7 A 98 SER C 241 SER.? 9.97 O3 PO4 C 349 A 228 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 257 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 9.47 41.64 34.15 9.10 39.28 33.93 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 2.03 38.95 28.44 3.60 38.60 29.83 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 6.85 37.62 29.99 7.50 38.47 31.78 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 8 3 # 8 A 98 SER D 64 SER~? 27.50 C6 PG4 C 350 A 228 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 257 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 9.47 41.64 34.15 9.10 39.28 33.93 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 2.03 38.95 28.44 3.60 38.60 29.83 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 6.85 37.62 29.99 7.50 38.47 31.78 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 9 3 # 9 A 98 SER D 241 SER.? 10.08 O3 PO4 D 349 A 228 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 257 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 9.47 41.64 34.15 9.10 39.28 33.93 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 2.03 38.95 28.44 3.60 38.60 29.83 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 6.85 37.62 29.99 7.50 38.47 31.78 -38.74 26.41 54.26 -37.48 24.84 54.87 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 9 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER A 64 SER~? 26.25 O3 PG4 B 350 B 228 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 257 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 28.35 71.07 3.94 30.08 69.46 4.49 1.46 56.04 50.07 2.12 55.38 52.31 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 1.74 60.96 43.57 3.36 61.47 42.28 coo 32.76 68.02 0.70 31.21 68.44 2.05 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 2 3 # 2 B 98 SER A 64 SER~? 26.25 O3 PG4 B 350 B 228 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 257 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 28.35 71.07 3.94 30.08 69.46 4.49 1.46 56.04 50.07 2.12 55.38 52.31 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 8.08 50.44 43.84 7.48 51.26 41.98 coo 32.76 68.02 0.70 31.21 68.44 2.05 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 3 3 # 3 B 98 SER A 241 SER.? 9.98 O3 PO4 A 349 B 228 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 257 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 28.35 71.07 3.94 30.08 69.46 4.49 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -1.16 62.88 18.52 0.68 62.16 19.33 coo 32.76 68.02 0.70 31.21 68.44 2.05 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 4 3 # 4 B 98 SER B 64 SER~? 26.98 C5 PG4 A 350 B 228 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 257 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 28.35 71.07 3.94 30.08 69.46 4.49 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 32.76 68.02 0.70 31.21 68.44 2.05 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 5 3 # 5 B 98 SER B 241 SER.? 10.02 O1 PO4 B 349 B 228 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 257 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 28.35 71.07 3.94 30.08 69.46 4.49 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 32.76 68.02 0.70 31.21 68.44 2.05 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 6 3 # 6 B 98 SER C 64 SER~? 25.88 C5 PG4 D 350 B 228 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 257 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 28.35 71.07 3.94 30.08 69.46 4.49 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 32.76 68.02 0.70 31.21 68.44 2.05 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 7 3 # 7 B 98 SER C 64 SER~? 25.88 C5 PG4 D 350 B 228 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 257 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 28.35 71.07 3.94 30.08 69.46 4.49 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 32.76 68.02 0.70 31.21 68.44 2.05 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 8 3 # 8 B 98 SER C 241 SER.? 9.97 O3 PO4 C 349 B 228 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 257 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 28.35 71.07 3.94 30.08 69.46 4.49 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 32.76 68.02 0.70 31.21 68.44 2.05 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 9 3 # 9 B 98 SER D 64 SER~? 27.50 C6 PG4 C 350 B 228 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 257 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 28.35 71.07 3.94 30.08 69.46 4.49 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 32.76 68.02 0.70 31.21 68.44 2.05 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 10 3 # 10 B 98 SER D 241 SER.? 10.08 O3 PO4 D 349 B 228 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 257 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 28.35 71.07 3.94 30.08 69.46 4.49 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 32.76 68.02 0.70 31.21 68.44 2.05 -38.74 26.41 54.26 -37.48 24.84 54.87 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 10 hits 1a7u_c03 naa= 3 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 1 3 # 1 16 ALA A 175 ALA~? 17.35 O1 PO4 A 349 19 HIS A 173 HIS~? 15.17 O1 PO4 A 349 22 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -24.81 67.41 24.63 -24.01 68.06 23.54 coo 46.88 33.59 48.26 46.24 34.32 46.40 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 48.05 31.12 44.60 48.20 33.05 43.77 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 2 3 # 2 16 ALA A 175 ALA~? 17.35 O1 PO4 A 349 19 HIS A 229 HIS^? 14.13 O1 PO4 A 349 22 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -24.81 67.41 24.63 -24.01 68.06 23.54 coo 46.88 33.59 48.26 46.24 34.32 46.40 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 48.05 31.12 44.60 48.20 33.05 43.77 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 3 3 # 3 16 ALA A 176 ALA~? 18.28 O1 PO4 A 349 19 HIS A 173 HIS~? 15.17 O1 PO4 A 349 22 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -27.00 64.71 23.01 -26.51 63.43 22.36 coo 46.88 33.59 48.26 46.24 34.32 46.40 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 48.05 31.12 44.60 48.20 33.05 43.77 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 4 3 # 4 16 ALA A 176 ALA~? 18.28 O1 PO4 A 349 19 HIS A 229 HIS^? 14.13 O1 PO4 A 349 22 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -27.00 64.71 23.01 -26.51 63.43 22.36 coo 46.88 33.59 48.26 46.24 34.32 46.40 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 48.05 31.12 44.60 48.20 33.05 43.77 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 5 3 # 5 16 ALA B 175 ALA~? 17.30 O2 PO4 B 349 19 HIS B 173 HIS~? 15.15 O2 PO4 B 349 22 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 14.10 34.75 -6.58 13.02 35.55 -7.27 coo 46.88 33.59 48.26 46.24 34.32 46.40 13.23 34.15 0.64 14.88 33.23 1.56 coo 48.05 31.12 44.60 48.20 33.05 43.77 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 6 3 # 6 16 ALA B 175 ALA~? 17.30 O2 PO4 B 349 19 HIS B 229 HIS^? 14.08 O2 PO4 B 349 22 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 14.10 34.75 -6.58 13.02 35.55 -7.27 coo 46.88 33.59 48.26 46.24 34.32 46.40 11.38 38.70 0.79 12.71 38.99 -0.80 coo 48.05 31.12 44.60 48.20 33.05 43.77 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 7 3 # 7 16 ALA B 176 ALA~? 18.30 O2 PO4 B 349 19 HIS B 173 HIS~? 15.15 O2 PO4 B 349 22 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 16.22 37.28 -4.66 15.77 38.11 -3.49 coo 46.88 33.59 48.26 46.24 34.32 46.40 13.23 34.15 0.64 14.88 33.23 1.56 coo 48.05 31.12 44.60 48.20 33.05 43.77 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 8 3 # 8 16 ALA B 176 ALA~? 18.30 O2 PO4 B 349 19 HIS B 229 HIS^? 14.08 O2 PO4 B 349 22 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 16.22 37.28 -4.66 15.77 38.11 -3.49 coo 46.88 33.59 48.26 46.24 34.32 46.40 11.38 38.70 0.79 12.71 38.99 -0.80 coo 48.05 31.12 44.60 48.20 33.05 43.77 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 9 3 # 9 16 ALA C 175 ALA~? 17.02 O2 PG4 A 350 19 HIS C 173 HIS~? 15.03 O2 PO4 C 349 22 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -28.16 28.46 20.32 -29.18 29.57 20.45 coo 46.88 33.59 48.26 46.24 34.32 46.40 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 48.05 31.12 44.60 48.20 33.05 43.77 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 10 3 # 10 16 ALA C 175 ALA~? 17.02 O2 PG4 A 350 19 HIS C 229 HIS^? 14.09 O2 PO4 C 349 22 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -28.16 28.46 20.32 -29.18 29.57 20.45 coo 46.88 33.59 48.26 46.24 34.32 46.40 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 48.05 31.12 44.60 48.20 33.05 43.77 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 11 3 # 11 16 ALA C 176 ALA~? 15.03 O2 PG4 A 350 19 HIS C 173 HIS~? 15.03 O2 PO4 C 349 22 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -25.95 28.73 23.42 -26.39 28.45 24.83 coo 46.88 33.59 48.26 46.24 34.32 46.40 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 48.05 31.12 44.60 48.20 33.05 43.77 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 12 3 # 12 16 ALA C 176 ALA~? 15.03 O2 PG4 A 350 19 HIS C 229 HIS^? 14.09 O2 PO4 C 349 22 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -25.95 28.73 23.42 -26.39 28.45 24.83 coo 46.88 33.59 48.26 46.24 34.32 46.40 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 48.05 31.12 44.60 48.20 33.05 43.77 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 13 3 # 13 16 ALA D 175 ALA~? 17.45 O1 PO4 D 349 19 HIS D 173 HIS~? 14.91 O1 PO4 D 349 22 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -64.41 28.74 68.50 -63.57 30.01 68.35 coo 46.88 33.59 48.26 46.24 34.32 46.40 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 48.05 31.12 44.60 48.20 33.05 43.77 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 14 3 # 14 16 ALA D 175 ALA~? 17.45 O1 PO4 D 349 19 HIS D 229 HIS^? 14.18 O1 PO4 D 349 22 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -64.41 28.74 68.50 -63.57 30.01 68.35 coo 46.88 33.59 48.26 46.24 34.32 46.40 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 48.05 31.12 44.60 48.20 33.05 43.77 -62.51 23.18 64.17 -63.84 21.56 64.29 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 15 3 # 15 16 ALA D 176 ALA~? 18.20 O1 PO4 D 349 19 HIS D 173 HIS~? 14.91 O1 PO4 D 349 22 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -66.56 28.54 65.37 -66.10 28.17 63.98 coo 46.88 33.59 48.26 46.24 34.32 46.40 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 48.05 31.12 44.60 48.20 33.05 43.77 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 16 3 # 16 16 ALA D 176 ALA~? 18.20 O1 PO4 D 349 19 HIS D 229 HIS^? 14.18 O1 PO4 D 349 22 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo 53.27 36.51 45.29 51.98 36.45 44.47 -66.56 28.54 65.37 -66.10 28.17 63.98 coo 46.88 33.59 48.26 46.24 34.32 46.40 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 48.05 31.12 44.60 48.20 33.05 43.77 -62.51 23.18 64.17 -63.84 21.56 64.29 1a8h_c02 source 1a8h METHIONYL-TRNA SYNTHETASE : 16 hits 1a8h_c02 naa= 3 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 1 3 # 1 94 SER A 64 SER~? 26.25 O3 PG4 B 350 223 ASP A 41 ASP.? 20.10 O2 PO4 A 349 252 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 40.95 0.07 3.20 39.54 1.39 4.66 1.46 56.04 50.07 2.12 55.38 52.31 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 1.74 60.96 43.57 3.36 61.47 42.28 coo 41.54 1.64 9.09 40.82 1.05 7.19 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 2 3 # 2 94 SER A 64 SER~? 26.25 O3 PG4 B 350 223 ASP A 90 ASP~? 15.98 C4 PG4 B 350 252 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 40.95 0.07 3.20 39.54 1.39 4.66 1.46 56.04 50.07 2.12 55.38 52.31 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 8.08 50.44 43.84 7.48 51.26 41.98 coo 41.54 1.64 9.09 40.82 1.05 7.19 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 3 3 # 3 94 SER A 241 SER.? 9.98 O3 PO4 A 349 223 ASP A 160 ASP.? 8.60 O4 PO4 A 349 252 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 40.95 0.07 3.20 39.54 1.39 4.66 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -1.16 62.88 18.52 0.68 62.16 19.33 coo 41.54 1.64 9.09 40.82 1.05 7.19 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 4 3 # 4 94 SER B 64 SER~? 26.98 C5 PG4 A 350 223 ASP B 41 ASP.? 20.21 O3 PO4 B 349 252 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 40.95 0.07 3.20 39.54 1.39 4.66 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 41.54 1.64 9.09 40.82 1.05 7.19 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 5 3 # 5 94 SER B 241 SER.? 10.02 O1 PO4 B 349 223 ASP B 160 ASP.? 8.62 O4 PO4 B 349 252 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 40.95 0.07 3.20 39.54 1.39 4.66 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 41.54 1.64 9.09 40.82 1.05 7.19 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 6 3 # 6 94 SER C 64 SER~? 25.88 C5 PG4 D 350 223 ASP C 41 ASP.? 20.22 O4 PO4 C 349 252 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 40.95 0.07 3.20 39.54 1.39 4.66 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 41.54 1.64 9.09 40.82 1.05 7.19 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 7 3 # 7 94 SER C 64 SER~? 25.88 C5 PG4 D 350 223 ASP C 90 ASP~? 15.56 C5 PG4 D 350 252 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 40.95 0.07 3.20 39.54 1.39 4.66 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 41.54 1.64 9.09 40.82 1.05 7.19 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 8 3 # 8 94 SER C 241 SER.? 9.97 O3 PO4 C 349 223 ASP C 160 ASP.? 8.57 O1 PO4 C 349 252 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 40.95 0.07 3.20 39.54 1.39 4.66 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 41.54 1.64 9.09 40.82 1.05 7.19 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 9 3 # 9 94 SER D 64 SER~? 27.50 C6 PG4 C 350 223 ASP D 41 ASP.? 20.92 O2 PO4 D 349 252 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 40.95 0.07 3.20 39.54 1.39 4.66 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 41.54 1.64 9.09 40.82 1.05 7.19 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 10 3 # 10 94 SER D 241 SER.? 10.08 O3 PO4 D 349 223 ASP D 160 ASP.? 8.58 O4 PO4 D 349 252 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 40.95 0.07 3.20 39.54 1.39 4.66 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 41.54 1.64 9.09 40.82 1.05 7.19 -38.74 26.41 54.26 -37.48 24.84 54.87 1a8q_c00 source 1a8q BROMOPEROXIDASE A1 : 10 hits 1a8q_c00 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER A 64 SER~? 26.25 O3 PG4 B 350 224 ASP A 41 ASP.? 20.10 O2 PO4 A 349 253 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 16.00 80.13 58.60 16.16 82.12 59.96 1.46 56.04 50.07 2.12 55.38 52.31 coo 8.47 84.84 62.27 10.52 84.40 62.08 1.74 60.96 43.57 3.36 61.47 42.28 coo 13.14 83.03 63.68 14.37 82.62 62.02 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 2 3 # 2 94 SER A 64 SER~? 26.25 O3 PG4 B 350 224 ASP A 90 ASP~? 15.98 C4 PG4 B 350 253 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 16.00 80.13 58.60 16.16 82.12 59.96 1.46 56.04 50.07 2.12 55.38 52.31 coo 8.47 84.84 62.27 10.52 84.40 62.08 8.08 50.44 43.84 7.48 51.26 41.98 coo 13.14 83.03 63.68 14.37 82.62 62.02 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 3 3 # 3 94 SER A 241 SER.? 9.98 O3 PO4 A 349 224 ASP A 160 ASP.? 8.60 O4 PO4 A 349 253 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 16.00 80.13 58.60 16.16 82.12 59.96 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 8.47 84.84 62.27 10.52 84.40 62.08 -1.16 62.88 18.52 0.68 62.16 19.33 coo 13.14 83.03 63.68 14.37 82.62 62.02 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 4 3 # 4 94 SER B 64 SER~? 26.98 C5 PG4 A 350 224 ASP B 41 ASP.? 20.21 O3 PO4 B 349 253 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 16.00 80.13 58.60 16.16 82.12 59.96 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 8.47 84.84 62.27 10.52 84.40 62.08 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 13.14 83.03 63.68 14.37 82.62 62.02 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 5 3 # 5 94 SER B 241 SER.? 10.02 O1 PO4 B 349 224 ASP B 160 ASP.? 8.62 O4 PO4 B 349 253 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 16.00 80.13 58.60 16.16 82.12 59.96 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 8.47 84.84 62.27 10.52 84.40 62.08 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 13.14 83.03 63.68 14.37 82.62 62.02 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 6 3 # 6 94 SER C 64 SER~? 25.88 C5 PG4 D 350 224 ASP C 41 ASP.? 20.22 O4 PO4 C 349 253 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 16.00 80.13 58.60 16.16 82.12 59.96 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 8.47 84.84 62.27 10.52 84.40 62.08 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 13.14 83.03 63.68 14.37 82.62 62.02 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 7 3 # 7 94 SER C 241 SER.? 9.97 O3 PO4 C 349 224 ASP C 160 ASP.? 8.57 O1 PO4 C 349 253 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 16.00 80.13 58.60 16.16 82.12 59.96 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 8.47 84.84 62.27 10.52 84.40 62.08 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 13.14 83.03 63.68 14.37 82.62 62.02 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 8 3 # 8 94 SER D 64 SER~? 27.50 C6 PG4 C 350 224 ASP D 41 ASP.? 20.92 O2 PO4 D 349 253 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 16.00 80.13 58.60 16.16 82.12 59.96 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 8.47 84.84 62.27 10.52 84.40 62.08 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 13.14 83.03 63.68 14.37 82.62 62.02 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 9 3 # 9 94 SER D 241 SER.? 10.08 O3 PO4 D 349 224 ASP D 160 ASP.? 8.58 O4 PO4 D 349 253 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 16.00 80.13 58.60 16.16 82.12 59.96 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 8.47 84.84 62.27 10.52 84.40 62.08 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 13.14 83.03 63.68 14.37 82.62 62.02 -38.74 26.41 54.26 -37.48 24.84 54.87 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 9 hits 1a8s_c00 naa= 3 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 1 3 # 1 44 LYS A 165 LYS~? -2.78 O4 PO4 A 349s 141 HIS A 110 HIS.? 5.77 C3 PG4 B 350 333 ARG B 206 ARG~? -3.06 O4 PG4 B 350s coo 69.56 26.03 31.04 72.53 30.39 31.84 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 85.95 39.62 33.57 84.70 40.34 35.09 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 87.31 36.08 32.89 89.57 36.58 34.95 -2.22 41.47 25.55 0.33 41.32 27.30 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 2 3 # 2 44 LYS B 96 LYS~? 18.72 C5 PG4 A 350 141 HIS B 110 HIS.? 5.25 C4 PG4 A 350 333 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo 69.56 26.03 31.04 72.53 30.39 31.84 -4.65 11.97 23.20 -9.16 12.78 27.52 coo 85.95 39.62 33.57 84.70 40.34 35.09 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 87.31 36.08 32.89 89.57 36.58 34.95 -3.22 31.42 16.60 -5.11 31.22 14.14 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 3 3 # 3 44 LYS B 165 LYS~? -2.78 O4 PO4 B 349s 141 HIS B 110 HIS.? 5.25 C4 PG4 A 350 333 ARG A 206 ARG~? -3.21 O4 PG4 A 350s coo 69.56 26.03 31.04 72.53 30.39 31.84 0.37 36.49 0.17 -3.63 37.66 2.73 coo 85.95 39.62 33.57 84.70 40.34 35.09 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 87.31 36.08 32.89 89.57 36.58 34.95 -5.76 36.17 21.40 -8.07 34.21 22.04 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 4 3 # 4 44 LYS C 165 LYS~? -2.77 O1 PO4 C 349s 141 HIS C 110 HIS.? 5.63 C6 PG4 D 350 333 ARG D 206 ARG~? -3.23 O2 PG4 D 350s coo 69.56 26.03 31.04 72.53 30.39 31.84 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 85.95 39.62 33.57 84.70 40.34 35.09 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 87.31 36.08 32.89 89.57 36.58 34.95 -46.64 9.92 42.41 -48.92 7.98 41.78 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 5 3 # 5 44 LYS D 96 LYS~? 18.18 C6 PG4 C 350 141 HIS D 110 HIS.? 5.57 O3 PG4 C 350 333 ARG D 133 ARG.? 8.84 C4 PG4 C 350 coo 69.56 26.03 31.04 72.53 30.39 31.84 -42.30 -5.81 66.82 -37.97 -8.16 62.87 coo 85.95 39.62 33.57 84.70 40.34 35.09 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 87.31 36.08 32.89 89.57 36.58 34.95 -45.06 11.05 55.96 -43.37 13.22 57.41 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 6 3 # 6 44 LYS D 165 LYS~? -2.89 O4 PO4 D 349s 141 HIS D 110 HIS.? 5.57 O3 PG4 C 350 333 ARG C 206 ARG~? -3.06 O3 PG4 C 350s coo 69.56 26.03 31.04 72.53 30.39 31.84 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 85.95 39.62 33.57 84.70 40.34 35.09 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 87.31 36.08 32.89 89.57 36.58 34.95 -42.81 10.68 48.87 -40.18 9.57 50.03 1aa6_c01 source 1aa6 FORMATE DEHYDROGENASE H : 6 hits 1aa6_c01 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 249 ARG~? 17.61 O4 PO4 B 349 78 HIS B 238 HIS.? 10.82 O1 PO4 B 349 122 TYR B 31 TYR~? 9.45 O3 PO4 B 349 coo 48.32 72.26 30.89 48.69 69.28 31.53 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 53.63 68.24 34.99 53.08 69.10 33.16 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 75.01 61.87 32.93 75.34 59.26 31.96 5.43 26.32 0.91 4.29 27.88 -1.11 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG A 249 ARG~? 17.61 O4 PO4 B 349 78 HIS B 238 HIS.? 10.82 O1 PO4 B 349 122 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 48.32 72.26 30.89 48.69 69.28 31.53 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 53.63 68.24 34.99 53.08 69.10 33.16 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 75.01 61.87 32.93 75.34 59.26 31.96 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG B 249 ARG~? 17.39 O4 PO4 A 349 78 HIS A 238 HIS.? 10.67 O3 PO4 A 349 122 TYR A 31 TYR~? 9.01 O2 PO4 A 349 coo 48.32 72.26 30.89 48.69 69.28 31.53 1.78 52.94 11.29 0.18 53.87 8.84 coo 53.63 68.24 34.99 53.08 69.10 33.16 1.50 56.90 17.79 2.83 56.38 19.33 coo 75.01 61.87 32.93 75.34 59.26 31.96 -13.67 63.12 32.54 -12.97 64.78 30.45 ULMN 3 1ab4_c00 GYRASE A user 4 3 # 4 32 ARG C 249 ARG~? 17.71 O4 PO4 D 349 78 HIS D 238 HIS.? 10.72 O3 PO4 D 349 122 TYR D 31 TYR~? 9.28 O2 PO4 D 349 coo 48.32 72.26 30.89 48.69 69.28 31.53 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 53.63 68.24 34.99 53.08 69.10 33.16 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 75.01 61.87 32.93 75.34 59.26 31.96 -53.52 20.07 70.01 -52.37 22.61 69.97 ULMN 3 1ab4_c00 GYRASE A user 5 3 # 5 32 ARG D 249 ARG~? 17.54 O1 PO4 C 349 78 HIS C 238 HIS.? 10.74 O3 PO4 C 349 122 TYR C 31 TYR~? 9.00 O4 PO4 C 349 coo 48.32 72.26 30.89 48.69 69.28 31.53 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 53.63 68.24 34.99 53.08 69.10 33.16 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 75.01 61.87 32.93 75.34 59.26 31.96 -38.22 17.89 20.09 -39.26 20.46 19.95 1ab4_c00 source 1ab4 GYRASE A : 5 hits 1ab4_c00 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 138 ASN.? -6.13 O2 PG4 A 350s 63 ARG C 179 ARG~? 14.85 O2 PG4 A 350 255 ARG A 220 ARG~? 15.84 O1 PG4 A 350 coo 42.10 13.02 11.14 41.85 11.12 10.23 -17.89 33.84 23.48 -17.76 31.89 24.26 coo 44.36 11.24 3.39 41.81 12.78 4.00 -24.98 33.12 21.00 -27.25 35.17 20.85 coo 38.40 3.83 10.26 40.02 6.30 9.25 -23.72 43.89 25.49 -25.14 44.23 28.23 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 270 ASN.? 15.06 O3 PO4 A 349 63 ARG B 147 ARG~? 21.77 C2 PG4 B 350 255 ARG B 249 ARG~? 17.39 O4 PO4 A 349 coo 42.10 13.02 11.14 41.85 11.12 10.23 7.80 59.00 17.23 7.36 57.24 18.34 coo 44.36 11.24 3.39 41.81 12.78 4.00 11.90 56.41 10.58 13.26 57.05 13.30 coo 38.40 3.83 10.26 40.02 6.30 9.25 1.78 52.94 11.29 0.18 53.87 8.84 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN A 306 ASN^? 8.27 O2 PO4 A 349 63 ARG A 335 ARG~? 17.04 O2 PO4 A 349 255 ARG A 30 ARG~? 10.33 O2 PO4 A 349 coo 42.10 13.02 11.14 41.85 11.12 10.23 -7.02 69.82 22.14 -6.25 69.91 24.11 coo 44.36 11.24 3.39 41.81 12.78 4.00 -10.94 77.02 25.36 -8.46 78.77 25.78 coo 38.40 3.83 10.26 40.02 6.30 9.25 -9.85 66.58 32.39 -7.32 68.13 33.36 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 4 3 # 4 22 ASN B 270 ASN.? 15.02 O1 PO4 B 349 63 ARG A 147 ARG~? 21.89 C2 PG4 A 350 255 ARG A 249 ARG~? 17.61 O4 PO4 B 349 coo 42.10 13.02 11.14 41.85 11.12 10.23 -17.98 39.50 4.84 -17.14 38.86 6.70 coo 44.36 11.24 3.39 41.81 12.78 4.00 -23.00 46.39 6.22 -24.32 43.65 5.76 coo 38.40 3.83 10.26 40.02 6.30 9.25 -12.58 47.35 8.37 -11.42 49.74 6.78 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 5 3 # 5 22 ASN B 270 ASN.? 15.02 O1 PO4 B 349 63 ARG A 249 ARG~? 17.61 O4 PO4 B 349 255 ARG A 147 ARG~? 21.89 C2 PG4 A 350 coo 42.10 13.02 11.14 41.85 11.12 10.23 -17.98 39.50 4.84 -17.14 38.86 6.70 coo 44.36 11.24 3.39 41.81 12.78 4.00 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 38.40 3.83 10.26 40.02 6.30 9.25 -23.00 46.39 6.22 -24.32 43.65 5.76 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 6 3 # 6 22 ASN B 306 ASN^? 8.17 O3 PO4 B 349 63 ARG B 335 ARG~? 17.10 O3 PO4 B 349 255 ARG B 30 ARG~? 9.80 O3 PO4 B 349 coo 42.10 13.02 11.14 41.85 11.12 10.23 -3.96 34.28 -6.86 -4.36 32.22 -6.36 coo 44.36 11.24 3.39 41.81 12.78 4.00 -0.53 29.97 -13.85 -3.08 28.75 -15.03 coo 38.40 3.83 10.26 40.02 6.30 9.25 1.86 25.26 -2.23 -1.04 24.22 -2.87 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 7 3 # 7 22 ASN C 270 ASN.? 15.22 O3 PO4 C 349 63 ARG D 147 ARG~? 21.65 O5 PG4 D 350 255 ARG D 249 ARG~? 17.54 O1 PO4 C 349 coo 42.10 13.02 11.14 41.85 11.12 10.23 -59.71 24.81 33.93 -59.02 22.97 34.76 coo 44.36 11.24 3.39 41.81 12.78 4.00 -64.41 28.02 40.25 -65.44 25.99 38.16 coo 38.40 3.83 10.26 40.02 6.30 9.25 -53.61 27.06 41.90 -52.49 29.90 42.42 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 8 3 # 8 22 ASN C 270 ASN.? 15.22 O3 PO4 C 349 63 ARG D 249 ARG~? 17.54 O1 PO4 C 349 255 ARG D 147 ARG~? 21.65 O5 PG4 D 350 coo 42.10 13.02 11.14 41.85 11.12 10.23 -59.71 24.81 33.93 -59.02 22.97 34.76 coo 44.36 11.24 3.39 41.81 12.78 4.00 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 38.40 3.83 10.26 40.02 6.30 9.25 -64.41 28.02 40.25 -65.44 25.99 38.16 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 9 3 # 9 22 ASN C 306 ASN^? 8.19 O4 PO4 C 349 63 ARG C 335 ARG~? 16.94 O4 PO4 C 349 255 ARG C 30 ARG~? 10.19 O4 PO4 C 349 coo 42.10 13.02 11.14 41.85 11.12 10.23 -46.37 29.17 21.30 -46.92 27.39 20.25 coo 44.36 11.24 3.39 41.81 12.78 4.00 -43.40 31.02 13.21 -46.07 30.90 11.67 coo 38.40 3.83 10.26 40.02 6.30 9.25 -42.41 19.48 17.74 -45.10 19.59 16.14 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 10 3 # 10 22 ASN C 348 ASN.? 21.93 O1 PG4 A 350 63 ARG C 152 ARG^? 15.32 O1 PG4 A 350 255 ARG A 220 ARG~? 15.84 O1 PG4 A 350 coo 42.10 13.02 11.14 41.85 11.12 10.23 -30.06 39.54 32.39 -31.15 40.21 34.08 coo 44.36 11.24 3.39 41.81 12.78 4.00 -26.55 34.01 32.08 -24.98 36.67 32.18 coo 38.40 3.83 10.26 40.02 6.30 9.25 -23.72 43.89 25.49 -25.14 44.23 28.23 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 11 3 # 11 22 ASN D 270 ASN.? 14.75 O3 PO4 D 349 63 ARG C 147 ARG~? 21.64 C2 PG4 C 350 255 ARG C 249 ARG~? 17.71 O4 PO4 D 349 coo 42.10 13.02 11.14 41.85 11.12 10.23 -32.60 27.92 55.07 -33.22 25.92 54.63 coo 44.36 11.24 3.39 41.81 12.78 4.00 -28.57 31.49 48.25 -26.95 30.26 50.59 coo 38.40 3.83 10.26 40.02 6.30 9.25 -38.85 28.76 46.96 -40.48 31.26 46.10 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 12 3 # 12 22 ASN D 270 ASN.? 14.75 O3 PO4 D 349 63 ARG C 249 ARG~? 17.71 O4 PO4 D 349 255 ARG C 147 ARG~? 21.64 C2 PG4 C 350 coo 42.10 13.02 11.14 41.85 11.12 10.23 -32.60 27.92 55.07 -33.22 25.92 54.63 coo 44.36 11.24 3.39 41.81 12.78 4.00 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 38.40 3.83 10.26 40.02 6.30 9.25 -28.57 31.49 48.25 -26.95 30.26 50.59 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 12 hits 1aj0_c00 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 309 HIS.? 13.93 O2 PO4 A 349 A 262 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 312 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 29.33 36.13 69.70 30.07 34.20 70.11 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 38.54 36.60 66.38 37.88 34.77 67.15 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 30.62 37.23 61.07 30.08 35.73 62.49 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS B 309 HIS.? 14.09 O3 PO4 B 349 A 262 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 312 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 29.33 36.13 69.70 30.07 34.20 70.11 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo 38.54 36.60 66.38 37.88 34.77 67.15 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 30.62 37.23 61.07 30.08 35.73 62.49 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 3 3 # 3 A 223 HIS C 309 HIS.? 14.15 O4 PO4 C 349 A 262 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 312 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 29.33 36.13 69.70 30.07 34.20 70.11 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 38.54 36.60 66.38 37.88 34.77 67.15 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 30.62 37.23 61.07 30.08 35.73 62.49 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 4 3 # 4 A 223 HIS D 309 HIS.? 14.00 O2 PO4 D 349 A 262 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 312 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.87 34.22 71.66 -41.37 35.58 70.15 coo 38.54 36.60 66.38 37.88 34.77 67.15 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 30.62 37.23 61.07 30.08 35.73 62.49 -51.05 35.32 70.59 -50.24 33.36 70.95 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 4 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 309 HIS.? 13.93 O2 PO4 A 349 B 262 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 312 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 23.86 29.50 91.20 24.12 31.58 91.00 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 29.35 31.42 99.15 28.72 33.09 98.04 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 20.42 28.25 99.26 20.25 29.62 97.63 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS B 309 HIS.? 14.09 O3 PO4 B 349 B 262 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 312 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 23.86 29.50 91.20 24.12 31.58 91.00 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo 29.35 31.42 99.15 28.72 33.09 98.04 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 20.42 28.25 99.26 20.25 29.62 97.63 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 3 3 # 3 B 223 HIS C 309 HIS.? 14.15 O4 PO4 C 349 B 262 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 312 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 23.86 29.50 91.20 24.12 31.58 91.00 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 29.35 31.42 99.15 28.72 33.09 98.04 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 20.42 28.25 99.26 20.25 29.62 97.63 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 4 3 # 4 B 223 HIS D 309 HIS.? 14.00 O2 PO4 D 349 B 262 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 312 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.87 34.22 71.66 -41.37 35.58 70.15 coo 29.35 31.42 99.15 28.72 33.09 98.04 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 20.42 28.25 99.26 20.25 29.62 97.63 -51.05 35.32 70.59 -50.24 33.36 70.95 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 4 hits 1aj8_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 260 HIS^? 11.64 O4 PO4 A 349 320 HIS A 266 HIS.? 18.54 O4 PO4 A 349 375 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 6.94 67.18 14.08 7.86 68.38 12.63 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS A 260 HIS^? 11.64 O4 PO4 A 349 320 HIS A 309 HIS.? 13.93 O2 PO4 A 349 375 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1al6_c00 CITRATE SYNTHASE user 3 3 # 3 274 HIS A 309 HIS.? 13.93 O2 PO4 A 349 320 HIS A 260 HIS^? 11.64 O4 PO4 A 349 375 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1al6_c00 CITRATE SYNTHASE user 4 3 # 4 274 HIS B 260 HIS^? 11.70 O4 PO4 B 349 320 HIS B 309 HIS.? 14.09 O3 PO4 B 349 375 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1al6_c00 CITRATE SYNTHASE user 5 3 # 5 274 HIS B 309 HIS.? 14.09 O3 PO4 B 349 320 HIS B 260 HIS^? 11.70 O4 PO4 B 349 375 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1al6_c00 CITRATE SYNTHASE user 6 3 # 6 274 HIS C 260 HIS^? 11.63 O1 PO4 C 349 320 HIS C 309 HIS.? 14.15 O4 PO4 C 349 375 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1al6_c00 CITRATE SYNTHASE user 7 3 # 7 274 HIS C 309 HIS.? 14.15 O4 PO4 C 349 320 HIS C 260 HIS^? 11.63 O1 PO4 C 349 375 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1al6_c00 CITRATE SYNTHASE user 8 3 # 8 274 HIS D 260 HIS^? 11.65 O4 PO4 D 349 320 HIS D 309 HIS.? 14.00 O2 PO4 D 349 375 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -40.87 34.22 71.66 -41.37 35.58 70.15 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1al6_c00 CITRATE SYNTHASE user 9 3 # 9 274 HIS D 309 HIS.? 14.00 O2 PO4 D 349 320 HIS D 260 HIS^? 11.65 O4 PO4 D 349 375 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.87 34.22 71.66 -41.37 35.58 70.15 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -51.05 35.32 70.59 -50.24 33.36 70.95 1al6_c00 source 1al6 CITRATE SYNTHASE : 9 hits 1al6_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 203 ASP~? 10.68 C3 PG4 B 350 187 GLU A 231 GLU.? 5.77 O1 PO4 A 349 229 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -12.78 56.62 24.13 -12.11 55.65 25.89 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 208 ASP~? 8.51 C3 PG4 A 350 187 GLU B 135 GLU.? -3.99 O5 PG4 B 350s 229 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -45.08 48.37 46.81 -46.53 49.74 45.96 2.30 38.46 22.67 1.14 39.98 23.57 coo -47.40 44.36 48.48 -50.80 49.18 46.20 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP B 203 ASP~? 9.89 C4 PG4 A 350 187 GLU B 231 GLU.? 5.72 O2 PO4 B 349 229 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -45.08 48.37 46.81 -46.53 49.74 45.96 3.23 35.71 5.73 3.00 33.97 6.89 coo -47.40 44.36 48.48 -50.80 49.18 46.20 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP C 203 ASP~? 10.24 C6 PG4 D 350 187 GLU C 231 GLU.? 5.70 O2 PO4 C 349 229 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -38.62 20.97 30.45 -38.95 18.93 30.05 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP D 203 ASP~? 10.40 O3 PG4 C 350 187 GLU D 231 GLU.? 5.62 O1 PO4 D 349 229 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -52.72 21.86 59.42 -51.91 19.95 59.86 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -50.59 27.20 61.67 -46.47 26.50 58.89 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 5 hits 1ald_c00 naa= 3 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 A 457 SER A 64 SER~? 26.25 O3 PG4 B 350 A 630 CYH A 44 CYH~? 20.51 O2 PO4 A 349 A 675 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 2.70 -0.05 22.31 2.42 1.39 24.24 1.46 56.04 50.07 2.12 55.38 52.31 coo 0.87 7.55 27.28 1.82 5.91 25.24 3.79 65.29 45.10 3.54 65.25 42.31 coo 0.10 3.62 28.03 1.23 2.44 26.67 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 2 3 # 2 A 457 SER A 183 SER^? 16.92 O1 PO4 A 349 A 630 CYH A 151 CYH.? 21.29 O1 PO4 A 349 A 675 ASP A 226 ASP.? 25.19 O1 PO4 A 349 coo 2.70 -0.05 22.31 2.42 1.39 24.24 -27.51 58.57 23.48 -25.56 60.04 23.47 coo 0.87 7.55 27.28 1.82 5.91 25.24 -28.58 54.43 14.94 -26.94 52.63 16.24 coo 0.10 3.62 28.03 1.23 2.44 26.67 -31.23 58.08 18.66 -33.23 57.82 19.18 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 3 3 # 3 A 457 SER B 64 SER~? 26.98 C5 PG4 A 350 A 630 CYH B 44 CYH.? 20.73 O3 PO4 B 349 A 675 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 2.70 -0.05 22.31 2.42 1.39 24.24 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 0.87 7.55 27.28 1.82 5.91 25.24 -8.90 10.53 1.89 -9.13 13.22 1.20 coo 0.10 3.62 28.03 1.23 2.44 26.67 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 4 3 # 4 A 457 SER B 183 SER^? 16.79 O2 PO4 B 349 A 630 CYH B 151 CYH.? 20.90 O2 PO4 B 349 A 675 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 2.70 -0.05 22.31 2.42 1.39 24.24 17.47 37.56 1.42 15.35 37.17 0.22 coo 0.87 7.55 27.28 1.82 5.91 25.24 17.77 46.72 3.80 16.28 45.67 5.92 coo 0.10 3.62 28.03 1.23 2.44 26.67 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 5 3 # 5 A 457 SER C 64 SER~? 25.88 C5 PG4 D 350 A 630 CYH C 44 CYH.? 20.66 O4 PO4 C 349 A 675 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 2.70 -0.05 22.31 2.42 1.39 24.24 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 0.87 7.55 27.28 1.82 5.91 25.24 -54.82 6.18 12.39 -54.72 8.60 13.80 coo 0.10 3.62 28.03 1.23 2.44 26.67 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 6 3 # 6 A 457 SER C 183 SER^? 16.83 O2 PO4 C 349 A 630 CYH C 151 CYH.? 19.97 C1 PG4 A 350 A 675 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 2.70 -0.05 22.31 2.42 1.39 24.24 -24.45 24.87 27.97 -26.59 25.58 27.05 coo 0.87 7.55 27.28 1.82 5.91 25.24 -23.43 29.67 36.17 -24.68 27.35 36.97 coo 0.10 3.62 28.03 1.23 2.44 26.67 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 7 3 # 7 A 457 SER D 64 SER~? 27.50 C6 PG4 C 350 A 630 CYH D 44 CYH.? 21.32 O2 PO4 D 349 A 675 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 2.70 -0.05 22.31 2.42 1.39 24.24 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 0.87 7.55 27.28 1.82 5.91 25.24 -38.23 10.32 81.00 -38.77 12.53 79.38 coo 0.10 3.62 28.03 1.23 2.44 26.67 -39.78 8.95 76.71 -38.11 10.21 76.27 1amo_c00 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 7 hits 1amo_c00 naa= 3 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 B 457 SER A 64 SER~? 26.25 O3 PG4 B 350 B 630 CYH A 44 CYH~? 20.51 O2 PO4 A 349 B 675 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 48.68 26.05 22.04 49.09 24.42 23.79 1.46 56.04 50.07 2.12 55.38 52.31 coo 50.83 17.98 26.05 49.75 19.82 24.27 3.79 65.29 45.10 3.54 65.25 42.31 coo 51.67 21.81 27.15 50.44 23.13 26.00 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 2 3 # 2 B 457 SER A 183 SER^? 16.92 O1 PO4 A 349 B 630 CYH A 151 CYH.? 21.29 O1 PO4 A 349 B 675 ASP A 226 ASP.? 25.19 O1 PO4 A 349 coo 48.68 26.05 22.04 49.09 24.42 23.79 -27.51 58.57 23.48 -25.56 60.04 23.47 coo 50.83 17.98 26.05 49.75 19.82 24.27 -28.58 54.43 14.94 -26.94 52.63 16.24 coo 51.67 21.81 27.15 50.44 23.13 26.00 -31.23 58.08 18.66 -33.23 57.82 19.18 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 3 3 # 3 B 457 SER B 64 SER~? 26.98 C5 PG4 A 350 B 630 CYH B 44 CYH.? 20.73 O3 PO4 B 349 B 675 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 48.68 26.05 22.04 49.09 24.42 23.79 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 50.83 17.98 26.05 49.75 19.82 24.27 -8.90 10.53 1.89 -9.13 13.22 1.20 coo 51.67 21.81 27.15 50.44 23.13 26.00 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 4 3 # 4 B 457 SER B 183 SER^? 16.79 O2 PO4 B 349 B 630 CYH B 151 CYH.? 20.90 O2 PO4 B 349 B 675 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 48.68 26.05 22.04 49.09 24.42 23.79 17.47 37.56 1.42 15.35 37.17 0.22 coo 50.83 17.98 26.05 49.75 19.82 24.27 17.77 46.72 3.80 16.28 45.67 5.92 coo 51.67 21.81 27.15 50.44 23.13 26.00 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 5 3 # 5 B 457 SER C 64 SER~? 25.88 C5 PG4 D 350 B 630 CYH C 44 CYH.? 20.66 O4 PO4 C 349 B 675 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 48.68 26.05 22.04 49.09 24.42 23.79 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 50.83 17.98 26.05 49.75 19.82 24.27 -54.82 6.18 12.39 -54.72 8.60 13.80 coo 51.67 21.81 27.15 50.44 23.13 26.00 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 6 3 # 6 B 457 SER C 183 SER^? 16.83 O2 PO4 C 349 B 630 CYH C 151 CYH.? 19.97 C1 PG4 A 350 B 675 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 48.68 26.05 22.04 49.09 24.42 23.79 -24.45 24.87 27.97 -26.59 25.58 27.05 coo 50.83 17.98 26.05 49.75 19.82 24.27 -23.43 29.67 36.17 -24.68 27.35 36.97 coo 51.67 21.81 27.15 50.44 23.13 26.00 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 7 3 # 7 B 457 SER D 64 SER~? 27.50 C6 PG4 C 350 B 630 CYH D 44 CYH.? 21.32 O2 PO4 D 349 B 675 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 48.68 26.05 22.04 49.09 24.42 23.79 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 50.83 17.98 26.05 49.75 19.82 24.27 -38.23 10.32 81.00 -38.77 12.53 79.38 coo 51.67 21.81 27.15 50.44 23.13 26.00 -39.78 8.95 76.71 -38.11 10.21 76.27 1amo_c01 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 7 hits 1amo_c01 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 140 ASP.? 7.37 O2 PG4 A 350 214 ASP A 160 ASP.? 8.60 O4 PO4 A 349 289 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo -0.62 65.95 29.97 0.31 67.47 31.05 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 26.86 59.76 46.36 25.42 58.23 45.92 -1.16 62.88 18.52 0.68 62.16 19.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 208 ASP~? 8.51 C3 PG4 A 350 214 ASP A 226 ASP.? 25.19 O1 PO4 A 349 289 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo -0.62 65.95 29.97 0.31 67.47 31.05 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 26.86 59.76 46.36 25.42 58.23 45.92 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 9.42 68.07 30.27 7.35 68.27 30.10 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 339 ASP~? 20.53 O1 PO4 A 349 214 ASP A 203 ASP~? 10.68 C3 PG4 B 350 289 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo -0.62 65.95 29.97 0.31 67.47 31.05 -24.08 73.03 20.51 -24.61 72.81 22.55 coo 26.86 59.76 46.36 25.42 58.23 45.92 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 140 ASP.? 7.99 O2 PG4 B 350 214 ASP B 160 ASP.? 8.62 O4 PO4 B 349 289 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo -0.62 65.95 29.97 0.31 67.47 31.05 8.40 47.76 23.89 8.35 49.33 25.35 coo 26.86 59.76 46.36 25.42 58.23 45.92 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 208 ASP~? 8.88 C3 PG4 B 350 214 ASP B 226 ASP.? 24.90 O2 PO4 B 349 289 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo -0.62 65.95 29.97 0.31 67.47 31.05 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 26.86 59.76 46.36 25.42 58.23 45.92 20.38 42.79 0.27 22.43 42.38 0.23 coo 9.42 68.07 30.27 7.35 68.27 30.10 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP C 140 ASP.? 7.74 C2 PG4 C 350 214 ASP C 160 ASP.? 8.57 O1 PO4 C 349 289 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo -0.62 65.95 29.97 0.31 67.47 31.05 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 26.86 59.76 46.36 25.42 58.23 45.92 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 208 ASP~? 8.73 O2 PG4 C 350 214 ASP C 226 ASP.? 11.40 C1 PG4 A 350 289 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 26.86 59.76 46.36 25.42 58.23 45.92 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 9.42 68.07 30.27 7.35 68.27 30.10 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 311 ASP~? 22.87 O4 PO4 C 349 214 ASP A 140 ASP.? 7.37 O2 PG4 A 350 289 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo -0.62 65.95 29.97 0.31 67.47 31.05 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 26.86 59.76 46.36 25.42 58.23 45.92 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 9.42 68.07 30.27 7.35 68.27 30.10 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 311 ASP~? 22.87 O4 PO4 C 349 214 ASP C 203 ASP~? 10.24 C6 PG4 D 350 289 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo -0.62 65.95 29.97 0.31 67.47 31.05 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 26.86 59.76 46.36 25.42 58.23 45.92 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP C 332 ASP~? 12.18 O4 PO4 C 349 214 ASP B 90 ASP~? 17.21 C5 PG4 A 350 289 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo -0.62 65.95 29.97 0.31 67.47 31.05 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 26.86 59.76 46.36 25.42 58.23 45.92 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP C 339 ASP~? 17.02 O2 PG4 A 350 214 ASP C 203 ASP~? 10.24 C6 PG4 D 350 289 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.42 35.10 18.03 -29.05 33.77 17.12 coo 26.86 59.76 46.36 25.42 58.23 45.92 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP D 339 ASP~? 21.27 O1 PO4 D 349 214 ASP D 203 ASP~? 10.40 O3 PG4 C 350 289 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo -0.62 65.95 29.97 0.31 67.47 31.05 -63.02 36.35 69.71 -64.42 35.04 70.68 coo 26.86 59.76 46.36 25.42 58.23 45.92 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 9.42 68.07 30.27 7.35 68.27 30.10 -51.05 35.32 70.59 -50.24 33.36 70.95 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 12 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 41 ASP.? 20.10 O2 PO4 A 349 204 GLU A 15 GLU.? 17.86 C3 PG4 B 350 289 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo -0.62 65.95 29.97 0.31 67.47 31.05 1.74 60.96 43.57 3.36 61.47 42.28 coo 4.34 62.44 32.05 4.22 64.48 32.53 7.25 58.10 39.87 8.59 56.71 39.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP C 311 ASP~? 22.87 O4 PO4 C 349 204 GLU C 312 GLU~? 22.95 O4 PO4 C 349 289 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo -0.62 65.95 29.97 0.31 67.47 31.05 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 4.34 62.44 32.05 4.22 64.48 32.53 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 9.42 68.07 30.27 7.35 68.27 30.10 -42.20 32.39 17.40 -42.88 30.35 17.40 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c05 naa= 3 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 A 38 ARG A 42 ARG~? 19.93 C3 PG4 B 350 A 42 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 71 ASN A 43 ASN~? 22.73 O3 PO4 A 349 coo 15.53 3.67 5.89 15.40 6.73 5.59 7.49 56.88 46.72 6.71 54.94 44.43 coo 20.65 4.50 6.93 19.74 4.89 5.08 3.61 55.89 43.73 3.10 55.52 45.73 coo 19.78 9.98 8.03 21.51 8.73 8.26 6.86 62.77 42.72 8.12 61.14 42.12 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 A 38 ARG A 147 ARG~? 21.89 C2 PG4 A 350 A 42 HIS B 272 HIS.? 20.00 O1 PO4 B 349 A 71 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo 15.53 3.67 5.89 15.40 6.73 5.59 -23.00 46.39 6.22 -24.32 43.65 5.76 coo 20.65 4.50 6.93 19.74 4.89 5.08 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 19.78 9.98 8.03 21.51 8.73 8.26 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 A 38 ARG B 42 ARG.? 20.99 C5 PG4 A 350 A 42 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 71 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo 15.53 3.67 5.89 15.40 6.73 5.59 -13.08 10.76 9.81 -13.21 13.36 11.51 coo 20.65 4.50 6.93 19.74 4.89 5.08 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 19.78 9.98 8.03 21.51 8.73 8.26 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 4 3 # 4 A 38 ARG B 147 ARG~? 21.77 C2 PG4 B 350 A 42 HIS A 272 HIS.? 19.95 O3 PO4 A 349 A 71 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo 15.53 3.67 5.89 15.40 6.73 5.59 11.90 56.41 10.58 13.26 57.05 13.30 coo 20.65 4.50 6.93 19.74 4.89 5.08 11.10 60.27 13.77 10.40 58.32 14.13 coo 19.78 9.98 8.03 21.51 8.73 8.26 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 5 3 # 5 A 38 ARG C 42 ARG.? 19.15 C5 PG4 D 350 A 42 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 71 ASN C 43 ASN.? 22.72 C5 PG4 D 350 coo 15.53 3.67 5.89 15.40 6.73 5.59 -57.88 0.79 18.76 -56.46 0.67 21.52 coo 20.65 4.50 6.93 19.74 4.89 5.08 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 19.78 9.98 8.03 21.51 8.73 8.26 -57.74 6.14 16.07 -58.97 5.36 17.64 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 6 3 # 6 A 38 ARG C 147 ARG~? 21.64 C2 PG4 C 350 A 42 HIS D 272 HIS.? 19.84 O3 PO4 D 349 A 71 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo 15.53 3.67 5.89 15.40 6.73 5.59 -28.57 31.49 48.25 -26.95 30.26 50.59 coo 20.65 4.50 6.93 19.74 4.89 5.08 -29.12 31.20 53.56 -30.01 29.84 52.23 coo 19.78 9.98 8.03 21.51 8.73 8.26 -32.60 27.92 55.07 -33.22 25.92 54.63 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 7 3 # 7 A 38 ARG D 147 ARG~? 21.65 O5 PG4 D 350 A 42 HIS C 272 HIS.? 20.13 O1 PO4 C 349 A 71 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo 15.53 3.67 5.89 15.40 6.73 5.59 -64.41 28.02 40.25 -65.44 25.99 38.16 coo 20.65 4.50 6.93 19.74 4.89 5.08 -63.70 27.74 35.03 -62.68 26.43 36.32 coo 19.78 9.98 8.03 21.51 8.73 8.26 -59.71 24.81 33.93 -59.02 22.97 34.76 1apx_c00 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 7 hits 1apx_c00 naa= 3 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 B 38 ARG A 147 ARG~? 21.89 C2 PG4 A 350 B 42 HIS B 272 HIS.? 20.00 O1 PO4 B 349 B 71 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 -23.00 46.39 6.22 -24.32 43.65 5.76 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 -21.96 42.12 3.17 -20.97 42.39 5.00 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 B 38 ARG B 42 ARG.? 20.99 C5 PG4 A 350 B 42 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 71 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 -13.08 10.76 9.81 -13.21 13.36 11.51 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 B 38 ARG B 147 ARG~? 21.77 C2 PG4 B 350 B 42 HIS A 272 HIS.? 19.95 O3 PO4 A 349 B 71 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 11.90 56.41 10.58 13.26 57.05 13.30 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 11.10 60.27 13.77 10.40 58.32 14.13 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 4 3 # 4 B 38 ARG C 147 ARG~? 21.64 C2 PG4 C 350 B 42 HIS D 272 HIS.? 19.84 O3 PO4 D 349 B 71 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 -28.57 31.49 48.25 -26.95 30.26 50.59 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 -29.12 31.20 53.56 -30.01 29.84 52.23 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 -32.60 27.92 55.07 -33.22 25.92 54.63 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 5 3 # 5 B 38 ARG D 147 ARG~? 21.65 O5 PG4 D 350 B 42 HIS C 272 HIS.? 20.13 O1 PO4 C 349 B 71 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 -64.41 28.02 40.25 -65.44 25.99 38.16 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 -63.70 27.74 35.03 -62.68 26.43 36.32 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 -59.71 24.81 33.93 -59.02 22.97 34.76 1apx_c01 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 5 hits 1apx_c01 naa= 3 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 C 38 ARG A 147 ARG~? 21.89 C2 PG4 A 350 C 42 HIS B 272 HIS.? 20.00 O1 PO4 B 349 C 71 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo 30.92 18.62 52.11 32.84 21.02 52.26 -23.00 46.39 6.22 -24.32 43.65 5.76 coo 34.83 15.89 54.93 35.12 16.59 52.97 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 37.12 20.79 56.54 37.65 18.79 57.02 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 C 38 ARG B 42 ARG.? 20.99 C5 PG4 A 350 C 42 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 71 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo 30.92 18.62 52.11 32.84 21.02 52.26 -13.08 10.76 9.81 -13.21 13.36 11.51 coo 34.83 15.89 54.93 35.12 16.59 52.97 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 37.12 20.79 56.54 37.65 18.79 57.02 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 C 38 ARG B 147 ARG~? 21.77 C2 PG4 B 350 C 42 HIS A 272 HIS.? 19.95 O3 PO4 A 349 C 71 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo 30.92 18.62 52.11 32.84 21.02 52.26 11.90 56.41 10.58 13.26 57.05 13.30 coo 34.83 15.89 54.93 35.12 16.59 52.97 11.10 60.27 13.77 10.40 58.32 14.13 coo 37.12 20.79 56.54 37.65 18.79 57.02 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 4 3 # 4 C 38 ARG C 147 ARG~? 21.64 C2 PG4 C 350 C 42 HIS D 272 HIS.? 19.84 O3 PO4 D 349 C 71 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo 30.92 18.62 52.11 32.84 21.02 52.26 -28.57 31.49 48.25 -26.95 30.26 50.59 coo 34.83 15.89 54.93 35.12 16.59 52.97 -29.12 31.20 53.56 -30.01 29.84 52.23 coo 37.12 20.79 56.54 37.65 18.79 57.02 -32.60 27.92 55.07 -33.22 25.92 54.63 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 5 3 # 5 C 38 ARG D 147 ARG~? 21.65 O5 PG4 D 350 C 42 HIS C 272 HIS.? 20.13 O1 PO4 C 349 C 71 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo 30.92 18.62 52.11 32.84 21.02 52.26 -64.41 28.02 40.25 -65.44 25.99 38.16 coo 34.83 15.89 54.93 35.12 16.59 52.97 -63.70 27.74 35.03 -62.68 26.43 36.32 coo 37.12 20.79 56.54 37.65 18.79 57.02 -59.71 24.81 33.93 -59.02 22.97 34.76 1apx_c02 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 5 hits 1apx_c02 naa= 3 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 D 38 ARG A 147 ARG~? 21.89 C2 PG4 A 350 D 42 HIS B 272 HIS.? 20.00 O1 PO4 B 349 D 71 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo -6.22 19.15 57.90 -8.28 20.35 55.95 -23.00 46.39 6.22 -24.32 43.65 5.76 coo -9.68 15.08 58.37 -9.88 17.07 58.99 -21.96 42.12 3.17 -20.97 42.39 5.00 coo -12.42 16.33 53.67 -12.99 14.86 55.12 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 D 38 ARG B 42 ARG.? 20.99 C5 PG4 A 350 D 42 HIS B 14 HIS.? 21.30 C5 PG4 A 350 D 71 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo -6.22 19.15 57.90 -8.28 20.35 55.95 -13.08 10.76 9.81 -13.21 13.36 11.51 coo -9.68 15.08 58.37 -9.88 17.07 58.99 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -12.42 16.33 53.67 -12.99 14.86 55.12 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 D 38 ARG B 147 ARG~? 21.77 C2 PG4 B 350 D 42 HIS A 272 HIS.? 19.95 O3 PO4 A 349 D 71 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo -6.22 19.15 57.90 -8.28 20.35 55.95 11.90 56.41 10.58 13.26 57.05 13.30 coo -9.68 15.08 58.37 -9.88 17.07 58.99 11.10 60.27 13.77 10.40 58.32 14.13 coo -12.42 16.33 53.67 -12.99 14.86 55.12 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 4 3 # 4 D 38 ARG C 147 ARG~? 21.64 C2 PG4 C 350 D 42 HIS D 272 HIS.? 19.84 O3 PO4 D 349 D 71 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo -6.22 19.15 57.90 -8.28 20.35 55.95 -28.57 31.49 48.25 -26.95 30.26 50.59 coo -9.68 15.08 58.37 -9.88 17.07 58.99 -29.12 31.20 53.56 -30.01 29.84 52.23 coo -12.42 16.33 53.67 -12.99 14.86 55.12 -32.60 27.92 55.07 -33.22 25.92 54.63 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 5 3 # 5 D 38 ARG D 147 ARG~? 21.65 O5 PG4 D 350 D 42 HIS C 272 HIS.? 20.13 O1 PO4 C 349 D 71 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo -6.22 19.15 57.90 -8.28 20.35 55.95 -64.41 28.02 40.25 -65.44 25.99 38.16 coo -9.68 15.08 58.37 -9.88 17.07 58.99 -63.70 27.74 35.03 -62.68 26.43 36.32 coo -12.42 16.33 53.67 -12.99 14.86 55.12 -59.71 24.81 33.93 -59.02 22.97 34.76 1apx_c03 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 5 hits 1apx_c03 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS B 110 HIS.? 5.25 C4 PG4 A 350 254 LYS B 134 LYS.? 7.94 O5 PG4 B 350 333 ARG B 206 ARG~? -3.06 O4 PG4 B 350s coo 28.11 -1.15 8.51 29.21 0.63 8.34 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 26.09 4.87 14.60 27.89 3.33 10.26 1.49 32.28 22.12 4.07 30.52 27.68 coo 37.35 7.47 11.84 34.90 6.11 10.60 -2.22 41.47 25.55 0.33 41.32 27.30 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 1 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 143 SER.? 14.48 C2 PG4 A 350 A 292 ASP A 198 ASP.? 17.22 O1 PO4 A 349 A 322 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 19.73 19.18 41.39 21.50 18.65 40.34 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 41.69 45.14 46.60 41.78 47.19 46.18 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 143 SER.? 14.48 C2 PG4 A 350 A 292 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 322 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 19.73 19.18 41.39 21.50 18.65 40.34 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 167 SER~? 5.73 O2 PO4 A 349 A 292 ASP A 226 ASP.? 25.19 O1 PO4 A 349 A 322 HIS A 309 HIS.? 13.93 O2 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -13.33 64.08 26.14 -11.49 64.89 27.48 coo 19.73 19.18 41.39 21.50 18.65 40.34 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 41.69 45.14 46.60 41.78 47.19 46.18 -1.71 74.54 24.02 -2.03 74.32 21.96 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 235 SER.? 9.13 O4 PO4 A 349 A 292 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -3.96 57.47 15.64 -2.97 59.52 14.86 coo 19.73 19.18 41.39 21.50 18.65 40.34 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 41.69 45.14 46.60 41.78 47.19 46.18 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER A 241 SER.? 9.98 O3 PO4 A 349 A 292 ASP A 131 ASP^? 9.75 C6 PG4 B 350 A 322 HIS A 260 HIS^? 11.64 O4 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 41.69 45.14 46.60 41.78 47.19 46.18 -4.97 68.88 15.23 -3.05 69.59 14.77 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER A 241 SER.? 9.98 O3 PO4 A 349 A 292 ASP A 131 ASP^? 9.75 C6 PG4 B 350 A 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 41.69 45.14 46.60 41.78 47.19 46.18 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER A 241 SER.? 9.98 O3 PO4 A 349 A 292 ASP A 131 ASP^? 9.75 C6 PG4 B 350 A 322 HIS A 272 HIS.? 19.95 O3 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 41.69 45.14 46.60 41.78 47.19 46.18 11.10 60.27 13.77 10.40 58.32 14.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER A 251 SER~? 15.16 O1 PO4 A 349 A 292 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 322 HIS B 272 HIS.? 20.00 O1 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -18.37 49.97 14.50 -17.17 52.05 14.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -1.16 62.88 18.52 0.68 62.16 19.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.96 42.12 3.17 -20.97 42.39 5.00 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER A 251 SER~? 15.16 O1 PO4 A 349 A 292 ASP A 343 ASP~? 23.03 O1 PO4 A 349 A 322 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -18.37 49.97 14.50 -17.17 52.05 14.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -25.30 71.23 14.76 -26.68 71.84 16.22 coo 41.69 45.14 46.60 41.78 47.19 46.18 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 A 194 SER A 251 SER~? 15.16 O1 PO4 A 349 A 292 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 322 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -18.37 49.97 14.50 -17.17 52.05 14.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 41.69 45.14 46.60 41.78 47.19 46.18 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 A 194 SER A 290 SER~? 22.09 O4 PO4 B 349 A 292 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 322 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.58 53.59 3.05 -13.34 54.72 1.34 coo 19.73 19.18 41.39 21.50 18.65 40.34 -1.16 62.88 18.52 0.68 62.16 19.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 A 194 SER A 290 SER~? 22.09 O4 PO4 B 349 A 292 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 322 HIS B 272 HIS.? 20.00 O1 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.58 53.59 3.05 -13.34 54.72 1.34 coo 19.73 19.18 41.39 21.50 18.65 40.34 -1.16 62.88 18.52 0.68 62.16 19.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.96 42.12 3.17 -20.97 42.39 5.00 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 A 194 SER B 143 SER.? 15.37 C2 PG4 B 350 A 292 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 8.40 53.62 17.31 10.72 53.32 17.95 coo 19.73 19.18 41.39 21.50 18.65 40.34 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 41.69 45.14 46.60 41.78 47.19 46.18 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 A 194 SER B 143 SER.? 15.37 C2 PG4 B 350 A 292 ASP B 198 ASP.? 14.38 O1 PG4 B 350 A 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 8.40 53.62 17.31 10.72 53.32 17.95 coo 19.73 19.18 41.39 21.50 18.65 40.34 11.89 31.57 14.26 12.37 32.72 16.00 coo 41.69 45.14 46.60 41.78 47.19 46.18 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 A 194 SER B 167 SER~? 5.62 O3 PO4 B 349 A 292 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 322 HIS B 309 HIS.? 14.09 O3 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 3.34 32.15 -1.39 1.57 30.56 -1.62 coo 19.73 19.18 41.39 21.50 18.65 40.34 20.38 42.79 0.27 22.43 42.38 0.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -9.40 30.81 -10.60 -9.30 32.90 -10.77 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 16 3 # 16 A 194 SER B 235 SER.? 9.35 O4 PO4 B 349 A 292 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 322 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -6.73 42.81 4.19 -8.03 43.03 2.17 coo 19.73 19.18 41.39 21.50 18.65 40.34 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 17 3 # 17 A 194 SER B 241 SER.? 10.02 O1 PO4 B 349 A 292 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 322 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 19.73 19.18 41.39 21.50 18.65 40.34 0.40 27.07 22.40 -0.62 25.51 23.42 coo 41.69 45.14 46.60 41.78 47.19 46.18 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 18 3 # 18 A 194 SER B 241 SER.? 10.02 O1 PO4 B 349 A 292 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 322 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 19.73 19.18 41.39 21.50 18.65 40.34 0.40 27.07 22.40 -0.62 25.51 23.42 coo 41.69 45.14 46.60 41.78 47.19 46.18 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 19 3 # 19 A 194 SER B 241 SER.? 10.02 O1 PO4 B 349 A 292 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 322 HIS B 272 HIS.? 20.00 O1 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 19.73 19.18 41.39 21.50 18.65 40.34 0.40 27.07 22.40 -0.62 25.51 23.42 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.96 42.12 3.17 -20.97 42.39 5.00 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 20 3 # 20 A 194 SER B 251 SER~? 14.95 O2 PO4 B 349 A 292 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 322 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 8.02 47.00 9.27 6.51 46.38 7.45 coo 19.73 19.18 41.39 21.50 18.65 40.34 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 41.69 45.14 46.60 41.78 47.19 46.18 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 21 3 # 21 A 194 SER B 251 SER~? 14.95 O2 PO4 B 349 A 292 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 322 HIS A 272 HIS.? 19.95 O3 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 8.02 47.00 9.27 6.51 46.38 7.45 coo 19.73 19.18 41.39 21.50 18.65 40.34 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 41.69 45.14 46.60 41.78 47.19 46.18 11.10 60.27 13.77 10.40 58.32 14.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 22 3 # 22 A 194 SER B 251 SER~? 14.95 O2 PO4 B 349 A 292 ASP B 343 ASP~? 22.96 O2 PO4 B 349 A 322 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 8.02 47.00 9.27 6.51 46.38 7.45 coo 19.73 19.18 41.39 21.50 18.65 40.34 12.62 43.49 -12.19 13.89 41.96 -12.92 coo 41.69 45.14 46.60 41.78 47.19 46.18 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 23 3 # 23 A 194 SER B 290 SER~? 21.99 O4 PO4 A 349 A 292 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 2.39 57.00 3.93 0.87 58.29 2.54 coo 19.73 19.18 41.39 21.50 18.65 40.34 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 41.69 45.14 46.60 41.78 47.19 46.18 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 24 3 # 24 A 194 SER C 48 SER~? 23.03 O4 PO4 C 349 A 292 ASP C 311 ASP~? 22.87 O4 PO4 C 349 A 322 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 36.34 32.23 39.60 36.43 34.62 39.93 -49.92 9.94 6.78 -48.92 11.89 5.74 coo 19.73 19.18 41.39 21.50 18.65 40.34 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 41.69 45.14 46.60 41.78 47.19 46.18 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 25 3 # 25 A 194 SER C 143 SER.? 14.49 C2 PG4 C 350 A 292 ASP C 198 ASP.? 14.11 O1 PG4 C 350 A 322 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 19.73 19.18 41.39 21.50 18.65 40.34 -29.82 11.85 32.90 -29.50 11.63 35.01 coo 41.69 45.14 46.60 41.78 47.19 46.18 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 26 3 # 26 A 194 SER C 143 SER.? 14.49 C2 PG4 C 350 A 292 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 322 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 19.73 19.18 41.39 21.50 18.65 40.34 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 41.69 45.14 46.60 41.78 47.19 46.18 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 27 3 # 27 A 194 SER C 167 SER~? 5.88 O4 PO4 C 349 A 292 ASP C 226 ASP.? 11.40 C1 PG4 A 350 A 322 HIS C 309 HIS.? 14.15 O4 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -38.98 23.58 23.13 -40.74 22.64 21.84 coo 19.73 19.18 41.39 21.50 18.65 40.34 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 41.69 45.14 46.60 41.78 47.19 46.18 -52.33 29.51 16.61 -52.04 31.11 17.93 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 28 3 # 28 A 194 SER C 235 SER.? 9.23 O1 PO4 C 349 A 292 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 322 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -48.25 27.10 35.26 -49.51 28.80 34.06 coo 19.73 19.18 41.39 21.50 18.65 40.34 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 41.69 45.14 46.60 41.78 47.19 46.18 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 29 3 # 29 A 194 SER C 241 SER.? 9.97 O3 PO4 C 349 A 292 ASP C 131 ASP^? 9.91 O2 PG4 D 350 A 322 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 41.69 45.14 46.60 41.78 47.19 46.18 -48.83 33.87 26.09 -50.85 34.38 25.82 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 30 3 # 30 A 194 SER C 241 SER.? 9.97 O3 PO4 C 349 A 292 ASP C 131 ASP^? 9.91 O2 PG4 D 350 A 322 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 41.69 45.14 46.60 41.78 47.19 46.18 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 31 3 # 31 A 194 SER C 241 SER.? 9.97 O3 PO4 C 349 A 292 ASP C 131 ASP^? 9.91 O2 PG4 D 350 A 322 HIS C 272 HIS.? 20.13 O1 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 41.69 45.14 46.60 41.78 47.19 46.18 -63.70 27.74 35.03 -62.68 26.43 36.32 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 32 3 # 32 A 194 SER C 251 SER~? 15.10 O2 PO4 C 349 A 292 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 322 HIS D 272 HIS.? 19.84 O3 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -33.02 26.07 40.83 -34.62 26.93 39.20 coo 19.73 19.18 41.39 21.50 18.65 40.34 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 41.69 45.14 46.60 41.78 47.19 46.18 -29.12 31.20 53.56 -30.01 29.84 52.23 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 33 3 # 33 A 194 SER C 251 SER~? 15.10 O2 PO4 C 349 A 292 ASP C 343 ASP~? 16.17 O1 PG4 A 350 A 322 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -33.02 26.07 40.83 -34.62 26.93 39.20 coo 19.73 19.18 41.39 21.50 18.65 40.34 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 41.69 45.14 46.60 41.78 47.19 46.18 -38.74 26.41 54.26 -37.48 24.84 54.87 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 34 3 # 34 A 194 SER C 251 SER~? 15.10 O2 PO4 C 349 A 292 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 322 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -33.02 26.07 40.83 -34.62 26.93 39.20 coo 19.73 19.18 41.39 21.50 18.65 40.34 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 41.69 45.14 46.60 41.78 47.19 46.18 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 35 3 # 35 A 194 SER C 290 SER~? 22.36 O4 PO4 D 349 A 292 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 322 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -38.30 36.92 44.82 -39.99 38.64 44.69 coo 19.73 19.18 41.39 21.50 18.65 40.34 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 41.69 45.14 46.60 41.78 47.19 46.18 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 36 3 # 36 A 194 SER C 290 SER~? 22.36 O4 PO4 D 349 A 292 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 322 HIS D 272 HIS.? 19.84 O3 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -38.30 36.92 44.82 -39.99 38.64 44.69 coo 19.73 19.18 41.39 21.50 18.65 40.34 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 41.69 45.14 46.60 41.78 47.19 46.18 -29.12 31.20 53.56 -30.01 29.84 52.23 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 37 3 # 37 A 194 SER D 143 SER.? 14.73 O4 PG4 D 350 A 292 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 322 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -59.66 21.71 38.39 -61.59 20.24 38.67 coo 19.73 19.18 41.39 21.50 18.65 40.34 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 41.69 45.14 46.60 41.78 47.19 46.18 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 38 3 # 38 A 194 SER D 143 SER.? 14.73 O4 PG4 D 350 A 292 ASP D 198 ASP.? 14.02 O5 PG4 D 350 A 322 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -59.66 21.71 38.39 -61.59 20.24 38.67 coo 19.73 19.18 41.39 21.50 18.65 40.34 -59.61 10.87 58.41 -59.89 10.18 56.43 coo 41.69 45.14 46.60 41.78 47.19 46.18 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 39 3 # 39 A 194 SER D 167 SER~? 5.79 O2 PO4 D 349 A 292 ASP D 226 ASP.? 25.08 O1 PO4 D 349 A 322 HIS D 309 HIS.? 14.00 O2 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -52.83 25.44 66.27 -50.98 24.93 67.73 coo 19.73 19.18 41.39 21.50 18.65 40.34 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 41.69 45.14 46.60 41.78 47.19 46.18 -40.87 34.22 71.66 -41.37 35.58 70.15 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 40 3 # 40 A 194 SER D 235 SER.? 9.32 O4 PO4 D 349 A 292 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 322 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -44.15 28.59 53.58 -43.17 30.60 54.60 coo 19.73 19.18 41.39 21.50 18.65 40.34 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 41.69 45.14 46.60 41.78 47.19 46.18 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 41 3 # 41 A 194 SER D 241 SER.? 10.08 O3 PO4 D 349 A 292 ASP D 131 ASP^? 9.77 C6 PG4 C 350 A 322 HIS D 260 HIS^? 11.65 O4 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 19.73 19.18 41.39 21.50 18.65 40.34 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.73 36.67 61.75 -42.79 37.49 61.80 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 42 3 # 42 A 194 SER D 241 SER.? 10.08 O3 PO4 D 349 A 292 ASP D 131 ASP^? 9.77 C6 PG4 C 350 A 322 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 19.73 19.18 41.39 21.50 18.65 40.34 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 41.69 45.14 46.60 41.78 47.19 46.18 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 43 3 # 43 A 194 SER D 241 SER.? 10.08 O3 PO4 D 349 A 292 ASP D 131 ASP^? 9.77 C6 PG4 C 350 A 322 HIS D 272 HIS.? 19.84 O3 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 19.73 19.18 41.39 21.50 18.65 40.34 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 41.69 45.14 46.60 41.78 47.19 46.18 -29.12 31.20 53.56 -30.01 29.84 52.23 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 44 3 # 44 A 194 SER D 251 SER~? 15.21 O1 PO4 D 349 A 292 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 322 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -58.95 24.32 48.36 -57.66 25.69 49.92 coo 19.73 19.18 41.39 21.50 18.65 40.34 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 41.69 45.14 46.60 41.78 47.19 46.18 -62.51 23.18 64.17 -63.84 21.56 64.29 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 45 3 # 45 A 194 SER D 251 SER~? 15.21 O1 PO4 D 349 A 292 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 322 HIS C 272 HIS.? 20.13 O1 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -58.95 24.32 48.36 -57.66 25.69 49.92 coo 19.73 19.18 41.39 21.50 18.65 40.34 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 41.69 45.14 46.60 41.78 47.19 46.18 -63.70 27.74 35.03 -62.68 26.43 36.32 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 46 3 # 46 A 194 SER D 251 SER~? 15.21 O1 PO4 D 349 A 292 ASP D 343 ASP~? 23.05 O1 PO4 D 349 A 322 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -58.95 24.32 48.36 -57.66 25.69 49.92 coo 19.73 19.18 41.39 21.50 18.65 40.34 -64.64 38.99 64.31 -65.73 38.68 66.10 coo 41.69 45.14 46.60 41.78 47.19 46.18 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 47 3 # 47 A 194 SER D 290 SER~? 21.91 O1 PO4 C 349 A 292 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 322 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -55.41 35.28 42.81 -54.12 37.28 42.41 coo 19.73 19.18 41.39 21.50 18.65 40.34 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 41.69 45.14 46.60 41.78 47.19 46.18 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 48 3 # 48 A 194 SER D 290 SER~? 21.91 O1 PO4 C 349 A 292 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 322 HIS C 272 HIS.? 20.13 O1 PO4 C 349 coo 36.34 32.23 39.60 36.43 34.62 39.93 -55.41 35.28 42.81 -54.12 37.28 42.41 coo 19.73 19.18 41.39 21.50 18.65 40.34 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 41.69 45.14 46.60 41.78 47.19 46.18 -63.70 27.74 35.03 -62.68 26.43 36.32 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 48 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 48 SER~? 23.12 O2 PO4 A 349 B 292 ASP A 311 ASP~? 22.72 O2 PO4 A 349 B 322 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 35.42 71.28 22.94 36.24 69.06 22.37 -1.95 71.28 45.67 -3.37 73.11 44.99 coo 24.74 78.07 5.59 24.32 79.03 7.46 -4.84 83.29 26.02 -4.08 84.26 24.26 coo 48.81 64.16 26.34 49.30 62.16 26.73 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 143 SER.? 14.48 C2 PG4 A 350 B 292 ASP A 198 ASP.? 17.22 O1 PO4 A 349 B 322 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 24.74 78.07 5.59 24.32 79.03 7.46 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 48.81 64.16 26.34 49.30 62.16 26.73 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER A 143 SER.? 14.48 C2 PG4 A 350 B 292 ASP A 226 ASP.? 25.19 O1 PO4 A 349 B 322 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo 35.42 71.28 22.94 36.24 69.06 22.37 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 24.74 78.07 5.59 24.32 79.03 7.46 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 48.81 64.16 26.34 49.30 62.16 26.73 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER A 143 SER.? 14.48 C2 PG4 A 350 B 292 ASP B 208 ASP~? 8.88 C3 PG4 B 350 B 322 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 24.74 78.07 5.59 24.32 79.03 7.46 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER A 167 SER~? 5.73 O2 PO4 A 349 B 292 ASP A 226 ASP.? 25.19 O1 PO4 A 349 B 322 HIS A 309 HIS.? 13.93 O2 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -13.33 64.08 26.14 -11.49 64.89 27.48 coo 24.74 78.07 5.59 24.32 79.03 7.46 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 48.81 64.16 26.34 49.30 62.16 26.73 -1.71 74.54 24.02 -2.03 74.32 21.96 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER A 235 SER.? 9.13 O4 PO4 A 349 B 292 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -3.96 57.47 15.64 -2.97 59.52 14.86 coo 24.74 78.07 5.59 24.32 79.03 7.46 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER A 241 SER.? 9.98 O3 PO4 A 349 B 292 ASP A 131 ASP^? 9.75 C6 PG4 B 350 B 322 HIS A 260 HIS^? 11.64 O4 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 48.81 64.16 26.34 49.30 62.16 26.73 -4.97 68.88 15.23 -3.05 69.59 14.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER A 241 SER.? 9.98 O3 PO4 A 349 B 292 ASP A 131 ASP^? 9.75 C6 PG4 B 350 B 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER A 241 SER.? 9.98 O3 PO4 A 349 B 292 ASP A 131 ASP^? 9.75 C6 PG4 B 350 B 322 HIS A 272 HIS.? 19.95 O3 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 48.81 64.16 26.34 49.30 62.16 26.73 11.10 60.27 13.77 10.40 58.32 14.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 B 194 SER A 241 SER.? 9.98 O3 PO4 A 349 B 292 ASP A 140 ASP.? 7.37 O2 PG4 A 350 B 322 HIS A 260 HIS^? 11.64 O4 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 48.81 64.16 26.34 49.30 62.16 26.73 -4.97 68.88 15.23 -3.05 69.59 14.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 B 194 SER A 251 SER~? 15.16 O1 PO4 A 349 B 292 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 322 HIS B 272 HIS.? 20.00 O1 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -18.37 49.97 14.50 -17.17 52.05 14.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -1.16 62.88 18.52 0.68 62.16 19.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.96 42.12 3.17 -20.97 42.39 5.00 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 B 194 SER A 251 SER~? 15.16 O1 PO4 A 349 B 292 ASP A 343 ASP~? 23.03 O1 PO4 A 349 B 322 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -18.37 49.97 14.50 -17.17 52.05 14.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -25.30 71.23 14.76 -26.68 71.84 16.22 coo 48.81 64.16 26.34 49.30 62.16 26.73 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 B 194 SER A 251 SER~? 15.16 O1 PO4 A 349 B 292 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 322 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -18.37 49.97 14.50 -17.17 52.05 14.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 48.81 64.16 26.34 49.30 62.16 26.73 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 B 194 SER A 290 SER~? 22.09 O4 PO4 B 349 B 292 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 322 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.58 53.59 3.05 -13.34 54.72 1.34 coo 24.74 78.07 5.59 24.32 79.03 7.46 -1.16 62.88 18.52 0.68 62.16 19.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 B 194 SER A 290 SER~? 22.09 O4 PO4 B 349 B 292 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 322 HIS B 272 HIS.? 20.00 O1 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.58 53.59 3.05 -13.34 54.72 1.34 coo 24.74 78.07 5.59 24.32 79.03 7.46 -1.16 62.88 18.52 0.68 62.16 19.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.96 42.12 3.17 -20.97 42.39 5.00 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 16 3 # 16 B 194 SER B 48 SER~? 23.24 O3 PO4 B 349 B 292 ASP B 311 ASP~? 22.86 O3 PO4 B 349 B 322 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 35.42 71.28 22.94 36.24 69.06 22.37 -2.83 10.14 -3.94 -1.62 10.85 -5.92 coo 24.74 78.07 5.59 24.32 79.03 7.46 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 48.81 64.16 26.34 49.30 62.16 26.73 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 17 3 # 17 B 194 SER B 143 SER.? 15.37 C2 PG4 B 350 B 292 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 8.40 53.62 17.31 10.72 53.32 17.95 coo 24.74 78.07 5.59 24.32 79.03 7.46 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 18 3 # 18 B 194 SER B 143 SER.? 15.37 C2 PG4 B 350 B 292 ASP B 198 ASP.? 14.38 O1 PG4 B 350 B 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 8.40 53.62 17.31 10.72 53.32 17.95 coo 24.74 78.07 5.59 24.32 79.03 7.46 11.89 31.57 14.26 12.37 32.72 16.00 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 19 3 # 19 B 194 SER B 143 SER.? 15.37 C2 PG4 B 350 B 292 ASP B 226 ASP.? 24.90 O2 PO4 B 349 B 322 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo 35.42 71.28 22.94 36.24 69.06 22.37 8.40 53.62 17.31 10.72 53.32 17.95 coo 24.74 78.07 5.59 24.32 79.03 7.46 20.38 42.79 0.27 22.43 42.38 0.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 20 3 # 20 B 194 SER B 167 SER~? 5.62 O3 PO4 B 349 B 292 ASP B 226 ASP.? 24.90 O2 PO4 B 349 B 322 HIS B 309 HIS.? 14.09 O3 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 3.34 32.15 -1.39 1.57 30.56 -1.62 coo 24.74 78.07 5.59 24.32 79.03 7.46 20.38 42.79 0.27 22.43 42.38 0.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -9.40 30.81 -10.60 -9.30 32.90 -10.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 21 3 # 21 B 194 SER B 235 SER.? 9.35 O4 PO4 B 349 B 292 ASP B 208 ASP~? 8.88 C3 PG4 B 350 B 322 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -6.73 42.81 4.19 -8.03 43.03 2.17 coo 24.74 78.07 5.59 24.32 79.03 7.46 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 22 3 # 22 B 194 SER B 241 SER.? 10.02 O1 PO4 B 349 B 292 ASP B 131 ASP^? 9.09 C8 PG4 A 350 B 322 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 24.74 78.07 5.59 24.32 79.03 7.46 0.40 27.07 22.40 -0.62 25.51 23.42 coo 48.81 64.16 26.34 49.30 62.16 26.73 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 23 3 # 23 B 194 SER B 241 SER.? 10.02 O1 PO4 B 349 B 292 ASP B 131 ASP^? 9.09 C8 PG4 A 350 B 322 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 24.74 78.07 5.59 24.32 79.03 7.46 0.40 27.07 22.40 -0.62 25.51 23.42 coo 48.81 64.16 26.34 49.30 62.16 26.73 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 24 3 # 24 B 194 SER B 241 SER.? 10.02 O1 PO4 B 349 B 292 ASP B 131 ASP^? 9.09 C8 PG4 A 350 B 322 HIS B 272 HIS.? 20.00 O1 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 24.74 78.07 5.59 24.32 79.03 7.46 0.40 27.07 22.40 -0.62 25.51 23.42 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.96 42.12 3.17 -20.97 42.39 5.00 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 25 3 # 25 B 194 SER B 241 SER.? 10.02 O1 PO4 B 349 B 292 ASP B 140 ASP.? 7.99 O2 PG4 B 350 B 322 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 24.74 78.07 5.59 24.32 79.03 7.46 8.40 47.76 23.89 8.35 49.33 25.35 coo 48.81 64.16 26.34 49.30 62.16 26.73 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 26 3 # 26 B 194 SER B 251 SER~? 14.95 O2 PO4 B 349 B 292 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 322 HIS A 272 HIS.? 19.95 O3 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 8.02 47.00 9.27 6.51 46.38 7.45 coo 24.74 78.07 5.59 24.32 79.03 7.46 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 48.81 64.16 26.34 49.30 62.16 26.73 11.10 60.27 13.77 10.40 58.32 14.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 27 3 # 27 B 194 SER B 251 SER~? 14.95 O2 PO4 B 349 B 292 ASP B 343 ASP~? 22.96 O2 PO4 B 349 B 322 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 8.02 47.00 9.27 6.51 46.38 7.45 coo 24.74 78.07 5.59 24.32 79.03 7.46 12.62 43.49 -12.19 13.89 41.96 -12.92 coo 48.81 64.16 26.34 49.30 62.16 26.73 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 28 3 # 28 B 194 SER B 290 SER~? 21.99 O4 PO4 A 349 B 292 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 2.39 57.00 3.93 0.87 58.29 2.54 coo 24.74 78.07 5.59 24.32 79.03 7.46 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 29 3 # 29 B 194 SER B 290 SER~? 21.99 O4 PO4 A 349 B 292 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 322 HIS A 272 HIS.? 19.95 O3 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 2.39 57.00 3.93 0.87 58.29 2.54 coo 24.74 78.07 5.59 24.32 79.03 7.46 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 48.81 64.16 26.34 49.30 62.16 26.73 11.10 60.27 13.77 10.40 58.32 14.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 30 3 # 30 B 194 SER B 290 SER~? 21.99 O4 PO4 A 349 B 292 ASP B 343 ASP~? 22.96 O2 PO4 B 349 B 322 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 2.39 57.00 3.93 0.87 58.29 2.54 coo 24.74 78.07 5.59 24.32 79.03 7.46 12.62 43.49 -12.19 13.89 41.96 -12.92 coo 48.81 64.16 26.34 49.30 62.16 26.73 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 31 3 # 31 B 194 SER B 290 SER~? 21.99 O4 PO4 A 349 B 292 ASP B 343 ASP~? 22.96 O2 PO4 B 349 B 322 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 2.39 57.00 3.93 0.87 58.29 2.54 coo 24.74 78.07 5.59 24.32 79.03 7.46 12.62 43.49 -12.19 13.89 41.96 -12.92 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 32 3 # 32 B 194 SER C 48 SER~? 23.03 O4 PO4 C 349 B 292 ASP C 311 ASP~? 22.87 O4 PO4 C 349 B 322 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 35.42 71.28 22.94 36.24 69.06 22.37 -49.92 9.94 6.78 -48.92 11.89 5.74 coo 24.74 78.07 5.59 24.32 79.03 7.46 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 48.81 64.16 26.34 49.30 62.16 26.73 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 33 3 # 33 B 194 SER C 143 SER.? 14.49 C2 PG4 C 350 B 292 ASP C 198 ASP.? 14.11 O1 PG4 C 350 B 322 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 24.74 78.07 5.59 24.32 79.03 7.46 -29.82 11.85 32.90 -29.50 11.63 35.01 coo 48.81 64.16 26.34 49.30 62.16 26.73 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 34 3 # 34 B 194 SER C 143 SER.? 14.49 C2 PG4 C 350 B 292 ASP D 208 ASP~? 8.41 C6 PG4 D 350 B 322 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 24.74 78.07 5.59 24.32 79.03 7.46 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 48.81 64.16 26.34 49.30 62.16 26.73 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 35 3 # 35 B 194 SER C 167 SER~? 5.88 O4 PO4 C 349 B 292 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 322 HIS C 309 HIS.? 14.15 O4 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -38.98 23.58 23.13 -40.74 22.64 21.84 coo 24.74 78.07 5.59 24.32 79.03 7.46 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 48.81 64.16 26.34 49.30 62.16 26.73 -52.33 29.51 16.61 -52.04 31.11 17.93 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 36 3 # 36 B 194 SER C 169 SER~? 7.39 O2 PO4 C 349 B 292 ASP A 140 ASP.? 7.37 O2 PG4 A 350 B 322 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -35.40 25.65 26.78 -36.52 25.32 28.91 coo 24.74 78.07 5.59 24.32 79.03 7.46 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 48.81 64.16 26.34 49.30 62.16 26.73 -48.83 33.87 26.09 -50.85 34.38 25.82 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 37 3 # 37 B 194 SER C 235 SER.? 9.23 O1 PO4 C 349 B 292 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 322 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -48.25 27.10 35.26 -49.51 28.80 34.06 coo 24.74 78.07 5.59 24.32 79.03 7.46 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 48.81 64.16 26.34 49.30 62.16 26.73 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 38 3 # 38 B 194 SER C 241 SER.? 9.97 O3 PO4 C 349 B 292 ASP C 131 ASP^? 9.91 O2 PG4 D 350 B 322 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 48.81 64.16 26.34 49.30 62.16 26.73 -48.83 33.87 26.09 -50.85 34.38 25.82 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 39 3 # 39 B 194 SER C 241 SER.? 9.97 O3 PO4 C 349 B 292 ASP C 131 ASP^? 9.91 O2 PG4 D 350 B 322 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 48.81 64.16 26.34 49.30 62.16 26.73 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 40 3 # 40 B 194 SER C 241 SER.? 9.97 O3 PO4 C 349 B 292 ASP C 131 ASP^? 9.91 O2 PG4 D 350 B 322 HIS C 272 HIS.? 20.13 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 48.81 64.16 26.34 49.30 62.16 26.73 -63.70 27.74 35.03 -62.68 26.43 36.32 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 41 3 # 41 B 194 SER C 241 SER.? 9.97 O3 PO4 C 349 B 292 ASP C 140 ASP.? 7.74 C2 PG4 C 350 B 322 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 24.74 78.07 5.59 24.32 79.03 7.46 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 48.81 64.16 26.34 49.30 62.16 26.73 -48.83 33.87 26.09 -50.85 34.38 25.82 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 42 3 # 42 B 194 SER C 251 SER~? 15.10 O2 PO4 C 349 B 292 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 322 HIS D 272 HIS.? 19.84 O3 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -33.02 26.07 40.83 -34.62 26.93 39.20 coo 24.74 78.07 5.59 24.32 79.03 7.46 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 48.81 64.16 26.34 49.30 62.16 26.73 -29.12 31.20 53.56 -30.01 29.84 52.23 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 43 3 # 43 B 194 SER C 251 SER~? 15.10 O2 PO4 C 349 B 292 ASP C 343 ASP~? 16.17 O1 PG4 A 350 B 322 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -33.02 26.07 40.83 -34.62 26.93 39.20 coo 24.74 78.07 5.59 24.32 79.03 7.46 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 48.81 64.16 26.34 49.30 62.16 26.73 -38.74 26.41 54.26 -37.48 24.84 54.87 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 44 3 # 44 B 194 SER C 251 SER~? 15.10 O2 PO4 C 349 B 292 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 322 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -33.02 26.07 40.83 -34.62 26.93 39.20 coo 24.74 78.07 5.59 24.32 79.03 7.46 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 48.81 64.16 26.34 49.30 62.16 26.73 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 45 3 # 45 B 194 SER C 290 SER~? 22.36 O4 PO4 D 349 B 292 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 322 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -38.30 36.92 44.82 -39.99 38.64 44.69 coo 24.74 78.07 5.59 24.32 79.03 7.46 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 48.81 64.16 26.34 49.30 62.16 26.73 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 46 3 # 46 B 194 SER C 290 SER~? 22.36 O4 PO4 D 349 B 292 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 322 HIS D 272 HIS.? 19.84 O3 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -38.30 36.92 44.82 -39.99 38.64 44.69 coo 24.74 78.07 5.59 24.32 79.03 7.46 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 48.81 64.16 26.34 49.30 62.16 26.73 -29.12 31.20 53.56 -30.01 29.84 52.23 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 47 3 # 47 B 194 SER D 143 SER.? 14.73 O4 PG4 D 350 B 292 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 322 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -59.66 21.71 38.39 -61.59 20.24 38.67 coo 24.74 78.07 5.59 24.32 79.03 7.46 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 48.81 64.16 26.34 49.30 62.16 26.73 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 48 3 # 48 B 194 SER D 143 SER.? 14.73 O4 PG4 D 350 B 292 ASP D 198 ASP.? 14.02 O5 PG4 D 350 B 322 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -59.66 21.71 38.39 -61.59 20.24 38.67 coo 24.74 78.07 5.59 24.32 79.03 7.46 -59.61 10.87 58.41 -59.89 10.18 56.43 coo 48.81 64.16 26.34 49.30 62.16 26.73 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 49 3 # 49 B 194 SER D 167 SER~? 5.79 O2 PO4 D 349 B 292 ASP D 226 ASP.? 25.08 O1 PO4 D 349 B 322 HIS D 309 HIS.? 14.00 O2 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -52.83 25.44 66.27 -50.98 24.93 67.73 coo 24.74 78.07 5.59 24.32 79.03 7.46 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 48.81 64.16 26.34 49.30 62.16 26.73 -40.87 34.22 71.66 -41.37 35.58 70.15 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 50 3 # 50 B 194 SER D 235 SER.? 9.32 O4 PO4 D 349 B 292 ASP D 208 ASP~? 8.41 C6 PG4 D 350 B 322 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -44.15 28.59 53.58 -43.17 30.60 54.60 coo 24.74 78.07 5.59 24.32 79.03 7.46 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 48.81 64.16 26.34 49.30 62.16 26.73 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 51 3 # 51 B 194 SER D 241 SER.? 10.08 O3 PO4 D 349 B 292 ASP D 131 ASP^? 9.77 C6 PG4 C 350 B 322 HIS D 260 HIS^? 11.65 O4 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 24.74 78.07 5.59 24.32 79.03 7.46 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 48.81 64.16 26.34 49.30 62.16 26.73 -44.73 36.67 61.75 -42.79 37.49 61.80 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 52 3 # 52 B 194 SER D 241 SER.? 10.08 O3 PO4 D 349 B 292 ASP D 131 ASP^? 9.77 C6 PG4 C 350 B 322 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 24.74 78.07 5.59 24.32 79.03 7.46 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 48.81 64.16 26.34 49.30 62.16 26.73 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 53 3 # 53 B 194 SER D 241 SER.? 10.08 O3 PO4 D 349 B 292 ASP D 131 ASP^? 9.77 C6 PG4 C 350 B 322 HIS D 272 HIS.? 19.84 O3 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 24.74 78.07 5.59 24.32 79.03 7.46 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 48.81 64.16 26.34 49.30 62.16 26.73 -29.12 31.20 53.56 -30.01 29.84 52.23 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 54 3 # 54 B 194 SER D 251 SER~? 15.21 O1 PO4 D 349 B 292 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 322 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -58.95 24.32 48.36 -57.66 25.69 49.92 coo 24.74 78.07 5.59 24.32 79.03 7.46 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 48.81 64.16 26.34 49.30 62.16 26.73 -62.51 23.18 64.17 -63.84 21.56 64.29 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 55 3 # 55 B 194 SER D 251 SER~? 15.21 O1 PO4 D 349 B 292 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 322 HIS C 272 HIS.? 20.13 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -58.95 24.32 48.36 -57.66 25.69 49.92 coo 24.74 78.07 5.59 24.32 79.03 7.46 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 48.81 64.16 26.34 49.30 62.16 26.73 -63.70 27.74 35.03 -62.68 26.43 36.32 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 56 3 # 56 B 194 SER D 251 SER~? 15.21 O1 PO4 D 349 B 292 ASP D 343 ASP~? 23.05 O1 PO4 D 349 B 322 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -58.95 24.32 48.36 -57.66 25.69 49.92 coo 24.74 78.07 5.59 24.32 79.03 7.46 -64.64 38.99 64.31 -65.73 38.68 66.10 coo 48.81 64.16 26.34 49.30 62.16 26.73 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 57 3 # 57 B 194 SER D 290 SER~? 21.91 O1 PO4 C 349 B 292 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 322 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -55.41 35.28 42.81 -54.12 37.28 42.41 coo 24.74 78.07 5.59 24.32 79.03 7.46 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 48.81 64.16 26.34 49.30 62.16 26.73 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 58 3 # 58 B 194 SER D 290 SER~? 21.91 O1 PO4 C 349 B 292 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 322 HIS C 272 HIS.? 20.13 O1 PO4 C 349 coo 35.42 71.28 22.94 36.24 69.06 22.37 -55.41 35.28 42.81 -54.12 37.28 42.41 coo 24.74 78.07 5.59 24.32 79.03 7.46 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 48.81 64.16 26.34 49.30 62.16 26.73 -63.70 27.74 35.03 -62.68 26.43 36.32 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 58 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 220 ARG~? 15.84 O1 PG4 A 350 B 342 ASP C 339 ASP~? 17.02 O2 PG4 A 350 B 531 ARG C 152 ARG^? 15.32 O1 PG4 A 350 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -23.72 43.89 25.49 -25.14 44.23 28.23 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -30.42 35.10 18.03 -29.05 33.77 17.12 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -26.55 34.01 32.08 -24.98 36.67 32.18 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 249 ARG~? 17.61 O4 PO4 B 349 B 342 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 531 ARG A 147 ARG~? 21.89 C2 PG4 A 350 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -23.00 46.39 6.22 -24.32 43.65 5.76 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG B 249 ARG~? 17.39 O4 PO4 A 349 B 342 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 531 ARG B 147 ARG~? 21.77 C2 PG4 B 350 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 1.78 52.94 11.29 0.18 53.87 8.84 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -1.16 62.88 18.52 0.68 62.16 19.33 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 11.90 56.41 10.58 13.26 57.05 13.30 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG C 179 ARG~? 14.85 O2 PG4 A 350 B 342 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 531 ARG A 220 ARG~? 15.84 O1 PG4 A 350 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -24.98 33.12 21.00 -27.25 35.17 20.85 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -23.72 43.89 25.49 -25.14 44.23 28.23 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG C 249 ARG~? 17.71 O4 PO4 D 349 B 342 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 531 ARG C 147 ARG~? 21.64 C2 PG4 C 350 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -28.57 31.49 48.25 -26.95 30.26 50.59 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 5 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 220 ARG~? 15.84 O1 PG4 A 350 A 342 ASP C 339 ASP~? 17.02 O2 PG4 A 350 A 531 ARG C 152 ARG^? 15.32 O1 PG4 A 350 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -23.72 43.89 25.49 -25.14 44.23 28.23 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -30.42 35.10 18.03 -29.05 33.77 17.12 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -26.55 34.01 32.08 -24.98 36.67 32.18 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 249 ARG~? 17.61 O4 PO4 B 349 A 342 ASP A 140 ASP.? 7.37 O2 PG4 A 350 A 531 ARG A 147 ARG~? 21.89 C2 PG4 A 350 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -23.00 46.39 6.22 -24.32 43.65 5.76 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG A 249 ARG~? 17.61 O4 PO4 B 349 A 342 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 531 ARG A 147 ARG~? 21.89 C2 PG4 A 350 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -23.00 46.39 6.22 -24.32 43.65 5.76 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG A 261 ARG^? 7.73 O2 PO4 A 349 A 342 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 531 ARG A 30 ARG~? 10.33 O2 PO4 A 349 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -1.53 69.75 22.21 -1.72 66.84 23.28 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -9.85 66.58 32.39 -7.32 68.13 33.36 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG B 249 ARG~? 17.39 O4 PO4 A 349 A 342 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 531 ARG B 147 ARG~? 21.77 C2 PG4 B 350 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 1.78 52.94 11.29 0.18 53.87 8.84 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -1.16 62.88 18.52 0.68 62.16 19.33 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 11.90 56.41 10.58 13.26 57.05 13.30 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG C 152 ARG^? 15.32 O1 PG4 A 350 A 342 ASP C 339 ASP~? 17.02 O2 PG4 A 350 A 531 ARG A 220 ARG~? 15.84 O1 PG4 A 350 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -26.55 34.01 32.08 -24.98 36.67 32.18 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -30.42 35.10 18.03 -29.05 33.77 17.12 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -23.72 43.89 25.49 -25.14 44.23 28.23 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 A 325 ARG C 220 ARG~? 11.31 O1 PG4 C 350 A 342 ASP C 140 ASP.? 7.74 C2 PG4 C 350 A 531 ARG C 153 ARG^? 21.82 O2 PO4 C 349 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -25.78 14.58 38.60 -28.17 14.03 40.55 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -28.52 27.96 39.05 -27.50 30.55 40.41 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 A 325 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 342 ASP C 140 ASP.? 7.74 C2 PG4 C 350 A 531 ARG C 147 ARG~? 21.64 C2 PG4 C 350 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -28.57 31.49 48.25 -26.95 30.26 50.59 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 A 325 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 342 ASP C 140 ASP.? 7.74 C2 PG4 C 350 A 531 ARG C 153 ARG^? 21.82 O2 PO4 C 349 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -28.52 27.96 39.05 -27.50 30.55 40.41 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 A 325 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 342 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 531 ARG C 147 ARG~? 21.64 C2 PG4 C 350 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -28.57 31.49 48.25 -26.95 30.26 50.59 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 A 325 ARG C 261 ARG^? 7.89 O4 PO4 C 349 A 342 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 531 ARG C 30 ARG~? 10.19 O4 PO4 C 349 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -51.94 28.25 21.63 -51.22 25.74 23.33 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -42.41 19.48 17.74 -45.10 19.59 16.14 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 11 hits 1asy_c01 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE B 185 PHE^? 9.61 O2 PO4 B 349 A 223 ASP B 198 ASP.? 14.38 O1 PG4 B 350 A 265 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 39.74 52.86 65.74 41.15 55.14 66.52 9.75 34.05 4.41 7.07 33.56 5.04 coo 30.70 47.50 67.53 29.83 49.47 67.39 11.89 31.57 14.26 12.37 32.72 16.00 coo 19.99 54.53 64.11 20.55 58.78 68.33 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE B 336 PHE~? 18.31 O3 PO4 B 349 A 223 ASP B 339 ASP~? 20.98 O2 PO4 B 349 A 265 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 39.74 52.86 65.74 41.15 55.14 66.52 3.33 32.70 -15.56 0.90 31.96 -16.75 coo 30.70 47.50 67.53 29.83 49.47 67.39 12.36 37.42 -12.59 13.93 36.17 -11.84 coo 19.99 54.53 64.11 20.55 58.78 68.33 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE D 336 PHE~? 18.33 O2 PO4 D 349 A 223 ASP D 339 ASP~? 21.27 O1 PO4 D 349 A 265 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 39.74 52.86 65.74 41.15 55.14 66.52 -54.15 37.21 74.25 -51.71 38.11 75.32 coo 30.70 47.50 67.53 29.83 49.47 67.39 -63.02 36.35 69.71 -64.42 35.04 70.68 coo 19.99 54.53 64.11 20.55 58.78 68.33 -68.08 25.33 66.69 -67.75 19.10 66.60 1ax4_c04 source 1ax4 TRYPTOPHANASE : 3 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE B 185 PHE^? 9.61 O2 PO4 B 349 B 223 ASP B 198 ASP.? 14.38 O1 PG4 B 350 B 265 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 7.48 54.94 99.62 7.67 52.27 100.42 9.75 34.05 4.41 7.07 33.56 5.04 coo 10.43 61.66 91.81 9.80 60.04 90.61 11.89 31.57 14.26 12.37 32.72 16.00 coo 5.43 58.06 80.08 8.57 53.00 79.37 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE B 336 PHE~? 18.31 O3 PO4 B 349 B 223 ASP B 339 ASP~? 20.98 O2 PO4 B 349 B 265 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 7.48 54.94 99.62 7.67 52.27 100.42 3.33 32.70 -15.56 0.90 31.96 -16.75 coo 10.43 61.66 91.81 9.80 60.04 90.61 12.36 37.42 -12.59 13.93 36.17 -11.84 coo 5.43 58.06 80.08 8.57 53.00 79.37 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE D 336 PHE~? 18.33 O2 PO4 D 349 B 223 ASP D 339 ASP~? 21.27 O1 PO4 D 349 B 265 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 7.48 54.94 99.62 7.67 52.27 100.42 -54.15 37.21 74.25 -51.71 38.11 75.32 coo 10.43 61.66 91.81 9.80 60.04 90.61 -63.02 36.35 69.71 -64.42 35.04 70.68 coo 5.43 58.06 80.08 8.57 53.00 79.37 -68.08 25.33 66.69 -67.75 19.10 66.60 1ax4_c05 source 1ax4 TRYPTOPHANASE : 3 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE B 185 PHE^? 9.61 O2 PO4 B 349 C 223 ASP B 198 ASP.? 14.38 O1 PG4 B 350 C 265 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo -6.55 73.45 23.60 -6.77 71.48 21.66 9.75 34.05 4.41 7.07 33.56 5.04 coo -9.52 75.74 33.62 -8.85 73.74 33.93 11.89 31.57 14.26 12.37 32.72 16.00 coo -4.44 67.20 42.32 -7.50 62.41 40.49 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE B 336 PHE~? 18.31 O3 PO4 B 349 C 223 ASP B 339 ASP~? 20.98 O2 PO4 B 349 C 265 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo -6.55 73.45 23.60 -6.77 71.48 21.66 3.33 32.70 -15.56 0.90 31.96 -16.75 coo -9.52 75.74 33.62 -8.85 73.74 33.93 12.36 37.42 -12.59 13.93 36.17 -11.84 coo -4.44 67.20 42.32 -7.50 62.41 40.49 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE D 336 PHE~? 18.33 O2 PO4 D 349 C 223 ASP D 339 ASP~? 21.27 O1 PO4 D 349 C 265 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -54.15 37.21 74.25 -51.71 38.11 75.32 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -63.02 36.35 69.71 -64.42 35.04 70.68 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -68.08 25.33 66.69 -67.75 19.10 66.60 1ax4_c06 source 1ax4 TRYPTOPHANASE : 3 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE B 185 PHE^? 9.61 O2 PO4 B 349 D 223 ASP B 198 ASP.? 14.38 O1 PG4 B 350 D 265 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo -38.60 55.38 52.70 -40.06 57.72 53.04 9.75 34.05 4.41 7.07 33.56 5.04 coo -29.46 51.67 48.51 -28.63 53.31 49.56 11.89 31.57 14.26 12.37 32.72 16.00 coo -18.87 56.53 54.79 -19.47 62.22 53.03 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE B 336 PHE~? 18.31 O3 PO4 B 349 D 223 ASP B 339 ASP~? 20.98 O2 PO4 B 349 D 265 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo -38.60 55.38 52.70 -40.06 57.72 53.04 3.33 32.70 -15.56 0.90 31.96 -16.75 coo -29.46 51.67 48.51 -28.63 53.31 49.56 12.36 37.42 -12.59 13.93 36.17 -11.84 coo -18.87 56.53 54.79 -19.47 62.22 53.03 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE D 336 PHE~? 18.33 O2 PO4 D 349 D 223 ASP D 339 ASP~? 21.27 O1 PO4 D 349 D 265 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -54.15 37.21 74.25 -51.71 38.11 75.32 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -63.02 36.35 69.71 -64.42 35.04 70.68 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -68.08 25.33 66.69 -67.75 19.10 66.60 1ax4_c07 source 1ax4 TRYPTOPHANASE : 3 hits 1ax4_c07 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 64 SER~? 26.25 O3 PG4 B 350 A 266 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 294 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 32.07 25.76 77.83 34.46 26.05 77.46 1.46 56.04 50.07 2.12 55.38 52.31 coo 33.07 35.01 79.81 33.39 33.02 79.13 1.74 60.96 43.57 3.36 61.47 42.28 coo 35.53 30.26 79.89 34.62 28.71 78.80 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 110 SER A 64 SER~? 26.25 O3 PG4 B 350 A 266 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 294 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 32.07 25.76 77.83 34.46 26.05 77.46 1.46 56.04 50.07 2.12 55.38 52.31 coo 33.07 35.01 79.81 33.39 33.02 79.13 8.08 50.44 43.84 7.48 51.26 41.98 coo 35.53 30.26 79.89 34.62 28.71 78.80 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 110 SER A 241 SER.? 9.98 O3 PO4 A 349 A 266 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 294 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 32.07 25.76 77.83 34.46 26.05 77.46 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 33.07 35.01 79.81 33.39 33.02 79.13 -1.16 62.88 18.52 0.68 62.16 19.33 coo 35.53 30.26 79.89 34.62 28.71 78.80 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 110 SER B 64 SER~? 26.98 C5 PG4 A 350 A 266 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 294 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 32.07 25.76 77.83 34.46 26.05 77.46 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 33.07 35.01 79.81 33.39 33.02 79.13 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 35.53 30.26 79.89 34.62 28.71 78.80 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 5 3 # 5 A 110 SER B 241 SER.? 10.02 O1 PO4 B 349 A 266 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 294 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 32.07 25.76 77.83 34.46 26.05 77.46 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 33.07 35.01 79.81 33.39 33.02 79.13 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 35.53 30.26 79.89 34.62 28.71 78.80 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 6 3 # 6 A 110 SER C 64 SER~? 25.88 C5 PG4 D 350 A 266 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 294 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 32.07 25.76 77.83 34.46 26.05 77.46 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 33.07 35.01 79.81 33.39 33.02 79.13 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 35.53 30.26 79.89 34.62 28.71 78.80 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 7 3 # 7 A 110 SER C 64 SER~? 25.88 C5 PG4 D 350 A 266 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 294 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 32.07 25.76 77.83 34.46 26.05 77.46 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 33.07 35.01 79.81 33.39 33.02 79.13 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 35.53 30.26 79.89 34.62 28.71 78.80 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 8 3 # 8 A 110 SER C 241 SER.? 9.97 O3 PO4 C 349 A 266 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 294 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 32.07 25.76 77.83 34.46 26.05 77.46 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 33.07 35.01 79.81 33.39 33.02 79.13 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 35.53 30.26 79.89 34.62 28.71 78.80 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 9 3 # 9 A 110 SER D 64 SER~? 27.50 C6 PG4 C 350 A 266 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 294 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 32.07 25.76 77.83 34.46 26.05 77.46 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 33.07 35.01 79.81 33.39 33.02 79.13 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 35.53 30.26 79.89 34.62 28.71 78.80 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 10 3 # 10 A 110 SER D 64 SER~? 27.50 C6 PG4 C 350 A 266 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 294 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 32.07 25.76 77.83 34.46 26.05 77.46 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 33.07 35.01 79.81 33.39 33.02 79.13 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 35.53 30.26 79.89 34.62 28.71 78.80 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 11 3 # 11 A 110 SER D 241 SER.? 10.08 O3 PO4 D 349 A 266 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 294 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 32.07 25.76 77.83 34.46 26.05 77.46 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 33.07 35.01 79.81 33.39 33.02 79.13 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 35.53 30.26 79.89 34.62 28.71 78.80 -38.74 26.41 54.26 -37.48 24.84 54.87 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 11 hits 1azw_c00 naa= 3 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 1 3 # 1 B 110 SER A 64 SER~? 26.25 O3 PG4 B 350 B 266 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 294 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 51.18 33.22 36.61 49.29 31.79 37.02 1.46 56.04 50.07 2.12 55.38 52.31 coo 44.19 39.32 34.54 45.21 37.66 35.38 1.74 60.96 43.57 3.36 61.47 42.28 coo 45.79 34.26 34.63 47.54 33.80 35.70 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 2 3 # 2 B 110 SER A 64 SER~? 26.25 O3 PG4 B 350 B 266 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 294 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 51.18 33.22 36.61 49.29 31.79 37.02 1.46 56.04 50.07 2.12 55.38 52.31 coo 44.19 39.32 34.54 45.21 37.66 35.38 8.08 50.44 43.84 7.48 51.26 41.98 coo 45.79 34.26 34.63 47.54 33.80 35.70 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 3 3 # 3 B 110 SER A 241 SER.? 9.98 O3 PO4 A 349 B 266 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 294 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 51.18 33.22 36.61 49.29 31.79 37.02 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 44.19 39.32 34.54 45.21 37.66 35.38 -1.16 62.88 18.52 0.68 62.16 19.33 coo 45.79 34.26 34.63 47.54 33.80 35.70 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 4 3 # 4 B 110 SER B 64 SER~? 26.98 C5 PG4 A 350 B 266 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 294 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 51.18 33.22 36.61 49.29 31.79 37.02 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 44.19 39.32 34.54 45.21 37.66 35.38 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 45.79 34.26 34.63 47.54 33.80 35.70 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 5 3 # 5 B 110 SER B 241 SER.? 10.02 O1 PO4 B 349 B 266 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 294 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 51.18 33.22 36.61 49.29 31.79 37.02 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 44.19 39.32 34.54 45.21 37.66 35.38 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 45.79 34.26 34.63 47.54 33.80 35.70 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 6 3 # 6 B 110 SER C 64 SER~? 25.88 C5 PG4 D 350 B 266 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 294 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 51.18 33.22 36.61 49.29 31.79 37.02 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 44.19 39.32 34.54 45.21 37.66 35.38 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 45.79 34.26 34.63 47.54 33.80 35.70 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 7 3 # 7 B 110 SER C 64 SER~? 25.88 C5 PG4 D 350 B 266 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 294 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 51.18 33.22 36.61 49.29 31.79 37.02 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 44.19 39.32 34.54 45.21 37.66 35.38 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 45.79 34.26 34.63 47.54 33.80 35.70 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 8 3 # 8 B 110 SER C 241 SER.? 9.97 O3 PO4 C 349 B 266 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 294 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 51.18 33.22 36.61 49.29 31.79 37.02 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 44.19 39.32 34.54 45.21 37.66 35.38 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 45.79 34.26 34.63 47.54 33.80 35.70 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 9 3 # 9 B 110 SER D 64 SER~? 27.50 C6 PG4 C 350 B 266 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 294 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 51.18 33.22 36.61 49.29 31.79 37.02 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 44.19 39.32 34.54 45.21 37.66 35.38 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 45.79 34.26 34.63 47.54 33.80 35.70 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 10 3 # 10 B 110 SER D 241 SER.? 10.08 O3 PO4 D 349 B 266 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 294 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 51.18 33.22 36.61 49.29 31.79 37.02 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 44.19 39.32 34.54 45.21 37.66 35.38 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 45.79 34.26 34.63 47.54 33.80 35.70 -38.74 26.41 54.26 -37.48 24.84 54.87 1azw_c01 source 1azw PROLINE IMINOPEPTIDASE : 10 hits 1azw_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 182 GLU A 94 GLU~? 21.51 O3 PG4 B 350 A 286 ASN A 43 ASN~? 22.73 O3 PO4 A 349 coo 26.03 44.66 108.90 25.67 42.61 108.82 1.74 60.96 43.57 3.36 61.47 42.28 coo 18.06 44.02 105.38 18.08 45.37 107.03 2.26 51.25 46.83 2.00 52.68 48.40 coo 25.47 38.28 112.06 27.26 39.30 111.54 6.86 62.77 42.72 8.12 61.14 42.12 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP A 140 ASP.? 7.37 O2 PG4 A 350 A 182 GLU A 215 GLU~? 13.07 C2 PG4 A 350 A 286 ASN A 138 ASN.? -6.13 O2 PG4 A 350s coo 26.03 44.66 108.90 25.67 42.61 108.82 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 18.06 44.02 105.38 18.08 45.37 107.03 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 25.47 38.28 112.06 27.26 39.30 111.54 -17.89 33.84 23.48 -17.76 31.89 24.26 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 182 GLU A 171 GLU~? 12.95 O2 PO4 A 349 A 286 ASN A 306 ASN^? 8.27 O2 PO4 A 349 coo 26.03 44.66 108.90 25.67 42.61 108.82 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 18.06 44.02 105.38 18.08 45.37 107.03 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 25.47 38.28 112.06 27.26 39.30 111.54 -7.02 69.82 22.14 -6.25 69.91 24.11 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 182 GLU B 94 GLU~? 22.11 C5 PG4 A 350 A 286 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo 26.03 44.66 108.90 25.67 42.61 108.82 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 18.06 44.02 105.38 18.08 45.37 107.03 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 25.47 38.28 112.06 27.26 39.30 111.54 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 A 109 ASP B 140 ASP.? 7.99 O2 PG4 B 350 A 182 GLU B 215 GLU~? 13.59 C2 PG4 B 350 A 286 ASN B 138 ASN.? -6.40 C1 PG4 B 350s coo 26.03 44.66 108.90 25.67 42.61 108.82 8.40 47.76 23.89 8.35 49.33 25.35 coo 18.06 44.02 105.38 18.08 45.37 107.03 10.14 48.09 15.50 9.78 49.78 16.69 coo 25.47 38.28 112.06 27.26 39.30 111.54 10.62 41.15 26.22 11.12 39.95 27.93 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 A 109 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 182 GLU B 171 GLU~? 12.87 O3 PO4 B 349 A 286 ASN B 306 ASN^? 8.17 O3 PO4 B 349 coo 26.03 44.66 108.90 25.67 42.61 108.82 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 18.06 44.02 105.38 18.08 45.37 107.03 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 25.47 38.28 112.06 27.26 39.30 111.54 -3.96 34.28 -6.86 -4.36 32.22 -6.36 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 A 109 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 182 GLU C 94 GLU~? 21.12 C5 PG4 D 350 A 286 ASN C 43 ASN.? 22.72 C5 PG4 D 350 coo 26.03 44.66 108.90 25.67 42.61 108.82 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 18.06 44.02 105.38 18.08 45.37 107.03 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 25.47 38.28 112.06 27.26 39.30 111.54 -57.74 6.14 16.07 -58.97 5.36 17.64 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 8 3 # 8 A 109 ASP C 140 ASP.? 7.74 C2 PG4 C 350 A 182 GLU C 215 GLU~? 13.26 C2 PG4 C 350 A 286 ASN C 138 ASN.? 6.71 C1 PG4 C 350 coo 26.03 44.66 108.90 25.67 42.61 108.82 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 18.06 44.02 105.38 18.08 45.37 107.03 -30.56 22.29 45.75 -30.82 22.67 47.79 coo 25.47 38.28 112.06 27.26 39.30 111.54 -29.85 10.06 48.10 -29.27 8.04 48.24 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 9 3 # 9 A 109 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 182 GLU C 171 GLU~? 12.90 O2 PO4 C 349 A 286 ASN C 306 ASN^? 8.19 O4 PO4 C 349 coo 26.03 44.66 108.90 25.67 42.61 108.82 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 18.06 44.02 105.38 18.08 45.37 107.03 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 25.47 38.28 112.06 27.26 39.30 111.54 -46.37 29.17 21.30 -46.92 27.39 20.25 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 10 3 # 10 A 109 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 182 GLU D 94 GLU~? 22.39 C6 PG4 C 350 A 286 ASN D 43 ASN.? 23.87 O2 PO4 D 349 coo 26.03 44.66 108.90 25.67 42.61 108.82 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 18.06 44.02 105.38 18.08 45.37 107.03 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 25.47 38.28 112.06 27.26 39.30 111.54 -34.60 10.60 78.03 -33.00 10.04 76.71 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 11 3 # 11 A 109 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 182 GLU D 171 GLU~? 12.87 O2 PO4 D 349 A 286 ASN D 306 ASN^? 8.15 O2 PO4 D 349 coo 26.03 44.66 108.90 25.67 42.61 108.82 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 18.06 44.02 105.38 18.08 45.37 107.03 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 25.47 38.28 112.06 27.26 39.30 111.54 -46.44 32.39 67.16 -45.73 30.88 68.47 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 11 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 182 GLU A 94 GLU~? 21.51 O3 PG4 B 350 B 286 ASN A 43 ASN~? 22.73 O3 PO4 A 349 coo 13.82 69.26 132.27 11.87 70.14 132.51 1.74 60.96 43.57 3.36 61.47 42.28 coo 8.74 63.05 136.42 9.87 62.19 134.79 2.26 51.25 46.83 2.00 52.68 48.40 coo 8.26 72.60 129.22 10.14 73.45 129.80 6.86 62.77 42.72 8.12 61.14 42.12 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP A 140 ASP.? 7.37 O2 PG4 A 350 B 182 GLU A 215 GLU~? 13.07 C2 PG4 A 350 B 286 ASN A 138 ASN.? -6.13 O2 PG4 A 350s coo 13.82 69.26 132.27 11.87 70.14 132.51 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 8.74 63.05 136.42 9.87 62.19 134.79 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 8.26 72.60 129.22 10.14 73.45 129.80 -17.89 33.84 23.48 -17.76 31.89 24.26 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP A 332 ASP~? 12.07 O2 PO4 A 349 B 182 GLU A 171 GLU~? 12.95 O2 PO4 A 349 B 286 ASN A 306 ASN^? 8.27 O2 PO4 A 349 coo 13.82 69.26 132.27 11.87 70.14 132.51 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 8.74 63.05 136.42 9.87 62.19 134.79 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 8.26 72.60 129.22 10.14 73.45 129.80 -7.02 69.82 22.14 -6.25 69.91 24.11 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP A 332 ASP~? 12.07 O2 PO4 A 349 B 182 GLU A 312 GLU~? 22.67 O2 PO4 A 349 B 286 ASN A 306 ASN^? 8.27 O2 PO4 A 349 coo 13.82 69.26 132.27 11.87 70.14 132.51 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 8.74 63.05 136.42 9.87 62.19 134.79 -11.55 82.77 24.82 -13.13 83.67 25.87 coo 8.26 72.60 129.22 10.14 73.45 129.80 -7.02 69.82 22.14 -6.25 69.91 24.11 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 B 109 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 182 GLU B 94 GLU~? 22.11 C5 PG4 A 350 B 286 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo 13.82 69.26 132.27 11.87 70.14 132.51 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 8.74 63.05 136.42 9.87 62.19 134.79 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 8.26 72.60 129.22 10.14 73.45 129.80 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 B 109 ASP B 140 ASP.? 7.99 O2 PG4 B 350 B 182 GLU B 215 GLU~? 13.59 C2 PG4 B 350 B 286 ASN B 138 ASN.? -6.40 C1 PG4 B 350s coo 13.82 69.26 132.27 11.87 70.14 132.51 8.40 47.76 23.89 8.35 49.33 25.35 coo 8.74 63.05 136.42 9.87 62.19 134.79 10.14 48.09 15.50 9.78 49.78 16.69 coo 8.26 72.60 129.22 10.14 73.45 129.80 10.62 41.15 26.22 11.12 39.95 27.93 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 B 109 ASP B 332 ASP~? 12.13 O3 PO4 B 349 B 182 GLU B 171 GLU~? 12.87 O3 PO4 B 349 B 286 ASN B 306 ASN^? 8.17 O3 PO4 B 349 coo 13.82 69.26 132.27 11.87 70.14 132.51 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 8.74 63.05 136.42 9.87 62.19 134.79 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 8.26 72.60 129.22 10.14 73.45 129.80 -3.96 34.28 -6.86 -4.36 32.22 -6.36 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 8 3 # 8 B 109 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 182 GLU C 94 GLU~? 21.12 C5 PG4 D 350 B 286 ASN C 43 ASN.? 22.72 C5 PG4 D 350 coo 13.82 69.26 132.27 11.87 70.14 132.51 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 8.74 63.05 136.42 9.87 62.19 134.79 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 8.26 72.60 129.22 10.14 73.45 129.80 -57.74 6.14 16.07 -58.97 5.36 17.64 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 9 3 # 9 B 109 ASP C 140 ASP.? 7.74 C2 PG4 C 350 B 182 GLU C 215 GLU~? 13.26 C2 PG4 C 350 B 286 ASN C 138 ASN.? 6.71 C1 PG4 C 350 coo 13.82 69.26 132.27 11.87 70.14 132.51 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 8.74 63.05 136.42 9.87 62.19 134.79 -30.56 22.29 45.75 -30.82 22.67 47.79 coo 8.26 72.60 129.22 10.14 73.45 129.80 -29.85 10.06 48.10 -29.27 8.04 48.24 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 10 3 # 10 B 109 ASP C 332 ASP~? 12.18 O4 PO4 C 349 B 182 GLU C 171 GLU~? 12.90 O2 PO4 C 349 B 286 ASN C 306 ASN^? 8.19 O4 PO4 C 349 coo 13.82 69.26 132.27 11.87 70.14 132.51 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 8.74 63.05 136.42 9.87 62.19 134.79 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 8.26 72.60 129.22 10.14 73.45 129.80 -46.37 29.17 21.30 -46.92 27.39 20.25 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 11 3 # 11 B 109 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 182 GLU D 94 GLU~? 22.39 C6 PG4 C 350 B 286 ASN D 43 ASN.? 23.87 O2 PO4 D 349 coo 13.82 69.26 132.27 11.87 70.14 132.51 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 8.74 63.05 136.42 9.87 62.19 134.79 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 8.26 72.60 129.22 10.14 73.45 129.80 -34.60 10.60 78.03 -33.00 10.04 76.71 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 12 3 # 12 B 109 ASP D 332 ASP~? 12.02 O2 PO4 D 349 B 182 GLU D 171 GLU~? 12.87 O2 PO4 D 349 B 286 ASN D 306 ASN^? 8.15 O2 PO4 D 349 coo 13.82 69.26 132.27 11.87 70.14 132.51 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 8.74 63.05 136.42 9.87 62.19 134.79 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 8.26 72.60 129.22 10.14 73.45 129.80 -46.44 32.39 67.16 -45.73 30.88 68.47 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 12 hits 1b57_c01 naa= 3 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 148 CYH A 330 CYH^? 15.75 O4 PO4 A 349 A 179 ASP A 343 ASP~? 23.03 O1 PO4 A 349 A 183 GLN A 347 GLN~? 24.63 O4 PO4 A 349 coo 21.87 3.71 21.27 20.32 3.55 23.64 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 17.09 11.24 20.19 17.85 10.05 21.76 -25.30 71.23 14.76 -26.68 71.84 16.22 coo 19.54 13.23 15.90 21.64 12.89 15.61 -25.79 69.32 9.60 -25.79 71.34 10.38 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 148 CYH B 330 CYH^? 15.61 O4 PO4 B 349 A 179 ASP B 343 ASP~? 22.96 O2 PO4 B 349 A 183 GLN B 347 GLN~? 25.46 O4 PO4 B 349 coo 21.87 3.71 21.27 20.32 3.55 23.64 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 17.09 11.24 20.19 17.85 10.05 21.76 12.62 43.49 -12.19 13.89 41.96 -12.92 coo 19.54 13.23 15.90 21.64 12.89 15.61 13.07 48.75 -11.49 13.61 47.74 -13.28 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 A 148 CYH C 330 CYH^? 15.66 O1 PO4 C 349 A 179 ASP C 343 ASP~? 16.17 O1 PG4 A 350 A 183 GLN C 347 GLN~? 17.39 O1 PG4 A 350 coo 21.87 3.71 21.27 20.32 3.55 23.64 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 17.09 11.24 20.19 17.85 10.05 21.76 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 19.54 13.23 15.90 21.64 12.89 15.61 -28.44 41.71 27.13 -28.62 42.30 25.08 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 4 3 # 4 A 148 CYH D 330 CYH^? 15.59 O4 PO4 D 349 A 179 ASP D 343 ASP~? 23.05 O1 PO4 D 349 A 183 GLN D 347 GLN~? 25.14 O4 PO4 D 349 coo 21.87 3.71 21.27 20.32 3.55 23.64 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 17.09 11.24 20.19 17.85 10.05 21.76 -64.64 38.99 64.31 -65.73 38.68 66.10 coo 19.54 13.23 15.90 21.64 12.89 15.61 -66.19 40.87 59.81 -66.45 41.78 61.75 1b5d_c00 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 4 hits 1b5d_c00 naa= 3 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 148 CYH A 330 CYH^? 15.75 O4 PO4 A 349 B 179 ASP A 343 ASP~? 23.03 O1 PO4 A 349 B 183 GLN A 347 GLN~? 24.63 O4 PO4 A 349 coo 30.30 0.93 3.58 31.01 1.18 0.88 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -25.30 71.23 14.76 -26.68 71.84 16.22 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 -25.79 69.32 9.60 -25.79 71.34 10.38 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 148 CYH B 330 CYH^? 15.61 O4 PO4 B 349 B 179 ASP B 343 ASP~? 22.96 O2 PO4 B 349 B 183 GLN B 347 GLN~? 25.46 O4 PO4 B 349 coo 30.30 0.93 3.58 31.01 1.18 0.88 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 12.62 43.49 -12.19 13.89 41.96 -12.92 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 13.07 48.75 -11.49 13.61 47.74 -13.28 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 B 148 CYH C 330 CYH^? 15.66 O1 PO4 C 349 B 179 ASP C 343 ASP~? 16.17 O1 PG4 A 350 B 183 GLN C 347 GLN~? 17.39 O1 PG4 A 350 coo 30.30 0.93 3.58 31.01 1.18 0.88 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 -28.44 41.71 27.13 -28.62 42.30 25.08 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 4 3 # 4 B 148 CYH D 330 CYH^? 15.59 O4 PO4 D 349 B 179 ASP D 343 ASP~? 23.05 O1 PO4 D 349 B 183 GLN D 347 GLN~? 25.14 O4 PO4 D 349 coo 30.30 0.93 3.58 31.01 1.18 0.88 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -64.64 38.99 64.31 -65.73 38.68 66.10 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 -66.19 40.87 59.81 -66.45 41.78 61.75 1b5d_c01 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 4 hits 1b5d_c01 naa= 3 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 60 GLU A 171 GLU~? 12.95 O2 PO4 A 349 A 148 CYH A 330 CYH^? 15.75 O4 PO4 A 349 A 179 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 20.47 15.77 27.32 19.04 14.27 26.94 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 21.87 3.71 21.27 20.32 3.55 23.64 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 17.09 11.24 20.19 17.85 10.05 21.76 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 60 GLU A 312 GLU~? 22.67 O2 PO4 A 349 A 148 CYH A 330 CYH^? 15.75 O4 PO4 A 349 A 179 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 20.47 15.77 27.32 19.04 14.27 26.94 -11.55 82.77 24.82 -13.13 83.67 25.87 coo 21.87 3.71 21.27 20.32 3.55 23.64 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 17.09 11.24 20.19 17.85 10.05 21.76 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 A 60 GLU B 171 GLU~? 12.87 O3 PO4 B 349 A 148 CYH B 330 CYH^? 15.61 O4 PO4 B 349 A 179 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 20.47 15.77 27.32 19.04 14.27 26.94 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 21.87 3.71 21.27 20.32 3.55 23.64 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 17.09 11.24 20.19 17.85 10.05 21.76 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 4 3 # 4 A 60 GLU B 312 GLU~? 22.88 O3 PO4 B 349 A 148 CYH B 330 CYH^? 15.61 O4 PO4 B 349 A 179 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 20.47 15.77 27.32 19.04 14.27 26.94 -0.30 29.09 -19.54 1.27 27.97 -20.48 coo 21.87 3.71 21.27 20.32 3.55 23.64 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 17.09 11.24 20.19 17.85 10.05 21.76 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 5 3 # 5 A 60 GLU C 171 GLU~? 12.90 O2 PO4 C 349 A 148 CYH C 330 CYH^? 15.66 O1 PO4 C 349 A 179 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 20.47 15.77 27.32 19.04 14.27 26.94 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 21.87 3.71 21.27 20.32 3.55 23.64 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 17.09 11.24 20.19 17.85 10.05 21.76 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 6 3 # 6 A 60 GLU C 171 GLU~? 12.90 O2 PO4 C 349 A 148 CYH C 330 CYH^? 15.66 O1 PO4 C 349 A 179 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 20.47 15.77 27.32 19.04 14.27 26.94 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 21.87 3.71 21.27 20.32 3.55 23.64 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 17.09 11.24 20.19 17.85 10.05 21.76 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 7 3 # 7 A 60 GLU C 312 GLU~? 22.95 O4 PO4 C 349 A 148 CYH C 330 CYH^? 15.66 O1 PO4 C 349 A 179 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 20.47 15.77 27.32 19.04 14.27 26.94 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 21.87 3.71 21.27 20.32 3.55 23.64 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 17.09 11.24 20.19 17.85 10.05 21.76 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 8 3 # 8 A 60 GLU D 171 GLU~? 12.87 O2 PO4 D 349 A 148 CYH D 330 CYH^? 15.59 O4 PO4 D 349 A 179 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 20.47 15.77 27.32 19.04 14.27 26.94 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 21.87 3.71 21.27 20.32 3.55 23.64 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 17.09 11.24 20.19 17.85 10.05 21.76 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 9 3 # 9 A 60 GLU D 171 GLU~? 12.87 O2 PO4 D 349 A 148 CYH D 330 CYH^? 15.59 O4 PO4 D 349 A 179 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 20.47 15.77 27.32 19.04 14.27 26.94 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 21.87 3.71 21.27 20.32 3.55 23.64 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 17.09 11.24 20.19 17.85 10.05 21.76 -63.02 36.35 69.71 -64.42 35.04 70.68 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 10 3 # 10 A 60 GLU D 312 GLU~? 22.27 O2 PO4 D 349 A 148 CYH D 330 CYH^? 15.59 O4 PO4 D 349 A 179 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 20.47 15.77 27.32 19.04 14.27 26.94 -50.13 39.19 79.01 -51.63 38.45 80.28 coo 21.87 3.71 21.27 20.32 3.55 23.64 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 17.09 11.24 20.19 17.85 10.05 21.76 -51.05 35.32 70.59 -50.24 33.36 70.95 1b5d_c04 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 10 hits 1b5d_c04 naa= 3 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 60 GLU A 171 GLU~? 12.95 O2 PO4 A 349 B 148 CYH A 330 CYH^? 15.75 O4 PO4 A 349 B 179 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 30.30 0.93 3.58 31.01 1.18 0.88 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 60 GLU A 312 GLU~? 22.67 O2 PO4 A 349 B 148 CYH A 330 CYH^? 15.75 O4 PO4 A 349 B 179 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -11.55 82.77 24.82 -13.13 83.67 25.87 coo 30.30 0.93 3.58 31.01 1.18 0.88 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 B 60 GLU B 171 GLU~? 12.87 O3 PO4 B 349 B 148 CYH B 330 CYH^? 15.61 O4 PO4 B 349 B 179 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 30.30 0.93 3.58 31.01 1.18 0.88 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 4 3 # 4 B 60 GLU B 312 GLU~? 22.88 O3 PO4 B 349 B 148 CYH B 330 CYH^? 15.61 O4 PO4 B 349 B 179 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -0.30 29.09 -19.54 1.27 27.97 -20.48 coo 30.30 0.93 3.58 31.01 1.18 0.88 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 5 3 # 5 B 60 GLU C 171 GLU~? 12.90 O2 PO4 C 349 B 148 CYH C 330 CYH^? 15.66 O1 PO4 C 349 B 179 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 30.30 0.93 3.58 31.01 1.18 0.88 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 6 3 # 6 B 60 GLU C 312 GLU~? 22.95 O4 PO4 C 349 B 148 CYH C 330 CYH^? 15.66 O1 PO4 C 349 B 179 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 30.30 0.93 3.58 31.01 1.18 0.88 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 7 3 # 7 B 60 GLU D 171 GLU~? 12.87 O2 PO4 D 349 B 148 CYH D 330 CYH^? 15.59 O4 PO4 D 349 B 179 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 30.30 0.93 3.58 31.01 1.18 0.88 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 8 3 # 8 B 60 GLU D 171 GLU~? 12.87 O2 PO4 D 349 B 148 CYH D 330 CYH^? 15.59 O4 PO4 D 349 B 179 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 30.30 0.93 3.58 31.01 1.18 0.88 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -63.02 36.35 69.71 -64.42 35.04 70.68 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 9 3 # 9 B 60 GLU D 312 GLU~? 22.27 O2 PO4 D 349 B 148 CYH D 330 CYH^? 15.59 O4 PO4 D 349 B 179 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -50.13 39.19 79.01 -51.63 38.45 80.28 coo 30.30 0.93 3.58 31.01 1.18 0.88 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -51.05 35.32 70.59 -50.24 33.36 70.95 1b5d_c05 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 9 hits 1b5d_c05 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 231 GLU.? 5.77 O1 PO4 A 349 B 88 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 89 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 44.53 38.98 5.35 43.53 40.60 6.22 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 58.74 13.49 55.78 58.72 14.38 57.67 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 60.89 12.20 60.42 60.43 13.81 61.68 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU A 231 GLU.? 5.77 O1 PO4 A 349 B 88 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 89 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 44.53 38.98 5.35 43.53 40.60 6.22 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 58.74 13.49 55.78 58.72 14.38 57.67 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 60.89 12.20 60.42 60.43 13.81 61.68 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU A 286 GLU~? 19.74 O4 PO4 A 349 B 88 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 89 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 44.53 38.98 5.35 43.53 40.60 6.22 -13.11 61.08 5.26 -13.84 62.85 4.34 coo 58.74 13.49 55.78 58.72 14.38 57.67 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 60.89 12.20 60.42 60.43 13.81 61.68 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU B 231 GLU.? 5.72 O2 PO4 B 349 B 88 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 89 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 44.53 38.98 5.35 43.53 40.60 6.22 3.23 35.71 5.73 3.00 33.97 6.89 coo 58.74 13.49 55.78 58.72 14.38 57.67 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 60.89 12.20 60.42 60.43 13.81 61.68 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 5 3 # 5 A 133 GLU D 70 GLU~? 33.04 O2 PO4 D 349 B 88 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 89 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 44.53 38.98 5.35 43.53 40.60 6.22 -48.44 -1.77 84.26 -46.89 -0.65 85.18 coo 58.74 13.49 55.78 58.72 14.38 57.67 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 60.89 12.20 60.42 60.43 13.81 61.68 -53.35 2.03 20.79 -52.66 0.23 19.95 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 5 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 231 GLU.? 5.77 O1 PO4 A 349 B 88 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 89 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 44.53 38.98 5.35 43.53 40.60 6.22 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 58.74 13.49 55.78 58.72 14.38 57.67 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 60.89 12.20 60.42 60.43 13.81 61.68 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU A 231 GLU.? 5.77 O1 PO4 A 349 B 88 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 89 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 44.53 38.98 5.35 43.53 40.60 6.22 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 58.74 13.49 55.78 58.72 14.38 57.67 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 60.89 12.20 60.42 60.43 13.81 61.68 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU A 286 GLU~? 19.74 O4 PO4 A 349 B 88 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 89 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 44.53 38.98 5.35 43.53 40.60 6.22 -13.11 61.08 5.26 -13.84 62.85 4.34 coo 58.74 13.49 55.78 58.72 14.38 57.67 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 60.89 12.20 60.42 60.43 13.81 61.68 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU B 231 GLU.? 5.72 O2 PO4 B 349 B 88 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 89 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 44.53 38.98 5.35 43.53 40.60 6.22 3.23 35.71 5.73 3.00 33.97 6.89 coo 58.74 13.49 55.78 58.72 14.38 57.67 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 60.89 12.20 60.42 60.43 13.81 61.68 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 5 3 # 5 A 133 GLU D 70 GLU~? 33.04 O2 PO4 D 349 B 88 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 89 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 44.53 38.98 5.35 43.53 40.60 6.22 -48.44 -1.77 84.26 -46.89 -0.65 85.18 coo 58.74 13.49 55.78 58.72 14.38 57.67 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 60.89 12.20 60.42 60.43 13.81 61.68 -53.35 2.03 20.79 -52.66 0.23 19.95 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 5 hits 1b66_c02 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 91 ARG B 249 ARG~? 17.39 O4 PO4 A 349 A 129 SER A 235 SER.? 9.13 O4 PO4 A 349 coo 24.39 47.01 49.70 26.42 47.04 49.21 1.50 56.90 17.79 2.83 56.38 19.33 coo 25.98 44.20 42.23 28.53 42.98 43.43 1.78 52.94 11.29 0.18 53.87 8.84 coo 30.00 49.76 45.68 28.73 48.72 47.47 -3.96 57.47 15.64 -2.97 59.52 14.86 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 A 18 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 91 ARG B 249 ARG~? 17.39 O4 PO4 A 349 A 129 SER B 143 SER.? 15.37 C2 PG4 B 350 coo 24.39 47.01 49.70 26.42 47.04 49.21 1.50 56.90 17.79 2.83 56.38 19.33 coo 25.98 44.20 42.23 28.53 42.98 43.43 1.78 52.94 11.29 0.18 53.87 8.84 coo 30.00 49.76 45.68 28.73 48.72 47.47 8.40 53.62 17.31 10.72 53.32 17.95 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 A 18 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 91 ARG A 249 ARG~? 17.61 O4 PO4 B 349 A 129 SER A 143 SER.? 14.48 C2 PG4 A 350 coo 24.39 47.01 49.70 26.42 47.04 49.21 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 25.98 44.20 42.23 28.53 42.98 43.43 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 30.00 49.76 45.68 28.73 48.72 47.47 -18.44 40.75 9.72 -20.35 39.92 10.87 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 A 18 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 91 ARG A 249 ARG~? 17.61 O4 PO4 B 349 A 129 SER B 235 SER.? 9.35 O4 PO4 B 349 coo 24.39 47.01 49.70 26.42 47.04 49.21 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 25.98 44.20 42.23 28.53 42.98 43.43 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 30.00 49.76 45.68 28.73 48.72 47.47 -6.73 42.81 4.19 -8.03 43.03 2.17 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 5 3 # 5 A 18 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 91 ARG D 249 ARG~? 17.54 O1 PO4 C 349 A 129 SER C 235 SER.? 9.23 O1 PO4 C 349 coo 24.39 47.01 49.70 26.42 47.04 49.21 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 25.98 44.20 42.23 28.53 42.98 43.43 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 30.00 49.76 45.68 28.73 48.72 47.47 -48.25 27.10 35.26 -49.51 28.80 34.06 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 6 3 # 6 A 18 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 91 ARG D 249 ARG~? 17.54 O1 PO4 C 349 A 129 SER D 143 SER.? 14.73 O4 PG4 D 350 coo 24.39 47.01 49.70 26.42 47.04 49.21 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 25.98 44.20 42.23 28.53 42.98 43.43 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 30.00 49.76 45.68 28.73 48.72 47.47 -59.66 21.71 38.39 -61.59 20.24 38.67 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 7 3 # 7 A 18 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 91 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 129 SER C 143 SER.? 14.49 C2 PG4 C 350 coo 24.39 47.01 49.70 26.42 47.04 49.21 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 25.98 44.20 42.23 28.53 42.98 43.43 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 30.00 49.76 45.68 28.73 48.72 47.47 -31.83 24.72 51.20 -29.72 23.61 51.01 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 8 3 # 8 A 18 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 91 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 129 SER D 235 SER.? 9.32 O4 PO4 D 349 coo 24.39 47.01 49.70 26.42 47.04 49.21 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 25.98 44.20 42.23 28.53 42.98 43.43 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 30.00 49.76 45.68 28.73 48.72 47.47 -44.15 28.59 53.58 -43.17 30.60 54.60 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 8 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 91 ARG A 152 ARG^? 23.60 O1 PO4 A 349 B 129 SER A 183 SER^? 16.92 O1 PO4 A 349 coo 18.19 17.03 40.71 18.55 17.18 38.64 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 25.60 21.10 38.54 23.57 20.93 36.25 -26.26 60.60 13.36 -28.56 61.89 11.76 coo 21.33 14.29 34.62 19.25 14.88 35.71 -27.51 58.57 23.48 -25.56 60.04 23.47 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 91 ARG B 249 ARG~? 17.39 O4 PO4 A 349 B 129 SER A 235 SER.? 9.13 O4 PO4 A 349 coo 18.19 17.03 40.71 18.55 17.18 38.64 1.50 56.90 17.79 2.83 56.38 19.33 coo 25.60 21.10 38.54 23.57 20.93 36.25 1.78 52.94 11.29 0.18 53.87 8.84 coo 21.33 14.29 34.62 19.25 14.88 35.71 -3.96 57.47 15.64 -2.97 59.52 14.86 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 B 18 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 91 ARG B 249 ARG~? 17.39 O4 PO4 A 349 B 129 SER B 143 SER.? 15.37 C2 PG4 B 350 coo 18.19 17.03 40.71 18.55 17.18 38.64 1.50 56.90 17.79 2.83 56.38 19.33 coo 25.60 21.10 38.54 23.57 20.93 36.25 1.78 52.94 11.29 0.18 53.87 8.84 coo 21.33 14.29 34.62 19.25 14.88 35.71 8.40 53.62 17.31 10.72 53.32 17.95 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 B 18 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 91 ARG B 152 ARG^? 23.80 O2 PO4 B 349 B 129 SER B 183 SER^? 16.79 O2 PO4 B 349 coo 18.19 17.03 40.71 18.55 17.18 38.64 11.38 38.70 0.79 12.71 38.99 -0.80 coo 25.60 21.10 38.54 23.57 20.93 36.25 14.94 46.89 -2.30 16.61 48.81 -4.04 coo 21.33 14.29 34.62 19.25 14.88 35.71 17.47 37.56 1.42 15.35 37.17 0.22 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 5 3 # 5 B 18 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 91 ARG A 249 ARG~? 17.61 O4 PO4 B 349 B 129 SER A 143 SER.? 14.48 C2 PG4 A 350 coo 18.19 17.03 40.71 18.55 17.18 38.64 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 25.60 21.10 38.54 23.57 20.93 36.25 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 21.33 14.29 34.62 19.25 14.88 35.71 -18.44 40.75 9.72 -20.35 39.92 10.87 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 6 3 # 6 B 18 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 91 ARG A 249 ARG~? 17.61 O4 PO4 B 349 B 129 SER B 235 SER.? 9.35 O4 PO4 B 349 coo 18.19 17.03 40.71 18.55 17.18 38.64 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 25.60 21.10 38.54 23.57 20.93 36.25 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 21.33 14.29 34.62 19.25 14.88 35.71 -6.73 42.81 4.19 -8.03 43.03 2.17 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 7 3 # 7 B 18 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 91 ARG C 152 ARG^? 15.32 O1 PG4 A 350 B 129 SER C 183 SER^? 16.83 O2 PO4 C 349 coo 18.19 17.03 40.71 18.55 17.18 38.64 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 25.60 21.10 38.54 23.57 20.93 36.25 -26.55 34.01 32.08 -24.98 36.67 32.18 coo 21.33 14.29 34.62 19.25 14.88 35.71 -24.45 24.87 27.97 -26.59 25.58 27.05 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 8 3 # 8 B 18 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 91 ARG D 249 ARG~? 17.54 O1 PO4 C 349 B 129 SER C 235 SER.? 9.23 O1 PO4 C 349 coo 18.19 17.03 40.71 18.55 17.18 38.64 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 25.60 21.10 38.54 23.57 20.93 36.25 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 21.33 14.29 34.62 19.25 14.88 35.71 -48.25 27.10 35.26 -49.51 28.80 34.06 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 9 3 # 9 B 18 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 91 ARG D 249 ARG~? 17.54 O1 PO4 C 349 B 129 SER D 143 SER.? 14.73 O4 PG4 D 350 coo 18.19 17.03 40.71 18.55 17.18 38.64 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 25.60 21.10 38.54 23.57 20.93 36.25 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 21.33 14.29 34.62 19.25 14.88 35.71 -59.66 21.71 38.39 -61.59 20.24 38.67 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 10 3 # 10 B 18 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 91 ARG D 152 ARG^? 23.56 O1 PO4 D 349 B 129 SER D 183 SER^? 16.97 O1 PO4 D 349 coo 18.19 17.03 40.71 18.55 17.18 38.64 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 25.60 21.10 38.54 23.57 20.93 36.25 -66.62 32.34 56.11 -68.43 34.76 55.54 coo 21.33 14.29 34.62 19.25 14.88 35.71 -67.39 23.51 61.42 -65.47 24.80 62.18 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 11 3 # 11 B 18 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 91 ARG C 249 ARG~? 17.71 O4 PO4 D 349 B 129 SER C 143 SER.? 14.49 C2 PG4 C 350 coo 18.19 17.03 40.71 18.55 17.18 38.64 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 25.60 21.10 38.54 23.57 20.93 36.25 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 21.33 14.29 34.62 19.25 14.88 35.71 -31.83 24.72 51.20 -29.72 23.61 51.01 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 12 3 # 12 B 18 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 91 ARG C 249 ARG~? 17.71 O4 PO4 D 349 B 129 SER D 235 SER.? 9.32 O4 PO4 D 349 coo 18.19 17.03 40.71 18.55 17.18 38.64 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 25.60 21.10 38.54 23.57 20.93 36.25 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 21.33 14.29 34.62 19.25 14.88 35.71 -44.15 28.59 53.58 -43.17 30.60 54.60 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 12 hits 1b6t_c01 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR D 91 TYR~? 13.46 C4 PG4 C 350 A 230 ASP D 89 ASP.? 16.35 C5 PG4 C 350 A 273 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 9.23 21.44 106.88 10.18 19.34 105.31 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 1.45 22.80 104.16 2.58 21.02 104.01 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 2.97 11.64 107.87 6.59 15.13 107.03 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 1 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR D 91 TYR~? 13.46 C4 PG4 C 350 B 230 ASP D 89 ASP.? 16.35 C5 PG4 C 350 B 273 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 11.81 13.41 73.03 10.00 13.03 75.12 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 19.17 11.01 76.14 17.26 10.42 76.77 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 11.10 2.31 76.60 10.24 7.24 75.62 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 1 hits 1b8g_c05 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 30 ARG~? 10.33 O2 PO4 A 349 A 141 THR A 53 THR~? 15.49 O2 PO4 A 349 A 235 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -9.85 66.58 32.39 -7.32 68.13 33.36 coo 6.80 92.87 28.33 4.91 92.74 27.40 -2.16 69.93 37.40 -2.96 68.31 38.59 coo 12.98 90.36 47.57 11.26 89.62 46.62 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 133 ARG.? 8.90 C3 PG4 B 350 A 141 THR A 111 THR.? -3.96 C5 PG4 B 350s A 235 ASP A 198 ASP.? 17.22 O1 PO4 A 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -4.79 46.92 29.78 -3.00 49.36 29.13 coo 6.80 92.87 28.33 4.91 92.74 27.40 -0.72 42.17 33.63 1.22 41.72 34.46 coo 12.98 90.36 47.57 11.26 89.62 46.62 -20.04 48.14 30.81 -21.28 49.70 29.91 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 133 ARG.? 8.90 C3 PG4 B 350 A 141 THR A 191 THR~? 7.95 O1 PO4 A 349 A 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -4.79 46.92 29.78 -3.00 49.36 29.13 coo 6.80 92.87 28.33 4.91 92.74 27.40 -9.97 54.73 31.48 -8.80 56.54 31.46 coo 12.98 90.36 47.57 11.26 89.62 46.62 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG A 152 ARG^? 23.60 O1 PO4 A 349 A 141 THR A 254 THR.? 20.09 O1 PO4 A 349 A 235 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -26.26 60.60 13.36 -28.56 61.89 11.76 coo 6.80 92.87 28.33 4.91 92.74 27.40 -21.73 56.84 10.14 -23.52 56.47 11.25 coo 12.98 90.36 47.57 11.26 89.62 46.62 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s A 141 THR B 111 THR.? -3.92 C5 PG4 A 350s A 235 ASP A 131 ASP^? 9.75 C6 PG4 B 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -5.76 36.17 21.40 -8.07 34.21 22.04 coo 6.80 92.87 28.33 4.91 92.74 27.40 -6.89 27.93 21.89 -8.77 26.98 22.40 coo 12.98 90.36 47.57 11.26 89.62 46.62 -8.03 41.96 35.37 -6.75 41.25 36.93 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s A 141 THR B 111 THR.? -3.92 C5 PG4 A 350s A 235 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -5.76 36.17 21.40 -8.07 34.21 22.04 coo 6.80 92.87 28.33 4.91 92.74 27.40 -6.89 27.93 21.89 -8.77 26.98 22.40 coo 12.98 90.36 47.57 11.26 89.62 46.62 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s A 141 THR B 111 THR.? -3.92 C5 PG4 A 350s A 235 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -5.76 36.17 21.40 -8.07 34.21 22.04 coo 6.80 92.87 28.33 4.91 92.74 27.40 -6.89 27.93 21.89 -8.77 26.98 22.40 coo 12.98 90.36 47.57 11.26 89.62 46.62 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG A 249 ARG~? 17.61 O4 PO4 B 349 A 141 THR A 244 THR~? 10.12 O4 PO4 A 349 A 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 6.80 92.87 28.33 4.91 92.74 27.40 -8.00 52.96 15.18 -7.58 55.05 14.79 coo 12.98 90.36 47.57 11.26 89.62 46.62 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 A 137 ARG A 249 ARG~? 17.61 O4 PO4 B 349 A 141 THR A 244 THR~? 10.12 O4 PO4 A 349 A 235 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 6.80 92.87 28.33 4.91 92.74 27.40 -8.00 52.96 15.18 -7.58 55.05 14.79 coo 12.98 90.36 47.57 11.26 89.62 46.62 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 A 137 ARG A 261 ARG^? 7.73 O2 PO4 A 349 A 141 THR A 265 THR.? 17.74 O4 PO4 A 349 A 235 ASP A 311 ASP~? 22.72 O2 PO4 A 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -1.53 69.75 22.21 -1.72 66.84 23.28 coo 6.80 92.87 28.33 4.91 92.74 27.40 3.16 69.70 14.04 4.54 71.38 14.15 coo 12.98 90.36 47.57 11.26 89.62 46.62 -4.84 83.29 26.02 -4.08 84.26 24.26 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 A 137 ARG B 133 ARG.? 8.50 C4 PG4 A 350 A 141 THR B 111 THR.? -3.92 C5 PG4 A 350s A 235 ASP B 198 ASP.? 14.38 O1 PG4 B 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -3.22 31.42 16.60 -5.11 31.22 14.14 coo 6.80 92.87 28.33 4.91 92.74 27.40 -6.89 27.93 21.89 -8.77 26.98 22.40 coo 12.98 90.36 47.57 11.26 89.62 46.62 11.89 31.57 14.26 12.37 32.72 16.00 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 A 137 ARG B 133 ARG.? 8.50 C4 PG4 A 350 A 141 THR B 191 THR~? 8.03 O2 PO4 B 349 A 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -3.22 31.42 16.60 -5.11 31.22 14.14 coo 6.80 92.87 28.33 4.91 92.74 27.40 1.66 28.50 9.29 0.44 28.02 7.58 coo 12.98 90.36 47.57 11.26 89.62 46.62 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 A 137 ARG B 152 ARG^? 23.80 O2 PO4 B 349 A 141 THR B 254 THR.? 20.12 O2 PO4 B 349 A 235 ASP B 339 ASP~? 20.98 O2 PO4 B 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 14.94 46.89 -2.30 16.61 48.81 -4.04 coo 6.80 92.87 28.33 4.91 92.74 27.40 10.14 50.29 1.40 12.13 49.53 1.68 coo 12.98 90.36 47.57 11.26 89.62 46.62 12.36 37.42 -12.59 13.93 36.17 -11.84 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 A 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s A 141 THR A 111 THR.? -3.96 C5 PG4 B 350s A 235 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -2.22 41.47 25.55 0.33 41.32 27.30 coo 6.80 92.87 28.33 4.91 92.74 27.40 -0.72 42.17 33.63 1.22 41.72 34.46 coo 12.98 90.36 47.57 11.26 89.62 46.62 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 A 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s A 141 THR A 111 THR.? -3.96 C5 PG4 B 350s A 235 ASP B 131 ASP^? 9.09 C8 PG4 A 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -2.22 41.47 25.55 0.33 41.32 27.30 coo 6.80 92.87 28.33 4.91 92.74 27.40 -0.72 42.17 33.63 1.22 41.72 34.46 coo 12.98 90.36 47.57 11.26 89.62 46.62 0.40 27.07 22.40 -0.62 25.51 23.42 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 A 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s A 141 THR A 111 THR.? -3.96 C5 PG4 B 350s A 235 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -2.22 41.47 25.55 0.33 41.32 27.30 coo 6.80 92.87 28.33 4.91 92.74 27.40 -0.72 42.17 33.63 1.22 41.72 34.46 coo 12.98 90.36 47.57 11.26 89.62 46.62 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 A 137 ARG B 249 ARG~? 17.39 O4 PO4 A 349 A 141 THR B 244 THR~? 10.49 O4 PO4 B 349 A 235 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 1.78 52.94 11.29 0.18 53.87 8.84 coo 6.80 92.87 28.33 4.91 92.74 27.40 -2.27 44.71 7.93 -2.99 44.80 5.89 coo 12.98 90.36 47.57 11.26 89.62 46.62 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 A 137 ARG B 249 ARG~? 17.39 O4 PO4 A 349 A 141 THR B 244 THR~? 10.49 O4 PO4 B 349 A 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 1.78 52.94 11.29 0.18 53.87 8.84 coo 6.80 92.87 28.33 4.91 92.74 27.40 -2.27 44.71 7.93 -2.99 44.80 5.89 coo 12.98 90.36 47.57 11.26 89.62 46.62 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 A 137 ARG B 261 ARG^? 7.86 O3 PO4 B 349 A 141 THR B 265 THR.? 17.72 O4 PO4 B 349 A 235 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo 6.80 92.87 28.33 4.91 92.74 27.40 -15.22 40.87 -6.76 -16.61 40.45 -8.39 coo 12.98 90.36 47.57 11.26 89.62 46.62 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 A 137 ARG C 30 ARG~? 10.19 O4 PO4 C 349 A 141 THR C 53 THR~? 15.62 O4 PO4 C 349 A 235 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -42.41 19.48 17.74 -45.10 19.59 16.14 coo 6.80 92.87 28.33 4.91 92.74 27.40 -50.24 15.72 12.79 -48.92 14.06 13.22 coo 12.98 90.36 47.57 11.26 89.62 46.62 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 A 137 ARG C 133 ARG.? 8.69 C6 PG4 D 350 A 141 THR C 111 THR.? -3.86 C3 PG4 D 350s A 235 ASP C 198 ASP.? 14.11 O1 PG4 C 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -44.64 9.69 35.41 -46.86 11.41 34.11 coo 6.80 92.87 28.33 4.91 92.74 27.40 -47.70 3.36 37.51 -49.56 2.24 37.49 coo 12.98 90.36 47.57 11.26 89.62 46.62 -29.82 11.85 32.90 -29.50 11.63 35.01 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 A 137 ARG C 152 ARG^? 15.32 O1 PG4 A 350 A 141 THR C 254 THR.? 20.37 O2 PO4 C 349 A 235 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -26.55 34.01 32.08 -24.98 36.67 32.18 coo 6.80 92.87 28.33 4.91 92.74 27.40 -30.89 33.85 37.59 -28.87 33.18 37.19 coo 12.98 90.36 47.57 11.26 89.62 46.62 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 A 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s A 141 THR D 111 THR.? 4.22 C6 PG4 C 350 A 235 ASP C 131 ASP^? 9.91 O2 PG4 D 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -42.81 10.68 48.87 -40.18 9.57 50.03 coo 6.80 92.87 28.33 4.91 92.74 27.40 -40.95 5.28 55.14 -39.04 4.37 55.56 coo 12.98 90.36 47.57 11.26 89.62 46.62 -40.29 2.77 35.99 -41.53 1.06 35.77 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 A 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s A 141 THR D 111 THR.? 4.22 C6 PG4 C 350 A 235 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -42.81 10.68 48.87 -40.18 9.57 50.03 coo 6.80 92.87 28.33 4.91 92.74 27.40 -40.95 5.28 55.14 -39.04 4.37 55.56 coo 12.98 90.36 47.57 11.26 89.62 46.62 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 A 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s A 141 THR D 111 THR.? 4.22 C6 PG4 C 350 A 235 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -42.81 10.68 48.87 -40.18 9.57 50.03 coo 6.80 92.87 28.33 4.91 92.74 27.40 -40.95 5.28 55.14 -39.04 4.37 55.56 coo 12.98 90.36 47.57 11.26 89.62 46.62 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 A 137 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 141 THR C 244 THR~? 10.31 O1 PO4 C 349 A 235 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 -43.52 25.65 38.88 -44.31 27.18 37.52 coo 12.98 90.36 47.57 11.26 89.62 46.62 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 A 137 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 141 THR C 244 THR~? 10.31 O1 PO4 C 349 A 235 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 -43.52 25.65 38.88 -44.31 27.18 37.52 coo 12.98 90.36 47.57 11.26 89.62 46.62 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 A 137 ARG C 261 ARG^? 7.89 O4 PO4 C 349 A 141 THR C 265 THR.? 17.66 O1 PO4 C 349 A 235 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -51.94 28.25 21.63 -51.22 25.74 23.33 coo 6.80 92.87 28.33 4.91 92.74 27.40 -57.14 33.92 26.73 -58.62 34.64 25.31 coo 12.98 90.36 47.57 11.26 89.62 46.62 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 A 137 ARG D 30 ARG~? 11.31 O2 PO4 D 349 A 141 THR D 53 THR~? 16.59 O2 PO4 D 349 A 235 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -49.79 21.88 72.70 -47.47 22.25 74.75 coo 6.80 92.87 28.33 4.91 92.74 27.40 -43.53 19.74 79.32 -44.41 17.86 78.69 coo 12.98 90.36 47.57 11.26 89.62 46.62 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 A 137 ARG D 133 ARG.? 8.84 C4 PG4 C 350 A 141 THR D 111 THR.? 4.22 C6 PG4 C 350 A 235 ASP D 198 ASP.? 14.02 O5 PG4 D 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -45.06 11.05 55.96 -43.37 13.22 57.41 coo 6.80 92.87 28.33 4.91 92.74 27.40 -40.95 5.28 55.14 -39.04 4.37 55.56 coo 12.98 90.36 47.57 11.26 89.62 46.62 -59.61 10.87 58.41 -59.89 10.18 56.43 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 A 137 ARG D 133 ARG.? 8.84 C4 PG4 C 350 A 141 THR D 191 THR~? 7.89 O1 PO4 D 349 A 235 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -45.06 11.05 55.96 -43.37 13.22 57.41 coo 6.80 92.87 28.33 4.91 92.74 27.40 -49.48 15.22 62.89 -48.24 16.38 64.26 coo 12.98 90.36 47.57 11.26 89.62 46.62 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 A 137 ARG D 152 ARG^? 23.56 O1 PO4 D 349 A 141 THR D 254 THR.? 20.33 O1 PO4 D 349 A 235 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -66.62 32.34 56.11 -68.43 34.76 55.54 coo 6.80 92.87 28.33 4.91 92.74 27.40 -62.28 32.28 50.56 -64.11 31.32 51.19 coo 12.98 90.36 47.57 11.26 89.62 46.62 -63.02 36.35 69.71 -64.42 35.04 70.68 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 A 137 ARG D 206 ARG~? -3.23 O2 PG4 D 350s A 141 THR C 111 THR.? -3.86 C3 PG4 D 350s A 235 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -46.64 9.92 42.41 -48.92 7.98 41.78 coo 6.80 92.87 28.33 4.91 92.74 27.40 -47.70 3.36 37.51 -49.56 2.24 37.49 coo 12.98 90.36 47.57 11.26 89.62 46.62 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 34 3 # 34 A 137 ARG D 206 ARG~? -3.23 O2 PG4 D 350s A 141 THR C 111 THR.? -3.86 C3 PG4 D 350s A 235 ASP D 131 ASP^? 9.77 C6 PG4 C 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -46.64 9.92 42.41 -48.92 7.98 41.78 coo 6.80 92.87 28.33 4.91 92.74 27.40 -47.70 3.36 37.51 -49.56 2.24 37.49 coo 12.98 90.36 47.57 11.26 89.62 46.62 -48.29 3.79 55.93 -46.95 2.25 56.44 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 35 3 # 35 A 137 ARG D 206 ARG~? -3.23 O2 PG4 D 350s A 141 THR C 111 THR.? -3.86 C3 PG4 D 350s A 235 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 6.21 93.81 36.58 4.58 96.33 37.17 -46.64 9.92 42.41 -48.92 7.98 41.78 coo 6.80 92.87 28.33 4.91 92.74 27.40 -47.70 3.36 37.51 -49.56 2.24 37.49 coo 12.98 90.36 47.57 11.26 89.62 46.62 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 36 3 # 36 A 137 ARG D 249 ARG~? 17.54 O1 PO4 C 349 A 141 THR D 244 THR~? 10.60 O4 PO4 D 349 A 235 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 6.80 92.87 28.33 4.91 92.74 27.40 -48.51 26.01 50.22 -48.02 27.82 51.30 coo 12.98 90.36 47.57 11.26 89.62 46.62 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 37 3 # 37 A 137 ARG D 261 ARG^? 8.01 O2 PO4 D 349 A 141 THR D 265 THR.? 17.54 O4 PO4 D 349 A 235 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo 6.21 93.81 36.58 4.58 96.33 37.17 -41.02 32.36 67.18 -41.18 29.51 65.99 coo 6.80 92.87 28.33 4.91 92.74 27.40 -36.48 37.67 60.85 -35.30 38.96 62.07 coo 12.98 90.36 47.57 11.26 89.62 46.62 -43.35 38.70 79.64 -42.93 40.74 79.14 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 37 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 30 ARG~? 10.33 O2 PO4 A 349 D 141 THR A 24 THR~? 10.16 O3 PO4 A 349 D 235 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -9.85 66.58 32.39 -7.32 68.13 33.36 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -5.47 57.24 33.63 -5.78 55.06 33.56 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 30 ARG~? 10.33 O2 PO4 A 349 D 141 THR A 53 THR~? 15.49 O2 PO4 A 349 D 235 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -9.85 66.58 32.39 -7.32 68.13 33.36 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -2.16 69.93 37.40 -2.96 68.31 38.59 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 133 ARG.? 8.90 C3 PG4 B 350 D 141 THR A 188 THR.? 8.85 O1 PO4 A 349 D 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -4.79 46.92 29.78 -3.00 49.36 29.13 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -12.86 51.47 24.24 -13.27 52.66 22.49 coo -14.64 87.74 89.51 -12.89 87.43 90.65 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG A 133 ARG.? 8.90 C3 PG4 B 350 D 141 THR A 191 THR~? 7.95 O1 PO4 A 349 D 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -4.79 46.92 29.78 -3.00 49.36 29.13 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -9.97 54.73 31.48 -8.80 56.54 31.46 coo -14.64 87.74 89.51 -12.89 87.43 90.65 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s D 141 THR B 111 THR.? -3.92 C5 PG4 A 350s D 235 ASP A 131 ASP^? 9.75 C6 PG4 B 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -5.76 36.17 21.40 -8.07 34.21 22.04 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -6.89 27.93 21.89 -8.77 26.98 22.40 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -8.03 41.96 35.37 -6.75 41.25 36.93 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s D 141 THR B 111 THR.? -3.92 C5 PG4 A 350s D 235 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -5.76 36.17 21.40 -8.07 34.21 22.04 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -6.89 27.93 21.89 -8.77 26.98 22.40 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s D 141 THR B 111 THR.? -3.92 C5 PG4 A 350s D 235 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -5.76 36.17 21.40 -8.07 34.21 22.04 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -6.89 27.93 21.89 -8.77 26.98 22.40 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG A 249 ARG~? 17.61 O4 PO4 B 349 D 141 THR A 244 THR~? 10.12 O4 PO4 A 349 D 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -8.00 52.96 15.18 -7.58 55.05 14.79 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 D 137 ARG A 249 ARG~? 17.61 O4 PO4 B 349 D 141 THR A 244 THR~? 10.12 O4 PO4 A 349 D 235 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -8.00 52.96 15.18 -7.58 55.05 14.79 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 D 137 ARG A 249 ARG~? 17.61 O4 PO4 B 349 D 141 THR B 244 THR~? 10.49 O4 PO4 B 349 D 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -2.27 44.71 7.93 -2.99 44.80 5.89 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 D 137 ARG A 261 ARG^? 7.73 O2 PO4 A 349 D 141 THR A 265 THR.? 17.74 O4 PO4 A 349 D 235 ASP A 311 ASP~? 22.72 O2 PO4 A 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -1.53 69.75 22.21 -1.72 66.84 23.28 coo -9.24 93.49 108.77 -7.37 94.21 109.61 3.16 69.70 14.04 4.54 71.38 14.15 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -4.84 83.29 26.02 -4.08 84.26 24.26 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 D 137 ARG B 30 ARG~? 9.80 O3 PO4 B 349 D 141 THR B 24 THR~? 10.13 O1 PO4 B 349 D 235 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 1.86 25.26 -2.23 -1.04 24.22 -2.87 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -2.45 25.09 7.36 -2.25 25.71 9.46 coo -14.64 87.74 89.51 -12.89 87.43 90.65 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 D 137 ARG B 133 ARG.? 8.50 C4 PG4 A 350 D 141 THR B 111 THR.? -3.92 C5 PG4 A 350s D 235 ASP B 198 ASP.? 14.38 O1 PG4 B 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -3.22 31.42 16.60 -5.11 31.22 14.14 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -6.89 27.93 21.89 -8.77 26.98 22.40 coo -14.64 87.74 89.51 -12.89 87.43 90.65 11.89 31.57 14.26 12.37 32.72 16.00 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 D 137 ARG B 133 ARG.? 8.50 C4 PG4 A 350 D 141 THR B 188 THR.? 8.78 O2 PO4 B 349 D 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -3.22 31.42 16.60 -5.11 31.22 14.14 coo -9.24 93.49 108.77 -7.37 94.21 109.61 3.85 36.60 10.61 3.87 38.08 9.08 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 D 137 ARG B 133 ARG.? 8.50 C4 PG4 A 350 D 141 THR B 191 THR~? 8.03 O2 PO4 B 349 D 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -3.22 31.42 16.60 -5.11 31.22 14.14 coo -9.24 93.49 108.77 -7.37 94.21 109.61 1.66 28.50 9.29 0.44 28.02 7.58 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 D 137 ARG B 152 ARG^? 23.80 O2 PO4 B 349 D 141 THR B 254 THR.? 20.12 O2 PO4 B 349 D 235 ASP B 339 ASP~? 20.98 O2 PO4 B 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 14.94 46.89 -2.30 16.61 48.81 -4.04 coo -9.24 93.49 108.77 -7.37 94.21 109.61 10.14 50.29 1.40 12.13 49.53 1.68 coo -14.64 87.74 89.51 -12.89 87.43 90.65 12.36 37.42 -12.59 13.93 36.17 -11.84 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 D 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s D 141 THR A 111 THR.? -3.96 C5 PG4 B 350s D 235 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -2.22 41.47 25.55 0.33 41.32 27.30 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -0.72 42.17 33.63 1.22 41.72 34.46 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 D 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s D 141 THR A 111 THR.? -3.96 C5 PG4 B 350s D 235 ASP B 131 ASP^? 9.09 C8 PG4 A 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -2.22 41.47 25.55 0.33 41.32 27.30 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -0.72 42.17 33.63 1.22 41.72 34.46 coo -14.64 87.74 89.51 -12.89 87.43 90.65 0.40 27.07 22.40 -0.62 25.51 23.42 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 D 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s D 141 THR A 111 THR.? -3.96 C5 PG4 B 350s D 235 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -2.22 41.47 25.55 0.33 41.32 27.30 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -0.72 42.17 33.63 1.22 41.72 34.46 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 D 137 ARG B 249 ARG~? 17.39 O4 PO4 A 349 D 141 THR A 244 THR~? 10.12 O4 PO4 A 349 D 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 1.78 52.94 11.29 0.18 53.87 8.84 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -8.00 52.96 15.18 -7.58 55.05 14.79 coo -14.64 87.74 89.51 -12.89 87.43 90.65 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 D 137 ARG B 249 ARG~? 17.39 O4 PO4 A 349 D 141 THR B 244 THR~? 10.49 O4 PO4 B 349 D 235 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 1.78 52.94 11.29 0.18 53.87 8.84 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -2.27 44.71 7.93 -2.99 44.80 5.89 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 D 137 ARG B 249 ARG~? 17.39 O4 PO4 A 349 D 141 THR B 244 THR~? 10.49 O4 PO4 B 349 D 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 1.78 52.94 11.29 0.18 53.87 8.84 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -2.27 44.71 7.93 -2.99 44.80 5.89 coo -14.64 87.74 89.51 -12.89 87.43 90.65 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 D 137 ARG B 261 ARG^? 7.86 O3 PO4 B 349 D 141 THR B 265 THR.? 17.72 O4 PO4 B 349 D 235 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -15.22 40.87 -6.76 -16.61 40.45 -8.39 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 D 137 ARG C 30 ARG~? 10.19 O4 PO4 C 349 D 141 THR C 24 THR~? 10.28 O3 PO4 C 349 D 235 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -42.41 19.48 17.74 -45.10 19.59 16.14 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -45.29 12.37 24.95 -44.75 11.19 26.72 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 D 137 ARG C 30 ARG~? 10.19 O4 PO4 C 349 D 141 THR C 53 THR~? 15.62 O4 PO4 C 349 D 235 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -42.41 19.48 17.74 -45.10 19.59 16.14 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -50.24 15.72 12.79 -48.92 14.06 13.22 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 D 137 ARG C 133 ARG.? 8.69 C6 PG4 D 350 D 141 THR C 111 THR.? -3.86 C3 PG4 D 350s D 235 ASP C 198 ASP.? 14.11 O1 PG4 C 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -44.64 9.69 35.41 -46.86 11.41 34.11 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -47.70 3.36 37.51 -49.56 2.24 37.49 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -29.82 11.85 32.90 -29.50 11.63 35.01 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 D 137 ARG C 152 ARG^? 15.32 O1 PG4 A 350 D 141 THR C 254 THR.? 20.37 O2 PO4 C 349 D 235 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -26.55 34.01 32.08 -24.98 36.67 32.18 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -30.89 33.85 37.59 -28.87 33.18 37.19 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 D 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s D 141 THR D 111 THR.? 4.22 C6 PG4 C 350 D 235 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -42.81 10.68 48.87 -40.18 9.57 50.03 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -40.95 5.28 55.14 -39.04 4.37 55.56 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 D 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s D 141 THR D 111 THR.? 4.22 C6 PG4 C 350 D 235 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -42.81 10.68 48.87 -40.18 9.57 50.03 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -40.95 5.28 55.14 -39.04 4.37 55.56 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 D 137 ARG C 249 ARG~? 17.71 O4 PO4 D 349 D 141 THR C 244 THR~? 10.31 O1 PO4 C 349 D 235 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -43.52 25.65 38.88 -44.31 27.18 37.52 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 D 137 ARG C 249 ARG~? 17.71 O4 PO4 D 349 D 141 THR C 244 THR~? 10.31 O1 PO4 C 349 D 235 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -43.52 25.65 38.88 -44.31 27.18 37.52 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 D 137 ARG C 249 ARG~? 17.71 O4 PO4 D 349 D 141 THR D 244 THR~? 10.60 O4 PO4 D 349 D 235 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -48.51 26.01 50.22 -48.02 27.82 51.30 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 D 137 ARG C 261 ARG^? 7.89 O4 PO4 C 349 D 141 THR C 265 THR.? 17.66 O1 PO4 C 349 D 235 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -51.94 28.25 21.63 -51.22 25.74 23.33 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -57.14 33.92 26.73 -58.62 34.64 25.31 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 34 3 # 34 D 137 ARG D 30 ARG~? 11.31 O2 PO4 D 349 D 141 THR D 24 THR~? 11.02 O3 PO4 D 349 D 235 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -49.79 21.88 72.70 -47.47 22.25 74.75 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -45.56 14.64 66.69 -45.66 13.25 65.02 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 35 3 # 35 D 137 ARG D 30 ARG~? 11.31 O2 PO4 D 349 D 141 THR D 53 THR~? 16.59 O2 PO4 D 349 D 235 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -49.79 21.88 72.70 -47.47 22.25 74.75 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -43.53 19.74 79.32 -44.41 17.86 78.69 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 36 3 # 36 D 137 ARG D 133 ARG.? 8.84 C4 PG4 C 350 D 141 THR D 111 THR.? 4.22 C6 PG4 C 350 D 235 ASP D 198 ASP.? 14.02 O5 PG4 D 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -45.06 11.05 55.96 -43.37 13.22 57.41 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -40.95 5.28 55.14 -39.04 4.37 55.56 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -59.61 10.87 58.41 -59.89 10.18 56.43 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 37 3 # 37 D 137 ARG D 152 ARG^? 23.56 O1 PO4 D 349 D 141 THR D 254 THR.? 20.33 O1 PO4 D 349 D 235 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -66.62 32.34 56.11 -68.43 34.76 55.54 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -62.28 32.28 50.56 -64.11 31.32 51.19 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -63.02 36.35 69.71 -64.42 35.04 70.68 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 38 3 # 38 D 137 ARG D 206 ARG~? -3.23 O2 PG4 D 350s D 141 THR C 111 THR.? -3.86 C3 PG4 D 350s D 235 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -46.64 9.92 42.41 -48.92 7.98 41.78 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -47.70 3.36 37.51 -49.56 2.24 37.49 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 39 3 # 39 D 137 ARG D 206 ARG~? -3.23 O2 PG4 D 350s D 141 THR C 111 THR.? -3.86 C3 PG4 D 350s D 235 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -46.64 9.92 42.41 -48.92 7.98 41.78 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -47.70 3.36 37.51 -49.56 2.24 37.49 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 40 3 # 40 D 137 ARG D 249 ARG~? 17.54 O1 PO4 C 349 D 141 THR D 244 THR~? 10.60 O4 PO4 D 349 D 235 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -53.61 27.06 41.90 -52.49 29.90 42.42 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -48.51 26.01 50.22 -48.02 27.82 51.30 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 41 3 # 41 D 137 ARG D 261 ARG^? 8.01 O2 PO4 D 349 D 141 THR D 265 THR.? 17.54 O4 PO4 D 349 D 235 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -41.02 32.36 67.18 -41.18 29.51 65.99 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -36.48 37.67 60.85 -35.30 38.96 62.07 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -43.35 38.70 79.64 -42.93 40.74 79.14 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 41 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 30 ARG~? 10.33 O2 PO4 A 349 C 141 THR A 24 THR~? 10.16 O3 PO4 A 349 C 235 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -9.85 66.58 32.39 -7.32 68.13 33.36 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -5.47 57.24 33.63 -5.78 55.06 33.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 30 ARG~? 10.33 O2 PO4 A 349 C 141 THR A 53 THR~? 15.49 O2 PO4 A 349 C 235 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -9.85 66.58 32.39 -7.32 68.13 33.36 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -2.16 69.93 37.40 -2.96 68.31 38.59 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 133 ARG.? 8.90 C3 PG4 B 350 C 141 THR A 111 THR.? -3.96 C5 PG4 B 350s C 235 ASP A 198 ASP.? 17.22 O1 PO4 A 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -4.79 46.92 29.78 -3.00 49.36 29.13 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -0.72 42.17 33.63 1.22 41.72 34.46 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -20.04 48.14 30.81 -21.28 49.70 29.91 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG A 133 ARG.? 8.90 C3 PG4 B 350 C 141 THR A 191 THR~? 7.95 O1 PO4 A 349 C 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -4.79 46.92 29.78 -3.00 49.36 29.13 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -9.97 54.73 31.48 -8.80 56.54 31.46 coo -13.01 70.96 47.58 -11.44 71.65 46.34 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG A 152 ARG^? 23.60 O1 PO4 A 349 C 141 THR A 254 THR.? 20.09 O1 PO4 A 349 C 235 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -26.26 60.60 13.36 -28.56 61.89 11.76 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -21.73 56.84 10.14 -23.52 56.47 11.25 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s C 141 THR B 111 THR.? -3.92 C5 PG4 A 350s C 235 ASP A 131 ASP^? 9.75 C6 PG4 B 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -5.76 36.17 21.40 -8.07 34.21 22.04 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -6.89 27.93 21.89 -8.77 26.98 22.40 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -8.03 41.96 35.37 -6.75 41.25 36.93 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s C 141 THR B 111 THR.? -3.92 C5 PG4 A 350s C 235 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -5.76 36.17 21.40 -8.07 34.21 22.04 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -6.89 27.93 21.89 -8.77 26.98 22.40 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s C 141 THR B 111 THR.? -3.92 C5 PG4 A 350s C 235 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -5.76 36.17 21.40 -8.07 34.21 22.04 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -6.89 27.93 21.89 -8.77 26.98 22.40 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 C 137 ARG A 249 ARG~? 17.61 O4 PO4 B 349 C 141 THR A 244 THR~? 10.12 O4 PO4 A 349 C 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -8.00 52.96 15.18 -7.58 55.05 14.79 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 C 137 ARG A 249 ARG~? 17.61 O4 PO4 B 349 C 141 THR A 244 THR~? 10.12 O4 PO4 A 349 C 235 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -8.00 52.96 15.18 -7.58 55.05 14.79 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 C 137 ARG A 249 ARG~? 17.61 O4 PO4 B 349 C 141 THR B 244 THR~? 10.49 O4 PO4 B 349 C 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -2.27 44.71 7.93 -2.99 44.80 5.89 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 C 137 ARG A 261 ARG^? 7.73 O2 PO4 A 349 C 141 THR A 265 THR.? 17.74 O4 PO4 A 349 C 235 ASP A 311 ASP~? 22.72 O2 PO4 A 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -1.53 69.75 22.21 -1.72 66.84 23.28 coo -6.81 68.31 28.28 -4.82 68.47 27.57 3.16 69.70 14.04 4.54 71.38 14.15 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -4.84 83.29 26.02 -4.08 84.26 24.26 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 C 137 ARG B 30 ARG~? 9.80 O3 PO4 B 349 C 141 THR B 24 THR~? 10.13 O1 PO4 B 349 C 235 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 1.86 25.26 -2.23 -1.04 24.22 -2.87 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -2.45 25.09 7.36 -2.25 25.71 9.46 coo -13.01 70.96 47.58 -11.44 71.65 46.34 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 C 137 ARG B 133 ARG.? 8.50 C4 PG4 A 350 C 141 THR B 111 THR.? -3.92 C5 PG4 A 350s C 235 ASP B 198 ASP.? 14.38 O1 PG4 B 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -3.22 31.42 16.60 -5.11 31.22 14.14 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -6.89 27.93 21.89 -8.77 26.98 22.40 coo -13.01 70.96 47.58 -11.44 71.65 46.34 11.89 31.57 14.26 12.37 32.72 16.00 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 C 137 ARG B 133 ARG.? 8.50 C4 PG4 A 350 C 141 THR B 188 THR.? 8.78 O2 PO4 B 349 C 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -3.22 31.42 16.60 -5.11 31.22 14.14 coo -6.81 68.31 28.28 -4.82 68.47 27.57 3.85 36.60 10.61 3.87 38.08 9.08 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 C 137 ARG B 133 ARG.? 8.50 C4 PG4 A 350 C 141 THR B 191 THR~? 8.03 O2 PO4 B 349 C 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -3.22 31.42 16.60 -5.11 31.22 14.14 coo -6.81 68.31 28.28 -4.82 68.47 27.57 1.66 28.50 9.29 0.44 28.02 7.58 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 C 137 ARG B 152 ARG^? 23.80 O2 PO4 B 349 C 141 THR B 254 THR.? 20.12 O2 PO4 B 349 C 235 ASP B 339 ASP~? 20.98 O2 PO4 B 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 14.94 46.89 -2.30 16.61 48.81 -4.04 coo -6.81 68.31 28.28 -4.82 68.47 27.57 10.14 50.29 1.40 12.13 49.53 1.68 coo -13.01 70.96 47.58 -11.44 71.65 46.34 12.36 37.42 -12.59 13.93 36.17 -11.84 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 C 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s C 141 THR A 111 THR.? -3.96 C5 PG4 B 350s C 235 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -2.22 41.47 25.55 0.33 41.32 27.30 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -0.72 42.17 33.63 1.22 41.72 34.46 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 C 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s C 141 THR A 111 THR.? -3.96 C5 PG4 B 350s C 235 ASP B 131 ASP^? 9.09 C8 PG4 A 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -2.22 41.47 25.55 0.33 41.32 27.30 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -0.72 42.17 33.63 1.22 41.72 34.46 coo -13.01 70.96 47.58 -11.44 71.65 46.34 0.40 27.07 22.40 -0.62 25.51 23.42 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 C 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s C 141 THR A 111 THR.? -3.96 C5 PG4 B 350s C 235 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -2.22 41.47 25.55 0.33 41.32 27.30 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -0.72 42.17 33.63 1.22 41.72 34.46 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 C 137 ARG B 249 ARG~? 17.39 O4 PO4 A 349 C 141 THR A 244 THR~? 10.12 O4 PO4 A 349 C 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 1.78 52.94 11.29 0.18 53.87 8.84 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -8.00 52.96 15.18 -7.58 55.05 14.79 coo -13.01 70.96 47.58 -11.44 71.65 46.34 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 C 137 ARG B 249 ARG~? 17.39 O4 PO4 A 349 C 141 THR B 244 THR~? 10.49 O4 PO4 B 349 C 235 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 1.78 52.94 11.29 0.18 53.87 8.84 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -2.27 44.71 7.93 -2.99 44.80 5.89 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 C 137 ARG B 249 ARG~? 17.39 O4 PO4 A 349 C 141 THR B 244 THR~? 10.49 O4 PO4 B 349 C 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 1.78 52.94 11.29 0.18 53.87 8.84 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -2.27 44.71 7.93 -2.99 44.80 5.89 coo -13.01 70.96 47.58 -11.44 71.65 46.34 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 C 137 ARG B 261 ARG^? 7.86 O3 PO4 B 349 C 141 THR B 265 THR.? 17.72 O4 PO4 B 349 C 235 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -15.22 40.87 -6.76 -16.61 40.45 -8.39 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 C 137 ARG C 30 ARG~? 10.19 O4 PO4 C 349 C 141 THR C 24 THR~? 10.28 O3 PO4 C 349 C 235 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -42.41 19.48 17.74 -45.10 19.59 16.14 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -45.29 12.37 24.95 -44.75 11.19 26.72 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 C 137 ARG C 30 ARG~? 10.19 O4 PO4 C 349 C 141 THR C 53 THR~? 15.62 O4 PO4 C 349 C 235 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -42.41 19.48 17.74 -45.10 19.59 16.14 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -50.24 15.72 12.79 -48.92 14.06 13.22 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 C 137 ARG C 133 ARG.? 8.69 C6 PG4 D 350 C 141 THR C 111 THR.? -3.86 C3 PG4 D 350s C 235 ASP C 198 ASP.? 14.11 O1 PG4 C 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -44.64 9.69 35.41 -46.86 11.41 34.11 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -47.70 3.36 37.51 -49.56 2.24 37.49 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -29.82 11.85 32.90 -29.50 11.63 35.01 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 C 137 ARG C 152 ARG^? 15.32 O1 PG4 A 350 C 141 THR C 254 THR.? 20.37 O2 PO4 C 349 C 235 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -26.55 34.01 32.08 -24.98 36.67 32.18 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -30.89 33.85 37.59 -28.87 33.18 37.19 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 C 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s C 141 THR D 111 THR.? 4.22 C6 PG4 C 350 C 235 ASP C 131 ASP^? 9.91 O2 PG4 D 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -42.81 10.68 48.87 -40.18 9.57 50.03 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -40.95 5.28 55.14 -39.04 4.37 55.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -40.29 2.77 35.99 -41.53 1.06 35.77 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 C 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s C 141 THR D 111 THR.? 4.22 C6 PG4 C 350 C 235 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -42.81 10.68 48.87 -40.18 9.57 50.03 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -40.95 5.28 55.14 -39.04 4.37 55.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 C 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s C 141 THR D 111 THR.? 4.22 C6 PG4 C 350 C 235 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -42.81 10.68 48.87 -40.18 9.57 50.03 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -40.95 5.28 55.14 -39.04 4.37 55.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 C 137 ARG C 249 ARG~? 17.71 O4 PO4 D 349 C 141 THR C 244 THR~? 10.31 O1 PO4 C 349 C 235 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -43.52 25.65 38.88 -44.31 27.18 37.52 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 C 137 ARG C 249 ARG~? 17.71 O4 PO4 D 349 C 141 THR C 244 THR~? 10.31 O1 PO4 C 349 C 235 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -43.52 25.65 38.88 -44.31 27.18 37.52 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 34 3 # 34 C 137 ARG C 249 ARG~? 17.71 O4 PO4 D 349 C 141 THR D 244 THR~? 10.60 O4 PO4 D 349 C 235 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -48.51 26.01 50.22 -48.02 27.82 51.30 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 35 3 # 35 C 137 ARG C 261 ARG^? 7.89 O4 PO4 C 349 C 141 THR C 265 THR.? 17.66 O1 PO4 C 349 C 235 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -51.94 28.25 21.63 -51.22 25.74 23.33 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -57.14 33.92 26.73 -58.62 34.64 25.31 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 36 3 # 36 C 137 ARG D 30 ARG~? 11.31 O2 PO4 D 349 C 141 THR D 24 THR~? 11.02 O3 PO4 D 349 C 235 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -49.79 21.88 72.70 -47.47 22.25 74.75 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -45.56 14.64 66.69 -45.66 13.25 65.02 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 37 3 # 37 C 137 ARG D 30 ARG~? 11.31 O2 PO4 D 349 C 141 THR D 53 THR~? 16.59 O2 PO4 D 349 C 235 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -49.79 21.88 72.70 -47.47 22.25 74.75 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -43.53 19.74 79.32 -44.41 17.86 78.69 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 38 3 # 38 C 137 ARG D 133 ARG.? 8.84 C4 PG4 C 350 C 141 THR D 111 THR.? 4.22 C6 PG4 C 350 C 235 ASP D 198 ASP.? 14.02 O5 PG4 D 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -45.06 11.05 55.96 -43.37 13.22 57.41 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -40.95 5.28 55.14 -39.04 4.37 55.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -59.61 10.87 58.41 -59.89 10.18 56.43 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 39 3 # 39 C 137 ARG D 133 ARG.? 8.84 C4 PG4 C 350 C 141 THR D 191 THR~? 7.89 O1 PO4 D 349 C 235 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -45.06 11.05 55.96 -43.37 13.22 57.41 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -49.48 15.22 62.89 -48.24 16.38 64.26 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 40 3 # 40 C 137 ARG D 152 ARG^? 23.56 O1 PO4 D 349 C 141 THR D 254 THR.? 20.33 O1 PO4 D 349 C 235 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -66.62 32.34 56.11 -68.43 34.76 55.54 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -62.28 32.28 50.56 -64.11 31.32 51.19 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -63.02 36.35 69.71 -64.42 35.04 70.68 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 41 3 # 41 C 137 ARG D 206 ARG~? -3.23 O2 PG4 D 350s C 141 THR C 111 THR.? -3.86 C3 PG4 D 350s C 235 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -46.64 9.92 42.41 -48.92 7.98 41.78 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -47.70 3.36 37.51 -49.56 2.24 37.49 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 42 3 # 42 C 137 ARG D 206 ARG~? -3.23 O2 PG4 D 350s C 141 THR C 111 THR.? -3.86 C3 PG4 D 350s C 235 ASP D 131 ASP^? 9.77 C6 PG4 C 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -46.64 9.92 42.41 -48.92 7.98 41.78 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -47.70 3.36 37.51 -49.56 2.24 37.49 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -48.29 3.79 55.93 -46.95 2.25 56.44 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 43 3 # 43 C 137 ARG D 206 ARG~? -3.23 O2 PG4 D 350s C 141 THR C 111 THR.? -3.86 C3 PG4 D 350s C 235 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -46.64 9.92 42.41 -48.92 7.98 41.78 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -47.70 3.36 37.51 -49.56 2.24 37.49 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 44 3 # 44 C 137 ARG D 249 ARG~? 17.54 O1 PO4 C 349 C 141 THR D 244 THR~? 10.60 O4 PO4 D 349 C 235 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -53.61 27.06 41.90 -52.49 29.90 42.42 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -48.51 26.01 50.22 -48.02 27.82 51.30 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 45 3 # 45 C 137 ARG D 261 ARG^? 8.01 O2 PO4 D 349 C 141 THR D 265 THR.? 17.54 O4 PO4 D 349 C 235 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -41.02 32.36 67.18 -41.18 29.51 65.99 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -36.48 37.67 60.85 -35.30 38.96 62.07 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -43.35 38.70 79.64 -42.93 40.74 79.14 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 45 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 30 ARG~? 10.33 O2 PO4 A 349 B 141 THR A 24 THR~? 10.16 O3 PO4 A 349 B 235 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -9.85 66.58 32.39 -7.32 68.13 33.36 coo 8.28 67.78 108.81 6.22 67.65 109.43 -5.47 57.24 33.63 -5.78 55.06 33.56 coo 14.55 73.52 89.47 12.81 73.95 90.56 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 133 ARG.? 8.90 C3 PG4 B 350 B 141 THR A 111 THR.? -3.96 C5 PG4 B 350s B 235 ASP A 198 ASP.? 17.22 O1 PO4 A 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -4.79 46.92 29.78 -3.00 49.36 29.13 coo 8.28 67.78 108.81 6.22 67.65 109.43 -0.72 42.17 33.63 1.22 41.72 34.46 coo 14.55 73.52 89.47 12.81 73.95 90.56 -20.04 48.14 30.81 -21.28 49.70 29.91 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG A 133 ARG.? 8.90 C3 PG4 B 350 B 141 THR A 191 THR~? 7.95 O1 PO4 A 349 B 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -4.79 46.92 29.78 -3.00 49.36 29.13 coo 8.28 67.78 108.81 6.22 67.65 109.43 -9.97 54.73 31.48 -8.80 56.54 31.46 coo 14.55 73.52 89.47 12.81 73.95 90.56 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG A 152 ARG^? 23.60 O1 PO4 A 349 B 141 THR A 254 THR.? 20.09 O1 PO4 A 349 B 235 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -26.26 60.60 13.36 -28.56 61.89 11.76 coo 8.28 67.78 108.81 6.22 67.65 109.43 -21.73 56.84 10.14 -23.52 56.47 11.25 coo 14.55 73.52 89.47 12.81 73.95 90.56 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s B 141 THR B 111 THR.? -3.92 C5 PG4 A 350s B 235 ASP A 131 ASP^? 9.75 C6 PG4 B 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -5.76 36.17 21.40 -8.07 34.21 22.04 coo 8.28 67.78 108.81 6.22 67.65 109.43 -6.89 27.93 21.89 -8.77 26.98 22.40 coo 14.55 73.52 89.47 12.81 73.95 90.56 -8.03 41.96 35.37 -6.75 41.25 36.93 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s B 141 THR B 111 THR.? -3.92 C5 PG4 A 350s B 235 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -5.76 36.17 21.40 -8.07 34.21 22.04 coo 8.28 67.78 108.81 6.22 67.65 109.43 -6.89 27.93 21.89 -8.77 26.98 22.40 coo 14.55 73.52 89.47 12.81 73.95 90.56 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 B 137 ARG A 206 ARG~? -3.21 O4 PG4 A 350s B 141 THR B 111 THR.? -3.92 C5 PG4 A 350s B 235 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -5.76 36.17 21.40 -8.07 34.21 22.04 coo 8.28 67.78 108.81 6.22 67.65 109.43 -6.89 27.93 21.89 -8.77 26.98 22.40 coo 14.55 73.52 89.47 12.81 73.95 90.56 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 B 137 ARG A 249 ARG~? 17.61 O4 PO4 B 349 B 141 THR A 244 THR~? 10.12 O4 PO4 A 349 B 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 8.28 67.78 108.81 6.22 67.65 109.43 -8.00 52.96 15.18 -7.58 55.05 14.79 coo 14.55 73.52 89.47 12.81 73.95 90.56 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 B 137 ARG A 249 ARG~? 17.61 O4 PO4 B 349 B 141 THR A 244 THR~? 10.12 O4 PO4 A 349 B 235 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 8.28 67.78 108.81 6.22 67.65 109.43 -8.00 52.96 15.18 -7.58 55.05 14.79 coo 14.55 73.52 89.47 12.81 73.95 90.56 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 B 137 ARG A 261 ARG^? 7.73 O2 PO4 A 349 B 141 THR A 159 THR.? 9.59 O4 PO4 A 349 B 235 ASP A 311 ASP~? 22.72 O2 PO4 A 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -1.53 69.75 22.21 -1.72 66.84 23.28 coo 8.28 67.78 108.81 6.22 67.65 109.43 -3.74 63.20 14.86 -4.14 65.31 14.68 coo 14.55 73.52 89.47 12.81 73.95 90.56 -4.84 83.29 26.02 -4.08 84.26 24.26 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 B 137 ARG A 261 ARG^? 7.73 O2 PO4 A 349 B 141 THR A 265 THR.? 17.74 O4 PO4 A 349 B 235 ASP A 311 ASP~? 22.72 O2 PO4 A 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -1.53 69.75 22.21 -1.72 66.84 23.28 coo 8.28 67.78 108.81 6.22 67.65 109.43 3.16 69.70 14.04 4.54 71.38 14.15 coo 14.55 73.52 89.47 12.81 73.95 90.56 -4.84 83.29 26.02 -4.08 84.26 24.26 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 B 137 ARG B 133 ARG.? 8.50 C4 PG4 A 350 B 141 THR B 111 THR.? -3.92 C5 PG4 A 350s B 235 ASP B 198 ASP.? 14.38 O1 PG4 B 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -3.22 31.42 16.60 -5.11 31.22 14.14 coo 8.28 67.78 108.81 6.22 67.65 109.43 -6.89 27.93 21.89 -8.77 26.98 22.40 coo 14.55 73.52 89.47 12.81 73.95 90.56 11.89 31.57 14.26 12.37 32.72 16.00 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 B 137 ARG B 133 ARG.? 8.50 C4 PG4 A 350 B 141 THR B 191 THR~? 8.03 O2 PO4 B 349 B 235 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -3.22 31.42 16.60 -5.11 31.22 14.14 coo 8.28 67.78 108.81 6.22 67.65 109.43 1.66 28.50 9.29 0.44 28.02 7.58 coo 14.55 73.52 89.47 12.81 73.95 90.56 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 B 137 ARG B 152 ARG^? 23.80 O2 PO4 B 349 B 141 THR B 254 THR.? 20.12 O2 PO4 B 349 B 235 ASP B 339 ASP~? 20.98 O2 PO4 B 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 14.94 46.89 -2.30 16.61 48.81 -4.04 coo 8.28 67.78 108.81 6.22 67.65 109.43 10.14 50.29 1.40 12.13 49.53 1.68 coo 14.55 73.52 89.47 12.81 73.95 90.56 12.36 37.42 -12.59 13.93 36.17 -11.84 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 B 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s B 141 THR A 111 THR.? -3.96 C5 PG4 B 350s B 235 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -2.22 41.47 25.55 0.33 41.32 27.30 coo 8.28 67.78 108.81 6.22 67.65 109.43 -0.72 42.17 33.63 1.22 41.72 34.46 coo 14.55 73.52 89.47 12.81 73.95 90.56 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 B 137 ARG B 206 ARG~? -3.06 O4 PG4 B 350s B 141 THR A 111 THR.? -3.96 C5 PG4 B 350s B 235 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -2.22 41.47 25.55 0.33 41.32 27.30 coo 8.28 67.78 108.81 6.22 67.65 109.43 -0.72 42.17 33.63 1.22 41.72 34.46 coo 14.55 73.52 89.47 12.81 73.95 90.56 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 B 137 ARG B 249 ARG~? 17.39 O4 PO4 A 349 B 141 THR B 244 THR~? 10.49 O4 PO4 B 349 B 235 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 1.78 52.94 11.29 0.18 53.87 8.84 coo 8.28 67.78 108.81 6.22 67.65 109.43 -2.27 44.71 7.93 -2.99 44.80 5.89 coo 14.55 73.52 89.47 12.81 73.95 90.56 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 B 137 ARG B 249 ARG~? 17.39 O4 PO4 A 349 B 141 THR B 244 THR~? 10.49 O4 PO4 B 349 B 235 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 1.78 52.94 11.29 0.18 53.87 8.84 coo 8.28 67.78 108.81 6.22 67.65 109.43 -2.27 44.71 7.93 -2.99 44.80 5.89 coo 14.55 73.52 89.47 12.81 73.95 90.56 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 B 137 ARG B 261 ARG^? 7.86 O3 PO4 B 349 B 141 THR B 159 THR.? 9.69 O4 PO4 B 349 B 235 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo 8.28 67.78 108.81 6.22 67.65 109.43 -7.46 42.26 -1.59 -7.39 42.02 -3.73 coo 14.55 73.52 89.47 12.81 73.95 90.56 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 B 137 ARG B 261 ARG^? 7.86 O3 PO4 B 349 B 141 THR B 265 THR.? 17.72 O4 PO4 B 349 B 235 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo 8.28 67.78 108.81 6.22 67.65 109.43 -15.22 40.87 -6.76 -16.61 40.45 -8.39 coo 14.55 73.52 89.47 12.81 73.95 90.56 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 B 137 ARG C 133 ARG.? 8.69 C6 PG4 D 350 B 141 THR C 111 THR.? -3.86 C3 PG4 D 350s B 235 ASP C 198 ASP.? 14.11 O1 PG4 C 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -44.64 9.69 35.41 -46.86 11.41 34.11 coo 8.28 67.78 108.81 6.22 67.65 109.43 -47.70 3.36 37.51 -49.56 2.24 37.49 coo 14.55 73.52 89.47 12.81 73.95 90.56 -29.82 11.85 32.90 -29.50 11.63 35.01 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 B 137 ARG C 152 ARG^? 15.32 O1 PG4 A 350 B 141 THR C 254 THR.? 20.37 O2 PO4 C 349 B 235 ASP A 198 ASP.? 17.22 O1 PO4 A 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -26.55 34.01 32.08 -24.98 36.67 32.18 coo 8.28 67.78 108.81 6.22 67.65 109.43 -30.89 33.85 37.59 -28.87 33.18 37.19 coo 14.55 73.52 89.47 12.81 73.95 90.56 -20.04 48.14 30.81 -21.28 49.70 29.91 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 B 137 ARG C 152 ARG^? 15.32 O1 PG4 A 350 B 141 THR C 254 THR.? 20.37 O2 PO4 C 349 B 235 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -26.55 34.01 32.08 -24.98 36.67 32.18 coo 8.28 67.78 108.81 6.22 67.65 109.43 -30.89 33.85 37.59 -28.87 33.18 37.19 coo 14.55 73.52 89.47 12.81 73.95 90.56 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 B 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s B 141 THR D 111 THR.? 4.22 C6 PG4 C 350 B 235 ASP C 131 ASP^? 9.91 O2 PG4 D 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -42.81 10.68 48.87 -40.18 9.57 50.03 coo 8.28 67.78 108.81 6.22 67.65 109.43 -40.95 5.28 55.14 -39.04 4.37 55.56 coo 14.55 73.52 89.47 12.81 73.95 90.56 -40.29 2.77 35.99 -41.53 1.06 35.77 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 B 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s B 141 THR D 111 THR.? 4.22 C6 PG4 C 350 B 235 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -42.81 10.68 48.87 -40.18 9.57 50.03 coo 8.28 67.78 108.81 6.22 67.65 109.43 -40.95 5.28 55.14 -39.04 4.37 55.56 coo 14.55 73.52 89.47 12.81 73.95 90.56 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 B 137 ARG C 206 ARG~? -3.06 O3 PG4 C 350s B 141 THR D 111 THR.? 4.22 C6 PG4 C 350 B 235 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -42.81 10.68 48.87 -40.18 9.57 50.03 coo 8.28 67.78 108.81 6.22 67.65 109.43 -40.95 5.28 55.14 -39.04 4.37 55.56 coo 14.55 73.52 89.47 12.81 73.95 90.56 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 B 137 ARG C 249 ARG~? 17.71 O4 PO4 D 349 B 141 THR C 244 THR~? 10.31 O1 PO4 C 349 B 235 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 -43.52 25.65 38.88 -44.31 27.18 37.52 coo 14.55 73.52 89.47 12.81 73.95 90.56 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 B 137 ARG C 261 ARG^? 7.89 O4 PO4 C 349 B 141 THR C 159 THR.? 9.76 O1 PO4 C 349 B 235 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -51.94 28.25 21.63 -51.22 25.74 23.33 coo 8.28 67.78 108.81 6.22 67.65 109.43 -49.22 30.92 31.00 -49.22 32.37 29.42 coo 14.55 73.52 89.47 12.81 73.95 90.56 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 B 137 ARG C 261 ARG^? 7.89 O4 PO4 C 349 B 141 THR C 265 THR.? 17.66 O1 PO4 C 349 B 235 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -51.94 28.25 21.63 -51.22 25.74 23.33 coo 8.28 67.78 108.81 6.22 67.65 109.43 -57.14 33.92 26.73 -58.62 34.64 25.31 coo 14.55 73.52 89.47 12.81 73.95 90.56 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 B 137 ARG D 30 ARG~? 11.31 O2 PO4 D 349 B 141 THR D 24 THR~? 11.02 O3 PO4 D 349 B 235 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -49.79 21.88 72.70 -47.47 22.25 74.75 coo 8.28 67.78 108.81 6.22 67.65 109.43 -45.56 14.64 66.69 -45.66 13.25 65.02 coo 14.55 73.52 89.47 12.81 73.95 90.56 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 B 137 ARG D 30 ARG~? 11.31 O2 PO4 D 349 B 141 THR D 53 THR~? 16.59 O2 PO4 D 349 B 235 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -49.79 21.88 72.70 -47.47 22.25 74.75 coo 8.28 67.78 108.81 6.22 67.65 109.43 -43.53 19.74 79.32 -44.41 17.86 78.69 coo 14.55 73.52 89.47 12.81 73.95 90.56 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 B 137 ARG D 133 ARG.? 8.84 C4 PG4 C 350 B 141 THR D 111 THR.? 4.22 C6 PG4 C 350 B 235 ASP D 198 ASP.? 14.02 O5 PG4 D 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -45.06 11.05 55.96 -43.37 13.22 57.41 coo 8.28 67.78 108.81 6.22 67.65 109.43 -40.95 5.28 55.14 -39.04 4.37 55.56 coo 14.55 73.52 89.47 12.81 73.95 90.56 -59.61 10.87 58.41 -59.89 10.18 56.43 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 B 137 ARG D 133 ARG.? 8.84 C4 PG4 C 350 B 141 THR D 191 THR~? 7.89 O1 PO4 D 349 B 235 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -45.06 11.05 55.96 -43.37 13.22 57.41 coo 8.28 67.78 108.81 6.22 67.65 109.43 -49.48 15.22 62.89 -48.24 16.38 64.26 coo 14.55 73.52 89.47 12.81 73.95 90.56 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 34 3 # 34 B 137 ARG D 152 ARG^? 23.56 O1 PO4 D 349 B 141 THR D 254 THR.? 20.33 O1 PO4 D 349 B 235 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -66.62 32.34 56.11 -68.43 34.76 55.54 coo 8.28 67.78 108.81 6.22 67.65 109.43 -62.28 32.28 50.56 -64.11 31.32 51.19 coo 14.55 73.52 89.47 12.81 73.95 90.56 -63.02 36.35 69.71 -64.42 35.04 70.68 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 35 3 # 35 B 137 ARG D 206 ARG~? -3.23 O2 PG4 D 350s B 141 THR C 111 THR.? -3.86 C3 PG4 D 350s B 235 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -46.64 9.92 42.41 -48.92 7.98 41.78 coo 8.28 67.78 108.81 6.22 67.65 109.43 -47.70 3.36 37.51 -49.56 2.24 37.49 coo 14.55 73.52 89.47 12.81 73.95 90.56 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 36 3 # 36 B 137 ARG D 206 ARG~? -3.23 O2 PG4 D 350s B 141 THR C 111 THR.? -3.86 C3 PG4 D 350s B 235 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 8.13 67.41 100.27 7.18 68.35 97.45 -46.64 9.92 42.41 -48.92 7.98 41.78 coo 8.28 67.78 108.81 6.22 67.65 109.43 -47.70 3.36 37.51 -49.56 2.24 37.49 coo 14.55 73.52 89.47 12.81 73.95 90.56 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 37 3 # 37 B 137 ARG D 249 ARG~? 17.54 O1 PO4 C 349 B 141 THR D 244 THR~? 10.60 O4 PO4 D 349 B 235 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 8.28 67.78 108.81 6.22 67.65 109.43 -48.51 26.01 50.22 -48.02 27.82 51.30 coo 14.55 73.52 89.47 12.81 73.95 90.56 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 38 3 # 38 B 137 ARG D 261 ARG^? 8.01 O2 PO4 D 349 B 141 THR D 159 THR.? 9.84 O4 PO4 D 349 B 235 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -41.02 32.36 67.18 -41.18 29.51 65.99 coo 8.28 67.78 108.81 6.22 67.65 109.43 -43.83 33.07 57.34 -43.96 34.77 58.72 coo 14.55 73.52 89.47 12.81 73.95 90.56 -43.35 38.70 79.64 -42.93 40.74 79.14 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 39 3 # 39 B 137 ARG D 261 ARG^? 8.01 O2 PO4 D 349 B 141 THR D 265 THR.? 17.54 O4 PO4 D 349 B 235 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo 8.13 67.41 100.27 7.18 68.35 97.45 -41.02 32.36 67.18 -41.18 29.51 65.99 coo 8.28 67.78 108.81 6.22 67.65 109.43 -36.48 37.67 60.85 -35.30 38.96 62.07 coo 14.55 73.52 89.47 12.81 73.95 90.56 -43.35 38.70 79.64 -42.93 40.74 79.14 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 39 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 41 ASP.? 20.10 O2 PO4 A 349 16 HIS A 14 HIS.? 20.33 C3 PG4 B 350 67 GLY A 102 GLY.? 25.71 C6 PG4 B 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 1.74 60.96 43.57 3.36 61.47 42.28 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 3.61 55.89 43.73 3.10 55.52 45.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -10.25 45.52 53.08 -9.82 46.01 52.67 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 41 ASP.? 20.10 O2 PO4 A 349 16 HIS A 14 HIS.? 20.33 C3 PG4 B 350 67 GLY A 192 GLY~? 8.82 O1 PO4 A 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 1.74 60.96 43.57 3.36 61.47 42.28 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 3.61 55.89 43.73 3.10 55.52 45.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -13.34 54.92 29.80 -13.05 54.30 30.24 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 90 ASP~? 15.98 C4 PG4 B 350 16 HIS A 14 HIS.? 20.33 C3 PG4 B 350 67 GLY A 102 GLY.? 25.71 C6 PG4 B 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 8.08 50.44 43.84 7.48 51.26 41.98 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 3.61 55.89 43.73 3.10 55.52 45.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -10.25 45.52 53.08 -9.82 46.01 52.67 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP A 160 ASP.? 8.60 O4 PO4 A 349 16 HIS A 238 HIS.? 10.67 O3 PO4 A 349 67 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -1.16 62.88 18.52 0.68 62.16 19.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP A 160 ASP.? 8.60 O4 PO4 A 349 16 HIS A 238 HIS.? 10.67 O3 PO4 A 349 67 GLY A 108 GLY.? 11.36 O3 PG4 B 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -1.16 62.88 18.52 0.68 62.16 19.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -5.80 48.81 34.39 -5.17 48.42 34.72 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP A 160 ASP.? 8.60 O4 PO4 A 349 16 HIS A 238 HIS.? 10.67 O3 PO4 A 349 67 GLY A 250 GLY~? 14.78 O1 PG4 A 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -1.16 62.88 18.52 0.68 62.16 19.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -16.12 46.96 14.05 -16.23 47.66 13.72 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP A 160 ASP.? 8.60 O4 PO4 A 349 16 HIS A 238 HIS.? 10.67 O3 PO4 A 349 67 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -1.16 62.88 18.52 0.68 62.16 19.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 8 3 # 8 14 ASP A 160 ASP.? 8.60 O4 PO4 A 349 16 HIS A 260 HIS^? 11.64 O4 PO4 A 349 67 GLY A 54 GLY~? 16.02 O2 PO4 A 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -1.16 62.88 18.52 0.68 62.16 19.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -4.86 72.57 36.81 -5.02 71.91 37.27 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 9 3 # 9 14 ASP A 203 ASP~? 10.68 C3 PG4 B 350 16 HIS A 110 HIS.? 5.77 C3 PG4 B 350 67 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 10 3 # 10 14 ASP A 203 ASP~? 10.68 C3 PG4 B 350 16 HIS A 110 HIS.? 5.77 C3 PG4 B 350 67 GLY B 189 GLY~? 8.50 O2 PO4 B 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 1.22 33.78 11.00 2.03 33.50 11.09 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 11 3 # 11 14 ASP A 203 ASP~? 10.68 C3 PG4 B 350 16 HIS A 110 HIS.? 5.77 C3 PG4 B 350 67 GLY B 199 GLY.? 13.71 O1 PG4 B 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 8.71 34.57 13.67 8.56 34.17 14.43 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 12 3 # 12 14 ASP A 208 ASP~? 8.51 C3 PG4 A 350 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 67 GLY B 16 GLY.? 15.34 O3 PO4 B 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.99 19.43 5.14 -8.92 18.73 4.81 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 13 3 # 13 14 ASP A 208 ASP~? 8.51 C3 PG4 A 350 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 67 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 14 3 # 14 14 ASP A 208 ASP~? 8.51 C3 PG4 A 350 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 67 GLY B 197 GLY~? 16.75 O2 PO4 B 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 10.33 27.51 13.12 10.25 28.32 12.87 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 15 3 # 15 14 ASP B 41 ASP.? 20.21 O3 PO4 B 349 16 HIS B 14 HIS.? 21.30 C5 PG4 A 350 67 GLY B 102 GLY.? 25.81 O4 PG4 A 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -7.40 13.29 5.68 -9.25 14.12 5.01 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 5.13 9.24 22.93 4.64 9.48 22.34 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 16 3 # 16 14 ASP B 90 ASP~? 17.21 C5 PG4 A 350 16 HIS B 14 HIS.? 21.30 C5 PG4 A 350 67 GLY B 102 GLY.? 25.81 O4 PG4 A 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 5.13 9.24 22.93 4.64 9.48 22.34 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 17 3 # 17 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 16 HIS B 238 HIS.? 10.82 O1 PO4 B 349 67 GLY B 25 GLY~? 12.55 O3 PO4 B 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -1.91 21.39 6.65 -1.94 22.01 6.12 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 18 3 # 18 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 16 HIS B 238 HIS.? 10.82 O1 PO4 B 349 67 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 19 3 # 19 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 16 HIS B 238 HIS.? 10.82 O1 PO4 B 349 67 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 20 3 # 20 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 16 HIS B 238 HIS.? 10.82 O1 PO4 B 349 67 GLY B 108 GLY.? 11.44 C5 PG4 A 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -1.45 26.58 15.61 -2.07 26.26 16.03 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 21 3 # 21 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 16 HIS B 238 HIS.? 10.82 O1 PO4 B 349 67 GLY B 250 GLY~? 14.99 O1 PG4 B 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 6.04 47.81 12.44 6.05 48.05 11.67 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 22 3 # 22 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 16 HIS B 238 HIS.? 10.82 O1 PO4 B 349 67 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 23 3 # 23 14 ASP B 203 ASP~? 9.89 C4 PG4 A 350 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 67 GLY A 189 GLY~? 8.76 O1 PO4 A 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -9.96 51.69 26.75 -10.72 51.67 27.15 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 24 3 # 24 14 ASP B 203 ASP~? 9.89 C4 PG4 A 350 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 67 GLY A 199 GLY.? 14.09 O1 PG4 A 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -17.17 48.70 27.51 -16.96 48.00 27.99 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 25 3 # 25 14 ASP B 203 ASP~? 9.89 C4 PG4 A 350 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 67 GLY B 16 GLY.? 15.34 O3 PO4 B 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.99 19.43 5.14 -8.92 18.73 4.81 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 26 3 # 26 14 ASP B 203 ASP~? 9.89 C4 PG4 A 350 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 67 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 27 3 # 27 14 ASP B 208 ASP~? 8.88 C3 PG4 B 350 16 HIS A 110 HIS.? 5.77 C3 PG4 B 350 67 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 28 3 # 28 14 ASP B 208 ASP~? 8.88 C3 PG4 B 350 16 HIS A 110 HIS.? 5.77 C3 PG4 B 350 67 GLY A 197 GLY~? 16.88 O1 PO4 A 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -18.17 50.44 34.47 -18.10 50.51 33.67 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 29 3 # 29 14 ASP C 41 ASP.? 20.22 O4 PO4 C 349 16 HIS C 14 HIS.? 19.64 C5 PG4 D 350 67 GLY C 102 GLY.? 25.79 C3 PG4 D 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -52.23 5.22 16.50 -53.97 6.36 17.05 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -37.71 -9.56 22.54 -38.24 -8.99 22.39 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 30 3 # 30 14 ASP C 90 ASP~? 15.56 C5 PG4 D 350 16 HIS C 14 HIS.? 19.64 C5 PG4 D 350 67 GLY C 102 GLY.? 25.79 C3 PG4 D 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -37.71 -9.56 22.54 -38.24 -8.99 22.39 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 31 3 # 31 14 ASP C 160 ASP.? 8.57 O1 PO4 C 349 16 HIS C 238 HIS.? 10.74 O3 PO4 C 349 67 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 32 3 # 32 14 ASP C 160 ASP.? 8.57 O1 PO4 C 349 16 HIS C 238 HIS.? 10.74 O3 PO4 C 349 67 GLY C 108 GLY.? 11.29 O3 PG4 D 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -43.60 7.14 31.15 -44.12 6.54 31.35 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 33 3 # 33 14 ASP C 160 ASP.? 8.57 O1 PO4 C 349 16 HIS C 238 HIS.? 10.74 O3 PO4 C 349 67 GLY C 250 GLY~? 15.20 C2 PG4 C 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -34.85 24.44 43.72 -34.85 25.15 43.35 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 34 3 # 34 14 ASP C 160 ASP.? 8.57 O1 PO4 C 349 16 HIS C 238 HIS.? 10.74 O3 PO4 C 349 67 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -40.50 35.55 47.63 -40.37 36.37 47.40 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 35 3 # 35 14 ASP C 160 ASP.? 8.57 O1 PO4 C 349 16 HIS C 260 HIS^? 11.63 O1 PO4 C 349 67 GLY C 54 GLY~? 15.97 O4 PO4 C 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -48.31 18.40 10.87 -47.94 17.71 11.21 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 36 3 # 36 14 ASP C 203 ASP~? 10.24 C6 PG4 D 350 16 HIS C 110 HIS.? 5.63 C6 PG4 D 350 67 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 37 3 # 37 14 ASP C 203 ASP~? 10.24 C6 PG4 D 350 16 HIS C 110 HIS.? 5.63 C6 PG4 D 350 67 GLY D 189 GLY~? 8.43 O1 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -49.90 16.88 57.52 -50.61 16.53 57.79 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 38 3 # 38 14 ASP C 203 ASP~? 10.24 C6 PG4 D 350 16 HIS C 110 HIS.? 5.63 C6 PG4 D 350 67 GLY D 199 GLY.? 13.68 O5 PG4 D 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -57.03 13.69 56.19 -56.77 12.88 56.00 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 39 3 # 39 14 ASP C 208 ASP~? 8.73 O2 PG4 C 350 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 67 GLY D 16 GLY.? 16.14 O2 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -38.65 13.48 72.21 -38.70 13.32 72.96 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 40 3 # 40 14 ASP C 208 ASP~? 8.73 O2 PG4 C 350 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 67 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 41 3 # 41 14 ASP C 208 ASP~? 8.73 O2 PG4 C 350 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 67 GLY D 197 GLY~? 16.72 O1 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -57.74 9.98 62.39 -57.72 10.62 61.86 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 42 3 # 42 14 ASP D 41 ASP.? 20.92 O2 PO4 D 349 16 HIS D 14 HIS.? 21.26 C4 PG4 C 350 67 GLY D 102 GLY.? 25.79 C6 PG4 C 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.78 8.95 76.71 -38.11 10.21 76.27 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -51.59 -7.91 69.55 -51.14 -7.28 69.70 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 43 3 # 43 14 ASP D 41 ASP.? 20.92 O2 PO4 D 349 16 HIS D 14 HIS.? 21.26 C4 PG4 C 350 67 GLY D 192 GLY~? 8.57 O1 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -39.78 8.95 76.71 -38.11 10.21 76.27 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -52.91 16.56 61.94 -52.62 15.79 61.81 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 44 3 # 44 14 ASP D 90 ASP~? 17.03 C4 PG4 C 350 16 HIS D 14 HIS.? 21.26 C4 PG4 C 350 67 GLY D 102 GLY.? 25.79 C6 PG4 C 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -51.59 -7.91 69.55 -51.14 -7.28 69.70 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 45 3 # 45 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 16 HIS D 238 HIS.? 10.72 O3 PO4 D 349 67 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 46 3 # 46 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 16 HIS D 238 HIS.? 10.72 O3 PO4 D 349 67 GLY D 25 GLY~? 13.17 O2 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -46.02 12.94 70.06 -45.99 13.73 69.92 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 47 3 # 47 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 16 HIS D 238 HIS.? 10.72 O3 PO4 D 349 67 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 48 3 # 48 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 16 HIS D 238 HIS.? 10.72 O3 PO4 D 349 67 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 49 3 # 49 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 16 HIS D 238 HIS.? 10.72 O3 PO4 D 349 67 GLY D 108 GLY.? 11.50 C6 PG4 C 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -46.34 8.93 60.42 -45.67 8.48 60.39 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 50 3 # 50 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 16 HIS D 238 HIS.? 10.72 O3 PO4 D 349 67 GLY D 250 GLY~? 14.38 O5 PG4 D 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -56.76 22.61 45.76 -56.89 23.34 46.02 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 51 3 # 51 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 16 HIS D 238 HIS.? 10.72 O3 PO4 D 349 67 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 52 3 # 52 14 ASP D 203 ASP~? 10.40 O3 PG4 C 350 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 67 GLY C 189 GLY~? 8.64 O2 PO4 C 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -40.49 15.78 32.96 -39.70 15.56 32.71 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 53 3 # 53 14 ASP D 203 ASP~? 10.40 O3 PG4 C 350 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 67 GLY C 199 GLY.? 14.01 O1 PG4 C 350 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -32.88 14.56 34.60 -33.00 13.70 34.89 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 54 3 # 54 14 ASP D 203 ASP~? 10.40 O3 PG4 C 350 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 67 GLY D 16 GLY.? 16.14 O2 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -38.65 13.48 72.21 -38.70 13.32 72.96 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 55 3 # 55 14 ASP D 203 ASP~? 10.40 O3 PG4 C 350 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 67 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 56 3 # 56 14 ASP D 208 ASP~? 8.41 C6 PG4 D 350 16 HIS C 110 HIS.? 5.63 C6 PG4 D 350 67 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 57 3 # 57 14 ASP D 208 ASP~? 8.41 C6 PG4 D 350 16 HIS C 110 HIS.? 5.63 C6 PG4 D 350 67 GLY C 197 GLY~? 16.71 O2 PO4 C 349 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -31.53 10.08 29.11 -31.70 10.77 29.54 1be1_c02 source 1be1 GLUTAMATE MUTASE : 57 hits 1be1_c02 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 15 GLU.? 17.86 C3 PG4 B 350 70 HIS A 14 HIS.? 20.33 C3 PG4 B 350 281 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 7.25 58.10 39.87 8.59 56.71 39.00 coo 69.05 50.55 157.03 68.00 52.29 156.51 3.61 55.89 43.73 3.10 55.52 45.73 coo 100.93 36.73 156.02 100.47 38.42 157.18 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU A 15 GLU.? 17.86 C3 PG4 B 350 70 HIS A 14 HIS.? 20.33 C3 PG4 B 350 281 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo 66.09 46.17 155.81 66.77 48.19 155.70 7.25 58.10 39.87 8.59 56.71 39.00 coo 69.05 50.55 157.03 68.00 52.29 156.51 3.61 55.89 43.73 3.10 55.52 45.73 coo 100.93 36.73 156.02 100.47 38.42 157.18 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 3 3 # 3 28 GLU A 94 GLU~? 21.51 O3 PG4 B 350 70 HIS A 14 HIS.? 20.33 C3 PG4 B 350 281 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 2.26 51.25 46.83 2.00 52.68 48.40 coo 69.05 50.55 157.03 68.00 52.29 156.51 3.61 55.89 43.73 3.10 55.52 45.73 coo 100.93 36.73 156.02 100.47 38.42 157.18 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 4 3 # 4 28 GLU A 94 GLU~? 21.51 O3 PG4 B 350 70 HIS A 14 HIS.? 20.33 C3 PG4 B 350 281 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo 66.09 46.17 155.81 66.77 48.19 155.70 2.26 51.25 46.83 2.00 52.68 48.40 coo 69.05 50.55 157.03 68.00 52.29 156.51 3.61 55.89 43.73 3.10 55.52 45.73 coo 100.93 36.73 156.02 100.47 38.42 157.18 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 5 3 # 5 28 GLU B 15 GLU.? 19.82 C3 PG4 A 350 70 HIS B 14 HIS.? 21.30 C5 PG4 A 350 281 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 -13.67 16.25 7.60 -15.45 16.94 8.51 coo 69.05 50.55 157.03 68.00 52.29 156.51 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 100.93 36.73 156.02 100.47 38.42 157.18 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 6 3 # 6 28 GLU B 94 GLU~? 22.11 C5 PG4 A 350 70 HIS B 14 HIS.? 21.30 C5 PG4 A 350 281 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 69.05 50.55 157.03 68.00 52.29 156.51 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 100.93 36.73 156.02 100.47 38.42 157.18 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 7 3 # 7 28 GLU C 15 GLU.? 17.45 C5 PG4 D 350 70 HIS C 14 HIS.? 19.64 C5 PG4 D 350 281 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 -57.75 5.96 21.41 -58.79 5.43 23.18 coo 69.05 50.55 157.03 68.00 52.29 156.51 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 100.93 36.73 156.02 100.47 38.42 157.18 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 8 3 # 8 28 GLU C 15 GLU.? 17.45 C5 PG4 D 350 70 HIS C 14 HIS.? 19.64 C5 PG4 D 350 281 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 66.09 46.17 155.81 66.77 48.19 155.70 -57.75 5.96 21.41 -58.79 5.43 23.18 coo 69.05 50.55 157.03 68.00 52.29 156.51 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 100.93 36.73 156.02 100.47 38.42 157.18 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 9 3 # 9 28 GLU C 94 GLU~? 21.12 C5 PG4 D 350 70 HIS C 14 HIS.? 19.64 C5 PG4 D 350 281 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 69.05 50.55 157.03 68.00 52.29 156.51 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 100.93 36.73 156.02 100.47 38.42 157.18 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 10 3 # 10 28 GLU C 94 GLU~? 21.12 C5 PG4 D 350 70 HIS C 14 HIS.? 19.64 C5 PG4 D 350 281 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 66.09 46.17 155.81 66.77 48.19 155.70 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 69.05 50.55 157.03 68.00 52.29 156.51 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 100.93 36.73 156.02 100.47 38.42 157.18 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 11 3 # 11 28 GLU C 325 GLU~? 19.31 O1 PO4 C 349 70 HIS C 321 HIS~? 21.29 O1 PO4 C 349 281 HIS B 272 HIS.? 20.00 O1 PO4 B 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 -49.52 44.21 26.45 -50.31 42.24 26.60 coo 69.05 50.55 157.03 68.00 52.29 156.51 -50.23 42.88 20.64 -51.67 43.34 22.10 coo 100.93 36.73 156.02 100.47 38.42 157.18 -21.96 42.12 3.17 -20.97 42.39 5.00 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 12 3 # 12 28 GLU D 15 GLU.? 19.32 C4 PG4 C 350 70 HIS D 14 HIS.? 21.26 C4 PG4 C 350 281 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 -33.73 9.80 72.63 -32.07 9.73 71.31 coo 69.05 50.55 157.03 68.00 52.29 156.51 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 100.93 36.73 156.02 100.47 38.42 157.18 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 13 3 # 13 28 GLU D 94 GLU~? 22.39 C6 PG4 C 350 70 HIS D 14 HIS.? 21.26 C4 PG4 C 350 281 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 69.05 50.55 157.03 68.00 52.29 156.51 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 100.93 36.73 156.02 100.47 38.42 157.18 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 14 3 # 14 28 GLU D 94 GLU~? 22.39 C6 PG4 C 350 70 HIS D 14 HIS.? 21.26 C4 PG4 C 350 281 HIS D 260 HIS^? 11.65 O4 PO4 D 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 69.05 50.55 157.03 68.00 52.29 156.51 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 100.93 36.73 156.02 100.47 38.42 157.18 -44.73 36.67 61.75 -42.79 37.49 61.80 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 15 3 # 15 28 GLU D 94 GLU~? 22.39 C6 PG4 C 350 70 HIS D 14 HIS.? 21.26 C4 PG4 C 350 281 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 69.05 50.55 157.03 68.00 52.29 156.51 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 100.93 36.73 156.02 100.47 38.42 157.18 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 16 3 # 16 28 GLU D 94 GLU~? 22.39 C6 PG4 C 350 70 HIS D 14 HIS.? 21.26 C4 PG4 C 350 281 HIS D 272 HIS.? 19.84 O3 PO4 D 349 coo 66.09 46.17 155.81 66.77 48.19 155.70 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 69.05 50.55 157.03 68.00 52.29 156.51 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 100.93 36.73 156.02 100.47 38.42 157.18 -29.12 31.20 53.56 -30.01 29.84 52.23 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 16 hits 1bfd_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU B 66 GLU~? 29.14 C5 PG4 A 350 A 503 TYR B 71 TYR~? 28.79 O3 PO4 B 349 A 537 GLU B 70 GLU~? 33.54 O3 PO4 B 349 coo 24.06 146.21 11.09 22.89 146.18 9.36 -4.41 2.86 15.92 -3.73 2.64 17.92 coo 15.91 140.69 8.32 15.71 143.39 9.13 3.73 5.71 7.80 2.32 4.41 5.78 coo 16.65 144.44 13.24 18.34 145.22 12.33 2.54 0.85 9.44 1.10 0.13 8.05 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU D 196 GLU~? 13.48 O1 PO4 D 349 A 503 TYR D 31 TYR~? 9.28 O2 PO4 D 349 A 537 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 24.06 146.21 11.09 22.89 146.18 9.36 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 15.91 140.69 8.32 15.71 143.39 9.13 -53.52 20.07 70.01 -52.37 22.61 69.97 coo 16.65 144.44 13.24 18.34 145.22 12.33 -60.02 15.53 71.55 -61.82 16.61 71.53 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 2 hits 1bgl_c08 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 30 ARG~? 10.33 O2 PO4 A 349 183 LYS A 165 LYS~? -2.78 O4 PO4 A 349s 317 ARG A 133 ARG.? 8.90 C3 PG4 B 350 coo 76.57 109.19 73.41 73.86 110.26 72.16 -9.85 66.58 32.39 -7.32 68.13 33.36 coo 82.09 117.51 66.37 80.60 114.32 71.44 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 65.21 120.62 58.76 63.62 123.14 59.66 -4.79 46.92 29.78 -3.00 49.36 29.13 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 30 ARG~? 10.33 O2 PO4 A 349 183 LYS A 165 LYS~? -2.78 O4 PO4 A 349s 317 ARG A 179 ARG~? 21.90 O1 PO4 A 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -9.85 66.58 32.39 -7.32 68.13 33.36 coo 82.09 117.51 66.37 80.60 114.32 71.44 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 65.21 120.62 58.76 63.62 123.14 59.66 -29.50 69.96 21.84 -27.37 70.37 19.60 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 261 ARG^? 7.73 O2 PO4 A 349 183 LYS A 165 LYS~? -2.78 O4 PO4 A 349s 317 ARG A 57 ARG.? 17.32 O2 PO4 A 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -1.53 69.75 22.21 -1.72 66.84 23.28 coo 82.09 117.51 66.37 80.60 114.32 71.44 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 65.21 120.62 58.76 63.62 123.14 59.66 -11.38 65.24 41.83 -13.84 63.42 41.14 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG A 261 ARG^? 7.73 O2 PO4 A 349 183 LYS A 165 LYS~? -2.78 O4 PO4 A 349s 317 ARG B 249 ARG~? 17.39 O4 PO4 A 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -1.53 69.75 22.21 -1.72 66.84 23.28 coo 82.09 117.51 66.37 80.60 114.32 71.44 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 65.21 120.62 58.76 63.62 123.14 59.66 1.78 52.94 11.29 0.18 53.87 8.84 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG B 30 ARG~? 9.80 O3 PO4 B 349 183 LYS B 165 LYS~? -2.78 O4 PO4 B 349s 317 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo 76.57 109.19 73.41 73.86 110.26 72.16 1.86 25.26 -2.23 -1.04 24.22 -2.87 coo 82.09 117.51 66.37 80.60 114.32 71.44 0.37 36.49 0.17 -3.63 37.66 2.73 coo 65.21 120.62 58.76 63.62 123.14 59.66 -3.22 31.42 16.60 -5.11 31.22 14.14 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG B 30 ARG~? 9.80 O3 PO4 B 349 183 LYS B 165 LYS~? -2.78 O4 PO4 B 349s 317 ARG B 179 ARG~? 22.83 O2 PO4 B 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 1.86 25.26 -2.23 -1.04 24.22 -2.87 coo 82.09 117.51 66.37 80.60 114.32 71.44 0.37 36.49 0.17 -3.63 37.66 2.73 coo 65.21 120.62 58.76 63.62 123.14 59.66 17.17 37.45 -10.17 16.17 40.20 -11.05 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG B 261 ARG^? 7.86 O3 PO4 B 349 183 LYS B 165 LYS~? -2.78 O4 PO4 B 349s 317 ARG A 249 ARG~? 17.61 O4 PO4 B 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo 82.09 117.51 66.37 80.60 114.32 71.44 0.37 36.49 0.17 -3.63 37.66 2.73 coo 65.21 120.62 58.76 63.62 123.14 59.66 -12.58 47.35 8.37 -11.42 49.74 6.78 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 8 3 # 8 118 ARG B 261 ARG^? 7.86 O3 PO4 B 349 183 LYS B 165 LYS~? -2.78 O4 PO4 B 349s 317 ARG B 57 ARG.? 17.74 O3 PO4 B 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo 82.09 117.51 66.37 80.60 114.32 71.44 0.37 36.49 0.17 -3.63 37.66 2.73 coo 65.21 120.62 58.76 63.62 123.14 59.66 5.49 16.86 0.47 7.09 17.94 2.86 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 9 3 # 9 118 ARG B 261 ARG^? 7.86 O3 PO4 B 349 183 LYS B 165 LYS~? -2.78 O4 PO4 B 349s 317 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo 76.57 109.19 73.41 73.86 110.26 72.16 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo 82.09 117.51 66.37 80.60 114.32 71.44 0.37 36.49 0.17 -3.63 37.66 2.73 coo 65.21 120.62 58.76 63.62 123.14 59.66 -3.22 31.42 16.60 -5.11 31.22 14.14 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 10 3 # 10 118 ARG C 30 ARG~? 10.19 O4 PO4 C 349 183 LYS C 165 LYS~? -2.77 O1 PO4 C 349s 317 ARG C 133 ARG.? 8.69 C6 PG4 D 350 coo 76.57 109.19 73.41 73.86 110.26 72.16 -42.41 19.48 17.74 -45.10 19.59 16.14 coo 82.09 117.51 66.37 80.60 114.32 71.44 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 65.21 120.62 58.76 63.62 123.14 59.66 -44.64 9.69 35.41 -46.86 11.41 34.11 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 11 3 # 11 118 ARG C 30 ARG~? 10.19 O4 PO4 C 349 183 LYS C 165 LYS~? -2.77 O1 PO4 C 349s 317 ARG C 179 ARG~? 14.85 O2 PG4 A 350 coo 76.57 109.19 73.41 73.86 110.26 72.16 -42.41 19.48 17.74 -45.10 19.59 16.14 coo 82.09 117.51 66.37 80.60 114.32 71.44 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 65.21 120.62 58.76 63.62 123.14 59.66 -24.98 33.12 21.00 -27.25 35.17 20.85 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 12 3 # 12 118 ARG C 179 ARG~? 14.85 O2 PG4 A 350 183 LYS C 184 LYS^? 18.13 O2 PO4 C 349 317 ARG C 30 ARG~? 10.19 O4 PO4 C 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -24.98 33.12 21.00 -27.25 35.17 20.85 coo 82.09 117.51 66.37 80.60 114.32 71.44 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 65.21 120.62 58.76 63.62 123.14 59.66 -42.41 19.48 17.74 -45.10 19.59 16.14 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 13 3 # 13 118 ARG C 261 ARG^? 7.89 O4 PO4 C 349 183 LYS C 165 LYS~? -2.77 O1 PO4 C 349s 317 ARG C 57 ARG.? 17.31 O4 PO4 C 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -51.94 28.25 21.63 -51.22 25.74 23.33 coo 82.09 117.51 66.37 80.60 114.32 71.44 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 65.21 120.62 58.76 63.62 123.14 59.66 -40.16 11.74 13.21 -37.69 10.86 14.87 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 14 3 # 14 118 ARG C 261 ARG^? 7.89 O4 PO4 C 349 183 LYS C 165 LYS~? -2.77 O1 PO4 C 349s 317 ARG D 249 ARG~? 17.54 O1 PO4 C 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -51.94 28.25 21.63 -51.22 25.74 23.33 coo 82.09 117.51 66.37 80.60 114.32 71.44 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 65.21 120.62 58.76 63.62 123.14 59.66 -53.61 27.06 41.90 -52.49 29.90 42.42 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 15 3 # 15 118 ARG D 30 ARG~? 11.31 O2 PO4 D 349 183 LYS D 165 LYS~? -2.89 O4 PO4 D 349s 317 ARG D 133 ARG.? 8.84 C4 PG4 C 350 coo 76.57 109.19 73.41 73.86 110.26 72.16 -49.79 21.88 72.70 -47.47 22.25 74.75 coo 82.09 117.51 66.37 80.60 114.32 71.44 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 65.21 120.62 58.76 63.62 123.14 59.66 -45.06 11.05 55.96 -43.37 13.22 57.41 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 16 3 # 16 118 ARG D 30 ARG~? 11.31 O2 PO4 D 349 183 LYS D 165 LYS~? -2.89 O4 PO4 D 349s 317 ARG D 179 ARG~? 21.69 O1 PO4 D 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -49.79 21.88 72.70 -47.47 22.25 74.75 coo 82.09 117.51 66.37 80.60 114.32 71.44 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 65.21 120.62 58.76 63.62 123.14 59.66 -67.72 32.24 67.66 -66.56 34.95 66.77 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 17 3 # 17 118 ARG D 152 ARG^? 23.56 O1 PO4 D 349 183 LYS D 177 LYS~? 20.36 O1 PO4 D 349 317 ARG D 220 ARG~? 10.23 O5 PG4 D 350 coo 76.57 109.19 73.41 73.86 110.26 72.16 -66.62 32.34 56.11 -68.43 34.76 55.54 coo 82.09 117.51 66.37 80.60 114.32 71.44 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 65.21 120.62 58.76 63.62 123.14 59.66 -64.10 12.09 51.59 -61.65 11.18 49.96 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 18 3 # 18 118 ARG D 179 ARG~? 21.69 O1 PO4 D 349 183 LYS D 184 LYS^? 18.69 O1 PO4 D 349 317 ARG D 30 ARG~? 11.31 O2 PO4 D 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -67.72 32.24 67.66 -66.56 34.95 66.77 coo 82.09 117.51 66.37 80.60 114.32 71.44 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 65.21 120.62 58.76 63.62 123.14 59.66 -49.79 21.88 72.70 -47.47 22.25 74.75 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 19 3 # 19 118 ARG D 261 ARG^? 8.01 O2 PO4 D 349 183 LYS D 165 LYS~? -2.89 O4 PO4 D 349s 317 ARG C 249 ARG~? 17.71 O4 PO4 D 349 coo 76.57 109.19 73.41 73.86 110.26 72.16 -41.02 32.36 67.18 -41.18 29.51 65.99 coo 82.09 117.51 66.37 80.60 114.32 71.44 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 65.21 120.62 58.76 63.62 123.14 59.66 -38.85 28.76 46.96 -40.48 31.26 46.10 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 19 hits 1bib_c00 naa= 3 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 1 3 # 1 A 102 TRP B 92 TRP~? 12.54 C5 PG4 A 350 A 174 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 198 LYS B 96 LYS~? 18.72 C5 PG4 A 350 coo 21.59 67.76 35.19 19.10 64.95 36.34 -11.95 17.23 22.74 -9.16 19.51 24.31 coo 19.39 73.14 39.98 19.70 71.07 40.14 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 27.94 65.10 43.55 24.20 64.94 40.01 -4.65 11.97 23.20 -9.16 12.78 27.52 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 2 3 # 2 A 102 TRP D 92 TRP~? 12.49 C6 PG4 C 350 A 174 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 198 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 21.59 67.76 35.19 19.10 64.95 36.34 -35.51 -1.29 62.69 -38.42 -1.60 60.06 coo 19.39 73.14 39.98 19.70 71.07 40.14 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 27.94 65.10 43.55 24.20 64.94 40.01 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1bjo_c00 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 2 hits 1bjo_c00 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 759 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 810 SER A 235 SER.? 9.13 O4 PO4 A 349 coo 30.11 61.02 29.12 29.36 59.77 27.63 -1.16 62.88 18.52 0.68 62.16 19.33 coo 30.94 56.62 25.28 29.94 54.94 26.14 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 25.05 62.74 29.97 26.88 61.45 29.19 -3.96 57.47 15.64 -2.97 59.52 14.86 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 A 757 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 759 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 810 SER B 235 SER.? 9.35 O4 PO4 B 349 coo 30.11 61.02 29.12 29.36 59.77 27.63 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 30.94 56.62 25.28 29.94 54.94 26.14 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 25.05 62.74 29.97 26.88 61.45 29.19 -6.73 42.81 4.19 -8.03 43.03 2.17 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 A 757 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 759 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 810 SER C 235 SER.? 9.23 O1 PO4 C 349 coo 30.11 61.02 29.12 29.36 59.77 27.63 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 30.94 56.62 25.28 29.94 54.94 26.14 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 25.05 62.74 29.97 26.88 61.45 29.19 -48.25 27.10 35.26 -49.51 28.80 34.06 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 A 757 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 759 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 810 SER D 235 SER.? 9.32 O4 PO4 D 349 coo 30.11 61.02 29.12 29.36 59.77 27.63 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 30.94 56.62 25.28 29.94 54.94 26.14 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 25.05 62.74 29.97 26.88 61.45 29.19 -44.15 28.59 53.58 -43.17 30.60 54.60 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 4 hits 1bmt_c04 naa= 3 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 B 757 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 759 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 810 SER A 235 SER.? 9.13 O4 PO4 A 349 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -1.16 62.88 18.52 0.68 62.16 19.33 coo 1.96 66.39 3.07 2.10 68.48 3.58 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -3.96 57.47 15.64 -2.97 59.52 14.86 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 B 757 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 759 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 810 SER B 235 SER.? 9.35 O4 PO4 B 349 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 1.96 66.39 3.07 2.10 68.48 3.58 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -6.73 42.81 4.19 -8.03 43.03 2.17 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 B 757 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 759 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 810 SER C 235 SER.? 9.23 O1 PO4 C 349 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 1.96 66.39 3.07 2.10 68.48 3.58 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -48.25 27.10 35.26 -49.51 28.80 34.06 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 B 757 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 759 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 810 SER D 235 SER.? 9.32 O4 PO4 D 349 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 1.96 66.39 3.07 2.10 68.48 3.58 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -44.15 28.59 53.58 -43.17 30.60 54.60 1bmt_c05 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 4 hits 1bmt_c05 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 16 GLY.? 15.23 O3 PO4 A 349 48 HIS A 14 HIS.? 20.33 C3 PG4 B 350 99 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 2.07 60.33 37.29 2.12 60.80 37.90 coo 18.80 12.68 24.53 17.69 13.54 26.08 3.61 55.89 43.73 3.10 55.52 45.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY A 19 GLY.? 15.80 O3 PO4 A 349 48 HIS A 14 HIS.? 20.33 C3 PG4 B 350 99 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 5.02 63.13 35.09 4.17 63.25 34.97 coo 18.80 12.68 24.53 17.69 13.54 26.08 3.61 55.89 43.73 3.10 55.52 45.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY A 22 GLY~? 12.04 O3 PO4 A 349 48 HIS A 14 HIS.? 20.33 C3 PG4 B 350 99 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -0.44 58.79 35.05 -0.39 59.06 34.34 coo 18.80 12.68 24.53 17.69 13.54 26.08 3.61 55.89 43.73 3.10 55.52 45.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 4 3 # 4 30 GLY A 79 GLY.? 14.13 O3 PO4 A 349 48 HIS A 14 HIS.? 20.33 C3 PG4 B 350 99 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -3.85 55.21 37.72 -3.17 54.79 37.80 coo 18.80 12.68 24.53 17.69 13.54 26.08 3.61 55.89 43.73 3.10 55.52 45.73 coo 17.07 18.51 26.62 16.67 17.07 28.09 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 5 3 # 5 30 GLY A 85 GLY.? 5.88 O2 PG4 B 350 48 HIS A 110 HIS.? 5.77 C3 PG4 B 350 99 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 7.14 46.81 31.62 6.42 46.78 31.19 coo 18.80 12.68 24.53 17.69 13.54 26.08 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 17.07 18.51 26.62 16.67 17.07 28.09 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 6 3 # 6 30 GLY A 86 GLY.? 5.00 C4 PG4 B 350 48 HIS A 110 HIS.? 5.77 C3 PG4 B 350 99 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 4.72 44.66 33.63 5.12 45.31 34.00 coo 18.80 12.68 24.53 17.69 13.54 26.08 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 17.07 18.51 26.62 16.67 17.07 28.09 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 7 3 # 7 30 GLY A 86 GLY.? 5.00 C4 PG4 B 350 48 HIS A 110 HIS.? 5.77 C3 PG4 B 350 99 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 4.72 44.66 33.63 5.12 45.31 34.00 coo 18.80 12.68 24.53 17.69 13.54 26.08 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 17.07 18.51 26.62 16.67 17.07 28.09 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 8 3 # 8 30 GLY A 144 GLY~? 17.41 C2 PG4 A 350 48 HIS B 238 HIS.? 10.82 O1 PO4 B 349 99 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 12.38 5.55 24.25 13.27 5.59 24.39 -19.62 44.35 9.26 -20.00 43.77 9.68 coo 18.80 12.68 24.53 17.69 13.54 26.08 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 17.07 18.51 26.62 16.67 17.07 28.09 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 9 3 # 9 30 GLY A 291 GLY~? 18.10 O4 PO4 B 349 48 HIS B 238 HIS.? 10.82 O1 PO4 B 349 99 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 12.38 5.55 24.25 13.27 5.59 24.39 -11.93 50.92 2.28 -12.21 51.53 1.80 coo 18.80 12.68 24.53 17.69 13.54 26.08 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 17.07 18.51 26.62 16.67 17.07 28.09 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 10 3 # 10 30 GLY B 16 GLY.? 15.34 O3 PO4 B 349 48 HIS B 14 HIS.? 21.30 C5 PG4 A 350 99 ASP B 90 ASP~? 17.21 C5 PG4 A 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -8.99 19.43 5.14 -8.92 18.73 4.81 coo 18.80 12.68 24.53 17.69 13.54 26.08 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 17.07 18.51 26.62 16.67 17.07 28.09 -14.26 14.51 16.36 -14.11 16.10 14.94 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 11 3 # 11 30 GLY B 19 GLY.? 15.74 O3 PO4 B 349 48 HIS B 14 HIS.? 21.30 C5 PG4 A 350 99 ASP B 90 ASP~? 17.21 C5 PG4 A 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -12.10 20.39 1.89 -11.31 20.65 1.71 coo 18.80 12.68 24.53 17.69 13.54 26.08 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 17.07 18.51 26.62 16.67 17.07 28.09 -14.26 14.51 16.36 -14.11 16.10 14.94 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 12 3 # 12 30 GLY B 22 GLY~? 12.30 O3 PO4 B 349 48 HIS B 14 HIS.? 21.30 C5 PG4 A 350 99 ASP B 90 ASP~? 17.21 C5 PG4 A 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -6.99 22.32 6.03 -7.16 22.99 5.70 coo 18.80 12.68 24.53 17.69 13.54 26.08 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 17.07 18.51 26.62 16.67 17.07 28.09 -14.26 14.51 16.36 -14.11 16.10 14.94 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 13 3 # 13 30 GLY B 79 GLY.? 14.35 O1 PO4 B 349 48 HIS B 14 HIS.? 21.30 C5 PG4 A 350 99 ASP B 90 ASP~? 17.21 C5 PG4 A 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 18.80 12.68 24.53 17.69 13.54 26.08 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 17.07 18.51 26.62 16.67 17.07 28.09 -14.26 14.51 16.36 -14.11 16.10 14.94 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 14 3 # 14 30 GLY B 84 GLY.? 7.18 C3 PG4 A 350 48 HIS B 110 HIS.? 5.25 C4 PG4 A 350 99 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -14.58 29.73 14.21 -14.80 28.98 14.10 coo 18.80 12.68 24.53 17.69 13.54 26.08 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 17.07 18.51 26.62 16.67 17.07 28.09 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 15 3 # 15 30 GLY B 85 GLY.? 7.55 C3 PG4 A 350 48 HIS B 110 HIS.? 5.25 C4 PG4 A 350 99 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -15.17 26.80 16.60 -14.44 26.95 16.65 coo 18.80 12.68 24.53 17.69 13.54 26.08 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 17.07 18.51 26.62 16.67 17.07 28.09 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 16 3 # 16 30 GLY B 85 GLY.? 7.55 C3 PG4 A 350 48 HIS B 110 HIS.? 5.25 C4 PG4 A 350 99 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -15.17 26.80 16.60 -14.44 26.95 16.65 coo 18.80 12.68 24.53 17.69 13.54 26.08 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 17.07 18.51 26.62 16.67 17.07 28.09 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 17 3 # 17 30 GLY B 86 GLY.? 6.11 C4 PG4 A 350 48 HIS B 110 HIS.? 5.25 C4 PG4 A 350 99 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -12.50 26.48 19.35 -12.60 26.05 18.67 coo 18.80 12.68 24.53 17.69 13.54 26.08 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 17.07 18.51 26.62 16.67 17.07 28.09 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 18 3 # 18 30 GLY B 86 GLY.? 6.11 C4 PG4 A 350 48 HIS B 110 HIS.? 5.25 C4 PG4 A 350 99 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -12.50 26.48 19.35 -12.60 26.05 18.67 coo 18.80 12.68 24.53 17.69 13.54 26.08 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 17.07 18.51 26.62 16.67 17.07 28.09 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 19 3 # 19 30 GLY B 108 GLY.? 11.44 C5 PG4 A 350 48 HIS B 110 HIS.? 5.25 C4 PG4 A 350 99 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -1.45 26.58 15.61 -2.07 26.26 16.03 coo 18.80 12.68 24.53 17.69 13.54 26.08 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 17.07 18.51 26.62 16.67 17.07 28.09 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 20 3 # 20 30 GLY B 144 GLY~? 17.74 C2 PG4 B 350 48 HIS A 238 HIS.? 10.67 O3 PO4 A 349 99 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 12.38 5.55 24.25 13.27 5.59 24.39 9.02 53.30 13.55 9.55 53.11 14.13 coo 18.80 12.68 24.53 17.69 13.54 26.08 1.50 56.90 17.79 2.83 56.38 19.33 coo 17.07 18.51 26.62 16.67 17.07 28.09 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 21 3 # 21 30 GLY B 291 GLY~? 17.91 O4 PO4 A 349 48 HIS A 238 HIS.? 10.67 O3 PO4 A 349 99 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 12.38 5.55 24.25 13.27 5.59 24.39 -0.11 58.00 6.65 0.09 58.36 5.91 coo 18.80 12.68 24.53 17.69 13.54 26.08 1.50 56.90 17.79 2.83 56.38 19.33 coo 17.07 18.51 26.62 16.67 17.07 28.09 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 22 3 # 22 30 GLY C 16 GLY.? 15.48 O4 PO4 C 349 48 HIS C 14 HIS.? 19.64 C5 PG4 D 350 99 ASP C 90 ASP~? 15.56 C5 PG4 D 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -52.98 9.90 20.86 -53.06 9.69 20.11 coo 18.80 12.68 24.53 17.69 13.54 26.08 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 17.07 18.51 26.62 16.67 17.07 28.09 -56.94 -1.99 25.63 -56.96 0.10 25.89 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 23 3 # 23 30 GLY C 19 GLY.? 15.83 O4 PO4 C 349 48 HIS C 14 HIS.? 19.64 C5 PG4 D 350 99 ASP C 90 ASP~? 15.56 C5 PG4 D 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -56.32 12.91 20.05 -55.54 13.23 19.94 coo 18.80 12.68 24.53 17.69 13.54 26.08 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 17.07 18.51 26.62 16.67 17.07 28.09 -56.94 -1.99 25.63 -56.96 0.10 25.89 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 24 3 # 24 30 GLY C 22 GLY~? 12.31 O3 PO4 C 349 48 HIS C 14 HIS.? 19.64 C5 PG4 D 350 99 ASP C 90 ASP~? 15.56 C5 PG4 D 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -50.31 11.35 23.15 -50.44 12.07 23.41 coo 18.80 12.68 24.53 17.69 13.54 26.08 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 17.07 18.51 26.62 16.67 17.07 28.09 -56.94 -1.99 25.63 -56.96 0.10 25.89 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 25 3 # 25 30 GLY C 79 GLY.? 14.41 O3 PO4 C 349 48 HIS C 14 HIS.? 19.64 C5 PG4 D 350 99 ASP C 90 ASP~? 15.56 C5 PG4 D 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -46.35 7.57 24.19 -46.94 7.17 24.58 coo 18.80 12.68 24.53 17.69 13.54 26.08 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 17.07 18.51 26.62 16.67 17.07 28.09 -56.94 -1.99 25.63 -56.96 0.10 25.89 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 26 3 # 26 30 GLY C 84 GLY.? 7.31 O4 PG4 D 350 48 HIS C 110 HIS.? 5.63 C6 PG4 D 350 99 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -56.51 10.28 34.21 -56.90 9.83 33.65 coo 18.80 12.68 24.53 17.69 13.54 26.08 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 17.07 18.51 26.62 16.67 17.07 28.09 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 27 3 # 27 30 GLY C 85 GLY.? 5.52 C5 PG4 D 350 48 HIS C 110 HIS.? 5.63 C6 PG4 D 350 99 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -56.18 6.72 35.54 -55.45 7.13 35.50 coo 18.80 12.68 24.53 17.69 13.54 26.08 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 17.07 18.51 26.62 16.67 17.07 28.09 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 28 3 # 28 30 GLY C 86 GLY.? 4.20 C5 PG4 D 350 48 HIS C 110 HIS.? 5.63 C6 PG4 D 350 99 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -53.55 4.02 36.09 -53.97 4.11 35.35 coo 18.80 12.68 24.53 17.69 13.54 26.08 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 17.07 18.51 26.62 16.67 17.07 28.09 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 29 3 # 29 30 GLY C 86 GLY.? 4.20 C5 PG4 D 350 48 HIS C 110 HIS.? 5.63 C6 PG4 D 350 99 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -53.55 4.02 36.09 -53.97 4.11 35.35 coo 18.80 12.68 24.53 17.69 13.54 26.08 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 17.07 18.51 26.62 16.67 17.07 28.09 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 30 3 # 30 30 GLY C 108 GLY.? 11.29 O3 PG4 D 350 48 HIS C 110 HIS.? 5.63 C6 PG4 D 350 99 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -43.60 7.14 31.15 -44.12 6.54 31.35 coo 18.80 12.68 24.53 17.69 13.54 26.08 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 17.07 18.51 26.62 16.67 17.07 28.09 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 31 3 # 31 30 GLY C 144 GLY~? 17.44 C2 PG4 C 350 48 HIS D 238 HIS.? 10.72 O3 PO4 D 349 99 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 12.38 5.55 24.25 13.27 5.59 24.39 -31.32 27.31 48.44 -30.80 26.72 48.62 coo 18.80 12.68 24.53 17.69 13.54 26.08 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 17.07 18.51 26.62 16.67 17.07 28.09 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 32 3 # 32 30 GLY C 291 GLY~? 18.24 O4 PO4 D 349 48 HIS D 238 HIS.? 10.72 O3 PO4 D 349 99 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 12.38 5.55 24.25 13.27 5.59 24.39 -40.50 35.55 47.63 -40.37 36.37 47.40 coo 18.80 12.68 24.53 17.69 13.54 26.08 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 17.07 18.51 26.62 16.67 17.07 28.09 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 33 3 # 33 30 GLY D 16 GLY.? 16.14 O2 PO4 D 349 48 HIS D 14 HIS.? 21.26 C4 PG4 C 350 99 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -38.65 13.48 72.21 -38.70 13.32 72.96 coo 18.80 12.68 24.53 17.69 13.54 26.08 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 17.07 18.51 26.62 16.67 17.07 28.09 -33.15 1.70 68.90 -33.50 3.76 68.48 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 34 3 # 34 30 GLY D 19 GLY.? 16.61 O2 PO4 D 349 48 HIS D 14 HIS.? 21.26 C4 PG4 C 350 99 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -35.71 16.74 73.26 -36.52 17.01 73.21 coo 18.80 12.68 24.53 17.69 13.54 26.08 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 17.07 18.51 26.62 16.67 17.07 28.09 -33.15 1.70 68.90 -33.50 3.76 68.48 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 35 3 # 35 30 GLY D 22 GLY~? 12.96 O2 PO4 D 349 48 HIS D 14 HIS.? 21.26 C4 PG4 C 350 99 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -40.91 14.48 69.44 -40.82 15.16 69.11 coo 18.80 12.68 24.53 17.69 13.54 26.08 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 17.07 18.51 26.62 16.67 17.07 28.09 -33.15 1.70 68.90 -33.50 3.76 68.48 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 36 3 # 36 30 GLY D 79 GLY.? 15.17 O2 PO4 D 349 48 HIS D 14 HIS.? 21.26 C4 PG4 C 350 99 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -44.38 10.12 68.07 -43.71 9.75 67.85 coo 18.80 12.68 24.53 17.69 13.54 26.08 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 17.07 18.51 26.62 16.67 17.07 28.09 -33.15 1.70 68.90 -33.50 3.76 68.48 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 37 3 # 37 30 GLY D 84 GLY.? 9.62 C4 PG4 C 350 48 HIS D 110 HIS.? 5.57 O3 PG4 C 350 99 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -31.98 13.03 59.70 -32.24 12.70 60.41 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 17.07 18.51 26.62 16.67 17.07 28.09 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 38 3 # 38 30 GLY D 84 GLY.? 9.62 C4 PG4 C 350 48 HIS D 110 HIS.? 5.57 O3 PG4 C 350 99 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -31.98 13.03 59.70 -32.24 12.70 60.41 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 17.07 18.51 26.62 16.67 17.07 28.09 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 39 3 # 39 30 GLY D 85 GLY.? 8.05 C4 PG4 C 350 48 HIS D 110 HIS.? 5.57 O3 PG4 C 350 99 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -32.50 9.26 59.23 -33.13 9.72 58.90 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 17.07 18.51 26.62 16.67 17.07 28.09 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 40 3 # 40 30 GLY D 86 GLY.? 5.93 C4 PG4 C 350 48 HIS D 110 HIS.? 5.57 O3 PG4 C 350 99 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -35.09 6.83 57.80 -34.85 6.87 58.64 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 17.07 18.51 26.62 16.67 17.07 28.09 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 41 3 # 41 30 GLY D 86 GLY.? 5.93 C4 PG4 C 350 48 HIS D 110 HIS.? 5.57 O3 PG4 C 350 99 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -35.09 6.83 57.80 -34.85 6.87 58.64 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 17.07 18.51 26.62 16.67 17.07 28.09 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 42 3 # 42 30 GLY D 108 GLY.? 11.50 C6 PG4 C 350 48 HIS D 110 HIS.? 5.57 O3 PG4 C 350 99 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 12.38 5.55 24.25 13.27 5.59 24.39 -46.34 8.93 60.42 -45.67 8.48 60.39 coo 18.80 12.68 24.53 17.69 13.54 26.08 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 17.07 18.51 26.62 16.67 17.07 28.09 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 43 3 # 43 30 GLY D 144 GLY~? 17.47 O5 PG4 D 350 48 HIS C 238 HIS.? 10.74 O3 PO4 C 349 99 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 12.38 5.55 24.25 13.27 5.59 24.39 -60.61 24.47 40.88 -61.01 23.76 40.72 coo 18.80 12.68 24.53 17.69 13.54 26.08 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 17.07 18.51 26.62 16.67 17.07 28.09 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 44 3 # 44 30 GLY D 291 GLY~? 17.95 O1 PO4 C 349 48 HIS C 238 HIS.? 10.74 O3 PO4 C 349 99 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 12.38 5.55 24.25 13.27 5.59 24.39 -52.94 33.94 40.24 -53.21 34.73 40.40 coo 18.80 12.68 24.53 17.69 13.54 26.08 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 17.07 18.51 26.62 16.67 17.07 28.09 -51.44 27.30 29.48 -53.03 25.88 29.75 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 44 hits 1bp2_c00 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS B 321 HIS~? 21.63 O4 PO4 B 349 A 168 ARG B 261 ARG^? 7.86 O3 PO4 B 349 A 187 LYS B 316 LYS~? 24.20 O3 PO4 B 349 coo 62.47 12.00 59.65 61.76 10.14 60.31 -8.21 43.10 -17.57 -9.89 44.30 -17.19 coo 55.10 8.37 73.00 55.48 9.59 70.20 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo 66.76 10.09 66.23 61.80 8.06 65.82 -2.04 35.41 -19.34 2.27 31.66 -22.14 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS C 321 HIS~? 21.29 O1 PO4 C 349 A 168 ARG C 261 ARG^? 7.89 O4 PO4 C 349 A 187 LYS C 316 LYS~? 23.27 O4 PO4 C 349 coo 62.47 12.00 59.65 61.76 10.14 60.31 -50.23 42.88 20.64 -51.67 43.34 22.10 coo 55.10 8.37 73.00 55.48 9.59 70.20 -51.94 28.25 21.63 -51.22 25.74 23.33 coo 66.76 10.09 66.23 61.80 8.06 65.82 -44.69 38.73 13.31 -40.21 38.10 9.89 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 A 82 HIS D 321 HIS~? 21.61 O4 PO4 D 349 A 168 ARG D 261 ARG^? 8.01 O2 PO4 D 349 A 187 LYS D 316 LYS~? 24.37 O2 PO4 D 349 coo 62.47 12.00 59.65 61.76 10.14 60.31 -44.81 46.75 66.01 -43.36 47.24 64.57 coo 55.10 8.37 73.00 55.48 9.59 70.20 -41.02 32.36 67.18 -41.18 29.51 65.99 coo 66.76 10.09 66.23 61.80 8.06 65.82 -49.65 42.56 73.75 -53.64 42.38 78.67 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 3 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B1168 ARG A 179 ARG~? 21.90 O1 PO4 A 349 B1187 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo 35.03 5.72 103.61 36.82 5.00 102.79 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 41.91 5.48 91.85 40.59 6.81 94.28 -29.50 69.96 21.84 -27.37 70.37 19.60 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 B1082 HIS B 173 HIS~? 15.15 O2 PO4 B 349 B1168 ARG B 152 ARG^? 23.80 O2 PO4 B 349 B1187 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 35.03 5.72 103.61 36.82 5.00 102.79 13.23 34.15 0.64 14.88 33.23 1.56 coo 41.91 5.48 91.85 40.59 6.81 94.28 14.94 46.89 -2.30 16.61 48.81 -4.04 coo 32.93 -0.12 99.60 37.71 2.39 99.23 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 B1082 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B1168 ARG B 179 ARG~? 22.83 O2 PO4 B 349 B1187 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo 35.03 5.72 103.61 36.82 5.00 102.79 11.38 38.70 0.79 12.71 38.99 -0.80 coo 41.91 5.48 91.85 40.59 6.81 94.28 17.17 37.45 -10.17 16.17 40.20 -11.05 coo 32.93 -0.12 99.60 37.71 2.39 99.23 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 3 # 4 B1082 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B1168 ARG C 179 ARG~? 14.85 O2 PG4 A 350 B1187 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo 35.03 5.72 103.61 36.82 5.00 102.79 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 41.91 5.48 91.85 40.59 6.81 94.28 -24.98 33.12 21.00 -27.25 35.17 20.85 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 5 3 # 5 B1082 HIS D 173 HIS~? 14.91 O1 PO4 D 349 B1168 ARG D 152 ARG^? 23.56 O1 PO4 D 349 B1187 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 35.03 5.72 103.61 36.82 5.00 102.79 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 41.91 5.48 91.85 40.59 6.81 94.28 -66.62 32.34 56.11 -68.43 34.76 55.54 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -68.08 25.33 66.69 -67.75 19.10 66.60 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 5 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE B 209 PHE~? 4.05 C2 PG4 B 350 A 205 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 236 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 4.14 2.10 36.34 6.69 3.08 36.92 2.22 44.73 23.56 2.13 45.64 26.21 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE B 209 PHE~? 4.05 C2 PG4 B 350 A 205 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 236 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 4.14 2.10 36.34 6.69 3.08 36.92 2.22 44.73 23.56 2.13 45.64 26.21 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 1.49 32.28 22.12 4.07 30.52 27.68 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 2 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 216 GLN~? 7.36 O1 PG4 A 350 A 91 LEU A 139 LEU.? -3.83 O1 PG4 A 350s A 133 GLU A 215 GLU~? 13.07 C2 PG4 A 350 coo 43.58 43.67 66.73 42.32 42.78 68.15 -19.93 41.08 21.62 -18.69 39.99 22.97 coo 38.58 45.09 70.44 38.28 45.21 72.59 -14.21 37.82 20.63 -14.15 39.67 21.77 coo 44.05 36.87 70.65 43.15 38.64 69.97 -19.69 43.42 15.07 -19.36 42.01 13.60 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 216 GLN~? 7.61 O1 PG4 B 350 A 91 LEU B 139 LEU.? -3.88 O1 PG4 B 350s A 133 GLU B 215 GLU~? 13.59 C2 PG4 B 350 coo 43.58 43.67 66.73 42.32 42.78 68.15 11.42 42.35 19.15 10.50 41.03 20.54 coo 38.58 45.09 70.44 38.28 45.21 72.59 5.82 42.83 22.92 5.79 41.39 21.29 coo 44.05 36.87 70.65 43.15 38.64 69.97 10.14 48.09 15.50 9.78 49.78 16.69 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN C 216 GLN~? 7.49 O1 PG4 C 350 A 91 LEU C 139 LEU.? -4.28 O1 PG4 C 350s A 133 GLU C 215 GLU~? 13.26 C2 PG4 C 350 coo 43.58 43.67 66.73 42.32 42.78 68.15 -29.55 15.50 43.86 -30.62 13.67 44.21 coo 38.58 45.09 70.44 38.28 45.21 72.59 -34.72 13.62 47.48 -34.93 13.62 45.32 coo 44.05 36.87 70.65 43.15 38.64 69.97 -30.56 22.29 45.75 -30.82 22.67 47.79 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN D 216 GLN~? 6.81 O5 PG4 D 350 A 91 LEU D 139 LEU.? -3.47 O5 PG4 D 350s A 133 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 43.58 43.67 66.73 42.32 42.78 68.15 -60.48 13.07 46.91 -59.29 11.30 46.96 coo 38.58 45.09 70.44 38.28 45.21 72.59 -55.20 11.62 43.43 -55.10 11.98 45.55 coo 44.05 36.87 70.65 43.15 38.64 69.97 -60.56 19.61 44.11 -60.32 19.66 42.03 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN D 252 GLN~? 19.62 O5 PG4 D 350 A 91 LEU D 149 LEU~? 20.41 O5 PG4 D 350 A 133 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 43.58 43.67 66.73 42.32 42.78 68.15 -60.59 26.35 44.25 -59.32 27.46 42.92 coo 38.58 45.09 70.44 38.28 45.21 72.59 -67.67 24.38 48.14 -67.04 22.30 48.02 coo 44.05 36.87 70.65 43.15 38.64 69.97 -60.56 19.61 44.11 -60.32 19.66 42.03 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 216 GLN~? 7.36 O1 PG4 A 350 B 591 LEU A 139 LEU.? -3.83 O1 PG4 A 350s B 633 GLU A 215 GLU~? 13.07 C2 PG4 A 350 coo 88.06 44.34 57.19 89.06 45.53 55.74 -19.93 41.08 21.62 -18.69 39.99 22.97 coo 86.70 48.66 52.61 87.15 48.69 50.51 -14.21 37.82 20.63 -14.15 39.67 21.77 coo 95.42 44.52 54.43 93.46 45.31 54.70 -19.69 43.42 15.07 -19.36 42.01 13.60 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN B 216 GLN~? 7.61 O1 PG4 B 350 B 591 LEU B 139 LEU.? -3.88 O1 PG4 B 350s B 633 GLU B 215 GLU~? 13.59 C2 PG4 B 350 coo 88.06 44.34 57.19 89.06 45.53 55.74 11.42 42.35 19.15 10.50 41.03 20.54 coo 86.70 48.66 52.61 87.15 48.69 50.51 5.82 42.83 22.92 5.79 41.39 21.29 coo 95.42 44.52 54.43 93.46 45.31 54.70 10.14 48.09 15.50 9.78 49.78 16.69 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN C 216 GLN~? 7.49 O1 PG4 C 350 B 591 LEU C 139 LEU.? -4.28 O1 PG4 C 350s B 633 GLU C 215 GLU~? 13.26 C2 PG4 C 350 coo 88.06 44.34 57.19 89.06 45.53 55.74 -29.55 15.50 43.86 -30.62 13.67 44.21 coo 86.70 48.66 52.61 87.15 48.69 50.51 -34.72 13.62 47.48 -34.93 13.62 45.32 coo 95.42 44.52 54.43 93.46 45.31 54.70 -30.56 22.29 45.75 -30.82 22.67 47.79 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN D 216 GLN~? 6.81 O5 PG4 D 350 B 591 LEU D 139 LEU.? -3.47 O5 PG4 D 350s B 633 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 88.06 44.34 57.19 89.06 45.53 55.74 -60.48 13.07 46.91 -59.29 11.30 46.96 coo 86.70 48.66 52.61 87.15 48.69 50.51 -55.20 11.62 43.43 -55.10 11.98 45.55 coo 95.42 44.52 54.43 93.46 45.31 54.70 -60.56 19.61 44.11 -60.32 19.66 42.03 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN D 252 GLN~? 19.62 O5 PG4 D 350 B 591 LEU D 149 LEU~? 20.41 O5 PG4 D 350 B 633 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 88.06 44.34 57.19 89.06 45.53 55.74 -60.59 26.35 44.25 -59.32 27.46 42.92 coo 86.70 48.66 52.61 87.15 48.69 50.51 -67.67 24.38 48.14 -67.04 22.30 48.02 coo 95.42 44.52 54.43 93.46 45.31 54.70 -60.56 19.61 44.11 -60.32 19.66 42.03 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 216 GLN~? 7.36 O1 PG4 A 350 C1091 LEU A 139 LEU.? -3.83 O1 PG4 A 350s C1133 GLU A 215 GLU~? 13.07 C2 PG4 A 350 coo 68.29 34.44 43.03 66.67 34.74 44.37 -19.93 41.08 21.62 -18.69 39.99 22.97 coo 65.83 38.95 47.05 65.46 38.90 49.20 -14.21 37.82 20.63 -14.15 39.67 21.77 coo 63.14 29.39 46.25 63.84 31.31 45.74 -19.69 43.42 15.07 -19.36 42.01 13.60 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN B 216 GLN~? 7.61 O1 PG4 B 350 C1091 LEU B 139 LEU.? -3.88 O1 PG4 B 350s C1133 GLU B 215 GLU~? 13.59 C2 PG4 B 350 coo 68.29 34.44 43.03 66.67 34.74 44.37 11.42 42.35 19.15 10.50 41.03 20.54 coo 65.83 38.95 47.05 65.46 38.90 49.20 5.82 42.83 22.92 5.79 41.39 21.29 coo 63.14 29.39 46.25 63.84 31.31 45.74 10.14 48.09 15.50 9.78 49.78 16.69 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN B 252 GLN~? 20.40 C2 PG4 B 350 C1091 LEU B 149 LEU~? 21.21 O1 PG4 B 350 C1133 GLU B 215 GLU~? 13.59 C2 PG4 B 350 coo 68.29 34.44 43.03 66.67 34.74 44.37 8.85 51.73 9.90 7.57 53.45 9.91 coo 65.83 38.95 47.05 65.46 38.90 49.20 16.58 48.64 8.60 16.30 47.40 10.36 coo 63.14 29.39 46.25 63.84 31.31 45.74 10.14 48.09 15.50 9.78 49.78 16.69 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN C 216 GLN~? 7.49 O1 PG4 C 350 C1091 LEU C 139 LEU.? -4.28 O1 PG4 C 350s C1133 GLU C 215 GLU~? 13.26 C2 PG4 C 350 coo 68.29 34.44 43.03 66.67 34.74 44.37 -29.55 15.50 43.86 -30.62 13.67 44.21 coo 65.83 38.95 47.05 65.46 38.90 49.20 -34.72 13.62 47.48 -34.93 13.62 45.32 coo 63.14 29.39 46.25 63.84 31.31 45.74 -30.56 22.29 45.75 -30.82 22.67 47.79 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN D 216 GLN~? 6.81 O5 PG4 D 350 C1091 LEU D 139 LEU.? -3.47 O5 PG4 D 350s C1133 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 68.29 34.44 43.03 66.67 34.74 44.37 -60.48 13.07 46.91 -59.29 11.30 46.96 coo 65.83 38.95 47.05 65.46 38.90 49.20 -55.20 11.62 43.43 -55.10 11.98 45.55 coo 63.14 29.39 46.25 63.84 31.31 45.74 -60.56 19.61 44.11 -60.32 19.66 42.03 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN D 252 GLN~? 19.62 O5 PG4 D 350 C1091 LEU D 149 LEU~? 20.41 O5 PG4 D 350 C1133 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 68.29 34.44 43.03 66.67 34.74 44.37 -60.59 26.35 44.25 -59.32 27.46 42.92 coo 65.83 38.95 47.05 65.46 38.90 49.20 -67.67 24.38 48.14 -67.04 22.30 48.02 coo 63.14 29.39 46.25 63.84 31.31 45.74 -60.56 19.61 44.11 -60.32 19.66 42.03 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 216 GLN~? 7.36 O1 PG4 A 350 A 91 LEU A 139 LEU.? -3.83 O1 PG4 A 350s A 133 GLU A 215 GLU~? 13.07 C2 PG4 A 350 coo 38.23 53.34 67.59 38.84 53.87 69.56 -19.93 41.08 21.62 -18.69 39.99 22.97 coo 35.40 53.22 73.30 35.37 54.87 74.74 -14.21 37.82 20.63 -14.15 39.67 21.77 coo 45.08 56.04 70.60 43.15 55.19 70.77 -19.69 43.42 15.07 -19.36 42.01 13.60 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 216 GLN~? 7.61 O1 PG4 B 350 A 91 LEU B 139 LEU.? -3.88 O1 PG4 B 350s A 133 GLU B 215 GLU~? 13.59 C2 PG4 B 350 coo 38.23 53.34 67.59 38.84 53.87 69.56 11.42 42.35 19.15 10.50 41.03 20.54 coo 35.40 53.22 73.30 35.37 54.87 74.74 5.82 42.83 22.92 5.79 41.39 21.29 coo 45.08 56.04 70.60 43.15 55.19 70.77 10.14 48.09 15.50 9.78 49.78 16.69 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN C 216 GLN~? 7.49 O1 PG4 C 350 A 91 LEU C 139 LEU.? -4.28 O1 PG4 C 350s A 133 GLU C 215 GLU~? 13.26 C2 PG4 C 350 coo 38.23 53.34 67.59 38.84 53.87 69.56 -29.55 15.50 43.86 -30.62 13.67 44.21 coo 35.40 53.22 73.30 35.37 54.87 74.74 -34.72 13.62 47.48 -34.93 13.62 45.32 coo 45.08 56.04 70.60 43.15 55.19 70.77 -30.56 22.29 45.75 -30.82 22.67 47.79 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN D 216 GLN~? 6.81 O5 PG4 D 350 A 91 LEU D 139 LEU.? -3.47 O5 PG4 D 350s A 133 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 38.23 53.34 67.59 38.84 53.87 69.56 -60.48 13.07 46.91 -59.29 11.30 46.96 coo 35.40 53.22 73.30 35.37 54.87 74.74 -55.20 11.62 43.43 -55.10 11.98 45.55 coo 45.08 56.04 70.60 43.15 55.19 70.77 -60.56 19.61 44.11 -60.32 19.66 42.03 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN D 252 GLN~? 19.62 O5 PG4 D 350 A 91 LEU D 149 LEU~? 20.41 O5 PG4 D 350 A 133 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 38.23 53.34 67.59 38.84 53.87 69.56 -60.59 26.35 44.25 -59.32 27.46 42.92 coo 35.40 53.22 73.30 35.37 54.87 74.74 -67.67 24.38 48.14 -67.04 22.30 48.02 coo 45.08 56.04 70.60 43.15 55.19 70.77 -60.56 19.61 44.11 -60.32 19.66 42.03 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 5 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 354 GLU A 15 GLU.? 17.86 C3 PG4 B 350 A 421 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 31.05 49.37 64.51 31.97 51.11 63.85 1.74 60.96 43.57 3.36 61.47 42.28 coo 29.07 50.42 58.36 29.02 52.18 59.49 7.25 58.10 39.87 8.59 56.71 39.00 coo 30.82 59.76 58.47 31.12 59.02 60.40 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 354 GLU A 94 GLU~? 21.51 O3 PG4 B 350 A 421 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 31.05 49.37 64.51 31.97 51.11 63.85 8.08 50.44 43.84 7.48 51.26 41.98 coo 29.07 50.42 58.36 29.02 52.18 59.49 2.26 51.25 46.83 2.00 52.68 48.40 coo 30.82 59.76 58.47 31.12 59.02 60.40 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP A 311 ASP~? 22.72 O2 PO4 A 349 A 354 GLU A 312 GLU~? 22.67 O2 PO4 A 349 A 421 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 31.05 49.37 64.51 31.97 51.11 63.85 -4.84 83.29 26.02 -4.08 84.26 24.26 coo 29.07 50.42 58.36 29.02 52.18 59.49 -11.55 82.77 24.82 -13.13 83.67 25.87 coo 30.82 59.76 58.47 31.12 59.02 60.40 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 354 GLU B 15 GLU.? 19.82 C3 PG4 A 350 A 421 ASP B 90 ASP~? 17.21 C5 PG4 A 350 coo 31.05 49.37 64.51 31.97 51.11 63.85 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 29.07 50.42 58.36 29.02 52.18 59.49 -13.67 16.25 7.60 -15.45 16.94 8.51 coo 30.82 59.76 58.47 31.12 59.02 60.40 -14.26 14.51 16.36 -14.11 16.10 14.94 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 354 GLU B 94 GLU~? 22.11 C5 PG4 A 350 A 421 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 31.05 49.37 64.51 31.97 51.11 63.85 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 29.07 50.42 58.36 29.02 52.18 59.49 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 30.82 59.76 58.47 31.12 59.02 60.40 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP B 311 ASP~? 22.86 O3 PO4 B 349 A 354 GLU B 312 GLU~? 22.88 O3 PO4 B 349 A 421 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 31.05 49.37 64.51 31.97 51.11 63.85 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 29.07 50.42 58.36 29.02 52.18 59.49 -0.30 29.09 -19.54 1.27 27.97 -20.48 coo 30.82 59.76 58.47 31.12 59.02 60.40 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 354 GLU C 15 GLU.? 17.45 C5 PG4 D 350 A 421 ASP C 90 ASP~? 15.56 C5 PG4 D 350 coo 31.05 49.37 64.51 31.97 51.11 63.85 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 29.07 50.42 58.36 29.02 52.18 59.49 -57.75 5.96 21.41 -58.79 5.43 23.18 coo 30.82 59.76 58.47 31.12 59.02 60.40 -56.94 -1.99 25.63 -56.96 0.10 25.89 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 8 3 # 8 A 325 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 354 GLU C 94 GLU~? 21.12 C5 PG4 D 350 A 421 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 31.05 49.37 64.51 31.97 51.11 63.85 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 29.07 50.42 58.36 29.02 52.18 59.49 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 30.82 59.76 58.47 31.12 59.02 60.40 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 9 3 # 9 A 325 ASP C 311 ASP~? 22.87 O4 PO4 C 349 A 354 GLU C 312 GLU~? 22.95 O4 PO4 C 349 A 421 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 31.05 49.37 64.51 31.97 51.11 63.85 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 29.07 50.42 58.36 29.02 52.18 59.49 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 30.82 59.76 58.47 31.12 59.02 60.40 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 10 3 # 10 A 325 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 354 GLU D 15 GLU.? 19.32 C4 PG4 C 350 A 421 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 31.05 49.37 64.51 31.97 51.11 63.85 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 29.07 50.42 58.36 29.02 52.18 59.49 -33.73 9.80 72.63 -32.07 9.73 71.31 coo 30.82 59.76 58.47 31.12 59.02 60.40 -33.15 1.70 68.90 -33.50 3.76 68.48 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 11 3 # 11 A 325 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 354 GLU D 94 GLU~? 22.39 C6 PG4 C 350 A 421 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 31.05 49.37 64.51 31.97 51.11 63.85 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 29.07 50.42 58.36 29.02 52.18 59.49 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 30.82 59.76 58.47 31.12 59.02 60.40 -39.78 8.95 76.71 -38.11 10.21 76.27 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 12 3 # 12 A 325 ASP D 311 ASP~? 22.85 O2 PO4 D 349 A 354 GLU D 312 GLU~? 22.27 O2 PO4 D 349 A 421 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 31.05 49.37 64.51 31.97 51.11 63.85 -43.35 38.70 79.64 -42.93 40.74 79.14 coo 29.07 50.42 58.36 29.02 52.18 59.49 -50.13 39.19 79.01 -51.63 38.45 80.28 coo 30.82 59.76 58.47 31.12 59.02 60.40 -51.05 35.32 70.59 -50.24 33.36 70.95 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 12 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 354 GLU A 15 GLU.? 17.86 C3 PG4 B 350 B 421 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 25.90 8.19 53.87 25.36 6.97 52.29 1.74 60.96 43.57 3.36 61.47 42.28 coo 27.87 10.66 47.95 27.82 8.60 48.27 7.25 58.10 39.87 8.59 56.71 39.00 coo 26.02 1.87 43.38 25.90 1.97 45.49 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 354 GLU A 94 GLU~? 21.51 O3 PG4 B 350 B 421 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 25.90 8.19 53.87 25.36 6.97 52.29 8.08 50.44 43.84 7.48 51.26 41.98 coo 27.87 10.66 47.95 27.82 8.60 48.27 2.26 51.25 46.83 2.00 52.68 48.40 coo 26.02 1.87 43.38 25.90 1.97 45.49 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP A 311 ASP~? 22.72 O2 PO4 A 349 B 354 GLU A 312 GLU~? 22.67 O2 PO4 A 349 B 421 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 25.90 8.19 53.87 25.36 6.97 52.29 -4.84 83.29 26.02 -4.08 84.26 24.26 coo 27.87 10.66 47.95 27.82 8.60 48.27 -11.55 82.77 24.82 -13.13 83.67 25.87 coo 26.02 1.87 43.38 25.90 1.97 45.49 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 354 GLU B 15 GLU.? 19.82 C3 PG4 A 350 B 421 ASP B 90 ASP~? 17.21 C5 PG4 A 350 coo 25.90 8.19 53.87 25.36 6.97 52.29 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 27.87 10.66 47.95 27.82 8.60 48.27 -13.67 16.25 7.60 -15.45 16.94 8.51 coo 26.02 1.87 43.38 25.90 1.97 45.49 -14.26 14.51 16.36 -14.11 16.10 14.94 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 354 GLU B 94 GLU~? 22.11 C5 PG4 A 350 B 421 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 25.90 8.19 53.87 25.36 6.97 52.29 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 27.87 10.66 47.95 27.82 8.60 48.27 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 26.02 1.87 43.38 25.90 1.97 45.49 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP B 311 ASP~? 22.86 O3 PO4 B 349 B 354 GLU B 312 GLU~? 22.88 O3 PO4 B 349 B 421 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 25.90 8.19 53.87 25.36 6.97 52.29 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 27.87 10.66 47.95 27.82 8.60 48.27 -0.30 29.09 -19.54 1.27 27.97 -20.48 coo 26.02 1.87 43.38 25.90 1.97 45.49 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 7 3 # 7 B 325 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 354 GLU C 15 GLU.? 17.45 C5 PG4 D 350 B 421 ASP C 90 ASP~? 15.56 C5 PG4 D 350 coo 25.90 8.19 53.87 25.36 6.97 52.29 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 27.87 10.66 47.95 27.82 8.60 48.27 -57.75 5.96 21.41 -58.79 5.43 23.18 coo 26.02 1.87 43.38 25.90 1.97 45.49 -56.94 -1.99 25.63 -56.96 0.10 25.89 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 8 3 # 8 B 325 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 354 GLU C 94 GLU~? 21.12 C5 PG4 D 350 B 421 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 25.90 8.19 53.87 25.36 6.97 52.29 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 27.87 10.66 47.95 27.82 8.60 48.27 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 26.02 1.87 43.38 25.90 1.97 45.49 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 9 3 # 9 B 325 ASP C 311 ASP~? 22.87 O4 PO4 C 349 B 354 GLU C 312 GLU~? 22.95 O4 PO4 C 349 B 421 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 25.90 8.19 53.87 25.36 6.97 52.29 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 27.87 10.66 47.95 27.82 8.60 48.27 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 26.02 1.87 43.38 25.90 1.97 45.49 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 10 3 # 10 B 325 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 354 GLU D 15 GLU.? 19.32 C4 PG4 C 350 B 421 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 25.90 8.19 53.87 25.36 6.97 52.29 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 27.87 10.66 47.95 27.82 8.60 48.27 -33.73 9.80 72.63 -32.07 9.73 71.31 coo 26.02 1.87 43.38 25.90 1.97 45.49 -33.15 1.70 68.90 -33.50 3.76 68.48 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 11 3 # 11 B 325 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 354 GLU D 94 GLU~? 22.39 C6 PG4 C 350 B 421 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 25.90 8.19 53.87 25.36 6.97 52.29 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 27.87 10.66 47.95 27.82 8.60 48.27 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 26.02 1.87 43.38 25.90 1.97 45.49 -39.78 8.95 76.71 -38.11 10.21 76.27 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 12 3 # 12 B 325 ASP D 311 ASP~? 22.85 O2 PO4 D 349 B 354 GLU D 312 GLU~? 22.27 O2 PO4 D 349 B 421 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 25.90 8.19 53.87 25.36 6.97 52.29 -43.35 38.70 79.64 -42.93 40.74 79.14 coo 27.87 10.66 47.95 27.82 8.60 48.27 -50.13 39.19 79.01 -51.63 38.45 80.28 coo 26.02 1.87 43.38 25.90 1.97 45.49 -51.05 35.32 70.59 -50.24 33.36 70.95 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 12 hits 1bvz_c09 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 107 ASN^? 9.64 C5 PG4 B 350 192 ASP A 203 ASP~? 10.68 C3 PG4 B 350 195 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -5.73 45.70 37.96 -3.97 45.35 36.84 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN A 107 ASN^? 9.64 C5 PG4 B 350 192 ASP B 208 ASP~? 8.88 C3 PG4 B 350 195 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -5.73 45.70 37.96 -3.97 45.35 36.84 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 3 3 # 3 104 ASN B 107 ASN^? 9.43 C5 PG4 A 350 192 ASP A 208 ASP~? 8.51 C3 PG4 A 350 195 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -1.39 23.50 19.22 -3.25 24.51 19.38 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 4 3 # 4 104 ASN B 107 ASN^? 9.43 C5 PG4 A 350 192 ASP B 203 ASP~? 9.89 C4 PG4 A 350 195 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -1.39 23.50 19.22 -3.25 24.51 19.38 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 5 3 # 5 104 ASN C 107 ASN^? 9.61 C3 PG4 D 350 192 ASP C 203 ASP~? 10.24 C6 PG4 D 350 195 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -42.97 2.46 31.63 -44.77 2.90 32.68 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -48.06 9.35 37.56 -47.54 11.38 37.75 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 6 3 # 6 104 ASN C 107 ASN^? 9.61 C3 PG4 D 350 192 ASP D 208 ASP~? 8.41 C6 PG4 D 350 195 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -42.97 2.46 31.63 -44.77 2.90 32.68 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -48.06 9.35 37.56 -47.54 11.38 37.75 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 7 3 # 7 104 ASN D 107 ASN^? 9.34 C6 PG4 C 350 192 ASP C 208 ASP~? 8.73 O2 PG4 C 350 195 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -46.02 4.22 60.61 -44.32 4.89 59.53 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 8 3 # 8 104 ASN D 107 ASN^? 9.34 C6 PG4 C 350 192 ASP D 203 ASP~? 10.40 O3 PG4 C 350 195 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -46.02 4.22 60.61 -44.32 4.89 59.53 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -41.52 11.20 54.17 -42.16 13.10 53.55 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 8 hits 1bwp_c01 naa= 3 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 43 ASN~? 22.73 O3 PO4 A 349 A 108 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 144 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 16.88 2.43 18.09 16.20 3.65 19.72 6.86 62.77 42.72 8.12 61.14 42.12 coo 16.00 9.54 19.61 16.53 10.80 21.20 3.61 55.89 43.73 3.10 55.52 45.73 coo 20.15 8.89 19.42 18.82 8.12 20.82 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN B 43 ASN.? 23.10 O3 PO4 B 349 A 108 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 144 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 16.88 2.43 18.09 16.20 3.65 19.72 -12.52 12.59 3.86 -14.07 13.20 5.18 coo 16.00 9.54 19.61 16.53 10.80 21.20 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 20.15 8.89 19.42 18.82 8.12 20.82 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN C 43 ASN.? 22.72 C5 PG4 D 350 A 108 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 144 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 16.88 2.43 18.09 16.20 3.65 19.72 -57.74 6.14 16.07 -58.97 5.36 17.64 coo 16.00 9.54 19.61 16.53 10.80 21.20 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 20.15 8.89 19.42 18.82 8.12 20.82 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 A 106 ASN D 43 ASN.? 23.87 O2 PO4 D 349 A 108 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 144 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 16.88 2.43 18.09 16.20 3.65 19.72 -34.60 10.60 78.03 -33.00 10.04 76.71 coo 16.00 9.54 19.61 16.53 10.80 21.20 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 20.15 8.89 19.42 18.82 8.12 20.82 -39.78 8.95 76.71 -38.11 10.21 76.27 1c2t_c02 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 4 hits 1c2t_c02 naa= 3 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 43 ASN~? 22.73 O3 PO4 A 349 B 108 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 144 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 6.86 62.77 42.72 8.12 61.14 42.12 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 3.61 55.89 43.73 3.10 55.52 45.73 coo 35.12 16.22 2.69 37.05 17.04 2.40 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN B 43 ASN.? 23.10 O3 PO4 B 349 B 108 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 144 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -12.52 12.59 3.86 -14.07 13.20 5.18 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 35.12 16.22 2.69 37.05 17.04 2.40 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN C 43 ASN.? 22.72 C5 PG4 D 350 B 108 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 144 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -57.74 6.14 16.07 -58.97 5.36 17.64 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 35.12 16.22 2.69 37.05 17.04 2.40 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN D 43 ASN.? 23.87 O2 PO4 D 349 B 108 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 144 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -34.60 10.60 78.03 -33.00 10.04 76.71 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 35.12 16.22 2.69 37.05 17.04 2.40 -39.78 8.95 76.71 -38.11 10.21 76.27 1c2t_c03 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 4 hits 1c2t_c03 naa= 3 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 1 3 # 1 A 110 SER A 64 SER~? 26.25 O3 PG4 B 350 A 235 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 263 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 30.32 56.27 16.76 31.62 57.99 17.94 1.46 56.04 50.07 2.12 55.38 52.31 coo 31.33 62.80 9.68 31.68 62.04 11.62 1.74 60.96 43.57 3.36 61.47 42.28 coo 30.23 62.32 14.77 30.86 60.47 15.53 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 2 3 # 2 A 110 SER A 64 SER~? 26.25 O3 PG4 B 350 A 235 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 263 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 30.32 56.27 16.76 31.62 57.99 17.94 1.46 56.04 50.07 2.12 55.38 52.31 coo 31.33 62.80 9.68 31.68 62.04 11.62 8.08 50.44 43.84 7.48 51.26 41.98 coo 30.23 62.32 14.77 30.86 60.47 15.53 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 3 3 # 3 A 110 SER A 241 SER.? 9.98 O3 PO4 A 349 A 235 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 263 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 30.32 56.27 16.76 31.62 57.99 17.94 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 31.33 62.80 9.68 31.68 62.04 11.62 -1.16 62.88 18.52 0.68 62.16 19.33 coo 30.23 62.32 14.77 30.86 60.47 15.53 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 4 3 # 4 A 110 SER B 64 SER~? 26.98 C5 PG4 A 350 A 235 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 263 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 30.32 56.27 16.76 31.62 57.99 17.94 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 31.33 62.80 9.68 31.68 62.04 11.62 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 30.23 62.32 14.77 30.86 60.47 15.53 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 5 3 # 5 A 110 SER B 241 SER.? 10.02 O1 PO4 B 349 A 235 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 263 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 30.32 56.27 16.76 31.62 57.99 17.94 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 31.33 62.80 9.68 31.68 62.04 11.62 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 30.23 62.32 14.77 30.86 60.47 15.53 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 6 3 # 6 A 110 SER C 64 SER~? 25.88 C5 PG4 D 350 A 235 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 263 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 30.32 56.27 16.76 31.62 57.99 17.94 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 31.33 62.80 9.68 31.68 62.04 11.62 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 30.23 62.32 14.77 30.86 60.47 15.53 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 7 3 # 7 A 110 SER C 241 SER.? 9.97 O3 PO4 C 349 A 235 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 263 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 30.32 56.27 16.76 31.62 57.99 17.94 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 31.33 62.80 9.68 31.68 62.04 11.62 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 30.23 62.32 14.77 30.86 60.47 15.53 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 8 3 # 8 A 110 SER D 64 SER~? 27.50 C6 PG4 C 350 A 235 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 263 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 30.32 56.27 16.76 31.62 57.99 17.94 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 31.33 62.80 9.68 31.68 62.04 11.62 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 30.23 62.32 14.77 30.86 60.47 15.53 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 9 3 # 9 A 110 SER D 241 SER.? 10.08 O3 PO4 D 349 A 235 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 263 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 30.32 56.27 16.76 31.62 57.99 17.94 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 31.33 62.80 9.68 31.68 62.04 11.62 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 30.23 62.32 14.77 30.86 60.47 15.53 -38.74 26.41 54.26 -37.48 24.84 54.87 1c4x_c00 source 1c4x 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDR: 9 hits 1c4x_c00 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 215 GLU~? 13.07 C2 PG4 A 350 A 65 ARG A 249 ARG~? 17.61 O4 PO4 B 349 A 85 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -19.69 43.42 15.07 -19.36 42.01 13.60 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU B 215 GLU~? 13.59 C2 PG4 B 350 A 65 ARG B 249 ARG~? 17.39 O4 PO4 A 349 A 85 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 10.14 48.09 15.50 9.78 49.78 16.69 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 1.78 52.94 11.29 0.18 53.87 8.84 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU C 215 GLU~? 13.26 C2 PG4 C 350 A 65 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 85 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -30.56 22.29 45.75 -30.82 22.67 47.79 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -38.74 26.41 54.26 -37.48 24.84 54.87 ULMN 3 1c54_c00 RIBONUCLEASE SA user 4 3 # 4 A 54 GLU D 215 GLU~? 12.92 O5 PG4 D 350 A 65 ARG D 249 ARG~? 17.54 O1 PO4 C 349 A 85 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -60.56 19.61 44.11 -60.32 19.66 42.03 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -53.61 27.06 41.90 -52.49 29.90 42.42 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -53.20 24.10 34.96 -54.25 22.32 34.57 1c54_c00 source 1c54 RIBONUCLEASE SA : 4 hits 1c54_c00 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 408 TYR B 91 TYR~? 13.43 C5 PG4 A 350 A 480 ARG C 182 ARG.? 12.42 C6 PG4 A 350 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -9.83 18.57 16.69 -10.13 20.18 14.41 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -17.19 25.58 29.52 -16.27 25.77 32.47 1c82_c02 source 1c82 HYALURONATE LYASE : 1 hits 1c82_c02 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 16 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 67 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 1.74 60.96 43.57 3.36 61.47 42.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 3.61 55.89 43.73 3.10 55.52 45.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 16 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 67 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 1.74 60.96 43.57 3.36 61.47 42.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 3.61 55.89 43.73 3.10 55.52 45.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 16 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 67 GLY A 46 GLY.? 27.18 O2 PO4 A 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 1.74 60.96 43.57 3.36 61.47 42.28 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 3.61 55.89 43.73 3.10 55.52 45.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 1.13 67.48 50.43 1.17 67.43 49.65 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 16 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 67 GLY A 158 GLY^? 6.81 O4 PO4 A 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -1.16 62.88 18.52 0.68 62.16 19.33 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 1.50 56.90 17.79 2.83 56.38 19.33 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -7.06 61.86 16.04 -6.88 61.32 15.53 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 5 3 # 5 A 14 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 16 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 67 GLY A 164 GLY~? -3.53 O2 PO4 A 349s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -1.16 62.88 18.52 0.68 62.16 19.33 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -8.93 64.61 23.96 -8.76 64.08 23.42 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 6 3 # 6 A 14 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 16 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 67 GLY A 268 GLY.? 11.90 O3 PO4 A 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -1.16 62.88 18.52 0.68 62.16 19.33 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 4.47 63.40 20.71 4.75 62.80 20.25 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 7 3 # 7 A 14 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 16 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 67 GLY A 189 GLY~? 8.76 O1 PO4 A 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -9.96 51.69 26.75 -10.72 51.67 27.15 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 8 3 # 8 A 14 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 67 GLY A 212 GLY~? 9.07 O1 PG4 A 350 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -15.16 41.65 16.73 -14.78 42.24 17.11 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 9 3 # 9 A 14 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 67 GLY B 240 GLY.? 13.32 C2 PG4 A 350 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -12.92 41.87 10.50 -12.39 42.07 9.95 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 10 3 # 10 A 14 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 16 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 67 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 11 3 # 11 A 14 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 16 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 67 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 12 3 # 12 A 14 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 16 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 67 GLY B 25 GLY~? 12.55 O3 PO4 B 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -1.91 21.39 6.65 -1.94 22.01 6.12 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 13 3 # 13 A 14 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 16 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 67 GLY B 46 GLY.? 27.45 O3 PO4 B 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -5.25 5.55 0.62 -5.43 6.30 0.53 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 14 3 # 14 A 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 16 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 67 GLY B 158 GLY^? 6.78 O4 PO4 B 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -3.93 41.69 -0.28 -4.14 42.31 0.12 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 15 3 # 15 A 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 16 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 67 GLY B 164 GLY~? -3.62 O3 PO4 B 349s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -1.30 33.64 -1.77 -1.48 34.26 -1.32 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 16 3 # 16 A 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 16 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 67 GLY B 234 GLY.? 7.16 O1 PO4 B 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -5.34 40.16 6.49 -4.85 40.15 5.88 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 17 3 # 17 A 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 16 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 67 GLY B 268 GLY.? 11.97 O4 PO4 B 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -14.82 35.55 0.64 -15.06 36.08 1.20 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 18 3 # 18 A 14 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 67 GLY B 189 GLY~? 8.50 O2 PO4 B 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 1.22 33.78 11.00 2.03 33.50 11.09 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 19 3 # 19 A 14 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 16 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 67 GLY B 212 GLY~? 9.26 O1 PG4 B 350 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 6.02 46.22 18.32 5.64 45.65 17.83 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 20 3 # 20 A 14 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 16 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 67 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 21 3 # 21 A 14 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 16 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 67 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 22 3 # 22 A 14 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 16 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 67 GLY C 46 GLY.? 27.31 O4 PO4 C 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -52.06 3.43 7.36 -52.19 4.02 7.83 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 23 3 # 23 A 14 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 16 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 67 GLY C 158 GLY^? 6.81 O1 PO4 C 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -45.67 29.61 31.18 -45.83 29.70 31.90 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 24 3 # 24 A 14 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 16 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 67 GLY C 164 GLY~? -3.64 O4 PO4 C 349s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -43.65 24.97 24.30 -43.77 25.11 25.06 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 25 3 # 25 A 14 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 16 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 67 GLY C 234 GLY.? 6.98 O3 PO4 C 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -46.93 23.60 34.75 -46.44 24.03 34.33 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 26 3 # 26 A 14 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 16 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 67 GLY C 268 GLY.? 12.08 O1 PO4 C 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -56.98 24.93 28.04 -57.19 24.96 28.84 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 27 3 # 27 A 14 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 16 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 67 GLY C 189 GLY~? 8.64 O2 PO4 C 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -40.49 15.78 32.96 -39.70 15.56 32.71 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 28 3 # 28 A 14 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 67 GLY C 212 GLY~? 9.26 C2 PG4 C 350 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -34.69 19.16 46.59 -35.10 19.11 45.88 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 29 3 # 29 A 14 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 16 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 67 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 30 3 # 30 A 14 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 16 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 67 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 31 3 # 31 A 14 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 16 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 67 GLY D 46 GLY.? 28.27 O2 PO4 D 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -41.37 7.83 85.88 -41.36 8.41 85.36 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 32 3 # 32 A 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 16 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 67 GLY D 158 GLY^? 6.87 O4 PO4 D 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -47.17 31.32 57.48 -47.03 31.32 56.71 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 33 3 # 33 A 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 16 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 67 GLY D 164 GLY~? -3.57 O2 PO4 D 349s coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -48.53 27.34 64.89 -48.44 27.44 64.12 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 34 3 # 34 A 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 16 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 67 GLY D 268 GLY.? 11.79 O3 PO4 D 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -35.40 28.55 60.91 -35.17 28.48 60.14 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 35 3 # 35 A 14 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 67 GLY D 189 GLY~? 8.43 O1 PO4 D 349 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -49.90 16.88 57.52 -50.61 16.53 57.79 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 36 3 # 36 A 14 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 16 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 67 GLY D 212 GLY~? 8.60 O5 PG4 D 350 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -55.90 16.99 43.52 -55.53 17.14 44.23 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 36 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 41 ASP.? 20.10 O2 PO4 A 349 C 16 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 67 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 1.74 60.96 43.57 3.36 61.47 42.28 coo 6.38 39.80 88.71 6.88 38.89 86.87 3.61 55.89 43.73 3.10 55.52 45.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 41 ASP.? 20.10 O2 PO4 A 349 C 16 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 67 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 1.74 60.96 43.57 3.36 61.47 42.28 coo 6.38 39.80 88.71 6.88 38.89 86.87 3.61 55.89 43.73 3.10 55.52 45.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 16 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 67 GLY A 158 GLY^? 6.81 O4 PO4 A 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -1.16 62.88 18.52 0.68 62.16 19.33 coo 6.38 39.80 88.71 6.88 38.89 86.87 1.50 56.90 17.79 2.83 56.38 19.33 coo 17.63 42.50 89.25 18.11 42.29 88.64 -7.06 61.86 16.04 -6.88 61.32 15.53 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP A 203 ASP~? 10.68 C3 PG4 B 350 C 16 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 67 GLY A 189 GLY~? 8.76 O1 PO4 A 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 6.38 39.80 88.71 6.88 38.89 86.87 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 17.63 42.50 89.25 18.11 42.29 88.64 -9.96 51.69 26.75 -10.72 51.67 27.15 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 5 3 # 5 C 14 ASP A 208 ASP~? 8.51 C3 PG4 A 350 C 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 67 GLY A 212 GLY~? 9.07 O1 PG4 A 350 coo 10.04 44.27 88.44 9.47 42.32 89.03 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 6.38 39.80 88.71 6.88 38.89 86.87 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 17.63 42.50 89.25 18.11 42.29 88.64 -15.16 41.65 16.73 -14.78 42.24 17.11 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 6 3 # 6 C 14 ASP A 208 ASP~? 8.51 C3 PG4 A 350 C 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 67 GLY B 240 GLY.? 13.32 C2 PG4 A 350 coo 10.04 44.27 88.44 9.47 42.32 89.03 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 6.38 39.80 88.71 6.88 38.89 86.87 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 17.63 42.50 89.25 18.11 42.29 88.64 -12.92 41.87 10.50 -12.39 42.07 9.95 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 7 3 # 7 C 14 ASP B 41 ASP.? 20.21 O3 PO4 B 349 C 16 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 67 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 6.38 39.80 88.71 6.88 38.89 86.87 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 17.63 42.50 89.25 18.11 42.29 88.64 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 8 3 # 8 C 14 ASP B 41 ASP.? 20.21 O3 PO4 B 349 C 16 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 67 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 6.38 39.80 88.71 6.88 38.89 86.87 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 17.63 42.50 89.25 18.11 42.29 88.64 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 9 3 # 9 C 14 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 16 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 67 GLY B 158 GLY^? 6.78 O4 PO4 B 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 6.38 39.80 88.71 6.88 38.89 86.87 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 17.63 42.50 89.25 18.11 42.29 88.64 -3.93 41.69 -0.28 -4.14 42.31 0.12 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 10 3 # 10 C 14 ASP B 203 ASP~? 9.89 C4 PG4 A 350 C 16 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 67 GLY B 189 GLY~? 8.50 O2 PO4 B 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 6.38 39.80 88.71 6.88 38.89 86.87 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 17.63 42.50 89.25 18.11 42.29 88.64 1.22 33.78 11.00 2.03 33.50 11.09 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 11 3 # 11 C 14 ASP B 208 ASP~? 8.88 C3 PG4 B 350 C 16 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 67 GLY B 212 GLY~? 9.26 O1 PG4 B 350 coo 10.04 44.27 88.44 9.47 42.32 89.03 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 6.38 39.80 88.71 6.88 38.89 86.87 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 17.63 42.50 89.25 18.11 42.29 88.64 6.02 46.22 18.32 5.64 45.65 17.83 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 12 3 # 12 C 14 ASP C 41 ASP.? 20.22 O4 PO4 C 349 C 16 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 67 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 6.38 39.80 88.71 6.88 38.89 86.87 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 17.63 42.50 89.25 18.11 42.29 88.64 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 13 3 # 13 C 14 ASP C 41 ASP.? 20.22 O4 PO4 C 349 C 16 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 67 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 6.38 39.80 88.71 6.88 38.89 86.87 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 17.63 42.50 89.25 18.11 42.29 88.64 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 14 3 # 14 C 14 ASP C 41 ASP.? 20.22 O4 PO4 C 349 C 16 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 67 GLY C 46 GLY.? 27.31 O4 PO4 C 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 6.38 39.80 88.71 6.88 38.89 86.87 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 17.63 42.50 89.25 18.11 42.29 88.64 -52.06 3.43 7.36 -52.19 4.02 7.83 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 15 3 # 15 C 14 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 16 HIS C 238 HIS.? 10.74 O3 PO4 C 349 C 67 GLY C 158 GLY^? 6.81 O1 PO4 C 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 6.38 39.80 88.71 6.88 38.89 86.87 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 17.63 42.50 89.25 18.11 42.29 88.64 -45.67 29.61 31.18 -45.83 29.70 31.90 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 16 3 # 16 C 14 ASP C 203 ASP~? 10.24 C6 PG4 D 350 C 16 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 67 GLY C 189 GLY~? 8.64 O2 PO4 C 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 6.38 39.80 88.71 6.88 38.89 86.87 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 17.63 42.50 89.25 18.11 42.29 88.64 -40.49 15.78 32.96 -39.70 15.56 32.71 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 17 3 # 17 C 14 ASP C 208 ASP~? 8.73 O2 PG4 C 350 C 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 67 GLY C 212 GLY~? 9.26 C2 PG4 C 350 coo 10.04 44.27 88.44 9.47 42.32 89.03 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 6.38 39.80 88.71 6.88 38.89 86.87 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 17.63 42.50 89.25 18.11 42.29 88.64 -34.69 19.16 46.59 -35.10 19.11 45.88 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 18 3 # 18 C 14 ASP D 41 ASP.? 20.92 O2 PO4 D 349 C 16 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 67 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 6.38 39.80 88.71 6.88 38.89 86.87 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 17.63 42.50 89.25 18.11 42.29 88.64 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 19 3 # 19 C 14 ASP D 41 ASP.? 20.92 O2 PO4 D 349 C 16 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 67 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 6.38 39.80 88.71 6.88 38.89 86.87 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 17.63 42.50 89.25 18.11 42.29 88.64 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 20 3 # 20 C 14 ASP D 41 ASP.? 20.92 O2 PO4 D 349 C 16 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 67 GLY D 46 GLY.? 28.27 O2 PO4 D 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 6.38 39.80 88.71 6.88 38.89 86.87 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 17.63 42.50 89.25 18.11 42.29 88.64 -41.37 7.83 85.88 -41.36 8.41 85.36 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 21 3 # 21 C 14 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 16 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 67 GLY D 158 GLY^? 6.87 O4 PO4 D 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 6.38 39.80 88.71 6.88 38.89 86.87 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 17.63 42.50 89.25 18.11 42.29 88.64 -47.17 31.32 57.48 -47.03 31.32 56.71 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 22 3 # 22 C 14 ASP D 203 ASP~? 10.40 O3 PG4 C 350 C 16 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 67 GLY D 189 GLY~? 8.43 O1 PO4 D 349 coo 10.04 44.27 88.44 9.47 42.32 89.03 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 6.38 39.80 88.71 6.88 38.89 86.87 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 17.63 42.50 89.25 18.11 42.29 88.64 -49.90 16.88 57.52 -50.61 16.53 57.79 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 23 3 # 23 C 14 ASP D 208 ASP~? 8.41 C6 PG4 D 350 C 16 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 67 GLY D 212 GLY~? 8.60 O5 PG4 D 350 coo 10.04 44.27 88.44 9.47 42.32 89.03 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 6.38 39.80 88.71 6.88 38.89 86.87 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 17.63 42.50 89.25 18.11 42.29 88.64 -55.90 16.99 43.52 -55.53 17.14 44.23 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 23 hits 1cb7_c07 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP D 339 ASP~? 21.27 O1 PO4 D 349 264 GLU D 317 GLU~? 25.08 O4 PO4 D 349 328 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 45.62 80.42 43.69 45.65 82.01 45.07 -63.02 36.35 69.71 -64.42 35.04 70.68 coo 59.69 92.71 39.85 58.53 92.03 41.47 -45.36 46.85 72.91 -43.76 47.38 74.18 coo 45.39 90.72 40.63 45.07 89.14 41.90 -51.05 35.32 70.59 -50.24 33.36 70.95 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 1 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 90 ASP~? 15.98 C4 PG4 B 350 257 GLU A 15 GLU.? 17.86 C3 PG4 B 350 328 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 45.62 80.42 43.69 45.65 82.01 45.07 8.08 50.44 43.84 7.48 51.26 41.98 coo 48.97 85.16 40.39 47.18 86.25 40.47 7.25 58.10 39.87 8.59 56.71 39.00 coo 45.39 90.72 40.63 45.07 89.14 41.90 1.74 60.96 43.57 3.36 61.47 42.28 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 1 hits 1cdg_c04 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 262 GLU A 196 GLU~? 14.14 O1 PO4 A 349 A 358 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 27.13 54.07 50.45 26.96 54.19 48.35 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 27.06 50.43 44.36 27.99 52.27 44.74 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 262 GLU A 196 GLU~? 14.14 O1 PO4 A 349 A 358 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 27.13 54.07 50.45 26.96 54.19 48.35 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 27.06 50.43 44.36 27.99 52.27 44.74 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 262 GLU A 231 GLU.? 5.77 O1 PO4 A 349 A 358 GLU A 196 GLU~? 14.14 O1 PO4 A 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 27.13 54.07 50.45 26.96 54.19 48.35 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 27.06 50.43 44.36 27.99 52.27 44.74 -18.66 54.90 30.43 -20.55 55.76 30.68 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 A 232 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 262 GLU B 196 GLU~? 13.82 O2 PO4 B 349 A 358 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 13.23 34.15 0.64 14.88 33.23 1.56 coo 27.13 54.07 50.45 26.96 54.19 48.35 10.06 30.74 8.04 11.63 30.24 6.70 coo 27.06 50.43 44.36 27.99 52.27 44.74 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 A 232 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 262 GLU B 231 GLU.? 5.72 O2 PO4 B 349 A 358 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 13.23 34.15 0.64 14.88 33.23 1.56 coo 27.13 54.07 50.45 26.96 54.19 48.35 3.23 35.71 5.73 3.00 33.97 6.89 coo 27.06 50.43 44.36 27.99 52.27 44.74 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 A 232 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 262 GLU B 196 GLU~? 13.82 O2 PO4 B 349 A 358 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 11.38 38.70 0.79 12.71 38.99 -0.80 coo 27.13 54.07 50.45 26.96 54.19 48.35 10.06 30.74 8.04 11.63 30.24 6.70 coo 27.06 50.43 44.36 27.99 52.27 44.74 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 A 232 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 262 GLU B 231 GLU.? 5.72 O2 PO4 B 349 A 358 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 11.38 38.70 0.79 12.71 38.99 -0.80 coo 27.13 54.07 50.45 26.96 54.19 48.35 3.23 35.71 5.73 3.00 33.97 6.89 coo 27.06 50.43 44.36 27.99 52.27 44.74 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 8 3 # 8 A 232 HIS C 173 HIS~? 15.03 O2 PO4 C 349 A 262 GLU C 196 GLU~? 13.61 O2 PO4 C 349 A 358 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 27.13 54.07 50.45 26.96 54.19 48.35 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 27.06 50.43 44.36 27.99 52.27 44.74 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 9 3 # 9 A 232 HIS C 229 HIS^? 14.09 O2 PO4 C 349 A 262 GLU C 196 GLU~? 13.61 O2 PO4 C 349 A 358 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 27.13 54.07 50.45 26.96 54.19 48.35 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 27.06 50.43 44.36 27.99 52.27 44.74 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 10 3 # 10 A 232 HIS C 229 HIS^? 14.09 O2 PO4 C 349 A 262 GLU C 231 GLU.? 5.70 O2 PO4 C 349 A 358 GLU C 196 GLU~? 13.61 O2 PO4 C 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 27.13 54.07 50.45 26.96 54.19 48.35 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 27.06 50.43 44.36 27.99 52.27 44.74 -32.17 15.85 27.58 -30.80 16.36 26.07 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 11 3 # 11 A 232 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 262 GLU D 196 GLU~? 13.48 O1 PO4 D 349 A 358 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 27.13 54.07 50.45 26.96 54.19 48.35 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 27.06 50.43 44.36 27.99 52.27 44.74 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 12 3 # 12 A 232 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 262 GLU D 231 GLU.? 5.62 O1 PO4 D 349 A 358 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 27.13 54.07 50.45 26.96 54.19 48.35 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 27.06 50.43 44.36 27.99 52.27 44.74 -58.16 15.98 62.44 -59.80 16.71 63.55 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 13 3 # 13 A 232 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 262 GLU D 196 GLU~? 13.48 O1 PO4 D 349 A 358 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 27.13 54.07 50.45 26.96 54.19 48.35 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 27.06 50.43 44.36 27.99 52.27 44.74 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 14 3 # 14 A 232 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 262 GLU D 231 GLU.? 5.62 O1 PO4 D 349 A 358 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 26.19 60.87 43.98 27.48 59.27 43.30 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 27.13 54.07 50.45 26.96 54.19 48.35 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 27.06 50.43 44.36 27.99 52.27 44.74 -58.16 15.98 62.44 -59.80 16.71 63.55 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 14 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 173 HIS~? 15.17 O1 PO4 A 349 B 262 GLU A 196 GLU~? 14.14 O1 PO4 A 349 B 358 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 41.60 83.57 54.16 42.46 83.24 52.25 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 44.05 87.61 48.73 43.15 85.67 48.52 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 262 GLU A 196 GLU~? 14.14 O1 PO4 A 349 B 358 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 41.60 83.57 54.16 42.46 83.24 52.25 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 44.05 87.61 48.73 43.15 85.67 48.52 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 262 GLU A 231 GLU.? 5.77 O1 PO4 A 349 B 358 GLU A 196 GLU~? 14.14 O1 PO4 A 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 41.60 83.57 54.16 42.46 83.24 52.25 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 44.05 87.61 48.73 43.15 85.67 48.52 -18.66 54.90 30.43 -20.55 55.76 30.68 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS B 173 HIS~? 15.15 O2 PO4 B 349 B 262 GLU B 196 GLU~? 13.82 O2 PO4 B 349 B 358 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 13.23 34.15 0.64 14.88 33.23 1.56 coo 41.60 83.57 54.16 42.46 83.24 52.25 10.06 30.74 8.04 11.63 30.24 6.70 coo 44.05 87.61 48.73 43.15 85.67 48.52 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 B 232 HIS B 173 HIS~? 15.15 O2 PO4 B 349 B 262 GLU B 231 GLU.? 5.72 O2 PO4 B 349 B 358 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 13.23 34.15 0.64 14.88 33.23 1.56 coo 41.60 83.57 54.16 42.46 83.24 52.25 3.23 35.71 5.73 3.00 33.97 6.89 coo 44.05 87.61 48.73 43.15 85.67 48.52 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 B 232 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 262 GLU B 196 GLU~? 13.82 O2 PO4 B 349 B 358 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 11.38 38.70 0.79 12.71 38.99 -0.80 coo 41.60 83.57 54.16 42.46 83.24 52.25 10.06 30.74 8.04 11.63 30.24 6.70 coo 44.05 87.61 48.73 43.15 85.67 48.52 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 B 232 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 262 GLU B 231 GLU.? 5.72 O2 PO4 B 349 B 358 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 11.38 38.70 0.79 12.71 38.99 -0.80 coo 41.60 83.57 54.16 42.46 83.24 52.25 3.23 35.71 5.73 3.00 33.97 6.89 coo 44.05 87.61 48.73 43.15 85.67 48.52 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 8 3 # 8 B 232 HIS C 173 HIS~? 15.03 O2 PO4 C 349 B 262 GLU C 196 GLU~? 13.61 O2 PO4 C 349 B 358 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 41.60 83.57 54.16 42.46 83.24 52.25 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 44.05 87.61 48.73 43.15 85.67 48.52 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 9 3 # 9 B 232 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 262 GLU C 196 GLU~? 13.61 O2 PO4 C 349 B 358 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 41.60 83.57 54.16 42.46 83.24 52.25 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 44.05 87.61 48.73 43.15 85.67 48.52 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 10 3 # 10 B 232 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 262 GLU C 231 GLU.? 5.70 O2 PO4 C 349 B 358 GLU C 196 GLU~? 13.61 O2 PO4 C 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 41.60 83.57 54.16 42.46 83.24 52.25 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 44.05 87.61 48.73 43.15 85.67 48.52 -32.17 15.85 27.58 -30.80 16.36 26.07 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 11 3 # 11 B 232 HIS D 173 HIS~? 14.91 O1 PO4 D 349 B 262 GLU D 196 GLU~? 13.48 O1 PO4 D 349 B 358 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 41.60 83.57 54.16 42.46 83.24 52.25 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 44.05 87.61 48.73 43.15 85.67 48.52 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 12 3 # 12 B 232 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 262 GLU D 196 GLU~? 13.48 O1 PO4 D 349 B 358 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 41.60 83.57 54.16 42.46 83.24 52.25 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 44.05 87.61 48.73 43.15 85.67 48.52 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 13 3 # 13 B 232 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 262 GLU D 231 GLU.? 5.62 O1 PO4 D 349 B 358 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 44.98 77.01 48.39 44.42 78.67 47.18 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 41.60 83.57 54.16 42.46 83.24 52.25 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 44.05 87.61 48.73 43.15 85.67 48.52 -58.16 15.98 62.44 -59.80 16.71 63.55 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 13 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 180 GLY.? 25.12 O1 PO4 A 349 A 228 SER A 183 SER^? 16.92 O1 PO4 A 349 A 549 ASP A 226 ASP.? 25.19 O1 PO4 A 349 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -33.34 64.64 24.90 -32.74 64.49 24.41 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -27.51 58.57 23.48 -25.56 60.04 23.47 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -31.23 58.08 18.66 -33.23 57.82 19.18 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY B 180 GLY.? 25.14 O2 PO4 B 349 A 228 SER B 183 SER^? 16.79 O2 PO4 B 349 A 549 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 22.69 36.63 -5.30 22.03 36.92 -5.12 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 17.47 37.56 1.42 15.35 37.17 0.22 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 234 GLY.? 7.16 O1 PO4 B 349 A 228 SER B 241 SER.? 10.02 O1 PO4 B 349 A 549 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -5.34 40.16 6.49 -4.85 40.15 5.88 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY C 180 GLY.? 8.23 O2 PG4 A 350 A 228 SER C 183 SER^? 16.83 O2 PO4 C 349 A 549 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -19.46 28.72 22.15 -20.11 28.91 22.57 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -24.45 24.87 27.97 -26.59 25.58 27.05 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY D 180 GLY~? 25.02 O1 PO4 D 349 A 228 SER D 183 SER^? 16.97 O1 PO4 D 349 A 549 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -72.85 27.38 66.69 -72.20 27.53 66.25 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -67.39 23.51 61.42 -65.47 24.80 62.18 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -71.26 26.87 58.29 -73.26 26.34 58.61 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY D 232 GLY.? 6.31 O1 PO4 D 349 A 228 SER D 235 SER.? 9.32 O4 PO4 D 349 A 549 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -51.56 25.17 56.57 -51.51 24.50 57.04 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -44.15 28.59 53.58 -43.17 30.60 54.60 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -41.09 30.11 59.34 -39.33 28.92 59.24 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 6 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 180 GLY.? 25.12 O1 PO4 A 349 B1228 SER A 183 SER^? 16.92 O1 PO4 A 349 B1549 ASP A 226 ASP.? 25.19 O1 PO4 A 349 coo 126.34 72.75 125.66 125.95 73.27 126.11 -33.34 64.64 24.90 -32.74 64.49 24.41 coo 131.65 74.68 129.41 130.31 72.73 128.82 -27.51 58.57 23.48 -25.56 60.04 23.47 coo 134.72 69.43 130.42 133.03 70.65 130.08 -31.23 58.08 18.66 -33.23 57.82 19.18 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 232 GLY.? 6.13 O1 PO4 A 349 B1228 SER A 235 SER.? 9.13 O4 PO4 A 349 B1549 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 126.34 72.75 125.66 125.95 73.27 126.11 -11.48 56.85 19.86 -11.43 56.72 20.67 coo 131.65 74.68 129.41 130.31 72.73 128.82 -3.96 57.47 15.64 -2.97 59.52 14.86 coo 134.72 69.43 130.42 133.03 70.65 130.08 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY A 250 GLY~? 14.78 O1 PG4 A 350 B1228 SER A 143 SER.? 14.48 C2 PG4 A 350 B1549 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 126.34 72.75 125.66 125.95 73.27 126.11 -16.12 46.96 14.05 -16.23 47.66 13.72 coo 131.65 74.68 129.41 130.31 72.73 128.82 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 134.72 69.43 130.42 133.03 70.65 130.08 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 180 GLY.? 25.14 O2 PO4 B 349 B1228 SER B 183 SER^? 16.79 O2 PO4 B 349 B1549 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 126.34 72.75 125.66 125.95 73.27 126.11 22.69 36.63 -5.30 22.03 36.92 -5.12 coo 131.65 74.68 129.41 130.31 72.73 128.82 17.47 37.56 1.42 15.35 37.17 0.22 coo 134.72 69.43 130.42 133.03 70.65 130.08 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY B 232 GLY.? 6.11 O2 PO4 B 349 B1228 SER B 235 SER.? 9.35 O4 PO4 B 349 B1549 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 126.34 72.75 125.66 125.95 73.27 126.11 1.39 39.60 4.72 1.45 38.82 4.98 coo 131.65 74.68 129.41 130.31 72.73 128.82 -6.73 42.81 4.19 -8.03 43.03 2.17 coo 134.72 69.43 130.42 133.03 70.65 130.08 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY B 234 GLY.? 7.16 O1 PO4 B 349 B1228 SER B 241 SER.? 10.02 O1 PO4 B 349 B1549 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 126.34 72.75 125.66 125.95 73.27 126.11 -5.34 40.16 6.49 -4.85 40.15 5.88 coo 131.65 74.68 129.41 130.31 72.73 128.82 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 134.72 69.43 130.42 133.03 70.65 130.08 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 B1198 GLY B 240 GLY.? 13.32 C2 PG4 A 350 B1228 SER A 143 SER.? 14.48 C2 PG4 A 350 B1549 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 126.34 72.75 125.66 125.95 73.27 126.11 -12.92 41.87 10.50 -12.39 42.07 9.95 coo 131.65 74.68 129.41 130.31 72.73 128.82 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 134.72 69.43 130.42 133.03 70.65 130.08 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 B1198 GLY C 180 GLY.? 8.23 O2 PG4 A 350 B1228 SER C 183 SER^? 16.83 O2 PO4 C 349 B1549 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 126.34 72.75 125.66 125.95 73.27 126.11 -19.46 28.72 22.15 -20.11 28.91 22.57 coo 131.65 74.68 129.41 130.31 72.73 128.82 -24.45 24.87 27.97 -26.59 25.58 27.05 coo 134.72 69.43 130.42 133.03 70.65 130.08 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 9 3 # 9 B1198 GLY C 250 GLY~? 15.20 C2 PG4 C 350 B1228 SER C 143 SER.? 14.49 C2 PG4 C 350 B1549 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 126.34 72.75 125.66 125.95 73.27 126.11 -34.85 24.44 43.72 -34.85 25.15 43.35 coo 131.65 74.68 129.41 130.31 72.73 128.82 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 134.72 69.43 130.42 133.03 70.65 130.08 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 10 3 # 10 B1198 GLY D 180 GLY~? 25.02 O1 PO4 D 349 B1228 SER D 183 SER^? 16.97 O1 PO4 D 349 B1549 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo 126.34 72.75 125.66 125.95 73.27 126.11 -72.85 27.38 66.69 -72.20 27.53 66.25 coo 131.65 74.68 129.41 130.31 72.73 128.82 -67.39 23.51 61.42 -65.47 24.80 62.18 coo 134.72 69.43 130.42 133.03 70.65 130.08 -71.26 26.87 58.29 -73.26 26.34 58.61 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 11 3 # 11 B1198 GLY D 232 GLY.? 6.31 O1 PO4 D 349 B1228 SER D 235 SER.? 9.32 O4 PO4 D 349 B1549 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 126.34 72.75 125.66 125.95 73.27 126.11 -51.56 25.17 56.57 -51.51 24.50 57.04 coo 131.65 74.68 129.41 130.31 72.73 128.82 -44.15 28.59 53.58 -43.17 30.60 54.60 coo 134.72 69.43 130.42 133.03 70.65 130.08 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 12 3 # 12 B1198 GLY D 234 GLY.? 7.11 O3 PO4 D 349 B1228 SER D 241 SER.? 10.08 O3 PO4 D 349 B1549 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 126.34 72.75 125.66 125.95 73.27 126.11 -44.87 24.99 54.53 -45.43 25.38 54.91 coo 131.65 74.68 129.41 130.31 72.73 128.82 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 134.72 69.43 130.42 133.03 70.65 130.08 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 13 3 # 13 B1198 GLY D 240 GLY.? 13.57 O2 PG4 C 350 B1228 SER C 143 SER.? 14.49 C2 PG4 C 350 B1549 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 126.34 72.75 125.66 125.95 73.27 126.11 -37.41 23.92 50.12 -38.01 24.41 50.36 coo 131.65 74.68 129.41 130.31 72.73 128.82 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 134.72 69.43 130.42 133.03 70.65 130.08 -31.75 16.85 51.07 -30.38 15.61 52.00 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 13 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 70 GLU~? 32.95 O2 PO4 A 349 A 89 GLU A 66 GLU~? 28.55 C5 PG4 B 350 A 120 SER A 64 SER~? 26.25 O3 PG4 B 350 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -6.11 60.40 57.95 -4.53 61.81 58.04 coo -31.18 6.91 75.60 -32.39 8.51 74.91 0.21 52.94 56.28 1.27 51.32 57.12 coo -34.73 8.57 68.21 -33.63 9.08 70.28 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU B 70 GLU~? 33.54 O3 PO4 B 349 A 89 GLU B 66 GLU~? 29.14 C5 PG4 A 350 A 120 SER B 64 SER~? 26.98 C5 PG4 A 350 coo -24.35 9.53 67.64 -25.07 11.29 68.60 2.54 0.85 9.44 1.10 0.13 8.05 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -4.41 2.86 15.92 -3.73 2.64 17.92 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU C 70 GLU~? 32.89 O4 PO4 C 349 A 89 GLU C 66 GLU~? 28.42 C3 PG4 D 350 A 120 SER C 64 SER~? 25.88 C5 PG4 D 350 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -43.64 -5.35 8.13 -45.41 -4.88 7.08 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -49.32 -9.41 15.52 -48.32 -10.85 16.74 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -51.01 -2.63 16.81 -51.42 -4.86 15.97 1cns_c00 source 1cns CHITINASE : 3 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 70 GLU~? 32.95 O2 PO4 A 349 B 89 GLU A 66 GLU~? 28.55 C5 PG4 B 350 B 120 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -6.11 60.40 57.95 -4.53 61.81 58.04 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 0.21 52.94 56.28 1.27 51.32 57.12 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU B 70 GLU~? 33.54 O3 PO4 B 349 B 89 GLU B 66 GLU~? 29.14 C5 PG4 A 350 B 120 SER B 64 SER~? 26.98 C5 PG4 A 350 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 2.54 0.85 9.44 1.10 0.13 8.05 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -4.41 2.86 15.92 -3.73 2.64 17.92 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU C 70 GLU~? 32.89 O4 PO4 C 349 B 89 GLU C 66 GLU~? 28.42 C3 PG4 D 350 B 120 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -43.64 -5.35 8.13 -45.41 -4.88 7.08 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -49.32 -9.41 15.52 -48.32 -10.85 16.74 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -51.01 -2.63 16.81 -51.42 -4.86 15.97 1cns_c01 source 1cns CHITINASE : 3 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 91 TYR~? 12.90 C4 PG4 B 350 A 173 ASP A 89 ASP~? 13.93 C4 PG4 B 350 C 48 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 3.23 49.01 40.90 3.18 50.90 38.82 coo 24.35 4.55 25.11 25.94 3.23 25.53 10.16 45.65 42.38 11.05 44.28 40.99 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR C 91 TYR~? 12.18 C5 PG4 D 350 A 173 ASP C 89 ASP.? 13.45 C5 PG4 D 350 C 48 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 24.35 4.55 25.11 25.94 3.23 25.53 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -57.88 0.79 18.76 -56.46 0.67 21.52 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR D 91 TYR~? 13.46 C4 PG4 C 350 A 173 ASP D 89 ASP.? 16.35 C5 PG4 C 350 C 48 ARG D 42 ARG.? 20.81 C4 PG4 C 350 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 24.35 4.55 25.11 25.94 3.23 25.53 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -33.94 3.86 75.82 -34.45 4.46 72.82 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 42 ARG~? 19.93 C3 PG4 B 350 C 101 TYR A 91 TYR~? 12.90 C4 PG4 B 350 C 173 ASP A 89 ASP~? 13.93 C4 PG4 B 350 coo 32.27 5.62 48.15 31.93 6.48 51.06 7.49 56.88 46.72 6.71 54.94 44.43 coo 29.64 3.64 57.39 31.22 5.14 55.65 3.23 49.01 40.90 3.18 50.90 38.82 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 10.16 45.65 42.38 11.05 44.28 40.99 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG C 42 ARG.? 19.15 C5 PG4 D 350 C 101 TYR C 91 TYR~? 12.18 C5 PG4 D 350 C 173 ASP C 89 ASP.? 13.45 C5 PG4 D 350 coo 32.27 5.62 48.15 31.93 6.48 51.06 -57.88 0.79 18.76 -56.46 0.67 21.52 coo 29.64 3.64 57.39 31.22 5.14 55.65 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -58.19 -3.49 30.72 -58.73 -3.38 32.77 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG D 42 ARG.? 20.81 C4 PG4 C 350 C 101 TYR D 91 TYR~? 13.46 C4 PG4 C 350 C 173 ASP D 89 ASP.? 16.35 C5 PG4 C 350 coo 32.27 5.62 48.15 31.93 6.48 51.06 -33.94 3.86 75.82 -34.45 4.46 72.82 coo 29.64 3.64 57.39 31.22 5.14 55.65 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -31.01 0.13 64.24 -30.68 -1.79 63.45 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 42 ARG~? 19.93 C3 PG4 B 350 D 101 TYR A 91 TYR~? 12.90 C4 PG4 B 350 D 173 ASP A 89 ASP~? 13.93 C4 PG4 B 350 coo 69.08 8.58 32.60 69.70 10.81 30.58 7.49 56.88 46.72 6.71 54.94 44.43 coo 71.77 11.86 24.26 70.23 12.22 26.56 3.23 49.01 40.90 3.18 50.90 38.82 coo 71.60 6.14 19.25 70.26 6.87 20.69 10.16 45.65 42.38 11.05 44.28 40.99 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG C 42 ARG.? 19.15 C5 PG4 D 350 D 101 TYR C 91 TYR~? 12.18 C5 PG4 D 350 D 173 ASP C 89 ASP.? 13.45 C5 PG4 D 350 coo 69.08 8.58 32.60 69.70 10.81 30.58 -57.88 0.79 18.76 -56.46 0.67 21.52 coo 71.77 11.86 24.26 70.23 12.22 26.56 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 71.60 6.14 19.25 70.26 6.87 20.69 -58.19 -3.49 30.72 -58.73 -3.38 32.77 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG D 42 ARG.? 20.81 C4 PG4 C 350 D 101 TYR D 91 TYR~? 13.46 C4 PG4 C 350 D 173 ASP D 89 ASP.? 16.35 C5 PG4 C 350 coo 69.08 8.58 32.60 69.70 10.81 30.58 -33.94 3.86 75.82 -34.45 4.46 72.82 coo 71.77 11.86 24.26 70.23 12.22 26.56 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 71.60 6.14 19.25 70.26 6.87 20.69 -31.01 0.13 64.24 -30.68 -1.79 63.45 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 91 TYR~? 12.90 C4 PG4 B 350 B 173 ASP A 89 ASP~? 13.93 C4 PG4 B 350 D 48 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 3.23 49.01 40.90 3.18 50.90 38.82 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 10.16 45.65 42.38 11.05 44.28 40.99 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR C 91 TYR~? 12.18 C5 PG4 D 350 B 173 ASP C 89 ASP.? 13.45 C5 PG4 D 350 D 48 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -57.88 0.79 18.76 -56.46 0.67 21.52 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR D 91 TYR~? 13.46 C4 PG4 C 350 B 173 ASP D 89 ASP.? 16.35 C5 PG4 C 350 D 48 ARG D 42 ARG.? 20.81 C4 PG4 C 350 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -33.94 3.86 75.82 -34.45 4.46 72.82 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 137 ALA.? 5.46 O1 PG4 A 350 A 74 ASN A 138 ASN.? -6.13 O2 PG4 A 350s A 75 GLY C 180 GLY.? 8.23 O2 PG4 A 350 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -15.24 36.07 26.36 -15.96 35.31 27.49 coo 1.20 66.40 122.20 2.03 64.53 121.46 -17.89 33.84 23.48 -17.76 31.89 24.26 coo 4.68 65.84 125.52 4.11 65.60 126.05 -19.46 28.72 22.15 -20.11 28.91 22.57 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 137 ALA.? 5.46 O1 PG4 A 350 B 74 ASN A 138 ASN.? -6.13 O2 PG4 A 350s B 75 GLY C 180 GLY.? 8.23 O2 PG4 A 350 coo 39.21 14.97 27.55 40.19 16.01 27.08 -15.24 36.07 26.36 -15.96 35.31 27.49 coo 43.06 12.94 25.74 42.26 11.81 27.44 -17.89 33.84 23.48 -17.76 31.89 24.26 coo 46.38 13.54 29.18 46.14 14.29 29.26 -19.46 28.72 22.15 -20.11 28.91 22.57 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 137 ALA.? 5.46 O1 PG4 A 350 C 74 ASN A 138 ASN.? -6.13 O2 PG4 A 350s C 75 GLY C 180 GLY.? 8.23 O2 PG4 A 350 coo 16.14 15.08 36.63 15.28 14.65 37.81 -15.24 36.07 26.36 -15.96 35.31 27.49 coo 11.60 16.13 36.70 12.80 17.74 35.96 -17.89 33.84 23.48 -17.76 31.89 24.26 coo 10.99 19.23 40.32 11.50 18.77 40.74 -19.46 28.72 22.15 -20.11 28.91 22.57 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 137 ALA.? 5.46 O1 PG4 A 350 D 74 ASN A 138 ASN.? -6.13 O2 PG4 A 350s D 75 GLY C 180 GLY.? 8.23 O2 PG4 A 350 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -15.24 36.07 26.36 -15.96 35.31 27.49 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -17.89 33.84 23.48 -17.76 31.89 24.26 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -19.46 28.72 22.15 -20.11 28.91 22.57 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c07 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 198 ASP.? 17.22 O1 PO4 A 349 315 GLU A 196 GLU~? 14.14 O1 PO4 A 349 390 TYR A 225 TYR.? 21.13 O1 PO4 A 349 coo 32.46 99.13 19.34 30.94 100.38 20.07 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 32.04 94.22 18.23 30.57 94.75 16.88 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 21.10 94.74 18.36 23.09 96.71 18.59 -28.82 53.90 23.23 -28.73 53.13 25.91 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP B 198 ASP.? 14.38 O1 PG4 B 350 315 GLU B 196 GLU~? 13.82 O2 PO4 B 349 390 TYR B 225 TYR~? 21.07 O2 PO4 B 349 coo 32.46 99.13 19.34 30.94 100.38 20.07 11.89 31.57 14.26 12.37 32.72 16.00 coo 32.04 94.22 18.23 30.57 94.75 16.88 10.06 30.74 8.04 11.63 30.24 6.70 coo 21.10 94.74 18.36 23.09 96.71 18.59 19.22 39.10 5.74 19.70 36.67 7.05 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP C 198 ASP.? 14.11 O1 PG4 C 350 315 GLU C 196 GLU~? 13.61 O2 PO4 C 349 390 TYR C 225 TYR~? 18.05 C6 PG4 A 350 coo 32.46 99.13 19.34 30.94 100.38 20.07 -29.82 11.85 32.90 -29.50 11.63 35.01 coo 32.04 94.22 18.23 30.57 94.75 16.88 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 21.10 94.74 18.36 23.09 96.71 18.59 -22.42 22.90 31.89 -22.15 20.23 31.17 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP D 198 ASP.? 14.02 O5 PG4 D 350 315 GLU D 196 GLU~? 13.48 O1 PO4 D 349 390 TYR D 225 TYR.? 21.05 O1 PO4 D 349 coo 32.46 99.13 19.34 30.94 100.38 20.07 -59.61 10.87 58.41 -59.89 10.18 56.43 coo 32.04 94.22 18.23 30.57 94.75 16.88 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 21.10 94.74 18.36 23.09 96.71 18.59 -68.84 20.67 57.80 -68.69 18.14 58.96 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 4 hits 1ctn_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 56 ILE A 78 ILE^? 13.32 O3 PG4 B 350 A 82 TYR A 91 TYR~? 12.90 C4 PG4 B 350 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 1.74 60.96 43.57 3.36 61.47 42.28 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -3.53 50.51 39.07 -2.48 49.42 39.24 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 3.23 49.01 40.90 3.18 50.90 38.82 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 56 ILE B 78 ILE^? 13.34 C5 PG4 A 350 A 82 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -3.37 20.99 14.93 -4.42 21.03 15.99 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 56 ILE C 78 ILE^? 13.09 O3 PG4 D 350 A 82 TYR C 91 TYR~? 12.18 C5 PG4 D 350 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -45.84 3.81 27.27 -46.71 2.92 28.12 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -52.07 0.67 28.08 -52.42 3.42 27.72 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 56 ILE D 78 ILE^? 13.84 C6 PG4 C 350 A 82 TYR D 91 TYR~? 13.46 C4 PG4 C 350 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -44.16 6.16 65.24 -43.23 5.36 64.49 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -37.64 3.76 65.52 -37.58 6.56 65.66 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 4 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 56 ILE A 78 ILE^? 13.32 O3 PG4 B 350 B 82 TYR A 91 TYR~? 12.90 C4 PG4 B 350 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 1.74 60.96 43.57 3.36 61.47 42.28 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -3.53 50.51 39.07 -2.48 49.42 39.24 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 3.23 49.01 40.90 3.18 50.90 38.82 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 56 ILE B 78 ILE^? 13.34 C5 PG4 A 350 B 82 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -3.37 20.99 14.93 -4.42 21.03 15.99 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 56 ILE C 78 ILE^? 13.09 O3 PG4 D 350 B 82 TYR C 91 TYR~? 12.18 C5 PG4 D 350 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -45.84 3.81 27.27 -46.71 2.92 28.12 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -52.07 0.67 28.08 -52.42 3.42 27.72 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 3 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP B 92 TRP~? 12.54 C5 PG4 A 350 A 243 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 272 LYS B 96 LYS~? 18.72 C5 PG4 A 350 coo 18.21 54.75 18.05 19.91 55.17 21.59 -11.95 17.23 22.74 -9.16 19.51 24.31 coo 16.93 55.67 9.65 17.16 54.23 11.19 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 14.13 45.79 13.40 14.25 49.41 18.30 -4.65 11.97 23.20 -9.16 12.78 27.52 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 138 TRP D 92 TRP~? 12.49 C6 PG4 C 350 A 243 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 272 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 18.21 54.75 18.05 19.91 55.17 21.59 -35.51 -1.29 62.69 -38.42 -1.60 60.06 coo 16.93 55.67 9.65 17.16 54.23 11.19 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 14.13 45.79 13.40 14.25 49.41 18.30 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 2 hits 1d7r_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 221 TYR~? 17.25 O1 PG4 A 350 A 243 ASP C 226 ASP.? 11.40 C1 PG4 A 350 A 272 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo 2.03 68.31 21.46 0.66 68.36 23.90 -24.98 48.97 24.49 -23.82 47.69 26.70 coo 16.93 55.67 9.65 17.16 54.23 11.19 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 14.13 45.79 13.40 14.25 49.41 18.30 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 285 TYR~? 11.91 O4 PO4 A 349 A 243 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 272 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 2.03 68.31 21.46 0.66 68.36 23.90 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 16.93 55.67 9.65 17.16 54.23 11.19 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 14.13 45.79 13.40 14.25 49.41 18.30 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR B 31 TYR~? 9.45 O3 PO4 B 349 A 243 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 272 LYS B 223 LYS~? 20.96 O1 PG4 B 350 coo 2.03 68.31 21.46 0.66 68.36 23.90 5.43 26.32 0.91 4.29 27.88 -1.11 coo 16.93 55.67 9.65 17.16 54.23 11.19 20.38 42.79 0.27 22.43 42.38 0.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 21.08 44.90 9.51 21.11 48.16 14.97 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 243 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 272 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 2.03 68.31 21.46 0.66 68.36 23.90 19.22 39.10 5.74 19.70 36.67 7.05 coo 16.93 55.67 9.65 17.16 54.23 11.19 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 14.13 45.79 13.40 14.25 49.41 18.30 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR B 285 TYR~? 12.05 O4 PO4 B 349 A 243 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 272 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 2.03 68.31 21.46 0.66 68.36 23.90 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 -1.16 62.88 18.52 0.68 62.16 19.33 coo 14.13 45.79 13.40 14.25 49.41 18.30 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 285 TYR~? 12.05 O4 PO4 B 349 A 243 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 272 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 2.03 68.31 21.46 0.66 68.36 23.90 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 20.38 42.79 0.27 22.43 42.38 0.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 285 TYR~? 12.05 O4 PO4 B 349 A 243 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 272 LYS B 223 LYS~? 20.96 O1 PG4 B 350 coo 2.03 68.31 21.46 0.66 68.36 23.90 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 20.38 42.79 0.27 22.43 42.38 0.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 21.08 44.90 9.51 21.11 48.16 14.97 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR B 285 TYR~? 12.05 O4 PO4 B 349 A 243 ASP B 339 ASP~? 20.98 O2 PO4 B 349 A 272 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 2.03 68.31 21.46 0.66 68.36 23.90 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 16.93 55.67 9.65 17.16 54.23 11.19 12.36 37.42 -12.59 13.93 36.17 -11.84 coo 14.13 45.79 13.40 14.25 49.41 18.30 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR C 31 TYR~? 9.00 O4 PO4 C 349 A 243 ASP C 226 ASP.? 11.40 C1 PG4 A 350 A 272 LYS C 223 LYS~? 21.04 C2 PG4 C 350 coo 2.03 68.31 21.46 0.66 68.36 23.90 -38.22 17.89 20.09 -39.26 20.46 19.95 coo 16.93 55.67 9.65 17.16 54.23 11.19 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 14.13 45.79 13.40 14.25 49.41 18.30 -19.98 24.16 38.56 -19.29 22.78 44.77 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR C 221 TYR~? 17.74 O1 PG4 C 350 A 243 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 272 LYS B 96 LYS~? 18.72 C5 PG4 A 350 coo 2.03 68.31 21.46 0.66 68.36 23.90 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 16.93 55.67 9.65 17.16 54.23 11.19 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 14.13 45.79 13.40 14.25 49.41 18.30 -4.65 11.97 23.20 -9.16 12.78 27.52 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR C 285 TYR~? 11.99 O1 PO4 C 349 A 243 ASP C 226 ASP.? 11.40 C1 PG4 A 350 A 272 LYS C 223 LYS~? 21.04 C2 PG4 C 350 coo 2.03 68.31 21.46 0.66 68.36 23.90 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 16.93 55.67 9.65 17.16 54.23 11.19 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 14.13 45.79 13.40 14.25 49.41 18.30 -19.98 24.16 38.56 -19.29 22.78 44.77 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR C 285 TYR~? 11.99 O1 PO4 C 349 A 243 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 272 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 2.03 68.31 21.46 0.66 68.36 23.90 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 16.93 55.67 9.65 17.16 54.23 11.19 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 14.13 45.79 13.40 14.25 49.41 18.30 -50.59 27.20 61.67 -46.47 26.50 58.89 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR D 285 TYR~? 12.08 O4 PO4 D 349 A 243 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 272 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 2.03 68.31 21.46 0.66 68.36 23.90 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 16.93 55.67 9.65 17.16 54.23 11.19 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 14.13 45.79 13.40 14.25 49.41 18.30 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 14 3 # 14 A 173 TYR D 285 TYR~? 12.08 O4 PO4 D 349 A 243 ASP D 226 ASP.? 25.08 O1 PO4 D 349 A 272 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 2.03 68.31 21.46 0.66 68.36 23.90 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 16.93 55.67 9.65 17.16 54.23 11.19 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 14.13 45.79 13.40 14.25 49.41 18.30 -68.08 25.33 66.69 -67.75 19.10 66.60 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 15 3 # 15 A 173 TYR D 285 TYR~? 12.08 O4 PO4 D 349 A 243 ASP D 339 ASP~? 21.27 O1 PO4 D 349 A 272 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 2.03 68.31 21.46 0.66 68.36 23.90 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 16.93 55.67 9.65 17.16 54.23 11.19 -63.02 36.35 69.71 -64.42 35.04 70.68 coo 14.13 45.79 13.40 14.25 49.41 18.30 -68.08 25.33 66.69 -67.75 19.10 66.60 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 15 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 184 LYS^? 18.49 O1 PO4 A 349 A 177 GLU A 231 GLU.? 5.77 O1 PO4 A 349 A 201 LEU A 186 LEU^? 14.16 O1 PO4 A 349 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -19.38 52.62 23.18 -21.24 51.48 22.89 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 184 LYS^? 17.27 O2 PO4 B 349 A 177 GLU B 231 GLU.? 5.72 O2 PO4 B 349 A 201 LEU B 186 LEU^? 14.03 O2 PO4 B 349 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 15.36 36.70 4.47 15.17 34.16 8.91 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 3.23 35.71 5.73 3.00 33.97 6.89 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 10.06 38.15 8.40 11.92 38.92 9.16 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS C 72 LYS~? 33.77 C3 PG4 D 350 A 177 GLU C 66 GLU~? 28.42 C3 PG4 D 350 A 201 LEU C 69 LEU~? 28.49 C3 PG4 D 350 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -38.31 -4.87 13.60 -38.37 -10.28 12.47 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -49.32 -9.41 15.52 -48.32 -10.85 16.74 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -43.47 -7.58 14.69 -43.71 -8.16 16.77 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS C 184 LYS^? 18.13 O2 PO4 C 349 A 177 GLU C 231 GLU.? 5.70 O2 PO4 C 349 A 201 LEU C 186 LEU^? 14.24 O2 PO4 C 349 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -31.51 20.62 33.77 -29.48 20.59 34.66 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 177 GLU D 231 GLU.? 5.62 O1 PO4 D 349 A 201 LEU D 186 LEU^? 14.08 O1 PO4 D 349 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -59.43 19.81 56.19 -61.37 19.42 55.27 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 5 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 184 LYS^? 18.49 O1 PO4 A 349 B 177 GLU A 231 GLU.? 5.77 O1 PO4 A 349 B 201 LEU A 186 LEU^? 14.16 O1 PO4 A 349 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 27.00 6.35 51.01 26.30 4.53 50.18 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -19.38 52.62 23.18 -21.24 51.48 22.89 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS B 184 LYS^? 17.27 O2 PO4 B 349 B 177 GLU B 196 GLU~? 13.82 O2 PO4 B 349 B 201 LEU B 186 LEU^? 14.03 O2 PO4 B 349 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 15.36 36.70 4.47 15.17 34.16 8.91 coo 27.00 6.35 51.01 26.30 4.53 50.18 10.06 30.74 8.04 11.63 30.24 6.70 coo 23.74 1.68 49.50 22.87 -0.24 49.97 10.06 38.15 8.40 11.92 38.92 9.16 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS B 184 LYS^? 17.27 O2 PO4 B 349 B 177 GLU B 231 GLU.? 5.72 O2 PO4 B 349 B 201 LEU B 186 LEU^? 14.03 O2 PO4 B 349 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 15.36 36.70 4.47 15.17 34.16 8.91 coo 27.00 6.35 51.01 26.30 4.53 50.18 3.23 35.71 5.73 3.00 33.97 6.89 coo 23.74 1.68 49.50 22.87 -0.24 49.97 10.06 38.15 8.40 11.92 38.92 9.16 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS C 72 LYS~? 33.77 C3 PG4 D 350 B 177 GLU C 66 GLU~? 28.42 C3 PG4 D 350 B 201 LEU C 69 LEU~? 28.49 C3 PG4 D 350 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -38.31 -4.87 13.60 -38.37 -10.28 12.47 coo 27.00 6.35 51.01 26.30 4.53 50.18 -49.32 -9.41 15.52 -48.32 -10.85 16.74 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -43.47 -7.58 14.69 -43.71 -8.16 16.77 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS C 184 LYS^? 18.13 O2 PO4 C 349 B 177 GLU C 231 GLU.? 5.70 O2 PO4 C 349 B 201 LEU C 186 LEU^? 14.24 O2 PO4 C 349 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 27.00 6.35 51.01 26.30 4.53 50.18 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -31.51 20.62 33.77 -29.48 20.59 34.66 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS D 184 LYS^? 18.69 O1 PO4 D 349 B 177 GLU D 231 GLU.? 5.62 O1 PO4 D 349 B 201 LEU D 186 LEU^? 14.08 O1 PO4 D 349 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 27.00 6.35 51.01 26.30 4.53 50.18 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -59.43 19.81 56.19 -61.37 19.42 55.27 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 6 hits 1daa_c01 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 739 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 3.61 55.89 43.73 3.10 55.52 45.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 8.08 50.44 43.84 7.48 51.26 41.98 coo 11.37 50.89 2.29 11.05 51.63 2.25 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 739 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 11.37 50.89 2.29 11.05 51.63 2.25 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 739 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 11.37 50.89 2.29 11.05 51.63 2.25 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 739 GLY B 212 GLY~? 9.26 O1 PG4 B 350 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 11.37 50.89 2.29 11.05 51.63 2.25 6.02 46.22 18.32 5.64 45.65 17.83 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY A 232 GLY.? 6.13 O1 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 1.50 56.90 17.79 2.83 56.38 19.33 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.37 50.89 2.29 11.05 51.63 2.25 -11.48 56.85 19.86 -11.43 56.72 20.67 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 1.50 56.90 17.79 2.83 56.38 19.33 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.37 50.89 2.29 11.05 51.63 2.25 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1ddj_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 1.50 56.90 17.79 2.83 56.38 19.33 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.37 50.89 2.29 11.05 51.63 2.25 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1ddj_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 1.50 56.90 17.79 2.83 56.38 19.33 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.37 50.89 2.29 11.05 51.63 2.25 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1ddj_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY A 232 GLY.? 6.13 O1 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.37 50.89 2.29 11.05 51.63 2.25 -11.48 56.85 19.86 -11.43 56.72 20.67 ULMN 3 1ddj_c12 PLASMINOGEN user 10 3 # 10 A 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.37 50.89 2.29 11.05 51.63 2.25 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1ddj_c12 PLASMINOGEN user 11 3 # 11 A 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.37 50.89 2.29 11.05 51.63 2.25 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1ddj_c12 PLASMINOGEN user 12 3 # 12 A 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.37 50.89 2.29 11.05 51.63 2.25 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1ddj_c12 PLASMINOGEN user 13 3 # 13 A 603 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 646 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 739 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 11.37 50.89 2.29 11.05 51.63 2.25 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1ddj_c12 PLASMINOGEN user 14 3 # 14 A 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 739 GLY B 192 GLY~? 8.75 O2 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 11.37 50.89 2.29 11.05 51.63 2.25 4.63 30.70 8.46 4.46 30.28 9.17 ULMN 3 1ddj_c12 PLASMINOGEN user 15 3 # 15 A 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 646 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 739 GLY A 212 GLY~? 9.07 O1 PG4 A 350 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 11.37 50.89 2.29 11.05 51.63 2.25 -15.16 41.65 16.73 -14.78 42.24 17.11 ULMN 3 1ddj_c12 PLASMINOGEN user 16 3 # 16 A 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 646 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 739 GLY B 192 GLY~? 8.75 O2 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 11.37 50.89 2.29 11.05 51.63 2.25 4.63 30.70 8.46 4.46 30.28 9.17 ULMN 3 1ddj_c12 PLASMINOGEN user 17 3 # 17 A 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1ddj_c12 PLASMINOGEN user 18 3 # 18 A 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1ddj_c12 PLASMINOGEN user 19 3 # 19 A 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY A 293 GLY.? 20.64 O4 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 -15.25 51.43 -1.86 -14.91 51.02 -1.25 ULMN 3 1ddj_c12 PLASMINOGEN user 20 3 # 20 A 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY B 232 GLY.? 6.11 O2 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 1.39 39.60 4.72 1.45 38.82 4.98 ULMN 3 1ddj_c12 PLASMINOGEN user 21 3 # 21 A 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1ddj_c12 PLASMINOGEN user 22 3 # 22 A 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1ddj_c12 PLASMINOGEN user 23 3 # 23 A 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY A 293 GLY.? 20.64 O4 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 -15.25 51.43 -1.86 -14.91 51.02 -1.25 ULMN 3 1ddj_c12 PLASMINOGEN user 24 3 # 24 A 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY B 232 GLY.? 6.11 O2 PO4 B 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 1.39 39.60 4.72 1.45 38.82 4.98 ULMN 3 1ddj_c12 PLASMINOGEN user 25 3 # 25 A 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 739 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 11.37 50.89 2.29 11.05 51.63 2.25 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1ddj_c12 PLASMINOGEN user 26 3 # 26 A 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 739 GLY D 212 GLY~? 8.60 O5 PG4 D 350 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 11.37 50.89 2.29 11.05 51.63 2.25 -55.90 16.99 43.52 -55.53 17.14 44.23 ULMN 3 1ddj_c12 PLASMINOGEN user 27 3 # 27 A 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY C 232 GLY.? 6.26 O2 PO4 C 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.37 50.89 2.29 11.05 51.63 2.25 -40.24 24.30 32.80 -40.26 23.59 32.39 ULMN 3 1ddj_c12 PLASMINOGEN user 28 3 # 28 A 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.37 50.89 2.29 11.05 51.63 2.25 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1ddj_c12 PLASMINOGEN user 29 3 # 29 A 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.37 50.89 2.29 11.05 51.63 2.25 -52.52 37.57 39.17 -53.18 37.10 39.11 ULMN 3 1ddj_c12 PLASMINOGEN user 30 3 # 30 A 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.37 50.89 2.29 11.05 51.63 2.25 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1ddj_c12 PLASMINOGEN user 31 3 # 31 A 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY C 232 GLY.? 6.26 O2 PO4 C 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.37 50.89 2.29 11.05 51.63 2.25 -40.24 24.30 32.80 -40.26 23.59 32.39 ULMN 3 1ddj_c12 PLASMINOGEN user 32 3 # 32 A 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.37 50.89 2.29 11.05 51.63 2.25 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1ddj_c12 PLASMINOGEN user 33 3 # 33 A 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.37 50.89 2.29 11.05 51.63 2.25 -52.52 37.57 39.17 -53.18 37.10 39.11 ULMN 3 1ddj_c12 PLASMINOGEN user 34 3 # 34 A 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.37 50.89 2.29 11.05 51.63 2.25 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1ddj_c12 PLASMINOGEN user 35 3 # 35 A 603 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 646 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 739 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 11.37 50.89 2.29 11.05 51.63 2.25 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1ddj_c12 PLASMINOGEN user 36 3 # 36 A 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 739 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 11.37 50.89 2.29 11.05 51.63 2.25 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1ddj_c12 PLASMINOGEN user 37 3 # 37 A 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 739 GLY D 192 GLY~? 8.57 O1 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 11.37 50.89 2.29 11.05 51.63 2.25 -52.91 16.56 61.94 -52.62 15.79 61.81 ULMN 3 1ddj_c12 PLASMINOGEN user 38 3 # 38 A 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 646 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 739 GLY C 212 GLY~? 9.26 C2 PG4 C 350 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 11.37 50.89 2.29 11.05 51.63 2.25 -34.69 19.16 46.59 -35.10 19.11 45.88 ULMN 3 1ddj_c12 PLASMINOGEN user 39 3 # 39 A 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 646 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 739 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 11.37 50.89 2.29 11.05 51.63 2.25 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1ddj_c12 PLASMINOGEN user 40 3 # 40 A 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 646 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 739 GLY D 192 GLY~? 8.57 O1 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 11.37 50.89 2.29 11.05 51.63 2.25 -52.91 16.56 61.94 -52.62 15.79 61.81 ULMN 3 1ddj_c12 PLASMINOGEN user 41 3 # 41 A 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -40.50 35.55 47.63 -40.37 36.37 47.40 ULMN 3 1ddj_c12 PLASMINOGEN user 42 3 # 42 A 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1ddj_c12 PLASMINOGEN user 43 3 # 43 A 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1ddj_c12 PLASMINOGEN user 44 3 # 44 A 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY D 232 GLY.? 6.31 O1 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -51.56 25.17 56.57 -51.51 24.50 57.04 ULMN 3 1ddj_c12 PLASMINOGEN user 45 3 # 45 A 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -40.50 35.55 47.63 -40.37 36.37 47.40 ULMN 3 1ddj_c12 PLASMINOGEN user 46 3 # 46 A 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1ddj_c12 PLASMINOGEN user 47 3 # 47 A 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1ddj_c12 PLASMINOGEN user 48 3 # 48 A 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY D 232 GLY.? 6.31 O1 PO4 D 349 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -51.56 25.17 56.57 -51.51 24.50 57.04 1ddj_c12 source 1ddj PLASMINOGEN : 48 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 739 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 3.61 55.89 43.73 3.10 55.52 45.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 8.08 50.44 43.84 7.48 51.26 41.98 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 739 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 739 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 646 ASP B 208 ASP~? 8.88 C3 PG4 B 350 B 739 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1ddj_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 646 ASP B 208 ASP~? 8.88 C3 PG4 B 350 B 739 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1ddj_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 1.50 56.90 17.79 2.83 56.38 19.33 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -1.16 62.88 18.52 0.68 62.16 19.33 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1ddj_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 1.50 56.90 17.79 2.83 56.38 19.33 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -1.16 62.88 18.52 0.68 62.16 19.33 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1ddj_c13 PLASMINOGEN user 8 3 # 8 B 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 1.50 56.90 17.79 2.83 56.38 19.33 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -1.16 62.88 18.52 0.68 62.16 19.33 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1ddj_c13 PLASMINOGEN user 9 3 # 9 B 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -1.16 62.88 18.52 0.68 62.16 19.33 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1ddj_c13 PLASMINOGEN user 10 3 # 10 B 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -1.16 62.88 18.52 0.68 62.16 19.33 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1ddj_c13 PLASMINOGEN user 11 3 # 11 B 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -1.16 62.88 18.52 0.68 62.16 19.33 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1ddj_c13 PLASMINOGEN user 12 3 # 12 B 603 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 646 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 739 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1ddj_c13 PLASMINOGEN user 13 3 # 13 B 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 739 GLY B 192 GLY~? 8.75 O2 PO4 B 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 4.63 30.70 8.46 4.46 30.28 9.17 ULMN 3 1ddj_c13 PLASMINOGEN user 14 3 # 14 B 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 739 GLY C 180 GLY.? 8.23 O2 PG4 A 350 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -19.46 28.72 22.15 -20.11 28.91 22.57 ULMN 3 1ddj_c13 PLASMINOGEN user 15 3 # 15 B 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 646 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 739 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1ddj_c13 PLASMINOGEN user 16 3 # 16 B 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1ddj_c13 PLASMINOGEN user 17 3 # 17 B 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1ddj_c13 PLASMINOGEN user 18 3 # 18 B 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 293 GLY.? 20.64 O4 PO4 B 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -15.25 51.43 -1.86 -14.91 51.02 -1.25 ULMN 3 1ddj_c13 PLASMINOGEN user 19 3 # 19 B 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1ddj_c13 PLASMINOGEN user 20 3 # 20 B 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1ddj_c13 PLASMINOGEN user 21 3 # 21 B 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 293 GLY.? 20.64 O4 PO4 B 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -15.25 51.43 -1.86 -14.91 51.02 -1.25 ULMN 3 1ddj_c13 PLASMINOGEN user 22 3 # 22 B 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 739 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1ddj_c13 PLASMINOGEN user 23 3 # 23 B 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 739 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1ddj_c13 PLASMINOGEN user 24 3 # 24 B 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 739 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1ddj_c13 PLASMINOGEN user 25 3 # 25 B 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 646 ASP D 208 ASP~? 8.41 C6 PG4 D 350 B 739 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1ddj_c13 PLASMINOGEN user 26 3 # 26 B 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1ddj_c13 PLASMINOGEN user 27 3 # 27 B 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -52.52 37.57 39.17 -53.18 37.10 39.11 ULMN 3 1ddj_c13 PLASMINOGEN user 28 3 # 28 B 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1ddj_c13 PLASMINOGEN user 29 3 # 29 B 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1ddj_c13 PLASMINOGEN user 30 3 # 30 B 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -52.52 37.57 39.17 -53.18 37.10 39.11 ULMN 3 1ddj_c13 PLASMINOGEN user 31 3 # 31 B 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1ddj_c13 PLASMINOGEN user 32 3 # 32 B 603 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 646 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 739 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1ddj_c13 PLASMINOGEN user 33 3 # 33 B 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 739 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1ddj_c13 PLASMINOGEN user 34 3 # 34 B 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 739 GLY D 192 GLY~? 8.57 O1 PO4 D 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -52.91 16.56 61.94 -52.62 15.79 61.81 ULMN 3 1ddj_c13 PLASMINOGEN user 35 3 # 35 B 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 646 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 739 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1ddj_c13 PLASMINOGEN user 36 3 # 36 B 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -40.50 35.55 47.63 -40.37 36.37 47.40 ULMN 3 1ddj_c13 PLASMINOGEN user 37 3 # 37 B 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1ddj_c13 PLASMINOGEN user 38 3 # 38 B 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1ddj_c13 PLASMINOGEN user 39 3 # 39 B 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY D 189 GLY~? 8.43 O1 PO4 D 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -49.90 16.88 57.52 -50.61 16.53 57.79 ULMN 3 1ddj_c13 PLASMINOGEN user 40 3 # 40 B 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -40.50 35.55 47.63 -40.37 36.37 47.40 ULMN 3 1ddj_c13 PLASMINOGEN user 41 3 # 41 B 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1ddj_c13 PLASMINOGEN user 42 3 # 42 B 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.76 39.68 49.36 -37.98 38.91 49.39 1ddj_c13 source 1ddj PLASMINOGEN : 42 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 C 739 GLY A 86 GLY.? 5.00 C4 PG4 B 350 coo 15.33 59.81 59.60 13.98 60.99 60.69 3.61 55.89 43.73 3.10 55.52 45.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 8.08 50.44 43.84 7.48 51.26 41.98 coo 9.38 49.29 65.28 9.01 50.03 65.31 4.72 44.66 33.63 5.12 45.31 34.00 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 C 739 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 16.06 55.72 54.73 15.97 56.49 56.70 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 9.38 49.29 65.28 9.01 50.03 65.31 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 C 739 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 16.06 55.72 54.73 15.97 56.49 56.70 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 9.38 49.29 65.28 9.01 50.03 65.31 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 C 739 GLY A 192 GLY~? 8.82 O1 PO4 A 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 16.06 55.72 54.73 15.97 56.49 56.70 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 9.38 49.29 65.28 9.01 50.03 65.31 -13.34 54.92 29.80 -13.05 54.30 30.24 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 C 739 GLY B 212 GLY~? 9.26 O1 PG4 B 350 coo 15.33 59.81 59.60 13.98 60.99 60.69 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 16.06 55.72 54.73 15.97 56.49 56.70 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 9.38 49.29 65.28 9.01 50.03 65.31 6.02 46.22 18.32 5.64 45.65 17.83 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 646 ASP B 208 ASP~? 8.88 C3 PG4 B 350 C 739 GLY A 192 GLY~? 8.82 O1 PO4 A 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 16.06 55.72 54.73 15.97 56.49 56.70 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 9.38 49.29 65.28 9.01 50.03 65.31 -13.34 54.92 29.80 -13.05 54.30 30.24 ULMN 3 1ddj_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 739 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 1.50 56.90 17.79 2.83 56.38 19.33 coo 16.06 55.72 54.73 15.97 56.49 56.70 -1.16 62.88 18.52 0.68 62.16 19.33 coo 9.38 49.29 65.28 9.01 50.03 65.31 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1ddj_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 1.50 56.90 17.79 2.83 56.38 19.33 coo 16.06 55.72 54.73 15.97 56.49 56.70 -1.16 62.88 18.52 0.68 62.16 19.33 coo 9.38 49.29 65.28 9.01 50.03 65.31 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1ddj_c14 PLASMINOGEN user 9 3 # 9 C 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 C 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 739 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 16.06 55.72 54.73 15.97 56.49 56.70 -1.16 62.88 18.52 0.68 62.16 19.33 coo 9.38 49.29 65.28 9.01 50.03 65.31 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1ddj_c14 PLASMINOGEN user 10 3 # 10 C 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 C 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 739 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 16.06 55.72 54.73 15.97 56.49 56.70 -1.16 62.88 18.52 0.68 62.16 19.33 coo 9.38 49.29 65.28 9.01 50.03 65.31 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1ddj_c14 PLASMINOGEN user 11 3 # 11 C 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 C 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 16.06 55.72 54.73 15.97 56.49 56.70 -1.16 62.88 18.52 0.68 62.16 19.33 coo 9.38 49.29 65.28 9.01 50.03 65.31 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1ddj_c14 PLASMINOGEN user 12 3 # 12 C 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 C 739 GLY B 192 GLY~? 8.75 O2 PO4 B 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 16.06 55.72 54.73 15.97 56.49 56.70 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 9.38 49.29 65.28 9.01 50.03 65.31 4.63 30.70 8.46 4.46 30.28 9.17 ULMN 3 1ddj_c14 PLASMINOGEN user 13 3 # 13 C 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 646 ASP B 203 ASP~? 9.89 C4 PG4 A 350 C 739 GLY A 212 GLY~? 9.07 O1 PG4 A 350 coo 15.33 59.81 59.60 13.98 60.99 60.69 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 16.06 55.72 54.73 15.97 56.49 56.70 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 9.38 49.29 65.28 9.01 50.03 65.31 -15.16 41.65 16.73 -14.78 42.24 17.11 ULMN 3 1ddj_c14 PLASMINOGEN user 14 3 # 14 C 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 739 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 16.06 55.72 54.73 15.97 56.49 56.70 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 9.38 49.29 65.28 9.01 50.03 65.31 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1ddj_c14 PLASMINOGEN user 15 3 # 15 C 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 739 GLY A 293 GLY.? 20.64 O4 PO4 B 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 16.06 55.72 54.73 15.97 56.49 56.70 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 9.38 49.29 65.28 9.01 50.03 65.31 -15.25 51.43 -1.86 -14.91 51.02 -1.25 ULMN 3 1ddj_c14 PLASMINOGEN user 16 3 # 16 C 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 C 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 739 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 16.06 55.72 54.73 15.97 56.49 56.70 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 9.38 49.29 65.28 9.01 50.03 65.31 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1ddj_c14 PLASMINOGEN user 17 3 # 17 C 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 C 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 739 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 16.06 55.72 54.73 15.97 56.49 56.70 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 9.38 49.29 65.28 9.01 50.03 65.31 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1ddj_c14 PLASMINOGEN user 18 3 # 18 C 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 C 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 739 GLY A 293 GLY.? 20.64 O4 PO4 B 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 16.06 55.72 54.73 15.97 56.49 56.70 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 9.38 49.29 65.28 9.01 50.03 65.31 -15.25 51.43 -1.86 -14.91 51.02 -1.25 ULMN 3 1ddj_c14 PLASMINOGEN user 19 3 # 19 C 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 C 739 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 16.06 55.72 54.73 15.97 56.49 56.70 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 9.38 49.29 65.28 9.01 50.03 65.31 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1ddj_c14 PLASMINOGEN user 20 3 # 20 C 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 C 739 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 16.06 55.72 54.73 15.97 56.49 56.70 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 9.38 49.29 65.28 9.01 50.03 65.31 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1ddj_c14 PLASMINOGEN user 21 3 # 21 C 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 C 739 GLY D 212 GLY~? 8.60 O5 PG4 D 350 coo 15.33 59.81 59.60 13.98 60.99 60.69 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 16.06 55.72 54.73 15.97 56.49 56.70 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 9.38 49.29 65.28 9.01 50.03 65.31 -55.90 16.99 43.52 -55.53 17.14 44.23 ULMN 3 1ddj_c14 PLASMINOGEN user 22 3 # 22 C 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 646 ASP D 208 ASP~? 8.41 C6 PG4 D 350 C 739 GLY C 192 GLY~? 8.67 O2 PO4 C 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 16.06 55.72 54.73 15.97 56.49 56.70 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.38 15.60 28.56 -37.54 14.80 28.74 ULMN 3 1ddj_c14 PLASMINOGEN user 23 3 # 23 C 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 C 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 739 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 16.06 55.72 54.73 15.97 56.49 56.70 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 9.38 49.29 65.28 9.01 50.03 65.31 -52.52 37.57 39.17 -53.18 37.10 39.11 ULMN 3 1ddj_c14 PLASMINOGEN user 24 3 # 24 C 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 C 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 16.06 55.72 54.73 15.97 56.49 56.70 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 9.38 49.29 65.28 9.01 50.03 65.31 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1ddj_c14 PLASMINOGEN user 25 3 # 25 C 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 C 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 739 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 16.06 55.72 54.73 15.97 56.49 56.70 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 9.38 49.29 65.28 9.01 50.03 65.31 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1ddj_c14 PLASMINOGEN user 26 3 # 26 C 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 C 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 739 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 16.06 55.72 54.73 15.97 56.49 56.70 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 9.38 49.29 65.28 9.01 50.03 65.31 -52.52 37.57 39.17 -53.18 37.10 39.11 ULMN 3 1ddj_c14 PLASMINOGEN user 27 3 # 27 C 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 C 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 16.06 55.72 54.73 15.97 56.49 56.70 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 9.38 49.29 65.28 9.01 50.03 65.31 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1ddj_c14 PLASMINOGEN user 28 3 # 28 C 603 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 646 ASP D 90 ASP~? 17.03 C4 PG4 C 350 C 739 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 15.33 59.81 59.60 13.98 60.99 60.69 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 16.06 55.72 54.73 15.97 56.49 56.70 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 9.38 49.29 65.28 9.01 50.03 65.31 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1ddj_c14 PLASMINOGEN user 29 3 # 29 C 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 C 739 GLY D 192 GLY~? 8.57 O1 PO4 D 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 9.38 49.29 65.28 9.01 50.03 65.31 -52.91 16.56 61.94 -52.62 15.79 61.81 ULMN 3 1ddj_c14 PLASMINOGEN user 30 3 # 30 C 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 646 ASP D 203 ASP~? 10.40 O3 PG4 C 350 C 739 GLY C 212 GLY~? 9.26 C2 PG4 C 350 coo 15.33 59.81 59.60 13.98 60.99 60.69 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 16.06 55.72 54.73 15.97 56.49 56.70 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 9.38 49.29 65.28 9.01 50.03 65.31 -34.69 19.16 46.59 -35.10 19.11 45.88 ULMN 3 1ddj_c14 PLASMINOGEN user 31 3 # 31 C 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -40.50 35.55 47.63 -40.37 36.37 47.40 ULMN 3 1ddj_c14 PLASMINOGEN user 32 3 # 32 C 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1ddj_c14 PLASMINOGEN user 33 3 # 33 C 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1ddj_c14 PLASMINOGEN user 34 3 # 34 C 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY D 189 GLY~? 8.43 O1 PO4 D 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -49.90 16.88 57.52 -50.61 16.53 57.79 ULMN 3 1ddj_c14 PLASMINOGEN user 35 3 # 35 C 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -40.50 35.55 47.63 -40.37 36.37 47.40 ULMN 3 1ddj_c14 PLASMINOGEN user 36 3 # 36 C 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1ddj_c14 PLASMINOGEN user 37 3 # 37 C 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo 15.33 59.81 59.60 13.98 60.99 60.69 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -37.76 39.68 49.36 -37.98 38.91 49.39 1ddj_c14 source 1ddj PLASMINOGEN : 37 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 D 739 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 3.61 55.89 43.73 3.10 55.52 45.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 8.08 50.44 43.84 7.48 51.26 41.98 coo -27.66 47.32 40.66 -27.81 47.01 41.41 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 D 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 D 739 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 D 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 D 739 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 D 646 ASP B 208 ASP~? 8.88 C3 PG4 B 350 D 739 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 D 646 ASP B 208 ASP~? 8.88 C3 PG4 B 350 D 739 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 D 646 ASP B 208 ASP~? 8.88 C3 PG4 B 350 D 739 GLY A 192 GLY~? 8.82 O1 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -13.34 54.92 29.80 -13.05 54.30 30.24 ULMN 3 1ddj_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY A 189 GLY~? 8.76 O1 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 1.50 56.90 17.79 2.83 56.38 19.33 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -1.16 62.88 18.52 0.68 62.16 19.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -9.96 51.69 26.75 -10.72 51.67 27.15 ULMN 3 1ddj_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 1.50 56.90 17.79 2.83 56.38 19.33 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -1.16 62.88 18.52 0.68 62.16 19.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1ddj_c15 PLASMINOGEN user 9 3 # 9 D 603 HIS A 238 HIS.? 10.67 O3 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 1.50 56.90 17.79 2.83 56.38 19.33 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -1.16 62.88 18.52 0.68 62.16 19.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1ddj_c15 PLASMINOGEN user 10 3 # 10 D 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -1.16 62.88 18.52 0.68 62.16 19.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1ddj_c15 PLASMINOGEN user 11 3 # 11 D 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -1.16 62.88 18.52 0.68 62.16 19.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1ddj_c15 PLASMINOGEN user 12 3 # 12 D 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -1.16 62.88 18.52 0.68 62.16 19.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1ddj_c15 PLASMINOGEN user 13 3 # 13 D 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 739 GLY B 192 GLY~? 8.75 O2 PO4 B 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -27.66 47.32 40.66 -27.81 47.01 41.41 4.63 30.70 8.46 4.46 30.28 9.17 ULMN 3 1ddj_c15 PLASMINOGEN user 14 3 # 14 D 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 739 GLY C 180 GLY.? 8.23 O2 PG4 A 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -19.46 28.72 22.15 -20.11 28.91 22.57 ULMN 3 1ddj_c15 PLASMINOGEN user 15 3 # 15 D 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 646 ASP B 203 ASP~? 9.89 C4 PG4 A 350 D 739 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1ddj_c15 PLASMINOGEN user 16 3 # 16 D 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 739 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1ddj_c15 PLASMINOGEN user 17 3 # 17 D 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 739 GLY A 293 GLY.? 20.64 O4 PO4 B 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -15.25 51.43 -1.86 -14.91 51.02 -1.25 ULMN 3 1ddj_c15 PLASMINOGEN user 18 3 # 18 D 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 739 GLY B 189 GLY~? 8.50 O2 PO4 B 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -27.66 47.32 40.66 -27.81 47.01 41.41 1.22 33.78 11.00 2.03 33.50 11.09 ULMN 3 1ddj_c15 PLASMINOGEN user 19 3 # 19 D 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 D 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 739 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1ddj_c15 PLASMINOGEN user 20 3 # 20 D 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 D 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 739 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1ddj_c15 PLASMINOGEN user 21 3 # 21 D 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 D 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 739 GLY A 293 GLY.? 20.64 O4 PO4 B 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -15.25 51.43 -1.86 -14.91 51.02 -1.25 ULMN 3 1ddj_c15 PLASMINOGEN user 22 3 # 22 D 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 D 739 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 1ddj_c15 PLASMINOGEN user 23 3 # 23 D 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 D 739 GLY C 86 GLY.? 4.20 C5 PG4 D 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -53.55 4.02 36.09 -53.97 4.11 35.35 ULMN 3 1ddj_c15 PLASMINOGEN user 24 3 # 24 D 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 D 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 D 739 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1ddj_c15 PLASMINOGEN user 25 3 # 25 D 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 D 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 D 739 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1ddj_c15 PLASMINOGEN user 26 3 # 26 D 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 D 646 ASP D 208 ASP~? 8.41 C6 PG4 D 350 D 739 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1ddj_c15 PLASMINOGEN user 27 3 # 27 D 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 D 646 ASP D 208 ASP~? 8.41 C6 PG4 D 350 D 739 GLY C 192 GLY~? 8.67 O2 PO4 C 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -37.38 15.60 28.56 -37.54 14.80 28.74 ULMN 3 1ddj_c15 PLASMINOGEN user 28 3 # 28 D 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY C 189 GLY~? 8.64 O2 PO4 C 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -40.49 15.78 32.96 -39.70 15.56 32.71 ULMN 3 1ddj_c15 PLASMINOGEN user 29 3 # 29 D 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -52.52 37.57 39.17 -53.18 37.10 39.11 ULMN 3 1ddj_c15 PLASMINOGEN user 30 3 # 30 D 603 HIS C 238 HIS.? 10.74 O3 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1ddj_c15 PLASMINOGEN user 31 3 # 31 D 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1ddj_c15 PLASMINOGEN user 32 3 # 32 D 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -52.52 37.57 39.17 -53.18 37.10 39.11 ULMN 3 1ddj_c15 PLASMINOGEN user 33 3 # 33 D 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1ddj_c15 PLASMINOGEN user 34 3 # 34 D 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 739 GLY D 192 GLY~? 8.57 O1 PO4 D 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -52.91 16.56 61.94 -52.62 15.79 61.81 ULMN 3 1ddj_c15 PLASMINOGEN user 35 3 # 35 D 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 739 GLY D 199 GLY.? 13.68 O5 PG4 D 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -57.03 13.69 56.19 -56.77 12.88 56.00 ULMN 3 1ddj_c15 PLASMINOGEN user 36 3 # 36 D 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 646 ASP D 203 ASP~? 10.40 O3 PG4 C 350 D 739 GLY D 199 GLY.? 13.68 O5 PG4 D 350 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -57.03 13.69 56.19 -56.77 12.88 56.00 ULMN 3 1ddj_c15 PLASMINOGEN user 37 3 # 37 D 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1ddj_c15 PLASMINOGEN user 38 3 # 38 D 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1ddj_c15 PLASMINOGEN user 39 3 # 39 D 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY D 189 GLY~? 8.43 O1 PO4 D 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -49.90 16.88 57.52 -50.61 16.53 57.79 ULMN 3 1ddj_c15 PLASMINOGEN user 40 3 # 40 D 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -40.50 35.55 47.63 -40.37 36.37 47.40 ULMN 3 1ddj_c15 PLASMINOGEN user 41 3 # 41 D 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1ddj_c15 PLASMINOGEN user 42 3 # 42 D 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -37.76 39.68 49.36 -37.98 38.91 49.39 1ddj_c15 source 1ddj PLASMINOGEN : 42 hits 1ddj_c15 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS B 321 HIS~? 21.63 O4 PO4 B 349 A 96 GLU B 325 GLU~? 19.47 O4 PO4 B 349 A 137 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 1.83 2.95 4.76 1.26 0.98 4.81 -8.21 43.10 -17.57 -9.89 44.30 -17.19 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -7.86 48.35 -14.01 -8.88 47.03 -12.75 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 2 3 # 2 A 50 HIS C 321 HIS~? 21.29 O1 PO4 C 349 A 96 GLU C 325 GLU~? 19.31 O1 PO4 C 349 A 137 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 1.83 2.95 4.76 1.26 0.98 4.81 -50.23 42.88 20.64 -51.67 43.34 22.10 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -49.52 44.21 26.45 -50.31 42.24 26.60 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -48.83 33.87 26.09 -50.85 34.38 25.82 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 3 3 # 3 A 50 HIS D 321 HIS~? 21.61 O4 PO4 D 349 A 96 GLU D 325 GLU~? 19.00 O4 PO4 D 349 A 137 HIS D 260 HIS^? 11.65 O4 PO4 D 349 coo 1.83 2.95 4.76 1.26 0.98 4.81 -44.81 46.75 66.01 -43.36 47.24 64.57 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -45.65 46.55 59.76 -44.68 44.67 59.92 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -44.73 36.67 61.75 -42.79 37.49 61.80 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 3 hits 1de3_c00 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 215 GLU~? 13.07 C2 PG4 A 350 A 226 THR C 331 THR^? 16.46 O1 PO4 C 349 A 229 LYS C 316 LYS~? 23.27 O4 PO4 C 349 coo 9.66 102.78 70.07 9.79 101.18 71.42 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 7.24 97.46 49.60 8.11 95.69 48.80 -39.89 36.19 19.34 -38.09 35.37 18.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 -44.69 38.73 13.31 -40.21 38.10 9.89 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU B 51 GLU~? 23.52 O3 PO4 B 349 A 226 THR B 307 THR.? 14.53 O3 PO4 B 349 A 229 LYS B 316 LYS~? 24.20 O3 PO4 B 349 coo 9.66 102.78 70.07 9.79 101.18 71.42 -3.55 11.69 -8.83 -2.89 12.70 -10.57 coo 7.24 97.46 49.60 8.11 95.69 48.80 -4.70 32.82 -11.47 -3.25 33.55 -12.93 coo 10.53 97.56 43.71 9.33 93.71 47.17 -2.04 35.41 -19.34 2.27 31.66 -22.14 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 215 GLU~? 13.07 C2 PG4 A 350 B 226 THR C 331 THR^? 16.46 O1 PO4 C 349 B 229 LYS C 316 LYS~? 23.27 O4 PO4 C 349 coo 15.90 87.61 49.61 13.92 86.96 49.36 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 20.74 95.78 68.68 19.29 96.84 69.83 -39.89 36.19 19.34 -38.09 35.37 18.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 -44.69 38.73 13.31 -40.21 38.10 9.89 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 215 GLU~? 13.07 C2 PG4 A 350 C 226 THR C 331 THR^? 16.46 O1 PO4 C 349 C 229 LYS C 316 LYS~? 23.27 O4 PO4 C 349 coo 5.43 40.40 61.63 4.27 41.99 60.90 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 22.16 45.88 73.63 23.23 47.70 73.25 -39.89 36.19 19.34 -38.09 35.37 18.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 -44.69 38.73 13.31 -40.21 38.10 9.89 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 215 GLU~? 13.07 C2 PG4 A 350 D 226 THR C 331 THR^? 16.46 O1 PO4 C 349 D 229 LYS C 316 LYS~? 23.27 O4 PO4 C 349 coo 26.07 55.89 66.14 25.33 56.50 68.01 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 11.79 47.62 52.67 10.10 46.51 53.39 -39.89 36.19 19.34 -38.09 35.37 18.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 -44.69 38.73 13.31 -40.21 38.10 9.89 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 200 ASP B 198 ASP.? 14.38 O1 PG4 B 350 A 229 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 1.13 77.49 40.64 0.62 75.57 39.98 11.38 38.70 0.79 12.71 38.99 -0.80 coo 0.84 91.24 49.01 2.91 91.61 49.23 11.89 31.57 14.26 12.37 32.72 16.00 coo 10.53 97.56 43.71 9.33 93.71 47.17 1.49 32.28 22.12 4.07 30.52 27.68 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 200 ASP B 198 ASP.? 14.38 O1 PG4 B 350 B 229 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 9.24 94.26 88.22 8.02 94.07 89.92 11.38 38.70 0.79 12.71 38.99 -0.80 coo 17.54 90.31 75.01 17.17 92.01 73.80 11.89 31.57 14.26 12.37 32.72 16.00 coo 22.32 101.61 71.64 17.89 98.63 71.55 1.49 32.28 22.12 4.07 30.52 27.68 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS B 229 HIS^? 14.08 O2 PO4 B 349 C 200 ASP B 198 ASP.? 14.38 O1 PG4 B 350 C 229 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 26.77 65.84 83.49 27.06 67.76 84.27 11.38 38.70 0.79 12.71 38.99 -0.80 coo 19.52 52.01 79.59 20.28 51.65 77.65 11.89 31.57 14.26 12.37 32.72 16.00 coo 28.90 45.91 73.55 25.22 49.72 72.97 1.49 32.28 22.12 4.07 30.52 27.68 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS B 229 HIS^? 14.08 O2 PO4 B 349 D 200 ASP B 198 ASP.? 14.38 O1 PG4 B 350 D 229 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo -10.90 48.74 53.41 -12.98 48.90 53.67 11.38 38.70 0.79 12.71 38.99 -0.80 coo 4.60 52.95 52.50 5.57 51.29 53.40 11.89 31.57 14.26 12.37 32.72 16.00 coo 10.05 41.79 49.80 7.94 44.71 53.76 1.49 32.28 22.12 4.07 30.52 27.68 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 24 THR~? 10.16 O3 PO4 A 349 A 45 THR A 191 THR~? 7.95 O1 PO4 A 349 A 161 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 26.16 88.25 79.16 25.22 89.47 80.71 -5.47 57.24 33.63 -5.78 55.06 33.56 coo 27.73 89.90 76.08 29.24 91.46 75.95 -9.97 54.73 31.48 -8.80 56.54 31.46 coo 33.83 91.15 88.62 31.07 91.06 83.02 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 191 THR~? 7.95 O1 PO4 A 349 A 45 THR A 24 THR~? 10.16 O3 PO4 A 349 A 161 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 26.16 88.25 79.16 25.22 89.47 80.71 -9.97 54.73 31.48 -8.80 56.54 31.46 coo 27.73 89.90 76.08 29.24 91.46 75.95 -5.47 57.24 33.63 -5.78 55.06 33.56 coo 33.83 91.15 88.62 31.07 91.06 83.02 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR B 24 THR~? 10.13 O1 PO4 B 349 A 45 THR B 191 THR~? 8.03 O2 PO4 B 349 A 161 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 26.16 88.25 79.16 25.22 89.47 80.71 -2.45 25.09 7.36 -2.25 25.71 9.46 coo 27.73 89.90 76.08 29.24 91.46 75.95 1.66 28.50 9.29 0.44 28.02 7.58 coo 33.83 91.15 88.62 31.07 91.06 83.02 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR B 191 THR~? 8.03 O2 PO4 B 349 A 45 THR B 24 THR~? 10.13 O1 PO4 B 349 A 161 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 26.16 88.25 79.16 25.22 89.47 80.71 1.66 28.50 9.29 0.44 28.02 7.58 coo 27.73 89.90 76.08 29.24 91.46 75.95 -2.45 25.09 7.36 -2.25 25.71 9.46 coo 33.83 91.15 88.62 31.07 91.06 83.02 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR B 244 THR~? 10.49 O4 PO4 B 349 A 45 THR B 242 THR.? 14.01 C2 PG4 A 350 A 161 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 26.16 88.25 79.16 25.22 89.47 80.71 -2.27 44.71 7.93 -2.99 44.80 5.89 coo 27.73 89.90 76.08 29.24 91.46 75.95 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 33.83 91.15 88.62 31.07 91.06 83.02 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR C 191 THR~? 8.00 O2 PO4 C 349 A 45 THR C 24 THR~? 10.28 O3 PO4 C 349 A 161 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 26.16 88.25 79.16 25.22 89.47 80.71 -40.48 13.53 27.76 -41.93 14.27 26.36 coo 27.73 89.90 76.08 29.24 91.46 75.95 -45.29 12.37 24.95 -44.75 11.19 26.72 coo 33.83 91.15 88.62 31.07 91.06 83.02 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 A 44 THR D 24 THR~? 11.02 O3 PO4 D 349 A 45 THR D 191 THR~? 7.89 O1 PO4 D 349 A 161 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 26.16 88.25 79.16 25.22 89.47 80.71 -45.56 14.64 66.69 -45.66 13.25 65.02 coo 27.73 89.90 76.08 29.24 91.46 75.95 -49.48 15.22 62.89 -48.24 16.38 64.26 coo 33.83 91.15 88.62 31.07 91.06 83.02 -50.59 27.20 61.67 -46.47 26.50 58.89 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 A 44 THR D 191 THR~? 7.89 O1 PO4 D 349 A 45 THR D 24 THR~? 11.02 O3 PO4 D 349 A 161 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 26.16 88.25 79.16 25.22 89.47 80.71 -49.48 15.22 62.89 -48.24 16.38 64.26 coo 27.73 89.90 76.08 29.24 91.46 75.95 -45.56 14.64 66.69 -45.66 13.25 65.02 coo 33.83 91.15 88.62 31.07 91.06 83.02 -50.59 27.20 61.67 -46.47 26.50 58.89 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 8 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 24 THR~? 10.16 O3 PO4 A 349 B 45 THR A 191 THR~? 7.95 O1 PO4 A 349 B 161 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 7.39 128.28 94.56 8.34 126.36 94.79 -5.47 57.24 33.63 -5.78 55.06 33.56 coo 5.75 129.25 91.25 4.29 128.16 90.07 -9.97 54.73 31.48 -8.80 56.54 31.46 coo -0.17 119.75 99.65 2.51 123.83 95.70 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 191 THR~? 7.95 O1 PO4 A 349 B 45 THR A 24 THR~? 10.16 O3 PO4 A 349 B 161 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 7.39 128.28 94.56 8.34 126.36 94.79 -9.97 54.73 31.48 -8.80 56.54 31.46 coo 5.75 129.25 91.25 4.29 128.16 90.07 -5.47 57.24 33.63 -5.78 55.06 33.56 coo -0.17 119.75 99.65 2.51 123.83 95.70 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR B 24 THR~? 10.13 O1 PO4 B 349 B 45 THR B 191 THR~? 8.03 O2 PO4 B 349 B 161 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 7.39 128.28 94.56 8.34 126.36 94.79 -2.45 25.09 7.36 -2.25 25.71 9.46 coo 5.75 129.25 91.25 4.29 128.16 90.07 1.66 28.50 9.29 0.44 28.02 7.58 coo -0.17 119.75 99.65 2.51 123.83 95.70 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR B 191 THR~? 8.03 O2 PO4 B 349 B 45 THR B 24 THR~? 10.13 O1 PO4 B 349 B 161 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 7.39 128.28 94.56 8.34 126.36 94.79 1.66 28.50 9.29 0.44 28.02 7.58 coo 5.75 129.25 91.25 4.29 128.16 90.07 -2.45 25.09 7.36 -2.25 25.71 9.46 coo -0.17 119.75 99.65 2.51 123.83 95.70 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR B 244 THR~? 10.49 O4 PO4 B 349 B 45 THR B 242 THR.? 14.01 C2 PG4 A 350 B 161 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 7.39 128.28 94.56 8.34 126.36 94.79 -2.27 44.71 7.93 -2.99 44.80 5.89 coo 5.75 129.25 91.25 4.29 128.16 90.07 -6.70 44.34 11.61 -7.01 44.85 13.75 coo -0.17 119.75 99.65 2.51 123.83 95.70 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR C 191 THR~? 8.00 O2 PO4 C 349 B 45 THR C 24 THR~? 10.28 O3 PO4 C 349 B 161 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 7.39 128.28 94.56 8.34 126.36 94.79 -40.48 13.53 27.76 -41.93 14.27 26.36 coo 5.75 129.25 91.25 4.29 128.16 90.07 -45.29 12.37 24.95 -44.75 11.19 26.72 coo -0.17 119.75 99.65 2.51 123.83 95.70 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 B 44 THR D 24 THR~? 11.02 O3 PO4 D 349 B 45 THR D 191 THR~? 7.89 O1 PO4 D 349 B 161 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 7.39 128.28 94.56 8.34 126.36 94.79 -45.56 14.64 66.69 -45.66 13.25 65.02 coo 5.75 129.25 91.25 4.29 128.16 90.07 -49.48 15.22 62.89 -48.24 16.38 64.26 coo -0.17 119.75 99.65 2.51 123.83 95.70 -50.59 27.20 61.67 -46.47 26.50 58.89 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 B 44 THR D 191 THR~? 7.89 O1 PO4 D 349 B 45 THR D 24 THR~? 11.02 O3 PO4 D 349 B 161 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 7.39 128.28 94.56 8.34 126.36 94.79 -49.48 15.22 62.89 -48.24 16.38 64.26 coo 5.75 129.25 91.25 4.29 128.16 90.07 -45.56 14.64 66.69 -45.66 13.25 65.02 coo -0.17 119.75 99.65 2.51 123.83 95.70 -50.59 27.20 61.67 -46.47 26.50 58.89 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 8 hits 1dhp_c03 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 221 TYR~? 17.25 O1 PG4 A 350 150 LYS A 184 LYS^? 18.49 O1 PO4 A 349 186 ASN C 348 ASN.? 21.93 O1 PG4 A 350 coo 32.88 50.55 24.33 31.89 51.78 26.65 -24.98 48.97 24.49 -23.82 47.69 26.70 coo 27.04 52.42 22.30 26.88 49.99 27.00 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 36.98 50.30 37.29 35.85 50.29 35.50 -30.06 39.54 32.39 -31.15 40.21 34.08 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR C 225 TYR~? 18.05 C6 PG4 A 350 150 LYS C 223 LYS~? 21.04 C2 PG4 C 350 186 ASN A 138 ASN.? -6.13 O2 PG4 A 350s coo 32.88 50.55 24.33 31.89 51.78 26.65 -22.42 22.90 31.89 -22.15 20.23 31.17 coo 27.04 52.42 22.30 26.88 49.99 27.00 -19.98 24.16 38.56 -19.29 22.78 44.77 coo 36.98 50.30 37.29 35.85 50.29 35.50 -17.89 33.84 23.48 -17.76 31.89 24.26 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 2 hits 1dhr_c00 naa= 3 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 1 3 # 1 A 222 TYR A 225 TYR.? 21.13 O1 PO4 A 349 A 238 ASP A 226 ASP.? 25.19 O1 PO4 A 349 A 272 TRP A 181 TRP.? 23.95 O1 PO4 A 349 coo -17.92 42.46 111.37 -18.35 40.11 109.91 -28.82 53.90 23.23 -28.73 53.13 25.91 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -31.23 58.08 18.66 -33.23 57.82 19.18 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -32.91 63.91 20.46 -30.26 66.07 18.54 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 2 3 # 2 A 222 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 238 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 272 TRP B 181 TRP.? 23.33 O2 PO4 B 349 coo -17.92 42.46 111.37 -18.35 40.11 109.91 19.22 39.10 5.74 19.70 36.67 7.05 coo -25.50 44.84 112.68 -25.52 43.37 111.17 20.38 42.79 0.27 22.43 42.38 0.23 coo -27.19 39.29 113.01 -23.27 39.61 112.78 20.38 42.01 -3.47 18.74 41.76 -7.01 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 3 3 # 3 A 222 TYR C 225 TYR~? 18.05 C6 PG4 A 350 A 238 ASP C 226 ASP.? 11.40 C1 PG4 A 350 A 272 TRP C 181 TRP.? 10.24 C1 PG4 A 350 coo -17.92 42.46 111.37 -18.35 40.11 109.91 -22.42 22.90 31.89 -22.15 20.23 31.17 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -21.22 29.31 30.63 -19.17 29.03 30.27 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -23.22 31.17 24.81 -20.89 33.85 26.48 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 4 3 # 4 A 222 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 238 ASP D 226 ASP.? 25.08 O1 PO4 D 349 A 272 TRP D 181 TRP.? 23.46 O1 PO4 D 349 coo -17.92 42.46 111.37 -18.35 40.11 109.91 -68.84 20.67 57.80 -68.69 18.14 58.96 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -71.26 26.87 58.29 -73.26 26.34 58.61 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -69.65 29.97 63.31 -72.25 31.63 60.90 1diz_c00 source 1diz 3-METHYLADENINE DNA GLYCOSYLASE II : 4 hits 1diz_c00 naa= 3 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 1 3 # 1 B 222 TYR A 225 TYR.? 21.13 O1 PO4 A 349 B 238 ASP A 226 ASP.? 25.19 O1 PO4 A 349 B 272 TRP A 181 TRP.? 23.95 O1 PO4 A 349 coo 17.91 42.42 121.64 18.26 40.06 123.11 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 25.38 44.99 120.20 25.38 43.50 121.71 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 27.19 39.35 120.02 23.28 39.60 120.23 -32.91 63.91 20.46 -30.26 66.07 18.54 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 2 3 # 2 B 222 TYR C 225 TYR~? 18.05 C6 PG4 A 350 B 238 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 272 TRP C 181 TRP.? 10.24 C1 PG4 A 350 coo 17.91 42.42 121.64 18.26 40.06 123.11 -22.42 22.90 31.89 -22.15 20.23 31.17 coo 25.38 44.99 120.20 25.38 43.50 121.71 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 27.19 39.35 120.02 23.28 39.60 120.23 -23.22 31.17 24.81 -20.89 33.85 26.48 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 3 3 # 3 B 222 TYR D 225 TYR.? 21.05 O1 PO4 D 349 B 238 ASP D 226 ASP.? 25.08 O1 PO4 D 349 B 272 TRP D 181 TRP.? 23.46 O1 PO4 D 349 coo 17.91 42.42 121.64 18.26 40.06 123.11 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 25.38 44.99 120.20 25.38 43.50 121.71 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 27.19 39.35 120.02 23.28 39.60 120.23 -69.65 29.97 63.31 -72.25 31.63 60.90 1diz_c01 source 1diz 3-METHYLADENINE DNA GLYCOSYLASE II : 3 hits 1diz_c01 naa= 3 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 1 3 # 1 A 48 ALA A 204 ALA~? 8.46 C8 PG4 B 350 A 52 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 191 TRP A 130 TRP^? 16.11 O1 PG4 A 350 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -5.64 44.18 25.28 -6.10 44.17 26.72 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -12.75 44.26 36.25 -14.22 47.86 35.68 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 2 3 # 2 A 48 ALA B 204 ALA~? 7.34 O5 PG4 A 350 A 52 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 191 TRP B 130 TRP^? 14.98 O5 PG4 B 350 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -2.79 36.37 18.37 -2.26 34.97 18.59 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -12.27 21.19 4.26 -8.94 21.66 2.22 5.35 26.39 20.25 6.70 26.34 16.54 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 3 3 # 3 A 48 ALA C 204 ALA~? 8.41 C1 PG4 D 350 A 52 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 191 TRP C 130 TRP^? 16.08 O1 PG4 C 350 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -43.72 12.08 40.27 -43.19 10.95 39.41 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -35.90 3.97 33.18 -35.19 6.75 30.48 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 4 3 # 4 A 48 ALA D 204 ALA~? 8.16 C7 PG4 C 350 A 52 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 191 TRP D 130 TRP^? 15.64 O5 PG4 D 350 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -45.88 12.76 50.82 -46.11 11.67 51.84 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -53.23 4.77 58.11 -54.46 7.60 60.55 1dj1_c00 source 1dj1 CYTOCHROME C PEROXIDASE : 4 hits 1dj1_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 221 TYR~? 17.25 O1 PG4 A 350 A 183 LYS A 184 LYS^? 18.49 O1 PO4 A 349 A 278 ASP A 226 ASP.? 25.19 O1 PO4 A 349 coo 19.43 18.53 42.32 17.66 18.80 40.15 -24.98 48.97 24.49 -23.82 47.69 26.70 coo 21.92 15.80 36.19 17.64 19.44 36.35 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 15.46 19.03 31.40 15.01 18.25 33.31 -31.23 58.08 18.66 -33.23 57.82 19.18 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR B 221 TYR~? 17.66 O1 PG4 B 350 A 183 LYS B 184 LYS^? 17.27 O2 PO4 B 349 A 278 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 19.43 18.53 42.32 17.66 18.80 40.15 16.24 38.44 11.23 15.50 36.34 12.94 coo 21.92 15.80 36.19 17.64 19.44 36.35 15.36 36.70 4.47 15.17 34.16 8.91 coo 15.46 19.03 31.40 15.01 18.25 33.31 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR B 221 TYR~? 17.66 O1 PG4 B 350 A 183 LYS B 223 LYS~? 20.96 O1 PG4 B 350 A 278 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 19.43 18.53 42.32 17.66 18.80 40.15 16.24 38.44 11.23 15.50 36.34 12.94 coo 21.92 15.80 36.19 17.64 19.44 36.35 21.08 44.90 9.51 21.11 48.16 14.97 coo 15.46 19.03 31.40 15.01 18.25 33.31 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR C 221 TYR~? 17.74 O1 PG4 C 350 A 183 LYS C 184 LYS^? 18.13 O2 PO4 C 349 A 278 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 19.43 18.53 42.32 17.66 18.80 40.15 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 21.92 15.80 36.19 17.64 19.44 36.35 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 15.46 19.03 31.40 15.01 18.25 33.31 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1do8_c00 MALIC ENZYME user 5 3 # 5 A 112 TYR C 221 TYR~? 17.74 O1 PG4 C 350 A 183 LYS C 223 LYS~? 21.04 C2 PG4 C 350 A 278 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 19.43 18.53 42.32 17.66 18.80 40.15 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 21.92 15.80 36.19 17.64 19.44 36.35 -19.98 24.16 38.56 -19.29 22.78 44.77 coo 15.46 19.03 31.40 15.01 18.25 33.31 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1do8_c00 MALIC ENZYME user 6 3 # 6 A 112 TYR D 221 TYR~? 17.09 O5 PG4 D 350 A 183 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 278 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo 19.43 18.53 42.32 17.66 18.80 40.15 -65.63 16.43 54.69 -64.60 13.90 55.16 coo 21.92 15.80 36.19 17.64 19.44 36.35 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 15.46 19.03 31.40 15.01 18.25 33.31 -71.26 26.87 58.29 -73.26 26.34 58.61 1do8_c00 source 1do8 MALIC ENZYME : 6 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 221 TYR~? 17.25 O1 PG4 A 350 B 183 LYS A 184 LYS^? 18.49 O1 PO4 A 349 B 278 ASP A 226 ASP.? 25.19 O1 PO4 A 349 coo 58.62 15.99 58.34 60.98 14.60 58.93 -24.98 48.97 24.49 -23.82 47.69 26.70 coo 60.11 10.60 53.63 62.59 10.74 58.67 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 66.50 7.32 58.45 66.26 9.42 58.23 -31.23 58.08 18.66 -33.23 57.82 19.18 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR B 221 TYR~? 17.66 O1 PG4 B 350 B 183 LYS B 184 LYS^? 17.27 O2 PO4 B 349 B 278 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 58.62 15.99 58.34 60.98 14.60 58.93 16.24 38.44 11.23 15.50 36.34 12.94 coo 60.11 10.60 53.63 62.59 10.74 58.67 15.36 36.70 4.47 15.17 34.16 8.91 coo 66.50 7.32 58.45 66.26 9.42 58.23 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR B 221 TYR~? 17.66 O1 PG4 B 350 B 183 LYS B 223 LYS~? 20.96 O1 PG4 B 350 B 278 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 58.62 15.99 58.34 60.98 14.60 58.93 16.24 38.44 11.23 15.50 36.34 12.94 coo 60.11 10.60 53.63 62.59 10.74 58.67 21.08 44.90 9.51 21.11 48.16 14.97 coo 66.50 7.32 58.45 66.26 9.42 58.23 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR C 221 TYR~? 17.74 O1 PG4 C 350 B 183 LYS C 184 LYS^? 18.13 O2 PO4 C 349 B 278 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 58.62 15.99 58.34 60.98 14.60 58.93 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 60.11 10.60 53.63 62.59 10.74 58.67 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 66.50 7.32 58.45 66.26 9.42 58.23 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1do8_c01 MALIC ENZYME user 5 3 # 5 B 112 TYR C 221 TYR~? 17.74 O1 PG4 C 350 B 183 LYS C 223 LYS~? 21.04 C2 PG4 C 350 B 278 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 58.62 15.99 58.34 60.98 14.60 58.93 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 60.11 10.60 53.63 62.59 10.74 58.67 -19.98 24.16 38.56 -19.29 22.78 44.77 coo 66.50 7.32 58.45 66.26 9.42 58.23 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1do8_c01 MALIC ENZYME user 6 3 # 6 B 112 TYR D 221 TYR~? 17.09 O5 PG4 D 350 B 183 LYS D 184 LYS^? 18.69 O1 PO4 D 349 B 278 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo 58.62 15.99 58.34 60.98 14.60 58.93 -65.63 16.43 54.69 -64.60 13.90 55.16 coo 60.11 10.60 53.63 62.59 10.74 58.67 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 66.50 7.32 58.45 66.26 9.42 58.23 -71.26 26.87 58.29 -73.26 26.34 58.61 1do8_c01 source 1do8 MALIC ENZYME : 6 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 221 TYR~? 17.25 O1 PG4 A 350 C 183 LYS A 184 LYS^? 18.49 O1 PO4 A 349 C 278 ASP A 226 ASP.? 25.19 O1 PO4 A 349 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -24.98 48.97 24.49 -23.82 47.69 26.70 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -31.23 58.08 18.66 -33.23 57.82 19.18 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR B 221 TYR~? 17.66 O1 PG4 B 350 C 183 LYS B 184 LYS^? 17.27 O2 PO4 B 349 C 278 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 16.24 38.44 11.23 15.50 36.34 12.94 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 15.36 36.70 4.47 15.17 34.16 8.91 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR B 221 TYR~? 17.66 O1 PG4 B 350 C 183 LYS B 223 LYS~? 20.96 O1 PG4 B 350 C 278 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 16.24 38.44 11.23 15.50 36.34 12.94 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 21.08 44.90 9.51 21.11 48.16 14.97 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR C 221 TYR~? 17.74 O1 PG4 C 350 C 183 LYS C 184 LYS^? 18.13 O2 PO4 C 349 C 278 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1do8_c02 MALIC ENZYME user 5 3 # 5 C 112 TYR C 221 TYR~? 17.74 O1 PG4 C 350 C 183 LYS C 223 LYS~? 21.04 C2 PG4 C 350 C 278 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -19.98 24.16 38.56 -19.29 22.78 44.77 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1do8_c02 MALIC ENZYME user 6 3 # 6 C 112 TYR D 221 TYR~? 17.09 O5 PG4 D 350 C 183 LYS D 184 LYS^? 18.69 O1 PO4 D 349 C 278 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -65.63 16.43 54.69 -64.60 13.90 55.16 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -71.26 26.87 58.29 -73.26 26.34 58.61 1do8_c02 source 1do8 MALIC ENZYME : 6 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 221 TYR~? 17.25 O1 PG4 A 350 D 183 LYS A 184 LYS^? 18.49 O1 PO4 A 349 D 278 ASP A 226 ASP.? 25.19 O1 PO4 A 349 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -24.98 48.97 24.49 -23.82 47.69 26.70 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -31.23 58.08 18.66 -33.23 57.82 19.18 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR B 221 TYR~? 17.66 O1 PG4 B 350 D 183 LYS B 184 LYS^? 17.27 O2 PO4 B 349 D 278 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 16.24 38.44 11.23 15.50 36.34 12.94 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 15.36 36.70 4.47 15.17 34.16 8.91 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR B 221 TYR~? 17.66 O1 PG4 B 350 D 183 LYS B 223 LYS~? 20.96 O1 PG4 B 350 D 278 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 16.24 38.44 11.23 15.50 36.34 12.94 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 21.08 44.90 9.51 21.11 48.16 14.97 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR C 221 TYR~? 17.74 O1 PG4 C 350 D 183 LYS C 184 LYS^? 18.13 O2 PO4 C 349 D 278 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1do8_c03 MALIC ENZYME user 5 3 # 5 D 112 TYR C 221 TYR~? 17.74 O1 PG4 C 350 D 183 LYS C 223 LYS~? 21.04 C2 PG4 C 350 D 278 ASP C 226 ASP.? 11.40 C1 PG4 A 350 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -19.98 24.16 38.56 -19.29 22.78 44.77 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -21.22 29.31 30.63 -19.17 29.03 30.27 ULMN 3 1do8_c03 MALIC ENZYME user 6 3 # 6 D 112 TYR D 221 TYR~? 17.09 O5 PG4 D 350 D 183 LYS D 184 LYS^? 18.69 O1 PO4 D 349 D 278 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -65.63 16.43 54.69 -64.60 13.90 55.16 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -71.26 26.87 58.29 -73.26 26.34 58.61 1do8_c03 source 1do8 MALIC ENZYME : 6 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 E 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 E 193 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 3.61 55.89 43.73 3.10 55.52 45.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 8.08 50.44 43.84 7.48 51.26 41.98 coo 4.57 20.60 30.29 4.74 21.36 30.66 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 E 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 E 193 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 3.61 55.89 43.73 3.10 55.52 45.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 8.08 50.44 43.84 7.48 51.26 41.98 coo 4.57 20.60 30.29 4.74 21.36 30.66 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 E 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 E 193 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 3.61 55.89 43.73 3.10 55.52 45.73 coo 10.90 32.83 25.96 10.83 30.68 25.98 8.08 50.44 43.84 7.48 51.26 41.98 coo 4.57 20.60 30.29 4.74 21.36 30.66 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 E 102 ASP A 203 ASP~? 10.68 C3 PG4 B 350 E 193 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 10.90 32.83 25.96 10.83 30.68 25.98 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 4.57 20.60 30.29 4.74 21.36 30.66 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 5 3 # 5 E 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 E 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 E 193 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.90 32.83 25.96 10.83 30.68 25.98 -1.16 62.88 18.52 0.68 62.16 19.33 coo 4.57 20.60 30.29 4.74 21.36 30.66 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 6 3 # 6 E 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 E 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 E 193 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.90 32.83 25.96 10.83 30.68 25.98 -1.16 62.88 18.52 0.68 62.16 19.33 coo 4.57 20.60 30.29 4.74 21.36 30.66 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 7 3 # 7 E 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 E 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 E 193 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 10.90 32.83 25.96 10.83 30.68 25.98 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 4.57 20.60 30.29 4.74 21.36 30.66 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 8 3 # 8 E 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 E 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 E 193 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 10.90 32.83 25.96 10.83 30.68 25.98 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 4.57 20.60 30.29 4.74 21.36 30.66 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 9 3 # 9 E 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 E 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 E 193 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 10.90 32.83 25.96 10.83 30.68 25.98 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 4.57 20.60 30.29 4.74 21.36 30.66 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 10 3 # 10 E 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 E 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 E 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.90 32.83 25.96 10.83 30.68 25.98 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 4.57 20.60 30.29 4.74 21.36 30.66 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 11 3 # 11 E 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 E 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 E 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.90 32.83 25.96 10.83 30.68 25.98 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 4.57 20.60 30.29 4.74 21.36 30.66 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 12 3 # 12 E 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 E 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 E 193 GLY B 84 GLY.? 7.18 C3 PG4 A 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.90 32.83 25.96 10.83 30.68 25.98 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 4.57 20.60 30.29 4.74 21.36 30.66 -14.58 29.73 14.21 -14.80 28.98 14.10 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 13 3 # 13 E 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 E 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 E 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.90 32.83 25.96 10.83 30.68 25.98 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 4.57 20.60 30.29 4.74 21.36 30.66 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 14 3 # 14 E 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 E 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 E 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 10.90 32.83 25.96 10.83 30.68 25.98 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 4.57 20.60 30.29 4.74 21.36 30.66 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 15 3 # 15 E 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 E 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 E 193 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 10.90 32.83 25.96 10.83 30.68 25.98 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 4.57 20.60 30.29 4.74 21.36 30.66 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 16 3 # 16 E 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 E 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 E 193 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 10.90 32.83 25.96 10.83 30.68 25.98 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 4.57 20.60 30.29 4.74 21.36 30.66 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 17 3 # 17 E 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 E 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 E 193 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 10.90 32.83 25.96 10.83 30.68 25.98 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 4.57 20.60 30.29 4.74 21.36 30.66 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 18 3 # 18 E 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 E 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 E 193 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 10.90 32.83 25.96 10.83 30.68 25.98 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 4.57 20.60 30.29 4.74 21.36 30.66 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 19 3 # 19 E 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 E 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 E 193 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 10.90 32.83 25.96 10.83 30.68 25.98 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 4.57 20.60 30.29 4.74 21.36 30.66 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 20 3 # 20 E 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 E 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 E 193 GLY C 84 GLY.? 7.31 O4 PG4 D 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 10.90 32.83 25.96 10.83 30.68 25.98 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 4.57 20.60 30.29 4.74 21.36 30.66 -56.51 10.28 34.21 -56.90 9.83 33.65 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 21 3 # 21 E 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 E 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 E 193 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 10.90 32.83 25.96 10.83 30.68 25.98 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 4.57 20.60 30.29 4.74 21.36 30.66 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 22 3 # 22 E 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 E 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 E 193 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 10.90 32.83 25.96 10.83 30.68 25.98 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 4.57 20.60 30.29 4.74 21.36 30.66 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 23 3 # 23 E 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 E 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 E 193 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 10.90 32.83 25.96 10.83 30.68 25.98 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 4.57 20.60 30.29 4.74 21.36 30.66 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 24 3 # 24 E 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 E 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 E 193 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 10.90 32.83 25.96 10.83 30.68 25.98 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 4.57 20.60 30.29 4.74 21.36 30.66 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 25 3 # 25 E 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 E 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 E 193 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 10.90 32.83 25.96 10.83 30.68 25.98 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 4.57 20.60 30.29 4.74 21.36 30.66 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 26 3 # 26 E 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 E 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 E 193 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 10.90 32.83 25.96 10.83 30.68 25.98 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 4.57 20.60 30.29 4.74 21.36 30.66 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 27 3 # 27 E 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 E 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 E 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.90 32.83 25.96 10.83 30.68 25.98 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 4.57 20.60 30.29 4.74 21.36 30.66 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 28 3 # 28 E 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 E 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 E 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.90 32.83 25.96 10.83 30.68 25.98 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 4.57 20.60 30.29 4.74 21.36 30.66 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 29 3 # 29 E 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 E 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 E 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.90 32.83 25.96 10.83 30.68 25.98 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 4.57 20.60 30.29 4.74 21.36 30.66 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 30 3 # 30 E 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 E 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 E 193 GLY D 108 GLY.? 11.50 C6 PG4 C 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.90 32.83 25.96 10.83 30.68 25.98 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 4.57 20.60 30.29 4.74 21.36 30.66 -46.34 8.93 60.42 -45.67 8.48 60.39 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 31 3 # 31 E 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 E 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 E 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.90 32.83 25.96 10.83 30.68 25.98 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 4.57 20.60 30.29 4.74 21.36 30.66 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 32 3 # 32 E 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 E 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 E 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.90 32.83 25.96 10.83 30.68 25.98 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 4.57 20.60 30.29 4.74 21.36 30.66 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 33 3 # 33 E 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 E 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 E 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 10.90 32.83 25.96 10.83 30.68 25.98 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 4.57 20.60 30.29 4.74 21.36 30.66 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 34 3 # 34 E 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 E 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 E 193 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo 11.39 26.86 25.95 9.85 26.64 27.36 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.90 32.83 25.96 10.83 30.68 25.98 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 4.57 20.60 30.29 4.74 21.36 30.66 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 35 3 # 35 E 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 E 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 E 193 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 11.39 26.86 25.95 9.85 26.64 27.36 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.90 32.83 25.96 10.83 30.68 25.98 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 4.57 20.60 30.29 4.74 21.36 30.66 -40.50 35.55 47.63 -40.37 36.37 47.40 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 35 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 192 GLY~? 8.82 O1 PO4 A 349 B 144 GLU A 196 GLU~? 14.14 O1 PO4 A 349 B 164 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 88.87 114.43 152.30 88.45 115.15 152.32 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 85.20 111.99 152.05 86.60 110.89 150.91 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 88.14 113.46 145.73 86.79 113.92 147.30 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY A 192 GLY~? 8.82 O1 PO4 A 349 B 144 GLU A 231 GLU.? 5.77 O1 PO4 A 349 B 164 GLU A 196 GLU~? 14.14 O1 PO4 A 349 coo 88.87 114.43 152.30 88.45 115.15 152.32 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 85.20 111.99 152.05 86.60 110.89 150.91 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 88.14 113.46 145.73 86.79 113.92 147.30 -18.66 54.90 30.43 -20.55 55.76 30.68 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY B 192 GLY~? 8.75 O2 PO4 B 349 B 144 GLU B 196 GLU~? 13.82 O2 PO4 B 349 B 164 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 88.87 114.43 152.30 88.45 115.15 152.32 4.63 30.70 8.46 4.46 30.28 9.17 coo 85.20 111.99 152.05 86.60 110.89 150.91 10.06 30.74 8.04 11.63 30.24 6.70 coo 88.14 113.46 145.73 86.79 113.92 147.30 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 4 3 # 4 B 141 GLY B 192 GLY~? 8.75 O2 PO4 B 349 B 144 GLU B 231 GLU.? 5.72 O2 PO4 B 349 B 164 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 88.87 114.43 152.30 88.45 115.15 152.32 4.63 30.70 8.46 4.46 30.28 9.17 coo 85.20 111.99 152.05 86.60 110.89 150.91 3.23 35.71 5.73 3.00 33.97 6.89 coo 88.14 113.46 145.73 86.79 113.92 147.30 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 5 3 # 5 B 141 GLY C 192 GLY~? 8.67 O2 PO4 C 349 B 144 GLU C 196 GLU~? 13.61 O2 PO4 C 349 B 164 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 88.87 114.43 152.30 88.45 115.15 152.32 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 85.20 111.99 152.05 86.60 110.89 150.91 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 88.14 113.46 145.73 86.79 113.92 147.30 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 6 3 # 6 B 141 GLY C 192 GLY~? 8.67 O2 PO4 C 349 B 144 GLU C 231 GLU.? 5.70 O2 PO4 C 349 B 164 GLU C 196 GLU~? 13.61 O2 PO4 C 349 coo 88.87 114.43 152.30 88.45 115.15 152.32 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 85.20 111.99 152.05 86.60 110.89 150.91 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 88.14 113.46 145.73 86.79 113.92 147.30 -32.17 15.85 27.58 -30.80 16.36 26.07 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 7 3 # 7 B 141 GLY D 192 GLY~? 8.57 O1 PO4 D 349 B 144 GLU D 196 GLU~? 13.48 O1 PO4 D 349 B 164 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 88.87 114.43 152.30 88.45 115.15 152.32 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 85.20 111.99 152.05 86.60 110.89 150.91 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 88.14 113.46 145.73 86.79 113.92 147.30 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 8 3 # 8 B 141 GLY D 192 GLY~? 8.57 O1 PO4 D 349 B 144 GLU D 231 GLU.? 5.62 O1 PO4 D 349 B 164 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 88.87 114.43 152.30 88.45 115.15 152.32 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 85.20 111.99 152.05 86.60 110.89 150.91 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 88.14 113.46 145.73 86.79 113.92 147.30 -58.16 15.98 62.44 -59.80 16.71 63.55 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 192 GLY~? 8.82 O1 PO4 A 349 C 144 GLU A 196 GLU~? 14.14 O1 PO4 A 349 C 164 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 56.28 104.55 135.84 56.09 105.34 136.05 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 58.46 103.90 139.48 57.57 102.00 139.16 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 51.71 102.03 140.09 53.02 103.62 140.54 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY A 192 GLY~? 8.82 O1 PO4 A 349 C 144 GLU A 231 GLU.? 5.77 O1 PO4 A 349 C 164 GLU A 196 GLU~? 14.14 O1 PO4 A 349 coo 56.28 104.55 135.84 56.09 105.34 136.05 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 58.46 103.90 139.48 57.57 102.00 139.16 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 51.71 102.03 140.09 53.02 103.62 140.54 -18.66 54.90 30.43 -20.55 55.76 30.68 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY B 192 GLY~? 8.75 O2 PO4 B 349 C 144 GLU B 196 GLU~? 13.82 O2 PO4 B 349 C 164 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 56.28 104.55 135.84 56.09 105.34 136.05 4.63 30.70 8.46 4.46 30.28 9.17 coo 58.46 103.90 139.48 57.57 102.00 139.16 10.06 30.74 8.04 11.63 30.24 6.70 coo 51.71 102.03 140.09 53.02 103.62 140.54 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 4 3 # 4 C 141 GLY B 192 GLY~? 8.75 O2 PO4 B 349 C 144 GLU B 231 GLU.? 5.72 O2 PO4 B 349 C 164 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 56.28 104.55 135.84 56.09 105.34 136.05 4.63 30.70 8.46 4.46 30.28 9.17 coo 58.46 103.90 139.48 57.57 102.00 139.16 3.23 35.71 5.73 3.00 33.97 6.89 coo 51.71 102.03 140.09 53.02 103.62 140.54 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 5 3 # 5 C 141 GLY C 192 GLY~? 8.67 O2 PO4 C 349 C 144 GLU C 196 GLU~? 13.61 O2 PO4 C 349 C 164 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 56.28 104.55 135.84 56.09 105.34 136.05 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 58.46 103.90 139.48 57.57 102.00 139.16 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 51.71 102.03 140.09 53.02 103.62 140.54 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 6 3 # 6 C 141 GLY C 192 GLY~? 8.67 O2 PO4 C 349 C 144 GLU C 231 GLU.? 5.70 O2 PO4 C 349 C 164 GLU C 196 GLU~? 13.61 O2 PO4 C 349 coo 56.28 104.55 135.84 56.09 105.34 136.05 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 58.46 103.90 139.48 57.57 102.00 139.16 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 51.71 102.03 140.09 53.02 103.62 140.54 -32.17 15.85 27.58 -30.80 16.36 26.07 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 7 3 # 7 C 141 GLY D 192 GLY~? 8.57 O1 PO4 D 349 C 144 GLU D 196 GLU~? 13.48 O1 PO4 D 349 C 164 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 56.28 104.55 135.84 56.09 105.34 136.05 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 58.46 103.90 139.48 57.57 102.00 139.16 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 51.71 102.03 140.09 53.02 103.62 140.54 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 8 3 # 8 C 141 GLY D 192 GLY~? 8.57 O1 PO4 D 349 C 144 GLU D 231 GLU.? 5.62 O1 PO4 D 349 C 164 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 56.28 104.55 135.84 56.09 105.34 136.05 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 58.46 103.90 139.48 57.57 102.00 139.16 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 51.71 102.03 140.09 53.02 103.62 140.54 -58.16 15.98 62.44 -59.80 16.71 63.55 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 192 GLY~? 8.82 O1 PO4 A 349 D 144 GLU A 196 GLU~? 14.14 O1 PO4 A 349 D 164 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 86.19 80.64 132.77 86.38 79.85 132.93 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 84.75 81.24 136.88 85.62 83.14 136.43 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 91.47 83.05 136.24 90.35 81.38 136.84 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY A 192 GLY~? 8.82 O1 PO4 A 349 D 144 GLU A 231 GLU.? 5.77 O1 PO4 A 349 D 164 GLU A 196 GLU~? 14.14 O1 PO4 A 349 coo 86.19 80.64 132.77 86.38 79.85 132.93 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 84.75 81.24 136.88 85.62 83.14 136.43 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 91.47 83.05 136.24 90.35 81.38 136.84 -18.66 54.90 30.43 -20.55 55.76 30.68 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY B 192 GLY~? 8.75 O2 PO4 B 349 D 144 GLU B 196 GLU~? 13.82 O2 PO4 B 349 D 164 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 86.19 80.64 132.77 86.38 79.85 132.93 4.63 30.70 8.46 4.46 30.28 9.17 coo 84.75 81.24 136.88 85.62 83.14 136.43 10.06 30.74 8.04 11.63 30.24 6.70 coo 91.47 83.05 136.24 90.35 81.38 136.84 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 4 3 # 4 D 141 GLY B 192 GLY~? 8.75 O2 PO4 B 349 D 144 GLU B 231 GLU.? 5.72 O2 PO4 B 349 D 164 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 86.19 80.64 132.77 86.38 79.85 132.93 4.63 30.70 8.46 4.46 30.28 9.17 coo 84.75 81.24 136.88 85.62 83.14 136.43 3.23 35.71 5.73 3.00 33.97 6.89 coo 91.47 83.05 136.24 90.35 81.38 136.84 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 5 3 # 5 D 141 GLY C 192 GLY~? 8.67 O2 PO4 C 349 D 144 GLU C 196 GLU~? 13.61 O2 PO4 C 349 D 164 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 86.19 80.64 132.77 86.38 79.85 132.93 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 84.75 81.24 136.88 85.62 83.14 136.43 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 91.47 83.05 136.24 90.35 81.38 136.84 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 6 3 # 6 D 141 GLY C 192 GLY~? 8.67 O2 PO4 C 349 D 144 GLU C 231 GLU.? 5.70 O2 PO4 C 349 D 164 GLU C 196 GLU~? 13.61 O2 PO4 C 349 coo 86.19 80.64 132.77 86.38 79.85 132.93 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 84.75 81.24 136.88 85.62 83.14 136.43 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 91.47 83.05 136.24 90.35 81.38 136.84 -32.17 15.85 27.58 -30.80 16.36 26.07 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 7 3 # 7 D 141 GLY D 192 GLY~? 8.57 O1 PO4 D 349 D 144 GLU D 196 GLU~? 13.48 O1 PO4 D 349 D 164 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 86.19 80.64 132.77 86.38 79.85 132.93 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 84.75 81.24 136.88 85.62 83.14 136.43 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 91.47 83.05 136.24 90.35 81.38 136.84 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 8 3 # 8 D 141 GLY D 192 GLY~? 8.57 O1 PO4 D 349 D 144 GLU D 231 GLU.? 5.62 O1 PO4 D 349 D 164 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 86.19 80.64 132.77 86.38 79.85 132.93 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 84.75 81.24 136.88 85.62 83.14 136.43 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 91.47 83.05 136.24 90.35 81.38 136.84 -58.16 15.98 62.44 -59.80 16.71 63.55 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 192 GLY~? 8.82 O1 PO4 A 349 E 144 GLU A 196 GLU~? 14.14 O1 PO4 A 349 E 164 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 90.07 81.07 170.50 90.23 80.26 170.38 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 87.05 81.30 167.53 86.38 82.74 168.94 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 84.40 80.02 173.80 85.08 79.06 172.03 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY A 192 GLY~? 8.82 O1 PO4 A 349 E 144 GLU A 231 GLU.? 5.77 O1 PO4 A 349 E 164 GLU A 196 GLU~? 14.14 O1 PO4 A 349 coo 90.07 81.07 170.50 90.23 80.26 170.38 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 87.05 81.30 167.53 86.38 82.74 168.94 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 84.40 80.02 173.80 85.08 79.06 172.03 -18.66 54.90 30.43 -20.55 55.76 30.68 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY B 192 GLY~? 8.75 O2 PO4 B 349 E 144 GLU B 196 GLU~? 13.82 O2 PO4 B 349 E 164 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 90.07 81.07 170.50 90.23 80.26 170.38 4.63 30.70 8.46 4.46 30.28 9.17 coo 87.05 81.30 167.53 86.38 82.74 168.94 10.06 30.74 8.04 11.63 30.24 6.70 coo 84.40 80.02 173.80 85.08 79.06 172.03 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 4 3 # 4 E 141 GLY B 192 GLY~? 8.75 O2 PO4 B 349 E 144 GLU B 231 GLU.? 5.72 O2 PO4 B 349 E 164 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 90.07 81.07 170.50 90.23 80.26 170.38 4.63 30.70 8.46 4.46 30.28 9.17 coo 87.05 81.30 167.53 86.38 82.74 168.94 3.23 35.71 5.73 3.00 33.97 6.89 coo 84.40 80.02 173.80 85.08 79.06 172.03 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 5 3 # 5 E 141 GLY C 192 GLY~? 8.67 O2 PO4 C 349 E 144 GLU C 196 GLU~? 13.61 O2 PO4 C 349 E 164 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 90.07 81.07 170.50 90.23 80.26 170.38 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 87.05 81.30 167.53 86.38 82.74 168.94 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 84.40 80.02 173.80 85.08 79.06 172.03 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 6 3 # 6 E 141 GLY C 192 GLY~? 8.67 O2 PO4 C 349 E 144 GLU C 231 GLU.? 5.70 O2 PO4 C 349 E 164 GLU C 196 GLU~? 13.61 O2 PO4 C 349 coo 90.07 81.07 170.50 90.23 80.26 170.38 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 87.05 81.30 167.53 86.38 82.74 168.94 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 84.40 80.02 173.80 85.08 79.06 172.03 -32.17 15.85 27.58 -30.80 16.36 26.07 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 7 3 # 7 E 141 GLY D 192 GLY~? 8.57 O1 PO4 D 349 E 144 GLU D 196 GLU~? 13.48 O1 PO4 D 349 E 164 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 90.07 81.07 170.50 90.23 80.26 170.38 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 87.05 81.30 167.53 86.38 82.74 168.94 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 84.40 80.02 173.80 85.08 79.06 172.03 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 8 3 # 8 E 141 GLY D 192 GLY~? 8.57 O1 PO4 D 349 E 144 GLU D 231 GLU.? 5.62 O1 PO4 D 349 E 164 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 90.07 81.07 170.50 90.23 80.26 170.38 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 87.05 81.30 167.53 86.38 82.74 168.94 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 84.40 80.02 173.80 85.08 79.06 172.03 -58.16 15.98 62.44 -59.80 16.71 63.55 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 192 GLY~? 8.82 O1 PO4 A 349 F 144 GLU A 196 GLU~? 14.14 O1 PO4 A 349 F 164 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 57.12 70.68 155.10 57.52 69.95 155.02 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 60.62 73.13 154.21 59.05 74.26 153.35 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 56.75 71.71 148.46 58.44 71.01 149.54 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY A 192 GLY~? 8.82 O1 PO4 A 349 F 144 GLU A 231 GLU.? 5.77 O1 PO4 A 349 F 164 GLU A 196 GLU~? 14.14 O1 PO4 A 349 coo 57.12 70.68 155.10 57.52 69.95 155.02 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 60.62 73.13 154.21 59.05 74.26 153.35 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 56.75 71.71 148.46 58.44 71.01 149.54 -18.66 54.90 30.43 -20.55 55.76 30.68 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY B 192 GLY~? 8.75 O2 PO4 B 349 F 144 GLU B 196 GLU~? 13.82 O2 PO4 B 349 F 164 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 57.12 70.68 155.10 57.52 69.95 155.02 4.63 30.70 8.46 4.46 30.28 9.17 coo 60.62 73.13 154.21 59.05 74.26 153.35 10.06 30.74 8.04 11.63 30.24 6.70 coo 56.75 71.71 148.46 58.44 71.01 149.54 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 4 3 # 4 F 141 GLY B 192 GLY~? 8.75 O2 PO4 B 349 F 144 GLU B 231 GLU.? 5.72 O2 PO4 B 349 F 164 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 57.12 70.68 155.10 57.52 69.95 155.02 4.63 30.70 8.46 4.46 30.28 9.17 coo 60.62 73.13 154.21 59.05 74.26 153.35 3.23 35.71 5.73 3.00 33.97 6.89 coo 56.75 71.71 148.46 58.44 71.01 149.54 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 5 3 # 5 F 141 GLY C 192 GLY~? 8.67 O2 PO4 C 349 F 144 GLU C 196 GLU~? 13.61 O2 PO4 C 349 F 164 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 57.12 70.68 155.10 57.52 69.95 155.02 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 60.62 73.13 154.21 59.05 74.26 153.35 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 56.75 71.71 148.46 58.44 71.01 149.54 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 6 3 # 6 F 141 GLY C 192 GLY~? 8.67 O2 PO4 C 349 F 144 GLU C 231 GLU.? 5.70 O2 PO4 C 349 F 164 GLU C 196 GLU~? 13.61 O2 PO4 C 349 coo 57.12 70.68 155.10 57.52 69.95 155.02 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 60.62 73.13 154.21 59.05 74.26 153.35 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 56.75 71.71 148.46 58.44 71.01 149.54 -32.17 15.85 27.58 -30.80 16.36 26.07 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 7 3 # 7 F 141 GLY D 192 GLY~? 8.57 O1 PO4 D 349 F 144 GLU D 196 GLU~? 13.48 O1 PO4 D 349 F 164 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 57.12 70.68 155.10 57.52 69.95 155.02 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 60.62 73.13 154.21 59.05 74.26 153.35 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 56.75 71.71 148.46 58.44 71.01 149.54 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 8 3 # 8 F 141 GLY D 192 GLY~? 8.57 O1 PO4 D 349 F 144 GLU D 231 GLU.? 5.62 O1 PO4 D 349 F 164 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 57.12 70.68 155.10 57.52 69.95 155.02 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 60.62 73.13 154.21 59.05 74.26 153.35 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 56.75 71.71 148.46 58.44 71.01 149.54 -58.16 15.98 62.44 -59.80 16.71 63.55 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c17 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 64 SER~? 26.25 O3 PG4 B 350 A 208 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 236 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 49.19 42.85 125.39 50.92 43.54 123.63 1.46 56.04 50.07 2.12 55.38 52.31 coo 57.80 42.94 129.59 56.47 43.28 127.93 1.74 60.96 43.57 3.36 61.47 42.28 coo 55.54 41.70 125.00 53.71 42.50 124.53 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER A 64 SER~? 26.25 O3 PG4 B 350 A 208 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 236 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 49.19 42.85 125.39 50.92 43.54 123.63 1.46 56.04 50.07 2.12 55.38 52.31 coo 57.80 42.94 129.59 56.47 43.28 127.93 8.08 50.44 43.84 7.48 51.26 41.98 coo 55.54 41.70 125.00 53.71 42.50 124.53 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER A 241 SER.? 9.98 O3 PO4 A 349 A 208 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 236 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 49.19 42.85 125.39 50.92 43.54 123.63 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 57.80 42.94 129.59 56.47 43.28 127.93 -1.16 62.88 18.52 0.68 62.16 19.33 coo 55.54 41.70 125.00 53.71 42.50 124.53 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 4 3 # 4 A 80 SER B 64 SER~? 26.98 C5 PG4 A 350 A 208 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 236 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 49.19 42.85 125.39 50.92 43.54 123.63 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 57.80 42.94 129.59 56.47 43.28 127.93 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 55.54 41.70 125.00 53.71 42.50 124.53 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 5 3 # 5 A 80 SER B 241 SER.? 10.02 O1 PO4 B 349 A 208 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 236 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 49.19 42.85 125.39 50.92 43.54 123.63 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 57.80 42.94 129.59 56.47 43.28 127.93 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 55.54 41.70 125.00 53.71 42.50 124.53 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 6 3 # 6 A 80 SER C 64 SER~? 25.88 C5 PG4 D 350 A 208 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 236 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 49.19 42.85 125.39 50.92 43.54 123.63 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 57.80 42.94 129.59 56.47 43.28 127.93 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 55.54 41.70 125.00 53.71 42.50 124.53 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 7 3 # 7 A 80 SER C 64 SER~? 25.88 C5 PG4 D 350 A 208 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 236 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 49.19 42.85 125.39 50.92 43.54 123.63 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 57.80 42.94 129.59 56.47 43.28 127.93 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 55.54 41.70 125.00 53.71 42.50 124.53 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 8 3 # 8 A 80 SER C 241 SER.? 9.97 O3 PO4 C 349 A 208 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 236 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 49.19 42.85 125.39 50.92 43.54 123.63 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 57.80 42.94 129.59 56.47 43.28 127.93 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 55.54 41.70 125.00 53.71 42.50 124.53 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 9 3 # 9 A 80 SER D 64 SER~? 27.50 C6 PG4 C 350 A 208 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 236 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 49.19 42.85 125.39 50.92 43.54 123.63 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 57.80 42.94 129.59 56.47 43.28 127.93 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 55.54 41.70 125.00 53.71 42.50 124.53 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 10 3 # 10 A 80 SER D 241 SER.? 10.08 O3 PO4 D 349 A 208 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 236 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 49.19 42.85 125.39 50.92 43.54 123.63 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 57.80 42.94 129.59 56.47 43.28 127.93 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 55.54 41.70 125.00 53.71 42.50 124.53 -38.74 26.41 54.26 -37.48 24.84 54.87 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 10 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER A 64 SER~? 26.25 O3 PG4 B 350 B 208 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 236 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 55.25 19.46 97.60 53.04 19.32 98.76 1.46 56.04 50.07 2.12 55.38 52.31 coo 57.34 11.46 102.30 56.11 13.10 101.70 1.74 60.96 43.57 3.36 61.47 42.28 coo 55.03 16.17 103.08 54.39 17.23 101.45 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 2 3 # 2 B 80 SER A 64 SER~? 26.25 O3 PG4 B 350 B 208 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 236 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 55.25 19.46 97.60 53.04 19.32 98.76 1.46 56.04 50.07 2.12 55.38 52.31 coo 57.34 11.46 102.30 56.11 13.10 101.70 8.08 50.44 43.84 7.48 51.26 41.98 coo 55.03 16.17 103.08 54.39 17.23 101.45 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 3 3 # 3 B 80 SER A 241 SER.? 9.98 O3 PO4 A 349 B 208 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 236 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 55.25 19.46 97.60 53.04 19.32 98.76 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 57.34 11.46 102.30 56.11 13.10 101.70 -1.16 62.88 18.52 0.68 62.16 19.33 coo 55.03 16.17 103.08 54.39 17.23 101.45 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 4 3 # 4 B 80 SER B 64 SER~? 26.98 C5 PG4 A 350 B 208 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 236 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 55.25 19.46 97.60 53.04 19.32 98.76 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 57.34 11.46 102.30 56.11 13.10 101.70 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 55.03 16.17 103.08 54.39 17.23 101.45 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 5 3 # 5 B 80 SER B 241 SER.? 10.02 O1 PO4 B 349 B 208 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 236 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 55.25 19.46 97.60 53.04 19.32 98.76 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 57.34 11.46 102.30 56.11 13.10 101.70 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 55.03 16.17 103.08 54.39 17.23 101.45 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 6 3 # 6 B 80 SER C 64 SER~? 25.88 C5 PG4 D 350 B 208 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 236 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 55.25 19.46 97.60 53.04 19.32 98.76 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 57.34 11.46 102.30 56.11 13.10 101.70 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 55.03 16.17 103.08 54.39 17.23 101.45 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 7 3 # 7 B 80 SER C 64 SER~? 25.88 C5 PG4 D 350 B 208 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 236 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 55.25 19.46 97.60 53.04 19.32 98.76 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 57.34 11.46 102.30 56.11 13.10 101.70 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 55.03 16.17 103.08 54.39 17.23 101.45 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 8 3 # 8 B 80 SER C 241 SER.? 9.97 O3 PO4 C 349 B 208 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 236 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 55.25 19.46 97.60 53.04 19.32 98.76 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 57.34 11.46 102.30 56.11 13.10 101.70 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 55.03 16.17 103.08 54.39 17.23 101.45 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 9 3 # 9 B 80 SER D 64 SER~? 27.50 C6 PG4 C 350 B 208 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 236 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 55.25 19.46 97.60 53.04 19.32 98.76 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 57.34 11.46 102.30 56.11 13.10 101.70 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 55.03 16.17 103.08 54.39 17.23 101.45 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 10 3 # 10 B 80 SER D 241 SER.? 10.08 O3 PO4 D 349 B 208 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 236 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 55.25 19.46 97.60 53.04 19.32 98.76 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 57.34 11.46 102.30 56.11 13.10 101.70 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 55.03 16.17 103.08 54.39 17.23 101.45 -38.74 26.41 54.26 -37.48 24.84 54.87 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 10 hits 1dwo_c01 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS B 165 LYS~? -2.78 O4 PO4 B 349s A 215 LYS B 184 LYS^? 17.27 O2 PO4 B 349 A 277 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 0.50 24.09 51.68 1.51 29.34 52.35 0.37 36.49 0.17 -3.63 37.66 2.73 coo 13.06 30.79 51.73 11.40 35.76 53.48 15.36 36.70 4.47 15.17 34.16 8.91 coo 13.04 31.88 60.72 10.57 35.34 57.49 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS D 165 LYS~? -2.89 O4 PO4 D 349s A 215 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 277 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 0.50 24.09 51.68 1.51 29.34 52.35 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 13.06 30.79 51.73 11.40 35.76 53.48 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 13.04 31.88 60.72 10.57 35.34 57.49 -68.08 25.33 66.69 -67.75 19.10 66.60 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS B 165 LYS~? -2.78 O4 PO4 B 349s B 215 LYS B 184 LYS^? 17.27 O2 PO4 B 349 B 277 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 6.78 45.91 16.15 7.82 40.81 15.84 0.37 36.49 0.17 -3.63 37.66 2.73 coo 17.88 38.77 19.81 16.38 34.23 17.24 15.36 36.70 4.47 15.17 34.16 8.91 coo 20.33 37.78 11.20 16.77 34.53 13.47 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS D 165 LYS~? -2.89 O4 PO4 D 349s B 215 LYS D 184 LYS^? 18.69 O1 PO4 D 349 B 277 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 6.78 45.91 16.15 7.82 40.81 15.84 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 17.88 38.77 19.81 16.38 34.23 17.24 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 20.33 37.78 11.20 16.77 34.53 13.47 -68.08 25.33 66.69 -67.75 19.10 66.60 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c01 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 173 HIS~? 15.17 O1 PO4 A 349 B 43 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 65 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 19.55 18.91 30.27 18.21 18.65 31.84 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 10.90 21.31 28.81 12.14 22.15 30.31 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS A 173 HIS~? 15.17 O1 PO4 A 349 B 43 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 65 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 19.55 18.91 30.27 18.21 18.65 31.84 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 10.90 21.31 28.81 12.14 22.15 30.31 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 43 HIS A 173 HIS~? 15.17 O1 PO4 A 349 B 65 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 19.55 18.91 30.27 18.21 18.65 31.84 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 10.90 21.31 28.81 12.14 22.15 30.31 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 43 HIS A 173 HIS~? 15.17 O1 PO4 A 349 B 65 GLU A 196 GLU~? 14.14 O1 PO4 A 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 19.55 18.91 30.27 18.21 18.65 31.84 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 10.90 21.31 28.81 12.14 22.15 30.31 -18.66 54.90 30.43 -20.55 55.76 30.68 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 5 3 # 5 B 41 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 43 HIS A 173 HIS~? 15.17 O1 PO4 A 349 B 65 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 19.55 18.91 30.27 18.21 18.65 31.84 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 10.90 21.31 28.81 12.14 22.15 30.31 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 6 3 # 6 B 41 HIS B 173 HIS~? 15.15 O2 PO4 B 349 B 43 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 65 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 13.23 34.15 0.64 14.88 33.23 1.56 coo 19.55 18.91 30.27 18.21 18.65 31.84 11.38 38.70 0.79 12.71 38.99 -0.80 coo 10.90 21.31 28.81 12.14 22.15 30.31 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 7 3 # 7 B 41 HIS B 173 HIS~? 15.15 O2 PO4 B 349 B 43 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 65 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 13.23 34.15 0.64 14.88 33.23 1.56 coo 19.55 18.91 30.27 18.21 18.65 31.84 11.38 38.70 0.79 12.71 38.99 -0.80 coo 10.90 21.31 28.81 12.14 22.15 30.31 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 8 3 # 8 B 41 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 43 HIS B 173 HIS~? 15.15 O2 PO4 B 349 B 65 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 11.38 38.70 0.79 12.71 38.99 -0.80 coo 19.55 18.91 30.27 18.21 18.65 31.84 13.23 34.15 0.64 14.88 33.23 1.56 coo 10.90 21.31 28.81 12.14 22.15 30.31 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 9 3 # 9 B 41 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 43 HIS B 173 HIS~? 15.15 O2 PO4 B 349 B 65 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 11.38 38.70 0.79 12.71 38.99 -0.80 coo 19.55 18.91 30.27 18.21 18.65 31.84 13.23 34.15 0.64 14.88 33.23 1.56 coo 10.90 21.31 28.81 12.14 22.15 30.31 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 10 3 # 10 B 41 HIS C 173 HIS~? 15.03 O2 PO4 C 349 B 43 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 65 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 19.55 18.91 30.27 18.21 18.65 31.84 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 10.90 21.31 28.81 12.14 22.15 30.31 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 11 3 # 11 B 41 HIS C 173 HIS~? 15.03 O2 PO4 C 349 B 43 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 65 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 19.55 18.91 30.27 18.21 18.65 31.84 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 10.90 21.31 28.81 12.14 22.15 30.31 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 12 3 # 12 B 41 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 43 HIS C 173 HIS~? 15.03 O2 PO4 C 349 B 65 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 19.55 18.91 30.27 18.21 18.65 31.84 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 10.90 21.31 28.81 12.14 22.15 30.31 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 13 3 # 13 B 41 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 43 HIS C 173 HIS~? 15.03 O2 PO4 C 349 B 65 GLU C 196 GLU~? 13.61 O2 PO4 C 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 19.55 18.91 30.27 18.21 18.65 31.84 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 10.90 21.31 28.81 12.14 22.15 30.31 -32.17 15.85 27.58 -30.80 16.36 26.07 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 14 3 # 14 B 41 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 43 HIS C 173 HIS~? 15.03 O2 PO4 C 349 B 65 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 19.55 18.91 30.27 18.21 18.65 31.84 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 10.90 21.31 28.81 12.14 22.15 30.31 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 15 3 # 15 B 41 HIS D 173 HIS~? 14.91 O1 PO4 D 349 B 43 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 65 GLU D 171 GLU~? 12.87 O2 PO4 D 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 19.55 18.91 30.27 18.21 18.65 31.84 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 10.90 21.31 28.81 12.14 22.15 30.31 -56.37 27.70 69.07 -57.02 27.32 71.04 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 16 3 # 16 B 41 HIS D 173 HIS~? 14.91 O1 PO4 D 349 B 43 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 65 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 19.55 18.91 30.27 18.21 18.65 31.84 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 10.90 21.31 28.81 12.14 22.15 30.31 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 17 3 # 17 B 41 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 43 HIS D 173 HIS~? 14.91 O1 PO4 D 349 B 65 GLU D 171 GLU~? 12.87 O2 PO4 D 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 19.55 18.91 30.27 18.21 18.65 31.84 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 10.90 21.31 28.81 12.14 22.15 30.31 -56.37 27.70 69.07 -57.02 27.32 71.04 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 18 3 # 18 B 41 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 43 HIS D 173 HIS~? 14.91 O1 PO4 D 349 B 65 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 19.55 18.91 30.27 18.21 18.65 31.84 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 10.90 21.31 28.81 12.14 22.15 30.31 -58.16 15.98 62.44 -59.80 16.71 63.55 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 19 3 # 19 B 41 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 43 HIS D 173 HIS~? 14.91 O1 PO4 D 349 B 65 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 20.15 22.08 34.36 20.84 20.10 34.21 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 19.55 18.91 30.27 18.21 18.65 31.84 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 10.90 21.31 28.81 12.14 22.15 30.31 -52.72 21.86 59.42 -51.91 19.95 59.86 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 19 hits 1e7l_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA C 10 ALA^? 23.13 O4 PO4 C 349 A 136 TYR C 71 TYR~? 28.61 O4 PO4 C 349 A 140 LYS C 72 LYS~? 33.77 C3 PG4 D 350 coo 55.90 7.49 23.83 56.71 8.23 22.76 -41.98 1.84 18.07 -42.52 0.45 17.93 coo 59.38 10.02 17.51 59.95 9.89 20.21 -42.04 -1.21 10.11 -44.02 -0.84 8.15 coo 59.52 3.69 18.67 62.31 6.19 22.58 -38.31 -4.87 13.60 -38.37 -10.28 12.47 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 1 hits 1e7q_c01 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS D 177 LYS~? 20.36 O1 PO4 D 349 A 207 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 366 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -68.08 25.33 66.69 -67.75 19.10 66.60 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -64.76 21.00 60.32 -64.61 15.17 58.23 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -71.26 26.87 58.29 -73.26 26.34 58.61 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 207 LYS D 177 LYS~? 20.36 O1 PO4 D 349 A 366 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -64.76 21.00 60.32 -64.61 15.17 58.23 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -68.08 25.33 66.69 -67.75 19.10 66.60 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -71.26 26.87 58.29 -73.26 26.34 58.61 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 2 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS D 177 LYS~? 20.36 O1 PO4 D 349 B 207 LYS D 184 LYS^? 18.69 O1 PO4 D 349 B 366 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -68.08 25.33 66.69 -67.75 19.10 66.60 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -64.76 21.00 60.32 -64.61 15.17 58.23 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -71.26 26.87 58.29 -73.26 26.34 58.61 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS D 184 LYS^? 18.69 O1 PO4 D 349 B 207 LYS D 177 LYS~? 20.36 O1 PO4 D 349 B 366 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -64.76 21.00 60.32 -64.61 15.17 58.23 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -68.08 25.33 66.69 -67.75 19.10 66.60 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -71.26 26.87 58.29 -73.26 26.34 58.61 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 2 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS D 177 LYS~? 20.36 O1 PO4 D 349 C 207 LYS D 184 LYS^? 18.69 O1 PO4 D 349 C 366 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -71.26 26.87 58.29 -73.26 26.34 58.61 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS D 184 LYS^? 18.69 O1 PO4 D 349 C 207 LYS D 177 LYS~? 20.36 O1 PO4 D 349 C 366 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -71.26 26.87 58.29 -73.26 26.34 58.61 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 2 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS D 177 LYS~? 20.36 O1 PO4 D 349 D 207 LYS D 184 LYS^? 18.69 O1 PO4 D 349 D 366 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -71.26 26.87 58.29 -73.26 26.34 58.61 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS D 184 LYS^? 18.69 O1 PO4 D 349 D 207 LYS D 177 LYS~? 20.36 O1 PO4 D 349 D 366 ASP D 226 ASP.? 25.08 O1 PO4 D 349 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -71.26 26.87 58.29 -73.26 26.34 58.61 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 2 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 177 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 203 LYS B 96 LYS~? 18.72 C5 PG4 A 350 coo 8.74 45.76 47.19 9.33 46.93 45.56 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 11.68 42.31 52.96 12.05 43.92 51.65 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 18.07 52.81 49.62 14.17 49.99 48.07 -4.65 11.97 23.20 -9.16 12.78 27.52 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 177 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 203 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 8.74 45.76 47.19 9.33 46.93 45.56 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 11.68 42.31 52.96 12.05 43.92 51.65 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 18.07 52.81 49.62 14.17 49.99 48.07 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1ecx_c02 source 1ecx AMINOTRANSFERASE : 2 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 177 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 203 LYS B 96 LYS~? 18.72 C5 PG4 A 350 coo 14.87 88.04 21.51 13.64 87.90 19.81 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 15.87 92.46 27.37 14.46 91.76 25.94 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 3.60 91.42 23.52 8.20 89.55 22.63 -4.65 11.97 23.20 -9.16 12.78 27.52 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 177 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 203 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 14.87 88.04 21.51 13.64 87.90 19.81 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 15.87 92.46 27.37 14.46 91.76 25.94 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 3.60 91.42 23.52 8.20 89.55 22.63 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1ecx_c03 source 1ecx AMINOTRANSFERASE : 2 hits 1ecx_c03 naa= 3 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 A 107 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 246 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 275 HIS A 260 HIS^? 11.64 O4 PO4 A 349 coo 28.44 37.56 46.79 26.87 37.11 48.10 -1.16 62.88 18.52 0.68 62.16 19.33 coo 22.84 50.35 52.24 23.24 48.32 52.90 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 26.67 42.94 48.26 27.49 41.07 48.73 -4.97 68.88 15.23 -3.05 69.59 14.77 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 A 107 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 246 ASP A 131 ASP^? 9.75 C6 PG4 B 350 A 275 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo 28.44 37.56 46.79 26.87 37.11 48.10 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 22.84 50.35 52.24 23.24 48.32 52.90 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 26.67 42.94 48.26 27.49 41.07 48.73 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 A 107 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 246 ASP B 140 ASP.? 7.99 O2 PG4 B 350 A 275 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo 28.44 37.56 46.79 26.87 37.11 48.10 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 22.84 50.35 52.24 23.24 48.32 52.90 8.40 47.76 23.89 8.35 49.33 25.35 coo 26.67 42.94 48.26 27.49 41.07 48.73 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 A 107 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 246 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 275 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo 28.44 37.56 46.79 26.87 37.11 48.10 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 22.84 50.35 52.24 23.24 48.32 52.90 0.40 27.07 22.40 -0.62 25.51 23.42 coo 26.67 42.94 48.26 27.49 41.07 48.73 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 A 107 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 246 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 275 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 28.44 37.56 46.79 26.87 37.11 48.10 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 22.84 50.35 52.24 23.24 48.32 52.90 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 26.67 42.94 48.26 27.49 41.07 48.73 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 A 107 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 246 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 275 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 28.44 37.56 46.79 26.87 37.11 48.10 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 22.84 50.35 52.24 23.24 48.32 52.90 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 26.67 42.94 48.26 27.49 41.07 48.73 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 A 107 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 246 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 275 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo 28.44 37.56 46.79 26.87 37.11 48.10 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 22.84 50.35 52.24 23.24 48.32 52.90 0.40 27.07 22.40 -0.62 25.51 23.42 coo 26.67 42.94 48.26 27.49 41.07 48.73 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 A 107 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 246 ASP A 131 ASP^? 9.75 C6 PG4 B 350 A 275 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo 28.44 37.56 46.79 26.87 37.11 48.10 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 22.84 50.35 52.24 23.24 48.32 52.90 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 26.67 42.94 48.26 27.49 41.07 48.73 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 A 107 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 246 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 275 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 28.44 37.56 46.79 26.87 37.11 48.10 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 22.84 50.35 52.24 23.24 48.32 52.90 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 26.67 42.94 48.26 27.49 41.07 48.73 -48.83 33.87 26.09 -50.85 34.38 25.82 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 A 107 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 246 ASP C 131 ASP^? 9.91 O2 PG4 D 350 A 275 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo 28.44 37.56 46.79 26.87 37.11 48.10 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 22.84 50.35 52.24 23.24 48.32 52.90 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 26.67 42.94 48.26 27.49 41.07 48.73 -48.06 9.35 37.56 -47.54 11.38 37.75 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 A 107 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 246 ASP D 131 ASP^? 9.77 C6 PG4 C 350 A 275 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 28.44 37.56 46.79 26.87 37.11 48.10 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 22.84 50.35 52.24 23.24 48.32 52.90 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 26.67 42.94 48.26 27.49 41.07 48.73 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 12 3 # 12 A 107 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 246 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 275 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 28.44 37.56 46.79 26.87 37.11 48.10 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 22.84 50.35 52.24 23.24 48.32 52.90 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 26.67 42.94 48.26 27.49 41.07 48.73 -38.74 26.41 54.26 -37.48 24.84 54.87 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 13 3 # 13 A 107 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 246 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 275 HIS D 260 HIS^? 11.65 O4 PO4 D 349 coo 28.44 37.56 46.79 26.87 37.11 48.10 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 22.84 50.35 52.24 23.24 48.32 52.90 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 26.67 42.94 48.26 27.49 41.07 48.73 -44.73 36.67 61.75 -42.79 37.49 61.80 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 14 3 # 14 A 107 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 246 ASP D 131 ASP^? 9.77 C6 PG4 C 350 A 275 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 28.44 37.56 46.79 26.87 37.11 48.10 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 22.84 50.35 52.24 23.24 48.32 52.90 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 26.67 42.94 48.26 27.49 41.07 48.73 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 15 3 # 15 A 107 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 246 ASP C 131 ASP^? 9.91 O2 PG4 D 350 A 275 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo 28.44 37.56 46.79 26.87 37.11 48.10 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 22.84 50.35 52.24 23.24 48.32 52.90 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 26.67 42.94 48.26 27.49 41.07 48.73 -48.06 9.35 37.56 -47.54 11.38 37.75 1ehy_c00 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 15 hits 1ehy_c00 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 246 ASP A 89 ASP~? 13.93 C4 PG4 B 350 B 275 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 34.84 56.77 81.62 34.95 54.74 82.03 1.74 60.96 43.57 3.36 61.47 42.28 coo 43.18 49.30 68.39 44.75 49.87 69.78 10.16 45.65 42.38 11.05 44.28 40.99 coo 38.73 55.10 77.62 36.80 55.01 78.46 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 246 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 275 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 34.84 56.77 81.62 34.95 54.74 82.03 -1.16 62.88 18.52 0.68 62.16 19.33 coo 43.18 49.30 68.39 44.75 49.87 69.78 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 38.73 55.10 77.62 36.80 55.01 78.46 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 246 ASP B 140 ASP.? 7.99 O2 PG4 B 350 B 275 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 34.84 56.77 81.62 34.95 54.74 82.03 -1.16 62.88 18.52 0.68 62.16 19.33 coo 43.18 49.30 68.39 44.75 49.87 69.78 8.40 47.76 23.89 8.35 49.33 25.35 coo 38.73 55.10 77.62 36.80 55.01 78.46 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 246 ASP B 208 ASP~? 8.88 C3 PG4 B 350 B 275 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 34.84 56.77 81.62 34.95 54.74 82.03 -1.16 62.88 18.52 0.68 62.16 19.33 coo 43.18 49.30 68.39 44.75 49.87 69.78 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 38.73 55.10 77.62 36.80 55.01 78.46 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 B 107 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 246 ASP A 140 ASP.? 7.37 O2 PG4 A 350 B 275 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 34.84 56.77 81.62 34.95 54.74 82.03 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 43.18 49.30 68.39 44.75 49.87 69.78 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 38.73 55.10 77.62 36.80 55.01 78.46 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 B 107 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 246 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 275 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 34.84 56.77 81.62 34.95 54.74 82.03 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 43.18 49.30 68.39 44.75 49.87 69.78 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 38.73 55.10 77.62 36.80 55.01 78.46 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 B 107 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 246 ASP C 89 ASP.? 13.45 C5 PG4 D 350 B 275 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 34.84 56.77 81.62 34.95 54.74 82.03 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 43.18 49.30 68.39 44.75 49.87 69.78 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 38.73 55.10 77.62 36.80 55.01 78.46 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 B 107 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 246 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 275 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 34.84 56.77 81.62 34.95 54.74 82.03 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 43.18 49.30 68.39 44.75 49.87 69.78 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 38.73 55.10 77.62 36.80 55.01 78.46 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 B 107 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 246 ASP D 208 ASP~? 8.41 C6 PG4 D 350 B 275 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 34.84 56.77 81.62 34.95 54.74 82.03 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 43.18 49.30 68.39 44.75 49.87 69.78 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 38.73 55.10 77.62 36.80 55.01 78.46 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 B 107 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 246 ASP D 89 ASP.? 16.35 C5 PG4 C 350 B 275 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 34.84 56.77 81.62 34.95 54.74 82.03 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 43.18 49.30 68.39 44.75 49.87 69.78 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 38.73 55.10 77.62 36.80 55.01 78.46 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 B 107 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 246 ASP C 140 ASP.? 7.74 C2 PG4 C 350 B 275 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 34.84 56.77 81.62 34.95 54.74 82.03 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 43.18 49.30 68.39 44.75 49.87 69.78 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 38.73 55.10 77.62 36.80 55.01 78.46 -38.74 26.41 54.26 -37.48 24.84 54.87 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 12 3 # 12 B 107 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 246 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 275 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 34.84 56.77 81.62 34.95 54.74 82.03 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 43.18 49.30 68.39 44.75 49.87 69.78 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 38.73 55.10 77.62 36.80 55.01 78.46 -38.74 26.41 54.26 -37.48 24.84 54.87 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 12 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 41 ASP.? 20.10 O2 PO4 A 349 C 246 ASP A 89 ASP~? 13.93 C4 PG4 B 350 C 275 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 1.90 35.26 72.76 3.20 35.74 71.18 1.74 60.96 43.57 3.36 61.47 42.28 coo 12.03 20.33 71.56 10.48 19.25 70.56 10.16 45.65 42.38 11.05 44.28 40.99 coo 3.92 29.96 71.75 4.22 31.96 72.31 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 246 ASP B 140 ASP.? 7.99 O2 PG4 B 350 C 275 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 1.90 35.26 72.76 3.20 35.74 71.18 -1.16 62.88 18.52 0.68 62.16 19.33 coo 12.03 20.33 71.56 10.48 19.25 70.56 8.40 47.76 23.89 8.35 49.33 25.35 coo 3.92 29.96 71.75 4.22 31.96 72.31 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 246 ASP B 208 ASP~? 8.88 C3 PG4 B 350 C 275 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 1.90 35.26 72.76 3.20 35.74 71.18 -1.16 62.88 18.52 0.68 62.16 19.33 coo 12.03 20.33 71.56 10.48 19.25 70.56 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 3.92 29.96 71.75 4.22 31.96 72.31 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 246 ASP A 140 ASP.? 7.37 O2 PG4 A 350 C 275 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 1.90 35.26 72.76 3.20 35.74 71.18 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 12.03 20.33 71.56 10.48 19.25 70.56 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 3.92 29.96 71.75 4.22 31.96 72.31 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 C 107 ASP C 41 ASP.? 20.22 O4 PO4 C 349 C 246 ASP C 89 ASP.? 13.45 C5 PG4 D 350 C 275 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 1.90 35.26 72.76 3.20 35.74 71.18 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 12.03 20.33 71.56 10.48 19.25 70.56 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 3.92 29.96 71.75 4.22 31.96 72.31 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 C 107 ASP D 41 ASP.? 20.92 O2 PO4 D 349 C 246 ASP D 89 ASP.? 16.35 C5 PG4 C 350 C 275 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 1.90 35.26 72.76 3.20 35.74 71.18 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 12.03 20.33 71.56 10.48 19.25 70.56 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 3.92 29.96 71.75 4.22 31.96 72.31 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 C 107 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 246 ASP C 140 ASP.? 7.74 C2 PG4 C 350 C 275 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 1.90 35.26 72.76 3.20 35.74 71.18 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 12.03 20.33 71.56 10.48 19.25 70.56 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 3.92 29.96 71.75 4.22 31.96 72.31 -38.74 26.41 54.26 -37.48 24.84 54.87 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 7 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 41 ASP.? 20.10 O2 PO4 A 349 D 246 ASP A 89 ASP~? 13.93 C4 PG4 B 350 D 275 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 37.41 19.89 81.58 37.64 21.98 81.53 1.74 60.96 43.57 3.36 61.47 42.28 coo 23.50 26.43 88.52 24.76 26.47 90.29 10.16 45.65 42.38 11.05 44.28 40.99 coo 33.16 21.44 85.29 34.07 21.53 83.40 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 246 ASP A 203 ASP~? 10.68 C3 PG4 B 350 D 275 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -1.16 62.88 18.52 0.68 62.16 19.33 coo 23.50 26.43 88.52 24.76 26.47 90.29 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 33.16 21.44 85.29 34.07 21.53 83.40 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 246 ASP B 140 ASP.? 7.99 O2 PG4 B 350 D 275 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -1.16 62.88 18.52 0.68 62.16 19.33 coo 23.50 26.43 88.52 24.76 26.47 90.29 8.40 47.76 23.89 8.35 49.33 25.35 coo 33.16 21.44 85.29 34.07 21.53 83.40 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 246 ASP B 208 ASP~? 8.88 C3 PG4 B 350 D 275 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -1.16 62.88 18.52 0.68 62.16 19.33 coo 23.50 26.43 88.52 24.76 26.47 90.29 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 33.16 21.44 85.29 34.07 21.53 83.40 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 D 107 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 246 ASP A 140 ASP.? 7.37 O2 PG4 A 350 D 275 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 23.50 26.43 88.52 24.76 26.47 90.29 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 33.16 21.44 85.29 34.07 21.53 83.40 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 D 107 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 246 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 275 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 23.50 26.43 88.52 24.76 26.47 90.29 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 33.16 21.44 85.29 34.07 21.53 83.40 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 D 107 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 246 ASP B 203 ASP~? 9.89 C4 PG4 A 350 D 275 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 23.50 26.43 88.52 24.76 26.47 90.29 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 33.16 21.44 85.29 34.07 21.53 83.40 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 D 107 ASP C 41 ASP.? 20.22 O4 PO4 C 349 D 246 ASP C 89 ASP.? 13.45 C5 PG4 D 350 D 275 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 37.41 19.89 81.58 37.64 21.98 81.53 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 23.50 26.43 88.52 24.76 26.47 90.29 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 33.16 21.44 85.29 34.07 21.53 83.40 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 D 107 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 246 ASP C 203 ASP~? 10.24 C6 PG4 D 350 D 275 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 23.50 26.43 88.52 24.76 26.47 90.29 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 33.16 21.44 85.29 34.07 21.53 83.40 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 D 107 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 246 ASP D 208 ASP~? 8.41 C6 PG4 D 350 D 275 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 23.50 26.43 88.52 24.76 26.47 90.29 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 33.16 21.44 85.29 34.07 21.53 83.40 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 11 3 # 11 D 107 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 246 ASP D 131 ASP^? 9.77 C6 PG4 C 350 D 275 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo 37.41 19.89 81.58 37.64 21.98 81.53 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 23.50 26.43 88.52 24.76 26.47 90.29 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 33.16 21.44 85.29 34.07 21.53 83.40 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 12 3 # 12 D 107 ASP D 41 ASP.? 20.92 O2 PO4 D 349 D 246 ASP D 89 ASP.? 16.35 C5 PG4 C 350 D 275 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 37.41 19.89 81.58 37.64 21.98 81.53 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 23.50 26.43 88.52 24.76 26.47 90.29 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 33.16 21.44 85.29 34.07 21.53 83.40 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 13 3 # 13 D 107 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 246 ASP C 140 ASP.? 7.74 C2 PG4 C 350 D 275 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 23.50 26.43 88.52 24.76 26.47 90.29 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 33.16 21.44 85.29 34.07 21.53 83.40 -38.74 26.41 54.26 -37.48 24.84 54.87 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 14 3 # 14 D 107 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 246 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 275 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 23.50 26.43 88.52 24.76 26.47 90.29 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 33.16 21.44 85.29 34.07 21.53 83.40 -38.74 26.41 54.26 -37.48 24.84 54.87 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 15 3 # 15 D 107 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 246 ASP D 203 ASP~? 10.40 O3 PG4 C 350 D 275 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 37.41 19.89 81.58 37.64 21.98 81.53 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 23.50 26.43 88.52 24.76 26.47 90.29 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 33.16 21.44 85.29 34.07 21.53 83.40 -38.74 26.41 54.26 -37.48 24.84 54.87 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 15 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 197 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 223 LYS B 96 LYS~? 18.72 C5 PG4 A 350 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -4.65 11.97 23.20 -9.16 12.78 27.52 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 197 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 223 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 2 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 197 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 223 LYS B 96 LYS~? 18.72 C5 PG4 A 350 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -4.65 11.97 23.20 -9.16 12.78 27.52 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 197 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 223 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 2 hits 1elq_c03 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 10 ALA^? 23.10 O2 PO4 A 349 A 257 ALA A 38 ALA^? 24.00 O2 PO4 A 349 A 328 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -7.72 56.24 46.31 -7.04 55.58 47.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.82 60.44 47.96 -6.30 59.52 49.08 coo 38.17 34.10 6.67 37.72 32.06 6.84 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 38 ALA^? 24.00 O2 PO4 A 349 A 257 ALA A 10 ALA^? 23.10 O2 PO4 A 349 A 328 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -6.82 60.44 47.96 -6.30 59.52 49.08 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.72 56.24 46.31 -7.04 55.58 47.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 68 ALA~? 26.35 O2 PO4 A 349 A 257 ALA A 10 ALA^? 23.10 O2 PO4 A 349 A 328 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -4.26 57.28 52.34 -4.41 56.76 50.92 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.72 56.24 46.31 -7.04 55.58 47.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 68 ALA~? 26.35 O2 PO4 A 349 A 257 ALA A 38 ALA^? 24.00 O2 PO4 A 349 A 328 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -4.26 57.28 52.34 -4.41 56.76 50.92 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.82 60.44 47.96 -6.30 59.52 49.08 coo 38.17 34.10 6.67 37.72 32.06 6.84 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 142 ALA.? 12.14 C2 PG4 A 350 A 257 ALA A 211 ALA~? 12.35 C2 PG4 A 350 A 328 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -16.20 40.87 12.81 -15.80 42.33 13.02 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.84 44.27 15.22 -12.77 44.00 13.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 175 ALA~? 17.35 O1 PO4 A 349 A 257 ALA A 176 ALA~? 18.28 O1 PO4 A 349 A 328 ASP A 343 ASP~? 23.03 O1 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -24.81 67.41 24.63 -24.01 68.06 23.54 coo 43.22 26.73 5.37 41.81 27.09 5.79 -27.00 64.71 23.01 -26.51 63.43 22.36 coo 38.17 34.10 6.67 37.72 32.06 6.84 -25.30 71.23 14.76 -26.68 71.84 16.22 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA A 175 ALA~? 17.35 O1 PO4 A 349 A 257 ALA A 338 ALA~? 14.94 O1 PO4 A 349 A 328 ASP A 343 ASP~? 23.03 O1 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -24.81 67.41 24.63 -24.01 68.06 23.54 coo 43.22 26.73 5.37 41.81 27.09 5.79 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -25.30 71.23 14.76 -26.68 71.84 16.22 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA A 176 ALA~? 18.28 O1 PO4 A 349 A 257 ALA A 175 ALA~? 17.35 O1 PO4 A 349 A 328 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -27.00 64.71 23.01 -26.51 63.43 22.36 coo 43.22 26.73 5.37 41.81 27.09 5.79 -24.81 67.41 24.63 -24.01 68.06 23.54 coo 38.17 34.10 6.67 37.72 32.06 6.84 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA A 176 ALA~? 18.28 O1 PO4 A 349 A 257 ALA A 175 ALA~? 17.35 O1 PO4 A 349 A 328 ASP A 343 ASP~? 23.03 O1 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -27.00 64.71 23.01 -26.51 63.43 22.36 coo 43.22 26.73 5.37 41.81 27.09 5.79 -24.81 67.41 24.63 -24.01 68.06 23.54 coo 38.17 34.10 6.67 37.72 32.06 6.84 -25.30 71.23 14.76 -26.68 71.84 16.22 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA A 201 ALA~? 12.43 O1 PG4 A 350 A 257 ALA A 204 ALA~? 8.46 C8 PG4 B 350 A 328 ASP A 131 ASP^? 9.75 C6 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.23 47.67 26.68 -9.44 47.25 27.90 coo 43.22 26.73 5.37 41.81 27.09 5.79 -5.64 44.18 25.28 -6.10 44.17 26.72 coo 38.17 34.10 6.67 37.72 32.06 6.84 -8.03 41.96 35.37 -6.75 41.25 36.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA A 204 ALA~? 8.46 C8 PG4 B 350 A 257 ALA A 201 ALA~? 12.43 O1 PG4 A 350 A 328 ASP A 131 ASP^? 9.75 C6 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -5.64 44.18 25.28 -6.10 44.17 26.72 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.23 47.67 26.68 -9.44 47.25 27.90 coo 38.17 34.10 6.67 37.72 32.06 6.84 -8.03 41.96 35.37 -6.75 41.25 36.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA A 210 ALA~? 10.48 O1 PG4 A 350 A 257 ALA A 211 ALA~? 12.35 C2 PG4 A 350 A 328 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.24 43.30 17.86 -8.96 44.01 17.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.84 44.27 15.22 -12.77 44.00 13.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA A 210 ALA~? 10.48 O1 PG4 A 350 A 257 ALA A 213 ALA~? 7.64 O1 PG4 A 350 A 328 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.24 43.30 17.86 -8.96 44.01 17.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 -14.74 43.07 20.23 -13.44 43.27 20.98 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA A 211 ALA~? 12.35 C2 PG4 A 350 A 257 ALA A 142 ALA.? 12.14 C2 PG4 A 350 A 328 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.84 44.27 15.22 -12.77 44.00 13.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 -16.20 40.87 12.81 -15.80 42.33 13.02 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA A 211 ALA~? 12.35 C2 PG4 A 350 A 257 ALA A 210 ALA~? 10.48 O1 PG4 A 350 A 328 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.84 44.27 15.22 -12.77 44.00 13.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.24 43.30 17.86 -8.96 44.01 17.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA A 211 ALA~? 12.35 C2 PG4 A 350 A 257 ALA A 210 ALA~? 10.48 O1 PG4 A 350 A 328 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.84 44.27 15.22 -12.77 44.00 13.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.24 43.30 17.86 -8.96 44.01 17.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA A 211 ALA~? 12.35 C2 PG4 A 350 A 257 ALA A 210 ALA~? 10.48 O1 PG4 A 350 A 328 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.84 44.27 15.22 -12.77 44.00 13.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.24 43.30 17.86 -8.96 44.01 17.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA A 211 ALA~? 12.35 C2 PG4 A 350 A 257 ALA A 213 ALA~? 7.64 O1 PG4 A 350 A 328 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.84 44.27 15.22 -12.77 44.00 13.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 -14.74 43.07 20.23 -13.44 43.27 20.98 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA A 211 ALA~? 12.35 C2 PG4 A 350 A 257 ALA A 213 ALA~? 7.64 O1 PG4 A 350 A 328 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.84 44.27 15.22 -12.77 44.00 13.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 -14.74 43.07 20.23 -13.44 43.27 20.98 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 20 3 # 20 A 229 ALA A 213 ALA~? 7.64 O1 PG4 A 350 A 257 ALA A 210 ALA~? 10.48 O1 PG4 A 350 A 328 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.74 43.07 20.23 -13.44 43.27 20.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.24 43.30 17.86 -8.96 44.01 17.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 21 3 # 21 A 229 ALA A 213 ALA~? 7.64 O1 PG4 A 350 A 257 ALA A 210 ALA~? 10.48 O1 PG4 A 350 A 328 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.74 43.07 20.23 -13.44 43.27 20.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.24 43.30 17.86 -8.96 44.01 17.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 22 3 # 22 A 229 ALA A 213 ALA~? 7.64 O1 PG4 A 350 A 257 ALA A 210 ALA~? 10.48 O1 PG4 A 350 A 328 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.74 43.07 20.23 -13.44 43.27 20.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.24 43.30 17.86 -8.96 44.01 17.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 23 3 # 23 A 229 ALA A 213 ALA~? 7.64 O1 PG4 A 350 A 257 ALA A 211 ALA~? 12.35 C2 PG4 A 350 A 328 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.74 43.07 20.23 -13.44 43.27 20.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.84 44.27 15.22 -12.77 44.00 13.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 24 3 # 24 A 229 ALA A 213 ALA~? 7.64 O1 PG4 A 350 A 257 ALA A 211 ALA~? 12.35 C2 PG4 A 350 A 328 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.74 43.07 20.23 -13.44 43.27 20.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.84 44.27 15.22 -12.77 44.00 13.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 25 3 # 25 A 229 ALA A 262 ALA.? 14.15 O4 PO4 A 349 A 257 ALA A 318 ALA~? 17.89 O4 PO4 A 349 A 328 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -3.81 73.23 18.07 -4.57 74.45 18.58 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.76 78.87 15.90 -6.16 78.10 17.06 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 26 3 # 26 A 229 ALA A 314 ALA~? 21.11 O2 PO4 A 349 A 257 ALA A 315 ALA~? 17.77 O2 PO4 A 349 A 328 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -5.48 82.54 20.34 -4.13 82.23 20.99 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.94 79.62 20.68 -8.62 79.20 21.97 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 27 3 # 27 A 229 ALA A 314 ALA~? 21.11 O2 PO4 A 349 A 257 ALA A 318 ALA~? 17.89 O4 PO4 A 349 A 328 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -5.48 82.54 20.34 -4.13 82.23 20.99 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.76 78.87 15.90 -6.16 78.10 17.06 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 28 3 # 28 A 229 ALA A 318 ALA~? 17.89 O4 PO4 A 349 A 257 ALA A 262 ALA.? 14.15 O4 PO4 A 349 A 328 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -6.76 78.87 15.90 -6.16 78.10 17.06 coo 43.22 26.73 5.37 41.81 27.09 5.79 -3.81 73.23 18.07 -4.57 74.45 18.58 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 29 3 # 29 A 229 ALA A 318 ALA~? 17.89 O4 PO4 A 349 A 257 ALA A 314 ALA~? 21.11 O2 PO4 A 349 A 328 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -6.76 78.87 15.90 -6.16 78.10 17.06 coo 43.22 26.73 5.37 41.81 27.09 5.79 -5.48 82.54 20.34 -4.13 82.23 20.99 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 30 3 # 30 A 229 ALA A 318 ALA~? 17.89 O4 PO4 A 349 A 257 ALA A 315 ALA~? 17.77 O2 PO4 A 349 A 328 ASP A 311 ASP~? 22.72 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -6.76 78.87 15.90 -6.16 78.10 17.06 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.94 79.62 20.68 -8.62 79.20 21.97 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.84 83.29 26.02 -4.08 84.26 24.26 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 31 3 # 31 A 229 ALA A 318 ALA~? 17.89 O4 PO4 A 349 A 257 ALA A 315 ALA~? 17.77 O2 PO4 A 349 A 328 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -6.76 78.87 15.90 -6.16 78.10 17.06 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.94 79.62 20.68 -8.62 79.20 21.97 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 32 3 # 32 A 229 ALA A 320 ALA~? 23.05 O4 PO4 A 349 A 257 ALA A 318 ALA~? 17.89 O4 PO4 A 349 A 328 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.88 80.11 12.63 -10.83 81.63 12.81 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.76 78.87 15.90 -6.16 78.10 17.06 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 33 3 # 33 A 229 ALA A 338 ALA~? 14.94 O1 PO4 A 349 A 257 ALA A 175 ALA~? 17.35 O1 PO4 A 349 A 328 ASP A 343 ASP~? 23.03 O1 PO4 A 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 -24.81 67.41 24.63 -24.01 68.06 23.54 coo 38.17 34.10 6.67 37.72 32.06 6.84 -25.30 71.23 14.76 -26.68 71.84 16.22 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 34 3 # 34 A 229 ALA B 10 ALA^? 23.36 O3 PO4 B 349 A 257 ALA B 38 ALA^? 24.33 O3 PO4 B 349 A 328 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 2.16 13.37 10.97 1.64 12.29 11.89 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.83 10.74 7.10 1.38 9.74 8.17 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 35 3 # 35 A 229 ALA B 38 ALA^? 24.33 O3 PO4 B 349 A 257 ALA B 10 ALA^? 23.36 O3 PO4 B 349 A 328 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 1.83 10.74 7.10 1.38 9.74 8.17 coo 43.22 26.73 5.37 41.81 27.09 5.79 2.16 13.37 10.97 1.64 12.29 11.89 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 36 3 # 36 A 229 ALA B 68 ALA~? 26.57 O3 PO4 B 349 A 257 ALA B 10 ALA^? 23.36 O3 PO4 B 349 A 328 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.20 6.85 11.17 -0.38 8.31 11.56 coo 43.22 26.73 5.37 41.81 27.09 5.79 2.16 13.37 10.97 1.64 12.29 11.89 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 37 3 # 37 A 229 ALA B 68 ALA~? 26.57 O3 PO4 B 349 A 257 ALA B 38 ALA^? 24.33 O3 PO4 B 349 A 328 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.20 6.85 11.17 -0.38 8.31 11.56 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.83 10.74 7.10 1.38 9.74 8.17 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 38 3 # 38 A 229 ALA B 142 ALA.? 12.37 C2 PG4 B 350 A 257 ALA B 211 ALA~? 12.63 O1 PG4 B 350 A 328 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 6.73 50.30 18.21 6.20 49.71 16.95 coo 43.22 26.73 5.37 41.81 27.09 5.79 3.26 46.82 15.74 3.00 48.33 15.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 39 3 # 39 A 229 ALA B 175 ALA~? 17.30 O2 PO4 B 349 A 257 ALA B 176 ALA~? 18.30 O2 PO4 B 349 A 328 ASP B 226 ASP.? 24.90 O2 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 14.10 34.75 -6.58 13.02 35.55 -7.27 coo 43.22 26.73 5.37 41.81 27.09 5.79 16.22 37.28 -4.66 15.77 38.11 -3.49 coo 38.17 34.10 6.67 37.72 32.06 6.84 20.38 42.79 0.27 22.43 42.38 0.23 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 40 3 # 40 A 229 ALA B 175 ALA~? 17.30 O2 PO4 B 349 A 257 ALA B 176 ALA~? 18.30 O2 PO4 B 349 A 328 ASP B 343 ASP~? 22.96 O2 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 14.10 34.75 -6.58 13.02 35.55 -7.27 coo 43.22 26.73 5.37 41.81 27.09 5.79 16.22 37.28 -4.66 15.77 38.11 -3.49 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.62 43.49 -12.19 13.89 41.96 -12.92 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 41 3 # 41 A 229 ALA B 175 ALA~? 17.30 O2 PO4 B 349 A 257 ALA B 338 ALA~? 14.85 O2 PO4 B 349 A 328 ASP B 343 ASP~? 22.96 O2 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 14.10 34.75 -6.58 13.02 35.55 -7.27 coo 43.22 26.73 5.37 41.81 27.09 5.79 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.62 43.49 -12.19 13.89 41.96 -12.92 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 42 3 # 42 A 229 ALA B 176 ALA~? 18.30 O2 PO4 B 349 A 257 ALA B 175 ALA~? 17.30 O2 PO4 B 349 A 328 ASP B 343 ASP~? 22.96 O2 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 16.22 37.28 -4.66 15.77 38.11 -3.49 coo 43.22 26.73 5.37 41.81 27.09 5.79 14.10 34.75 -6.58 13.02 35.55 -7.27 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.62 43.49 -12.19 13.89 41.96 -12.92 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 43 3 # 43 A 229 ALA B 201 ALA~? 11.68 O5 PG4 A 350 A 257 ALA B 204 ALA~? 7.34 O5 PG4 A 350 A 328 ASP B 131 ASP^? 9.09 C8 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 1.77 34.76 14.91 1.15 33.57 15.58 coo 43.22 26.73 5.37 41.81 27.09 5.79 -2.79 36.37 18.37 -2.26 34.97 18.59 coo 38.17 34.10 6.67 37.72 32.06 6.84 0.40 27.07 22.40 -0.62 25.51 23.42 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 44 3 # 44 A 229 ALA B 204 ALA~? 7.34 O5 PG4 A 350 A 257 ALA B 201 ALA~? 11.68 O5 PG4 A 350 A 328 ASP B 131 ASP^? 9.09 C8 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -2.79 36.37 18.37 -2.26 34.97 18.59 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.77 34.76 14.91 1.15 33.57 15.58 coo 38.17 34.10 6.67 37.72 32.06 6.84 0.40 27.07 22.40 -0.62 25.51 23.42 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 45 3 # 45 A 229 ALA B 210 ALA~? 10.64 O1 PG4 B 350 A 257 ALA B 211 ALA~? 12.63 O1 PG4 B 350 A 328 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 1.12 44.24 17.53 -0.27 44.37 16.85 coo 43.22 26.73 5.37 41.81 27.09 5.79 3.26 46.82 15.74 3.00 48.33 15.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 46 3 # 46 A 229 ALA B 210 ALA~? 10.64 O1 PG4 B 350 A 257 ALA B 213 ALA~? 7.87 O1 PG4 B 350 A 328 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 1.12 44.24 17.53 -0.27 44.37 16.85 coo 43.22 26.73 5.37 41.81 27.09 5.79 5.93 42.50 17.57 4.67 41.60 17.62 coo 38.17 34.10 6.67 37.72 32.06 6.84 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 47 3 # 47 A 229 ALA B 211 ALA~? 12.63 O1 PG4 B 350 A 257 ALA B 142 ALA.? 12.37 C2 PG4 B 350 A 328 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 3.26 46.82 15.74 3.00 48.33 15.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 6.73 50.30 18.21 6.20 49.71 16.95 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 48 3 # 48 A 229 ALA B 211 ALA~? 12.63 O1 PG4 B 350 A 257 ALA B 210 ALA~? 10.64 O1 PG4 B 350 A 328 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 3.26 46.82 15.74 3.00 48.33 15.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.12 44.24 17.53 -0.27 44.37 16.85 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 49 3 # 49 A 229 ALA B 211 ALA~? 12.63 O1 PG4 B 350 A 257 ALA B 210 ALA~? 10.64 O1 PG4 B 350 A 328 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 3.26 46.82 15.74 3.00 48.33 15.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.12 44.24 17.53 -0.27 44.37 16.85 coo 38.17 34.10 6.67 37.72 32.06 6.84 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 50 3 # 50 A 229 ALA B 211 ALA~? 12.63 O1 PG4 B 350 A 257 ALA B 210 ALA~? 10.64 O1 PG4 B 350 A 328 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 3.26 46.82 15.74 3.00 48.33 15.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.12 44.24 17.53 -0.27 44.37 16.85 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 51 3 # 51 A 229 ALA B 211 ALA~? 12.63 O1 PG4 B 350 A 257 ALA B 213 ALA~? 7.87 O1 PG4 B 350 A 328 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 3.26 46.82 15.74 3.00 48.33 15.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 5.93 42.50 17.57 4.67 41.60 17.62 coo 38.17 34.10 6.67 37.72 32.06 6.84 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 52 3 # 52 A 229 ALA B 211 ALA~? 12.63 O1 PG4 B 350 A 257 ALA B 213 ALA~? 7.87 O1 PG4 B 350 A 328 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 3.26 46.82 15.74 3.00 48.33 15.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 5.93 42.50 17.57 4.67 41.60 17.62 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 53 3 # 53 A 229 ALA B 213 ALA~? 7.87 O1 PG4 B 350 A 257 ALA B 210 ALA~? 10.64 O1 PG4 B 350 A 328 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 5.93 42.50 17.57 4.67 41.60 17.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.12 44.24 17.53 -0.27 44.37 16.85 coo 38.17 34.10 6.67 37.72 32.06 6.84 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 54 3 # 54 A 229 ALA B 213 ALA~? 7.87 O1 PG4 B 350 A 257 ALA B 210 ALA~? 10.64 O1 PG4 B 350 A 328 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 5.93 42.50 17.57 4.67 41.60 17.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.12 44.24 17.53 -0.27 44.37 16.85 coo 38.17 34.10 6.67 37.72 32.06 6.84 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 55 3 # 55 A 229 ALA B 213 ALA~? 7.87 O1 PG4 B 350 A 257 ALA B 210 ALA~? 10.64 O1 PG4 B 350 A 328 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 5.93 42.50 17.57 4.67 41.60 17.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 1.12 44.24 17.53 -0.27 44.37 16.85 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 56 3 # 56 A 229 ALA B 213 ALA~? 7.87 O1 PG4 B 350 A 257 ALA B 211 ALA~? 12.63 O1 PG4 B 350 A 328 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 5.93 42.50 17.57 4.67 41.60 17.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 3.26 46.82 15.74 3.00 48.33 15.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 57 3 # 57 A 229 ALA B 213 ALA~? 7.87 O1 PG4 B 350 A 257 ALA B 211 ALA~? 12.63 O1 PG4 B 350 A 328 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 5.93 42.50 17.57 4.67 41.60 17.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 3.26 46.82 15.74 3.00 48.33 15.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 58 3 # 58 A 229 ALA B 262 ALA.? 14.24 O4 PO4 B 349 A 257 ALA B 318 ALA~? 17.72 O4 PO4 B 349 A 328 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -8.15 37.18 -10.66 -7.46 36.53 -11.87 coo 43.22 26.73 5.37 41.81 27.09 5.79 -5.89 38.26 -16.81 -6.24 37.24 -15.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 59 3 # 59 A 229 ALA B 314 ALA~? 21.17 O3 PO4 B 349 A 257 ALA B 318 ALA~? 17.72 O4 PO4 B 349 A 328 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -6.84 32.96 -19.51 -8.02 32.23 -18.85 coo 43.22 26.73 5.37 41.81 27.09 5.79 -5.89 38.26 -16.81 -6.24 37.24 -15.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 60 3 # 60 A 229 ALA B 318 ALA~? 17.72 O4 PO4 B 349 A 257 ALA B 262 ALA.? 14.24 O4 PO4 B 349 A 328 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -5.89 38.26 -16.81 -6.24 37.24 -15.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.15 37.18 -10.66 -7.46 36.53 -11.87 coo 38.17 34.10 6.67 37.72 32.06 6.84 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 61 3 # 61 A 229 ALA B 318 ALA~? 17.72 O4 PO4 B 349 A 257 ALA B 314 ALA~? 21.17 O3 PO4 B 349 A 328 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -5.89 38.26 -16.81 -6.24 37.24 -15.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.84 32.96 -19.51 -8.02 32.23 -18.85 coo 38.17 34.10 6.67 37.72 32.06 6.84 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 62 3 # 62 A 229 ALA B 318 ALA~? 17.72 O4 PO4 B 349 A 257 ALA B 315 ALA~? 17.89 O3 PO4 B 349 A 328 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -5.89 38.26 -16.81 -6.24 37.24 -15.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 -4.15 33.50 -16.84 -3.20 32.43 -16.31 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 63 3 # 63 A 229 ALA B 320 ALA~? 23.13 O4 PO4 B 349 A 257 ALA B 318 ALA~? 17.72 O4 PO4 B 349 A 328 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -2.44 41.56 -19.41 -2.68 41.04 -20.84 coo 43.22 26.73 5.37 41.81 27.09 5.79 -5.89 38.26 -16.81 -6.24 37.24 -15.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 64 3 # 64 A 229 ALA B 338 ALA~? 14.85 O2 PO4 B 349 A 257 ALA B 175 ALA~? 17.30 O2 PO4 B 349 A 328 ASP B 343 ASP~? 22.96 O2 PO4 B 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 43.22 26.73 5.37 41.81 27.09 5.79 14.10 34.75 -6.58 13.02 35.55 -7.27 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.62 43.49 -12.19 13.89 41.96 -12.92 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 65 3 # 65 A 229 ALA C 10 ALA^? 23.13 O4 PO4 C 349 A 257 ALA C 38 ALA^? 24.18 O4 PO4 C 349 A 328 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -41.98 1.84 18.07 -42.52 0.45 17.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 -43.34 2.68 13.68 -43.68 1.18 13.78 coo 38.17 34.10 6.67 37.72 32.06 6.84 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 66 3 # 66 A 229 ALA C 38 ALA^? 24.18 O4 PO4 C 349 A 257 ALA C 10 ALA^? 23.13 O4 PO4 C 349 A 328 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -43.34 2.68 13.68 -43.68 1.18 13.78 coo 43.22 26.73 5.37 41.81 27.09 5.79 -41.98 1.84 18.07 -42.52 0.45 17.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 67 3 # 67 A 229 ALA C 68 ALA~? 26.31 O3 PG4 D 350 A 257 ALA C 10 ALA^? 23.13 O4 PO4 C 349 A 328 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -45.24 -3.04 14.02 -45.15 -2.24 15.32 coo 43.22 26.73 5.37 41.81 27.09 5.79 -41.98 1.84 18.07 -42.52 0.45 17.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 68 3 # 68 A 229 ALA C 68 ALA~? 26.31 O3 PG4 D 350 A 257 ALA C 38 ALA^? 24.18 O4 PO4 C 349 A 328 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -45.24 -3.04 14.02 -45.15 -2.24 15.32 coo 43.22 26.73 5.37 41.81 27.09 5.79 -43.34 2.68 13.68 -43.68 1.18 13.78 coo 38.17 34.10 6.67 37.72 32.06 6.84 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 69 3 # 69 A 229 ALA C 142 ALA.? 12.35 C2 PG4 C 350 A 257 ALA C 211 ALA~? 12.74 C2 PG4 C 350 A 328 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -33.86 22.03 49.44 -34.51 22.67 48.24 coo 43.22 26.73 5.37 41.81 27.09 5.79 -37.50 21.48 45.38 -37.66 22.61 46.37 coo 38.17 34.10 6.67 37.72 32.06 6.84 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 70 3 # 70 A 229 ALA C 175 ALA~? 17.02 O2 PG4 A 350 A 257 ALA C 176 ALA~? 15.03 O2 PG4 A 350 A 328 ASP C 343 ASP~? 16.17 O1 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -28.16 28.46 20.32 -29.18 29.57 20.45 coo 43.22 26.73 5.37 41.81 27.09 5.79 -25.95 28.73 23.42 -26.39 28.45 24.83 coo 38.17 34.10 6.67 37.72 32.06 6.84 -29.47 38.91 22.93 -28.30 38.51 21.17 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 71 3 # 71 A 229 ALA C 175 ALA~? 17.02 O2 PG4 A 350 A 257 ALA C 338 ALA~? 14.81 O2 PO4 C 349 A 328 ASP C 343 ASP~? 16.17 O1 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -28.16 28.46 20.32 -29.18 29.57 20.45 coo 43.22 26.73 5.37 41.81 27.09 5.79 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 38.17 34.10 6.67 37.72 32.06 6.84 -29.47 38.91 22.93 -28.30 38.51 21.17 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 72 3 # 72 A 229 ALA C 176 ALA~? 15.03 O2 PG4 A 350 A 257 ALA C 175 ALA~? 17.02 O2 PG4 A 350 A 328 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -25.95 28.73 23.42 -26.39 28.45 24.83 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.16 28.46 20.32 -29.18 29.57 20.45 coo 38.17 34.10 6.67 37.72 32.06 6.84 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 73 3 # 73 A 229 ALA C 176 ALA~? 15.03 O2 PG4 A 350 A 257 ALA C 175 ALA~? 17.02 O2 PG4 A 350 A 328 ASP C 343 ASP~? 16.17 O1 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -25.95 28.73 23.42 -26.39 28.45 24.83 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.16 28.46 20.32 -29.18 29.57 20.45 coo 38.17 34.10 6.67 37.72 32.06 6.84 -29.47 38.91 22.93 -28.30 38.51 21.17 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 74 3 # 74 A 229 ALA C 201 ALA~? 12.26 O1 PG4 C 350 A 257 ALA C 204 ALA~? 8.41 C1 PG4 D 350 A 328 ASP C 131 ASP^? 9.91 O2 PG4 D 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -39.60 13.45 36.30 -40.20 12.08 36.02 coo 43.22 26.73 5.37 41.81 27.09 5.79 -43.72 12.08 40.27 -43.19 10.95 39.41 coo 38.17 34.10 6.67 37.72 32.06 6.84 -40.29 2.77 35.99 -41.53 1.06 35.77 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 75 3 # 75 A 229 ALA C 204 ALA~? 8.41 C1 PG4 D 350 A 257 ALA C 201 ALA~? 12.26 O1 PG4 C 350 A 328 ASP C 131 ASP^? 9.91 O2 PG4 D 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -43.72 12.08 40.27 -43.19 10.95 39.41 coo 43.22 26.73 5.37 41.81 27.09 5.79 -39.60 13.45 36.30 -40.20 12.08 36.02 coo 38.17 34.10 6.67 37.72 32.06 6.84 -40.29 2.77 35.99 -41.53 1.06 35.77 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 76 3 # 76 A 229 ALA C 210 ALA~? 10.91 O1 PG4 C 350 A 257 ALA C 211 ALA~? 12.74 C2 PG4 C 350 A 328 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -39.73 18.40 44.95 -41.09 18.98 44.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 -37.50 21.48 45.38 -37.66 22.61 46.37 coo 38.17 34.10 6.67 37.72 32.06 6.84 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 77 3 # 77 A 229 ALA C 210 ALA~? 10.91 O1 PG4 C 350 A 257 ALA C 213 ALA~? 8.04 O1 PG4 C 350 A 328 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -39.73 18.40 44.95 -41.09 18.98 44.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 -34.93 17.01 43.45 -36.20 16.37 42.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 78 3 # 78 A 229 ALA C 211 ALA~? 12.74 C2 PG4 C 350 A 257 ALA C 142 ALA.? 12.35 C2 PG4 C 350 A 328 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -37.50 21.48 45.38 -37.66 22.61 46.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 -33.86 22.03 49.44 -34.51 22.67 48.24 coo 38.17 34.10 6.67 37.72 32.06 6.84 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 79 3 # 79 A 229 ALA C 211 ALA~? 12.74 C2 PG4 C 350 A 257 ALA C 210 ALA~? 10.91 O1 PG4 C 350 A 328 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -37.50 21.48 45.38 -37.66 22.61 46.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 -39.73 18.40 44.95 -41.09 18.98 44.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 80 3 # 80 A 229 ALA C 211 ALA~? 12.74 C2 PG4 C 350 A 257 ALA C 210 ALA~? 10.91 O1 PG4 C 350 A 328 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -37.50 21.48 45.38 -37.66 22.61 46.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 -39.73 18.40 44.95 -41.09 18.98 44.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 81 3 # 81 A 229 ALA C 211 ALA~? 12.74 C2 PG4 C 350 A 257 ALA C 210 ALA~? 10.91 O1 PG4 C 350 A 328 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -37.50 21.48 45.38 -37.66 22.61 46.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 -39.73 18.40 44.95 -41.09 18.98 44.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 82 3 # 82 A 229 ALA C 211 ALA~? 12.74 C2 PG4 C 350 A 257 ALA C 213 ALA~? 8.04 O1 PG4 C 350 A 328 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -37.50 21.48 45.38 -37.66 22.61 46.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 -34.93 17.01 43.45 -36.20 16.37 42.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 83 3 # 83 A 229 ALA C 211 ALA~? 12.74 C2 PG4 C 350 A 257 ALA C 213 ALA~? 8.04 O1 PG4 C 350 A 328 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -37.50 21.48 45.38 -37.66 22.61 46.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 -34.93 17.01 43.45 -36.20 16.37 42.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 84 3 # 84 A 229 ALA C 213 ALA~? 8.04 O1 PG4 C 350 A 257 ALA C 210 ALA~? 10.91 O1 PG4 C 350 A 328 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.93 17.01 43.45 -36.20 16.37 42.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 -39.73 18.40 44.95 -41.09 18.98 44.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 85 3 # 85 A 229 ALA C 213 ALA~? 8.04 O1 PG4 C 350 A 257 ALA C 210 ALA~? 10.91 O1 PG4 C 350 A 328 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.93 17.01 43.45 -36.20 16.37 42.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 -39.73 18.40 44.95 -41.09 18.98 44.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 86 3 # 86 A 229 ALA C 213 ALA~? 8.04 O1 PG4 C 350 A 257 ALA C 211 ALA~? 12.74 C2 PG4 C 350 A 328 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.93 17.01 43.45 -36.20 16.37 42.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 -37.50 21.48 45.38 -37.66 22.61 46.37 coo 38.17 34.10 6.67 37.72 32.06 6.84 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 87 3 # 87 A 229 ALA C 262 ALA.? 14.18 O1 PO4 C 349 A 257 ALA C 318 ALA~? 17.77 O1 PO4 C 349 A 328 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -50.44 33.90 21.10 -49.80 34.39 19.83 coo 43.22 26.73 5.37 41.81 27.09 5.79 -48.31 39.11 17.38 -48.73 37.65 17.44 coo 38.17 34.10 6.67 37.72 32.06 6.84 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 88 3 # 88 A 229 ALA C 314 ALA~? 21.13 O4 PO4 C 349 A 257 ALA C 318 ALA~? 17.77 O1 PO4 C 349 A 328 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -49.85 37.16 11.69 -51.06 36.23 11.72 coo 43.22 26.73 5.37 41.81 27.09 5.79 -48.31 39.11 17.38 -48.73 37.65 17.44 coo 38.17 34.10 6.67 37.72 32.06 6.84 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 89 3 # 89 A 229 ALA C 318 ALA~? 17.77 O1 PO4 C 349 A 257 ALA C 262 ALA.? 14.18 O1 PO4 C 349 A 328 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -48.31 39.11 17.38 -48.73 37.65 17.44 coo 43.22 26.73 5.37 41.81 27.09 5.79 -50.44 33.90 21.10 -49.80 34.39 19.83 coo 38.17 34.10 6.67 37.72 32.06 6.84 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 90 3 # 90 A 229 ALA C 318 ALA~? 17.77 O1 PO4 C 349 A 257 ALA C 314 ALA~? 21.13 O4 PO4 C 349 A 328 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -48.31 39.11 17.38 -48.73 37.65 17.44 coo 43.22 26.73 5.37 41.81 27.09 5.79 -49.85 37.16 11.69 -51.06 36.23 11.72 coo 38.17 34.10 6.67 37.72 32.06 6.84 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 91 3 # 91 A 229 ALA C 318 ALA~? 17.77 O1 PO4 C 349 A 257 ALA C 315 ALA~? 17.93 O4 PO4 C 349 A 328 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -48.31 39.11 17.38 -48.73 37.65 17.44 coo 43.22 26.73 5.37 41.81 27.09 5.79 -46.99 35.68 13.73 -46.10 34.53 13.27 coo 38.17 34.10 6.67 37.72 32.06 6.84 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 92 3 # 92 A 229 ALA C 318 ALA~? 17.77 O1 PO4 C 349 A 257 ALA C 320 ALA~? 23.00 O1 PO4 C 349 A 328 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -48.31 39.11 17.38 -48.73 37.65 17.44 coo 43.22 26.73 5.37 41.81 27.09 5.79 -44.64 43.07 17.84 -44.87 43.74 16.50 coo 38.17 34.10 6.67 37.72 32.06 6.84 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 93 3 # 93 A 229 ALA C 320 ALA~? 23.00 O1 PO4 C 349 A 257 ALA C 318 ALA~? 17.77 O1 PO4 C 349 A 328 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -44.64 43.07 17.84 -44.87 43.74 16.50 coo 43.22 26.73 5.37 41.81 27.09 5.79 -48.31 39.11 17.38 -48.73 37.65 17.44 coo 38.17 34.10 6.67 37.72 32.06 6.84 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 94 3 # 94 A 229 ALA C 338 ALA~? 14.81 O2 PO4 C 349 A 257 ALA C 175 ALA~? 17.02 O2 PG4 A 350 A 328 ASP C 343 ASP~? 16.17 O1 PG4 A 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.16 28.46 20.32 -29.18 29.57 20.45 coo 38.17 34.10 6.67 37.72 32.06 6.84 -29.47 38.91 22.93 -28.30 38.51 21.17 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 95 3 # 95 A 229 ALA D 10 ALA^? 23.89 O2 PO4 D 349 A 257 ALA D 38 ALA^? 24.99 O2 PO4 D 349 A 328 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -49.31 4.33 73.71 -48.80 2.93 73.95 coo 43.22 26.73 5.37 41.81 27.09 5.79 -48.81 5.65 78.20 -48.34 4.19 78.26 coo 38.17 34.10 6.67 37.72 32.06 6.84 -39.78 8.95 76.71 -38.11 10.21 76.27 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 96 3 # 96 A 229 ALA D 68 ALA~? 26.99 C6 PG4 C 350 A 257 ALA D 38 ALA^? 24.99 O2 PO4 D 349 A 328 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -46.39 0.09 78.61 -46.33 0.83 77.26 coo 43.22 26.73 5.37 41.81 27.09 5.79 -48.81 5.65 78.20 -48.34 4.19 78.26 coo 38.17 34.10 6.67 37.72 32.06 6.84 -39.78 8.95 76.71 -38.11 10.21 76.27 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 97 3 # 97 A 229 ALA D 142 ALA.? 12.20 O5 PG4 D 350 A 257 ALA D 211 ALA~? 12.21 O5 PG4 D 350 A 328 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -57.25 19.43 40.27 -56.72 20.25 41.44 coo 43.22 26.73 5.37 41.81 27.09 5.79 -53.58 19.89 44.33 -53.59 20.84 43.15 coo 38.17 34.10 6.67 37.72 32.06 6.84 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 98 3 # 98 A 229 ALA D 175 ALA~? 17.45 O1 PO4 D 349 A 257 ALA D 176 ALA~? 18.20 O1 PO4 D 349 A 328 ASP D 343 ASP~? 23.05 O1 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -64.41 28.74 68.50 -63.57 30.01 68.35 coo 43.22 26.73 5.37 41.81 27.09 5.79 -66.56 28.54 65.37 -66.10 28.17 63.98 coo 38.17 34.10 6.67 37.72 32.06 6.84 -64.64 38.99 64.31 -65.73 38.68 66.10 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 99 3 # 99 A 229 ALA D 175 ALA~? 17.45 O1 PO4 D 349 A 257 ALA D 338 ALA~? 15.02 O1 PO4 D 349 A 328 ASP D 343 ASP~? 23.05 O1 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -64.41 28.74 68.50 -63.57 30.01 68.35 coo 43.22 26.73 5.37 41.81 27.09 5.79 -59.57 33.12 68.34 -59.94 31.78 67.75 coo 38.17 34.10 6.67 37.72 32.06 6.84 -64.64 38.99 64.31 -65.73 38.68 66.10 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 100 3 # 100 A 229 ALA D 176 ALA~? 18.20 O1 PO4 D 349 A 257 ALA D 175 ALA~? 17.45 O1 PO4 D 349 A 328 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -66.56 28.54 65.37 -66.10 28.17 63.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -64.41 28.74 68.50 -63.57 30.01 68.35 coo 38.17 34.10 6.67 37.72 32.06 6.84 -63.02 36.35 69.71 -64.42 35.04 70.68 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 101 3 # 101 A 229 ALA D 201 ALA~? 12.42 C7 PG4 C 350 A 257 ALA D 204 ALA~? 8.16 C7 PG4 C 350 A 328 ASP D 131 ASP^? 9.77 C6 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -50.29 13.95 54.51 -49.45 12.81 55.00 coo 43.22 26.73 5.37 41.81 27.09 5.79 -45.88 12.76 50.82 -46.11 11.67 51.84 coo 38.17 34.10 6.67 37.72 32.06 6.84 -48.29 3.79 55.93 -46.95 2.25 56.44 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 102 3 # 102 A 229 ALA D 204 ALA~? 8.16 C7 PG4 C 350 A 257 ALA D 201 ALA~? 12.42 C7 PG4 C 350 A 328 ASP D 131 ASP^? 9.77 C6 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -45.88 12.76 50.82 -46.11 11.67 51.84 coo 43.22 26.73 5.37 41.81 27.09 5.79 -50.29 13.95 54.51 -49.45 12.81 55.00 coo 38.17 34.10 6.67 37.72 32.06 6.84 -48.29 3.79 55.93 -46.95 2.25 56.44 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 103 3 # 103 A 229 ALA D 211 ALA~? 12.21 O5 PG4 D 350 A 257 ALA D 142 ALA.? 12.20 O5 PG4 D 350 A 328 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -53.58 19.89 44.33 -53.59 20.84 43.15 coo 43.22 26.73 5.37 41.81 27.09 5.79 -57.25 19.43 40.27 -56.72 20.25 41.44 coo 38.17 34.10 6.67 37.72 32.06 6.84 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 104 3 # 104 A 229 ALA D 211 ALA~? 12.21 O5 PG4 D 350 A 257 ALA D 210 ALA~? 10.58 O5 PG4 D 350 A 328 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -53.58 19.89 44.33 -53.59 20.84 43.15 coo 43.22 26.73 5.37 41.81 27.09 5.79 -50.88 17.40 45.28 -49.60 18.23 45.45 coo 38.17 34.10 6.67 37.72 32.06 6.84 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 105 3 # 105 A 229 ALA D 211 ALA~? 12.21 O5 PG4 D 350 A 257 ALA D 210 ALA~? 10.58 O5 PG4 D 350 A 328 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -53.58 19.89 44.33 -53.59 20.84 43.15 coo 43.22 26.73 5.37 41.81 27.09 5.79 -50.88 17.40 45.28 -49.60 18.23 45.45 coo 38.17 34.10 6.67 37.72 32.06 6.84 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 106 3 # 106 A 229 ALA D 211 ALA~? 12.21 O5 PG4 D 350 A 257 ALA D 213 ALA~? 7.41 O5 PG4 D 350 A 328 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -53.58 19.89 44.33 -53.59 20.84 43.15 coo 43.22 26.73 5.37 41.81 27.09 5.79 -55.49 15.49 46.99 -54.18 15.05 47.61 coo 38.17 34.10 6.67 37.72 32.06 6.84 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 107 3 # 107 A 229 ALA D 213 ALA~? 7.41 O5 PG4 D 350 A 257 ALA D 210 ALA~? 10.58 O5 PG4 D 350 A 328 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -55.49 15.49 46.99 -54.18 15.05 47.61 coo 43.22 26.73 5.37 41.81 27.09 5.79 -50.88 17.40 45.28 -49.60 18.23 45.45 coo 38.17 34.10 6.67 37.72 32.06 6.84 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 108 3 # 108 A 229 ALA D 213 ALA~? 7.41 O5 PG4 D 350 A 257 ALA D 210 ALA~? 10.58 O5 PG4 D 350 A 328 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -55.49 15.49 46.99 -54.18 15.05 47.61 coo 43.22 26.73 5.37 41.81 27.09 5.79 -50.88 17.40 45.28 -49.60 18.23 45.45 coo 38.17 34.10 6.67 37.72 32.06 6.84 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 109 3 # 109 A 229 ALA D 213 ALA~? 7.41 O5 PG4 D 350 A 257 ALA D 211 ALA~? 12.21 O5 PG4 D 350 A 328 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 39.84 24.12 8.44 38.50 24.23 9.11 -55.49 15.49 46.99 -54.18 15.05 47.61 coo 43.22 26.73 5.37 41.81 27.09 5.79 -53.58 19.89 44.33 -53.59 20.84 43.15 coo 38.17 34.10 6.67 37.72 32.06 6.84 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 110 3 # 110 A 229 ALA D 262 ALA.? 14.16 O4 PO4 D 349 A 257 ALA D 318 ALA~? 17.72 O4 PO4 D 349 A 328 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -43.19 37.69 66.65 -43.90 38.22 67.91 coo 43.22 26.73 5.37 41.81 27.09 5.79 -46.09 42.95 69.61 -45.44 41.57 69.77 coo 38.17 34.10 6.67 37.72 32.06 6.84 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 111 3 # 111 A 229 ALA D 314 ALA~? 21.06 O2 PO4 D 349 A 257 ALA D 318 ALA~? 17.72 O4 PO4 D 349 A 328 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -44.47 42.22 75.35 -43.13 41.48 75.40 coo 43.22 26.73 5.37 41.81 27.09 5.79 -46.09 42.95 69.61 -45.44 41.57 69.77 coo 38.17 34.10 6.67 37.72 32.06 6.84 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 112 3 # 112 A 229 ALA D 318 ALA~? 17.72 O4 PO4 D 349 A 257 ALA D 262 ALA.? 14.16 O4 PO4 D 349 A 328 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -46.09 42.95 69.61 -45.44 41.57 69.77 coo 43.22 26.73 5.37 41.81 27.09 5.79 -43.19 37.69 66.65 -43.90 38.22 67.91 coo 38.17 34.10 6.67 37.72 32.06 6.84 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 113 3 # 113 A 229 ALA D 318 ALA~? 17.72 O4 PO4 D 349 A 257 ALA D 314 ALA~? 21.06 O2 PO4 D 349 A 328 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -46.09 42.95 69.61 -45.44 41.57 69.77 coo 43.22 26.73 5.37 41.81 27.09 5.79 -44.47 42.22 75.35 -43.13 41.48 75.40 coo 38.17 34.10 6.67 37.72 32.06 6.84 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 114 3 # 114 A 229 ALA D 318 ALA~? 17.72 O4 PO4 D 349 A 257 ALA D 315 ALA~? 17.83 O2 PO4 D 349 A 328 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -46.09 42.95 69.61 -45.44 41.57 69.77 coo 43.22 26.73 5.37 41.81 27.09 5.79 -46.93 39.91 73.63 -47.63 38.72 74.27 coo 38.17 34.10 6.67 37.72 32.06 6.84 -43.35 38.70 79.64 -42.93 40.74 79.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 115 3 # 115 A 229 ALA D 320 ALA~? 23.04 O4 PO4 D 349 A 257 ALA D 318 ALA~? 17.72 O4 PO4 D 349 A 328 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 39.84 24.12 8.44 38.50 24.23 9.11 -50.30 46.26 68.76 -50.08 47.15 69.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -46.09 42.95 69.61 -45.44 41.57 69.77 coo 38.17 34.10 6.67 37.72 32.06 6.84 -51.05 35.32 70.59 -50.24 33.36 70.95 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 115 hits 1eo7_c00 naa= 3 ULMN 3 1esc_c00 ESTERASE user 1 3 # 1 14 SER C 169 SER~? 7.39 O2 PO4 C 349 280 TRP C 181 TRP.? 10.24 C1 PG4 A 350 283 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -35.40 25.65 26.78 -36.52 25.32 28.91 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -23.22 31.17 24.81 -20.89 33.85 26.48 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 1esc_c00 ESTERASE user 2 3 # 2 14 SER C 169 SER~? 7.39 O2 PO4 C 349 280 TRP C 181 TRP.? 10.24 C1 PG4 A 350 283 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -35.40 25.65 26.78 -36.52 25.32 28.91 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -23.22 31.17 24.81 -20.89 33.85 26.48 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1esc_c00 ESTERASE user 3 3 # 3 14 SER D 169 SER~? 7.40 O1 PO4 D 349 280 TRP D 181 TRP.? 23.46 O1 PO4 D 349 283 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -56.61 26.42 62.40 -55.41 26.04 60.30 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -69.65 29.97 63.31 -72.25 31.63 60.90 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -62.51 23.18 64.17 -63.84 21.56 64.29 ULMN 3 1esc_c00 ESTERASE user 4 3 # 4 14 SER D 169 SER~? 7.40 O1 PO4 D 349 280 TRP D 181 TRP.? 23.46 O1 PO4 D 349 283 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -56.61 26.42 62.40 -55.41 26.04 60.30 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -69.65 29.97 63.31 -72.25 31.63 60.90 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -61.67 25.88 60.45 -63.21 27.00 61.32 1esc_c00 source 1esc ESTERASE : 4 hits 1esc_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 188 THR.? 8.85 O1 PO4 A 349 A 159 LYS A 165 LYS~? -2.78 O4 PO4 A 349s A 193 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -12.86 51.47 24.24 -13.27 52.66 22.49 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -10.69 61.92 21.86 -6.45 59.75 20.54 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 159 THR.? 9.69 O4 PO4 B 349 A 159 LYS B 165 LYS~? -2.78 O4 PO4 B 349s A 193 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -7.46 42.26 -1.59 -7.39 42.02 -3.73 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.37 36.49 0.17 -3.63 37.66 2.73 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 188 THR.? 8.78 O2 PO4 B 349 A 159 LYS B 165 LYS~? -2.78 O4 PO4 B 349s A 193 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo -2.58 16.31 54.79 -4.02 14.93 55.64 3.85 36.60 10.61 3.87 38.08 9.08 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.37 36.49 0.17 -3.63 37.66 2.73 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR C 188 THR.? 8.83 O2 PO4 C 349 A 159 LYS C 165 LYS~? -2.77 O1 PO4 C 349s A 193 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -37.76 18.01 34.48 -37.79 20.16 34.48 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -41.72 25.46 27.54 -45.65 24.70 30.33 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR D 188 THR.? 8.76 O1 PO4 D 349 A 159 LYS D 165 LYS~? -2.89 O4 PO4 D 349s A 193 GLU D 171 GLU~? 12.87 O2 PO4 D 349 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -52.97 18.36 55.76 -53.30 20.49 55.46 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -50.59 27.20 61.67 -46.47 26.50 58.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -56.37 27.70 69.07 -57.02 27.32 71.04 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 5 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 41 ASP.? 20.10 O2 PO4 A 349 260 GLU A 94 GLU~? 21.51 O3 PG4 B 350 370 TYR A 91 TYR~? 12.90 C4 PG4 B 350 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 1.74 60.96 43.57 3.36 61.47 42.28 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 2.26 51.25 46.83 2.00 52.68 48.40 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 3.23 49.01 40.90 3.18 50.90 38.82 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP B 41 ASP.? 20.21 O3 PO4 B 349 260 GLU B 94 GLU~? 22.11 C5 PG4 A 350 370 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP C 41 ASP.? 20.22 O4 PO4 C 349 260 GLU C 94 GLU~? 21.12 C5 PG4 D 350 370 TYR C 91 TYR~? 12.18 C5 PG4 D 350 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -52.07 0.67 28.08 -52.42 3.42 27.72 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP D 41 ASP.? 20.92 O2 PO4 D 349 260 GLU D 94 GLU~? 22.39 C6 PG4 C 350 370 TYR D 91 TYR~? 13.46 C4 PG4 C 350 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -37.64 3.76 65.52 -37.58 6.56 65.66 1euu_c00 source 1euu SIALIDASE : 4 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 171 GLU~? 12.95 O2 PO4 A 349 A 260 ARG A 261 ARG^? 7.73 O2 PO4 A 349 A 270 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 50.99 29.43 12.86 52.11 29.45 14.65 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 39.80 27.50 22.98 42.20 26.56 21.34 -1.53 69.75 22.21 -1.72 66.84 23.28 coo 48.83 21.70 19.50 47.44 24.99 15.25 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 196 GLU~? 14.14 O1 PO4 A 349 A 260 ARG A 153 ARG^? 21.78 O1 PO4 A 349 A 270 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 39.80 27.50 22.98 42.20 26.56 21.34 -23.08 51.89 14.34 -24.46 52.07 11.57 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 231 GLU.? 5.77 O1 PO4 A 349 A 260 ARG A 153 ARG^? 21.78 O1 PO4 A 349 A 270 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 39.80 27.50 22.98 42.20 26.56 21.34 -23.08 51.89 14.34 -24.46 52.07 11.57 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU A 231 GLU.? 5.77 O1 PO4 A 349 A 260 ARG A 220 ARG~? 15.84 O1 PG4 A 350 A 270 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 39.80 27.50 22.98 42.20 26.56 21.34 -23.72 43.89 25.49 -25.14 44.23 28.23 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU B 171 GLU~? 12.87 O3 PO4 B 349 A 260 ARG B 261 ARG^? 7.86 O3 PO4 B 349 A 270 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 50.99 29.43 12.86 52.11 29.45 14.65 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 39.80 27.50 22.98 42.20 26.56 21.34 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo 48.83 21.70 19.50 47.44 24.99 15.25 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU B 196 GLU~? 13.82 O2 PO4 B 349 A 260 ARG B 153 ARG^? 21.71 O2 PO4 B 349 A 270 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 10.06 30.74 8.04 11.63 30.24 6.70 coo 39.80 27.50 22.98 42.20 26.56 21.34 12.56 47.43 6.76 13.42 50.26 5.86 coo 48.83 21.70 19.50 47.44 24.99 15.25 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU B 231 GLU.? 5.72 O2 PO4 B 349 A 260 ARG B 153 ARG^? 21.71 O2 PO4 B 349 A 270 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 3.23 35.71 5.73 3.00 33.97 6.89 coo 39.80 27.50 22.98 42.20 26.56 21.34 12.56 47.43 6.76 13.42 50.26 5.86 coo 48.83 21.70 19.50 47.44 24.99 15.25 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 8 3 # 8 A 34 GLU C 171 GLU~? 12.90 O2 PO4 C 349 A 260 ARG C 261 ARG^? 7.89 O4 PO4 C 349 A 270 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 50.99 29.43 12.86 52.11 29.45 14.65 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 39.80 27.50 22.98 42.20 26.56 21.34 -51.94 28.25 21.63 -51.22 25.74 23.33 coo 48.83 21.70 19.50 47.44 24.99 15.25 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 9 3 # 9 A 34 GLU C 196 GLU~? 13.61 O2 PO4 C 349 A 260 ARG C 153 ARG^? 21.82 O2 PO4 C 349 A 270 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 39.80 27.50 22.98 42.20 26.56 21.34 -28.52 27.96 39.05 -27.50 30.55 40.41 coo 48.83 21.70 19.50 47.44 24.99 15.25 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 10 3 # 10 A 34 GLU C 231 GLU.? 5.70 O2 PO4 C 349 A 260 ARG C 153 ARG^? 21.82 O2 PO4 C 349 A 270 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 39.80 27.50 22.98 42.20 26.56 21.34 -28.52 27.96 39.05 -27.50 30.55 40.41 coo 48.83 21.70 19.50 47.44 24.99 15.25 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 11 3 # 11 A 34 GLU C 231 GLU.? 5.70 O2 PO4 C 349 A 260 ARG C 220 ARG~? 11.31 O1 PG4 C 350 A 270 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 39.80 27.50 22.98 42.20 26.56 21.34 -25.78 14.58 38.60 -28.17 14.03 40.55 coo 48.83 21.70 19.50 47.44 24.99 15.25 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 12 3 # 12 A 34 GLU D 171 GLU~? 12.87 O2 PO4 D 349 A 260 ARG D 152 ARG^? 23.56 O1 PO4 D 349 A 270 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 39.80 27.50 22.98 42.20 26.56 21.34 -66.62 32.34 56.11 -68.43 34.76 55.54 coo 48.83 21.70 19.50 47.44 24.99 15.25 -68.08 25.33 66.69 -67.75 19.10 66.60 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 13 3 # 13 A 34 GLU D 171 GLU~? 12.87 O2 PO4 D 349 A 260 ARG D 261 ARG^? 8.01 O2 PO4 D 349 A 270 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 50.99 29.43 12.86 52.11 29.45 14.65 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 39.80 27.50 22.98 42.20 26.56 21.34 -41.02 32.36 67.18 -41.18 29.51 65.99 coo 48.83 21.70 19.50 47.44 24.99 15.25 -50.59 27.20 61.67 -46.47 26.50 58.89 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 14 3 # 14 A 34 GLU D 196 GLU~? 13.48 O1 PO4 D 349 A 260 ARG D 153 ARG^? 21.95 O1 PO4 D 349 A 270 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 39.80 27.50 22.98 42.20 26.56 21.34 -63.61 25.82 49.88 -65.26 27.93 48.32 coo 48.83 21.70 19.50 47.44 24.99 15.25 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 15 3 # 15 A 34 GLU D 231 GLU.? 5.62 O1 PO4 D 349 A 260 ARG D 153 ARG^? 21.95 O1 PO4 D 349 A 270 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 39.80 27.50 22.98 42.20 26.56 21.34 -63.61 25.82 49.88 -65.26 27.93 48.32 coo 48.83 21.70 19.50 47.44 24.99 15.25 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 16 3 # 16 A 34 GLU D 231 GLU.? 5.62 O1 PO4 D 349 A 260 ARG D 220 ARG~? 10.23 O5 PG4 D 350 A 270 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo 50.99 29.43 12.86 52.11 29.45 14.65 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 39.80 27.50 22.98 42.20 26.56 21.34 -64.10 12.09 51.59 -61.65 11.18 49.96 coo 48.83 21.70 19.50 47.44 24.99 15.25 -64.76 21.00 60.32 -64.61 15.17 58.23 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 16 hits 1euy_c00 naa= 3 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 1 3 # 1 A 156 LYS B 177 LYS~? 21.19 O2 PO4 B 349 A 159 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 162 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 18.35 34.41 -3.27 19.41 29.18 0.25 coo 29.80 39.37 7.24 28.18 38.06 7.48 13.23 34.15 0.64 14.88 33.23 1.56 coo 30.26 35.04 5.34 28.61 35.92 4.39 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 2 3 # 2 A 156 LYS B 177 LYS~? 21.19 O2 PO4 B 349 A 159 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 162 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 18.35 34.41 -3.27 19.41 29.18 0.25 coo 29.80 39.37 7.24 28.18 38.06 7.48 11.38 38.70 0.79 12.71 38.99 -0.80 coo 30.26 35.04 5.34 28.61 35.92 4.39 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 3 3 # 3 A 156 LYS D 177 LYS~? 20.36 O1 PO4 D 349 A 159 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 162 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 29.80 39.37 7.24 28.18 38.06 7.48 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 30.26 35.04 5.34 28.61 35.92 4.39 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 4 3 # 4 A 156 LYS D 177 LYS~? 20.36 O1 PO4 D 349 A 159 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 162 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 29.80 39.37 7.24 28.18 38.06 7.48 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 30.26 35.04 5.34 28.61 35.92 4.39 -62.51 23.18 64.17 -63.84 21.56 64.29 1f7u_c00 source 1f7u ARGINYL-TRNA SYNTHETASE : 4 hits 1f7u_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 62 LYS B 96 LYS~? 18.72 C5 PG4 A 350 F 35 ASP B 90 ASP~? 17.21 C5 PG4 A 350 coo 15.40 22.79 16.66 13.93 24.10 15.98 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 19.95 18.98 4.81 18.82 20.94 10.49 -4.65 11.97 23.20 -9.16 12.78 27.52 coo 16.32 15.30 17.19 17.71 14.73 18.69 -14.26 14.51 16.36 -14.11 16.10 14.94 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 62 LYS D 96 LYS~? 18.18 C6 PG4 C 350 F 35 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 15.40 22.79 16.66 13.93 24.10 15.98 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 19.95 18.98 4.81 18.82 20.94 10.49 -42.30 -5.81 66.82 -37.97 -8.16 62.87 coo 16.32 15.30 17.19 17.71 14.73 18.69 -33.15 1.70 68.90 -33.50 3.76 68.48 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c03 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS B 96 LYS~? 18.72 C5 PG4 A 350 B 105 HIS B 14 HIS.? 21.30 C5 PG4 A 350 E 35 ASP B 90 ASP~? 17.21 C5 PG4 A 350 coo 20.51 39.76 8.83 21.23 37.38 14.18 -4.65 11.97 23.20 -9.16 12.78 27.52 coo 27.18 37.56 20.68 29.07 38.28 20.13 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 19.97 40.39 22.03 18.53 39.30 23.18 -14.26 14.51 16.36 -14.11 16.10 14.94 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS D 96 LYS~? 18.18 C6 PG4 C 350 B 105 HIS D 14 HIS.? 21.26 C4 PG4 C 350 E 35 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 20.51 39.76 8.83 21.23 37.38 14.18 -42.30 -5.81 66.82 -37.97 -8.16 62.87 coo 27.18 37.56 20.68 29.07 38.28 20.13 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 19.97 40.39 22.03 18.53 39.30 23.18 -33.15 1.70 68.90 -33.50 3.76 68.48 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c05 naa= 3 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 1 3 # 1 A 180 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 191 CYH A 44 CYH~? 20.51 O2 PO4 A 349 A 228 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 26.35 46.39 51.64 24.52 45.66 52.39 3.61 55.89 43.73 3.10 55.52 45.73 coo 16.62 40.80 48.93 16.46 38.74 50.82 3.79 65.29 45.10 3.54 65.25 42.31 coo 24.60 42.24 47.99 21.60 41.75 48.44 7.49 56.88 46.72 6.71 54.94 44.43 1f8m_c00 source 1f8m ISOCITRATE LYASE : 1 hits 1f8m_c00 naa= 3 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 1 3 # 1 B 180 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 191 CYH A 44 CYH~? 20.51 O2 PO4 A 349 B 228 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo -1.29 58.02 79.43 0.64 57.19 79.31 3.61 55.89 43.73 3.10 55.52 45.73 coo 8.78 59.01 84.54 9.56 56.29 85.16 3.79 65.29 45.10 3.54 65.25 42.31 coo 0.68 59.10 84.66 3.77 58.91 84.59 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 2 3 # 2 B 180 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 191 CYH B 44 CYH.? 20.73 O3 PO4 B 349 B 228 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo -1.29 58.02 79.43 0.64 57.19 79.31 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 8.78 59.01 84.54 9.56 56.29 85.16 -8.90 10.53 1.89 -9.13 13.22 1.20 coo 0.68 59.10 84.66 3.77 58.91 84.59 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 3 3 # 3 B 180 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 191 CYH C 44 CYH.? 20.66 O4 PO4 C 349 B 228 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo -1.29 58.02 79.43 0.64 57.19 79.31 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 8.78 59.01 84.54 9.56 56.29 85.16 -54.82 6.18 12.39 -54.72 8.60 13.80 coo 0.68 59.10 84.66 3.77 58.91 84.59 -57.88 0.79 18.76 -56.46 0.67 21.52 1f8m_c01 source 1f8m ISOCITRATE LYASE : 3 hits 1f8m_c01 naa= 3 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 1 3 # 1 C 180 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 191 CYH A 44 CYH~? 20.51 O2 PO4 A 349 C 228 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 2.43 65.34 36.80 3.92 66.76 37.21 3.61 55.89 43.73 3.10 55.52 45.73 coo 13.01 68.26 34.18 13.01 71.04 33.71 3.79 65.29 45.10 3.54 65.25 42.31 coo 5.82 65.41 32.29 8.60 66.57 33.01 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 2 3 # 2 C 180 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 191 CYH B 44 CYH.? 20.73 O3 PO4 B 349 C 228 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 2.43 65.34 36.80 3.92 66.76 37.21 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 13.01 68.26 34.18 13.01 71.04 33.71 -8.90 10.53 1.89 -9.13 13.22 1.20 coo 5.82 65.41 32.29 8.60 66.57 33.01 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 3 3 # 3 C 180 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 191 CYH C 44 CYH.? 20.66 O4 PO4 C 349 C 228 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 2.43 65.34 36.80 3.92 66.76 37.21 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 13.01 68.26 34.18 13.01 71.04 33.71 -54.82 6.18 12.39 -54.72 8.60 13.80 coo 5.82 65.41 32.29 8.60 66.57 33.01 -57.88 0.79 18.76 -56.46 0.67 21.52 1f8m_c02 source 1f8m ISOCITRATE LYASE : 3 hits 1f8m_c02 naa= 3 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 1 3 # 1 D 180 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 191 CYH A 44 CYH~? 20.51 O2 PO4 A 349 D 228 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 17.18 84.74 69.76 15.58 84.83 68.40 3.61 55.89 43.73 3.10 55.52 45.73 coo 5.89 86.47 69.92 5.21 88.39 67.91 3.79 65.29 45.10 3.54 65.25 42.31 coo 13.48 87.80 72.67 10.60 87.44 71.57 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 2 3 # 2 D 180 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 191 CYH C 44 CYH.? 20.66 O4 PO4 C 349 D 228 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 17.18 84.74 69.76 15.58 84.83 68.40 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 5.89 86.47 69.92 5.21 88.39 67.91 -54.82 6.18 12.39 -54.72 8.60 13.80 coo 13.48 87.80 72.67 10.60 87.44 71.57 -57.88 0.79 18.76 -56.46 0.67 21.52 1f8m_c03 source 1f8m ISOCITRATE LYASE : 2 hits 1f8m_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 210 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 244 LYS B 96 LYS~? 18.72 C5 PG4 A 350 coo 11.28 44.53 18.60 9.91 46.00 19.20 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -1.20 42.34 17.67 3.19 45.13 19.06 -4.65 11.97 23.20 -9.16 12.78 27.52 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 210 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 244 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 11.28 44.53 18.60 9.91 46.00 19.20 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -1.20 42.34 17.67 3.19 45.13 19.06 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 210 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 244 LYS B 96 LYS~? 18.72 C5 PG4 A 350 coo 10.08 50.18 41.78 8.91 48.61 41.04 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -2.38 51.82 41.62 2.07 49.19 40.42 -4.65 11.97 23.20 -9.16 12.78 27.52 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 210 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 244 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 10.08 50.18 41.78 8.91 48.61 41.04 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -2.38 51.82 41.62 2.07 49.19 40.42 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 221 TYR~? 17.25 O1 PG4 A 350 A 142 LEU A 149 LEU~? 20.90 O1 PG4 A 350 A 165 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -24.98 48.97 24.49 -23.82 47.69 26.70 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -27.09 49.45 14.10 -26.48 47.95 15.59 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 225 TYR.? 21.13 O1 PO4 A 349 A 142 LEU A 149 LEU~? 20.90 O1 PG4 A 350 A 165 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -28.82 53.90 23.23 -28.73 53.13 25.91 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -27.09 49.45 14.10 -26.48 47.95 15.59 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR B 221 TYR~? 17.66 O1 PG4 B 350 A 142 LEU B 149 LEU~? 21.21 O1 PG4 B 350 A 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 16.24 38.44 11.23 15.50 36.34 12.94 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 16.58 48.64 8.60 16.30 47.40 10.36 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 142 LEU B 149 LEU~? 21.21 O1 PG4 B 350 A 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 19.22 39.10 5.74 19.70 36.67 7.05 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 16.58 48.64 8.60 16.30 47.40 10.36 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 142 LEU B 186 LEU^? 14.03 O2 PO4 B 349 A 165 LYS B 223 LYS~? 20.96 O1 PG4 B 350 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 19.22 39.10 5.74 19.70 36.67 7.05 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 10.06 38.15 8.40 11.92 38.92 9.16 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 21.08 44.90 9.51 21.11 48.16 14.97 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR C 221 TYR~? 17.74 O1 PG4 C 350 A 142 LEU C 149 LEU~? 21.32 C2 PG4 C 350 A 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -25.26 18.68 35.52 -25.91 16.01 35.07 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -24.26 27.54 40.96 -24.59 25.42 41.35 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR C 225 TYR~? 18.05 C6 PG4 A 350 A 142 LEU C 149 LEU~? 21.32 C2 PG4 C 350 A 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -22.42 22.90 31.89 -22.15 20.23 31.17 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -24.26 27.54 40.96 -24.59 25.42 41.35 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 137 TYR C 225 TYR~? 18.05 C6 PG4 A 350 A 142 LEU C 186 LEU^? 14.24 O2 PO4 C 349 A 165 LYS C 223 LYS~? 21.04 C2 PG4 C 350 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -22.42 22.90 31.89 -22.15 20.23 31.17 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -31.51 20.62 33.77 -29.48 20.59 34.66 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -19.98 24.16 38.56 -19.29 22.78 44.77 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 A 137 TYR D 221 TYR~? 17.09 O5 PG4 D 350 A 142 LEU D 149 LEU~? 20.41 O5 PG4 D 350 A 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -65.63 16.43 54.69 -64.60 13.90 55.16 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -67.67 24.38 48.14 -67.04 22.30 48.02 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 A 137 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 142 LEU D 149 LEU~? 20.41 O5 PG4 D 350 A 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -68.84 20.67 57.80 -68.69 18.14 58.96 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -67.67 24.38 48.14 -67.04 22.30 48.02 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -64.76 21.00 60.32 -64.61 15.17 58.23 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 10 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 221 TYR~? 17.25 O1 PG4 A 350 B 142 LEU A 149 LEU~? 20.90 O1 PG4 A 350 B 165 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -24.98 48.97 24.49 -23.82 47.69 26.70 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -27.09 49.45 14.10 -26.48 47.95 15.59 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 225 TYR.? 21.13 O1 PO4 A 349 B 142 LEU A 149 LEU~? 20.90 O1 PG4 A 350 B 165 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -28.82 53.90 23.23 -28.73 53.13 25.91 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -27.09 49.45 14.10 -26.48 47.95 15.59 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR B 221 TYR~? 17.66 O1 PG4 B 350 B 142 LEU B 149 LEU~? 21.21 O1 PG4 B 350 B 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 16.24 38.44 11.23 15.50 36.34 12.94 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 16.58 48.64 8.60 16.30 47.40 10.36 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR B 225 TYR~? 21.07 O2 PO4 B 349 B 142 LEU B 149 LEU~? 21.21 O1 PG4 B 350 B 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 19.22 39.10 5.74 19.70 36.67 7.05 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 16.58 48.64 8.60 16.30 47.40 10.36 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR B 225 TYR~? 21.07 O2 PO4 B 349 B 142 LEU B 186 LEU^? 14.03 O2 PO4 B 349 B 165 LYS B 223 LYS~? 20.96 O1 PG4 B 350 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 19.22 39.10 5.74 19.70 36.67 7.05 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 10.06 38.15 8.40 11.92 38.92 9.16 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 21.08 44.90 9.51 21.11 48.16 14.97 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR C 221 TYR~? 17.74 O1 PG4 C 350 B 142 LEU C 149 LEU~? 21.32 C2 PG4 C 350 B 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -25.26 18.68 35.52 -25.91 16.01 35.07 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -24.26 27.54 40.96 -24.59 25.42 41.35 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 137 TYR C 225 TYR~? 18.05 C6 PG4 A 350 B 142 LEU C 149 LEU~? 21.32 C2 PG4 C 350 B 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -22.42 22.90 31.89 -22.15 20.23 31.17 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -24.26 27.54 40.96 -24.59 25.42 41.35 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 B 137 TYR C 225 TYR~? 18.05 C6 PG4 A 350 B 142 LEU C 186 LEU^? 14.24 O2 PO4 C 349 B 165 LYS C 223 LYS~? 21.04 C2 PG4 C 350 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -22.42 22.90 31.89 -22.15 20.23 31.17 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -31.51 20.62 33.77 -29.48 20.59 34.66 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -19.98 24.16 38.56 -19.29 22.78 44.77 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 B 137 TYR D 221 TYR~? 17.09 O5 PG4 D 350 B 142 LEU D 149 LEU~? 20.41 O5 PG4 D 350 B 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -65.63 16.43 54.69 -64.60 13.90 55.16 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -67.67 24.38 48.14 -67.04 22.30 48.02 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 B 137 TYR D 225 TYR.? 21.05 O1 PO4 D 349 B 142 LEU D 149 LEU~? 20.41 O5 PG4 D 350 B 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -68.84 20.67 57.80 -68.69 18.14 58.96 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -67.67 24.38 48.14 -67.04 22.30 48.02 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -64.76 21.00 60.32 -64.61 15.17 58.23 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 10 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 221 TYR~? 17.25 O1 PG4 A 350 C 142 LEU A 149 LEU~? 20.90 O1 PG4 A 350 C 165 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -24.98 48.97 24.49 -23.82 47.69 26.70 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -27.09 49.45 14.10 -26.48 47.95 15.59 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 225 TYR.? 21.13 O1 PO4 A 349 C 142 LEU A 149 LEU~? 20.90 O1 PG4 A 350 C 165 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -28.82 53.90 23.23 -28.73 53.13 25.91 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -27.09 49.45 14.10 -26.48 47.95 15.59 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR B 221 TYR~? 17.66 O1 PG4 B 350 C 142 LEU B 149 LEU~? 21.21 O1 PG4 B 350 C 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 16.24 38.44 11.23 15.50 36.34 12.94 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 16.58 48.64 8.60 16.30 47.40 10.36 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR B 225 TYR~? 21.07 O2 PO4 B 349 C 142 LEU B 149 LEU~? 21.21 O1 PG4 B 350 C 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 19.22 39.10 5.74 19.70 36.67 7.05 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 16.58 48.64 8.60 16.30 47.40 10.36 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR B 225 TYR~? 21.07 O2 PO4 B 349 C 142 LEU B 186 LEU^? 14.03 O2 PO4 B 349 C 165 LYS B 223 LYS~? 20.96 O1 PG4 B 350 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 19.22 39.10 5.74 19.70 36.67 7.05 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 10.06 38.15 8.40 11.92 38.92 9.16 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 21.08 44.90 9.51 21.11 48.16 14.97 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR C 221 TYR~? 17.74 O1 PG4 C 350 C 142 LEU C 149 LEU~? 21.32 C2 PG4 C 350 C 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -25.26 18.68 35.52 -25.91 16.01 35.07 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -24.26 27.54 40.96 -24.59 25.42 41.35 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 137 TYR C 225 TYR~? 18.05 C6 PG4 A 350 C 142 LEU C 149 LEU~? 21.32 C2 PG4 C 350 C 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -22.42 22.90 31.89 -22.15 20.23 31.17 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -24.26 27.54 40.96 -24.59 25.42 41.35 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 137 TYR C 225 TYR~? 18.05 C6 PG4 A 350 C 142 LEU C 186 LEU^? 14.24 O2 PO4 C 349 C 165 LYS C 223 LYS~? 21.04 C2 PG4 C 350 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -22.42 22.90 31.89 -22.15 20.23 31.17 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -31.51 20.62 33.77 -29.48 20.59 34.66 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -19.98 24.16 38.56 -19.29 22.78 44.77 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 C 137 TYR D 221 TYR~? 17.09 O5 PG4 D 350 C 142 LEU D 149 LEU~? 20.41 O5 PG4 D 350 C 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -65.63 16.43 54.69 -64.60 13.90 55.16 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -67.67 24.38 48.14 -67.04 22.30 48.02 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 C 137 TYR D 225 TYR.? 21.05 O1 PO4 D 349 C 142 LEU D 149 LEU~? 20.41 O5 PG4 D 350 C 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -68.84 20.67 57.80 -68.69 18.14 58.96 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -67.67 24.38 48.14 -67.04 22.30 48.02 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -64.76 21.00 60.32 -64.61 15.17 58.23 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 10 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 221 TYR~? 17.25 O1 PG4 A 350 D 142 LEU A 149 LEU~? 20.90 O1 PG4 A 350 D 165 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -24.98 48.97 24.49 -23.82 47.69 26.70 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -27.09 49.45 14.10 -26.48 47.95 15.59 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 225 TYR.? 21.13 O1 PO4 A 349 D 142 LEU A 149 LEU~? 20.90 O1 PG4 A 350 D 165 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -28.82 53.90 23.23 -28.73 53.13 25.91 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -27.09 49.45 14.10 -26.48 47.95 15.59 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR B 221 TYR~? 17.66 O1 PG4 B 350 D 142 LEU B 149 LEU~? 21.21 O1 PG4 B 350 D 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 16.24 38.44 11.23 15.50 36.34 12.94 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 16.58 48.64 8.60 16.30 47.40 10.36 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR B 225 TYR~? 21.07 O2 PO4 B 349 D 142 LEU B 149 LEU~? 21.21 O1 PG4 B 350 D 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 19.22 39.10 5.74 19.70 36.67 7.05 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 16.58 48.64 8.60 16.30 47.40 10.36 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR B 225 TYR~? 21.07 O2 PO4 B 349 D 142 LEU B 186 LEU^? 14.03 O2 PO4 B 349 D 165 LYS B 223 LYS~? 20.96 O1 PG4 B 350 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 19.22 39.10 5.74 19.70 36.67 7.05 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 10.06 38.15 8.40 11.92 38.92 9.16 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 21.08 44.90 9.51 21.11 48.16 14.97 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR C 221 TYR~? 17.74 O1 PG4 C 350 D 142 LEU C 149 LEU~? 21.32 C2 PG4 C 350 D 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -25.26 18.68 35.52 -25.91 16.01 35.07 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -24.26 27.54 40.96 -24.59 25.42 41.35 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 137 TYR C 225 TYR~? 18.05 C6 PG4 A 350 D 142 LEU C 149 LEU~? 21.32 C2 PG4 C 350 D 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -22.42 22.90 31.89 -22.15 20.23 31.17 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -24.26 27.54 40.96 -24.59 25.42 41.35 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 137 TYR C 225 TYR~? 18.05 C6 PG4 A 350 D 142 LEU C 186 LEU^? 14.24 O2 PO4 C 349 D 165 LYS C 223 LYS~? 21.04 C2 PG4 C 350 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -22.42 22.90 31.89 -22.15 20.23 31.17 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -31.51 20.62 33.77 -29.48 20.59 34.66 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -19.98 24.16 38.56 -19.29 22.78 44.77 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 D 137 TYR D 221 TYR~? 17.09 O5 PG4 D 350 D 142 LEU D 149 LEU~? 20.41 O5 PG4 D 350 D 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -65.63 16.43 54.69 -64.60 13.90 55.16 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -67.67 24.38 48.14 -67.04 22.30 48.02 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 D 137 TYR D 225 TYR.? 21.05 O1 PO4 D 349 D 142 LEU D 149 LEU~? 20.41 O5 PG4 D 350 D 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -68.84 20.67 57.80 -68.69 18.14 58.96 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -67.67 24.38 48.14 -67.04 22.30 48.02 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -64.76 21.00 60.32 -64.61 15.17 58.23 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 10 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER B 167 SER~? 5.62 O3 PO4 B 349 A 48 THR B 168 THR~? 8.22 O4 PO4 B 349 A 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 3.34 32.15 -1.39 1.57 30.56 -1.62 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 4.28 35.49 -3.02 3.03 37.03 -3.88 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 169 SER~? 7.42 O2 PO4 B 349 A 48 THR B 168 THR~? 8.22 O4 PO4 B 349 A 165 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 6.64 36.52 -0.21 5.42 37.80 1.47 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 4.28 35.49 -3.02 3.03 37.03 -3.88 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER C 167 SER~? 5.88 O4 PO4 C 349 A 48 THR C 168 THR~? 8.28 O2 PO4 C 349 A 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -38.98 23.58 23.13 -40.74 22.64 21.84 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -37.96 27.03 24.30 -39.13 28.80 24.77 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER D 167 SER~? 5.79 O2 PO4 D 349 A 48 THR D 168 THR~? 8.31 O4 PO4 D 349 A 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -52.83 25.44 66.27 -50.98 24.93 67.73 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -54.41 28.51 64.67 -53.64 30.36 63.84 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 47 SER D 169 SER~? 7.40 O1 PO4 D 349 A 48 THR D 168 THR~? 8.31 O4 PO4 D 349 A 165 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -56.61 26.42 62.40 -55.41 26.04 60.30 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -54.41 28.51 64.67 -53.64 30.36 63.84 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -68.08 25.33 66.69 -67.75 19.10 66.60 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 167 SER~? 5.73 O2 PO4 A 349 B 48 THR A 168 THR~? 8.34 O4 PO4 A 349 B 165 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -13.33 64.08 26.14 -11.49 64.89 27.48 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -14.79 64.88 22.75 -13.97 65.51 20.85 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 167 SER~? 5.62 O3 PO4 B 349 B 48 THR B 168 THR~? 8.22 O4 PO4 B 349 B 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 3.34 32.15 -1.39 1.57 30.56 -1.62 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 4.28 35.49 -3.02 3.03 37.03 -3.88 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER B 169 SER~? 7.42 O2 PO4 B 349 B 48 THR B 168 THR~? 8.22 O4 PO4 B 349 B 165 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 6.64 36.52 -0.21 5.42 37.80 1.47 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 4.28 35.49 -3.02 3.03 37.03 -3.88 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 47 SER C 167 SER~? 5.88 O4 PO4 C 349 B 48 THR C 168 THR~? 8.28 O2 PO4 C 349 B 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -38.98 23.58 23.13 -40.74 22.64 21.84 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -37.96 27.03 24.30 -39.13 28.80 24.77 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 47 SER D 167 SER~? 5.79 O2 PO4 D 349 B 48 THR D 168 THR~? 8.31 O4 PO4 D 349 B 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -52.83 25.44 66.27 -50.98 24.93 67.73 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -54.41 28.51 64.67 -53.64 30.36 63.84 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 47 SER D 169 SER~? 7.40 O1 PO4 D 349 B 48 THR D 168 THR~? 8.31 O4 PO4 D 349 B 165 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -56.61 26.42 62.40 -55.41 26.04 60.30 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -54.41 28.51 64.67 -53.64 30.36 63.84 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -68.08 25.33 66.69 -67.75 19.10 66.60 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER B 167 SER~? 5.62 O3 PO4 B 349 C 48 THR B 168 THR~? 8.22 O4 PO4 B 349 C 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 3.34 32.15 -1.39 1.57 30.56 -1.62 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 4.28 35.49 -3.02 3.03 37.03 -3.88 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 169 SER~? 7.42 O2 PO4 B 349 C 48 THR B 168 THR~? 8.22 O4 PO4 B 349 C 165 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 6.64 36.52 -0.21 5.42 37.80 1.47 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 4.28 35.49 -3.02 3.03 37.03 -3.88 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER C 167 SER~? 5.88 O4 PO4 C 349 C 48 THR C 168 THR~? 8.28 O2 PO4 C 349 C 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -38.98 23.58 23.13 -40.74 22.64 21.84 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -37.96 27.03 24.30 -39.13 28.80 24.77 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER D 167 SER~? 5.79 O2 PO4 D 349 C 48 THR D 168 THR~? 8.31 O4 PO4 D 349 C 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -52.83 25.44 66.27 -50.98 24.93 67.73 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -54.41 28.51 64.67 -53.64 30.36 63.84 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 47 SER D 169 SER~? 7.40 O1 PO4 D 349 C 48 THR D 168 THR~? 8.31 O4 PO4 D 349 C 165 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -56.61 26.42 62.40 -55.41 26.04 60.30 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -54.41 28.51 64.67 -53.64 30.36 63.84 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.08 25.33 66.69 -67.75 19.10 66.60 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 167 SER~? 5.73 O2 PO4 A 349 D 48 THR A 168 THR~? 8.34 O4 PO4 A 349 D 165 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -13.33 64.08 26.14 -11.49 64.89 27.48 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -14.79 64.88 22.75 -13.97 65.51 20.85 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 167 SER~? 5.62 O3 PO4 B 349 D 48 THR B 168 THR~? 8.22 O4 PO4 B 349 D 165 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 3.34 32.15 -1.39 1.57 30.56 -1.62 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 4.28 35.49 -3.02 3.03 37.03 -3.88 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER B 169 SER~? 7.42 O2 PO4 B 349 D 48 THR B 168 THR~? 8.22 O4 PO4 B 349 D 165 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 6.64 36.52 -0.21 5.42 37.80 1.47 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 4.28 35.49 -3.02 3.03 37.03 -3.88 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER C 167 SER~? 5.88 O4 PO4 C 349 D 48 THR C 168 THR~? 8.28 O2 PO4 C 349 D 165 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -38.98 23.58 23.13 -40.74 22.64 21.84 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -37.96 27.03 24.30 -39.13 28.80 24.77 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 47 SER D 167 SER~? 5.79 O2 PO4 D 349 D 48 THR D 168 THR~? 8.31 O4 PO4 D 349 D 165 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -52.83 25.44 66.27 -50.98 24.93 67.73 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -54.41 28.51 64.67 -53.64 30.36 63.84 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 47 SER D 169 SER~? 7.40 O1 PO4 D 349 D 48 THR D 168 THR~? 8.31 O4 PO4 D 349 D 165 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -56.61 26.42 62.40 -55.41 26.04 60.30 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -54.41 28.51 64.67 -53.64 30.36 63.84 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -68.08 25.33 66.69 -67.75 19.10 66.60 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c07 naa= 3 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 1 3 # 1 A 94 GLU C 312 GLU~? 22.95 O4 PO4 C 349 A 198 CYH C 330 CYH^? 15.66 O1 PO4 C 349 A 206 CYH A 151 CYH.? 21.29 O1 PO4 A 349 coo 49.92 26.66 0.19 51.26 25.02 0.19 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 51.25 11.31 6.04 51.91 8.58 5.83 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 38.98 17.42 20.63 38.42 14.68 20.70 -28.58 54.43 14.94 -26.94 52.63 16.24 1ff3_c00 source 1ff3 PEPTIDE METHIONINE SULFOXIDE REDUCTASE : 1 hits 1ff3_c00 naa= 3 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 1 3 # 1 A 94 GLU C 312 GLU~? 22.95 O4 PO4 C 349 A 198 CYH C 330 CYH^? 15.66 O1 PO4 C 349 A 206 CYH A 151 CYH.? 21.29 O1 PO4 A 349 coo 49.92 26.66 0.19 51.26 25.02 0.19 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 51.25 11.31 6.04 51.91 8.58 5.83 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 38.98 17.42 20.63 38.42 14.68 20.70 -28.58 54.43 14.94 -26.94 52.63 16.24 1ff3_c01 source 1ff3 PEPTIDE METHIONINE SULFOXIDE REDUCTASE : 1 hits 1ff3_c01 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 171 GLU~? 12.95 O2 PO4 A 349 A 319 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 359 ARG A 335 ARG~? 17.04 O2 PO4 A 349 coo 14.41 12.40 16.42 12.92 13.74 15.71 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 12.25 13.04 23.85 11.56 15.02 23.93 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 10.89 14.95 28.28 12.39 12.53 29.31 -10.94 77.02 25.36 -8.46 78.77 25.78 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU B 171 GLU~? 12.87 O3 PO4 B 349 A 319 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 359 ARG B 335 ARG~? 17.10 O3 PO4 B 349 coo 14.41 12.40 16.42 12.92 13.74 15.71 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 12.25 13.04 23.85 11.56 15.02 23.93 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 10.89 14.95 28.28 12.39 12.53 29.31 -0.53 29.97 -13.85 -3.08 28.75 -15.03 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU C 171 GLU~? 12.90 O2 PO4 C 349 A 319 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 359 ARG C 335 ARG~? 16.94 O4 PO4 C 349 coo 14.41 12.40 16.42 12.92 13.74 15.71 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 12.25 13.04 23.85 11.56 15.02 23.93 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 10.89 14.95 28.28 12.39 12.53 29.31 -43.40 31.02 13.21 -46.07 30.90 11.67 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 A 317 GLU D 171 GLU~? 12.87 O2 PO4 D 349 A 319 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 359 ARG D 335 ARG~? 17.05 O2 PO4 D 349 coo 14.41 12.40 16.42 12.92 13.74 15.71 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 12.25 13.04 23.85 11.56 15.02 23.93 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 10.89 14.95 28.28 12.39 12.53 29.31 -49.77 35.01 75.03 -47.14 35.61 76.51 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 4 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 171 GLU~? 12.95 O2 PO4 A 349 B 319 ASP A 332 ASP~? 12.07 O2 PO4 A 349 B 359 ARG A 335 ARG~? 17.04 O2 PO4 A 349 coo 10.77 13.13 40.94 11.03 14.73 39.51 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 3.77 12.64 38.21 3.35 14.53 37.39 -12.09 74.10 21.91 -11.23 73.05 23.55 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -10.94 77.02 25.36 -8.46 78.77 25.78 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 196 GLU~? 14.14 O1 PO4 A 349 B 319 ASP A 198 ASP.? 17.22 O1 PO4 A 349 B 359 ARG A 220 ARG~? 15.84 O1 PG4 A 350 coo 10.77 13.13 40.94 11.03 14.73 39.51 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 3.77 12.64 38.21 3.35 14.53 37.39 -20.04 48.14 30.81 -21.28 49.70 29.91 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -23.72 43.89 25.49 -25.14 44.23 28.23 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU C 196 GLU~? 13.61 O2 PO4 C 349 B 319 ASP C 198 ASP.? 14.11 O1 PG4 C 350 B 359 ARG C 220 ARG~? 11.31 O1 PG4 C 350 coo 10.77 13.13 40.94 11.03 14.73 39.51 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 3.77 12.64 38.21 3.35 14.53 37.39 -29.82 11.85 32.90 -29.50 11.63 35.01 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -25.78 14.58 38.60 -28.17 14.03 40.55 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU D 135 GLU.? -4.27 C8 PG4 D 350s B 319 ASP D 208 ASP~? 8.41 C6 PG4 D 350 B 359 ARG C 133 ARG.? 8.69 C6 PG4 D 350 coo 10.77 13.13 40.94 11.03 14.73 39.51 -50.80 9.98 46.92 -49.80 10.03 45.07 coo 3.77 12.64 38.21 3.35 14.53 37.39 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -44.64 9.69 35.41 -46.86 11.41 34.11 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU D 171 GLU~? 12.87 O2 PO4 D 349 B 319 ASP D 332 ASP~? 12.02 O2 PO4 D 349 B 359 ARG D 335 ARG~? 17.05 O2 PO4 D 349 coo 10.77 13.13 40.94 11.03 14.73 39.51 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 3.77 12.64 38.21 3.35 14.53 37.39 -51.05 35.32 70.59 -50.24 33.36 70.95 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -49.77 35.01 75.03 -47.14 35.61 76.51 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 5 hits 1fr8_c01 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG A 153 ARG^? 21.78 O1 PO4 A 349 A 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -23.08 51.89 14.34 -24.46 52.07 11.57 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG A 179 ARG~? 21.90 O1 PO4 A 349 A 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -29.50 69.96 21.84 -27.37 70.37 19.60 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG A 179 ARG~? 21.90 O1 PO4 A 349 A 201 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 204 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -29.50 69.96 21.84 -27.37 70.37 19.60 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -21.69 59.77 21.49 -23.21 61.13 21.02 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 4 3 # 4 A 197 ARG A 182 ARG.? 27.04 O1 PO4 A 349 A 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -34.46 56.29 23.08 -34.82 53.96 21.09 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 5 3 # 5 A 197 ARG A 182 ARG.? 27.04 O1 PO4 A 349 A 201 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 204 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -34.46 56.29 23.08 -34.82 53.96 21.09 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -21.69 59.77 21.49 -23.21 61.13 21.02 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 6 3 # 6 A 197 ARG B 153 ARG^? 21.71 O2 PO4 B 349 A 201 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 204 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 12.56 47.43 6.76 13.42 50.26 5.86 coo -15.08 14.90 41.58 -16.70 13.64 42.02 13.23 34.15 0.64 14.88 33.23 1.56 coo -15.44 20.23 39.72 -16.43 18.87 38.47 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 7 3 # 7 A 197 ARG B 179 ARG~? 22.83 O2 PO4 B 349 A 201 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 204 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 17.17 37.45 -10.17 16.17 40.20 -11.05 coo -15.08 14.90 41.58 -16.70 13.64 42.02 11.38 38.70 0.79 12.71 38.99 -0.80 coo -15.44 20.23 39.72 -16.43 18.87 38.47 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 8 3 # 8 A 197 ARG B 182 ARG.? 25.41 O2 PO4 B 349 A 201 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 204 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 24.54 38.99 2.73 24.16 37.16 5.19 coo -15.08 14.90 41.58 -16.70 13.64 42.02 13.23 34.15 0.64 14.88 33.23 1.56 coo -15.44 20.23 39.72 -16.43 18.87 38.47 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 9 3 # 9 A 197 ARG B 182 ARG.? 25.41 O2 PO4 B 349 A 201 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 204 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 24.54 38.99 2.73 24.16 37.16 5.19 coo -15.08 14.90 41.58 -16.70 13.64 42.02 11.38 38.70 0.79 12.71 38.99 -0.80 coo -15.44 20.23 39.72 -16.43 18.87 38.47 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 10 3 # 10 A 197 ARG C 153 ARG^? 21.82 O2 PO4 C 349 A 201 HIS C 173 HIS~? 15.03 O2 PO4 C 349 A 204 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -28.52 27.96 39.05 -27.50 30.55 40.41 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -28.98 23.20 25.42 -27.39 21.83 25.46 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 11 3 # 11 A 197 ARG C 182 ARG.? 12.42 C6 PG4 A 350 A 201 HIS C 173 HIS~? 15.03 O2 PO4 C 349 A 204 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -17.19 25.58 29.52 -16.27 25.77 32.47 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -28.98 23.20 25.42 -27.39 21.83 25.46 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 12 3 # 12 A 197 ARG C 182 ARG.? 12.42 C6 PG4 A 350 A 201 HIS C 229 HIS^? 14.09 O2 PO4 C 349 A 204 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -17.19 25.58 29.52 -16.27 25.77 32.47 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -30.48 26.35 28.68 -29.26 27.76 27.72 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 13 3 # 13 A 197 ARG D 153 ARG^? 21.95 O1 PO4 D 349 A 201 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 204 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -63.61 25.82 49.88 -65.26 27.93 48.32 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -62.51 23.18 64.17 -63.84 21.56 64.29 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 14 3 # 14 A 197 ARG D 182 ARG.? 26.89 O1 PO4 D 349 A 201 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 204 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -74.46 22.20 60.05 -74.88 21.98 57.01 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -62.51 23.18 64.17 -63.84 21.56 64.29 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 15 3 # 15 A 197 ARG D 182 ARG.? 26.89 O1 PO4 D 349 A 201 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 204 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -74.46 22.20 60.05 -74.88 21.98 57.01 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -61.67 25.88 60.45 -63.21 27.00 61.32 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -62.51 23.18 64.17 -63.84 21.56 64.29 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 15 hits 1g8f_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 174 TRP~? 13.64 O1 PO4 A 349 A 317 GLU A 171 GLU~? 12.95 O2 PO4 A 349 A 365 ARG A 179 ARG~? 21.90 O1 PO4 A 349 coo 79.91 26.87 38.77 78.95 23.18 37.81 -22.27 63.33 29.47 -18.64 64.46 30.43 coo 85.55 26.30 41.25 85.59 24.97 39.65 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 83.47 25.30 27.10 83.44 27.82 25.29 -29.50 69.96 21.84 -27.37 70.37 19.60 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP B 174 TRP~? 13.88 O2 PO4 B 349 A 317 GLU B 171 GLU~? 12.87 O3 PO4 B 349 A 365 ARG B 179 ARG~? 22.83 O2 PO4 B 349 coo 79.91 26.87 38.77 78.95 23.18 37.81 13.10 30.34 -1.45 9.52 28.76 -1.64 coo 85.55 26.30 41.25 85.59 24.97 39.65 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 83.47 25.30 27.10 83.44 27.82 25.29 17.17 37.45 -10.17 16.17 40.20 -11.05 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP C 174 TRP~? 13.47 O2 PO4 C 349 A 317 GLU C 171 GLU~? 12.90 O2 PO4 C 349 A 365 ARG C 179 ARG~? 14.85 O2 PG4 A 350 coo 79.91 26.87 38.77 78.95 23.18 37.81 -29.82 21.90 21.11 -33.50 21.40 19.83 coo 85.55 26.30 41.25 85.59 24.97 39.65 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 83.47 25.30 27.10 83.44 27.82 25.29 -24.98 33.12 21.00 -27.25 35.17 20.85 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 4 3 # 4 A 314 TRP D 174 TRP~? 13.44 O1 PO4 D 349 A 317 GLU D 171 GLU~? 12.87 O2 PO4 D 349 A 365 ARG D 179 ARG~? 21.69 O1 PO4 D 349 coo 79.91 26.87 38.77 78.95 23.18 37.81 -61.69 22.51 68.50 -57.96 22.67 69.71 coo 85.55 26.30 41.25 85.59 24.97 39.65 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 83.47 25.30 27.10 83.44 27.82 25.29 -67.72 32.24 67.66 -66.56 34.95 66.77 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 4 hits 1g8o_c01 naa= 3 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 1 3 # 1 A 130 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 153 ASN A 267 ASN.? 11.93 O4 PO4 A 349 A 189 GLN A 264 GLN.? 9.90 O4 PO4 A 349 coo 27.45 53.97 73.24 26.29 54.34 71.54 -1.16 62.88 18.52 0.68 62.16 19.33 coo 29.93 52.22 70.56 29.34 51.93 68.54 4.37 61.77 16.42 3.54 60.20 17.57 coo 26.19 47.96 71.25 25.92 49.81 70.24 1.25 68.04 18.04 0.43 66.37 19.03 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 2 3 # 2 A 130 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 153 ASN B 267 ASN.? 11.96 O4 PO4 B 349 A 189 GLN B 264 GLN.? 10.00 O4 PO4 B 349 coo 27.45 53.97 73.24 26.29 54.34 71.54 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 29.93 52.22 70.56 29.34 51.93 68.54 -15.10 40.08 1.51 -14.03 39.29 3.16 coo 26.19 47.96 71.25 25.92 49.81 70.24 -12.69 37.44 -4.88 -11.52 36.95 -3.20 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 3 3 # 3 A 130 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 153 ASN C 267 ASN.? 11.87 O1 PO4 C 349 A 189 GLN C 264 GLN.? 9.92 O1 PO4 C 349 coo 27.45 53.97 73.24 26.29 54.34 71.54 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 29.93 52.22 70.56 29.34 51.93 68.54 -56.89 27.38 32.00 -55.68 25.71 32.54 coo 26.19 47.96 71.25 25.92 49.81 70.24 -54.76 30.03 25.62 -53.57 28.46 26.44 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 4 3 # 4 A 130 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 153 ASN D 267 ASN.? 11.74 O3 PO4 D 349 A 189 GLN D 264 GLN.? 9.80 O4 PO4 D 349 coo 27.45 53.97 73.24 26.29 54.34 71.54 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 29.93 52.22 70.56 29.34 51.93 68.54 -35.75 30.56 56.76 -36.75 28.68 56.44 coo 26.19 47.96 71.25 25.92 49.81 70.24 -38.31 33.76 62.74 -39.26 31.90 62.31 1ga8_c00 source 1ga8 GALACTOSYL TRANSFERASE LGTC : 4 hits 1ga8_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU B 196 GLU~? 13.82 O2 PO4 B 349 516 HIS B 229 HIS^? 14.08 O2 PO4 B 349 559 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo 49.01 14.50 52.53 46.99 14.61 52.78 10.06 30.74 8.04 11.63 30.24 6.70 coo 41.59 7.83 54.15 41.16 9.87 53.87 11.38 38.70 0.79 12.71 38.99 -0.80 coo 42.22 14.55 52.50 43.91 14.87 53.60 13.23 34.15 0.64 14.88 33.23 1.56 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 1 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU B 94 GLU~? 22.11 C5 PG4 A 350 A 47 ASP B 118 ASP~? 16.08 C6 PG4 A 350 A 161 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 37.12 18.35 73.76 37.09 16.69 72.44 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 29.81 8.06 73.13 30.21 10.11 72.95 -7.43 16.06 29.70 -8.95 16.74 31.02 coo 37.29 15.56 67.90 37.37 13.79 70.08 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU C 94 GLU~? 21.12 C5 PG4 D 350 A 47 ASP C 118 ASP~? 17.28 C3 PG4 D 350 A 161 TYR C 91 TYR~? 12.18 C5 PG4 D 350 coo 37.12 18.35 73.76 37.09 16.69 72.44 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 29.81 8.06 73.13 30.21 10.11 72.95 -47.97 -10.84 34.12 -49.33 -12.17 35.08 coo 37.29 15.56 67.90 37.37 13.79 70.08 -52.07 0.67 28.08 -52.42 3.42 27.72 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 2 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU B 94 GLU~? 22.11 C5 PG4 A 350 B 47 ASP B 118 ASP~? 16.08 C6 PG4 A 350 B 161 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 53.87 35.49 53.22 55.44 35.72 54.61 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 63.47 43.65 53.95 61.45 43.07 54.06 -7.43 16.06 29.70 -8.95 16.74 31.02 coo 56.38 35.81 59.19 58.25 35.77 57.10 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU C 94 GLU~? 21.12 C5 PG4 D 350 B 47 ASP C 118 ASP~? 17.28 C3 PG4 D 350 B 161 TYR C 91 TYR~? 12.18 C5 PG4 D 350 coo 53.87 35.49 53.22 55.44 35.72 54.61 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 63.47 43.65 53.95 61.45 43.07 54.06 -47.97 -10.84 34.12 -49.33 -12.17 35.08 coo 56.38 35.81 59.19 58.25 35.77 57.10 -52.07 0.67 28.08 -52.42 3.42 27.72 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 2 hits 1geq_c03 naa= 3 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 1 3 # 1 13 ASP A 203 ASP~? 10.68 C3 PG4 B 350 41 HIS A 110 HIS.? 5.77 C3 PG4 B 350 224 GLN A 190 GLN~? 10.79 O3 PO4 A 349 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -6.76 51.91 30.68 -4.92 51.72 31.72 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 2 3 # 2 13 ASP B 131 ASP^? 9.09 C8 PG4 A 350 41 HIS B 110 HIS.? 5.25 C4 PG4 A 350 224 GLN B 190 GLN~? 8.74 O1 PO4 B 349 coo -3.80 50.71 49.48 -5.59 51.85 49.27 0.40 27.07 22.40 -0.62 25.51 23.42 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -1.34 29.17 12.50 -2.56 30.72 11.73 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 3 3 # 3 13 ASP B 203 ASP~? 9.89 C4 PG4 A 350 41 HIS B 110 HIS.? 5.25 C4 PG4 A 350 224 GLN B 190 GLN~? 8.74 O1 PO4 B 349 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -1.34 29.17 12.50 -2.56 30.72 11.73 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 4 3 # 4 13 ASP C 203 ASP~? 10.24 C6 PG4 D 350 41 HIS C 110 HIS.? 5.63 C6 PG4 D 350 224 GLN C 190 GLN~? 10.75 O3 PO4 C 349 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -43.39 12.11 31.01 -44.93 10.78 30.39 1gim_c00 source 1gim ADENYLOSUCCINATE SYNTHETASE : 4 hits 1gim_c00 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 64 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 155 ASN A 107 ASN^? 9.64 C5 PG4 B 350 coo 3.12 38.70 24.20 3.24 38.59 26.33 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 1.90 38.00 29.77 3.91 38.35 29.95 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 9.89 36.55 37.38 9.27 37.99 36.08 -5.73 45.70 37.96 -3.97 45.35 36.84 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 64 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 155 ASN A 138 ASN.? -6.13 O2 PG4 A 350s coo 3.12 38.70 24.20 3.24 38.59 26.33 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 1.90 38.00 29.77 3.91 38.35 29.95 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 9.89 36.55 37.38 9.27 37.99 36.08 -17.89 33.84 23.48 -17.76 31.89 24.26 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 64 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 155 ASN B 107 ASN^? 9.43 C5 PG4 A 350 coo 3.12 38.70 24.20 3.24 38.59 26.33 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 1.90 38.00 29.77 3.91 38.35 29.95 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 9.89 36.55 37.38 9.27 37.99 36.08 -1.39 23.50 19.22 -3.25 24.51 19.38 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 64 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 155 ASN B 107 ASN^? 9.43 C5 PG4 A 350 coo 3.12 38.70 24.20 3.24 38.59 26.33 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 1.90 38.00 29.77 3.91 38.35 29.95 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 9.89 36.55 37.38 9.27 37.99 36.08 -1.39 23.50 19.22 -3.25 24.51 19.38 ULMN 3 1gns_c00 SUBTILISIN BPN' user 5 3 # 5 A 32 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 64 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 155 ASN A 107 ASN^? 9.64 C5 PG4 B 350 coo 3.12 38.70 24.20 3.24 38.59 26.33 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 1.90 38.00 29.77 3.91 38.35 29.95 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 9.89 36.55 37.38 9.27 37.99 36.08 -5.73 45.70 37.96 -3.97 45.35 36.84 ULMN 3 1gns_c00 SUBTILISIN BPN' user 6 3 # 6 A 32 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 64 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 155 ASN B 138 ASN.? -6.40 C1 PG4 B 350s coo 3.12 38.70 24.20 3.24 38.59 26.33 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 1.90 38.00 29.77 3.91 38.35 29.95 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 9.89 36.55 37.38 9.27 37.99 36.08 10.62 41.15 26.22 11.12 39.95 27.93 ULMN 3 1gns_c00 SUBTILISIN BPN' user 7 3 # 7 A 32 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 64 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 155 ASN C 107 ASN^? 9.61 C3 PG4 D 350 coo 3.12 38.70 24.20 3.24 38.59 26.33 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 1.90 38.00 29.77 3.91 38.35 29.95 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 9.89 36.55 37.38 9.27 37.99 36.08 -42.97 2.46 31.63 -44.77 2.90 32.68 ULMN 3 1gns_c00 SUBTILISIN BPN' user 8 3 # 8 A 32 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 64 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 155 ASN D 107 ASN^? 9.34 C6 PG4 C 350 coo 3.12 38.70 24.20 3.24 38.59 26.33 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 1.90 38.00 29.77 3.91 38.35 29.95 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 9.89 36.55 37.38 9.27 37.99 36.08 -46.02 4.22 60.61 -44.32 4.89 59.53 ULMN 3 1gns_c00 SUBTILISIN BPN' user 9 3 # 9 A 32 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 64 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 155 ASN D 107 ASN^? 9.34 C6 PG4 C 350 coo 3.12 38.70 24.20 3.24 38.59 26.33 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 1.90 38.00 29.77 3.91 38.35 29.95 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 9.89 36.55 37.38 9.27 37.99 36.08 -46.02 4.22 60.61 -44.32 4.89 59.53 ULMN 3 1gns_c00 SUBTILISIN BPN' user 10 3 # 10 A 32 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 64 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 155 ASN C 107 ASN^? 9.61 C3 PG4 D 350 coo 3.12 38.70 24.20 3.24 38.59 26.33 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 1.90 38.00 29.77 3.91 38.35 29.95 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 9.89 36.55 37.38 9.27 37.99 36.08 -42.97 2.46 31.63 -44.77 2.90 32.68 ULMN 3 1gns_c00 SUBTILISIN BPN' user 11 3 # 11 A 32 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 64 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 155 ASN D 138 ASN.? -6.36 C7 PG4 D 350s coo 3.12 38.70 24.20 3.24 38.59 26.33 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 1.90 38.00 29.77 3.91 38.35 29.95 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 9.89 36.55 37.38 9.27 37.99 36.08 -59.25 7.10 43.19 -59.38 4.97 43.35 1gns_c00 source 1gns SUBTILISIN BPN' : 11 hits 1gns_c00 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 43 ASN~? 22.73 O3 PO4 A 349 A 108 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 144 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 6.86 62.77 42.72 8.12 61.14 42.12 coo 52.62 57.63 23.12 50.77 57.51 22.26 3.61 55.89 43.73 3.10 55.52 45.73 coo 46.65 56.95 20.09 48.42 58.17 20.01 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN A 267 ASN.? 11.93 O4 PO4 A 349 A 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 144 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 4.37 61.77 16.42 3.54 60.20 17.57 coo 52.62 57.63 23.12 50.77 57.51 22.26 1.50 56.90 17.79 2.83 56.38 19.33 coo 46.65 56.95 20.09 48.42 58.17 20.01 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN A 269 ASN.? 10.42 O3 PO4 A 349 A 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 144 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 5.56 58.73 21.48 4.09 58.66 22.99 coo 52.62 57.63 23.12 50.77 57.51 22.26 1.50 56.90 17.79 2.83 56.38 19.33 coo 46.65 56.95 20.09 48.42 58.17 20.01 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 A 106 ASN B 43 ASN.? 23.10 O3 PO4 B 349 A 108 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 144 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -12.52 12.59 3.86 -14.07 13.20 5.18 coo 52.62 57.63 23.12 50.77 57.51 22.26 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 46.65 56.95 20.09 48.42 58.17 20.01 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 A 106 ASN B 267 ASN.? 11.96 O4 PO4 B 349 A 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 144 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -15.10 40.08 1.51 -14.03 39.29 3.16 coo 52.62 57.63 23.12 50.77 57.51 22.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 46.65 56.95 20.09 48.42 58.17 20.01 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 A 106 ASN B 269 ASN.? 10.41 O1 PO4 B 349 A 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 144 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 52.62 57.63 23.12 50.77 57.51 22.26 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 46.65 56.95 20.09 48.42 58.17 20.01 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 7 3 # 7 A 106 ASN C 43 ASN.? 22.72 C5 PG4 D 350 A 108 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 144 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -57.74 6.14 16.07 -58.97 5.36 17.64 coo 52.62 57.63 23.12 50.77 57.51 22.26 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 46.65 56.95 20.09 48.42 58.17 20.01 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 8 3 # 8 A 106 ASN C 267 ASN.? 11.87 O1 PO4 C 349 A 108 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 144 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -56.89 27.38 32.00 -55.68 25.71 32.54 coo 52.62 57.63 23.12 50.77 57.51 22.26 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 46.65 56.95 20.09 48.42 58.17 20.01 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 9 3 # 9 A 106 ASN C 269 ASN.? 10.45 O3 PO4 C 349 A 108 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 144 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -57.17 21.55 31.51 -55.49 20.56 30.60 coo 52.62 57.63 23.12 50.77 57.51 22.26 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 46.65 56.95 20.09 48.42 58.17 20.01 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 10 3 # 10 A 106 ASN D 43 ASN.? 23.87 O2 PO4 D 349 A 108 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 144 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -34.60 10.60 78.03 -33.00 10.04 76.71 coo 52.62 57.63 23.12 50.77 57.51 22.26 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 46.65 56.95 20.09 48.42 58.17 20.01 -39.78 8.95 76.71 -38.11 10.21 76.27 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 11 3 # 11 A 106 ASN D 267 ASN.? 11.74 O3 PO4 D 349 A 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 144 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -35.75 30.56 56.76 -36.75 28.68 56.44 coo 52.62 57.63 23.12 50.77 57.51 22.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 46.65 56.95 20.09 48.42 58.17 20.01 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 12 3 # 12 A 106 ASN D 269 ASN.? 10.24 O3 PO4 D 349 A 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 144 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 51.28 61.14 17.85 51.16 61.61 19.96 -34.61 24.72 58.03 -36.14 23.70 59.12 coo 52.62 57.63 23.12 50.77 57.51 22.26 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 46.65 56.95 20.09 48.42 58.17 20.01 -41.09 30.11 59.34 -39.33 28.92 59.24 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 12 hits 1grc_c02 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 269 ASN.? 10.42 O3 PO4 A 349 B 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 144 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 5.56 58.73 21.48 4.09 58.66 22.99 coo 41.00 107.18 12.86 42.70 107.82 11.96 1.50 56.90 17.79 2.83 56.38 19.33 coo 31.60 110.69 6.14 29.69 109.74 5.94 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN A 269 ASN.? 10.42 O3 PO4 A 349 B 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 144 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 5.56 58.73 21.48 4.09 58.66 22.99 coo 41.00 107.18 12.86 42.70 107.82 11.96 1.50 56.90 17.79 2.83 56.38 19.33 coo 31.60 110.69 6.14 29.69 109.74 5.94 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN A 269 ASN.? 10.42 O3 PO4 A 349 B 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 144 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 5.56 58.73 21.48 4.09 58.66 22.99 coo 41.00 107.18 12.86 42.70 107.82 11.96 1.50 56.90 17.79 2.83 56.38 19.33 coo 31.60 110.69 6.14 29.69 109.74 5.94 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN A 270 ASN.? 15.06 O3 PO4 A 349 B 108 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 144 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 7.80 59.00 17.23 7.36 57.24 18.34 coo 41.00 107.18 12.86 42.70 107.82 11.96 1.50 56.90 17.79 2.83 56.38 19.33 coo 31.60 110.69 6.14 29.69 109.74 5.94 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 B 106 ASN B 269 ASN.? 10.41 O1 PO4 B 349 B 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 144 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 31.60 110.69 6.14 29.69 109.74 5.94 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 B 106 ASN B 269 ASN.? 10.41 O1 PO4 B 349 B 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 144 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 31.60 110.69 6.14 29.69 109.74 5.94 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 7 3 # 7 B 106 ASN B 269 ASN.? 10.41 O1 PO4 B 349 B 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 144 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 41.00 107.18 12.86 42.70 107.82 11.96 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 31.60 110.69 6.14 29.69 109.74 5.94 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 8 3 # 8 B 106 ASN B 270 ASN.? 15.02 O1 PO4 B 349 B 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 144 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -17.98 39.50 4.84 -17.14 38.86 6.70 coo 41.00 107.18 12.86 42.70 107.82 11.96 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 31.60 110.69 6.14 29.69 109.74 5.94 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 9 3 # 9 B 106 ASN B 270 ASN.? 15.02 O1 PO4 B 349 B 108 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 144 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -17.98 39.50 4.84 -17.14 38.86 6.70 coo 41.00 107.18 12.86 42.70 107.82 11.96 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 31.60 110.69 6.14 29.69 109.74 5.94 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 10 3 # 10 B 106 ASN C 269 ASN.? 10.45 O3 PO4 C 349 B 108 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 144 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -57.17 21.55 31.51 -55.49 20.56 30.60 coo 41.00 107.18 12.86 42.70 107.82 11.96 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 31.60 110.69 6.14 29.69 109.74 5.94 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 11 3 # 11 B 106 ASN C 269 ASN.? 10.45 O3 PO4 C 349 B 108 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 144 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -57.17 21.55 31.51 -55.49 20.56 30.60 coo 41.00 107.18 12.86 42.70 107.82 11.96 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 31.60 110.69 6.14 29.69 109.74 5.94 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 12 3 # 12 B 106 ASN D 269 ASN.? 10.24 O3 PO4 D 349 B 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 144 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.61 24.72 58.03 -36.14 23.70 59.12 coo 41.00 107.18 12.86 42.70 107.82 11.96 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 31.60 110.69 6.14 29.69 109.74 5.94 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 13 3 # 13 B 106 ASN D 269 ASN.? 10.24 O3 PO4 D 349 B 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 144 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.61 24.72 58.03 -36.14 23.70 59.12 coo 41.00 107.18 12.86 42.70 107.82 11.96 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 31.60 110.69 6.14 29.69 109.74 5.94 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 14 3 # 14 B 106 ASN D 270 ASN.? 14.75 O3 PO4 D 349 B 108 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 144 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 36.64 101.02 13.15 38.55 101.84 12.78 -32.60 27.92 55.07 -33.22 25.92 54.63 coo 41.00 107.18 12.86 42.70 107.82 11.96 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 31.60 110.69 6.14 29.69 109.74 5.94 -31.75 16.85 51.07 -30.38 15.61 52.00 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 14 hits 1grc_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 209 PHE~? -4.26 C3 PG4 A 350s A 298 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 329 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -10.72 37.17 18.24 -10.31 34.51 17.57 coo 2.59 0.29 25.55 4.65 0.18 25.07 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 12.42 6.10 23.27 9.95 1.57 20.16 1.49 32.28 22.12 4.07 30.52 27.68 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 209 PHE~? -4.26 C3 PG4 A 350s B 298 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 329 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -10.72 37.17 18.24 -10.31 34.51 17.57 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 1.49 32.28 22.12 4.07 30.52 27.68 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 209 PHE~? -4.26 C3 PG4 A 350s C 298 ASP B 203 ASP~? 9.89 C4 PG4 A 350 C 329 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 17.41 60.57 64.39 18.40 58.12 65.34 -10.72 37.17 18.24 -10.31 34.51 17.57 coo 24.10 66.43 63.33 24.18 64.30 63.40 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 27.64 56.61 58.17 22.18 57.92 60.36 1.49 32.28 22.12 4.07 30.52 27.68 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 209 PHE~? -4.26 C3 PG4 A 350s D 298 ASP B 203 ASP~? 9.89 C4 PG4 A 350 D 329 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 35.44 53.35 83.81 35.65 54.53 81.28 -10.72 37.17 18.24 -10.31 34.51 17.57 coo 29.72 46.46 83.60 30.79 47.36 81.99 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 36.89 44.91 74.55 37.33 48.94 79.01 1.49 32.28 22.12 4.07 30.52 27.68 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN B 216 GLN~? 7.61 O1 PG4 B 350 A 296 GLU B 215 GLU~? 13.59 C2 PG4 B 350 A 383 TYR B 221 TYR~? 17.66 O1 PG4 B 350 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 11.42 42.35 19.15 10.50 41.03 20.54 coo 40.93 4.45 2.36 38.91 3.75 2.26 10.14 48.09 15.50 9.78 49.78 16.69 coo 30.54 7.22 6.23 31.38 5.79 3.97 16.24 38.44 11.23 15.50 36.34 12.94 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN C 216 GLN~? 7.49 O1 PG4 C 350 A 296 GLU C 215 GLU~? 13.26 C2 PG4 C 350 A 383 TYR C 221 TYR~? 17.74 O1 PG4 C 350 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -29.55 15.50 43.86 -30.62 13.67 44.21 coo 40.93 4.45 2.36 38.91 3.75 2.26 -30.56 22.29 45.75 -30.82 22.67 47.79 coo 30.54 7.22 6.23 31.38 5.79 3.97 -25.26 18.68 35.52 -25.91 16.01 35.07 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN D 216 GLN~? 6.81 O5 PG4 D 350 A 296 GLU D 215 GLU~? 12.92 O5 PG4 D 350 A 383 TYR D 221 TYR~? 17.09 O5 PG4 D 350 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -60.48 13.07 46.91 -59.29 11.30 46.96 coo 40.93 4.45 2.36 38.91 3.75 2.26 -60.56 19.61 44.11 -60.32 19.66 42.03 coo 30.54 7.22 6.23 31.38 5.79 3.97 -65.63 16.43 54.69 -64.60 13.90 55.16 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 3 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 118 ASP~? 17.27 C5 PG4 B 350 A 327 GLU B 15 GLU.? 19.82 C3 PG4 A 350 A 339 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 0.76 36.83 47.04 2.33 35.40 47.32 coo 75.11 41.01 160.30 76.65 40.06 161.41 -13.67 16.25 7.60 -15.45 16.94 8.51 coo 82.23 40.35 159.87 85.09 40.67 161.01 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 198 ASP.? 17.22 O1 PO4 A 349 A 327 GLU B 171 GLU~? 12.87 O3 PO4 B 349 A 339 ARG B 30 ARG~? 9.80 O3 PO4 B 349 coo 85.81 57.99 116.01 86.03 55.86 115.89 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 82.23 40.35 159.87 85.09 40.67 161.01 1.86 25.26 -2.23 -1.04 24.22 -2.87 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 327 GLU C 280 GLU~? 22.63 O1 PO4 C 349 A 339 ARG C 283 ARG~? 24.80 O1 PO4 C 349 coo 85.81 57.99 116.01 86.03 55.86 115.89 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 75.11 41.01 160.30 76.65 40.06 161.41 -51.90 42.15 35.36 -51.16 43.57 36.78 coo 82.23 40.35 159.87 85.09 40.67 161.01 -47.36 43.82 38.18 -45.87 46.48 37.65 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 327 GLU C 286 GLU~? 19.95 O1 PO4 C 349 A 339 ARG C 283 ARG~? 24.80 O1 PO4 C 349 coo 85.81 57.99 116.01 86.03 55.86 115.89 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.61 39.13 37.58 -40.31 41.01 36.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 -47.36 43.82 38.18 -45.87 46.48 37.65 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 343 ASP~? 23.03 O1 PO4 A 349 A 327 GLU A 94 GLU~? 21.51 O3 PG4 B 350 A 339 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 -25.30 71.23 14.76 -26.68 71.84 16.22 coo 75.11 41.01 160.30 76.65 40.06 161.41 2.26 51.25 46.83 2.00 52.68 48.40 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 327 GLU C 280 GLU~? 22.63 O1 PO4 C 349 A 339 ARG C 283 ARG~? 24.80 O1 PO4 C 349 coo 85.81 57.99 116.01 86.03 55.86 115.89 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 -51.90 42.15 35.36 -51.16 43.57 36.78 coo 82.23 40.35 159.87 85.09 40.67 161.01 -47.36 43.82 38.18 -45.87 46.48 37.65 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP B 343 ASP~? 22.96 O2 PO4 B 349 A 327 GLU B 94 GLU~? 22.11 C5 PG4 A 350 A 339 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 12.62 43.49 -12.19 13.89 41.96 -12.92 coo 75.11 41.01 160.30 76.65 40.06 161.41 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 82.23 40.35 159.87 85.09 40.67 161.01 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP C 89 ASP.? 13.45 C5 PG4 D 350 A 327 GLU C 286 GLU~? 19.95 O1 PO4 C 349 A 339 ARG C 283 ARG~? 24.80 O1 PO4 C 349 coo 85.81 57.99 116.01 86.03 55.86 115.89 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.61 39.13 37.58 -40.31 41.01 36.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 -47.36 43.82 38.18 -45.87 46.48 37.65 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 327 GLU B 15 GLU.? 19.82 C3 PG4 A 350 A 339 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 75.11 41.01 160.30 76.65 40.06 161.41 -13.67 16.25 7.60 -15.45 16.94 8.51 coo 82.23 40.35 159.87 85.09 40.67 161.01 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP C 118 ASP~? 17.28 C3 PG4 D 350 A 327 GLU B 94 GLU~? 22.11 C5 PG4 A 350 A 339 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 -47.97 -10.84 34.12 -49.33 -12.17 35.08 coo 75.11 41.01 160.30 76.65 40.06 161.41 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 82.23 40.35 159.87 85.09 40.67 161.01 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP C 140 ASP.? 7.74 C2 PG4 C 350 A 327 GLU B 15 GLU.? 19.82 C3 PG4 A 350 A 339 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 75.11 41.01 160.30 76.65 40.06 161.41 -13.67 16.25 7.60 -15.45 16.94 8.51 coo 82.23 40.35 159.87 85.09 40.67 161.01 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP C 140 ASP.? 7.74 C2 PG4 C 350 A 327 GLU B 135 GLU.? -3.99 O5 PG4 B 350s A 339 ARG B 206 ARG~? -3.06 O4 PG4 B 350s coo 85.81 57.99 116.01 86.03 55.86 115.89 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 75.11 41.01 160.30 76.65 40.06 161.41 2.30 38.46 22.67 1.14 39.98 23.57 coo 82.23 40.35 159.87 85.09 40.67 161.01 -2.22 41.47 25.55 0.33 41.32 27.30 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 327 GLU B 94 GLU~? 22.11 C5 PG4 A 350 A 339 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 75.11 41.01 160.30 76.65 40.06 161.41 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 82.23 40.35 159.87 85.09 40.67 161.01 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP C 226 ASP.? 11.40 C1 PG4 A 350 A 327 GLU A 280 GLU~? 22.33 O4 PO4 A 349 A 339 ARG A 283 ARG~? 22.10 O4 PO4 A 349 coo 85.81 57.99 116.01 86.03 55.86 115.89 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 75.11 41.01 160.30 76.65 40.06 161.41 -2.67 65.99 2.80 -3.14 64.76 1.14 coo 82.23 40.35 159.87 85.09 40.67 161.01 -6.83 62.59 -0.10 -4.11 61.39 0.92 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP C 343 ASP~? 16.17 O1 PG4 A 350 A 327 GLU C 94 GLU~? 21.12 C5 PG4 D 350 A 339 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 75.11 41.01 160.30 76.65 40.06 161.41 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 82.23 40.35 159.87 85.09 40.67 161.01 -57.88 0.79 18.76 -56.46 0.67 21.52 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 327 GLU B 15 GLU.? 19.82 C3 PG4 A 350 A 339 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 75.11 41.01 160.30 76.65 40.06 161.41 -13.67 16.25 7.60 -15.45 16.94 8.51 coo 82.23 40.35 159.87 85.09 40.67 161.01 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 327 GLU B 94 GLU~? 22.11 C5 PG4 A 350 A 339 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 75.11 41.01 160.30 76.65 40.06 161.41 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 82.23 40.35 159.87 85.09 40.67 161.01 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP D 226 ASP.? 25.08 O1 PO4 D 349 A 327 GLU C 94 GLU~? 21.12 C5 PG4 D 350 A 339 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 75.11 41.01 160.30 76.65 40.06 161.41 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 82.23 40.35 159.87 85.09 40.67 161.01 -57.88 0.79 18.76 -56.46 0.67 21.52 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP D 343 ASP~? 23.05 O1 PO4 D 349 A 327 GLU D 94 GLU~? 22.39 C6 PG4 C 350 A 339 ARG D 42 ARG.? 20.81 C4 PG4 C 350 coo 85.81 57.99 116.01 86.03 55.86 115.89 -64.64 38.99 64.31 -65.73 38.68 66.10 coo 75.11 41.01 160.30 76.65 40.06 161.41 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo 82.23 40.35 159.87 85.09 40.67 161.01 -33.94 3.86 75.82 -34.45 4.46 72.82 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 19 hits 1hto_c00 naa= 3 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 1 3 # 1 A 267 GLU A 70 GLU~? 32.95 O2 PO4 A 349 A 369 ARG A 8 ARG.? 30.34 O2 PO4 A 349 A 372 TYR A 71 TYR~? 28.56 O2 PO4 A 349 coo 16.47 7.99 31.03 17.36 6.90 32.63 -6.11 60.40 57.95 -4.53 61.81 58.04 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -15.12 57.52 51.68 -16.41 55.28 53.39 coo 16.01 4.58 27.39 13.82 5.38 28.94 -7.92 60.98 53.46 -6.24 63.13 54.07 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 2 3 # 2 A 267 GLU B 70 GLU~? 33.54 O3 PO4 B 349 A 369 ARG B 8 ARG.? 30.97 O3 PO4 B 349 A 372 TYR B 71 TYR~? 28.79 O3 PO4 B 349 coo 16.47 7.99 31.03 17.36 6.90 32.63 2.54 0.85 9.44 1.10 0.13 8.05 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 10.20 9.25 11.13 12.17 8.18 13.25 coo 16.01 4.58 27.39 13.82 5.38 28.94 3.73 5.71 7.80 2.32 4.41 5.78 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 3 3 # 3 A 267 GLU C 70 GLU~? 32.89 O4 PO4 C 349 A 369 ARG C 8 ARG.? 30.39 O4 PO4 C 349 A 372 TYR C 71 TYR~? 28.61 O4 PO4 C 349 coo 16.47 7.99 31.03 17.36 6.90 32.63 -43.64 -5.35 8.13 -45.41 -4.88 7.08 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -34.38 -0.74 13.28 -32.98 -3.36 14.17 coo 16.01 4.58 27.39 13.82 5.38 28.94 -42.04 -1.21 10.11 -44.02 -0.84 8.15 1i1e_c00 source 1i1e BOTULINUM NEUROTOXIN TYPE B : 3 hits 1i1e_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 200 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 226 LYS B 96 LYS~? 18.72 C5 PG4 A 350 coo 23.24 46.58 4.39 24.43 46.59 2.66 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 24.51 43.28 11.18 25.17 44.50 9.58 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 34.47 51.09 7.19 28.58 51.18 7.53 -4.65 11.97 23.20 -9.16 12.78 27.52 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 200 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 226 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 23.24 46.58 4.39 24.43 46.59 2.66 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 24.51 43.28 11.18 25.17 44.50 9.58 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 34.47 51.09 7.19 28.58 51.18 7.53 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1i29_c01 source 1i29 CSDB : 2 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 132 VAL.? 13.34 C6 PG4 B 350 A 200 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 226 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 19.13 38.05 1.41 19.72 38.80 -0.53 -10.07 45.98 33.36 -10.51 48.12 33.74 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 34.47 51.09 7.19 28.58 51.18 7.53 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 214 VAL~? 12.61 O1 PG4 A 350 A 200 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 226 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -15.88 46.48 18.88 -14.78 48.25 18.14 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 34.47 51.09 7.19 28.58 51.18 7.53 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL B 132 VAL.? 12.49 C8 PG4 A 350 A 200 ASP B 198 ASP.? 14.38 O1 PG4 B 350 A 226 LYS B 184 LYS^? 17.27 O2 PO4 B 349 coo 19.13 38.05 1.41 19.72 38.80 -0.53 2.43 28.48 18.14 2.79 27.81 16.06 coo 24.51 43.28 11.18 25.17 44.50 9.58 11.89 31.57 14.26 12.37 32.72 16.00 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.36 36.70 4.47 15.17 34.16 8.91 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL B 132 VAL.? 12.49 C8 PG4 A 350 A 200 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 226 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 19.13 38.05 1.41 19.72 38.80 -0.53 2.43 28.48 18.14 2.79 27.81 16.06 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 300 VAL^? 15.66 O4 PO4 B 349 A 200 ASP B 343 ASP~? 22.96 O2 PO4 B 349 A 226 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 19.13 38.05 1.41 19.72 38.80 -0.53 2.68 49.37 -4.57 0.60 48.61 -4.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 12.62 43.49 -12.19 13.89 41.96 -12.92 coo 34.47 51.09 7.19 28.58 51.18 7.53 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 301 VAL^? 17.67 O4 PO4 B 349 A 200 ASP B 339 ASP~? 20.98 O2 PO4 B 349 A 226 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 19.13 38.05 1.41 19.72 38.80 -0.53 5.31 48.32 -7.12 7.12 47.80 -5.95 coo 24.51 43.28 11.18 25.17 44.50 9.58 12.36 37.42 -12.59 13.93 36.17 -11.84 coo 34.47 51.09 7.19 28.58 51.18 7.53 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL C 132 VAL.? 13.32 O2 PG4 D 350 A 200 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 226 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 19.13 38.05 1.41 19.72 38.80 -0.53 -39.07 6.96 33.72 -39.07 7.99 31.75 coo 24.51 43.28 11.18 25.17 44.50 9.58 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 34.47 51.09 7.19 28.58 51.18 7.53 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL D 106 VAL^? 16.51 C6 PG4 C 350 A 200 ASP D 198 ASP.? 14.02 O5 PG4 D 350 A 226 LYS D 184 LYS^? 18.69 O1 PO4 D 349 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -49.74 4.22 63.50 -51.42 5.52 64.00 coo 24.51 43.28 11.18 25.17 44.50 9.58 -59.61 10.87 58.41 -59.89 10.18 56.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 -64.76 21.00 60.32 -64.61 15.17 58.23 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL D 132 VAL.? 13.27 C6 PG4 C 350 A 200 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 226 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 19.13 38.05 1.41 19.72 38.80 -0.53 -50.38 7.90 57.55 -50.66 9.13 59.37 coo 24.51 43.28 11.18 25.17 44.50 9.58 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 34.47 51.09 7.19 28.58 51.18 7.53 -50.59 27.20 61.67 -46.47 26.50 58.89 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL D 300 VAL^? 15.59 O4 PO4 D 349 A 200 ASP D 343 ASP~? 23.05 O1 PO4 D 349 A 226 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -55.34 37.70 54.18 -53.19 37.46 54.55 coo 24.51 43.28 11.18 25.17 44.50 9.58 -64.64 38.99 64.31 -65.73 38.68 66.10 coo 34.47 51.09 7.19 28.58 51.18 7.53 -68.08 25.33 66.69 -67.75 19.10 66.60 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL D 301 VAL^? 17.62 O4 PO4 D 349 A 200 ASP D 339 ASP~? 21.27 O1 PO4 D 349 A 226 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -57.99 38.81 56.72 -59.53 37.22 56.68 coo 24.51 43.28 11.18 25.17 44.50 9.58 -63.02 36.35 69.71 -64.42 35.04 70.68 coo 34.47 51.09 7.19 28.58 51.18 7.53 -68.08 25.33 66.69 -67.75 19.10 66.60 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL D 301 VAL^? 17.62 O4 PO4 D 349 A 200 ASP D 339 ASP~? 21.27 O1 PO4 D 349 A 226 LYS D 316 LYS~? 24.37 O2 PO4 D 349 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -57.99 38.81 56.72 -59.53 37.22 56.68 coo 24.51 43.28 11.18 25.17 44.50 9.58 -63.02 36.35 69.71 -64.42 35.04 70.68 coo 34.47 51.09 7.19 28.58 51.18 7.53 -49.65 42.56 73.75 -53.64 42.38 78.67 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL D 345 VAL~? 17.86 O1 PO4 D 349 A 200 ASP D 339 ASP~? 21.27 O1 PO4 D 349 A 226 LYS D 316 LYS~? 24.37 O2 PO4 D 349 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -62.79 35.71 58.69 -62.07 33.62 58.85 coo 24.51 43.28 11.18 25.17 44.50 9.58 -63.02 36.35 69.71 -64.42 35.04 70.68 coo 34.47 51.09 7.19 28.58 51.18 7.53 -49.65 42.56 73.75 -53.64 42.38 78.67 1i29_c03 source 1i29 CSDB : 13 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS D 177 LYS~? 20.36 O1 PO4 D 349 A 74 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 165 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -60.02 15.53 71.55 -61.82 16.61 71.53 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 74 LYS D 177 LYS~? 20.36 O1 PO4 D 349 A 165 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -60.02 15.53 71.55 -61.82 16.61 71.53 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 2 hits 1idt_c00 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER C 143 SER.? 14.49 C2 PG4 C 350 A 173 ARG C 153 ARG^? 21.82 O2 PO4 C 349 A 211 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 18.77 77.82 11.69 20.55 80.22 10.73 -28.52 27.96 39.05 -27.50 30.55 40.41 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -31.75 16.85 51.07 -30.38 15.61 52.00 1ig8_c00 source 1ig8 HEXOKINASE PII : 1 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 131 ASP^? 9.75 C6 PG4 B 350 158 THR A 111 THR.? -3.96 C5 PG4 B 350s 317 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -8.03 41.96 35.37 -6.75 41.25 36.93 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -0.72 42.17 33.63 1.22 41.72 34.46 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 131 ASP^? 9.75 C6 PG4 B 350 158 THR A 111 THR.? -3.96 C5 PG4 B 350s 317 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -8.03 41.96 35.37 -6.75 41.25 36.93 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -0.72 42.17 33.63 1.22 41.72 34.46 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP A 203 ASP~? 10.68 C3 PG4 B 350 158 THR A 242 THR.? 14.16 O1 PG4 B 350 317 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -3.11 49.78 15.72 -2.58 47.68 15.65 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP A 203 ASP~? 10.68 C3 PG4 B 350 158 THR A 242 THR.? 14.16 O1 PG4 B 350 317 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -3.11 49.78 15.72 -2.58 47.68 15.65 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP A 203 ASP~? 10.68 C3 PG4 B 350 158 THR A 242 THR.? 14.16 O1 PG4 B 350 317 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -3.11 49.78 15.72 -2.58 47.68 15.65 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 3 # 6 54 ASP A 203 ASP~? 10.68 C3 PG4 B 350 158 THR A 244 THR~? 10.12 O4 PO4 A 349 317 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -8.00 52.96 15.18 -7.58 55.05 14.79 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 7 3 # 7 54 ASP A 208 ASP~? 8.51 C3 PG4 A 350 158 THR B 242 THR.? 14.01 C2 PG4 A 350 317 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.70 44.34 11.61 -7.01 44.85 13.75 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 8 3 # 8 54 ASP A 208 ASP~? 8.51 C3 PG4 A 350 158 THR B 242 THR.? 14.01 C2 PG4 A 350 317 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.70 44.34 11.61 -7.01 44.85 13.75 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 9 3 # 9 54 ASP A 208 ASP~? 8.51 C3 PG4 A 350 158 THR B 242 THR.? 14.01 C2 PG4 A 350 317 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.70 44.34 11.61 -7.01 44.85 13.75 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 10 3 # 10 54 ASP A 332 ASP~? 12.07 O2 PO4 A 349 158 THR A 168 THR~? 8.34 O4 PO4 A 349 317 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -12.09 74.10 21.91 -11.23 73.05 23.55 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -14.79 64.88 22.75 -13.97 65.51 20.85 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 11 3 # 11 54 ASP B 131 ASP^? 9.09 C8 PG4 A 350 158 THR B 111 THR.? -3.92 C5 PG4 A 350s 317 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 0.40 27.07 22.40 -0.62 25.51 23.42 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.89 27.93 21.89 -8.77 26.98 22.40 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 12 3 # 12 54 ASP B 131 ASP^? 9.09 C8 PG4 A 350 158 THR B 111 THR.? -3.92 C5 PG4 A 350s 317 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 0.40 27.07 22.40 -0.62 25.51 23.42 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.89 27.93 21.89 -8.77 26.98 22.40 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 13 3 # 13 54 ASP B 203 ASP~? 9.89 C4 PG4 A 350 158 THR B 242 THR.? 14.01 C2 PG4 A 350 317 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.70 44.34 11.61 -7.01 44.85 13.75 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 14 3 # 14 54 ASP B 203 ASP~? 9.89 C4 PG4 A 350 158 THR B 242 THR.? 14.01 C2 PG4 A 350 317 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.70 44.34 11.61 -7.01 44.85 13.75 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 15 3 # 15 54 ASP B 203 ASP~? 9.89 C4 PG4 A 350 158 THR B 242 THR.? 14.01 C2 PG4 A 350 317 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.70 44.34 11.61 -7.01 44.85 13.75 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 16 3 # 16 54 ASP B 203 ASP~? 9.89 C4 PG4 A 350 158 THR B 244 THR~? 10.49 O4 PO4 B 349 317 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -2.27 44.71 7.93 -2.99 44.80 5.89 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 17 3 # 17 54 ASP B 208 ASP~? 8.88 C3 PG4 B 350 158 THR A 242 THR.? 14.16 O1 PG4 B 350 317 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -3.11 49.78 15.72 -2.58 47.68 15.65 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 18 3 # 18 54 ASP B 208 ASP~? 8.88 C3 PG4 B 350 158 THR A 242 THR.? 14.16 O1 PG4 B 350 317 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -3.11 49.78 15.72 -2.58 47.68 15.65 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 19 3 # 19 54 ASP B 332 ASP~? 12.13 O3 PO4 B 349 158 THR B 168 THR~? 8.22 O4 PO4 B 349 317 ASP B 339 ASP~? 20.98 O2 PO4 B 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo -5.30 12.75 41.86 -4.34 13.05 39.99 4.28 35.49 -3.02 3.03 37.03 -3.88 coo -12.63 17.64 33.66 -10.65 17.90 34.40 12.36 37.42 -12.59 13.93 36.17 -11.84 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 20 3 # 20 54 ASP C 131 ASP^? 9.91 O2 PG4 D 350 158 THR C 111 THR.? -3.86 C3 PG4 D 350s 317 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -40.29 2.77 35.99 -41.53 1.06 35.77 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -47.70 3.36 37.51 -49.56 2.24 37.49 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 21 3 # 21 54 ASP C 131 ASP^? 9.91 O2 PG4 D 350 158 THR C 111 THR.? -3.86 C3 PG4 D 350s 317 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -40.29 2.77 35.99 -41.53 1.06 35.77 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -47.70 3.36 37.51 -49.56 2.24 37.49 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 22 3 # 22 54 ASP C 203 ASP~? 10.24 C6 PG4 D 350 158 THR C 242 THR.? 14.00 O5 PG4 D 350 317 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -47.88 22.66 41.54 -48.06 21.40 43.36 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 23 3 # 23 54 ASP C 203 ASP~? 10.24 C6 PG4 D 350 158 THR C 242 THR.? 14.00 O5 PG4 D 350 317 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -47.88 22.66 41.54 -48.06 21.40 43.36 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 24 3 # 24 54 ASP C 203 ASP~? 10.24 C6 PG4 D 350 158 THR C 242 THR.? 14.00 O5 PG4 D 350 317 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -47.88 22.66 41.54 -48.06 21.40 43.36 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 25 3 # 25 54 ASP C 203 ASP~? 10.24 C6 PG4 D 350 158 THR C 244 THR~? 10.31 O1 PO4 C 349 317 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -43.52 25.65 38.88 -44.31 27.18 37.52 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 26 3 # 26 54 ASP C 208 ASP~? 8.73 O2 PG4 C 350 158 THR D 242 THR.? 14.33 O2 PG4 C 350 317 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -43.74 23.47 47.95 -43.28 22.17 46.24 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 27 3 # 27 54 ASP C 208 ASP~? 8.73 O2 PG4 C 350 158 THR D 242 THR.? 14.33 O2 PG4 C 350 317 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -43.74 23.47 47.95 -43.28 22.17 46.24 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 28 3 # 28 54 ASP C 332 ASP~? 12.18 O4 PO4 C 349 158 THR C 168 THR~? 8.28 O2 PO4 C 349 317 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -42.20 32.39 17.40 -42.88 30.35 17.40 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -37.96 27.03 24.30 -39.13 28.80 24.77 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 29 3 # 29 54 ASP D 131 ASP^? 9.77 C6 PG4 C 350 158 THR D 111 THR.? 4.22 C6 PG4 C 350 317 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -48.29 3.79 55.93 -46.95 2.25 56.44 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -40.95 5.28 55.14 -39.04 4.37 55.56 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 30 3 # 30 54 ASP D 131 ASP^? 9.77 C6 PG4 C 350 158 THR D 111 THR.? 4.22 C6 PG4 C 350 317 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -48.29 3.79 55.93 -46.95 2.25 56.44 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -40.95 5.28 55.14 -39.04 4.37 55.56 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 31 3 # 31 54 ASP D 203 ASP~? 10.40 O3 PG4 C 350 158 THR D 242 THR.? 14.33 O2 PG4 C 350 317 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -43.74 23.47 47.95 -43.28 22.17 46.24 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 32 3 # 32 54 ASP D 203 ASP~? 10.40 O3 PG4 C 350 158 THR D 242 THR.? 14.33 O2 PG4 C 350 317 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -43.74 23.47 47.95 -43.28 22.17 46.24 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 33 3 # 33 54 ASP D 203 ASP~? 10.40 O3 PG4 C 350 158 THR D 242 THR.? 14.33 O2 PG4 C 350 317 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -43.74 23.47 47.95 -43.28 22.17 46.24 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 34 3 # 34 54 ASP D 203 ASP~? 10.40 O3 PG4 C 350 158 THR D 244 THR~? 10.60 O4 PO4 D 349 317 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -48.51 26.01 50.22 -48.02 27.82 51.30 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 35 3 # 35 54 ASP D 208 ASP~? 8.41 C6 PG4 D 350 158 THR C 242 THR.? 14.00 O5 PG4 D 350 317 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -47.88 22.66 41.54 -48.06 21.40 43.36 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 36 3 # 36 54 ASP D 208 ASP~? 8.41 C6 PG4 D 350 158 THR C 242 THR.? 14.00 O5 PG4 D 350 317 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -47.88 22.66 41.54 -48.06 21.40 43.36 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 37 3 # 37 54 ASP D 332 ASP~? 12.02 O2 PO4 D 349 158 THR D 168 THR~? 8.31 O4 PO4 D 349 317 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -51.05 35.32 70.59 -50.24 33.36 70.95 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -54.41 28.51 64.67 -53.64 30.36 63.84 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -63.02 36.35 69.71 -64.42 35.04 70.68 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 37 hits 1inp_c02 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 167 SER A 235 SER.? 9.13 O4 PO4 A 349 A 201 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.44 7.96 22.51 12.16 7.57 20.82 -3.96 57.47 15.64 -2.97 59.52 14.86 coo 19.43 6.74 22.83 19.09 5.15 21.60 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 3 1iph_c00 CATALASE HPII user 2 3 # 2 A 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 167 SER A 241 SER.? 9.98 O3 PO4 A 349 A 201 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.44 7.96 22.51 12.16 7.57 20.82 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 19.43 6.74 22.83 19.09 5.15 21.60 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 3 1iph_c00 CATALASE HPII user 3 3 # 3 A 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 167 SER A 241 SER.? 9.98 O3 PO4 A 349 A 201 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.44 7.96 22.51 12.16 7.57 20.82 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 19.43 6.74 22.83 19.09 5.15 21.60 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 3 1iph_c00 CATALASE HPII user 4 3 # 4 A 128 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 167 SER B 64 SER~? 26.98 C5 PG4 A 350 A 201 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 10.44 7.96 22.51 12.16 7.57 20.82 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 19.43 6.74 22.83 19.09 5.15 21.60 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 3 1iph_c00 CATALASE HPII user 5 3 # 5 A 128 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 167 SER B 241 SER.? 10.02 O1 PO4 B 349 A 201 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 10.44 7.96 22.51 12.16 7.57 20.82 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 19.43 6.74 22.83 19.09 5.15 21.60 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 3 1iph_c00 CATALASE HPII user 6 3 # 6 A 128 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 167 SER C 64 SER~? 25.88 C5 PG4 D 350 A 201 ASN C 43 ASN.? 22.72 C5 PG4 D 350 coo 12.95 4.49 19.05 14.87 4.39 19.77 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 10.44 7.96 22.51 12.16 7.57 20.82 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 19.43 6.74 22.83 19.09 5.15 21.60 -57.74 6.14 16.07 -58.97 5.36 17.64 ULMN 3 1iph_c00 CATALASE HPII user 7 3 # 7 A 128 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 167 SER C 241 SER.? 9.97 O3 PO4 C 349 A 201 ASN C 269 ASN.? 10.45 O3 PO4 C 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 10.44 7.96 22.51 12.16 7.57 20.82 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 19.43 6.74 22.83 19.09 5.15 21.60 -57.17 21.55 31.51 -55.49 20.56 30.60 ULMN 3 1iph_c00 CATALASE HPII user 8 3 # 8 A 128 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 167 SER C 241 SER.? 9.97 O3 PO4 C 349 A 201 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 10.44 7.96 22.51 12.16 7.57 20.82 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 19.43 6.74 22.83 19.09 5.15 21.60 -59.71 24.81 33.93 -59.02 22.97 34.76 ULMN 3 1iph_c00 CATALASE HPII user 9 3 # 9 A 128 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 167 SER D 241 SER.? 10.08 O3 PO4 D 349 A 201 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.44 7.96 22.51 12.16 7.57 20.82 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 19.43 6.74 22.83 19.09 5.15 21.60 -34.61 24.72 58.03 -36.14 23.70 59.12 ULMN 3 1iph_c00 CATALASE HPII user 10 3 # 10 A 128 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 167 SER D 241 SER.? 10.08 O3 PO4 D 349 A 201 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.44 7.96 22.51 12.16 7.57 20.82 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 19.43 6.74 22.83 19.09 5.15 21.60 -32.60 27.92 55.07 -33.22 25.92 54.63 ULMN 3 1iph_c00 CATALASE HPII user 11 3 # 11 A 128 HIS D 272 HIS.? 19.84 O3 PO4 D 349 A 167 SER C 143 SER.? 14.49 C2 PG4 C 350 A 201 ASN D 267 ASN.? 11.74 O3 PO4 D 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 -29.12 31.20 53.56 -30.01 29.84 52.23 coo 10.44 7.96 22.51 12.16 7.57 20.82 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 19.43 6.74 22.83 19.09 5.15 21.60 -35.75 30.56 56.76 -36.75 28.68 56.44 ULMN 3 1iph_c00 CATALASE HPII user 12 3 # 12 A 128 HIS D 272 HIS.? 19.84 O3 PO4 D 349 A 167 SER C 143 SER.? 14.49 C2 PG4 C 350 A 201 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo 12.95 4.49 19.05 14.87 4.39 19.77 -29.12 31.20 53.56 -30.01 29.84 52.23 coo 10.44 7.96 22.51 12.16 7.57 20.82 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 19.43 6.74 22.83 19.09 5.15 21.60 -34.61 24.72 58.03 -36.14 23.70 59.12 1iph_c00 source 1iph CATALASE HPII : 12 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 167 SER A 235 SER.? 9.13 O4 PO4 A 349 B 201 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -3.96 57.47 15.64 -2.97 59.52 14.86 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 3 1iph_c01 CATALASE HPII user 2 3 # 2 B 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 167 SER A 241 SER.? 9.98 O3 PO4 A 349 B 201 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -0.69 52.51 16.88 -2.72 53.79 17.21 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 3 1iph_c01 CATALASE HPII user 3 3 # 3 B 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 167 SER A 241 SER.? 9.98 O3 PO4 A 349 B 201 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -0.69 52.51 16.88 -2.72 53.79 17.21 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 3 1iph_c01 CATALASE HPII user 4 3 # 4 B 128 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 167 SER B 64 SER~? 26.98 C5 PG4 A 350 B 201 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -6.23 8.13 11.77 -6.66 5.89 12.66 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 3 1iph_c01 CATALASE HPII user 5 3 # 5 B 128 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 167 SER B 241 SER.? 10.02 O1 PO4 B 349 B 201 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -9.21 42.20 9.74 -7.29 41.83 8.32 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 3 1iph_c01 CATALASE HPII user 6 3 # 6 B 128 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 167 SER C 64 SER~? 25.88 C5 PG4 D 350 B 201 ASN C 43 ASN.? 22.72 C5 PG4 D 350 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -57.74 6.14 16.07 -58.97 5.36 17.64 ULMN 3 1iph_c01 CATALASE HPII user 7 3 # 7 B 128 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 167 SER C 241 SER.? 9.97 O3 PO4 C 349 B 201 ASN C 269 ASN.? 10.45 O3 PO4 C 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -50.53 22.77 38.79 -48.65 23.56 37.48 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -57.17 21.55 31.51 -55.49 20.56 30.60 ULMN 3 1iph_c01 CATALASE HPII user 8 3 # 8 B 128 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 167 SER C 241 SER.? 9.97 O3 PO4 C 349 B 201 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -50.53 22.77 38.79 -48.65 23.56 37.48 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -59.71 24.81 33.93 -59.02 22.97 34.76 ULMN 3 1iph_c01 CATALASE HPII user 9 3 # 9 B 128 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 167 SER D 241 SER.? 10.08 O3 PO4 D 349 B 201 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -41.15 24.23 50.62 -43.08 24.97 51.88 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -34.61 24.72 58.03 -36.14 23.70 59.12 ULMN 3 1iph_c01 CATALASE HPII user 10 3 # 10 B 128 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 167 SER D 241 SER.? 10.08 O3 PO4 D 349 B 201 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -41.15 24.23 50.62 -43.08 24.97 51.88 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -32.60 27.92 55.07 -33.22 25.92 54.63 ULMN 3 1iph_c01 CATALASE HPII user 11 3 # 11 B 128 HIS D 272 HIS.? 19.84 O3 PO4 D 349 B 167 SER C 143 SER.? 14.49 C2 PG4 C 350 B 201 ASN D 267 ASN.? 11.74 O3 PO4 D 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -29.12 31.20 53.56 -30.01 29.84 52.23 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -31.83 24.72 51.20 -29.72 23.61 51.01 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -35.75 30.56 56.76 -36.75 28.68 56.44 ULMN 3 1iph_c01 CATALASE HPII user 12 3 # 12 B 128 HIS D 272 HIS.? 19.84 O3 PO4 D 349 B 167 SER C 143 SER.? 14.49 C2 PG4 C 350 B 201 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -29.12 31.20 53.56 -30.01 29.84 52.23 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -31.83 24.72 51.20 -29.72 23.61 51.01 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -34.61 24.72 58.03 -36.14 23.70 59.12 1iph_c01 source 1iph CATALASE HPII : 12 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 167 SER A 235 SER.? 9.13 O4 PO4 A 349 C 201 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -3.96 57.47 15.64 -2.97 59.52 14.86 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 3 1iph_c02 CATALASE HPII user 2 3 # 2 C 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 167 SER A 241 SER.? 9.98 O3 PO4 A 349 C 201 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -0.69 52.51 16.88 -2.72 53.79 17.21 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 3 1iph_c02 CATALASE HPII user 3 3 # 3 C 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 167 SER A 241 SER.? 9.98 O3 PO4 A 349 C 201 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -0.69 52.51 16.88 -2.72 53.79 17.21 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 3 1iph_c02 CATALASE HPII user 4 3 # 4 C 128 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 167 SER B 64 SER~? 26.98 C5 PG4 A 350 C 201 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -6.23 8.13 11.77 -6.66 5.89 12.66 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 3 1iph_c02 CATALASE HPII user 5 3 # 5 C 128 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 167 SER B 241 SER.? 10.02 O1 PO4 B 349 C 201 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -9.21 42.20 9.74 -7.29 41.83 8.32 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 3 1iph_c02 CATALASE HPII user 6 3 # 6 C 128 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 167 SER C 64 SER~? 25.88 C5 PG4 D 350 C 201 ASN C 43 ASN.? 22.72 C5 PG4 D 350 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -57.74 6.14 16.07 -58.97 5.36 17.64 ULMN 3 1iph_c02 CATALASE HPII user 7 3 # 7 C 128 HIS C 238 HIS.? 10.74 O3 PO4 C 349 C 167 SER C 241 SER.? 9.97 O3 PO4 C 349 C 201 ASN C 269 ASN.? 10.45 O3 PO4 C 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -50.53 22.77 38.79 -48.65 23.56 37.48 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -57.17 21.55 31.51 -55.49 20.56 30.60 ULMN 3 1iph_c02 CATALASE HPII user 8 3 # 8 C 128 HIS C 238 HIS.? 10.74 O3 PO4 C 349 C 167 SER C 241 SER.? 9.97 O3 PO4 C 349 C 201 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -50.53 22.77 38.79 -48.65 23.56 37.48 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -59.71 24.81 33.93 -59.02 22.97 34.76 ULMN 3 1iph_c02 CATALASE HPII user 9 3 # 9 C 128 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 167 SER D 241 SER.? 10.08 O3 PO4 D 349 C 201 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -41.15 24.23 50.62 -43.08 24.97 51.88 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -34.61 24.72 58.03 -36.14 23.70 59.12 ULMN 3 1iph_c02 CATALASE HPII user 10 3 # 10 C 128 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 167 SER D 241 SER.? 10.08 O3 PO4 D 349 C 201 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -41.15 24.23 50.62 -43.08 24.97 51.88 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -32.60 27.92 55.07 -33.22 25.92 54.63 ULMN 3 1iph_c02 CATALASE HPII user 11 3 # 11 C 128 HIS D 272 HIS.? 19.84 O3 PO4 D 349 C 167 SER C 143 SER.? 14.49 C2 PG4 C 350 C 201 ASN D 267 ASN.? 11.74 O3 PO4 D 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -29.12 31.20 53.56 -30.01 29.84 52.23 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -31.83 24.72 51.20 -29.72 23.61 51.01 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -35.75 30.56 56.76 -36.75 28.68 56.44 ULMN 3 1iph_c02 CATALASE HPII user 12 3 # 12 C 128 HIS D 272 HIS.? 19.84 O3 PO4 D 349 C 167 SER C 143 SER.? 14.49 C2 PG4 C 350 C 201 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -29.12 31.20 53.56 -30.01 29.84 52.23 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -31.83 24.72 51.20 -29.72 23.61 51.01 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -34.61 24.72 58.03 -36.14 23.70 59.12 1iph_c02 source 1iph CATALASE HPII : 12 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 D 167 SER A 235 SER.? 9.13 O4 PO4 A 349 D 201 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -3.96 57.47 15.64 -2.97 59.52 14.86 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 3 1iph_c03 CATALASE HPII user 2 3 # 2 D 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 D 167 SER A 241 SER.? 9.98 O3 PO4 A 349 D 201 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 3 1iph_c03 CATALASE HPII user 3 3 # 3 D 128 HIS A 238 HIS.? 10.67 O3 PO4 A 349 D 167 SER A 241 SER.? 9.98 O3 PO4 A 349 D 201 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 1.50 56.90 17.79 2.83 56.38 19.33 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 3 1iph_c03 CATALASE HPII user 4 3 # 4 D 128 HIS B 14 HIS.? 21.30 C5 PG4 A 350 D 167 SER B 64 SER~? 26.98 C5 PG4 A 350 D 201 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 3 1iph_c03 CATALASE HPII user 5 3 # 5 D 128 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 167 SER B 241 SER.? 10.02 O1 PO4 B 349 D 201 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 3 1iph_c03 CATALASE HPII user 6 3 # 6 D 128 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 167 SER C 64 SER~? 25.88 C5 PG4 D 350 D 201 ASN C 43 ASN.? 22.72 C5 PG4 D 350 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -57.74 6.14 16.07 -58.97 5.36 17.64 ULMN 3 1iph_c03 CATALASE HPII user 7 3 # 7 D 128 HIS C 238 HIS.? 10.74 O3 PO4 C 349 D 167 SER C 241 SER.? 9.97 O3 PO4 C 349 D 201 ASN C 269 ASN.? 10.45 O3 PO4 C 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -57.17 21.55 31.51 -55.49 20.56 30.60 ULMN 3 1iph_c03 CATALASE HPII user 8 3 # 8 D 128 HIS C 238 HIS.? 10.74 O3 PO4 C 349 D 167 SER C 241 SER.? 9.97 O3 PO4 C 349 D 201 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -59.71 24.81 33.93 -59.02 22.97 34.76 ULMN 3 1iph_c03 CATALASE HPII user 9 3 # 9 D 128 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 167 SER D 241 SER.? 10.08 O3 PO4 D 349 D 201 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -34.61 24.72 58.03 -36.14 23.70 59.12 ULMN 3 1iph_c03 CATALASE HPII user 10 3 # 10 D 128 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 167 SER D 241 SER.? 10.08 O3 PO4 D 349 D 201 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -32.60 27.92 55.07 -33.22 25.92 54.63 ULMN 3 1iph_c03 CATALASE HPII user 11 3 # 11 D 128 HIS D 272 HIS.? 19.84 O3 PO4 D 349 D 167 SER C 143 SER.? 14.49 C2 PG4 C 350 D 201 ASN D 267 ASN.? 11.74 O3 PO4 D 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -29.12 31.20 53.56 -30.01 29.84 52.23 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -35.75 30.56 56.76 -36.75 28.68 56.44 ULMN 3 1iph_c03 CATALASE HPII user 12 3 # 12 D 128 HIS D 272 HIS.? 19.84 O3 PO4 D 349 D 167 SER C 143 SER.? 14.49 C2 PG4 C 350 D 201 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -29.12 31.20 53.56 -30.01 29.84 52.23 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -34.61 24.72 58.03 -36.14 23.70 59.12 1iph_c03 source 1iph CATALASE HPII : 12 hits 1iph_c03 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 118 ASP~? 17.27 C5 PG4 B 350 A1134 ALA A 121 ALA~? 20.80 C6 PG4 B 350 A1137 ASN A 120 ASN~? 17.71 C6 PG4 B 350 coo -27.05 34.58 17.12 -25.81 32.84 17.16 0.76 36.83 47.04 2.33 35.40 47.32 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -5.43 35.40 49.76 -4.09 34.80 50.17 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -6.35 35.53 45.32 -8.38 34.93 45.14 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A1134 ALA A 308 ALA.? 11.21 O2 PO4 A 349 A1137 ASN A 306 ASN^? 8.27 O2 PO4 A 349 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -12.09 74.10 21.91 -11.23 73.05 23.55 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -6.36 74.21 26.20 -6.22 72.82 26.84 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -7.02 69.82 22.14 -6.25 69.91 24.11 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 3 3 # 3 A1132 ASP B 118 ASP~? 16.08 C6 PG4 A 350 A1134 ALA B 121 ALA~? 20.81 C6 PG4 A 350 A1137 ASN B 120 ASN~? 15.18 C8 PG4 A 350 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -7.43 16.06 29.70 -8.95 16.74 31.02 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -1.03 13.88 32.02 -2.37 13.48 32.61 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -0.30 18.23 31.33 0.39 20.12 30.68 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 4 3 # 4 A1132 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A1134 ALA B 308 ALA.? 11.34 O3 PO4 B 349 A1137 ASN B 306 ASN^? 8.17 O3 PO4 B 349 coo -27.05 34.58 17.12 -25.81 32.84 17.16 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -4.57 29.17 -10.27 -4.28 28.71 -8.84 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -3.96 34.28 -6.86 -4.36 32.22 -6.36 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 5 3 # 5 A1132 ASP C 118 ASP~? 17.28 C3 PG4 D 350 A1134 ALA C 121 ALA~? 21.00 C3 PG4 D 350 A1137 ASN C 120 ASN~? 16.10 C3 PG4 D 350 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -47.97 -10.84 34.12 -49.33 -12.17 35.08 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -41.66 -13.47 32.88 -42.86 -14.29 33.36 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -40.48 -9.89 35.46 -40.04 -7.95 36.21 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 6 3 # 6 A1132 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A1134 ALA C 308 ALA.? 11.16 O4 PO4 C 349 A1137 ASN C 306 ASN^? 8.19 O4 PO4 C 349 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -42.20 32.39 17.40 -42.88 30.35 17.40 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -47.63 27.77 15.40 -47.50 26.46 16.16 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -46.37 29.17 21.30 -46.92 27.39 20.25 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 7 3 # 7 A1132 ASP D 118 ASP~? 17.29 C6 PG4 C 350 A1134 ALA D 121 ALA~? 20.89 O4 PG4 C 350 A1137 ASN D 120 ASN~? 15.59 O4 PG4 C 350 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -39.99 -8.60 59.76 -38.31 -9.56 58.92 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -46.05 -11.84 59.78 -44.69 -12.51 59.67 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -46.79 -8.62 56.97 -47.29 -6.96 55.79 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 8 3 # 8 A1132 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A1134 ALA D 308 ALA.? 11.28 O2 PO4 D 349 A1137 ASN D 306 ASN^? 8.15 O2 PO4 D 349 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -51.05 35.32 70.59 -50.24 33.36 70.95 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -45.31 32.26 73.28 -45.38 30.82 72.81 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -46.44 32.39 67.16 -45.73 30.88 68.47 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 8 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP B 198 ASP.? 14.38 O1 PG4 B 350 A 204 GLU B 196 GLU~? 13.82 O2 PO4 B 349 A 279 TYR B 225 TYR~? 21.07 O2 PO4 B 349 coo 5.85 5.60 30.32 5.00 7.49 29.88 11.89 31.57 14.26 12.37 32.72 16.00 coo 7.79 1.83 27.81 9.08 3.25 26.92 10.06 30.74 8.04 11.63 30.24 6.70 coo 8.22 7.77 18.64 7.58 8.47 21.28 19.22 39.10 5.74 19.70 36.67 7.05 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP D 198 ASP.? 14.02 O5 PG4 D 350 A 204 GLU D 196 GLU~? 13.48 O1 PO4 D 349 A 279 TYR D 225 TYR.? 21.05 O1 PO4 D 349 coo 5.85 5.60 30.32 5.00 7.49 29.88 -59.61 10.87 58.41 -59.89 10.18 56.43 coo 7.79 1.83 27.81 9.08 3.25 26.92 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 8.22 7.77 18.64 7.58 8.47 21.28 -68.84 20.67 57.80 -68.69 18.14 58.96 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 2 hits 1itx_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 153 ARG^? 21.78 O1 PO4 A 349 A 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -23.08 51.89 14.34 -24.46 52.07 11.57 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG A 179 ARG~? 21.90 O1 PO4 A 349 A 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -29.50 69.96 21.84 -27.37 70.37 19.60 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG A 179 ARG~? 21.90 O1 PO4 A 349 A 201 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 204 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -29.50 69.96 21.84 -27.37 70.37 19.60 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -21.69 59.77 21.49 -23.21 61.13 21.02 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1j70_c00 ATP SULPHURYLASE user 4 3 # 4 A 197 ARG A 182 ARG.? 27.04 O1 PO4 A 349 A 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -34.46 56.29 23.08 -34.82 53.96 21.09 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1j70_c00 ATP SULPHURYLASE user 5 3 # 5 A 197 ARG A 182 ARG.? 27.04 O1 PO4 A 349 A 201 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 204 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -34.46 56.29 23.08 -34.82 53.96 21.09 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -21.69 59.77 21.49 -23.21 61.13 21.02 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1j70_c00 ATP SULPHURYLASE user 6 3 # 6 A 197 ARG B 153 ARG^? 21.71 O2 PO4 B 349 A 201 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 204 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 12.56 47.43 6.76 13.42 50.26 5.86 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 13.23 34.15 0.64 14.88 33.23 1.56 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1j70_c00 ATP SULPHURYLASE user 7 3 # 7 A 197 ARG B 179 ARG~? 22.83 O2 PO4 B 349 A 201 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 204 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 17.17 37.45 -10.17 16.17 40.20 -11.05 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 11.38 38.70 0.79 12.71 38.99 -0.80 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1j70_c00 ATP SULPHURYLASE user 8 3 # 8 A 197 ARG B 182 ARG.? 25.41 O2 PO4 B 349 A 201 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 204 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 24.54 38.99 2.73 24.16 37.16 5.19 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 13.23 34.15 0.64 14.88 33.23 1.56 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1j70_c00 ATP SULPHURYLASE user 9 3 # 9 A 197 ARG B 182 ARG.? 25.41 O2 PO4 B 349 A 201 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 204 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 24.54 38.99 2.73 24.16 37.16 5.19 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 11.38 38.70 0.79 12.71 38.99 -0.80 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1j70_c00 ATP SULPHURYLASE user 10 3 # 10 A 197 ARG C 153 ARG^? 21.82 O2 PO4 C 349 A 201 HIS C 173 HIS~? 15.03 O2 PO4 C 349 A 204 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -28.52 27.96 39.05 -27.50 30.55 40.41 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -28.98 23.20 25.42 -27.39 21.83 25.46 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1j70_c00 ATP SULPHURYLASE user 11 3 # 11 A 197 ARG C 182 ARG.? 12.42 C6 PG4 A 350 A 201 HIS C 173 HIS~? 15.03 O2 PO4 C 349 A 204 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -17.19 25.58 29.52 -16.27 25.77 32.47 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -28.98 23.20 25.42 -27.39 21.83 25.46 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1j70_c00 ATP SULPHURYLASE user 12 3 # 12 A 197 ARG C 182 ARG.? 12.42 C6 PG4 A 350 A 201 HIS C 229 HIS^? 14.09 O2 PO4 C 349 A 204 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -17.19 25.58 29.52 -16.27 25.77 32.47 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -30.48 26.35 28.68 -29.26 27.76 27.72 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 1j70_c00 ATP SULPHURYLASE user 13 3 # 13 A 197 ARG D 153 ARG^? 21.95 O1 PO4 D 349 A 201 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 204 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -63.61 25.82 49.88 -65.26 27.93 48.32 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -62.51 23.18 64.17 -63.84 21.56 64.29 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1j70_c00 ATP SULPHURYLASE user 14 3 # 14 A 197 ARG D 182 ARG.? 26.89 O1 PO4 D 349 A 201 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 204 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -74.46 22.20 60.05 -74.88 21.98 57.01 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -62.51 23.18 64.17 -63.84 21.56 64.29 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1j70_c00 ATP SULPHURYLASE user 15 3 # 15 A 197 ARG D 182 ARG.? 26.89 O1 PO4 D 349 A 201 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 204 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -74.46 22.20 60.05 -74.88 21.98 57.01 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -61.67 25.88 60.45 -63.21 27.00 61.32 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -62.51 23.18 64.17 -63.84 21.56 64.29 1j70_c00 source 1j70 ATP SULPHURYLASE : 15 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 153 ARG^? 21.78 O1 PO4 A 349 B 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 B 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -23.08 51.89 14.34 -24.46 52.07 11.57 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG A 179 ARG~? 21.90 O1 PO4 A 349 B 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 B 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -29.50 69.96 21.84 -27.37 70.37 19.60 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG A 179 ARG~? 21.90 O1 PO4 A 349 B 201 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 204 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -29.50 69.96 21.84 -27.37 70.37 19.60 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -21.69 59.77 21.49 -23.21 61.13 21.02 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1j70_c01 ATP SULPHURYLASE user 4 3 # 4 B 197 ARG A 182 ARG.? 27.04 O1 PO4 A 349 B 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 B 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -34.46 56.29 23.08 -34.82 53.96 21.09 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1j70_c01 ATP SULPHURYLASE user 5 3 # 5 B 197 ARG A 182 ARG.? 27.04 O1 PO4 A 349 B 201 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 204 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -34.46 56.29 23.08 -34.82 53.96 21.09 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -21.69 59.77 21.49 -23.21 61.13 21.02 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1j70_c01 ATP SULPHURYLASE user 6 3 # 6 B 197 ARG B 153 ARG^? 21.71 O2 PO4 B 349 B 201 HIS B 173 HIS~? 15.15 O2 PO4 B 349 B 204 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 12.56 47.43 6.76 13.42 50.26 5.86 coo -8.48 114.03 24.38 -10.47 114.55 23.97 13.23 34.15 0.64 14.88 33.23 1.56 coo -6.99 108.94 26.28 -8.54 109.57 27.55 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1j70_c01 ATP SULPHURYLASE user 7 3 # 7 B 197 ARG B 179 ARG~? 22.83 O2 PO4 B 349 B 201 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 204 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 17.17 37.45 -10.17 16.17 40.20 -11.05 coo -8.48 114.03 24.38 -10.47 114.55 23.97 11.38 38.70 0.79 12.71 38.99 -0.80 coo -6.99 108.94 26.28 -8.54 109.57 27.55 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1j70_c01 ATP SULPHURYLASE user 8 3 # 8 B 197 ARG B 182 ARG.? 25.41 O2 PO4 B 349 B 201 HIS B 173 HIS~? 15.15 O2 PO4 B 349 B 204 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 24.54 38.99 2.73 24.16 37.16 5.19 coo -8.48 114.03 24.38 -10.47 114.55 23.97 13.23 34.15 0.64 14.88 33.23 1.56 coo -6.99 108.94 26.28 -8.54 109.57 27.55 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1j70_c01 ATP SULPHURYLASE user 9 3 # 9 B 197 ARG B 182 ARG.? 25.41 O2 PO4 B 349 B 201 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 204 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 24.54 38.99 2.73 24.16 37.16 5.19 coo -8.48 114.03 24.38 -10.47 114.55 23.97 11.38 38.70 0.79 12.71 38.99 -0.80 coo -6.99 108.94 26.28 -8.54 109.57 27.55 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1j70_c01 ATP SULPHURYLASE user 10 3 # 10 B 197 ARG C 153 ARG^? 21.82 O2 PO4 C 349 B 201 HIS C 173 HIS~? 15.03 O2 PO4 C 349 B 204 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -28.52 27.96 39.05 -27.50 30.55 40.41 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -28.98 23.20 25.42 -27.39 21.83 25.46 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1j70_c01 ATP SULPHURYLASE user 11 3 # 11 B 197 ARG C 182 ARG.? 12.42 C6 PG4 A 350 B 201 HIS C 173 HIS~? 15.03 O2 PO4 C 349 B 204 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -17.19 25.58 29.52 -16.27 25.77 32.47 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -28.98 23.20 25.42 -27.39 21.83 25.46 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1j70_c01 ATP SULPHURYLASE user 12 3 # 12 B 197 ARG C 182 ARG.? 12.42 C6 PG4 A 350 B 201 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 204 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -17.19 25.58 29.52 -16.27 25.77 32.47 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -30.48 26.35 28.68 -29.26 27.76 27.72 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 1j70_c01 ATP SULPHURYLASE user 13 3 # 13 B 197 ARG D 153 ARG^? 21.95 O1 PO4 D 349 B 201 HIS D 173 HIS~? 14.91 O1 PO4 D 349 B 204 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -63.61 25.82 49.88 -65.26 27.93 48.32 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -62.51 23.18 64.17 -63.84 21.56 64.29 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1j70_c01 ATP SULPHURYLASE user 14 3 # 14 B 197 ARG D 182 ARG.? 26.89 O1 PO4 D 349 B 201 HIS D 173 HIS~? 14.91 O1 PO4 D 349 B 204 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -74.46 22.20 60.05 -74.88 21.98 57.01 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -62.51 23.18 64.17 -63.84 21.56 64.29 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1j70_c01 ATP SULPHURYLASE user 15 3 # 15 B 197 ARG D 182 ARG.? 26.89 O1 PO4 D 349 B 201 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 204 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -74.46 22.20 60.05 -74.88 21.98 57.01 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -61.67 25.88 60.45 -63.21 27.00 61.32 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -62.51 23.18 64.17 -63.84 21.56 64.29 1j70_c01 source 1j70 ATP SULPHURYLASE : 15 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 153 ARG^? 21.78 O1 PO4 A 349 C 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 C 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -23.08 51.89 14.34 -24.46 52.07 11.57 coo 20.16 5.55 18.86 20.00 7.59 19.34 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 24.92 3.29 16.90 24.41 4.92 15.69 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG A 179 ARG~? 21.90 O1 PO4 A 349 C 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 C 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -29.50 69.96 21.84 -27.37 70.37 19.60 coo 20.16 5.55 18.86 20.00 7.59 19.34 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 24.92 3.29 16.90 24.41 4.92 15.69 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG A 179 ARG~? 21.90 O1 PO4 A 349 C 201 HIS A 229 HIS^? 14.13 O1 PO4 A 349 C 204 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -29.50 69.96 21.84 -27.37 70.37 19.60 coo 20.16 5.55 18.86 20.00 7.59 19.34 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 24.92 3.29 16.90 24.41 4.92 15.69 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1j70_c02 ATP SULPHURYLASE user 4 3 # 4 C 197 ARG A 182 ARG.? 27.04 O1 PO4 A 349 C 201 HIS A 173 HIS~? 15.17 O1 PO4 A 349 C 204 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -34.46 56.29 23.08 -34.82 53.96 21.09 coo 20.16 5.55 18.86 20.00 7.59 19.34 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 24.92 3.29 16.90 24.41 4.92 15.69 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 1j70_c02 ATP SULPHURYLASE user 5 3 # 5 C 197 ARG A 182 ARG.? 27.04 O1 PO4 A 349 C 201 HIS A 229 HIS^? 14.13 O1 PO4 A 349 C 204 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -34.46 56.29 23.08 -34.82 53.96 21.09 coo 20.16 5.55 18.86 20.00 7.59 19.34 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 24.92 3.29 16.90 24.41 4.92 15.69 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 1j70_c02 ATP SULPHURYLASE user 6 3 # 6 C 197 ARG B 153 ARG^? 21.71 O2 PO4 B 349 C 201 HIS B 173 HIS~? 15.15 O2 PO4 B 349 C 204 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 12.56 47.43 6.76 13.42 50.26 5.86 coo 20.16 5.55 18.86 20.00 7.59 19.34 13.23 34.15 0.64 14.88 33.23 1.56 coo 24.92 3.29 16.90 24.41 4.92 15.69 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1j70_c02 ATP SULPHURYLASE user 7 3 # 7 C 197 ARG B 179 ARG~? 22.83 O2 PO4 B 349 C 201 HIS B 229 HIS^? 14.08 O2 PO4 B 349 C 204 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 17.17 37.45 -10.17 16.17 40.20 -11.05 coo 20.16 5.55 18.86 20.00 7.59 19.34 11.38 38.70 0.79 12.71 38.99 -0.80 coo 24.92 3.29 16.90 24.41 4.92 15.69 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1j70_c02 ATP SULPHURYLASE user 8 3 # 8 C 197 ARG B 182 ARG.? 25.41 O2 PO4 B 349 C 201 HIS B 173 HIS~? 15.15 O2 PO4 B 349 C 204 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 24.54 38.99 2.73 24.16 37.16 5.19 coo 20.16 5.55 18.86 20.00 7.59 19.34 13.23 34.15 0.64 14.88 33.23 1.56 coo 24.92 3.29 16.90 24.41 4.92 15.69 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1j70_c02 ATP SULPHURYLASE user 9 3 # 9 C 197 ARG B 182 ARG.? 25.41 O2 PO4 B 349 C 201 HIS B 229 HIS^? 14.08 O2 PO4 B 349 C 204 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 24.54 38.99 2.73 24.16 37.16 5.19 coo 20.16 5.55 18.86 20.00 7.59 19.34 11.38 38.70 0.79 12.71 38.99 -0.80 coo 24.92 3.29 16.90 24.41 4.92 15.69 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 1j70_c02 ATP SULPHURYLASE user 10 3 # 10 C 197 ARG C 153 ARG^? 21.82 O2 PO4 C 349 C 201 HIS C 173 HIS~? 15.03 O2 PO4 C 349 C 204 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -28.52 27.96 39.05 -27.50 30.55 40.41 coo 20.16 5.55 18.86 20.00 7.59 19.34 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 24.92 3.29 16.90 24.41 4.92 15.69 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1j70_c02 ATP SULPHURYLASE user 11 3 # 11 C 197 ARG C 182 ARG.? 12.42 C6 PG4 A 350 C 201 HIS C 173 HIS~? 15.03 O2 PO4 C 349 C 204 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -17.19 25.58 29.52 -16.27 25.77 32.47 coo 20.16 5.55 18.86 20.00 7.59 19.34 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 24.92 3.29 16.90 24.41 4.92 15.69 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1j70_c02 ATP SULPHURYLASE user 12 3 # 12 C 197 ARG C 182 ARG.? 12.42 C6 PG4 A 350 C 201 HIS C 229 HIS^? 14.09 O2 PO4 C 349 C 204 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -17.19 25.58 29.52 -16.27 25.77 32.47 coo 20.16 5.55 18.86 20.00 7.59 19.34 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 24.92 3.29 16.90 24.41 4.92 15.69 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 1j70_c02 ATP SULPHURYLASE user 13 3 # 13 C 197 ARG D 153 ARG^? 21.95 O1 PO4 D 349 C 201 HIS D 173 HIS~? 14.91 O1 PO4 D 349 C 204 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -63.61 25.82 49.88 -65.26 27.93 48.32 coo 20.16 5.55 18.86 20.00 7.59 19.34 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 24.92 3.29 16.90 24.41 4.92 15.69 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1j70_c02 ATP SULPHURYLASE user 14 3 # 14 C 197 ARG D 182 ARG.? 26.89 O1 PO4 D 349 C 201 HIS D 173 HIS~? 14.91 O1 PO4 D 349 C 204 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -74.46 22.20 60.05 -74.88 21.98 57.01 coo 20.16 5.55 18.86 20.00 7.59 19.34 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 24.92 3.29 16.90 24.41 4.92 15.69 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 1j70_c02 ATP SULPHURYLASE user 15 3 # 15 C 197 ARG D 182 ARG.? 26.89 O1 PO4 D 349 C 201 HIS D 229 HIS^? 14.18 O1 PO4 D 349 C 204 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo 30.92 14.23 15.70 28.82 13.90 13.48 -74.46 22.20 60.05 -74.88 21.98 57.01 coo 20.16 5.55 18.86 20.00 7.59 19.34 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 24.92 3.29 16.90 24.41 4.92 15.69 -62.51 23.18 64.17 -63.84 21.56 64.29 1j70_c02 source 1j70 ATP SULPHURYLASE : 15 hits 1j70_c02 naa= 3 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 1 3 # 1 A 202 SER A 64 SER~? 26.25 O3 PG4 B 350 A 308 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 338 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 37.44 15.05 21.90 37.18 17.02 20.71 1.46 56.04 50.07 2.12 55.38 52.31 coo 45.75 18.77 19.41 43.72 18.70 19.99 1.74 60.96 43.57 3.36 61.47 42.28 coo 41.13 18.39 17.83 39.67 17.70 19.17 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 2 3 # 2 A 202 SER A 241 SER.? 9.98 O3 PO4 A 349 A 308 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 338 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 37.44 15.05 21.90 37.18 17.02 20.71 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 45.75 18.77 19.41 43.72 18.70 19.99 -1.16 62.88 18.52 0.68 62.16 19.33 coo 41.13 18.39 17.83 39.67 17.70 19.17 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 3 3 # 3 A 202 SER B 64 SER~? 26.98 C5 PG4 A 350 A 308 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 338 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 37.44 15.05 21.90 37.18 17.02 20.71 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 45.75 18.77 19.41 43.72 18.70 19.99 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 41.13 18.39 17.83 39.67 17.70 19.17 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 4 3 # 4 A 202 SER B 241 SER.? 10.02 O1 PO4 B 349 A 308 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 338 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 37.44 15.05 21.90 37.18 17.02 20.71 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 45.75 18.77 19.41 43.72 18.70 19.99 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 41.13 18.39 17.83 39.67 17.70 19.17 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 5 3 # 5 A 202 SER C 64 SER~? 25.88 C5 PG4 D 350 A 308 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 338 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 37.44 15.05 21.90 37.18 17.02 20.71 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 45.75 18.77 19.41 43.72 18.70 19.99 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 41.13 18.39 17.83 39.67 17.70 19.17 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 6 3 # 6 A 202 SER C 241 SER.? 9.97 O3 PO4 C 349 A 308 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 338 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 37.44 15.05 21.90 37.18 17.02 20.71 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 45.75 18.77 19.41 43.72 18.70 19.99 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 41.13 18.39 17.83 39.67 17.70 19.17 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 7 3 # 7 A 202 SER D 64 SER~? 27.50 C6 PG4 C 350 A 308 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 338 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 37.44 15.05 21.90 37.18 17.02 20.71 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 45.75 18.77 19.41 43.72 18.70 19.99 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 41.13 18.39 17.83 39.67 17.70 19.17 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 8 3 # 8 A 202 SER D 241 SER.? 10.08 O3 PO4 D 349 A 308 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 338 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 37.44 15.05 21.90 37.18 17.02 20.71 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 45.75 18.77 19.41 43.72 18.70 19.99 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 41.13 18.39 17.83 39.67 17.70 19.17 -38.74 26.41 54.26 -37.48 24.84 54.87 1jkm_c00 source 1jkm BREFELDIN A ESTERASE : 8 hits 1jkm_c00 naa= 3 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 1 3 # 1 B 202 SER A 64 SER~? 26.25 O3 PG4 B 350 B 308 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 338 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 67.81 2.11 21.29 69.09 3.00 23.04 1.46 56.04 50.07 2.12 55.38 52.31 coo 64.20 9.21 26.15 65.67 7.96 25.24 1.74 60.96 43.57 3.36 61.47 42.28 coo 66.92 5.20 26.82 67.69 4.22 25.14 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 2 3 # 2 B 202 SER A 241 SER.? 9.98 O3 PO4 A 349 B 308 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 338 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 67.81 2.11 21.29 69.09 3.00 23.04 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 64.20 9.21 26.15 65.67 7.96 25.24 -1.16 62.88 18.52 0.68 62.16 19.33 coo 66.92 5.20 26.82 67.69 4.22 25.14 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 3 3 # 3 B 202 SER B 64 SER~? 26.98 C5 PG4 A 350 B 308 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 338 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 67.81 2.11 21.29 69.09 3.00 23.04 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 64.20 9.21 26.15 65.67 7.96 25.24 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 66.92 5.20 26.82 67.69 4.22 25.14 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 4 3 # 4 B 202 SER B 241 SER.? 10.02 O1 PO4 B 349 B 308 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 338 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 67.81 2.11 21.29 69.09 3.00 23.04 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 64.20 9.21 26.15 65.67 7.96 25.24 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 66.92 5.20 26.82 67.69 4.22 25.14 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 5 3 # 5 B 202 SER C 64 SER~? 25.88 C5 PG4 D 350 B 308 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 338 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 67.81 2.11 21.29 69.09 3.00 23.04 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 64.20 9.21 26.15 65.67 7.96 25.24 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 66.92 5.20 26.82 67.69 4.22 25.14 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 6 3 # 6 B 202 SER C 241 SER.? 9.97 O3 PO4 C 349 B 308 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 338 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 67.81 2.11 21.29 69.09 3.00 23.04 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 64.20 9.21 26.15 65.67 7.96 25.24 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 66.92 5.20 26.82 67.69 4.22 25.14 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 7 3 # 7 B 202 SER D 64 SER~? 27.50 C6 PG4 C 350 B 308 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 338 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 67.81 2.11 21.29 69.09 3.00 23.04 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 64.20 9.21 26.15 65.67 7.96 25.24 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 66.92 5.20 26.82 67.69 4.22 25.14 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 8 3 # 8 B 202 SER D 241 SER.? 10.08 O3 PO4 D 349 B 308 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 338 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 67.81 2.11 21.29 69.09 3.00 23.04 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 64.20 9.21 26.15 65.67 7.96 25.24 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 66.92 5.20 26.82 67.69 4.22 25.14 -38.74 26.41 54.26 -37.48 24.84 54.87 1jkm_c01 source 1jkm BREFELDIN A ESTERASE : 8 hits 1jkm_c01 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG C 179 ARG~? 14.85 O2 PG4 A 350 A 581 ARG C 152 ARG^? 15.32 O1 PG4 A 350 A 713 ARG A 220 ARG~? 15.84 O1 PG4 A 350 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -24.98 33.12 21.00 -27.25 35.17 20.85 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -26.55 34.01 32.08 -24.98 36.67 32.18 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -23.72 43.89 25.49 -25.14 44.23 28.23 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 1 hits 1jqn_c01 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 89 ASP~? 13.93 C4 PG4 B 350 B 58 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 424 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo 112.10 61.46 19.99 111.82 60.65 18.07 10.16 45.65 42.38 11.05 44.28 40.99 coo 117.85 63.62 21.08 115.96 63.25 20.18 8.08 50.44 43.84 7.48 51.26 41.98 coo 118.47 57.23 15.57 119.32 58.77 16.73 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP C 89 ASP.? 13.45 C5 PG4 D 350 B 58 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 424 GLU C 94 GLU~? 21.12 C5 PG4 D 350 coo 112.10 61.46 19.99 111.82 60.65 18.07 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 117.85 63.62 21.08 115.96 63.25 20.18 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 118.47 57.23 15.57 119.32 58.77 16.73 -51.22 -2.72 22.56 -51.13 -3.21 20.49 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP D 89 ASP.? 16.35 C5 PG4 C 350 B 58 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 424 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo 112.10 61.46 19.99 111.82 60.65 18.07 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 117.85 63.62 21.08 115.96 63.25 20.18 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 118.47 57.23 15.57 119.32 58.77 16.73 -39.10 0.33 71.21 -39.59 -0.04 73.26 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 3 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 171 GLU~? 12.95 O2 PO4 A 349 A 56 LYS A 165 LYS~? -2.78 O4 PO4 A 349s A 258 ARG A 335 ARG~? 17.04 O2 PO4 A 349 coo 42.33 1.56 26.99 42.38 2.91 28.66 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -10.94 77.02 25.36 -8.46 78.77 25.78 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 171 GLU~? 12.87 O3 PO4 B 349 A 56 LYS B 165 LYS~? -2.78 O4 PO4 B 349s A 258 ARG B 335 ARG~? 17.10 O3 PO4 B 349 coo 42.33 1.56 26.99 42.38 2.91 28.66 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 38.45 -0.44 19.89 37.36 0.90 25.90 0.37 36.49 0.17 -3.63 37.66 2.73 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -0.53 29.97 -13.85 -3.08 28.75 -15.03 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU C 171 GLU~? 12.90 O2 PO4 C 349 A 56 LYS C 165 LYS~? -2.77 O1 PO4 C 349s A 258 ARG C 335 ARG~? 16.94 O4 PO4 C 349 coo 42.33 1.56 26.99 42.38 2.91 28.66 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -43.40 31.02 13.21 -46.07 30.90 11.67 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU D 171 GLU~? 12.87 O2 PO4 D 349 A 56 LYS D 165 LYS~? -2.89 O4 PO4 D 349s A 258 ARG D 335 ARG~? 17.05 O2 PO4 D 349 coo 42.33 1.56 26.99 42.38 2.91 28.66 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -49.77 35.01 75.03 -47.14 35.61 76.51 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 171 GLU~? 12.95 O2 PO4 A 349 B 56 LYS A 165 LYS~? -2.78 O4 PO4 A 349s B 258 ARG A 335 ARG~? 17.04 O2 PO4 A 349 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 2.64 1.83 34.81 1.56 1.13 32.02 -10.94 77.02 25.36 -8.46 78.77 25.78 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 171 GLU~? 12.87 O3 PO4 B 349 B 56 LYS B 165 LYS~? -2.78 O4 PO4 B 349s B 258 ARG B 335 ARG~? 17.10 O3 PO4 B 349 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 0.37 36.49 0.17 -3.63 37.66 2.73 coo 2.64 1.83 34.81 1.56 1.13 32.02 -0.53 29.97 -13.85 -3.08 28.75 -15.03 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU C 171 GLU~? 12.90 O2 PO4 C 349 B 56 LYS C 165 LYS~? -2.77 O1 PO4 C 349s B 258 ARG C 335 ARG~? 16.94 O4 PO4 C 349 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 2.64 1.83 34.81 1.56 1.13 32.02 -43.40 31.02 13.21 -46.07 30.90 11.67 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU D 171 GLU~? 12.87 O2 PO4 D 349 B 56 LYS D 165 LYS~? -2.89 O4 PO4 D 349s B 258 ARG D 335 ARG~? 17.05 O2 PO4 D 349 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 2.64 1.83 34.81 1.56 1.13 32.02 -49.77 35.01 75.03 -47.14 35.61 76.51 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 171 GLU~? 12.95 O2 PO4 A 349 C 56 LYS A 165 LYS~? -2.78 O4 PO4 A 349s C 258 ARG A 335 ARG~? 17.04 O2 PO4 A 349 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -10.94 77.02 25.36 -8.46 78.77 25.78 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 171 GLU~? 12.87 O3 PO4 B 349 C 56 LYS B 165 LYS~? -2.78 O4 PO4 B 349s C 258 ARG B 335 ARG~? 17.10 O3 PO4 B 349 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 0.37 36.49 0.17 -3.63 37.66 2.73 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -0.53 29.97 -13.85 -3.08 28.75 -15.03 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU C 171 GLU~? 12.90 O2 PO4 C 349 C 56 LYS C 165 LYS~? -2.77 O1 PO4 C 349s C 258 ARG C 335 ARG~? 16.94 O4 PO4 C 349 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -43.40 31.02 13.21 -46.07 30.90 11.67 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU D 171 GLU~? 12.87 O2 PO4 D 349 C 56 LYS D 165 LYS~? -2.89 O4 PO4 D 349s C 258 ARG D 335 ARG~? 17.05 O2 PO4 D 349 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -49.77 35.01 75.03 -47.14 35.61 76.51 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 171 GLU~? 12.95 O2 PO4 A 349 D 56 LYS A 165 LYS~? -2.78 O4 PO4 A 349s D 258 ARG A 335 ARG~? 17.04 O2 PO4 A 349 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -10.94 77.02 25.36 -8.46 78.77 25.78 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 171 GLU~? 12.87 O3 PO4 B 349 D 56 LYS B 165 LYS~? -2.78 O4 PO4 B 349s D 258 ARG B 335 ARG~? 17.10 O3 PO4 B 349 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 0.37 36.49 0.17 -3.63 37.66 2.73 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -0.53 29.97 -13.85 -3.08 28.75 -15.03 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU C 171 GLU~? 12.90 O2 PO4 C 349 D 56 LYS C 165 LYS~? -2.77 O1 PO4 C 349s D 258 ARG C 335 ARG~? 16.94 O4 PO4 C 349 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -43.40 31.02 13.21 -46.07 30.90 11.67 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU D 171 GLU~? 12.87 O2 PO4 D 349 D 56 LYS D 165 LYS~? -2.89 O4 PO4 D 349s D 258 ARG D 335 ARG~? 17.05 O2 PO4 D 349 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -49.77 35.01 75.03 -47.14 35.61 76.51 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU C 135 GLU.? -3.67 O1 PG4 C 350s A 163 ARG C 206 ARG~? -3.06 O3 PG4 C 350s A 222 ARG D 206 ARG~? -3.23 O2 PG4 D 350s coo 51.27 81.34 48.31 51.67 80.79 50.28 -38.59 10.74 44.23 -39.39 10.87 46.20 coo 48.06 78.22 50.94 48.51 78.27 53.98 -42.81 10.68 48.87 -40.18 9.57 50.03 coo 54.85 84.16 52.60 54.26 81.23 53.34 -46.64 9.92 42.41 -48.92 7.98 41.78 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU D 135 GLU.? -4.27 C8 PG4 D 350s A 163 ARG D 206 ARG~? -3.23 O2 PG4 D 350s A 222 ARG C 206 ARG~? -3.06 O3 PG4 C 350s coo 51.27 81.34 48.31 51.67 80.79 50.28 -50.80 9.98 46.92 -49.80 10.03 45.07 coo 48.06 78.22 50.94 48.51 78.27 53.98 -46.64 9.92 42.41 -48.92 7.98 41.78 coo 54.85 84.16 52.60 54.26 81.23 53.34 -42.81 10.68 48.87 -40.18 9.57 50.03 1kim_c00 source 1kim THYMIDINE KINASE : 2 hits 1kim_c00 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG A 249 ARG~? 17.61 O4 PO4 B 349 A 351 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 386 LEU B 236 LEU.? 13.69 O4 PO4 B 349 coo 57.36 53.34 128.83 58.45 50.56 128.34 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 60.60 50.64 133.59 60.63 48.82 132.56 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 63.28 54.23 126.45 63.53 52.07 126.70 -7.17 47.64 4.03 -5.58 48.63 5.14 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG A 249 ARG~? 17.61 O4 PO4 B 349 A 351 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 386 LEU B 237 LEU.? 12.67 O4 PO4 B 349 coo 57.36 53.34 128.83 58.45 50.56 128.34 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 60.60 50.64 133.59 60.63 48.82 132.56 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 63.28 54.23 126.45 63.53 52.07 126.70 -10.81 44.71 1.03 -10.07 45.97 -0.56 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 3 3 # 3 A 290 ARG B 249 ARG~? 17.39 O4 PO4 A 349 A 351 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 386 LEU A 236 LEU.? 13.48 O4 PO4 A 349 coo 57.36 53.34 128.83 58.45 50.56 128.34 1.78 52.94 11.29 0.18 53.87 8.84 coo 60.60 50.64 133.59 60.63 48.82 132.56 1.50 56.90 17.79 2.83 56.38 19.33 coo 63.28 54.23 126.45 63.53 52.07 126.70 -4.08 56.51 10.90 -5.57 54.97 10.53 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 4 3 # 4 A 290 ARG B 249 ARG~? 17.39 O4 PO4 A 349 A 351 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 386 LEU A 237 LEU.? 12.58 O4 PO4 A 349 coo 57.36 53.34 128.83 58.45 50.56 128.34 1.78 52.94 11.29 0.18 53.87 8.84 coo 60.60 50.64 133.59 60.63 48.82 132.56 1.50 56.90 17.79 2.83 56.38 19.33 coo 63.28 54.23 126.45 63.53 52.07 126.70 -0.58 60.53 12.48 -1.70 61.73 11.03 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 5 3 # 5 A 290 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 351 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 386 LEU D 236 LEU.? 13.82 O4 PO4 D 349 coo 57.36 53.34 128.83 58.45 50.56 128.34 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 60.60 50.64 133.59 60.63 48.82 132.56 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 63.28 54.23 126.45 63.53 52.07 126.70 -44.49 31.48 49.70 -46.09 30.95 48.36 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 6 3 # 6 A 290 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 351 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 386 LEU D 237 LEU.? 12.72 O4 PO4 D 349 coo 57.36 53.34 128.83 58.45 50.56 128.34 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 60.60 50.64 133.59 60.63 48.82 132.56 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 63.28 54.23 126.45 63.53 52.07 126.70 -40.74 32.88 53.53 -41.84 34.75 53.48 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 7 3 # 7 A 290 ARG D 249 ARG~? 17.54 O1 PO4 C 349 A 351 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 386 LEU C 236 LEU.? 13.51 O1 PO4 C 349 coo 57.36 53.34 128.83 58.45 50.56 128.34 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 60.60 50.64 133.59 60.63 48.82 132.56 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 63.28 54.23 126.45 63.53 52.07 126.70 -48.29 30.43 38.79 -46.56 30.05 40.04 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 8 3 # 8 A 290 ARG D 249 ARG~? 17.54 O1 PO4 C 349 A 351 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 386 LEU C 237 LEU.? 12.76 O1 PO4 C 349 coo 57.36 53.34 128.83 58.45 50.56 128.34 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 60.60 50.64 133.59 60.63 48.82 132.56 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 63.28 54.23 126.45 63.53 52.07 126.70 -52.35 30.84 34.89 -51.55 32.85 34.62 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 8 hits 1knp_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS D 177 LYS~? 20.36 O1 PO4 D 349 A 74 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 165 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 24.97 5.82 58.78 26.79 1.97 55.46 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 19.46 3.44 61.93 23.95 1.12 60.13 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -60.02 15.53 71.55 -61.82 16.61 71.53 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS D 177 LYS~? 20.36 O1 PO4 D 349 B 74 LYS D 184 LYS^? 18.69 O1 PO4 D 349 B 165 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 4.84 5.09 23.75 3.30 1.39 27.48 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 10.43 2.88 20.75 5.72 0.41 23.95 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -60.02 15.53 71.55 -61.82 16.61 71.53 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS D 177 LYS~? 20.36 O1 PO4 D 349 C 74 LYS D 184 LYS^? 18.69 O1 PO4 D 349 C 165 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 17.59 37.25 25.80 19.64 34.15 21.60 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 12.29 34.52 28.11 16.84 32.47 25.43 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 12.06 27.10 15.56 13.23 27.02 13.80 -60.02 15.53 71.55 -61.82 16.61 71.53 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS D 177 LYS~? 20.36 O1 PO4 D 349 D 74 LYS D 184 LYS^? 18.69 O1 PO4 D 349 D 165 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -60.02 15.53 71.55 -61.82 16.61 71.53 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1kqc_c03 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS A 165 LYS~? -2.78 O4 PO4 A 349s A 197 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 446 ARG A 133 ARG.? 8.90 C3 PG4 B 350 coo 3.26 62.02 109.14 4.83 57.73 107.38 -10.69 61.92 21.86 -6.45 59.75 20.54 coo 9.48 43.28 113.60 10.05 44.21 111.80 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 12.14 46.28 115.16 13.57 43.60 115.68 -4.79 46.92 29.78 -3.00 49.36 29.13 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 2 3 # 2 A 94 LYS B 96 LYS~? 18.72 C5 PG4 A 350 A 197 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 446 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo 3.26 62.02 109.14 4.83 57.73 107.38 -4.65 11.97 23.20 -9.16 12.78 27.52 coo 9.48 43.28 113.60 10.05 44.21 111.80 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 12.14 46.28 115.16 13.57 43.60 115.68 -3.22 31.42 16.60 -5.11 31.22 14.14 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 3 3 # 3 A 94 LYS B 165 LYS~? -2.78 O4 PO4 B 349s A 197 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 446 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo 3.26 62.02 109.14 4.83 57.73 107.38 0.37 36.49 0.17 -3.63 37.66 2.73 coo 9.48 43.28 113.60 10.05 44.21 111.80 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 12.14 46.28 115.16 13.57 43.60 115.68 -3.22 31.42 16.60 -5.11 31.22 14.14 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 4 3 # 4 A 94 LYS C 165 LYS~? -2.77 O1 PO4 C 349s A 197 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 446 ARG C 133 ARG.? 8.69 C6 PG4 D 350 coo 3.26 62.02 109.14 4.83 57.73 107.38 -41.72 25.46 27.54 -45.65 24.70 30.33 coo 9.48 43.28 113.60 10.05 44.21 111.80 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 12.14 46.28 115.16 13.57 43.60 115.68 -44.64 9.69 35.41 -46.86 11.41 34.11 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 5 3 # 5 A 94 LYS D 96 LYS~? 18.18 C6 PG4 C 350 A 197 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 446 ARG D 133 ARG.? 8.84 C4 PG4 C 350 coo 3.26 62.02 109.14 4.83 57.73 107.38 -42.30 -5.81 66.82 -37.97 -8.16 62.87 coo 9.48 43.28 113.60 10.05 44.21 111.80 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 12.14 46.28 115.16 13.57 43.60 115.68 -45.06 11.05 55.96 -43.37 13.22 57.41 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 6 3 # 6 A 94 LYS D 165 LYS~? -2.89 O4 PO4 D 349s A 197 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 446 ARG D 133 ARG.? 8.84 C4 PG4 C 350 coo 3.26 62.02 109.14 4.83 57.73 107.38 -50.59 27.20 61.67 -46.47 26.50 58.89 coo 9.48 43.28 113.60 10.05 44.21 111.80 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 12.14 46.28 115.16 13.57 43.60 115.68 -45.06 11.05 55.96 -43.37 13.22 57.41 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 6 hits 1kqf_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 226 ASP.? 25.19 O1 PO4 A 349 262 LYS A 184 LYS^? 18.49 O1 PO4 A 349 336 ARG A 179 ARG~? 21.90 O1 PO4 A 349 coo 61.88 50.78 12.96 63.84 50.60 13.71 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 63.59 44.40 18.32 63.20 49.74 17.95 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 72.60 57.42 15.86 71.61 56.68 18.70 -29.50 69.96 21.84 -27.37 70.37 19.60 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP B 226 ASP.? 24.90 O2 PO4 B 349 262 LYS B 177 LYS~? 21.19 O2 PO4 B 349 336 ARG B 153 ARG^? 21.71 O2 PO4 B 349 coo 61.88 50.78 12.96 63.84 50.60 13.71 20.38 42.79 0.27 22.43 42.38 0.23 coo 63.59 44.40 18.32 63.20 49.74 17.95 18.35 34.41 -3.27 19.41 29.18 0.25 coo 72.60 57.42 15.86 71.61 56.68 18.70 12.56 47.43 6.76 13.42 50.26 5.86 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP B 226 ASP.? 24.90 O2 PO4 B 349 262 LYS B 184 LYS^? 17.27 O2 PO4 B 349 336 ARG B 179 ARG~? 22.83 O2 PO4 B 349 coo 61.88 50.78 12.96 63.84 50.60 13.71 20.38 42.79 0.27 22.43 42.38 0.23 coo 63.59 44.40 18.32 63.20 49.74 17.95 15.36 36.70 4.47 15.17 34.16 8.91 coo 72.60 57.42 15.86 71.61 56.68 18.70 17.17 37.45 -10.17 16.17 40.20 -11.05 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 311 ASP~? 22.86 O3 PO4 B 349 262 LYS B 316 LYS~? 24.20 O3 PO4 B 349 336 ARG B 261 ARG^? 7.86 O3 PO4 B 349 coo 61.88 50.78 12.96 63.84 50.60 13.71 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 63.59 44.40 18.32 63.20 49.74 17.95 -2.04 35.41 -19.34 2.27 31.66 -22.14 coo 72.60 57.42 15.86 71.61 56.68 18.70 -9.45 33.50 -6.22 -8.65 32.83 -3.27 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP B 332 ASP~? 12.13 O3 PO4 B 349 262 LYS B 316 LYS~? 24.20 O3 PO4 B 349 336 ARG B 261 ARG^? 7.86 O3 PO4 B 349 coo 61.88 50.78 12.96 63.84 50.60 13.71 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 63.59 44.40 18.32 63.20 49.74 17.95 -2.04 35.41 -19.34 2.27 31.66 -22.14 coo 72.60 57.42 15.86 71.61 56.68 18.70 -9.45 33.50 -6.22 -8.65 32.83 -3.27 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP C 226 ASP.? 11.40 C1 PG4 A 350 262 LYS C 184 LYS^? 18.13 O2 PO4 C 349 336 ARG C 179 ARG~? 14.85 O2 PG4 A 350 coo 61.88 50.78 12.96 63.84 50.60 13.71 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 63.59 44.40 18.32 63.20 49.74 17.95 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 72.60 57.42 15.86 71.61 56.68 18.70 -24.98 33.12 21.00 -27.25 35.17 20.85 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 7 3 # 7 255 ASP C 311 ASP~? 22.87 O4 PO4 C 349 262 LYS C 316 LYS~? 23.27 O4 PO4 C 349 336 ARG C 261 ARG^? 7.89 O4 PO4 C 349 coo 61.88 50.78 12.96 63.84 50.60 13.71 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 63.59 44.40 18.32 63.20 49.74 17.95 -44.69 38.73 13.31 -40.21 38.10 9.89 coo 72.60 57.42 15.86 71.61 56.68 18.70 -51.94 28.25 21.63 -51.22 25.74 23.33 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 8 3 # 8 255 ASP C 332 ASP~? 12.18 O4 PO4 C 349 262 LYS C 316 LYS~? 23.27 O4 PO4 C 349 336 ARG C 261 ARG^? 7.89 O4 PO4 C 349 coo 61.88 50.78 12.96 63.84 50.60 13.71 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 63.59 44.40 18.32 63.20 49.74 17.95 -44.69 38.73 13.31 -40.21 38.10 9.89 coo 72.60 57.42 15.86 71.61 56.68 18.70 -51.94 28.25 21.63 -51.22 25.74 23.33 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 9 3 # 9 255 ASP D 226 ASP.? 25.08 O1 PO4 D 349 262 LYS D 177 LYS~? 20.36 O1 PO4 D 349 336 ARG D 153 ARG^? 21.95 O1 PO4 D 349 coo 61.88 50.78 12.96 63.84 50.60 13.71 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 63.59 44.40 18.32 63.20 49.74 17.95 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 72.60 57.42 15.86 71.61 56.68 18.70 -63.61 25.82 49.88 -65.26 27.93 48.32 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 10 3 # 10 255 ASP D 311 ASP~? 22.85 O2 PO4 D 349 262 LYS D 316 LYS~? 24.37 O2 PO4 D 349 336 ARG D 261 ARG^? 8.01 O2 PO4 D 349 coo 61.88 50.78 12.96 63.84 50.60 13.71 -43.35 38.70 79.64 -42.93 40.74 79.14 coo 63.59 44.40 18.32 63.20 49.74 17.95 -49.65 42.56 73.75 -53.64 42.38 78.67 coo 72.60 57.42 15.86 71.61 56.68 18.70 -41.02 32.36 67.18 -41.18 29.51 65.99 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 11 3 # 11 255 ASP D 332 ASP~? 12.02 O2 PO4 D 349 262 LYS D 316 LYS~? 24.37 O2 PO4 D 349 336 ARG D 261 ARG^? 8.01 O2 PO4 D 349 coo 61.88 50.78 12.96 63.84 50.60 13.71 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 63.59 44.40 18.32 63.20 49.74 17.95 -49.65 42.56 73.75 -53.64 42.38 78.67 coo 72.60 57.42 15.86 71.61 56.68 18.70 -41.02 32.36 67.18 -41.18 29.51 65.99 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 11 hits 1lam_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 261 ARG^? 7.73 O2 PO4 A 349 245 HIS A 238 HIS.? 10.67 O3 PO4 A 349 343 THR A 159 THR.? 9.59 O4 PO4 A 349 coo 18.11 85.25 41.19 18.04 83.33 43.59 -1.53 69.75 22.21 -1.72 66.84 23.28 coo 5.34 86.23 43.48 6.16 87.26 45.12 1.50 56.90 17.79 2.83 56.38 19.33 coo 9.06 92.76 42.80 7.04 92.63 42.14 -3.74 63.20 14.86 -4.14 65.31 14.68 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG B 261 ARG^? 7.86 O3 PO4 B 349 245 HIS B 238 HIS.? 10.82 O1 PO4 B 349 343 THR B 159 THR.? 9.69 O4 PO4 B 349 coo 18.11 85.25 41.19 18.04 83.33 43.59 -9.45 33.50 -6.22 -8.65 32.83 -3.27 coo 5.34 86.23 43.48 6.16 87.26 45.12 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 9.06 92.76 42.80 7.04 92.63 42.14 -7.46 42.26 -1.59 -7.39 42.02 -3.73 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG C 261 ARG^? 7.89 O4 PO4 C 349 245 HIS C 238 HIS.? 10.74 O3 PO4 C 349 343 THR C 159 THR.? 9.76 O1 PO4 C 349 coo 18.11 85.25 41.19 18.04 83.33 43.59 -51.94 28.25 21.63 -51.22 25.74 23.33 coo 5.34 86.23 43.48 6.16 87.26 45.12 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 9.06 92.76 42.80 7.04 92.63 42.14 -49.22 30.92 31.00 -49.22 32.37 29.42 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG D 261 ARG^? 8.01 O2 PO4 D 349 245 HIS D 238 HIS.? 10.72 O3 PO4 D 349 343 THR D 159 THR.? 9.84 O4 PO4 D 349 coo 18.11 85.25 41.19 18.04 83.33 43.59 -41.02 32.36 67.18 -41.18 29.51 65.99 coo 5.34 86.23 43.48 6.16 87.26 45.12 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 9.06 92.76 42.80 7.04 92.63 42.14 -43.83 33.07 57.34 -43.96 34.77 58.72 1lci_c00 source 1lci LUCIFERASE : 4 hits 1lci_c00 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 142 ALA.? 12.14 C2 PG4 A 350 A 317 GLY A 212 GLY~? 9.07 O1 PG4 A 350 A 318 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -16.20 40.87 12.81 -15.80 42.33 13.02 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -15.16 41.65 16.73 -14.78 42.24 17.11 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 201 ALA~? 12.43 O1 PG4 A 350 A 317 GLY A 189 GLY~? 8.76 O1 PO4 A 349 A 318 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -10.23 47.67 26.68 -9.44 47.25 27.90 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA A 338 ALA~? 14.94 O1 PO4 A 349 A 317 GLY A 337 GLY~? 17.24 O2 PO4 A 349 A 318 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -19.69 73.64 23.95 -19.01 73.56 23.47 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 142 ALA.? 12.37 C2 PG4 B 350 A 317 GLY B 212 GLY~? 9.26 O1 PG4 B 350 A 318 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 6.73 50.30 18.21 6.20 49.71 16.95 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 6.02 46.22 18.32 5.64 45.65 17.83 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1lij_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA B 187 ALA.? 10.53 O2 PO4 B 349 A 317 GLY B 199 GLY.? 13.71 O1 PG4 B 350 A 318 ASP B 198 ASP.? 14.38 O1 PG4 B 350 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 6.84 34.76 9.15 6.94 33.32 9.66 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 8.71 34.57 13.67 8.56 34.17 14.43 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 11.89 31.57 14.26 12.37 32.72 16.00 ULMN 3 1lij_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA B 201 ALA~? 11.68 O5 PG4 A 350 A 317 GLY B 189 GLY~? 8.50 O2 PO4 B 349 A 318 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 1.77 34.76 14.91 1.15 33.57 15.58 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 1.22 33.78 11.00 2.03 33.50 11.09 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1lij_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA B 338 ALA~? 14.85 O2 PO4 B 349 A 317 GLY B 337 GLY~? 16.94 O3 PO4 B 349 A 318 ASP B 339 ASP~? 20.98 O2 PO4 B 349 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 8.09 33.07 -11.69 7.39 33.52 -11.68 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 12.36 37.42 -12.59 13.93 36.17 -11.84 ULMN 3 1lij_c01 ADENOSINE KINASE user 8 3 # 8 A 316 ALA C 142 ALA.? 12.35 C2 PG4 C 350 A 317 GLY C 212 GLY~? 9.26 C2 PG4 C 350 A 318 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -33.86 22.03 49.44 -34.51 22.67 48.24 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -34.69 19.16 46.59 -35.10 19.11 45.88 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1lij_c01 ADENOSINE KINASE user 9 3 # 9 A 316 ALA C 187 ALA.? 10.66 O2 PO4 C 349 A 317 GLY C 199 GLY.? 14.01 O1 PG4 C 350 A 318 ASP C 198 ASP.? 14.11 O1 PG4 C 350 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -34.89 17.65 31.97 -34.86 16.31 31.26 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -32.88 14.56 34.60 -33.00 13.70 34.89 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -29.82 11.85 32.90 -29.50 11.63 35.01 ULMN 3 1lij_c01 ADENOSINE KINASE user 10 3 # 10 A 316 ALA C 201 ALA~? 12.26 O1 PG4 C 350 A 317 GLY C 189 GLY~? 8.64 O2 PO4 C 349 A 318 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -39.60 13.45 36.30 -40.20 12.08 36.02 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -40.49 15.78 32.96 -39.70 15.56 32.71 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1lij_c01 ADENOSINE KINASE user 11 3 # 11 A 316 ALA C 338 ALA~? 14.81 O2 PO4 C 349 A 317 GLY C 337 GLY~? 17.12 O2 PO4 C 349 A 318 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -34.47 31.36 16.09 -35.14 31.66 16.46 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1lij_c01 ADENOSINE KINASE user 12 3 # 12 A 316 ALA D 201 ALA~? 12.42 C7 PG4 C 350 A 317 GLY D 189 GLY~? 8.43 O1 PO4 D 349 A 318 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -50.29 13.95 54.51 -49.45 12.81 55.00 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1lij_c01 ADENOSINE KINASE user 13 3 # 13 A 316 ALA D 338 ALA~? 15.02 O1 PO4 D 349 A 317 GLY D 337 GLY~? 16.88 O2 PO4 D 349 A 318 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -59.57 33.12 68.34 -59.94 31.78 67.75 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -58.47 33.44 71.99 -57.91 33.83 71.55 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -63.02 36.35 69.71 -64.42 35.04 70.68 1lij_c01 source 1lij ADENOSINE KINASE : 13 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 142 ALA.? 12.14 C2 PG4 A 350 A 317 GLY A 212 GLY~? 9.07 O1 PG4 A 350 A 318 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 27.04 23.54 41.85 25.72 24.19 42.18 -16.20 40.87 12.81 -15.80 42.33 13.02 coo 27.87 23.16 38.17 28.43 22.97 38.87 -15.16 41.65 16.73 -14.78 42.24 17.11 coo 32.11 22.71 40.58 33.42 24.22 39.78 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 201 ALA~? 12.43 O1 PG4 A 350 A 317 GLY A 189 GLY~? 8.76 O1 PO4 A 349 A 318 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 27.04 23.54 41.85 25.72 24.19 42.18 -10.23 47.67 26.68 -9.44 47.25 27.90 coo 27.87 23.16 38.17 28.43 22.97 38.87 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 32.11 22.71 40.58 33.42 24.22 39.78 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA A 338 ALA~? 14.94 O1 PO4 A 349 A 317 GLY A 337 GLY~? 17.24 O2 PO4 A 349 A 318 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo 27.04 23.54 41.85 25.72 24.19 42.18 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 27.87 23.16 38.17 28.43 22.97 38.87 -19.69 73.64 23.95 -19.01 73.56 23.47 coo 32.11 22.71 40.58 33.42 24.22 39.78 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 142 ALA.? 12.37 C2 PG4 B 350 A 317 GLY B 212 GLY~? 9.26 O1 PG4 B 350 A 318 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 27.04 23.54 41.85 25.72 24.19 42.18 6.73 50.30 18.21 6.20 49.71 16.95 coo 27.87 23.16 38.17 28.43 22.97 38.87 6.02 46.22 18.32 5.64 45.65 17.83 coo 32.11 22.71 40.58 33.42 24.22 39.78 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1lio_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA B 201 ALA~? 11.68 O5 PG4 A 350 A 317 GLY B 189 GLY~? 8.50 O2 PO4 B 349 A 318 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 27.04 23.54 41.85 25.72 24.19 42.18 1.77 34.76 14.91 1.15 33.57 15.58 coo 27.87 23.16 38.17 28.43 22.97 38.87 1.22 33.78 11.00 2.03 33.50 11.09 coo 32.11 22.71 40.58 33.42 24.22 39.78 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1lio_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA B 338 ALA~? 14.85 O2 PO4 B 349 A 317 GLY B 337 GLY~? 16.94 O3 PO4 B 349 A 318 ASP B 339 ASP~? 20.98 O2 PO4 B 349 coo 27.04 23.54 41.85 25.72 24.19 42.18 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 27.87 23.16 38.17 28.43 22.97 38.87 8.09 33.07 -11.69 7.39 33.52 -11.68 coo 32.11 22.71 40.58 33.42 24.22 39.78 12.36 37.42 -12.59 13.93 36.17 -11.84 ULMN 3 1lio_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA C 142 ALA.? 12.35 C2 PG4 C 350 A 317 GLY C 212 GLY~? 9.26 C2 PG4 C 350 A 318 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 27.04 23.54 41.85 25.72 24.19 42.18 -33.86 22.03 49.44 -34.51 22.67 48.24 coo 27.87 23.16 38.17 28.43 22.97 38.87 -34.69 19.16 46.59 -35.10 19.11 45.88 coo 32.11 22.71 40.58 33.42 24.22 39.78 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1lio_c01 ADENOSINE KINASE user 8 3 # 8 A 316 ALA C 201 ALA~? 12.26 O1 PG4 C 350 A 317 GLY C 189 GLY~? 8.64 O2 PO4 C 349 A 318 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 27.04 23.54 41.85 25.72 24.19 42.18 -39.60 13.45 36.30 -40.20 12.08 36.02 coo 27.87 23.16 38.17 28.43 22.97 38.87 -40.49 15.78 32.96 -39.70 15.56 32.71 coo 32.11 22.71 40.58 33.42 24.22 39.78 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1lio_c01 ADENOSINE KINASE user 9 3 # 9 A 316 ALA C 338 ALA~? 14.81 O2 PO4 C 349 A 317 GLY C 337 GLY~? 17.12 O2 PO4 C 349 A 318 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 27.04 23.54 41.85 25.72 24.19 42.18 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 27.87 23.16 38.17 28.43 22.97 38.87 -34.47 31.36 16.09 -35.14 31.66 16.46 coo 32.11 22.71 40.58 33.42 24.22 39.78 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1lio_c01 ADENOSINE KINASE user 10 3 # 10 A 316 ALA D 201 ALA~? 12.42 C7 PG4 C 350 A 317 GLY D 189 GLY~? 8.43 O1 PO4 D 349 A 318 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 27.04 23.54 41.85 25.72 24.19 42.18 -50.29 13.95 54.51 -49.45 12.81 55.00 coo 27.87 23.16 38.17 28.43 22.97 38.87 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 32.11 22.71 40.58 33.42 24.22 39.78 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1lio_c01 ADENOSINE KINASE user 11 3 # 11 A 316 ALA D 338 ALA~? 15.02 O1 PO4 D 349 A 317 GLY D 337 GLY~? 16.88 O2 PO4 D 349 A 318 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 27.04 23.54 41.85 25.72 24.19 42.18 -59.57 33.12 68.34 -59.94 31.78 67.75 coo 27.87 23.16 38.17 28.43 22.97 38.87 -58.47 33.44 71.99 -57.91 33.83 71.55 coo 32.11 22.71 40.58 33.42 24.22 39.78 -63.02 36.35 69.71 -64.42 35.04 70.68 1lio_c01 source 1lio ADENOSINE KINASE : 11 hits 1lio_c01 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 279 GLU B 196 GLU~? 13.82 O2 PO4 B 349 A 369 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 16.54 46.37 63.94 14.77 45.79 62.95 10.06 30.74 8.04 11.63 30.24 6.70 coo 12.19 31.08 87.29 11.13 32.66 86.38 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 279 GLU B 215 GLU~? 13.59 C2 PG4 B 350 A 369 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 16.54 46.37 63.94 14.77 45.79 62.95 10.14 48.09 15.50 9.78 49.78 16.69 coo 12.19 31.08 87.29 11.13 32.66 86.38 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 279 GLU A 196 GLU~? 14.14 O1 PO4 A 349 A 369 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 16.54 46.37 63.94 14.77 45.79 62.95 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 279 GLU A 215 GLU~? 13.07 C2 PG4 A 350 A 369 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 16.54 46.37 63.94 14.77 45.79 62.95 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 279 GLU D 196 GLU~? 13.48 O1 PO4 D 349 A 369 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 16.54 46.37 63.94 14.77 45.79 62.95 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 12.19 31.08 87.29 11.13 32.66 86.38 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 279 GLU D 215 GLU~? 12.92 O5 PG4 D 350 A 369 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 16.54 46.37 63.94 14.77 45.79 62.95 -60.56 19.61 44.11 -60.32 19.66 42.03 coo 12.19 31.08 87.29 11.13 32.66 86.38 -31.75 16.85 51.07 -30.38 15.61 52.00 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 6 hits 1m53_c06 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 168 ASN A 269 ASN.? 10.42 O3 PO4 A 349 A 241 HIS A 272 HIS.? 19.95 O3 PO4 A 349 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -1.16 62.88 18.52 0.68 62.16 19.33 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 5.56 58.73 21.48 4.09 58.66 22.99 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 11.10 60.27 13.77 10.40 58.32 14.13 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 168 ASN B 269 ASN.? 10.41 O1 PO4 B 349 A 241 HIS B 272 HIS.? 20.00 O1 PO4 B 349 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -15.16 35.63 5.50 -13.49 34.32 5.66 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -21.96 42.12 3.17 -20.97 42.39 5.00 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 3 3 # 3 A 10 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 168 ASN C 269 ASN.? 10.45 O3 PO4 C 349 A 241 HIS C 272 HIS.? 20.13 O1 PO4 C 349 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -57.17 21.55 31.51 -55.49 20.56 30.60 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -63.70 27.74 35.03 -62.68 26.43 36.32 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 4 3 # 4 A 10 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 168 ASN D 269 ASN.? 10.24 O3 PO4 D 349 A 241 HIS D 272 HIS.? 19.84 O3 PO4 D 349 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -34.61 24.72 58.03 -36.14 23.70 59.12 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -29.12 31.20 53.56 -30.01 29.84 52.23 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 4 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 168 ASN A 269 ASN.? 10.42 O3 PO4 A 349 B 241 HIS A 272 HIS.? 19.95 O3 PO4 A 349 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -1.16 62.88 18.52 0.68 62.16 19.33 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 5.56 58.73 21.48 4.09 58.66 22.99 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 11.10 60.27 13.77 10.40 58.32 14.13 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 B 10 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 168 ASN B 269 ASN.? 10.41 O1 PO4 B 349 B 241 HIS B 272 HIS.? 20.00 O1 PO4 B 349 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -15.16 35.63 5.50 -13.49 34.32 5.66 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -21.96 42.12 3.17 -20.97 42.39 5.00 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 3 3 # 3 B 10 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 168 ASN B 306 ASN^? 8.17 O3 PO4 B 349 B 241 HIS B 309 HIS.? 14.09 O3 PO4 B 349 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -3.96 34.28 -6.86 -4.36 32.22 -6.36 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -9.40 30.81 -10.60 -9.30 32.90 -10.77 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 4 3 # 4 B 10 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 168 ASN C 269 ASN.? 10.45 O3 PO4 C 349 B 241 HIS C 272 HIS.? 20.13 O1 PO4 C 349 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -57.17 21.55 31.51 -55.49 20.56 30.60 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -63.70 27.74 35.03 -62.68 26.43 36.32 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 5 3 # 5 B 10 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 168 ASN C 306 ASN^? 8.19 O4 PO4 C 349 B 241 HIS C 309 HIS.? 14.15 O4 PO4 C 349 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -46.37 29.17 21.30 -46.92 27.39 20.25 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -52.33 29.51 16.61 -52.04 31.11 17.93 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 6 3 # 6 B 10 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 168 ASN D 269 ASN.? 10.24 O3 PO4 D 349 B 241 HIS D 272 HIS.? 19.84 O3 PO4 D 349 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -34.61 24.72 58.03 -36.14 23.70 59.12 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -29.12 31.20 53.56 -30.01 29.84 52.23 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 6 hits 1mas_c01 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 25 GLY~? 12.48 O2 PO4 A 349 A 501 ASP B 140 ASP.? 7.99 O2 PG4 B 350 B 367 TYR A 225 TYR.? 21.13 O1 PO4 A 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -5.57 58.65 37.18 -5.59 59.05 36.47 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 8.40 47.76 23.89 8.35 49.33 25.35 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -28.82 53.90 23.23 -28.73 53.13 25.91 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 79 GLY.? 14.13 O3 PO4 A 349 A 501 ASP A 118 ASP~? 17.27 C5 PG4 B 350 B 367 TYR A 221 TYR~? 17.25 O1 PG4 A 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.85 55.21 37.72 -3.17 54.79 37.80 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 0.76 36.83 47.04 2.33 35.40 47.32 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -24.98 48.97 24.49 -23.82 47.69 26.70 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 86 GLY.? 5.00 C4 PG4 B 350 A 501 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 367 TYR A 71 TYR~? 28.56 O2 PO4 A 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 4.72 44.66 33.63 5.12 45.31 34.00 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -1.16 62.88 18.52 0.68 62.16 19.33 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.92 60.98 53.46 -6.24 63.13 54.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 158 GLY^? 6.81 O4 PO4 A 349 A 501 ASP B 140 ASP.? 7.99 O2 PG4 B 350 B 367 TYR A 56 TYR.? 19.12 O2 PO4 A 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -7.06 61.86 16.04 -6.88 61.32 15.53 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 8.40 47.76 23.89 8.35 49.33 25.35 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -10.91 73.95 38.94 -9.98 76.39 38.02 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 164 GLY~? -3.53 O2 PO4 A 349s A 501 ASP A 226 ASP.? 25.19 O1 PO4 A 349 B 367 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -8.93 64.61 23.96 -8.76 64.08 23.42 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY A 189 GLY~? 8.76 O1 PO4 A 349 A 501 ASP A 226 ASP.? 25.19 O1 PO4 A 349 B 367 TYR A 58 TYR.? 25.18 O2 PO4 A 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -9.28 69.56 48.22 -7.53 68.84 50.27 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY A 189 GLY~? 8.76 O1 PO4 A 349 A 501 ASP A 226 ASP.? 25.19 O1 PO4 A 349 B 367 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY A 189 GLY~? 8.76 O1 PO4 A 349 A 501 ASP C 343 ASP~? 16.17 O1 PG4 A 350 B 367 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY A 197 GLY~? 16.88 O1 PO4 A 349 A 501 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 367 TYR A 285 TYR~? 11.91 O4 PO4 A 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -18.17 50.44 34.47 -18.10 50.51 33.67 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 1.74 60.96 43.57 3.36 61.47 42.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -8.78 59.29 10.05 -7.08 58.89 12.20 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY A 197 GLY~? 16.88 O1 PO4 A 349 A 501 ASP A 226 ASP.? 25.19 O1 PO4 A 349 B 367 TYR C 225 TYR~? 18.05 C6 PG4 A 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -18.17 50.44 34.47 -18.10 50.51 33.67 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.42 22.90 31.89 -22.15 20.23 31.17 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY A 197 GLY~? 16.88 O1 PO4 A 349 A 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 367 TYR A 285 TYR~? 11.91 O4 PO4 A 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -18.17 50.44 34.47 -18.10 50.51 33.67 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -8.78 59.29 10.05 -7.08 58.89 12.20 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY A 222 GLY~? 20.58 O1 PG4 A 350 A 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 367 TYR C 313 TYR~? 27.17 O4 PO4 C 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -27.23 49.69 18.85 -27.74 49.39 19.29 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -48.51 39.37 7.07 -48.60 42.05 6.33 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY A 232 GLY.? 6.13 O1 PO4 A 349 A 501 ASP B 140 ASP.? 7.99 O2 PG4 B 350 B 367 TYR A 56 TYR.? 19.12 O2 PO4 A 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -11.48 56.85 19.86 -11.43 56.72 20.67 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 8.40 47.76 23.89 8.35 49.33 25.35 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -10.91 73.95 38.94 -9.98 76.39 38.02 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY A 268 GLY.? 11.90 O3 PO4 A 349 A 501 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 367 TYR A 313 TYR~? 26.58 O2 PO4 A 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 4.47 63.40 20.71 4.75 62.80 20.25 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 1.74 60.96 43.57 3.36 61.47 42.28 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.13 87.01 20.69 -6.82 88.46 18.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY B 19 GLY.? 15.74 O3 PO4 B 349 A 501 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 367 TYR B 313 TYR~? 26.96 O3 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -12.10 20.39 1.89 -11.31 20.65 1.71 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -5.51 31.63 -24.11 -6.16 33.31 -26.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY B 25 GLY~? 12.55 O3 PO4 B 349 A 501 ASP A 140 ASP.? 7.37 O2 PG4 A 350 B 367 TYR B 225 TYR~? 21.07 O2 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.91 21.39 6.65 -1.94 22.01 6.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 19.22 39.10 5.74 19.70 36.67 7.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY B 25 GLY~? 12.55 O3 PO4 B 349 A 501 ASP B 118 ASP~? 16.08 C6 PG4 A 350 B 367 TYR B 221 TYR~? 17.66 O1 PG4 B 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.91 21.39 6.65 -1.94 22.01 6.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -7.43 16.06 29.70 -8.95 16.74 31.02 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 16.24 38.44 11.23 15.50 36.34 12.94 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY B 79 GLY.? 14.35 O1 PO4 B 349 A 501 ASP A 140 ASP.? 7.37 O2 PG4 A 350 B 367 TYR B 225 TYR~? 21.07 O2 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 19.22 39.10 5.74 19.70 36.67 7.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY B 79 GLY.? 14.35 O1 PO4 B 349 A 501 ASP B 118 ASP~? 16.08 C6 PG4 A 350 B 367 TYR B 221 TYR~? 17.66 O1 PG4 B 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -7.43 16.06 29.70 -8.95 16.74 31.02 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 16.24 38.44 11.23 15.50 36.34 12.94 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY B 79 GLY.? 14.35 O1 PO4 B 349 A 501 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 367 TYR C 225 TYR~? 18.05 C6 PG4 A 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.42 22.90 31.89 -22.15 20.23 31.17 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY B 84 GLY.? 7.18 C3 PG4 A 350 A 501 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 367 TYR C 221 TYR~? 17.74 O1 PG4 C 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -14.58 29.73 14.21 -14.80 28.98 14.10 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -25.26 18.68 35.52 -25.91 16.01 35.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY B 85 GLY.? 7.55 C3 PG4 A 350 A 501 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 367 TYR C 56 TYR.? 20.70 O4 PO4 C 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -15.17 26.80 16.60 -14.44 26.95 16.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -41.24 17.60 7.53 -40.11 17.22 5.03 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 23 3 # 23 A 465 GLY B 86 GLY.? 6.11 C4 PG4 A 350 A 501 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 367 TYR B 71 TYR~? 28.79 O3 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -12.50 26.48 19.35 -12.60 26.05 18.67 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.73 5.71 7.80 2.32 4.41 5.78 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 24 3 # 24 A 465 GLY B 108 GLY.? 11.44 C5 PG4 A 350 A 501 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 367 TYR C 225 TYR~? 18.05 C6 PG4 A 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.45 26.58 15.61 -2.07 26.26 16.03 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.42 22.90 31.89 -22.15 20.23 31.17 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 25 3 # 25 A 465 GLY B 158 GLY^? 6.78 O4 PO4 B 349 A 501 ASP A 140 ASP.? 7.37 O2 PG4 A 350 B 367 TYR B 56 TYR.? 18.57 O3 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.93 41.69 -0.28 -4.14 42.31 0.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 4.03 18.56 -8.28 2.40 19.30 -10.40 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 26 3 # 26 A 465 GLY B 158 GLY^? 6.78 O4 PO4 B 349 A 501 ASP B 226 ASP.? 24.90 O2 PO4 B 349 B 367 TYR B 313 TYR~? 26.96 O3 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.93 41.69 -0.28 -4.14 42.31 0.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 20.38 42.79 0.27 22.43 42.38 0.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -5.51 31.63 -24.11 -6.16 33.31 -26.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 27 3 # 27 A 465 GLY B 158 GLY^? 6.78 O4 PO4 B 349 A 501 ASP B 311 ASP~? 22.86 O3 PO4 B 349 B 367 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.93 41.69 -0.28 -4.14 42.31 0.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 28 3 # 28 A 465 GLY B 164 GLY~? -3.62 O3 PO4 B 349s A 501 ASP B 226 ASP.? 24.90 O2 PO4 B 349 B 367 TYR A 285 TYR~? 11.91 O4 PO4 A 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.30 33.64 -1.77 -1.48 34.26 -1.32 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 20.38 42.79 0.27 22.43 42.38 0.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -8.78 59.29 10.05 -7.08 58.89 12.20 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 29 3 # 29 A 465 GLY B 189 GLY~? 8.50 O2 PO4 B 349 A 501 ASP B 226 ASP.? 24.90 O2 PO4 B 349 B 367 TYR A 285 TYR~? 11.91 O4 PO4 A 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 1.22 33.78 11.00 2.03 33.50 11.09 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 20.38 42.79 0.27 22.43 42.38 0.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -8.78 59.29 10.05 -7.08 58.89 12.20 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 30 3 # 30 A 465 GLY B 189 GLY~? 8.50 O2 PO4 B 349 A 501 ASP B 226 ASP.? 24.90 O2 PO4 B 349 B 367 TYR B 58 TYR.? 25.36 O3 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 1.22 33.78 11.00 2.03 33.50 11.09 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 20.38 42.79 0.27 22.43 42.38 0.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 4.06 9.43 -1.88 2.81 7.26 -0.64 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 31 3 # 31 A 465 GLY B 197 GLY~? 16.75 O2 PO4 B 349 A 501 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 367 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 10.33 27.51 13.12 10.25 28.32 12.87 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 32 3 # 32 A 465 GLY B 232 GLY.? 6.11 O2 PO4 B 349 A 501 ASP B 140 ASP.? 7.99 O2 PG4 B 350 B 367 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 1.39 39.60 4.72 1.45 38.82 4.98 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 8.40 47.76 23.89 8.35 49.33 25.35 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 33 3 # 33 A 465 GLY B 268 GLY.? 11.97 O4 PO4 B 349 A 501 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 367 TYR B 313 TYR~? 26.96 O3 PO4 B 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -14.82 35.55 0.64 -15.06 36.08 1.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -5.51 31.63 -24.11 -6.16 33.31 -26.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 34 3 # 34 A 465 GLY C 79 GLY.? 14.41 O3 PO4 C 349 A 501 ASP C 118 ASP~? 17.28 C3 PG4 D 350 B 367 TYR C 221 TYR~? 17.74 O1 PG4 C 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -46.35 7.57 24.19 -46.94 7.17 24.58 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -47.97 -10.84 34.12 -49.33 -12.17 35.08 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -25.26 18.68 35.52 -25.91 16.01 35.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 35 3 # 35 A 465 GLY C 84 GLY.? 7.31 O4 PG4 D 350 A 501 ASP D 131 ASP^? 9.77 C6 PG4 C 350 B 367 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -56.51 10.28 34.21 -56.90 9.83 33.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 36 3 # 36 A 465 GLY C 86 GLY.? 4.20 C5 PG4 D 350 A 501 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 367 TYR C 71 TYR~? 28.61 O4 PO4 C 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -53.55 4.02 36.09 -53.97 4.11 35.35 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -42.04 -1.21 10.11 -44.02 -0.84 8.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 37 3 # 37 A 465 GLY C 158 GLY^? 6.81 O1 PO4 C 349 A 501 ASP C 198 ASP.? 14.11 O1 PG4 C 350 B 367 TYR A 221 TYR~? 17.25 O1 PG4 A 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -45.67 29.61 31.18 -45.83 29.70 31.90 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -29.82 11.85 32.90 -29.50 11.63 35.01 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -24.98 48.97 24.49 -23.82 47.69 26.70 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 38 3 # 38 A 465 GLY C 164 GLY~? -3.64 O4 PO4 C 349s A 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 367 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -43.65 24.97 24.30 -43.77 25.11 25.06 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 39 3 # 39 A 465 GLY C 180 GLY.? 8.23 O2 PG4 A 350 A 501 ASP A 131 ASP^? 9.75 C6 PG4 B 350 B 367 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -19.46 28.72 22.15 -20.11 28.91 22.57 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 40 3 # 40 A 465 GLY C 189 GLY~? 8.64 O2 PO4 C 349 A 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 367 TYR C 58 TYR.? 25.51 O4 PO4 C 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -40.49 15.78 32.96 -39.70 15.56 32.71 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -41.92 7.88 6.18 -42.73 5.30 5.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 41 3 # 41 A 465 GLY C 189 GLY~? 8.64 O2 PO4 C 349 A 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 367 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -40.49 15.78 32.96 -39.70 15.56 32.71 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 42 3 # 42 A 465 GLY C 268 GLY.? 12.08 O1 PO4 C 349 A 501 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 367 TYR C 313 TYR~? 27.17 O4 PO4 C 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -56.98 24.93 28.04 -57.19 24.96 28.84 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -48.51 39.37 7.07 -48.60 42.05 6.33 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 43 3 # 43 A 465 GLY C 302 GLY^? 15.82 O1 PO4 C 349 A 501 ASP A 198 ASP.? 17.22 O1 PO4 A 349 B 367 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -38.20 38.03 27.59 -38.48 37.54 28.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 44 3 # 44 A 465 GLY C 327 GLY~? 22.90 O1 PO4 C 349 A 501 ASP A 198 ASP.? 17.22 O1 PO4 A 349 B 367 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -41.66 46.37 26.74 -41.71 45.54 26.84 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 45 3 # 45 A 465 GLY D 25 GLY~? 13.17 O2 PO4 D 349 A 501 ASP C 140 ASP.? 7.74 C2 PG4 C 350 B 367 TYR D 225 TYR.? 21.05 O1 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -46.02 12.94 70.06 -45.99 13.73 69.92 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -68.84 20.67 57.80 -68.69 18.14 58.96 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 46 3 # 46 A 465 GLY D 79 GLY.? 15.17 O2 PO4 D 349 A 501 ASP C 140 ASP.? 7.74 C2 PG4 C 350 B 367 TYR D 225 TYR.? 21.05 O1 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -44.38 10.12 68.07 -43.71 9.75 67.85 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -68.84 20.67 57.80 -68.69 18.14 58.96 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 47 3 # 47 A 465 GLY D 79 GLY.? 15.17 O2 PO4 D 349 A 501 ASP D 118 ASP~? 17.29 C6 PG4 C 350 B 367 TYR D 221 TYR~? 17.09 O5 PG4 D 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -44.38 10.12 68.07 -43.71 9.75 67.85 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -39.99 -8.60 59.76 -38.31 -9.56 58.92 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -65.63 16.43 54.69 -64.60 13.90 55.16 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 48 3 # 48 A 465 GLY D 86 GLY.? 5.93 C4 PG4 C 350 A 501 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 367 TYR D 71 TYR~? 29.61 O2 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -35.09 6.83 57.80 -34.85 6.87 58.64 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -50.15 1.87 82.02 -48.64 2.61 84.24 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 49 3 # 49 A 465 GLY D 158 GLY^? 6.87 O4 PO4 D 349 A 501 ASP C 140 ASP.? 7.74 C2 PG4 C 350 B 367 TYR D 56 TYR.? 20.92 O2 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -47.17 31.32 57.48 -47.03 31.32 56.71 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -51.59 21.66 83.26 -50.28 23.43 84.94 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 50 3 # 50 A 465 GLY D 164 GLY~? -3.57 O2 PO4 D 349s A 501 ASP D 198 ASP.? 14.02 O5 PG4 D 350 B 367 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -48.53 27.34 64.89 -48.44 27.44 64.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -59.61 10.87 58.41 -59.89 10.18 56.43 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 51 3 # 51 A 465 GLY D 164 GLY~? -3.57 O2 PO4 D 349s A 501 ASP D 226 ASP.? 25.08 O1 PO4 D 349 B 367 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -48.53 27.34 64.89 -48.44 27.44 64.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 52 3 # 52 A 465 GLY D 164 GLY~? -3.57 O2 PO4 D 349s A 501 ASP D 226 ASP.? 25.08 O1 PO4 D 349 B 367 TYR D 58 TYR.? 26.59 O2 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -48.53 27.34 64.89 -48.44 27.44 64.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -51.78 11.22 85.17 -50.35 9.07 86.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 53 3 # 53 A 465 GLY D 189 GLY~? 8.43 O1 PO4 D 349 A 501 ASP D 226 ASP.? 25.08 O1 PO4 D 349 B 367 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 54 3 # 54 A 465 GLY D 189 GLY~? 8.43 O1 PO4 D 349 A 501 ASP D 226 ASP.? 25.08 O1 PO4 D 349 B 367 TYR D 58 TYR.? 26.59 O2 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -51.78 11.22 85.17 -50.35 9.07 86.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 55 3 # 55 A 465 GLY D 189 GLY~? 8.43 O1 PO4 D 349 A 501 ASP D 332 ASP~? 12.02 O2 PO4 D 349 B 367 TYR D 71 TYR~? 29.61 O2 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -50.15 1.87 82.02 -48.64 2.61 84.24 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 56 3 # 56 A 465 GLY D 197 GLY~? 16.72 O1 PO4 D 349 A 501 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 367 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -57.74 9.98 62.39 -57.72 10.62 61.86 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 57 3 # 57 A 465 GLY D 199 GLY.? 13.68 O5 PG4 D 350 A 501 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 367 TYR D 71 TYR~? 29.61 O2 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -57.03 13.69 56.19 -56.77 12.88 56.00 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -50.15 1.87 82.02 -48.64 2.61 84.24 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 58 3 # 58 A 465 GLY D 232 GLY.? 6.31 O1 PO4 D 349 A 501 ASP C 140 ASP.? 7.74 C2 PG4 C 350 B 367 TYR D 56 TYR.? 20.92 O2 PO4 D 349 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -51.56 25.17 56.57 -51.51 24.50 57.04 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -51.59 21.66 83.26 -50.28 23.43 84.94 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 59 3 # 59 A 465 GLY D 268 GLY.? 11.79 O3 PO4 D 349 A 501 ASP D 311 ASP~? 22.85 O2 PO4 D 349 B 367 TYR D 91 TYR~? 13.46 C4 PG4 C 350 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -35.40 28.55 60.91 -35.17 28.48 60.14 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -43.35 38.70 79.64 -42.93 40.74 79.14 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -37.64 3.76 65.52 -37.58 6.56 65.66 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 59 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 25 GLY~? 12.48 O2 PO4 A 349 D 501 ASP B 140 ASP.? 7.99 O2 PG4 B 350 E 367 TYR A 225 TYR.? 21.13 O1 PO4 A 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -5.57 58.65 37.18 -5.59 59.05 36.47 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 8.40 47.76 23.89 8.35 49.33 25.35 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -28.82 53.90 23.23 -28.73 53.13 25.91 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 79 GLY.? 14.13 O3 PO4 A 349 D 501 ASP A 118 ASP~? 17.27 C5 PG4 B 350 E 367 TYR A 221 TYR~? 17.25 O1 PG4 A 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.85 55.21 37.72 -3.17 54.79 37.80 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 0.76 36.83 47.04 2.33 35.40 47.32 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -24.98 48.97 24.49 -23.82 47.69 26.70 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 86 GLY.? 5.00 C4 PG4 B 350 D 501 ASP A 160 ASP.? 8.60 O4 PO4 A 349 E 367 TYR A 71 TYR~? 28.56 O2 PO4 A 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 4.72 44.66 33.63 5.12 45.31 34.00 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -1.16 62.88 18.52 0.68 62.16 19.33 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.92 60.98 53.46 -6.24 63.13 54.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 158 GLY^? 6.81 O4 PO4 A 349 D 501 ASP B 140 ASP.? 7.99 O2 PG4 B 350 E 367 TYR A 56 TYR.? 19.12 O2 PO4 A 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -7.06 61.86 16.04 -6.88 61.32 15.53 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 8.40 47.76 23.89 8.35 49.33 25.35 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -10.91 73.95 38.94 -9.98 76.39 38.02 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY A 164 GLY~? -3.53 O2 PO4 A 349s D 501 ASP A 226 ASP.? 25.19 O1 PO4 A 349 E 367 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -8.93 64.61 23.96 -8.76 64.08 23.42 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY A 189 GLY~? 8.76 O1 PO4 A 349 D 501 ASP A 226 ASP.? 25.19 O1 PO4 A 349 E 367 TYR A 58 TYR.? 25.18 O2 PO4 A 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -9.28 69.56 48.22 -7.53 68.84 50.27 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY A 189 GLY~? 8.76 O1 PO4 A 349 D 501 ASP A 226 ASP.? 25.19 O1 PO4 A 349 E 367 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY A 189 GLY~? 8.76 O1 PO4 A 349 D 501 ASP C 343 ASP~? 16.17 O1 PG4 A 350 E 367 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY A 197 GLY~? 16.88 O1 PO4 A 349 D 501 ASP A 41 ASP.? 20.10 O2 PO4 A 349 E 367 TYR A 285 TYR~? 11.91 O4 PO4 A 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -18.17 50.44 34.47 -18.10 50.51 33.67 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 1.74 60.96 43.57 3.36 61.47 42.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -8.78 59.29 10.05 -7.08 58.89 12.20 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY A 197 GLY~? 16.88 O1 PO4 A 349 D 501 ASP A 226 ASP.? 25.19 O1 PO4 A 349 E 367 TYR C 225 TYR~? 18.05 C6 PG4 A 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -18.17 50.44 34.47 -18.10 50.51 33.67 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.42 22.90 31.89 -22.15 20.23 31.17 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY A 197 GLY~? 16.88 O1 PO4 A 349 D 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 E 367 TYR A 285 TYR~? 11.91 O4 PO4 A 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -18.17 50.44 34.47 -18.10 50.51 33.67 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -8.78 59.29 10.05 -7.08 58.89 12.20 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY A 222 GLY~? 20.58 O1 PG4 A 350 D 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 E 367 TYR C 313 TYR~? 27.17 O4 PO4 C 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -27.23 49.69 18.85 -27.74 49.39 19.29 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -48.51 39.37 7.07 -48.60 42.05 6.33 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY A 232 GLY.? 6.13 O1 PO4 A 349 D 501 ASP B 140 ASP.? 7.99 O2 PG4 B 350 E 367 TYR A 56 TYR.? 19.12 O2 PO4 A 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -11.48 56.85 19.86 -11.43 56.72 20.67 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 8.40 47.76 23.89 8.35 49.33 25.35 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -10.91 73.95 38.94 -9.98 76.39 38.02 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY A 268 GLY.? 11.90 O3 PO4 A 349 D 501 ASP A 41 ASP.? 20.10 O2 PO4 A 349 E 367 TYR A 313 TYR~? 26.58 O2 PO4 A 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 4.47 63.40 20.71 4.75 62.80 20.25 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 1.74 60.96 43.57 3.36 61.47 42.28 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.13 87.01 20.69 -6.82 88.46 18.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY B 19 GLY.? 15.74 O3 PO4 B 349 D 501 ASP B 203 ASP~? 9.89 C4 PG4 A 350 E 367 TYR B 313 TYR~? 26.96 O3 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -12.10 20.39 1.89 -11.31 20.65 1.71 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -5.51 31.63 -24.11 -6.16 33.31 -26.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY B 25 GLY~? 12.55 O3 PO4 B 349 D 501 ASP A 140 ASP.? 7.37 O2 PG4 A 350 E 367 TYR B 225 TYR~? 21.07 O2 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.91 21.39 6.65 -1.94 22.01 6.12 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 19.22 39.10 5.74 19.70 36.67 7.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY B 25 GLY~? 12.55 O3 PO4 B 349 D 501 ASP B 118 ASP~? 16.08 C6 PG4 A 350 E 367 TYR B 221 TYR~? 17.66 O1 PG4 B 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.91 21.39 6.65 -1.94 22.01 6.12 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -7.43 16.06 29.70 -8.95 16.74 31.02 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 16.24 38.44 11.23 15.50 36.34 12.94 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY B 79 GLY.? 14.35 O1 PO4 B 349 D 501 ASP A 140 ASP.? 7.37 O2 PG4 A 350 E 367 TYR B 225 TYR~? 21.07 O2 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 19.22 39.10 5.74 19.70 36.67 7.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY B 79 GLY.? 14.35 O1 PO4 B 349 D 501 ASP B 118 ASP~? 16.08 C6 PG4 A 350 E 367 TYR B 221 TYR~? 17.66 O1 PG4 B 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -7.43 16.06 29.70 -8.95 16.74 31.02 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 16.24 38.44 11.23 15.50 36.34 12.94 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY B 79 GLY.? 14.35 O1 PO4 B 349 D 501 ASP B 160 ASP.? 8.62 O4 PO4 B 349 E 367 TYR C 225 TYR~? 18.05 C6 PG4 A 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.42 22.90 31.89 -22.15 20.23 31.17 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY B 84 GLY.? 7.18 C3 PG4 A 350 D 501 ASP A 203 ASP~? 10.68 C3 PG4 B 350 E 367 TYR C 221 TYR~? 17.74 O1 PG4 C 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -14.58 29.73 14.21 -14.80 28.98 14.10 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -25.26 18.68 35.52 -25.91 16.01 35.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY B 85 GLY.? 7.55 C3 PG4 A 350 D 501 ASP B 160 ASP.? 8.62 O4 PO4 B 349 E 367 TYR C 56 TYR.? 20.70 O4 PO4 C 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -15.17 26.80 16.60 -14.44 26.95 16.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -41.24 17.60 7.53 -40.11 17.22 5.03 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY B 86 GLY.? 6.11 C4 PG4 A 350 D 501 ASP B 160 ASP.? 8.62 O4 PO4 B 349 E 367 TYR B 71 TYR~? 28.79 O3 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -12.50 26.48 19.35 -12.60 26.05 18.67 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.73 5.71 7.80 2.32 4.41 5.78 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY B 108 GLY.? 11.44 C5 PG4 A 350 D 501 ASP B 160 ASP.? 8.62 O4 PO4 B 349 E 367 TYR C 225 TYR~? 18.05 C6 PG4 A 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.45 26.58 15.61 -2.07 26.26 16.03 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.42 22.90 31.89 -22.15 20.23 31.17 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 25 3 # 25 D 465 GLY B 158 GLY^? 6.78 O4 PO4 B 349 D 501 ASP A 140 ASP.? 7.37 O2 PG4 A 350 E 367 TYR B 56 TYR.? 18.57 O3 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.93 41.69 -0.28 -4.14 42.31 0.12 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 4.03 18.56 -8.28 2.40 19.30 -10.40 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 26 3 # 26 D 465 GLY B 158 GLY^? 6.78 O4 PO4 B 349 D 501 ASP B 226 ASP.? 24.90 O2 PO4 B 349 E 367 TYR B 313 TYR~? 26.96 O3 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.93 41.69 -0.28 -4.14 42.31 0.12 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 20.38 42.79 0.27 22.43 42.38 0.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -5.51 31.63 -24.11 -6.16 33.31 -26.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 27 3 # 27 D 465 GLY B 189 GLY~? 8.50 O2 PO4 B 349 D 501 ASP B 226 ASP.? 24.90 O2 PO4 B 349 E 367 TYR A 285 TYR~? 11.91 O4 PO4 A 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 1.22 33.78 11.00 2.03 33.50 11.09 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 20.38 42.79 0.27 22.43 42.38 0.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -8.78 59.29 10.05 -7.08 58.89 12.20 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 28 3 # 28 D 465 GLY B 189 GLY~? 8.50 O2 PO4 B 349 D 501 ASP B 226 ASP.? 24.90 O2 PO4 B 349 E 367 TYR B 58 TYR.? 25.36 O3 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 1.22 33.78 11.00 2.03 33.50 11.09 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 20.38 42.79 0.27 22.43 42.38 0.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 4.06 9.43 -1.88 2.81 7.26 -0.64 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 29 3 # 29 D 465 GLY B 197 GLY~? 16.75 O2 PO4 B 349 D 501 ASP B 41 ASP.? 20.21 O3 PO4 B 349 E 367 TYR B 285 TYR~? 12.05 O4 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 10.33 27.51 13.12 10.25 28.32 12.87 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -2.93 48.39 0.67 -4.25 46.17 1.73 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 30 3 # 30 D 465 GLY B 232 GLY.? 6.11 O2 PO4 B 349 D 501 ASP B 140 ASP.? 7.99 O2 PG4 B 350 E 367 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 1.39 39.60 4.72 1.45 38.82 4.98 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 8.40 47.76 23.89 8.35 49.33 25.35 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 31 3 # 31 D 465 GLY B 268 GLY.? 11.97 O4 PO4 B 349 D 501 ASP B 41 ASP.? 20.21 O3 PO4 B 349 E 367 TYR B 313 TYR~? 26.96 O3 PO4 B 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -14.82 35.55 0.64 -15.06 36.08 1.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -5.51 31.63 -24.11 -6.16 33.31 -26.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 32 3 # 32 D 465 GLY C 79 GLY.? 14.41 O3 PO4 C 349 D 501 ASP C 118 ASP~? 17.28 C3 PG4 D 350 E 367 TYR C 221 TYR~? 17.74 O1 PG4 C 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -46.35 7.57 24.19 -46.94 7.17 24.58 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -47.97 -10.84 34.12 -49.33 -12.17 35.08 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -25.26 18.68 35.52 -25.91 16.01 35.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 33 3 # 33 D 465 GLY C 84 GLY.? 7.31 O4 PG4 D 350 D 501 ASP D 131 ASP^? 9.77 C6 PG4 C 350 E 367 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -56.51 10.28 34.21 -56.90 9.83 33.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 34 3 # 34 D 465 GLY C 86 GLY.? 4.20 C5 PG4 D 350 D 501 ASP C 160 ASP.? 8.57 O1 PO4 C 349 E 367 TYR C 71 TYR~? 28.61 O4 PO4 C 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -53.55 4.02 36.09 -53.97 4.11 35.35 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -42.04 -1.21 10.11 -44.02 -0.84 8.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 35 3 # 35 D 465 GLY C 158 GLY^? 6.81 O1 PO4 C 349 D 501 ASP C 198 ASP.? 14.11 O1 PG4 C 350 E 367 TYR A 221 TYR~? 17.25 O1 PG4 A 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -45.67 29.61 31.18 -45.83 29.70 31.90 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -29.82 11.85 32.90 -29.50 11.63 35.01 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -24.98 48.97 24.49 -23.82 47.69 26.70 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 36 3 # 36 D 465 GLY C 164 GLY~? -3.64 O4 PO4 C 349s D 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 E 367 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -43.65 24.97 24.30 -43.77 25.11 25.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 37 3 # 37 D 465 GLY C 180 GLY.? 8.23 O2 PG4 A 350 D 501 ASP A 131 ASP^? 9.75 C6 PG4 B 350 E 367 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -19.46 28.72 22.15 -20.11 28.91 22.57 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 38 3 # 38 D 465 GLY C 189 GLY~? 8.64 O2 PO4 C 349 D 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 E 367 TYR C 58 TYR.? 25.51 O4 PO4 C 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -40.49 15.78 32.96 -39.70 15.56 32.71 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -41.92 7.88 6.18 -42.73 5.30 5.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 39 3 # 39 D 465 GLY C 189 GLY~? 8.64 O2 PO4 C 349 D 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 E 367 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -40.49 15.78 32.96 -39.70 15.56 32.71 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 40 3 # 40 D 465 GLY C 197 GLY~? 16.71 O2 PO4 C 349 D 501 ASP C 226 ASP.? 11.40 C1 PG4 A 350 E 367 TYR C 58 TYR.? 25.51 O4 PO4 C 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -31.53 10.08 29.11 -31.70 10.77 29.54 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -41.92 7.88 6.18 -42.73 5.30 5.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 41 3 # 41 D 465 GLY C 268 GLY.? 12.08 O1 PO4 C 349 D 501 ASP C 41 ASP.? 20.22 O4 PO4 C 349 E 367 TYR C 313 TYR~? 27.17 O4 PO4 C 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -56.98 24.93 28.04 -57.19 24.96 28.84 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -48.51 39.37 7.07 -48.60 42.05 6.33 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 42 3 # 42 D 465 GLY C 302 GLY^? 15.82 O1 PO4 C 349 D 501 ASP A 198 ASP.? 17.22 O1 PO4 A 349 E 367 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -38.20 38.03 27.59 -38.48 37.54 28.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 43 3 # 43 D 465 GLY C 327 GLY~? 22.90 O1 PO4 C 349 D 501 ASP A 198 ASP.? 17.22 O1 PO4 A 349 E 367 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -41.66 46.37 26.74 -41.71 45.54 26.84 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 44 3 # 44 D 465 GLY D 25 GLY~? 13.17 O2 PO4 D 349 D 501 ASP C 140 ASP.? 7.74 C2 PG4 C 350 E 367 TYR D 225 TYR.? 21.05 O1 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -46.02 12.94 70.06 -45.99 13.73 69.92 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -68.84 20.67 57.80 -68.69 18.14 58.96 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 45 3 # 45 D 465 GLY D 79 GLY.? 15.17 O2 PO4 D 349 D 501 ASP C 140 ASP.? 7.74 C2 PG4 C 350 E 367 TYR D 225 TYR.? 21.05 O1 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -44.38 10.12 68.07 -43.71 9.75 67.85 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -68.84 20.67 57.80 -68.69 18.14 58.96 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 46 3 # 46 D 465 GLY D 79 GLY.? 15.17 O2 PO4 D 349 D 501 ASP D 118 ASP~? 17.29 C6 PG4 C 350 E 367 TYR D 221 TYR~? 17.09 O5 PG4 D 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -44.38 10.12 68.07 -43.71 9.75 67.85 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -39.99 -8.60 59.76 -38.31 -9.56 58.92 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -65.63 16.43 54.69 -64.60 13.90 55.16 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 47 3 # 47 D 465 GLY D 86 GLY.? 5.93 C4 PG4 C 350 D 501 ASP D 160 ASP.? 8.58 O4 PO4 D 349 E 367 TYR D 71 TYR~? 29.61 O2 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -35.09 6.83 57.80 -34.85 6.87 58.64 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -50.15 1.87 82.02 -48.64 2.61 84.24 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 48 3 # 48 D 465 GLY D 158 GLY^? 6.87 O4 PO4 D 349 D 501 ASP C 140 ASP.? 7.74 C2 PG4 C 350 E 367 TYR D 56 TYR.? 20.92 O2 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -47.17 31.32 57.48 -47.03 31.32 56.71 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -51.59 21.66 83.26 -50.28 23.43 84.94 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 49 3 # 49 D 465 GLY D 164 GLY~? -3.57 O2 PO4 D 349s D 501 ASP D 226 ASP.? 25.08 O1 PO4 D 349 E 367 TYR D 58 TYR.? 26.59 O2 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -48.53 27.34 64.89 -48.44 27.44 64.12 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -51.78 11.22 85.17 -50.35 9.07 86.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 50 3 # 50 D 465 GLY D 189 GLY~? 8.43 O1 PO4 D 349 D 501 ASP D 226 ASP.? 25.08 O1 PO4 D 349 E 367 TYR C 285 TYR~? 11.99 O1 PO4 C 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -44.26 33.47 36.56 -45.76 31.25 35.74 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 51 3 # 51 D 465 GLY D 189 GLY~? 8.43 O1 PO4 D 349 D 501 ASP D 226 ASP.? 25.08 O1 PO4 D 349 E 367 TYR D 58 TYR.? 26.59 O2 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -51.78 11.22 85.17 -50.35 9.07 86.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 52 3 # 52 D 465 GLY D 189 GLY~? 8.43 O1 PO4 D 349 D 501 ASP D 332 ASP~? 12.02 O2 PO4 D 349 E 367 TYR D 71 TYR~? 29.61 O2 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -50.15 1.87 82.02 -48.64 2.61 84.24 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 53 3 # 53 D 465 GLY D 197 GLY~? 16.72 O1 PO4 D 349 D 501 ASP D 41 ASP.? 20.92 O2 PO4 D 349 E 367 TYR D 285 TYR~? 12.08 O4 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -57.74 9.98 62.39 -57.72 10.62 61.86 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.07 33.98 51.47 -47.27 32.17 52.61 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 54 3 # 54 D 465 GLY D 232 GLY.? 6.31 O1 PO4 D 349 D 501 ASP C 140 ASP.? 7.74 C2 PG4 C 350 E 367 TYR D 56 TYR.? 20.92 O2 PO4 D 349 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -51.56 25.17 56.57 -51.51 24.50 57.04 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -51.59 21.66 83.26 -50.28 23.43 84.94 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 55 3 # 55 D 465 GLY D 268 GLY.? 11.79 O3 PO4 D 349 D 501 ASP D 311 ASP~? 22.85 O2 PO4 D 349 E 367 TYR D 91 TYR~? 13.46 C4 PG4 C 350 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -35.40 28.55 60.91 -35.17 28.48 60.14 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -43.35 38.70 79.64 -42.93 40.74 79.14 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -37.64 3.76 65.52 -37.58 6.56 65.66 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 55 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 198 ASP.? 17.22 O1 PO4 A 349 A 55 TYR A 221 TYR~? 17.25 O1 PG4 A 350 A 84 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo 11.09 42.89 24.44 11.32 42.06 22.49 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 4.60 40.33 20.42 7.25 39.50 20.05 -24.98 48.97 24.49 -23.82 47.69 26.70 coo 9.71 44.83 15.47 10.13 41.43 19.93 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 55 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 84 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 11.09 42.89 24.44 11.32 42.06 22.49 20.38 42.79 0.27 22.43 42.38 0.23 coo 4.60 40.33 20.42 7.25 39.50 20.05 19.22 39.10 5.74 19.70 36.67 7.05 coo 9.71 44.83 15.47 10.13 41.43 19.93 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 55 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 84 LYS B 223 LYS~? 20.96 O1 PG4 B 350 coo 11.09 42.89 24.44 11.32 42.06 22.49 20.38 42.79 0.27 22.43 42.38 0.23 coo 4.60 40.33 20.42 7.25 39.50 20.05 19.22 39.10 5.74 19.70 36.67 7.05 coo 9.71 44.83 15.47 10.13 41.43 19.93 21.08 44.90 9.51 21.11 48.16 14.97 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP B 311 ASP~? 22.86 O3 PO4 B 349 A 55 TYR B 313 TYR~? 26.96 O3 PO4 B 349 A 84 LYS B 316 LYS~? 24.20 O3 PO4 B 349 coo 11.09 42.89 24.44 11.32 42.06 22.49 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 4.60 40.33 20.42 7.25 39.50 20.05 -5.51 31.63 -24.11 -6.16 33.31 -26.25 coo 9.71 44.83 15.47 10.13 41.43 19.93 -2.04 35.41 -19.34 2.27 31.66 -22.14 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP C 198 ASP.? 14.11 O1 PG4 C 350 A 55 TYR C 221 TYR~? 17.74 O1 PG4 C 350 A 84 LYS C 184 LYS^? 18.13 O2 PO4 C 349 coo 11.09 42.89 24.44 11.32 42.06 22.49 -29.82 11.85 32.90 -29.50 11.63 35.01 coo 4.60 40.33 20.42 7.25 39.50 20.05 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 9.71 44.83 15.47 10.13 41.43 19.93 -26.52 22.11 29.66 -26.07 16.73 31.07 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP C 226 ASP.? 11.40 C1 PG4 A 350 A 55 TYR C 225 TYR~? 18.05 C6 PG4 A 350 A 84 LYS C 223 LYS~? 21.04 C2 PG4 C 350 coo 11.09 42.89 24.44 11.32 42.06 22.49 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 4.60 40.33 20.42 7.25 39.50 20.05 -22.42 22.90 31.89 -22.15 20.23 31.17 coo 9.71 44.83 15.47 10.13 41.43 19.93 -19.98 24.16 38.56 -19.29 22.78 44.77 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 7 3 # 7 A 50 ASP C 311 ASP~? 22.87 O4 PO4 C 349 A 55 TYR C 313 TYR~? 27.17 O4 PO4 C 349 A 84 LYS C 316 LYS~? 23.27 O4 PO4 C 349 coo 11.09 42.89 24.44 11.32 42.06 22.49 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 4.60 40.33 20.42 7.25 39.50 20.05 -48.51 39.37 7.07 -48.60 42.05 6.33 coo 9.71 44.83 15.47 10.13 41.43 19.93 -44.69 38.73 13.31 -40.21 38.10 9.89 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 8 3 # 8 A 50 ASP D 226 ASP.? 25.08 O1 PO4 D 349 A 55 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 84 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 11.09 42.89 24.44 11.32 42.06 22.49 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 4.60 40.33 20.42 7.25 39.50 20.05 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 9.71 44.83 15.47 10.13 41.43 19.93 -68.08 25.33 66.69 -67.75 19.10 66.60 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 9 3 # 9 A 50 ASP D 311 ASP~? 22.85 O2 PO4 D 349 A 55 TYR D 313 TYR~? 26.83 O2 PO4 D 349 A 84 LYS D 316 LYS~? 24.37 O2 PO4 D 349 coo 11.09 42.89 24.44 11.32 42.06 22.49 -43.35 38.70 79.64 -42.93 40.74 79.14 coo 4.60 40.33 20.42 7.25 39.50 20.05 -45.78 44.87 79.28 -45.52 47.64 79.09 coo 9.71 44.83 15.47 10.13 41.43 19.93 -49.65 42.56 73.75 -53.64 42.38 78.67 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 9 hits 1mrq_c02 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 197 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 223 ALA A 98 ALA~? 20.83 C5 PG4 B 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 3.61 55.89 43.73 3.10 55.52 45.73 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 8.08 50.44 43.84 7.48 51.26 41.98 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -4.80 48.00 50.25 -4.93 48.51 48.79 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 197 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 223 ALA B 142 ALA.? 12.37 C2 PG4 B 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 6.73 50.30 18.21 6.20 49.71 16.95 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 197 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 223 ALA B 204 ALA~? 7.34 O5 PG4 A 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -2.79 36.37 18.37 -2.26 34.97 18.59 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 197 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 223 ALA B 211 ALA~? 12.63 O1 PG4 B 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 3.26 46.82 15.74 3.00 48.33 15.70 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 197 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 223 ALA B 213 ALA~? 7.87 O1 PG4 B 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 5.93 42.50 17.57 4.67 41.60 17.62 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 197 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 223 ALA A 308 ALA.? 11.21 O2 PO4 A 349 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -1.16 62.88 18.52 0.68 62.16 19.33 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -6.36 74.21 26.20 -6.22 72.82 26.84 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 197 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 223 ALA B 294 ALA~? 16.64 O4 PO4 A 349 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -1.16 62.88 18.52 0.68 62.16 19.33 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 3.51 61.12 8.27 2.59 60.51 9.32 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 197 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 223 ALA B 98 ALA~? 20.95 C5 PG4 A 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -0.63 10.86 19.74 -0.63 12.19 18.99 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 A 114 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 197 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 223 ALA A 142 ALA.? 12.14 C2 PG4 A 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -16.20 40.87 12.81 -15.80 42.33 13.02 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 A 114 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 197 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 223 ALA A 204 ALA~? 8.46 C8 PG4 B 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -5.64 44.18 25.28 -6.10 44.17 26.72 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 11 3 # 11 A 114 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 197 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 223 ALA A 211 ALA~? 12.35 C2 PG4 A 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -12.84 44.27 15.22 -12.77 44.00 13.74 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 12 3 # 12 A 114 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 197 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 223 ALA A 213 ALA~? 7.64 O1 PG4 A 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -14.74 43.07 20.23 -13.44 43.27 20.98 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 13 3 # 13 A 114 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 197 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 223 ALA B 308 ALA.? 11.34 O3 PO4 B 349 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -4.57 29.17 -10.27 -4.28 28.71 -8.84 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 14 3 # 14 A 114 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 197 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 223 ALA C 98 ALA~? 20.93 C3 PG4 D 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -43.76 -6.51 22.55 -43.80 -5.04 22.97 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 15 3 # 15 A 114 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 197 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 223 ALA D 142 ALA.? 12.20 O5 PG4 D 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -57.25 19.43 40.27 -56.72 20.25 41.44 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 16 3 # 16 A 114 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 197 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 223 ALA D 204 ALA~? 8.16 C7 PG4 C 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -45.88 12.76 50.82 -46.11 11.67 51.84 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 17 3 # 17 A 114 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 197 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 223 ALA D 211 ALA~? 12.21 O5 PG4 D 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -53.58 19.89 44.33 -53.59 20.84 43.15 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 18 3 # 18 A 114 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 197 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 223 ALA D 213 ALA~? 7.41 O5 PG4 D 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -55.49 15.49 46.99 -54.18 15.05 47.61 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 19 3 # 19 A 114 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 197 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 223 ALA C 308 ALA.? 11.16 O4 PO4 C 349 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -47.63 27.77 15.40 -47.50 26.46 16.16 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 20 3 # 20 A 114 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 197 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 223 ALA D 294 ALA~? 16.73 O1 PO4 C 349 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -56.74 34.00 37.04 -55.63 32.95 36.83 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 21 3 # 21 A 114 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 197 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 223 ALA D 98 ALA~? 21.08 C6 PG4 C 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -46.21 -4.06 70.08 -46.37 -2.63 69.56 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 22 3 # 22 A 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 197 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 223 ALA C 137 ALA.? 4.99 O1 PG4 C 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -32.98 8.36 45.57 -32.22 7.01 45.61 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 23 3 # 23 A 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 197 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 223 ALA C 204 ALA~? 8.41 C1 PG4 D 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -43.72 12.08 40.27 -43.19 10.95 39.41 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 24 3 # 24 A 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 197 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 223 ALA C 142 ALA.? 12.35 C2 PG4 C 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -33.86 22.03 49.44 -34.51 22.67 48.24 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 25 3 # 25 A 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 197 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 223 ALA C 204 ALA~? 8.41 C1 PG4 D 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -43.72 12.08 40.27 -43.19 10.95 39.41 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 26 3 # 26 A 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 197 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 223 ALA C 211 ALA~? 12.74 C2 PG4 C 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -37.50 21.48 45.38 -37.66 22.61 46.37 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 27 3 # 27 A 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 197 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 223 ALA C 213 ALA~? 8.04 O1 PG4 C 350 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -34.93 17.01 43.45 -36.20 16.37 42.93 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 28 3 # 28 A 114 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 197 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 223 ALA C 294 ALA~? 16.90 O4 PO4 D 349 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -36.72 36.26 50.70 -37.65 35.11 51.01 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 29 3 # 29 A 114 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 197 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 223 ALA D 308 ALA.? 11.28 O2 PO4 D 349 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -45.31 32.26 73.28 -45.38 30.82 72.81 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 29 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 197 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 223 ALA A 98 ALA~? 20.83 C5 PG4 B 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 3.61 55.89 43.73 3.10 55.52 45.73 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 8.08 50.44 43.84 7.48 51.26 41.98 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -4.80 48.00 50.25 -4.93 48.51 48.79 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 197 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 223 ALA B 142 ALA.? 12.37 C2 PG4 B 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 6.73 50.30 18.21 6.20 49.71 16.95 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 197 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 223 ALA B 204 ALA~? 7.34 O5 PG4 A 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -2.79 36.37 18.37 -2.26 34.97 18.59 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 197 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 223 ALA B 211 ALA~? 12.63 O1 PG4 B 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 3.26 46.82 15.74 3.00 48.33 15.70 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 197 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 223 ALA B 213 ALA~? 7.87 O1 PG4 B 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 5.93 42.50 17.57 4.67 41.60 17.62 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 197 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 223 ALA A 308 ALA.? 11.21 O2 PO4 A 349 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -1.16 62.88 18.52 0.68 62.16 19.33 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -6.36 74.21 26.20 -6.22 72.82 26.84 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 197 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 223 ALA B 294 ALA~? 16.64 O4 PO4 A 349 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -1.16 62.88 18.52 0.68 62.16 19.33 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 3.51 61.12 8.27 2.59 60.51 9.32 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 197 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 223 ALA B 98 ALA~? 20.95 C5 PG4 A 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -0.63 10.86 19.74 -0.63 12.19 18.99 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 B 114 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 197 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 223 ALA A 142 ALA.? 12.14 C2 PG4 A 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -16.20 40.87 12.81 -15.80 42.33 13.02 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 B 114 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 197 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 223 ALA A 204 ALA~? 8.46 C8 PG4 B 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -5.64 44.18 25.28 -6.10 44.17 26.72 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 11 3 # 11 B 114 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 197 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 223 ALA A 211 ALA~? 12.35 C2 PG4 A 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -12.84 44.27 15.22 -12.77 44.00 13.74 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 12 3 # 12 B 114 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 197 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 223 ALA A 213 ALA~? 7.64 O1 PG4 A 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -14.74 43.07 20.23 -13.44 43.27 20.98 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 13 3 # 13 B 114 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 197 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 223 ALA B 308 ALA.? 11.34 O3 PO4 B 349 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -4.57 29.17 -10.27 -4.28 28.71 -8.84 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 14 3 # 14 B 114 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 197 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 223 ALA C 98 ALA~? 20.93 C3 PG4 D 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -43.76 -6.51 22.55 -43.80 -5.04 22.97 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 15 3 # 15 B 114 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 197 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 223 ALA D 142 ALA.? 12.20 O5 PG4 D 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -57.25 19.43 40.27 -56.72 20.25 41.44 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 16 3 # 16 B 114 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 197 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 223 ALA D 204 ALA~? 8.16 C7 PG4 C 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -45.88 12.76 50.82 -46.11 11.67 51.84 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 17 3 # 17 B 114 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 197 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 223 ALA D 211 ALA~? 12.21 O5 PG4 D 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -53.58 19.89 44.33 -53.59 20.84 43.15 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 18 3 # 18 B 114 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 197 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 223 ALA D 213 ALA~? 7.41 O5 PG4 D 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -55.49 15.49 46.99 -54.18 15.05 47.61 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 19 3 # 19 B 114 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 197 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 223 ALA C 308 ALA.? 11.16 O4 PO4 C 349 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -47.63 27.77 15.40 -47.50 26.46 16.16 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 20 3 # 20 B 114 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 197 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 223 ALA D 294 ALA~? 16.73 O1 PO4 C 349 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -56.74 34.00 37.04 -55.63 32.95 36.83 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 21 3 # 21 B 114 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 197 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 223 ALA D 98 ALA~? 21.08 C6 PG4 C 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -46.21 -4.06 70.08 -46.37 -2.63 69.56 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 22 3 # 22 B 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 197 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 223 ALA C 137 ALA.? 4.99 O1 PG4 C 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -32.98 8.36 45.57 -32.22 7.01 45.61 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 23 3 # 23 B 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 197 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 223 ALA C 204 ALA~? 8.41 C1 PG4 D 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -43.72 12.08 40.27 -43.19 10.95 39.41 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 24 3 # 24 B 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 197 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 223 ALA C 142 ALA.? 12.35 C2 PG4 C 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -33.86 22.03 49.44 -34.51 22.67 48.24 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 25 3 # 25 B 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 197 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 223 ALA C 204 ALA~? 8.41 C1 PG4 D 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -43.72 12.08 40.27 -43.19 10.95 39.41 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 26 3 # 26 B 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 197 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 223 ALA C 211 ALA~? 12.74 C2 PG4 C 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -37.50 21.48 45.38 -37.66 22.61 46.37 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 27 3 # 27 B 114 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 197 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 223 ALA C 213 ALA~? 8.04 O1 PG4 C 350 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -34.93 17.01 43.45 -36.20 16.37 42.93 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 28 3 # 28 B 114 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 197 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 223 ALA C 294 ALA~? 16.90 O4 PO4 D 349 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -36.72 36.26 50.70 -37.65 35.11 51.01 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 29 3 # 29 B 114 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 197 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 223 ALA D 308 ALA.? 11.28 O2 PO4 D 349 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -45.31 32.26 73.28 -45.38 30.82 72.81 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 29 hits 1n2t_c03 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 290 LYS B 134 LYS.? 7.94 O5 PG4 B 350 A 405 ARG B 206 ARG~? -3.06 O4 PG4 B 350s coo 41.33 25.99 28.05 41.95 26.95 29.80 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 37.11 33.75 31.82 38.72 27.95 29.90 1.49 32.28 22.12 4.07 30.52 27.68 coo 42.28 27.98 41.30 43.16 28.14 38.35 -2.22 41.47 25.55 0.33 41.32 27.30 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 1 hits 1nhx_c00 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 280 GLU~? 22.33 O4 PO4 A 349 B 128 HIS A 260 HIS^? 11.64 O4 PO4 A 349 C 263 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -2.67 65.99 2.80 -3.14 64.76 1.14 coo 12.51 16.35 80.99 13.16 14.90 82.37 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 11.58 14.94 93.26 12.25 14.03 91.50 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 280 GLU~? 22.33 O4 PO4 A 349 B 128 HIS A 260 HIS^? 11.64 O4 PO4 A 349 C 263 HIS A 321 HIS~? 22.96 O4 PO4 A 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -2.67 65.99 2.80 -3.14 64.76 1.14 coo 12.51 16.35 80.99 13.16 14.90 82.37 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 11.58 14.94 93.26 12.25 14.03 91.50 -5.72 80.36 11.81 -5.04 82.32 12.10 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU A 312 GLU~? 22.67 O2 PO4 A 349 B 128 HIS A 309 HIS.? 13.93 O2 PO4 A 349 C 263 HIS A 321 HIS~? 22.96 O4 PO4 A 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -11.55 82.77 24.82 -13.13 83.67 25.87 coo 12.51 16.35 80.99 13.16 14.90 82.37 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 11.58 14.94 93.26 12.25 14.03 91.50 -5.72 80.36 11.81 -5.04 82.32 12.10 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU A 317 GLU~? 25.40 O4 PO4 A 349 B 128 HIS A 309 HIS.? 13.93 O2 PO4 A 349 C 263 HIS A 260 HIS^? 11.64 O4 PO4 A 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -6.54 84.03 15.10 -5.06 85.44 15.56 coo 12.51 16.35 80.99 13.16 14.90 82.37 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 11.58 14.94 93.26 12.25 14.03 91.50 -4.97 68.88 15.23 -3.05 69.59 14.77 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 B 59 GLU B 280 GLU~? 22.45 O4 PO4 B 349 B 128 HIS B 260 HIS^? 11.70 O4 PO4 B 349 C 263 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -10.91 53.12 -6.46 -10.34 55.07 -5.90 coo 12.51 16.35 80.99 13.16 14.90 82.37 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 11.58 14.94 93.26 12.25 14.03 91.50 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 B 59 GLU B 280 GLU~? 22.45 O4 PO4 B 349 B 128 HIS B 260 HIS^? 11.70 O4 PO4 B 349 C 263 HIS B 321 HIS~? 21.63 O4 PO4 B 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -10.91 53.12 -6.46 -10.34 55.07 -5.90 coo 12.51 16.35 80.99 13.16 14.90 82.37 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 11.58 14.94 93.26 12.25 14.03 91.50 -8.21 43.10 -17.57 -9.89 44.30 -17.19 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 B 59 GLU B 312 GLU~? 22.88 O3 PO4 B 349 B 128 HIS B 309 HIS.? 14.09 O3 PO4 B 349 C 263 HIS B 321 HIS~? 21.63 O4 PO4 B 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -0.30 29.09 -19.54 1.27 27.97 -20.48 coo 12.51 16.35 80.99 13.16 14.90 82.37 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo 11.58 14.94 93.26 12.25 14.03 91.50 -8.21 43.10 -17.57 -9.89 44.30 -17.19 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 B 59 GLU B 317 GLU~? 25.52 O4 PO4 B 349 B 128 HIS B 309 HIS.? 14.09 O3 PO4 B 349 C 263 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -6.27 36.67 -22.50 -8.15 36.31 -23.40 coo 12.51 16.35 80.99 13.16 14.90 82.37 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo 11.58 14.94 93.26 12.25 14.03 91.50 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 9 3 # 9 B 59 GLU C 280 GLU~? 22.63 O1 PO4 C 349 B 128 HIS C 260 HIS^? 11.63 O1 PO4 C 349 C 263 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -51.90 42.15 35.36 -51.16 43.57 36.78 coo 12.51 16.35 80.99 13.16 14.90 82.37 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 11.58 14.94 93.26 12.25 14.03 91.50 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 10 3 # 10 B 59 GLU C 280 GLU~? 22.63 O1 PO4 C 349 B 128 HIS C 260 HIS^? 11.63 O1 PO4 C 349 C 263 HIS C 321 HIS~? 21.29 O1 PO4 C 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -51.90 42.15 35.36 -51.16 43.57 36.78 coo 12.51 16.35 80.99 13.16 14.90 82.37 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 11.58 14.94 93.26 12.25 14.03 91.50 -50.23 42.88 20.64 -51.67 43.34 22.10 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 11 3 # 11 B 59 GLU C 312 GLU~? 22.95 O4 PO4 C 349 B 128 HIS C 309 HIS.? 14.15 O4 PO4 C 349 C 263 HIS C 321 HIS~? 21.29 O1 PO4 C 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 12.51 16.35 80.99 13.16 14.90 82.37 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 11.58 14.94 93.26 12.25 14.03 91.50 -50.23 42.88 20.64 -51.67 43.34 22.10 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 12 3 # 12 B 59 GLU C 325 GLU~? 19.31 O1 PO4 C 349 B 128 HIS C 260 HIS^? 11.63 O1 PO4 C 349 C 263 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -49.52 44.21 26.45 -50.31 42.24 26.60 coo 12.51 16.35 80.99 13.16 14.90 82.37 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 11.58 14.94 93.26 12.25 14.03 91.50 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 13 3 # 13 B 59 GLU D 280 GLU~? 22.63 O4 PO4 D 349 B 128 HIS D 260 HIS^? 11.65 O4 PO4 D 349 C 263 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -42.78 43.78 51.37 -43.64 44.83 49.74 coo 12.51 16.35 80.99 13.16 14.90 82.37 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 11.58 14.94 93.26 12.25 14.03 91.50 -32.64 35.78 59.13 -31.61 37.59 58.96 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 14 3 # 14 B 59 GLU D 280 GLU~? 22.63 O4 PO4 D 349 B 128 HIS D 260 HIS^? 11.65 O4 PO4 D 349 C 263 HIS D 321 HIS~? 21.61 O4 PO4 D 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -42.78 43.78 51.37 -43.64 44.83 49.74 coo 12.51 16.35 80.99 13.16 14.90 82.37 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 11.58 14.94 93.26 12.25 14.03 91.50 -44.81 46.75 66.01 -43.36 47.24 64.57 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 15 3 # 15 B 59 GLU D 312 GLU~? 22.27 O2 PO4 D 349 B 128 HIS D 309 HIS.? 14.00 O2 PO4 D 349 C 263 HIS D 321 HIS~? 21.61 O4 PO4 D 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -50.13 39.19 79.01 -51.63 38.45 80.28 coo 12.51 16.35 80.99 13.16 14.90 82.37 -40.87 34.22 71.66 -41.37 35.58 70.15 coo 11.58 14.94 93.26 12.25 14.03 91.50 -44.81 46.75 66.01 -43.36 47.24 64.57 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 16 3 # 16 B 59 GLU D 317 GLU~? 25.08 O4 PO4 D 349 B 128 HIS D 309 HIS.? 14.00 O2 PO4 D 349 C 263 HIS D 260 HIS^? 11.65 O4 PO4 D 349 coo 6.12 5.94 82.00 7.16 6.32 83.81 -45.36 46.85 72.91 -43.76 47.38 74.18 coo 12.51 16.35 80.99 13.16 14.90 82.37 -40.87 34.22 71.66 -41.37 35.58 70.15 coo 11.58 14.94 93.26 12.25 14.03 91.50 -44.73 36.67 61.75 -42.79 37.49 61.80 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 16 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 260 HIS^? 11.64 O4 PO4 A 349 D 59 GLU A 317 GLU~? 25.40 O4 PO4 A 349 D 128 HIS A 309 HIS.? 13.93 O2 PO4 A 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -6.54 84.03 15.10 -5.06 85.44 15.56 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -1.71 74.54 24.02 -2.03 74.32 21.96 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 266 HIS.? 18.54 O4 PO4 A 349 D 59 GLU A 280 GLU~? 22.33 O4 PO4 A 349 D 128 HIS A 260 HIS^? 11.64 O4 PO4 A 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 6.94 67.18 14.08 7.86 68.38 12.63 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -2.67 65.99 2.80 -3.14 64.76 1.14 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -4.97 68.88 15.23 -3.05 69.59 14.77 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS A 321 HIS~? 22.96 O4 PO4 A 349 D 59 GLU A 312 GLU~? 22.67 O2 PO4 A 349 D 128 HIS A 309 HIS.? 13.93 O2 PO4 A 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -5.72 80.36 11.81 -5.04 82.32 12.10 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -11.55 82.77 24.82 -13.13 83.67 25.87 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -1.71 74.54 24.02 -2.03 74.32 21.96 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS B 260 HIS^? 11.70 O4 PO4 B 349 D 59 GLU B 317 GLU~? 25.52 O4 PO4 B 349 D 128 HIS B 309 HIS.? 14.09 O3 PO4 B 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -6.27 36.67 -22.50 -8.15 36.31 -23.40 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -9.40 30.81 -10.60 -9.30 32.90 -10.77 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 A 263 HIS B 266 HIS.? 18.54 O4 PO4 B 349 D 59 GLU B 280 GLU~? 22.45 O4 PO4 B 349 D 128 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -10.91 53.12 -6.46 -10.34 55.07 -5.90 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 A 263 HIS B 266 HIS.? 18.54 O4 PO4 B 349 D 59 GLU B 325 GLU~? 19.47 O4 PO4 B 349 D 128 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -7.86 48.35 -14.01 -8.88 47.03 -12.75 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 A 263 HIS B 321 HIS~? 21.63 O4 PO4 B 349 D 59 GLU B 280 GLU~? 22.45 O4 PO4 B 349 D 128 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -8.21 43.10 -17.57 -9.89 44.30 -17.19 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -10.91 53.12 -6.46 -10.34 55.07 -5.90 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 A 263 HIS B 321 HIS~? 21.63 O4 PO4 B 349 D 59 GLU B 312 GLU~? 22.88 O3 PO4 B 349 D 128 HIS B 309 HIS.? 14.09 O3 PO4 B 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -8.21 43.10 -17.57 -9.89 44.30 -17.19 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -0.30 29.09 -19.54 1.27 27.97 -20.48 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -9.40 30.81 -10.60 -9.30 32.90 -10.77 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 9 3 # 9 A 263 HIS C 266 HIS.? 18.53 O1 PO4 C 349 D 59 GLU C 280 GLU~? 22.63 O1 PO4 C 349 D 128 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -60.48 31.92 28.90 -61.75 33.58 29.06 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -51.90 42.15 35.36 -51.16 43.57 36.78 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -48.83 33.87 26.09 -50.85 34.38 25.82 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 10 3 # 10 A 263 HIS C 266 HIS.? 18.53 O1 PO4 C 349 D 59 GLU C 325 GLU~? 19.31 O1 PO4 C 349 D 128 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -60.48 31.92 28.90 -61.75 33.58 29.06 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -49.52 44.21 26.45 -50.31 42.24 26.60 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -48.83 33.87 26.09 -50.85 34.38 25.82 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 11 3 # 11 A 263 HIS C 321 HIS~? 21.29 O1 PO4 C 349 D 59 GLU C 280 GLU~? 22.63 O1 PO4 C 349 D 128 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -50.23 42.88 20.64 -51.67 43.34 22.10 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -51.90 42.15 35.36 -51.16 43.57 36.78 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -48.83 33.87 26.09 -50.85 34.38 25.82 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 12 3 # 12 A 263 HIS C 321 HIS~? 21.29 O1 PO4 C 349 D 59 GLU C 312 GLU~? 22.95 O4 PO4 C 349 D 128 HIS C 309 HIS.? 14.15 O4 PO4 C 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -50.23 42.88 20.64 -51.67 43.34 22.10 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -52.33 29.51 16.61 -52.04 31.11 17.93 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 13 3 # 13 A 263 HIS D 260 HIS^? 11.65 O4 PO4 D 349 D 59 GLU D 317 GLU~? 25.08 O4 PO4 D 349 D 128 HIS D 309 HIS.? 14.00 O2 PO4 D 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -45.36 46.85 72.91 -43.76 47.38 74.18 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -40.87 34.22 71.66 -41.37 35.58 70.15 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 14 3 # 14 A 263 HIS D 266 HIS.? 18.55 O4 PO4 D 349 D 59 GLU D 280 GLU~? 22.63 O4 PO4 D 349 D 128 HIS D 260 HIS^? 11.65 O4 PO4 D 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -32.64 35.78 59.13 -31.61 37.59 58.96 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -42.78 43.78 51.37 -43.64 44.83 49.74 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -44.73 36.67 61.75 -42.79 37.49 61.80 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 15 3 # 15 A 263 HIS D 321 HIS~? 21.61 O4 PO4 D 349 D 59 GLU D 280 GLU~? 22.63 O4 PO4 D 349 D 128 HIS D 260 HIS^? 11.65 O4 PO4 D 349 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -44.81 46.75 66.01 -43.36 47.24 64.57 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -42.78 43.78 51.37 -43.64 44.83 49.74 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -44.73 36.67 61.75 -42.79 37.49 61.80 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 15 hits 1ni4_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS B 184 LYS^? 17.27 O2 PO4 B 349 631 LYS B 134 LYS.? 7.94 O5 PG4 B 350 708 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 8.61 33.06 11.15 10.12 29.19 8.82 15.36 36.70 4.47 15.17 34.16 8.91 coo -11.99 27.40 17.14 -13.60 24.52 11.71 1.49 32.28 22.12 4.07 30.52 27.68 coo 18.16 32.86 9.85 16.06 28.20 13.56 18.35 34.41 -3.27 19.41 29.18 0.25 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 1 hits 1nsf_c00 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER B 64 SER~? 26.98 C5 PG4 A 350 A 154 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 261 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 16.10 74.10 3.11 17.18 73.52 5.20 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 16.07 84.71 8.14 15.20 82.81 8.14 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 10.59 77.85 4.81 13.09 76.36 5.76 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER C 64 SER~? 25.88 C5 PG4 D 350 A 154 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 261 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 16.10 74.10 3.11 17.18 73.52 5.20 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 16.07 84.71 8.14 15.20 82.81 8.14 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 10.59 77.85 4.81 13.09 76.36 5.76 -57.88 0.79 18.76 -56.46 0.67 21.52 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 2 hits 1o98_c00 naa= 3 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 A 1 CYH A 44 CYH~? 20.51 O2 PO4 A 349 A 903 GLU A 196 GLU~? 14.14 O1 PO4 A 349 A 972 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 88.42 112.53 24.94 87.72 110.88 27.11 3.79 65.29 45.10 3.54 65.25 42.31 coo 61.58 117.15 13.99 62.31 115.51 15.12 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 60.18 107.64 21.53 58.13 110.55 17.14 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 A 1 CYH B 44 CYH.? 20.73 O3 PO4 B 349 A 903 GLU B 196 GLU~? 13.82 O2 PO4 B 349 A 972 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 88.42 112.53 24.94 87.72 110.88 27.11 -8.90 10.53 1.89 -9.13 13.22 1.20 coo 61.58 117.15 13.99 62.31 115.51 15.12 10.06 30.74 8.04 11.63 30.24 6.70 coo 60.18 107.64 21.53 58.13 110.55 17.14 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 A 1 CYH B 330 CYH^? 15.61 O4 PO4 B 349 A 903 GLU B 215 GLU~? 13.59 C2 PG4 B 350 A 972 LYS B 223 LYS~? 20.96 O1 PG4 B 350 coo 88.42 112.53 24.94 87.72 110.88 27.11 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 61.58 117.15 13.99 62.31 115.51 15.12 10.14 48.09 15.50 9.78 49.78 16.69 coo 60.18 107.64 21.53 58.13 110.55 17.14 21.08 44.90 9.51 21.11 48.16 14.97 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 A 1 CYH C 44 CYH.? 20.66 O4 PO4 C 349 A 903 GLU C 196 GLU~? 13.61 O2 PO4 C 349 A 972 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 88.42 112.53 24.94 87.72 110.88 27.11 -54.82 6.18 12.39 -54.72 8.60 13.80 coo 61.58 117.15 13.99 62.31 115.51 15.12 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 60.18 107.64 21.53 58.13 110.55 17.14 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 A 1 CYH C 151 CYH.? 19.97 C1 PG4 A 350 A 903 GLU A 231 GLU.? 5.77 O1 PO4 A 349 A 972 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo 88.42 112.53 24.94 87.72 110.88 27.11 -23.43 29.67 36.17 -24.68 27.35 36.97 coo 61.58 117.15 13.99 62.31 115.51 15.12 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 60.18 107.64 21.53 58.13 110.55 17.14 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 6 3 # 6 A 1 CYH C 330 CYH^? 15.66 O1 PO4 C 349 A 903 GLU C 215 GLU~? 13.26 C2 PG4 C 350 A 972 LYS C 223 LYS~? 21.04 C2 PG4 C 350 coo 88.42 112.53 24.94 87.72 110.88 27.11 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 61.58 117.15 13.99 62.31 115.51 15.12 -30.56 22.29 45.75 -30.82 22.67 47.79 coo 60.18 107.64 21.53 58.13 110.55 17.14 -19.98 24.16 38.56 -19.29 22.78 44.77 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 7 3 # 7 A 1 CYH D 44 CYH.? 21.32 O2 PO4 D 349 A 903 GLU D 196 GLU~? 13.48 O1 PO4 D 349 A 972 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 88.42 112.53 24.94 87.72 110.88 27.11 -38.23 10.32 81.00 -38.77 12.53 79.38 coo 61.58 117.15 13.99 62.31 115.51 15.12 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 60.18 107.64 21.53 58.13 110.55 17.14 -50.59 27.20 61.67 -46.47 26.50 58.89 1ofd_c02 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 7 hits 1ofd_c02 naa= 3 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 B 1 CYH A 44 CYH~? 20.51 O2 PO4 A 349 B 903 GLU A 196 GLU~? 14.14 O1 PO4 A 349 B 972 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 31.47 38.87 24.90 30.94 36.98 26.93 3.79 65.29 45.10 3.54 65.25 42.31 coo 4.13 40.53 14.21 5.06 38.89 15.19 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 4.08 30.40 21.12 1.62 33.28 16.83 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 B 1 CYH B 44 CYH.? 20.73 O3 PO4 B 349 B 903 GLU B 196 GLU~? 13.82 O2 PO4 B 349 B 972 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 31.47 38.87 24.90 30.94 36.98 26.93 -8.90 10.53 1.89 -9.13 13.22 1.20 coo 4.13 40.53 14.21 5.06 38.89 15.19 10.06 30.74 8.04 11.63 30.24 6.70 coo 4.08 30.40 21.12 1.62 33.28 16.83 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 B 1 CYH B 330 CYH^? 15.61 O4 PO4 B 349 B 903 GLU B 215 GLU~? 13.59 C2 PG4 B 350 B 972 LYS B 223 LYS~? 20.96 O1 PG4 B 350 coo 31.47 38.87 24.90 30.94 36.98 26.93 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 4.13 40.53 14.21 5.06 38.89 15.19 10.14 48.09 15.50 9.78 49.78 16.69 coo 4.08 30.40 21.12 1.62 33.28 16.83 21.08 44.90 9.51 21.11 48.16 14.97 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 B 1 CYH C 44 CYH.? 20.66 O4 PO4 C 349 B 903 GLU C 196 GLU~? 13.61 O2 PO4 C 349 B 972 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 31.47 38.87 24.90 30.94 36.98 26.93 -54.82 6.18 12.39 -54.72 8.60 13.80 coo 4.13 40.53 14.21 5.06 38.89 15.19 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 4.08 30.40 21.12 1.62 33.28 16.83 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 B 1 CYH C 151 CYH.? 19.97 C1 PG4 A 350 B 903 GLU A 231 GLU.? 5.77 O1 PO4 A 349 B 972 LYS A 184 LYS^? 18.49 O1 PO4 A 349 coo 31.47 38.87 24.90 30.94 36.98 26.93 -23.43 29.67 36.17 -24.68 27.35 36.97 coo 4.13 40.53 14.21 5.06 38.89 15.19 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 4.08 30.40 21.12 1.62 33.28 16.83 -24.93 56.02 24.66 -24.65 51.60 28.30 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 6 3 # 6 B 1 CYH C 330 CYH^? 15.66 O1 PO4 C 349 B 903 GLU C 215 GLU~? 13.26 C2 PG4 C 350 B 972 LYS C 223 LYS~? 21.04 C2 PG4 C 350 coo 31.47 38.87 24.90 30.94 36.98 26.93 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 4.13 40.53 14.21 5.06 38.89 15.19 -30.56 22.29 45.75 -30.82 22.67 47.79 coo 4.08 30.40 21.12 1.62 33.28 16.83 -19.98 24.16 38.56 -19.29 22.78 44.77 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 7 3 # 7 B 1 CYH D 44 CYH.? 21.32 O2 PO4 D 349 B 903 GLU D 196 GLU~? 13.48 O1 PO4 D 349 B 972 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 31.47 38.87 24.90 30.94 36.98 26.93 -38.23 10.32 81.00 -38.77 12.53 79.38 coo 4.13 40.53 14.21 5.06 38.89 15.19 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 4.08 30.40 21.12 1.62 33.28 16.83 -50.59 27.20 61.67 -46.47 26.50 58.89 1ofd_c03 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 7 hits 1ofd_c03 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 96 GLU A 231 GLU.? 5.77 O1 PO4 A 349 A 132 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 31.23 12.29 16.44 30.82 11.56 18.39 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 26.82 3.20 24.36 27.99 4.86 24.98 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 29.99 0.62 22.18 30.38 6.69 20.81 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 96 GLU B 135 GLU.? -3.99 O5 PG4 B 350s A 132 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 31.23 12.29 16.44 30.82 11.56 18.39 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 26.82 3.20 24.36 27.99 4.86 24.98 2.30 38.46 22.67 1.14 39.98 23.57 coo 29.99 0.62 22.18 30.38 6.69 20.81 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP B 198 ASP.? 14.38 O1 PG4 B 350 A 96 GLU B 135 GLU.? -3.99 O5 PG4 B 350s A 132 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 31.23 12.29 16.44 30.82 11.56 18.39 11.89 31.57 14.26 12.37 32.72 16.00 coo 26.82 3.20 24.36 27.99 4.86 24.98 2.30 38.46 22.67 1.14 39.98 23.57 coo 29.99 0.62 22.18 30.38 6.69 20.81 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 96 GLU B 231 GLU.? 5.72 O2 PO4 B 349 A 132 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 31.23 12.29 16.44 30.82 11.56 18.39 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 26.82 3.20 24.36 27.99 4.86 24.98 3.23 35.71 5.73 3.00 33.97 6.89 coo 29.99 0.62 22.18 30.38 6.69 20.81 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 96 GLU C 231 GLU.? 5.70 O2 PO4 C 349 A 132 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 31.23 12.29 16.44 30.82 11.56 18.39 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 26.82 3.20 24.36 27.99 4.86 24.98 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 29.99 0.62 22.18 30.38 6.69 20.81 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 96 GLU D 231 GLU.? 5.62 O1 PO4 D 349 A 132 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 31.23 12.29 16.44 30.82 11.56 18.39 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 26.82 3.20 24.36 27.99 4.86 24.98 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 29.99 0.62 22.18 30.38 6.69 20.81 -50.59 27.20 61.67 -46.47 26.50 58.89 1onr_c00 source 1onr TRANSALDOLASE B : 6 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 96 GLU A 231 GLU.? 5.77 O1 PO4 A 349 B 132 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 26.69 48.45 7.18 27.85 50.13 7.74 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 29.82 45.80 5.07 30.26 51.81 3.56 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 96 GLU B 135 GLU.? -3.99 O5 PG4 B 350s B 132 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 26.69 48.45 7.18 27.85 50.13 7.74 2.30 38.46 22.67 1.14 39.98 23.57 coo 29.82 45.80 5.07 30.26 51.81 3.56 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP B 198 ASP.? 14.38 O1 PG4 B 350 B 96 GLU B 135 GLU.? -3.99 O5 PG4 B 350s B 132 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 31.16 57.31 -0.94 30.73 56.64 1.01 11.89 31.57 14.26 12.37 32.72 16.00 coo 26.69 48.45 7.18 27.85 50.13 7.74 2.30 38.46 22.67 1.14 39.98 23.57 coo 29.82 45.80 5.07 30.26 51.81 3.56 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 96 GLU B 231 GLU.? 5.72 O2 PO4 B 349 B 132 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 26.69 48.45 7.18 27.85 50.13 7.74 3.23 35.71 5.73 3.00 33.97 6.89 coo 29.82 45.80 5.07 30.26 51.81 3.56 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 96 GLU C 231 GLU.? 5.70 O2 PO4 C 349 B 132 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 26.69 48.45 7.18 27.85 50.13 7.74 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 29.82 45.80 5.07 30.26 51.81 3.56 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 96 GLU D 231 GLU.? 5.62 O1 PO4 D 349 B 132 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 26.69 48.45 7.18 27.85 50.13 7.74 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 29.82 45.80 5.07 30.26 51.81 3.56 -50.59 27.20 61.67 -46.47 26.50 58.89 1onr_c01 source 1onr TRANSALDOLASE B : 6 hits 1onr_c01 naa= 3 ULMN 3 1opm_c00 1.14.17.0003 user 1 3 # 1 A 108 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 170 GLN A 264 GLN.? 9.90 O4 PO4 A 349 A 242 HIS A 309 HIS.? 13.93 O2 PO4 A 349 coo 36.16 34.36 39.40 38.12 34.09 40.00 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 40.85 35.41 43.73 41.85 33.73 42.88 1.25 68.04 18.04 0.43 66.37 19.03 coo 40.72 26.15 37.61 42.10 27.69 37.19 -1.71 74.54 24.02 -2.03 74.32 21.96 ULMN 3 1opm_c00 1.14.17.0003 user 2 3 # 2 A 108 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 170 GLN B 264 GLN.? 10.00 O4 PO4 B 349 A 242 HIS B 309 HIS.? 14.09 O3 PO4 B 349 coo 36.16 34.36 39.40 38.12 34.09 40.00 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 40.85 35.41 43.73 41.85 33.73 42.88 -12.69 37.44 -4.88 -11.52 36.95 -3.20 coo 40.72 26.15 37.61 42.10 27.69 37.19 -9.40 30.81 -10.60 -9.30 32.90 -10.77 ULMN 3 1opm_c00 1.14.17.0003 user 3 3 # 3 A 108 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 170 GLN C 264 GLN.? 9.92 O1 PO4 C 349 A 242 HIS C 309 HIS.? 14.15 O4 PO4 C 349 coo 36.16 34.36 39.40 38.12 34.09 40.00 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 40.85 35.41 43.73 41.85 33.73 42.88 -54.76 30.03 25.62 -53.57 28.46 26.44 coo 40.72 26.15 37.61 42.10 27.69 37.19 -52.33 29.51 16.61 -52.04 31.11 17.93 ULMN 3 1opm_c00 1.14.17.0003 user 4 3 # 4 A 108 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 170 GLN D 264 GLN.? 9.80 O4 PO4 D 349 A 242 HIS D 309 HIS.? 14.00 O2 PO4 D 349 coo 36.16 34.36 39.40 38.12 34.09 40.00 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 40.85 35.41 43.73 41.85 33.73 42.88 -38.31 33.76 62.74 -39.26 31.90 62.31 coo 40.72 26.15 37.61 42.10 27.69 37.19 -40.87 34.22 71.66 -41.37 35.58 70.15 1opm_c00 source 1opm 1.14.17.0003 : 4 hits 1opm_c00 naa= 3 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 1 8 TYR A 225 TYR.? 21.13 O1 PO4 A 349 1 14 ARG A 182 ARG.? 27.04 O1 PO4 A 349 1 104 TRP A 181 TRP.? 23.95 O1 PO4 A 349 coo -6.26 36.66 22.35 -5.62 38.66 24.20 -28.82 53.90 23.23 -28.73 53.13 25.91 coo -1.84 42.97 23.45 -1.37 45.90 22.68 -34.46 56.29 23.08 -34.82 53.96 21.09 coo -2.17 45.44 30.78 -5.80 46.76 31.55 -32.91 63.91 20.46 -30.26 66.07 18.54 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 2 3 # 2 1 8 TYR C 225 TYR~? 18.05 C6 PG4 A 350 1 14 ARG C 182 ARG.? 12.42 C6 PG4 A 350 1 104 TRP C 181 TRP.? 10.24 C1 PG4 A 350 coo -6.26 36.66 22.35 -5.62 38.66 24.20 -22.42 22.90 31.89 -22.15 20.23 31.17 coo -1.84 42.97 23.45 -1.37 45.90 22.68 -17.19 25.58 29.52 -16.27 25.77 32.47 coo -2.17 45.44 30.78 -5.80 46.76 31.55 -23.22 31.17 24.81 -20.89 33.85 26.48 1pd2_c02 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 2 hits 1pd2_c02 naa= 3 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 2 8 TYR A 225 TYR.? 21.13 O1 PO4 A 349 2 14 ARG A 182 ARG.? 27.04 O1 PO4 A 349 2 104 TRP A 181 TRP.? 23.95 O1 PO4 A 349 coo 14.82 62.39 20.28 14.73 60.21 22.02 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 10.81 55.96 22.08 10.04 53.12 21.26 -34.46 56.29 23.08 -34.82 53.96 21.09 coo 13.42 52.88 28.75 17.04 51.48 28.24 -32.91 63.91 20.46 -30.26 66.07 18.54 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 2 3 # 2 2 8 TYR C 225 TYR~? 18.05 C6 PG4 A 350 2 14 ARG C 182 ARG.? 12.42 C6 PG4 A 350 2 104 TRP C 181 TRP.? 10.24 C1 PG4 A 350 coo 14.82 62.39 20.28 14.73 60.21 22.02 -22.42 22.90 31.89 -22.15 20.23 31.17 coo 10.81 55.96 22.08 10.04 53.12 21.26 -17.19 25.58 29.52 -16.27 25.77 32.47 coo 13.42 52.88 28.75 17.04 51.48 28.24 -23.22 31.17 24.81 -20.89 33.85 26.48 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 3 3 # 3 2 8 TYR D 225 TYR.? 21.05 O1 PO4 D 349 2 14 ARG D 182 ARG.? 26.89 O1 PO4 D 349 2 104 TRP D 181 TRP.? 23.46 O1 PO4 D 349 coo 14.82 62.39 20.28 14.73 60.21 22.02 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 10.81 55.96 22.08 10.04 53.12 21.26 -74.46 22.20 60.05 -74.88 21.98 57.01 coo 13.42 52.88 28.75 17.04 51.48 28.24 -69.65 29.97 63.31 -72.25 31.63 60.90 1pd2_c03 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 3 hits 1pd2_c03 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 64 SER~? 26.25 O3 PG4 B 350 A 708 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 740 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo -7.09 7.44 6.22 -7.53 5.14 5.59 1.46 56.04 50.07 2.12 55.38 52.31 coo -5.35 2.36 14.19 -6.28 2.60 12.26 1.74 60.96 43.57 3.36 61.47 42.28 coo -8.70 2.86 9.96 -8.03 3.92 8.29 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER A 64 SER~? 26.25 O3 PG4 B 350 A 708 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 740 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo -7.09 7.44 6.22 -7.53 5.14 5.59 1.46 56.04 50.07 2.12 55.38 52.31 coo -5.35 2.36 14.19 -6.28 2.60 12.26 8.08 50.44 43.84 7.48 51.26 41.98 coo -8.70 2.86 9.96 -8.03 3.92 8.29 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER A 241 SER.? 9.98 O3 PO4 A 349 A 708 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 740 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -0.69 52.51 16.88 -2.72 53.79 17.21 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -1.16 62.88 18.52 0.68 62.16 19.33 coo -8.70 2.86 9.96 -8.03 3.92 8.29 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER B 64 SER~? 26.98 C5 PG4 A 350 A 708 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 740 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -6.23 8.13 11.77 -6.66 5.89 12.66 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -7.40 13.29 5.68 -9.25 14.12 5.01 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 A 630 SER B 241 SER.? 10.02 O1 PO4 B 349 A 708 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 740 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -9.21 42.20 9.74 -7.29 41.83 8.32 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 A 630 SER C 64 SER~? 25.88 C5 PG4 D 350 A 708 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 740 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -52.23 5.22 16.50 -53.97 6.36 17.05 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 A 630 SER C 64 SER~? 25.88 C5 PG4 D 350 A 708 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 740 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 A 630 SER C 241 SER.? 9.97 O3 PO4 C 349 A 708 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 740 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -50.53 22.77 38.79 -48.65 23.56 37.48 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 9 3 # 9 A 630 SER D 64 SER~? 27.50 C6 PG4 C 350 A 708 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 740 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -39.78 8.95 76.71 -38.11 10.21 76.27 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 10 3 # 10 A 630 SER D 64 SER~? 27.50 C6 PG4 C 350 A 708 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 740 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 11 3 # 11 A 630 SER D 241 SER.? 10.08 O3 PO4 D 349 A 708 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 740 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -41.15 24.23 50.62 -43.08 24.97 51.88 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -38.74 26.41 54.26 -37.48 24.84 54.87 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 11 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 64 SER~? 26.25 O3 PG4 B 350 B 708 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 740 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 4.44 13.29 37.64 6.01 11.66 38.49 1.46 56.04 50.07 2.12 55.38 52.31 coo 6.39 7.18 30.33 6.92 8.20 32.17 1.74 60.96 43.57 3.36 61.47 42.28 coo 8.57 10.09 34.47 7.10 10.73 35.82 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER A 64 SER~? 26.25 O3 PG4 B 350 B 708 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 740 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 4.44 13.29 37.64 6.01 11.66 38.49 1.46 56.04 50.07 2.12 55.38 52.31 coo 6.39 7.18 30.33 6.92 8.20 32.17 8.08 50.44 43.84 7.48 51.26 41.98 coo 8.57 10.09 34.47 7.10 10.73 35.82 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER A 241 SER.? 9.98 O3 PO4 A 349 B 708 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 740 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 6.39 7.18 30.33 6.92 8.20 32.17 -1.16 62.88 18.52 0.68 62.16 19.33 coo 8.57 10.09 34.47 7.10 10.73 35.82 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER B 64 SER~? 26.98 C5 PG4 A 350 B 708 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 740 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 4.44 13.29 37.64 6.01 11.66 38.49 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 6.39 7.18 30.33 6.92 8.20 32.17 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 8.57 10.09 34.47 7.10 10.73 35.82 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER B 64 SER~? 26.98 C5 PG4 A 350 B 708 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 740 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 4.44 13.29 37.64 6.01 11.66 38.49 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 6.39 7.18 30.33 6.92 8.20 32.17 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 8.57 10.09 34.47 7.10 10.73 35.82 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER B 241 SER.? 10.02 O1 PO4 B 349 B 708 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 740 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 6.39 7.18 30.33 6.92 8.20 32.17 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 8.57 10.09 34.47 7.10 10.73 35.82 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 B 630 SER C 64 SER~? 25.88 C5 PG4 D 350 B 708 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 740 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 4.44 13.29 37.64 6.01 11.66 38.49 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 6.39 7.18 30.33 6.92 8.20 32.17 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 8.57 10.09 34.47 7.10 10.73 35.82 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 B 630 SER C 64 SER~? 25.88 C5 PG4 D 350 B 708 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 740 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 4.44 13.29 37.64 6.01 11.66 38.49 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 6.39 7.18 30.33 6.92 8.20 32.17 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 8.57 10.09 34.47 7.10 10.73 35.82 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 9 3 # 9 B 630 SER C 241 SER.? 9.97 O3 PO4 C 349 B 708 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 740 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 6.39 7.18 30.33 6.92 8.20 32.17 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 8.57 10.09 34.47 7.10 10.73 35.82 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 10 3 # 10 B 630 SER D 64 SER~? 27.50 C6 PG4 C 350 B 708 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 740 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 4.44 13.29 37.64 6.01 11.66 38.49 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 6.39 7.18 30.33 6.92 8.20 32.17 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 8.57 10.09 34.47 7.10 10.73 35.82 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 11 3 # 11 B 630 SER D 64 SER~? 27.50 C6 PG4 C 350 B 708 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 740 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 4.44 13.29 37.64 6.01 11.66 38.49 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 6.39 7.18 30.33 6.92 8.20 32.17 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 8.57 10.09 34.47 7.10 10.73 35.82 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 12 3 # 12 B 630 SER D 241 SER.? 10.08 O3 PO4 D 349 B 708 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 740 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 6.39 7.18 30.33 6.92 8.20 32.17 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 8.57 10.09 34.47 7.10 10.73 35.82 -38.74 26.41 54.26 -37.48 24.84 54.87 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 12 hits 1pfq_c01 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 143 SER.? 14.48 C2 PG4 A 350 A 709 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 740 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -18.44 40.75 9.72 -20.35 39.92 10.87 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 143 SER.? 15.37 C2 PG4 B 350 A 709 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 740 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo -7.09 7.44 6.22 -7.53 5.14 5.59 8.40 53.62 17.31 10.72 53.32 17.95 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -1.16 62.88 18.52 0.68 62.16 19.33 coo -8.70 2.86 9.96 -8.03 3.92 8.29 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER C 143 SER.? 14.49 C2 PG4 C 350 A 709 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 740 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -31.83 24.72 51.20 -29.72 23.61 51.01 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -38.74 26.41 54.26 -37.48 24.84 54.87 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER D 143 SER.? 14.73 O4 PG4 D 350 A 709 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 740 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -59.66 21.71 38.39 -61.59 20.24 38.67 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -53.20 24.10 34.96 -54.25 22.32 34.57 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 4 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 143 SER.? 14.48 C2 PG4 A 350 B 709 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 740 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 -18.44 40.75 9.72 -20.35 39.92 10.87 coo 10.26 2.81 31.69 11.64 4.30 32.43 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 8.57 10.09 34.47 7.10 10.73 35.82 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 143 SER.? 15.37 C2 PG4 B 350 B 709 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 740 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 8.40 53.62 17.31 10.72 53.32 17.95 coo 10.26 2.81 31.69 11.64 4.30 32.43 -1.16 62.88 18.52 0.68 62.16 19.33 coo 8.57 10.09 34.47 7.10 10.73 35.82 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER B 169 SER~? 7.42 O2 PO4 B 349 B 709 ASP B 226 ASP.? 24.90 O2 PO4 B 349 B 740 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 6.64 36.52 -0.21 5.42 37.80 1.47 coo 10.26 2.81 31.69 11.64 4.30 32.43 20.38 42.79 0.27 22.43 42.38 0.23 coo 8.57 10.09 34.47 7.10 10.73 35.82 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER C 143 SER.? 14.49 C2 PG4 C 350 B 709 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 740 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 -31.83 24.72 51.20 -29.72 23.61 51.01 coo 10.26 2.81 31.69 11.64 4.30 32.43 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 8.57 10.09 34.47 7.10 10.73 35.82 -38.74 26.41 54.26 -37.48 24.84 54.87 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER C 169 SER~? 7.39 O2 PO4 C 349 B 709 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 740 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 -35.40 25.65 26.78 -36.52 25.32 28.91 coo 10.26 2.81 31.69 11.64 4.30 32.43 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 8.57 10.09 34.47 7.10 10.73 35.82 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER D 143 SER.? 14.73 O4 PG4 D 350 B 709 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 740 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 -59.66 21.71 38.39 -61.59 20.24 38.67 coo 10.26 2.81 31.69 11.64 4.30 32.43 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 8.57 10.09 34.47 7.10 10.73 35.82 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 B 630 SER D 169 SER~? 7.40 O1 PO4 D 349 B 709 ASP D 226 ASP.? 25.08 O1 PO4 D 349 B 740 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo 4.44 13.29 37.64 6.01 11.66 38.49 -56.61 26.42 62.40 -55.41 26.04 60.30 coo 10.26 2.81 31.69 11.64 4.30 32.43 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 8.57 10.09 34.47 7.10 10.73 35.82 -61.67 25.88 60.45 -63.21 27.00 61.32 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 7 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 259 TYR A 91 TYR~? 12.90 C4 PG4 B 350 A 552 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo 11.34 95.90 25.54 12.13 96.42 23.67 3.61 55.89 43.73 3.10 55.52 45.73 coo 14.91 97.39 18.63 13.39 95.60 20.20 3.23 49.01 40.90 3.18 50.90 38.82 coo 46.37 82.54 38.83 45.97 84.66 38.77 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 259 TYR A 225 TYR.? 21.13 O1 PO4 A 349 A 552 ASP A 118 ASP~? 17.27 C5 PG4 B 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 14.91 97.39 18.63 13.39 95.60 20.20 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 46.37 82.54 38.83 45.97 84.66 38.77 0.76 36.83 47.04 2.33 35.40 47.32 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 259 TYR A 225 TYR.? 21.13 O1 PO4 A 349 A 552 ASP B 131 ASP^? 9.09 C8 PG4 A 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 14.91 97.39 18.63 13.39 95.60 20.20 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 46.37 82.54 38.83 45.97 84.66 38.77 0.40 27.07 22.40 -0.62 25.51 23.42 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 259 TYR A 225 TYR.? 21.13 O1 PO4 A 349 A 552 ASP A 118 ASP~? 17.27 C5 PG4 B 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 14.91 97.39 18.63 13.39 95.60 20.20 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 46.37 82.54 38.83 45.97 84.66 38.77 0.76 36.83 47.04 2.33 35.40 47.32 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 259 TYR A 225 TYR.? 21.13 O1 PO4 A 349 A 552 ASP B 131 ASP^? 9.09 C8 PG4 A 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 14.91 97.39 18.63 13.39 95.60 20.20 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 46.37 82.54 38.83 45.97 84.66 38.77 0.40 27.07 22.40 -0.62 25.51 23.42 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 6 3 # 6 A 225 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 259 TYR B 91 TYR~? 13.43 C5 PG4 A 350 A 552 ASP B 339 ASP~? 20.98 O2 PO4 B 349 coo 11.34 95.90 25.54 12.13 96.42 23.67 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 14.91 97.39 18.63 13.39 95.60 20.20 -9.83 18.57 16.69 -10.13 20.18 14.41 coo 46.37 82.54 38.83 45.97 84.66 38.77 12.36 37.42 -12.59 13.93 36.17 -11.84 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 7 3 # 7 A 225 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 259 TYR B 91 TYR~? 13.43 C5 PG4 A 350 A 552 ASP C 131 ASP^? 9.91 O2 PG4 D 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 14.91 97.39 18.63 13.39 95.60 20.20 -9.83 18.57 16.69 -10.13 20.18 14.41 coo 46.37 82.54 38.83 45.97 84.66 38.77 -40.29 2.77 35.99 -41.53 1.06 35.77 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 8 3 # 8 A 225 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 259 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 552 ASP A 131 ASP^? 9.75 C6 PG4 B 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 13.23 34.15 0.64 14.88 33.23 1.56 coo 14.91 97.39 18.63 13.39 95.60 20.20 19.22 39.10 5.74 19.70 36.67 7.05 coo 46.37 82.54 38.83 45.97 84.66 38.77 -8.03 41.96 35.37 -6.75 41.25 36.93 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 9 3 # 9 A 225 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 259 TYR B 225 TYR~? 21.07 O2 PO4 B 349 A 552 ASP A 131 ASP^? 9.75 C6 PG4 B 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 11.38 38.70 0.79 12.71 38.99 -0.80 coo 14.91 97.39 18.63 13.39 95.60 20.20 19.22 39.10 5.74 19.70 36.67 7.05 coo 46.37 82.54 38.83 45.97 84.66 38.77 -8.03 41.96 35.37 -6.75 41.25 36.93 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 10 3 # 10 A 225 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 259 TYR C 91 TYR~? 12.18 C5 PG4 D 350 A 552 ASP B 90 ASP~? 17.21 C5 PG4 A 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 14.91 97.39 18.63 13.39 95.60 20.20 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 46.37 82.54 38.83 45.97 84.66 38.77 -14.26 14.51 16.36 -14.11 16.10 14.94 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 11 3 # 11 A 225 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 259 TYR C 91 TYR~? 12.18 C5 PG4 D 350 A 552 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 14.91 97.39 18.63 13.39 95.60 20.20 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 46.37 82.54 38.83 45.97 84.66 38.77 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 12 3 # 12 A 225 HIS C 173 HIS~? 15.03 O2 PO4 C 349 A 259 TYR C 225 TYR~? 18.05 C6 PG4 A 350 A 552 ASP D 131 ASP^? 9.77 C6 PG4 C 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 14.91 97.39 18.63 13.39 95.60 20.20 -22.42 22.90 31.89 -22.15 20.23 31.17 coo 46.37 82.54 38.83 45.97 84.66 38.77 -48.29 3.79 55.93 -46.95 2.25 56.44 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 13 3 # 13 A 225 HIS C 229 HIS^? 14.09 O2 PO4 C 349 A 259 TYR C 225 TYR~? 18.05 C6 PG4 A 350 A 552 ASP D 131 ASP^? 9.77 C6 PG4 C 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 14.91 97.39 18.63 13.39 95.60 20.20 -22.42 22.90 31.89 -22.15 20.23 31.17 coo 46.37 82.54 38.83 45.97 84.66 38.77 -48.29 3.79 55.93 -46.95 2.25 56.44 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 14 3 # 14 A 225 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 259 TYR D 91 TYR~? 13.46 C4 PG4 C 350 A 552 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 11.34 95.90 25.54 12.13 96.42 23.67 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 14.91 97.39 18.63 13.39 95.60 20.20 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 46.37 82.54 38.83 45.97 84.66 38.77 -63.02 36.35 69.71 -64.42 35.04 70.68 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 15 3 # 15 A 225 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 259 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 552 ASP C 131 ASP^? 9.91 O2 PG4 D 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 14.91 97.39 18.63 13.39 95.60 20.20 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 46.37 82.54 38.83 45.97 84.66 38.77 -40.29 2.77 35.99 -41.53 1.06 35.77 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 16 3 # 16 A 225 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 259 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 552 ASP D 118 ASP~? 17.29 C6 PG4 C 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 14.91 97.39 18.63 13.39 95.60 20.20 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 46.37 82.54 38.83 45.97 84.66 38.77 -39.99 -8.60 59.76 -38.31 -9.56 58.92 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 17 3 # 17 A 225 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 259 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 552 ASP C 131 ASP^? 9.91 O2 PG4 D 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 14.91 97.39 18.63 13.39 95.60 20.20 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 46.37 82.54 38.83 45.97 84.66 38.77 -40.29 2.77 35.99 -41.53 1.06 35.77 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 18 3 # 18 A 225 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 259 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 552 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 14.91 97.39 18.63 13.39 95.60 20.20 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 46.37 82.54 38.83 45.97 84.66 38.77 -33.15 1.70 68.90 -33.50 3.76 68.48 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 19 3 # 19 A 225 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 259 TYR D 225 TYR.? 21.05 O1 PO4 D 349 A 552 ASP D 118 ASP~? 17.29 C6 PG4 C 350 coo 11.34 95.90 25.54 12.13 96.42 23.67 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 14.91 97.39 18.63 13.39 95.60 20.20 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 46.37 82.54 38.83 45.97 84.66 38.77 -39.99 -8.60 59.76 -38.31 -9.56 58.92 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 19 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 10 ALA^? 23.10 O2 PO4 A 349 A 126 LEU A 12 LEU^? 17.63 O3 PG4 B 350 A 158 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -7.72 56.24 46.31 -7.04 55.58 47.47 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -1.87 53.48 42.74 -0.15 52.44 43.53 coo -0.83 29.57 149.77 -0.39 31.47 148.95 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 98 ALA~? 20.83 C5 PG4 B 350 A 126 LEU A 95 LEU~? 14.86 C5 PG4 B 350 A 158 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -4.80 48.00 50.25 -4.93 48.51 48.79 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -1.08 45.57 45.33 -1.12 46.19 43.25 coo -0.83 29.57 149.77 -0.39 31.47 148.95 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 101 ALA~? 26.23 C5 PG4 B 350 A 126 LEU A 69 LEU~? 28.45 C5 PG4 B 350 A 158 GLU A 66 GLU~? 28.55 C5 PG4 B 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -7.09 47.06 54.67 -6.54 48.43 54.36 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -5.35 53.86 55.77 -4.95 51.86 55.05 coo -0.83 29.57 149.77 -0.39 31.47 148.95 0.21 52.94 56.28 1.27 51.32 57.12 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 175 ALA~? 17.35 O1 PO4 A 349 A 126 LEU A 172 LEU~? 12.94 O1 PO4 A 349 A 158 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -24.81 67.41 24.63 -24.01 68.06 23.54 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -20.38 64.41 21.11 -19.45 65.50 19.45 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 176 ALA~? 18.28 O1 PO4 A 349 A 126 LEU A 172 LEU~? 12.94 O1 PO4 A 349 A 158 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -27.00 64.71 23.01 -26.51 63.43 22.36 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -20.38 64.41 21.11 -19.45 65.50 19.45 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA A 210 ALA~? 10.48 O1 PG4 A 350 A 126 LEU A 139 LEU.? -3.83 O1 PG4 A 350s A 158 GLU A 135 GLU.? -3.98 O1 PG4 A 350s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -10.24 43.30 17.86 -8.96 44.01 17.47 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -14.21 37.82 20.63 -14.15 39.67 21.77 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -10.19 39.37 24.45 -9.09 38.16 23.13 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA B 10 ALA^? 23.36 O3 PO4 B 349 A 126 LEU B 12 LEU^? 17.91 C5 PG4 A 350 A 158 GLU B 94 GLU~? 22.11 C5 PG4 A 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 2.16 13.37 10.97 1.64 12.29 11.89 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -4.23 16.40 12.91 -5.95 15.65 14.04 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -7.91 12.10 15.72 -7.33 10.19 14.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 98 ALA~? 20.95 C5 PG4 A 350 A 126 LEU B 95 LEU~? 15.02 C5 PG4 A 350 A 158 GLU B 94 GLU~? 22.11 C5 PG4 A 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -0.63 10.86 19.74 -0.63 12.19 18.99 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -5.12 15.67 20.83 -5.40 17.52 19.66 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -7.91 12.10 15.72 -7.33 10.19 14.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 101 ALA~? 26.36 C5 PG4 A 350 A 126 LEU B 69 LEU~? 28.69 C5 PG4 A 350 A 158 GLU B 66 GLU~? 29.14 C5 PG4 A 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 2.20 7.05 21.69 1.76 7.10 20.23 coo -4.62 32.83 147.14 -5.50 32.85 149.12 1.27 4.37 15.16 0.59 5.42 16.94 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -4.41 2.86 15.92 -3.73 2.64 17.92 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA B 175 ALA~? 17.30 O2 PO4 B 349 A 126 LEU B 172 LEU~? 12.69 O2 PO4 B 349 A 158 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.10 34.75 -6.58 13.02 35.55 -7.27 coo -4.62 32.83 147.14 -5.50 32.85 149.12 9.32 37.94 -3.58 8.05 39.24 -4.84 coo -0.83 29.57 149.77 -0.39 31.47 148.95 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA B 176 ALA~? 18.30 O2 PO4 B 349 A 126 LEU B 172 LEU~? 12.69 O2 PO4 B 349 A 158 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo -2.29 37.66 144.73 -1.46 37.12 145.87 16.22 37.28 -4.66 15.77 38.11 -3.49 coo -4.62 32.83 147.14 -5.50 32.85 149.12 9.32 37.94 -3.58 8.05 39.24 -4.84 coo -0.83 29.57 149.77 -0.39 31.47 148.95 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA B 210 ALA~? 10.64 O1 PG4 B 350 A 126 LEU B 139 LEU.? -3.88 O1 PG4 B 350s A 158 GLU B 135 GLU.? -3.99 O5 PG4 B 350s coo -2.29 37.66 144.73 -1.46 37.12 145.87 1.12 44.24 17.53 -0.27 44.37 16.85 coo -4.62 32.83 147.14 -5.50 32.85 149.12 5.82 42.83 22.92 5.79 41.39 21.29 coo -0.83 29.57 149.77 -0.39 31.47 148.95 2.30 38.46 22.67 1.14 39.98 23.57 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA C 10 ALA^? 23.13 O4 PO4 C 349 A 126 LEU C 12 LEU^? 17.34 C5 PG4 D 350 A 158 GLU C 94 GLU~? 21.12 C5 PG4 D 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -41.98 1.84 18.07 -42.52 0.45 17.93 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -47.60 2.29 22.79 -49.16 0.88 23.31 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -51.22 -2.72 22.56 -51.13 -3.21 20.49 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 A 70 ALA C 68 ALA~? 26.31 O3 PG4 D 350 A 126 LEU C 69 LEU~? 28.49 C3 PG4 D 350 A 158 GLU C 66 GLU~? 28.42 C3 PG4 D 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -45.24 -3.04 14.02 -45.15 -2.24 15.32 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -43.47 -7.58 14.69 -43.71 -8.16 16.77 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -49.32 -9.41 15.52 -48.32 -10.85 16.74 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 A 70 ALA C 101 ALA~? 26.29 C3 PG4 D 350 A 126 LEU C 69 LEU~? 28.49 C3 PG4 D 350 A 158 GLU C 66 GLU~? 28.42 C3 PG4 D 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -40.98 -10.30 20.66 -41.67 -9.32 19.72 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -43.47 -7.58 14.69 -43.71 -8.16 16.77 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -49.32 -9.41 15.52 -48.32 -10.85 16.74 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 A 70 ALA C 175 ALA~? 17.02 O2 PG4 A 350 A 126 LEU C 172 LEU~? 12.83 O2 PO4 C 349 A 158 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -28.16 28.46 20.32 -29.18 29.57 20.45 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -32.58 29.02 25.18 -33.78 30.85 25.40 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 A 70 ALA C 176 ALA~? 15.03 O2 PG4 A 350 A 126 LEU C 172 LEU~? 12.83 O2 PO4 C 349 A 158 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -25.95 28.73 23.42 -26.39 28.45 24.83 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -32.58 29.02 25.18 -33.78 30.85 25.40 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 A 70 ALA C 210 ALA~? 10.91 O1 PG4 C 350 A 126 LEU C 139 LEU.? -4.28 O1 PG4 C 350s A 158 GLU C 135 GLU.? -3.67 O1 PG4 C 350s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -39.73 18.40 44.95 -41.09 18.98 44.68 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -34.72 13.62 47.48 -34.93 13.62 45.32 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -38.59 10.74 44.23 -39.39 10.87 46.20 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 A 70 ALA D 10 ALA^? 23.89 O2 PO4 D 349 A 126 LEU D 12 LEU^? 18.47 C6 PG4 C 350 A 158 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -49.31 4.33 73.71 -48.80 2.93 73.95 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -43.02 5.08 69.98 -41.32 3.75 69.83 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 A 70 ALA D 98 ALA~? 21.08 C6 PG4 C 350 A 126 LEU D 95 LEU~? 15.12 C6 PG4 C 350 A 158 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -46.21 -4.06 70.08 -46.37 -2.63 69.56 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -42.02 -1.64 65.38 -42.15 0.38 64.56 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 A 70 ALA D 175 ALA~? 17.45 O1 PO4 D 349 A 126 LEU D 172 LEU~? 12.88 O1 PO4 D 349 A 158 GLU D 171 GLU~? 12.87 O2 PO4 D 349 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -64.41 28.74 68.50 -63.57 30.01 68.35 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -60.04 29.40 63.58 -59.15 31.30 63.00 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -56.37 27.70 69.07 -57.02 27.32 71.04 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 A 70 ALA D 176 ALA~? 18.20 O1 PO4 D 349 A 126 LEU D 172 LEU~? 12.88 O1 PO4 D 349 A 158 GLU D 171 GLU~? 12.87 O2 PO4 D 349 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -66.56 28.54 65.37 -66.10 28.17 63.98 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -60.04 29.40 63.58 -59.15 31.30 63.00 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -56.37 27.70 69.07 -57.02 27.32 71.04 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 22 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 10 ALA^? 23.10 O2 PO4 A 349 B 126 LEU A 12 LEU^? 17.63 O3 PG4 B 350 B 158 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -7.72 56.24 46.31 -7.04 55.58 47.47 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -1.87 53.48 42.74 -0.15 52.44 43.53 coo -33.03 9.93 151.71 -34.98 9.38 151.11 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 98 ALA~? 20.83 C5 PG4 B 350 B 126 LEU A 95 LEU~? 14.86 C5 PG4 B 350 B 158 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -4.80 48.00 50.25 -4.93 48.51 48.79 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -1.08 45.57 45.33 -1.12 46.19 43.25 coo -33.03 9.93 151.71 -34.98 9.38 151.11 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 101 ALA~? 26.23 C5 PG4 B 350 B 126 LEU A 69 LEU~? 28.45 C5 PG4 B 350 B 158 GLU A 66 GLU~? 28.55 C5 PG4 B 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -7.09 47.06 54.67 -6.54 48.43 54.36 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -5.35 53.86 55.77 -4.95 51.86 55.05 coo -33.03 9.93 151.71 -34.98 9.38 151.11 0.21 52.94 56.28 1.27 51.32 57.12 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 175 ALA~? 17.35 O1 PO4 A 349 B 126 LEU A 172 LEU~? 12.94 O1 PO4 A 349 B 158 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -24.81 67.41 24.63 -24.01 68.06 23.54 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -20.38 64.41 21.11 -19.45 65.50 19.45 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 176 ALA~? 18.28 O1 PO4 A 349 B 126 LEU A 172 LEU~? 12.94 O1 PO4 A 349 B 158 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -27.00 64.71 23.01 -26.51 63.43 22.36 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -20.38 64.41 21.11 -19.45 65.50 19.45 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA B 10 ALA^? 23.36 O3 PO4 B 349 B 126 LEU B 12 LEU^? 17.91 C5 PG4 A 350 B 158 GLU B 94 GLU~? 22.11 C5 PG4 A 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 2.16 13.37 10.97 1.64 12.29 11.89 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -4.23 16.40 12.91 -5.95 15.65 14.04 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -7.91 12.10 15.72 -7.33 10.19 14.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA B 98 ALA~? 20.95 C5 PG4 A 350 B 126 LEU B 95 LEU~? 15.02 C5 PG4 A 350 B 158 GLU B 94 GLU~? 22.11 C5 PG4 A 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -0.63 10.86 19.74 -0.63 12.19 18.99 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -5.12 15.67 20.83 -5.40 17.52 19.66 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -7.91 12.10 15.72 -7.33 10.19 14.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 101 ALA~? 26.36 C5 PG4 A 350 B 126 LEU B 69 LEU~? 28.69 C5 PG4 A 350 B 158 GLU B 66 GLU~? 29.14 C5 PG4 A 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 2.20 7.05 21.69 1.76 7.10 20.23 coo -34.22 5.06 149.25 -33.65 4.24 151.15 1.27 4.37 15.16 0.59 5.42 16.94 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -4.41 2.86 15.92 -3.73 2.64 17.92 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 175 ALA~? 17.30 O2 PO4 B 349 B 126 LEU B 172 LEU~? 12.69 O2 PO4 B 349 B 158 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.10 34.75 -6.58 13.02 35.55 -7.27 coo -34.22 5.06 149.25 -33.65 4.24 151.15 9.32 37.94 -3.58 8.05 39.24 -4.84 coo -33.03 9.93 151.71 -34.98 9.38 151.11 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA B 176 ALA~? 18.30 O2 PO4 B 349 B 126 LEU B 172 LEU~? 12.69 O2 PO4 B 349 B 158 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo -39.79 4.61 147.27 -39.61 5.56 148.47 16.22 37.28 -4.66 15.77 38.11 -3.49 coo -34.22 5.06 149.25 -33.65 4.24 151.15 9.32 37.94 -3.58 8.05 39.24 -4.84 coo -33.03 9.93 151.71 -34.98 9.38 151.11 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA B 210 ALA~? 10.64 O1 PG4 B 350 B 126 LEU B 139 LEU.? -3.88 O1 PG4 B 350s B 158 GLU B 135 GLU.? -3.99 O5 PG4 B 350s coo -39.79 4.61 147.27 -39.61 5.56 148.47 1.12 44.24 17.53 -0.27 44.37 16.85 coo -34.22 5.06 149.25 -33.65 4.24 151.15 5.82 42.83 22.92 5.79 41.39 21.29 coo -33.03 9.93 151.71 -34.98 9.38 151.11 2.30 38.46 22.67 1.14 39.98 23.57 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA C 10 ALA^? 23.13 O4 PO4 C 349 B 126 LEU C 12 LEU^? 17.34 C5 PG4 D 350 B 158 GLU C 94 GLU~? 21.12 C5 PG4 D 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -41.98 1.84 18.07 -42.52 0.45 17.93 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -47.60 2.29 22.79 -49.16 0.88 23.31 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -51.22 -2.72 22.56 -51.13 -3.21 20.49 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA C 68 ALA~? 26.31 O3 PG4 D 350 B 126 LEU C 69 LEU~? 28.49 C3 PG4 D 350 B 158 GLU C 66 GLU~? 28.42 C3 PG4 D 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -45.24 -3.04 14.02 -45.15 -2.24 15.32 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -43.47 -7.58 14.69 -43.71 -8.16 16.77 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -49.32 -9.41 15.52 -48.32 -10.85 16.74 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 B 70 ALA C 101 ALA~? 26.29 C3 PG4 D 350 B 126 LEU C 69 LEU~? 28.49 C3 PG4 D 350 B 158 GLU C 66 GLU~? 28.42 C3 PG4 D 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -40.98 -10.30 20.66 -41.67 -9.32 19.72 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -43.47 -7.58 14.69 -43.71 -8.16 16.77 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -49.32 -9.41 15.52 -48.32 -10.85 16.74 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 B 70 ALA C 175 ALA~? 17.02 O2 PG4 A 350 B 126 LEU C 172 LEU~? 12.83 O2 PO4 C 349 B 158 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -28.16 28.46 20.32 -29.18 29.57 20.45 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -32.58 29.02 25.18 -33.78 30.85 25.40 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 B 70 ALA C 176 ALA~? 15.03 O2 PG4 A 350 B 126 LEU C 172 LEU~? 12.83 O2 PO4 C 349 B 158 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -25.95 28.73 23.42 -26.39 28.45 24.83 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -32.58 29.02 25.18 -33.78 30.85 25.40 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 B 70 ALA C 210 ALA~? 10.91 O1 PG4 C 350 B 126 LEU C 139 LEU.? -4.28 O1 PG4 C 350s B 158 GLU C 135 GLU.? -3.67 O1 PG4 C 350s coo -39.79 4.61 147.27 -39.61 5.56 148.47 -39.73 18.40 44.95 -41.09 18.98 44.68 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -34.72 13.62 47.48 -34.93 13.62 45.32 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -38.59 10.74 44.23 -39.39 10.87 46.20 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 B 70 ALA D 10 ALA^? 23.89 O2 PO4 D 349 B 126 LEU D 12 LEU^? 18.47 C6 PG4 C 350 B 158 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -49.31 4.33 73.71 -48.80 2.93 73.95 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -43.02 5.08 69.98 -41.32 3.75 69.83 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 B 70 ALA D 98 ALA~? 21.08 C6 PG4 C 350 B 126 LEU D 95 LEU~? 15.12 C6 PG4 C 350 B 158 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -46.21 -4.06 70.08 -46.37 -2.63 69.56 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -42.02 -1.64 65.38 -42.15 0.38 64.56 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 B 70 ALA D 175 ALA~? 17.45 O1 PO4 D 349 B 126 LEU D 172 LEU~? 12.88 O1 PO4 D 349 B 158 GLU D 171 GLU~? 12.87 O2 PO4 D 349 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -64.41 28.74 68.50 -63.57 30.01 68.35 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -60.04 29.40 63.58 -59.15 31.30 63.00 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -56.37 27.70 69.07 -57.02 27.32 71.04 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 B 70 ALA D 176 ALA~? 18.20 O1 PO4 D 349 B 126 LEU D 172 LEU~? 12.88 O1 PO4 D 349 B 158 GLU D 171 GLU~? 12.87 O2 PO4 D 349 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -66.56 28.54 65.37 -66.10 28.17 63.98 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -60.04 29.40 63.58 -59.15 31.30 63.00 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -56.37 27.70 69.07 -57.02 27.32 71.04 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 21 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 10 ALA^? 23.10 O2 PO4 A 349 C 126 LEU A 12 LEU^? 17.63 O3 PG4 B 350 C 158 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -7.72 56.24 46.31 -7.04 55.58 47.47 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -1.87 53.48 42.74 -0.15 52.44 43.53 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 98 ALA~? 20.83 C5 PG4 B 350 C 126 LEU A 95 LEU~? 14.86 C5 PG4 B 350 C 158 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -4.80 48.00 50.25 -4.93 48.51 48.79 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -1.08 45.57 45.33 -1.12 46.19 43.25 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 101 ALA~? 26.23 C5 PG4 B 350 C 126 LEU A 69 LEU~? 28.45 C5 PG4 B 350 C 158 GLU A 66 GLU~? 28.55 C5 PG4 B 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -7.09 47.06 54.67 -6.54 48.43 54.36 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -5.35 53.86 55.77 -4.95 51.86 55.05 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 0.21 52.94 56.28 1.27 51.32 57.12 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 175 ALA~? 17.35 O1 PO4 A 349 C 126 LEU A 172 LEU~? 12.94 O1 PO4 A 349 C 158 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -24.81 67.41 24.63 -24.01 68.06 23.54 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -20.38 64.41 21.11 -19.45 65.50 19.45 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 176 ALA~? 18.28 O1 PO4 A 349 C 126 LEU A 172 LEU~? 12.94 O1 PO4 A 349 C 158 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -27.00 64.71 23.01 -26.51 63.43 22.36 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -20.38 64.41 21.11 -19.45 65.50 19.45 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA A 210 ALA~? 10.48 O1 PG4 A 350 C 126 LEU A 139 LEU.? -3.83 O1 PG4 A 350s C 158 GLU A 135 GLU.? -3.98 O1 PG4 A 350s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -10.24 43.30 17.86 -8.96 44.01 17.47 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -14.21 37.82 20.63 -14.15 39.67 21.77 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -10.19 39.37 24.45 -9.09 38.16 23.13 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA B 10 ALA^? 23.36 O3 PO4 B 349 C 126 LEU B 12 LEU^? 17.91 C5 PG4 A 350 C 158 GLU B 94 GLU~? 22.11 C5 PG4 A 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 2.16 13.37 10.97 1.64 12.29 11.89 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -4.23 16.40 12.91 -5.95 15.65 14.04 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -7.91 12.10 15.72 -7.33 10.19 14.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA B 98 ALA~? 20.95 C5 PG4 A 350 C 126 LEU B 95 LEU~? 15.02 C5 PG4 A 350 C 158 GLU B 94 GLU~? 22.11 C5 PG4 A 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.63 10.86 19.74 -0.63 12.19 18.99 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -5.12 15.67 20.83 -5.40 17.52 19.66 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -7.91 12.10 15.72 -7.33 10.19 14.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA B 101 ALA~? 26.36 C5 PG4 A 350 C 126 LEU B 69 LEU~? 28.69 C5 PG4 A 350 C 158 GLU B 66 GLU~? 29.14 C5 PG4 A 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 2.20 7.05 21.69 1.76 7.10 20.23 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 1.27 4.37 15.16 0.59 5.42 16.94 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -4.41 2.86 15.92 -3.73 2.64 17.92 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA B 175 ALA~? 17.30 O2 PO4 B 349 C 126 LEU B 172 LEU~? 12.69 O2 PO4 B 349 C 158 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.10 34.75 -6.58 13.02 35.55 -7.27 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 9.32 37.94 -3.58 8.05 39.24 -4.84 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA B 176 ALA~? 18.30 O2 PO4 B 349 C 126 LEU B 172 LEU~? 12.69 O2 PO4 B 349 C 158 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 16.22 37.28 -4.66 15.77 38.11 -3.49 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 9.32 37.94 -3.58 8.05 39.24 -4.84 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA B 210 ALA~? 10.64 O1 PG4 B 350 C 126 LEU B 139 LEU.? -3.88 O1 PG4 B 350s C 158 GLU B 135 GLU.? -3.99 O5 PG4 B 350s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 1.12 44.24 17.53 -0.27 44.37 16.85 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 5.82 42.83 22.92 5.79 41.39 21.29 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 2.30 38.46 22.67 1.14 39.98 23.57 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA C 10 ALA^? 23.13 O4 PO4 C 349 C 126 LEU C 12 LEU^? 17.34 C5 PG4 D 350 C 158 GLU C 94 GLU~? 21.12 C5 PG4 D 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -41.98 1.84 18.07 -42.52 0.45 17.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -47.60 2.29 22.79 -49.16 0.88 23.31 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -51.22 -2.72 22.56 -51.13 -3.21 20.49 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 C 70 ALA C 68 ALA~? 26.31 O3 PG4 D 350 C 126 LEU C 69 LEU~? 28.49 C3 PG4 D 350 C 158 GLU C 66 GLU~? 28.42 C3 PG4 D 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -45.24 -3.04 14.02 -45.15 -2.24 15.32 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -43.47 -7.58 14.69 -43.71 -8.16 16.77 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -49.32 -9.41 15.52 -48.32 -10.85 16.74 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 C 70 ALA C 101 ALA~? 26.29 C3 PG4 D 350 C 126 LEU C 69 LEU~? 28.49 C3 PG4 D 350 C 158 GLU C 66 GLU~? 28.42 C3 PG4 D 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -40.98 -10.30 20.66 -41.67 -9.32 19.72 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -43.47 -7.58 14.69 -43.71 -8.16 16.77 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -49.32 -9.41 15.52 -48.32 -10.85 16.74 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 C 70 ALA C 175 ALA~? 17.02 O2 PG4 A 350 C 126 LEU C 172 LEU~? 12.83 O2 PO4 C 349 C 158 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -28.16 28.46 20.32 -29.18 29.57 20.45 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -32.58 29.02 25.18 -33.78 30.85 25.40 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 C 70 ALA C 176 ALA~? 15.03 O2 PG4 A 350 C 126 LEU C 172 LEU~? 12.83 O2 PO4 C 349 C 158 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -25.95 28.73 23.42 -26.39 28.45 24.83 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -32.58 29.02 25.18 -33.78 30.85 25.40 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 C 70 ALA C 210 ALA~? 10.91 O1 PG4 C 350 C 126 LEU C 139 LEU.? -4.28 O1 PG4 C 350s C 158 GLU C 135 GLU.? -3.67 O1 PG4 C 350s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -39.73 18.40 44.95 -41.09 18.98 44.68 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -34.72 13.62 47.48 -34.93 13.62 45.32 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -38.59 10.74 44.23 -39.39 10.87 46.20 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 19 3 # 19 C 70 ALA D 10 ALA^? 23.89 O2 PO4 D 349 C 126 LEU D 12 LEU^? 18.47 C6 PG4 C 350 C 158 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -49.31 4.33 73.71 -48.80 2.93 73.95 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -43.02 5.08 69.98 -41.32 3.75 69.83 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 20 3 # 20 C 70 ALA D 98 ALA~? 21.08 C6 PG4 C 350 C 126 LEU D 95 LEU~? 15.12 C6 PG4 C 350 C 158 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -46.21 -4.06 70.08 -46.37 -2.63 69.56 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -42.02 -1.64 65.38 -42.15 0.38 64.56 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 21 3 # 21 C 70 ALA D 175 ALA~? 17.45 O1 PO4 D 349 C 126 LEU D 172 LEU~? 12.88 O1 PO4 D 349 C 158 GLU D 171 GLU~? 12.87 O2 PO4 D 349 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -64.41 28.74 68.50 -63.57 30.01 68.35 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -60.04 29.40 63.58 -59.15 31.30 63.00 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -56.37 27.70 69.07 -57.02 27.32 71.04 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 22 3 # 22 C 70 ALA D 176 ALA~? 18.20 O1 PO4 D 349 C 126 LEU D 172 LEU~? 12.88 O1 PO4 D 349 C 158 GLU D 171 GLU~? 12.87 O2 PO4 D 349 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -66.56 28.54 65.37 -66.10 28.17 63.98 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -60.04 29.40 63.58 -59.15 31.30 63.00 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -56.37 27.70 69.07 -57.02 27.32 71.04 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 22 hits 1pjh_c02 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 190 GLN~? 10.79 O3 PO4 A 349 294 GLU A 196 GLU~? 14.14 O1 PO4 A 349 304 ARG A 133 ARG.? 8.90 C3 PG4 B 350 coo 15.89 18.45 46.53 15.82 16.91 48.02 -6.76 51.91 30.68 -4.92 51.72 31.72 coo 22.84 13.44 52.91 20.84 13.18 52.38 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 8.71 17.11 46.51 7.23 17.64 49.20 -4.79 46.92 29.78 -3.00 49.36 29.13 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 216 GLN~? 7.36 O1 PG4 A 350 294 GLU A 135 GLU.? -3.98 O1 PG4 A 350s 304 ARG A 220 ARG~? 15.84 O1 PG4 A 350 coo 15.89 18.45 46.53 15.82 16.91 48.02 -19.93 41.08 21.62 -18.69 39.99 22.97 coo 22.84 13.44 52.91 20.84 13.18 52.38 -10.19 39.37 24.45 -9.09 38.16 23.13 coo 8.71 17.11 46.51 7.23 17.64 49.20 -23.72 43.89 25.49 -25.14 44.23 28.23 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN B 255 GLN^? 19.82 O2 PO4 B 349 294 GLU B 286 GLU~? 20.04 O4 PO4 B 349 304 ARG B 152 ARG^? 23.80 O2 PO4 B 349 coo 15.89 18.45 46.53 15.82 16.91 48.02 9.74 48.71 -3.07 11.56 48.89 -1.98 coo 22.84 13.44 52.91 20.84 13.18 52.38 0.48 53.28 -2.68 0.79 53.94 -4.67 coo 8.71 17.11 46.51 7.23 17.64 49.20 14.94 46.89 -2.30 16.61 48.81 -4.04 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 4 3 # 4 111 GLN C 216 GLN~? 7.49 O1 PG4 C 350 294 GLU C 135 GLU.? -3.67 O1 PG4 C 350s 304 ARG C 220 ARG~? 11.31 O1 PG4 C 350 coo 15.89 18.45 46.53 15.82 16.91 48.02 -29.55 15.50 43.86 -30.62 13.67 44.21 coo 22.84 13.44 52.91 20.84 13.18 52.38 -38.59 10.74 44.23 -39.39 10.87 46.20 coo 8.71 17.11 46.51 7.23 17.64 49.20 -25.78 14.58 38.60 -28.17 14.03 40.55 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 5 3 # 5 111 GLN C 255 GLN^? 19.93 O2 PO4 C 349 294 GLU C 286 GLU~? 19.95 O1 PO4 C 349 304 ARG C 152 ARG^? 15.32 O1 PG4 A 350 coo 15.89 18.45 46.53 15.82 16.91 48.02 -31.54 35.93 33.35 -29.61 35.34 34.05 coo 22.84 13.44 52.91 20.84 13.18 52.38 -40.61 39.13 37.58 -40.31 41.01 36.65 coo 8.71 17.11 46.51 7.23 17.64 49.20 -26.55 34.01 32.08 -24.98 36.67 32.18 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 6 3 # 6 111 GLN D 216 GLN~? 6.81 O5 PG4 D 350 294 GLU D 135 GLU.? -4.27 C8 PG4 D 350s 304 ARG D 220 ARG~? 10.23 O5 PG4 D 350 coo 15.89 18.45 46.53 15.82 16.91 48.02 -60.48 13.07 46.91 -59.29 11.30 46.96 coo 22.84 13.44 52.91 20.84 13.18 52.38 -50.80 9.98 46.92 -49.80 10.03 45.07 coo 8.71 17.11 46.51 7.23 17.64 49.20 -64.10 12.09 51.59 -61.65 11.18 49.96 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 7 3 # 7 111 GLN D 255 GLN^? 19.91 O1 PO4 D 349 294 GLU D 286 GLU~? 19.90 O4 PO4 D 349 304 ARG D 152 ARG^? 23.56 O1 PO4 D 349 coo 15.89 18.45 46.53 15.82 16.91 48.02 -61.97 34.83 54.50 -63.76 33.87 53.88 coo 22.84 13.44 52.91 20.84 13.18 52.38 -53.47 38.80 49.84 -54.10 40.73 50.49 coo 8.71 17.11 46.51 7.23 17.64 49.20 -66.62 32.34 56.11 -68.43 34.76 55.54 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 7 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 206 ARG~? -3.21 O4 PG4 A 350s A 479 PHE A 209 PHE~? -4.26 C3 PG4 A 350s A 483 GLU A 135 GLU.? -3.98 O1 PG4 A 350s coo 17.33 52.29 2.24 18.71 54.03 0.18 -5.76 36.17 21.40 -8.07 34.21 22.04 coo 20.06 57.44 1.28 18.39 56.19 3.12 -10.72 37.17 18.24 -10.31 34.51 17.57 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -10.19 39.37 24.45 -9.09 38.16 23.13 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG A 335 ARG~? 17.04 O2 PO4 A 349 A 479 PHE A 336 PHE~? 18.45 O2 PO4 A 349 A 483 GLU A 312 GLU~? 22.67 O2 PO4 A 349 coo 17.33 52.29 2.24 18.71 54.03 0.18 -10.94 77.02 25.36 -8.46 78.77 25.78 coo 20.06 57.44 1.28 18.39 56.19 3.12 -15.28 77.93 22.83 -13.03 79.55 23.13 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -11.55 82.77 24.82 -13.13 83.67 25.87 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG B 206 ARG~? -3.06 O4 PG4 B 350s A 479 PHE B 209 PHE~? 4.05 C2 PG4 B 350 A 483 GLU B 135 GLU.? -3.99 O5 PG4 B 350s coo 17.33 52.29 2.24 18.71 54.03 0.18 -2.22 41.47 25.55 0.33 41.32 27.30 coo 20.06 57.44 1.28 18.39 56.19 3.12 2.22 44.73 23.56 2.13 45.64 26.21 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 2.30 38.46 22.67 1.14 39.98 23.57 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG B 335 ARG~? 17.10 O3 PO4 B 349 A 479 PHE B 336 PHE~? 18.31 O3 PO4 B 349 A 483 GLU B 312 GLU~? 22.88 O3 PO4 B 349 coo 17.33 52.29 2.24 18.71 54.03 0.18 -0.53 29.97 -13.85 -3.08 28.75 -15.03 coo 20.06 57.44 1.28 18.39 56.19 3.12 3.33 32.70 -15.56 0.90 31.96 -16.75 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -0.30 29.09 -19.54 1.27 27.97 -20.48 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 A 264 ARG C 206 ARG~? -3.06 O3 PG4 C 350s A 479 PHE C 209 PHE~? 4.08 O2 PG4 C 350 A 483 GLU C 135 GLU.? -3.67 O1 PG4 C 350s coo 17.33 52.29 2.24 18.71 54.03 0.18 -42.81 10.68 48.87 -40.18 9.57 50.03 coo 20.06 57.44 1.28 18.39 56.19 3.12 -38.21 14.67 49.53 -38.41 13.44 51.99 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -38.59 10.74 44.23 -39.39 10.87 46.20 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 A 264 ARG C 335 ARG~? 16.94 O4 PO4 C 349 A 479 PHE C 336 PHE~? 18.40 O4 PO4 C 349 A 483 GLU C 312 GLU~? 22.95 O4 PO4 C 349 coo 17.33 52.29 2.24 18.71 54.03 0.18 -43.40 31.02 13.21 -46.07 30.90 11.67 coo 20.06 57.44 1.28 18.39 56.19 3.12 -39.42 34.04 13.48 -41.90 34.29 12.27 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -43.40 34.54 8.60 -41.92 34.59 7.07 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 A 264 ARG D 206 ARG~? -3.23 O2 PG4 D 350s A 479 PHE D 209 PHE~? -4.27 C6 PG4 D 350s A 483 GLU D 135 GLU.? -4.27 C8 PG4 D 350s coo 17.33 52.29 2.24 18.71 54.03 0.18 -46.64 9.92 42.41 -48.92 7.98 41.78 coo 20.06 57.44 1.28 18.39 56.19 3.12 -51.72 12.73 41.35 -51.42 11.25 39.00 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -50.80 9.98 46.92 -49.80 10.03 45.07 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 A 264 ARG D 335 ARG~? 17.05 O2 PO4 D 349 A 479 PHE D 336 PHE~? 18.33 O2 PO4 D 349 A 483 GLU D 312 GLU~? 22.27 O2 PO4 D 349 coo 17.33 52.29 2.24 18.71 54.03 0.18 -49.77 35.01 75.03 -47.14 35.61 76.51 coo 20.06 57.44 1.28 18.39 56.19 3.12 -54.15 37.21 74.25 -51.71 38.11 75.32 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -50.13 39.19 79.01 -51.63 38.45 80.28 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 8 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 206 ARG~? -3.21 O4 PG4 A 350s B 479 PHE A 209 PHE~? -4.26 C3 PG4 A 350s B 483 GLU A 135 GLU.? -3.98 O1 PG4 A 350s coo -26.72 93.28 20.13 -28.02 93.55 17.39 -5.76 36.17 21.40 -8.07 34.21 22.04 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -10.72 37.17 18.24 -10.31 34.51 17.57 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -10.19 39.37 24.45 -9.09 38.16 23.13 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG A 335 ARG~? 17.04 O2 PO4 A 349 B 479 PHE A 336 PHE~? 18.45 O2 PO4 A 349 B 483 GLU A 312 GLU~? 22.67 O2 PO4 A 349 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -10.94 77.02 25.36 -8.46 78.77 25.78 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -15.28 77.93 22.83 -13.03 79.55 23.13 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -11.55 82.77 24.82 -13.13 83.67 25.87 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG B 206 ARG~? -3.06 O4 PG4 B 350s B 479 PHE B 209 PHE~? 4.05 C2 PG4 B 350 B 483 GLU B 135 GLU.? -3.99 O5 PG4 B 350s coo -26.72 93.28 20.13 -28.02 93.55 17.39 -2.22 41.47 25.55 0.33 41.32 27.30 coo -29.34 90.48 15.69 -27.62 89.95 17.80 2.22 44.73 23.56 2.13 45.64 26.21 coo -26.63 95.49 14.65 -25.77 93.77 13.77 2.30 38.46 22.67 1.14 39.98 23.57 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG B 335 ARG~? 17.10 O3 PO4 B 349 B 479 PHE B 336 PHE~? 18.31 O3 PO4 B 349 B 483 GLU B 312 GLU~? 22.88 O3 PO4 B 349 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -0.53 29.97 -13.85 -3.08 28.75 -15.03 coo -29.34 90.48 15.69 -27.62 89.95 17.80 3.33 32.70 -15.56 0.90 31.96 -16.75 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -0.30 29.09 -19.54 1.27 27.97 -20.48 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 B 264 ARG C 206 ARG~? -3.06 O3 PG4 C 350s B 479 PHE C 209 PHE~? 4.08 O2 PG4 C 350 B 483 GLU C 135 GLU.? -3.67 O1 PG4 C 350s coo -26.72 93.28 20.13 -28.02 93.55 17.39 -42.81 10.68 48.87 -40.18 9.57 50.03 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -38.21 14.67 49.53 -38.41 13.44 51.99 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -38.59 10.74 44.23 -39.39 10.87 46.20 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 B 264 ARG C 335 ARG~? 16.94 O4 PO4 C 349 B 479 PHE C 336 PHE~? 18.40 O4 PO4 C 349 B 483 GLU C 312 GLU~? 22.95 O4 PO4 C 349 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -43.40 31.02 13.21 -46.07 30.90 11.67 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -39.42 34.04 13.48 -41.90 34.29 12.27 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -43.40 34.54 8.60 -41.92 34.59 7.07 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 B 264 ARG D 206 ARG~? -3.23 O2 PG4 D 350s B 479 PHE D 209 PHE~? -4.27 C6 PG4 D 350s B 483 GLU D 135 GLU.? -4.27 C8 PG4 D 350s coo -26.72 93.28 20.13 -28.02 93.55 17.39 -46.64 9.92 42.41 -48.92 7.98 41.78 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -51.72 12.73 41.35 -51.42 11.25 39.00 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -50.80 9.98 46.92 -49.80 10.03 45.07 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 B 264 ARG D 335 ARG~? 17.05 O2 PO4 D 349 B 479 PHE D 336 PHE~? 18.33 O2 PO4 D 349 B 483 GLU D 312 GLU~? 22.27 O2 PO4 D 349 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -49.77 35.01 75.03 -47.14 35.61 76.51 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -54.15 37.21 74.25 -51.71 38.11 75.32 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -50.13 39.19 79.01 -51.63 38.45 80.28 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 8 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 107 ASN^? 9.64 C5 PG4 B 350 A 192 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 195 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -5.73 45.70 37.96 -3.97 45.35 36.84 coo 2.03 47.14 19.75 1.72 46.26 21.64 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN A 107 ASN^? 9.64 C5 PG4 B 350 A 192 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 195 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -5.73 45.70 37.96 -3.97 45.35 36.84 coo 2.03 47.14 19.75 1.72 46.26 21.64 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 A 74 ASN A 138 ASN.? -6.13 O2 PG4 A 350s A 192 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 195 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -17.89 33.84 23.48 -17.76 31.89 24.26 coo 2.03 47.14 19.75 1.72 46.26 21.64 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 A 74 ASN B 107 ASN^? 9.43 C5 PG4 A 350 A 192 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 195 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -1.39 23.50 19.22 -3.25 24.51 19.38 coo 2.03 47.14 19.75 1.72 46.26 21.64 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 A 74 ASN B 107 ASN^? 9.43 C5 PG4 A 350 A 192 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 195 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -1.39 23.50 19.22 -3.25 24.51 19.38 coo 2.03 47.14 19.75 1.72 46.26 21.64 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 A 74 ASN C 107 ASN^? 9.61 C3 PG4 D 350 A 192 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 195 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -42.97 2.46 31.63 -44.77 2.90 32.68 coo 2.03 47.14 19.75 1.72 46.26 21.64 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -48.06 9.35 37.56 -47.54 11.38 37.75 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 7 3 # 7 A 74 ASN C 107 ASN^? 9.61 C3 PG4 D 350 A 192 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 195 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -42.97 2.46 31.63 -44.77 2.90 32.68 coo 2.03 47.14 19.75 1.72 46.26 21.64 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -48.06 9.35 37.56 -47.54 11.38 37.75 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 8 3 # 8 A 74 ASN D 107 ASN^? 9.34 C6 PG4 C 350 A 192 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 195 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -46.02 4.22 60.61 -44.32 4.89 59.53 coo 2.03 47.14 19.75 1.72 46.26 21.64 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 9 3 # 9 A 74 ASN D 138 ASN.? -6.36 C7 PG4 D 350s A 192 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 195 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -59.25 7.10 43.19 -59.38 4.97 43.35 coo 2.03 47.14 19.75 1.72 46.26 21.64 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -48.06 9.35 37.56 -47.54 11.38 37.75 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 9 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 107 ASN^? 9.64 C5 PG4 B 350 B 192 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 195 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo -1.08 51.41 10.34 0.65 52.62 10.17 -5.73 45.70 37.96 -3.97 45.35 36.84 coo 11.36 52.33 5.59 10.18 53.87 6.47 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 7.99 56.74 7.55 6.88 55.39 8.70 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN A 107 ASN^? 9.64 C5 PG4 B 350 B 192 ASP B 208 ASP~? 8.88 C3 PG4 B 350 B 195 HIS A 110 HIS.? 5.77 C3 PG4 B 350 coo -1.08 51.41 10.34 0.65 52.62 10.17 -5.73 45.70 37.96 -3.97 45.35 36.84 coo 11.36 52.33 5.59 10.18 53.87 6.47 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 7.99 56.74 7.55 6.88 55.39 8.70 -1.26 45.53 28.70 -1.92 46.50 26.97 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN A 138 ASN.? -6.13 O2 PG4 A 350s B 192 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 195 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo -1.08 51.41 10.34 0.65 52.62 10.17 -17.89 33.84 23.48 -17.76 31.89 24.26 coo 11.36 52.33 5.59 10.18 53.87 6.47 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 7.99 56.74 7.55 6.88 55.39 8.70 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 B 74 ASN B 107 ASN^? 9.43 C5 PG4 A 350 B 192 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 195 HIS B 110 HIS.? 5.25 C4 PG4 A 350 coo -1.08 51.41 10.34 0.65 52.62 10.17 -1.39 23.50 19.22 -3.25 24.51 19.38 coo 11.36 52.33 5.59 10.18 53.87 6.47 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 7.99 56.74 7.55 6.88 55.39 8.70 -6.85 32.28 17.79 -6.48 33.98 16.61 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 B 74 ASN C 107 ASN^? 9.61 C3 PG4 D 350 B 192 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 195 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo -1.08 51.41 10.34 0.65 52.62 10.17 -42.97 2.46 31.63 -44.77 2.90 32.68 coo 11.36 52.33 5.59 10.18 53.87 6.47 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 7.99 56.74 7.55 6.88 55.39 8.70 -48.06 9.35 37.56 -47.54 11.38 37.75 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 B 74 ASN D 107 ASN^? 9.34 C6 PG4 C 350 B 192 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 195 HIS D 110 HIS.? 5.57 O3 PG4 C 350 coo -1.08 51.41 10.34 0.65 52.62 10.17 -46.02 4.22 60.61 -44.32 4.89 59.53 coo 11.36 52.33 5.59 10.18 53.87 6.47 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 7.99 56.74 7.55 6.88 55.39 8.70 -41.52 11.20 54.17 -42.16 13.10 53.55 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 7 3 # 7 B 74 ASN D 138 ASN.? -6.36 C7 PG4 D 350s B 192 ASP D 208 ASP~? 8.41 C6 PG4 D 350 B 195 HIS C 110 HIS.? 5.63 C6 PG4 D 350 coo -1.08 51.41 10.34 0.65 52.62 10.17 -59.25 7.10 43.19 -59.38 4.97 43.35 coo 11.36 52.33 5.59 10.18 53.87 6.47 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 7.99 56.74 7.55 6.88 55.39 8.70 -48.06 9.35 37.56 -47.54 11.38 37.75 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 7 hits 1pp4_c03 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 131 ASP^? 9.75 C6 PG4 B 350 A 68 ALA A 114 ALA.? 12.43 C6 PG4 B 350 A 72 LEU A 113 LEU.? 10.33 C5 PG4 B 350 coo 46.76 7.59 18.65 45.27 6.01 18.52 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 48.88 4.35 16.59 48.73 5.09 15.20 -7.01 38.67 40.06 -8.35 38.78 39.31 coo 53.89 6.25 15.09 52.88 7.92 14.14 -3.65 41.90 39.87 -1.97 43.31 39.82 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 68 ALA B 204 ALA~? 7.34 O5 PG4 A 350 A 72 LEU B 202 LEU~? 12.39 O1 PG4 B 350 coo 46.76 7.59 18.65 45.27 6.01 18.52 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 48.88 4.35 16.59 48.73 5.09 15.20 -2.79 36.37 18.37 -2.26 34.97 18.59 coo 53.89 6.25 15.09 52.88 7.92 14.14 0.89 39.31 13.54 1.10 41.47 13.60 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP A 339 ASP~? 20.53 O1 PO4 A 349 A 68 ALA A 338 ALA~? 14.94 O1 PO4 A 349 A 72 LEU A 172 LEU~? 12.94 O1 PO4 A 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 -24.08 73.03 20.51 -24.61 72.81 22.55 coo 48.88 4.35 16.59 48.73 5.09 15.20 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 53.89 6.25 15.09 52.88 7.92 14.14 -20.38 64.41 21.11 -19.45 65.50 19.45 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP A 339 ASP~? 20.53 O1 PO4 A 349 A 68 ALA A 338 ALA~? 14.94 O1 PO4 A 349 A 72 LEU A 341 LEU~? 14.71 O4 PO4 A 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 -24.08 73.03 20.51 -24.61 72.81 22.55 coo 48.88 4.35 16.59 48.73 5.09 15.20 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 53.89 6.25 15.09 52.88 7.92 14.14 -18.78 68.84 16.87 -16.77 69.49 16.22 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP A 343 ASP~? 23.03 O1 PO4 A 349 A 68 ALA A 344 ALA~? 19.12 O4 PO4 A 349 A 72 LEU A 341 LEU~? 14.71 O4 PO4 A 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 -25.30 71.23 14.76 -26.68 71.84 16.22 coo 48.88 4.35 16.59 48.73 5.09 15.20 -22.48 68.79 12.16 -20.98 69.05 12.26 coo 53.89 6.25 15.09 52.88 7.92 14.14 -18.78 68.84 16.87 -16.77 69.49 16.22 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 68 ALA B 114 ALA.? 11.26 C8 PG4 A 350 A 72 LEU B 113 LEU.? 10.26 C5 PG4 A 350 coo 46.76 7.59 18.65 45.27 6.01 18.52 0.40 27.07 22.40 -0.62 25.51 23.42 coo 48.88 4.35 16.59 48.73 5.09 15.20 -0.01 23.09 26.59 1.16 24.05 26.40 coo 53.89 6.25 15.09 52.88 7.92 14.14 -3.30 22.27 23.33 -5.06 21.84 22.10 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 68 ALA A 204 ALA~? 8.46 C8 PG4 B 350 A 72 LEU A 202 LEU~? 12.40 O1 PG4 A 350 coo 46.76 7.59 18.65 45.27 6.01 18.52 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 48.88 4.35 16.59 48.73 5.09 15.20 -5.64 44.18 25.28 -6.10 44.17 26.72 coo 53.89 6.25 15.09 52.88 7.92 14.14 -9.78 48.31 21.89 -10.31 47.66 19.89 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP B 339 ASP~? 20.98 O2 PO4 B 349 A 68 ALA B 338 ALA~? 14.85 O2 PO4 B 349 A 72 LEU B 172 LEU~? 12.69 O2 PO4 B 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 12.36 37.42 -12.59 13.93 36.17 -11.84 coo 48.88 4.35 16.59 48.73 5.09 15.20 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 53.89 6.25 15.09 52.88 7.92 14.14 9.32 37.94 -3.58 8.05 39.24 -4.84 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 9 3 # 9 A 67 ASP B 339 ASP~? 20.98 O2 PO4 B 349 A 68 ALA B 338 ALA~? 14.85 O2 PO4 B 349 A 72 LEU B 341 LEU~? 14.80 O4 PO4 B 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 12.36 37.42 -12.59 13.93 36.17 -11.84 coo 48.88 4.35 16.59 48.73 5.09 15.20 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 53.89 6.25 15.09 52.88 7.92 14.14 6.89 40.99 -8.64 4.77 41.10 -9.21 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 10 3 # 10 A 67 ASP B 343 ASP~? 22.96 O2 PO4 B 349 A 68 ALA B 344 ALA~? 19.16 O4 PO4 B 349 A 72 LEU B 341 LEU~? 14.80 O4 PO4 B 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 12.62 43.49 -12.19 13.89 41.96 -12.92 coo 48.88 4.35 16.59 48.73 5.09 15.20 9.86 46.08 -9.76 8.38 45.76 -9.84 coo 53.89 6.25 15.09 52.88 7.92 14.14 6.89 40.99 -8.64 4.77 41.10 -9.21 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 11 3 # 11 A 67 ASP C 131 ASP^? 9.91 O2 PG4 D 350 A 68 ALA C 114 ALA.? 12.46 O2 PG4 D 350 A 72 LEU C 113 LEU.? 10.04 C3 PG4 D 350 coo 46.76 7.59 18.65 45.27 6.01 18.52 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 48.88 4.35 16.59 48.73 5.09 15.20 -40.63 -2.88 36.08 -39.47 -2.01 36.56 coo 53.89 6.25 15.09 52.88 7.92 14.14 -44.51 -1.43 33.80 -46.42 -0.80 32.96 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 12 3 # 12 A 67 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 68 ALA D 204 ALA~? 8.16 C7 PG4 C 350 A 72 LEU D 202 LEU~? 12.30 O5 PG4 D 350 coo 46.76 7.59 18.65 45.27 6.01 18.52 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 48.88 4.35 16.59 48.73 5.09 15.20 -45.88 12.76 50.82 -46.11 11.67 51.84 coo 53.89 6.25 15.09 52.88 7.92 14.14 -50.27 17.81 51.60 -50.85 18.91 49.81 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 13 3 # 13 A 67 ASP C 339 ASP~? 17.02 O2 PG4 A 350 A 68 ALA C 338 ALA~? 14.81 O2 PO4 C 349 A 72 LEU C 172 LEU~? 12.83 O2 PO4 C 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 -30.42 35.10 18.03 -29.05 33.77 17.12 coo 48.88 4.35 16.59 48.73 5.09 15.20 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 53.89 6.25 15.09 52.88 7.92 14.14 -32.58 29.02 25.18 -33.78 30.85 25.40 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 14 3 # 14 A 67 ASP C 339 ASP~? 17.02 O2 PG4 A 350 A 68 ALA C 338 ALA~? 14.81 O2 PO4 C 349 A 72 LEU C 341 LEU~? 14.78 O1 PO4 C 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 -30.42 35.10 18.03 -29.05 33.77 17.12 coo 48.88 4.35 16.59 48.73 5.09 15.20 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 53.89 6.25 15.09 52.88 7.92 14.14 -35.17 34.77 24.10 -37.28 35.35 24.17 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 15 3 # 15 A 67 ASP C 343 ASP~? 16.17 O1 PG4 A 350 A 68 ALA C 344 ALA~? 19.14 O1 PO4 C 349 A 72 LEU C 341 LEU~? 14.78 O1 PO4 C 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 48.88 4.35 16.59 48.73 5.09 15.20 -31.78 38.95 26.74 -33.30 38.86 26.59 coo 53.89 6.25 15.09 52.88 7.92 14.14 -35.17 34.77 24.10 -37.28 35.35 24.17 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 16 3 # 16 A 67 ASP D 131 ASP^? 9.77 C6 PG4 C 350 A 68 ALA D 114 ALA.? 12.33 O4 PG4 C 350 A 72 LEU D 113 LEU.? 10.17 C6 PG4 C 350 coo 46.76 7.59 18.65 45.27 6.01 18.52 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 48.88 4.35 16.59 48.73 5.09 15.20 -47.38 -1.81 56.23 -48.62 -1.08 55.70 coo 53.89 6.25 15.09 52.88 7.92 14.14 -44.05 0.20 58.87 -42.37 1.14 59.88 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 17 3 # 17 A 67 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 68 ALA C 204 ALA~? 8.41 C1 PG4 D 350 A 72 LEU C 202 LEU~? 12.40 O3 PO4 C 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 48.88 4.35 16.59 48.73 5.09 15.20 -43.72 12.08 40.27 -43.19 10.95 39.41 coo 53.89 6.25 15.09 52.88 7.92 14.14 -40.44 17.70 38.50 -40.10 19.13 40.10 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 18 3 # 18 A 67 ASP D 339 ASP~? 21.27 O1 PO4 D 349 A 68 ALA D 338 ALA~? 15.02 O1 PO4 D 349 A 72 LEU D 172 LEU~? 12.88 O1 PO4 D 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 -63.02 36.35 69.71 -64.42 35.04 70.68 coo 48.88 4.35 16.59 48.73 5.09 15.20 -59.57 33.12 68.34 -59.94 31.78 67.75 coo 53.89 6.25 15.09 52.88 7.92 14.14 -60.04 29.40 63.58 -59.15 31.30 63.00 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 19 3 # 19 A 67 ASP D 339 ASP~? 21.27 O1 PO4 D 349 A 68 ALA D 338 ALA~? 15.02 O1 PO4 D 349 A 72 LEU D 341 LEU~? 14.58 O4 PO4 D 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 -63.02 36.35 69.71 -64.42 35.04 70.68 coo 48.88 4.35 16.59 48.73 5.09 15.20 -59.57 33.12 68.34 -59.94 31.78 67.75 coo 53.89 6.25 15.09 52.88 7.92 14.14 -58.31 35.62 63.80 -56.27 36.38 63.64 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 20 3 # 20 A 67 ASP D 343 ASP~? 23.05 O1 PO4 D 349 A 68 ALA D 344 ALA~? 19.09 O4 PO4 D 349 A 72 LEU D 341 LEU~? 14.58 O4 PO4 D 349 coo 46.76 7.59 18.65 45.27 6.01 18.52 -64.64 38.99 64.31 -65.73 38.68 66.10 coo 48.88 4.35 16.59 48.73 5.09 15.20 -62.25 38.94 60.61 -60.77 39.06 60.76 coo 53.89 6.25 15.09 52.88 7.92 14.14 -58.31 35.62 63.80 -56.27 36.38 63.64 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 20 hits 1q6l_c05 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 224 ASN.? 23.11 O1 PG4 A 350 A 239 ARG A 182 ARG.? 27.04 O1 PO4 A 349 A 246 TYR A 225 TYR.? 21.13 O1 PO4 A 349 coo 2.50 7.27 18.06 0.76 7.28 16.81 -31.46 49.91 23.23 -32.31 47.94 23.27 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -34.46 56.29 23.08 -34.82 53.96 21.09 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -28.82 53.90 23.23 -28.73 53.13 25.91 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN A 224 ASN.? 23.11 O1 PG4 A 350 A 239 ARG A 220 ARG~? 15.84 O1 PG4 A 350 A 246 TYR A 221 TYR~? 17.25 O1 PG4 A 350 coo 2.50 7.27 18.06 0.76 7.28 16.81 -31.46 49.91 23.23 -32.31 47.94 23.27 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -23.72 43.89 25.49 -25.14 44.23 28.23 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -24.98 48.97 24.49 -23.82 47.69 26.70 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 3 3 # 3 A 191 ASN B 224 ASN~? 23.43 O1 PG4 B 350 A 239 ARG B 182 ARG.? 25.41 O2 PO4 B 349 A 246 TYR B 225 TYR~? 21.07 O2 PO4 B 349 coo 2.50 7.27 18.06 0.76 7.28 16.81 22.11 40.26 9.14 23.14 40.57 10.98 coo -1.16 0.95 13.41 -2.50 3.71 13.61 24.54 38.99 2.73 24.16 37.16 5.19 coo 1.59 5.18 12.30 -0.74 6.52 11.61 19.22 39.10 5.74 19.70 36.67 7.05 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 4 3 # 4 A 191 ASN C 224 ASN~? 19.07 C6 PG4 A 350 A 239 ARG C 182 ARG.? 12.42 C6 PG4 A 350 A 246 TYR C 225 TYR~? 18.05 C6 PG4 A 350 coo 2.50 7.27 18.06 0.76 7.28 16.81 -19.05 21.33 34.82 -18.35 20.29 36.53 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -17.19 25.58 29.52 -16.27 25.77 32.47 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -22.42 22.90 31.89 -22.15 20.23 31.17 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 5 3 # 5 A 191 ASN C 224 ASN~? 19.07 C6 PG4 A 350 A 239 ARG C 220 ARG~? 11.31 O1 PG4 C 350 A 246 TYR C 221 TYR~? 17.74 O1 PG4 C 350 coo 2.50 7.27 18.06 0.76 7.28 16.81 -19.05 21.33 34.82 -18.35 20.29 36.53 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -25.78 14.58 38.60 -28.17 14.03 40.55 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -25.26 18.68 35.52 -25.91 16.01 35.07 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 6 3 # 6 A 191 ASN D 224 ASN.? 21.91 O5 PG4 D 350 A 239 ARG D 182 ARG.? 26.89 O1 PO4 D 349 A 246 TYR D 225 TYR.? 21.05 O1 PO4 D 349 coo 2.50 7.27 18.06 0.76 7.28 16.81 -71.47 18.11 55.17 -71.73 16.64 53.65 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -74.46 22.20 60.05 -74.88 21.98 57.01 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -68.84 20.67 57.80 -68.69 18.14 58.96 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 7 3 # 7 A 191 ASN D 224 ASN.? 21.91 O5 PG4 D 350 A 239 ARG D 220 ARG~? 10.23 O5 PG4 D 350 A 246 TYR D 221 TYR~? 17.09 O5 PG4 D 350 coo 2.50 7.27 18.06 0.76 7.28 16.81 -71.47 18.11 55.17 -71.73 16.64 53.65 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -64.10 12.09 51.59 -61.65 11.18 49.96 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -65.63 16.43 54.69 -64.60 13.90 55.16 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 7 hits 1qaz_c00 naa= 3 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 1 3 # 1 A 348 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 378 CYH A 151 CYH.? 21.29 O1 PO4 A 349 A 380 GLY A 222 GLY~? 20.58 O1 PG4 A 350 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -28.58 54.43 14.94 -26.94 52.63 16.24 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -27.23 49.69 18.85 -27.74 49.39 19.29 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 2 3 # 2 A 348 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 378 CYH A 330 CYH^? 15.75 O4 PO4 A 349 A 380 GLY A 302 GLY^? 15.79 O4 PO4 A 349 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -16.13 68.37 12.01 -15.71 67.65 12.00 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 3 3 # 3 A 348 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 378 CYH B 151 CYH.? 20.90 O2 PO4 B 349 A 380 GLY B 222 GLY~? 20.95 O1 PG4 B 350 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 11.38 38.70 0.79 12.71 38.99 -0.80 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 17.77 46.72 3.80 16.28 45.67 5.92 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 17.42 43.97 9.17 18.02 43.67 9.46 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 4 3 # 4 A 348 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 378 CYH B 330 CYH^? 15.61 O4 PO4 B 349 A 380 GLY B 302 GLY^? 15.90 O4 PO4 B 349 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 3.38 45.56 -8.81 3.08 45.63 -8.02 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 5 3 # 5 A 348 HIS C 229 HIS^? 14.09 O2 PO4 C 349 A 378 CYH C 151 CYH.? 19.97 C1 PG4 A 350 A 380 GLY C 222 GLY~? 21.11 O1 PG4 C 350 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -23.43 29.67 36.17 -24.68 27.35 36.97 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -23.73 23.95 37.95 -23.14 23.48 37.89 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 6 3 # 6 A 348 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 378 CYH C 330 CYH^? 15.66 O1 PO4 C 349 A 380 GLY C 302 GLY^? 15.82 O1 PO4 C 349 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -38.20 38.03 27.59 -38.48 37.54 28.20 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 7 3 # 7 A 348 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 378 CYH D 151 CYH.? 21.19 O1 PO4 D 349 A 380 GLY D 222 GLY~? 20.24 O5 PG4 D 350 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -68.87 26.89 52.59 -67.21 24.68 51.99 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -67.82 21.13 51.50 -68.33 20.61 51.68 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 8 3 # 8 A 348 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 378 CYH D 330 CYH^? 15.59 O4 PO4 D 349 A 380 GLY D 302 GLY^? 15.79 O4 PO4 D 349 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -55.83 38.84 59.83 -55.49 38.30 59.29 1qfl_c00 source 1qfl ACETOACETYL-COA THIOLASE : 8 hits 1qfl_c00 naa= 3 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 1 3 # 1 B 348 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 378 CYH A 151 CYH.? 21.29 O1 PO4 A 349 B 380 GLY A 222 GLY~? 20.58 O1 PG4 A 350 coo 13.24 15.55 12.21 14.75 15.10 10.80 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 20.14 17.58 5.68 19.50 18.95 7.99 -28.58 54.43 14.94 -26.94 52.63 16.24 coo 24.06 14.49 10.58 24.24 14.15 9.79 -27.23 49.69 18.85 -27.74 49.39 19.29 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 2 3 # 2 B 348 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 378 CYH A 330 CYH^? 15.75 O4 PO4 A 349 B 380 GLY A 302 GLY^? 15.79 O4 PO4 A 349 coo 13.24 15.55 12.21 14.75 15.10 10.80 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 20.14 17.58 5.68 19.50 18.95 7.99 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 24.06 14.49 10.58 24.24 14.15 9.79 -16.13 68.37 12.01 -15.71 67.65 12.00 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 3 3 # 3 B 348 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 378 CYH B 151 CYH.? 20.90 O2 PO4 B 349 B 380 GLY B 222 GLY~? 20.95 O1 PG4 B 350 coo 13.24 15.55 12.21 14.75 15.10 10.80 11.38 38.70 0.79 12.71 38.99 -0.80 coo 20.14 17.58 5.68 19.50 18.95 7.99 17.77 46.72 3.80 16.28 45.67 5.92 coo 24.06 14.49 10.58 24.24 14.15 9.79 17.42 43.97 9.17 18.02 43.67 9.46 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 4 3 # 4 B 348 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 378 CYH B 330 CYH^? 15.61 O4 PO4 B 349 B 380 GLY B 302 GLY^? 15.90 O4 PO4 B 349 coo 13.24 15.55 12.21 14.75 15.10 10.80 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 20.14 17.58 5.68 19.50 18.95 7.99 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 24.06 14.49 10.58 24.24 14.15 9.79 3.38 45.56 -8.81 3.08 45.63 -8.02 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 5 3 # 5 B 348 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 378 CYH C 151 CYH.? 19.97 C1 PG4 A 350 B 380 GLY C 222 GLY~? 21.11 O1 PG4 C 350 coo 13.24 15.55 12.21 14.75 15.10 10.80 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 20.14 17.58 5.68 19.50 18.95 7.99 -23.43 29.67 36.17 -24.68 27.35 36.97 coo 24.06 14.49 10.58 24.24 14.15 9.79 -23.73 23.95 37.95 -23.14 23.48 37.89 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 6 3 # 6 B 348 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 378 CYH C 330 CYH^? 15.66 O1 PO4 C 349 B 380 GLY C 302 GLY^? 15.82 O1 PO4 C 349 coo 13.24 15.55 12.21 14.75 15.10 10.80 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 20.14 17.58 5.68 19.50 18.95 7.99 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 24.06 14.49 10.58 24.24 14.15 9.79 -38.20 38.03 27.59 -38.48 37.54 28.20 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 7 3 # 7 B 348 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 378 CYH D 151 CYH.? 21.19 O1 PO4 D 349 B 380 GLY D 222 GLY~? 20.24 O5 PG4 D 350 coo 13.24 15.55 12.21 14.75 15.10 10.80 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 20.14 17.58 5.68 19.50 18.95 7.99 -68.87 26.89 52.59 -67.21 24.68 51.99 coo 24.06 14.49 10.58 24.24 14.15 9.79 -67.82 21.13 51.50 -68.33 20.61 51.68 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 8 3 # 8 B 348 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 378 CYH D 330 CYH^? 15.59 O4 PO4 D 349 B 380 GLY D 302 GLY^? 15.79 O4 PO4 D 349 coo 13.24 15.55 12.21 14.75 15.10 10.80 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 20.14 17.58 5.68 19.50 18.95 7.99 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 24.06 14.49 10.58 24.24 14.15 9.79 -55.83 38.84 59.83 -55.49 38.30 59.29 1qfl_c01 source 1qfl ACETOACETYL-COA THIOLASE : 8 hits 1qfl_c01 naa= 3 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 1 3 # 1 C 348 HIS A 229 HIS^? 14.13 O1 PO4 A 349 C 378 CYH A 151 CYH.? 21.29 O1 PO4 A 349 C 380 GLY A 222 GLY~? 20.58 O1 PG4 A 350 coo 39.92 0.27 55.80 38.80 1.56 57.03 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 38.90 7.44 62.34 40.19 7.59 59.85 -28.58 54.43 14.94 -26.94 52.63 16.24 coo 34.29 9.51 57.55 33.93 9.43 58.29 -27.23 49.69 18.85 -27.74 49.39 19.29 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 2 3 # 2 C 348 HIS A 260 HIS^? 11.64 O4 PO4 A 349 C 378 CYH A 330 CYH^? 15.75 O4 PO4 A 349 C 380 GLY A 302 GLY^? 15.79 O4 PO4 A 349 coo 39.92 0.27 55.80 38.80 1.56 57.03 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 38.90 7.44 62.34 40.19 7.59 59.85 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 34.29 9.51 57.55 33.93 9.43 58.29 -16.13 68.37 12.01 -15.71 67.65 12.00 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 3 3 # 3 C 348 HIS A 321 HIS~? 22.96 O4 PO4 A 349 C 378 CYH A 330 CYH^? 15.75 O4 PO4 A 349 C 380 GLY A 327 GLY~? 22.81 O4 PO4 A 349 coo 39.92 0.27 55.80 38.80 1.56 57.03 -5.72 80.36 11.81 -5.04 82.32 12.10 coo 38.90 7.44 62.34 40.19 7.59 59.85 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 34.29 9.51 57.55 33.93 9.43 58.29 -13.96 74.24 5.41 -13.80 73.71 6.02 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 4 3 # 4 C 348 HIS B 229 HIS^? 14.08 O2 PO4 B 349 C 378 CYH B 151 CYH.? 20.90 O2 PO4 B 349 C 380 GLY B 222 GLY~? 20.95 O1 PG4 B 350 coo 39.92 0.27 55.80 38.80 1.56 57.03 11.38 38.70 0.79 12.71 38.99 -0.80 coo 38.90 7.44 62.34 40.19 7.59 59.85 17.77 46.72 3.80 16.28 45.67 5.92 coo 34.29 9.51 57.55 33.93 9.43 58.29 17.42 43.97 9.17 18.02 43.67 9.46 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 5 3 # 5 C 348 HIS B 260 HIS^? 11.70 O4 PO4 B 349 C 378 CYH B 330 CYH^? 15.61 O4 PO4 B 349 C 380 GLY B 302 GLY^? 15.90 O4 PO4 B 349 coo 39.92 0.27 55.80 38.80 1.56 57.03 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 38.90 7.44 62.34 40.19 7.59 59.85 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 34.29 9.51 57.55 33.93 9.43 58.29 3.38 45.56 -8.81 3.08 45.63 -8.02 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 6 3 # 6 C 348 HIS C 229 HIS^? 14.09 O2 PO4 C 349 C 378 CYH C 151 CYH.? 19.97 C1 PG4 A 350 C 380 GLY C 222 GLY~? 21.11 O1 PG4 C 350 coo 39.92 0.27 55.80 38.80 1.56 57.03 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 38.90 7.44 62.34 40.19 7.59 59.85 -23.43 29.67 36.17 -24.68 27.35 36.97 coo 34.29 9.51 57.55 33.93 9.43 58.29 -23.73 23.95 37.95 -23.14 23.48 37.89 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 7 3 # 7 C 348 HIS C 260 HIS^? 11.63 O1 PO4 C 349 C 378 CYH C 330 CYH^? 15.66 O1 PO4 C 349 C 380 GLY C 302 GLY^? 15.82 O1 PO4 C 349 coo 39.92 0.27 55.80 38.80 1.56 57.03 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 38.90 7.44 62.34 40.19 7.59 59.85 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 34.29 9.51 57.55 33.93 9.43 58.29 -38.20 38.03 27.59 -38.48 37.54 28.20 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 8 3 # 8 C 348 HIS D 229 HIS^? 14.18 O1 PO4 D 349 C 378 CYH D 151 CYH.? 21.19 O1 PO4 D 349 C 380 GLY D 222 GLY~? 20.24 O5 PG4 D 350 coo 39.92 0.27 55.80 38.80 1.56 57.03 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 38.90 7.44 62.34 40.19 7.59 59.85 -68.87 26.89 52.59 -67.21 24.68 51.99 coo 34.29 9.51 57.55 33.93 9.43 58.29 -67.82 21.13 51.50 -68.33 20.61 51.68 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 9 3 # 9 C 348 HIS D 260 HIS^? 11.65 O4 PO4 D 349 C 378 CYH D 330 CYH^? 15.59 O4 PO4 D 349 C 380 GLY D 302 GLY^? 15.79 O4 PO4 D 349 coo 39.92 0.27 55.80 38.80 1.56 57.03 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 38.90 7.44 62.34 40.19 7.59 59.85 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 34.29 9.51 57.55 33.93 9.43 58.29 -55.83 38.84 59.83 -55.49 38.30 59.29 1qfl_c02 source 1qfl ACETOACETYL-COA THIOLASE : 9 hits 1qfl_c02 naa= 3 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 1 3 # 1 D 348 HIS A 229 HIS^? 14.13 O1 PO4 A 349 D 378 CYH A 151 CYH.? 21.29 O1 PO4 A 349 D 380 GLY A 222 GLY~? 20.58 O1 PG4 A 350 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -28.58 54.43 14.94 -26.94 52.63 16.24 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -27.23 49.69 18.85 -27.74 49.39 19.29 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 2 3 # 2 D 348 HIS A 260 HIS^? 11.64 O4 PO4 A 349 D 378 CYH A 330 CYH^? 15.75 O4 PO4 A 349 D 380 GLY A 302 GLY^? 15.79 O4 PO4 A 349 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -16.13 68.37 12.01 -15.71 67.65 12.00 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 3 3 # 3 D 348 HIS A 321 HIS~? 22.96 O4 PO4 A 349 D 378 CYH A 330 CYH^? 15.75 O4 PO4 A 349 D 380 GLY A 327 GLY~? 22.81 O4 PO4 A 349 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -5.72 80.36 11.81 -5.04 82.32 12.10 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -14.88 73.36 14.18 -12.11 73.72 14.67 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -13.96 74.24 5.41 -13.80 73.71 6.02 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 4 3 # 4 D 348 HIS B 229 HIS^? 14.08 O2 PO4 B 349 D 378 CYH B 151 CYH.? 20.90 O2 PO4 B 349 D 380 GLY B 222 GLY~? 20.95 O1 PG4 B 350 coo 4.85 0.61 57.13 5.96 -0.63 58.38 11.38 38.70 0.79 12.71 38.99 -0.80 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 17.77 46.72 3.80 16.28 45.67 5.92 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 17.42 43.97 9.17 18.02 43.67 9.46 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 5 3 # 5 D 348 HIS B 260 HIS^? 11.70 O4 PO4 B 349 D 378 CYH B 330 CYH^? 15.61 O4 PO4 B 349 D 380 GLY B 302 GLY^? 15.90 O4 PO4 B 349 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 2.17 41.99 -12.90 -0.49 41.01 -12.76 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 3.38 45.56 -8.81 3.08 45.63 -8.02 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 6 3 # 6 D 348 HIS C 229 HIS^? 14.09 O2 PO4 C 349 D 378 CYH C 151 CYH.? 19.97 C1 PG4 A 350 D 380 GLY C 222 GLY~? 21.11 O1 PG4 C 350 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -23.43 29.67 36.17 -24.68 27.35 36.97 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -23.73 23.95 37.95 -23.14 23.48 37.89 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 7 3 # 7 D 348 HIS C 260 HIS^? 11.63 O1 PO4 C 349 D 378 CYH C 330 CYH^? 15.66 O1 PO4 C 349 D 380 GLY C 302 GLY^? 15.82 O1 PO4 C 349 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -39.83 38.74 22.16 -42.53 38.02 21.91 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -38.20 38.03 27.59 -38.48 37.54 28.20 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 8 3 # 8 D 348 HIS D 229 HIS^? 14.18 O1 PO4 D 349 D 378 CYH D 151 CYH.? 21.19 O1 PO4 D 349 D 380 GLY D 222 GLY~? 20.24 O5 PG4 D 350 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -68.87 26.89 52.59 -67.21 24.68 51.99 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -67.82 21.13 51.50 -68.33 20.61 51.68 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 9 3 # 9 D 348 HIS D 260 HIS^? 11.65 O4 PO4 D 349 D 378 CYH D 330 CYH^? 15.59 O4 PO4 D 349 D 380 GLY D 302 GLY^? 15.79 O4 PO4 D 349 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -54.33 40.49 65.01 -51.55 40.30 65.47 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -55.83 38.84 59.83 -55.49 38.30 59.29 1qfl_c03 source 1qfl ACETOACETYL-COA THIOLASE : 9 hits 1qfl_c03 naa= 3 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 1 3 # 1 A 554 SER A 64 SER~? 26.25 O3 PG4 B 350 A 641 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 680 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 34.48 40.33 79.08 36.40 39.98 80.55 1.46 56.04 50.07 2.12 55.38 52.31 coo 40.64 47.22 77.43 39.90 45.49 78.43 1.74 60.96 43.57 3.36 61.47 42.28 coo 38.53 44.50 81.45 37.60 42.73 80.84 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 2 3 # 2 A 554 SER A 64 SER~? 26.25 O3 PG4 B 350 A 641 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 680 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 34.48 40.33 79.08 36.40 39.98 80.55 1.46 56.04 50.07 2.12 55.38 52.31 coo 40.64 47.22 77.43 39.90 45.49 78.43 8.08 50.44 43.84 7.48 51.26 41.98 coo 38.53 44.50 81.45 37.60 42.73 80.84 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 3 3 # 3 A 554 SER A 241 SER.? 9.98 O3 PO4 A 349 A 641 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 680 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 34.48 40.33 79.08 36.40 39.98 80.55 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 40.64 47.22 77.43 39.90 45.49 78.43 -1.16 62.88 18.52 0.68 62.16 19.33 coo 38.53 44.50 81.45 37.60 42.73 80.84 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 4 3 # 4 A 554 SER B 64 SER~? 26.98 C5 PG4 A 350 A 641 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 680 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 34.48 40.33 79.08 36.40 39.98 80.55 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 40.64 47.22 77.43 39.90 45.49 78.43 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 38.53 44.50 81.45 37.60 42.73 80.84 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 5 3 # 5 A 554 SER B 241 SER.? 10.02 O1 PO4 B 349 A 641 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 680 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 34.48 40.33 79.08 36.40 39.98 80.55 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 40.64 47.22 77.43 39.90 45.49 78.43 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 38.53 44.50 81.45 37.60 42.73 80.84 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 6 3 # 6 A 554 SER C 64 SER~? 25.88 C5 PG4 D 350 A 641 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 680 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 34.48 40.33 79.08 36.40 39.98 80.55 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 40.64 47.22 77.43 39.90 45.49 78.43 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 38.53 44.50 81.45 37.60 42.73 80.84 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 7 3 # 7 A 554 SER C 64 SER~? 25.88 C5 PG4 D 350 A 641 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 680 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 34.48 40.33 79.08 36.40 39.98 80.55 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 40.64 47.22 77.43 39.90 45.49 78.43 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 38.53 44.50 81.45 37.60 42.73 80.84 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 8 3 # 8 A 554 SER C 241 SER.? 9.97 O3 PO4 C 349 A 641 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 680 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 34.48 40.33 79.08 36.40 39.98 80.55 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 40.64 47.22 77.43 39.90 45.49 78.43 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 38.53 44.50 81.45 37.60 42.73 80.84 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 9 3 # 9 A 554 SER D 64 SER~? 27.50 C6 PG4 C 350 A 641 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 680 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 34.48 40.33 79.08 36.40 39.98 80.55 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 40.64 47.22 77.43 39.90 45.49 78.43 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 38.53 44.50 81.45 37.60 42.73 80.84 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 10 3 # 10 A 554 SER D 241 SER.? 10.08 O3 PO4 D 349 A 641 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 680 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 34.48 40.33 79.08 36.40 39.98 80.55 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 40.64 47.22 77.43 39.90 45.49 78.43 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 38.53 44.50 81.45 37.60 42.73 80.84 -38.74 26.41 54.26 -37.48 24.84 54.87 1qfm_c00 source 1qfm PROLYL OLIGOPEPTIDASE : 10 hits 1qfm_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS B 272 HIS.? 20.00 O1 PO4 B 349 A 236 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 261 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 55.45 46.76 42.08 57.34 46.16 42.75 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 48.87 29.19 44.63 49.10 27.34 43.63 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 47.58 17.35 41.83 51.40 20.85 40.83 1.49 32.28 22.12 4.07 30.52 27.68 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS B 272 HIS.? 20.00 O1 PO4 B 349 B 236 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 261 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 1.49 32.28 22.12 4.07 30.52 27.68 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS B 272 HIS.? 20.00 O1 PO4 B 349 C 236 ASP A 208 ASP~? 8.51 C3 PG4 A 350 C 261 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 55.11 47.10 12.61 53.44 47.85 11.58 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 45.78 31.11 9.51 44.25 30.06 10.53 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 37.54 22.37 12.10 37.83 27.55 13.24 1.49 32.28 22.12 4.07 30.52 27.68 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS B 272 HIS.? 20.00 O1 PO4 B 349 D 236 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 261 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 1.49 32.28 22.12 4.07 30.52 27.68 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS B 272 HIS.? 20.00 O1 PO4 B 349 E 236 ASP A 208 ASP~? 8.51 C3 PG4 A 350 E 261 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 1.49 32.28 22.12 4.07 30.52 27.68 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS B 272 HIS.? 20.00 O1 PO4 B 349 F 236 ASP A 208 ASP~? 8.51 C3 PG4 A 350 F 261 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 1.49 32.28 22.12 4.07 30.52 27.68 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS B 272 HIS.? 20.00 O1 PO4 B 349 G 236 ASP A 208 ASP~? 8.51 C3 PG4 A 350 G 261 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 1.49 32.28 22.12 4.07 30.52 27.68 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS B 272 HIS.? 20.00 O1 PO4 B 349 H 236 ASP A 208 ASP~? 8.51 C3 PG4 A 350 H 261 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 1.49 32.28 22.12 4.07 30.52 27.68 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 A 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 A 261 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 55.48 26.51 40.65 55.39 23.99 39.43 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 48.87 29.19 44.63 49.10 27.34 43.63 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 47.58 17.35 41.83 51.40 20.85 40.83 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 B 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 B 261 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 C 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 C 261 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 39.51 34.34 13.63 37.63 32.61 14.79 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 45.78 31.11 9.51 44.25 30.06 10.53 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 37.54 22.37 12.10 37.83 27.55 13.24 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 D 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 D 261 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 E 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 E 261 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 F 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 F 261 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 G 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 G 261 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 H 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 H 261 LYS D 96 LYS~? 18.18 C6 PG4 C 350 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -42.30 -5.81 66.82 -37.97 -8.16 62.87 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 42 ARG~? 19.93 C3 PG4 B 350 C 163 TYR A 91 TYR~? 12.90 C4 PG4 B 350 C 236 ASP A 89 ASP~? 13.93 C4 PG4 B 350 coo 39.01 29.77 22.02 37.48 31.30 19.84 7.49 56.88 46.72 6.71 54.94 44.43 coo 39.51 34.34 13.63 37.63 32.61 14.79 3.23 49.01 40.90 3.18 50.90 38.82 coo 45.78 31.11 9.51 44.25 30.06 10.53 10.16 45.65 42.38 11.05 44.28 40.99 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG C 42 ARG.? 19.15 C5 PG4 D 350 C 163 TYR C 91 TYR~? 12.18 C5 PG4 D 350 C 236 ASP C 89 ASP.? 13.45 C5 PG4 D 350 coo 39.01 29.77 22.02 37.48 31.30 19.84 -57.88 0.79 18.76 -56.46 0.67 21.52 coo 39.51 34.34 13.63 37.63 32.61 14.79 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 45.78 31.11 9.51 44.25 30.06 10.53 -58.19 -3.49 30.72 -58.73 -3.38 32.77 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG D 42 ARG.? 20.81 C4 PG4 C 350 C 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 C 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 coo 39.01 29.77 22.02 37.48 31.30 19.84 -33.94 3.86 75.82 -34.45 4.46 72.82 coo 39.51 34.34 13.63 37.63 32.61 14.79 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 45.78 31.11 9.51 44.25 30.06 10.53 -31.01 0.13 64.24 -30.68 -1.79 63.45 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 42 ARG~? 19.93 C3 PG4 B 350 D 163 TYR A 91 TYR~? 12.90 C4 PG4 B 350 D 236 ASP A 89 ASP~? 13.93 C4 PG4 B 350 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 7.49 56.88 46.72 6.71 54.94 44.43 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 3.23 49.01 40.90 3.18 50.90 38.82 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 10.16 45.65 42.38 11.05 44.28 40.99 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG C 42 ARG.? 19.15 C5 PG4 D 350 D 163 TYR C 91 TYR~? 12.18 C5 PG4 D 350 D 236 ASP C 89 ASP.? 13.45 C5 PG4 D 350 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -57.88 0.79 18.76 -56.46 0.67 21.52 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -58.19 -3.49 30.72 -58.73 -3.38 32.77 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG D 42 ARG.? 20.81 C4 PG4 C 350 D 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 D 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -33.94 3.86 75.82 -34.45 4.46 72.82 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -31.01 0.13 64.24 -30.68 -1.79 63.45 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 91 TYR~? 12.90 C4 PG4 B 350 A 236 ASP A 89 ASP~? 13.93 C4 PG4 B 350 C 110 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 55.48 26.51 40.65 55.39 23.99 39.43 3.23 49.01 40.90 3.18 50.90 38.82 coo 48.87 29.19 44.63 49.10 27.34 43.63 10.16 45.65 42.38 11.05 44.28 40.99 coo 52.39 23.42 32.10 54.51 23.27 34.29 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR C 91 TYR~? 12.18 C5 PG4 D 350 A 236 ASP C 89 ASP.? 13.45 C5 PG4 D 350 C 110 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 55.48 26.51 40.65 55.39 23.99 39.43 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 48.87 29.19 44.63 49.10 27.34 43.63 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 52.39 23.42 32.10 54.51 23.27 34.29 -57.88 0.79 18.76 -56.46 0.67 21.52 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 A 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 C 110 ARG D 42 ARG.? 20.81 C4 PG4 C 350 coo 55.48 26.51 40.65 55.39 23.99 39.43 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 48.87 29.19 44.63 49.10 27.34 43.63 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 52.39 23.42 32.10 54.51 23.27 34.29 -33.94 3.86 75.82 -34.45 4.46 72.82 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 91 TYR~? 12.90 C4 PG4 B 350 B 236 ASP A 89 ASP~? 13.93 C4 PG4 B 350 D 110 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 3.23 49.01 40.90 3.18 50.90 38.82 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 10.16 45.65 42.38 11.05 44.28 40.99 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR C 91 TYR~? 12.18 C5 PG4 D 350 B 236 ASP C 89 ASP.? 13.45 C5 PG4 D 350 D 110 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -57.88 0.79 18.76 -56.46 0.67 21.52 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 B 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 D 110 ARG D 42 ARG.? 20.81 C4 PG4 C 350 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -33.94 3.86 75.82 -34.45 4.46 72.82 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 42 ARG~? 19.93 C3 PG4 B 350 G 163 TYR A 91 TYR~? 12.90 C4 PG4 B 350 G 236 ASP A 89 ASP~? 13.93 C4 PG4 B 350 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 7.49 56.88 46.72 6.71 54.94 44.43 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 3.23 49.01 40.90 3.18 50.90 38.82 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 10.16 45.65 42.38 11.05 44.28 40.99 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG C 42 ARG.? 19.15 C5 PG4 D 350 G 163 TYR C 91 TYR~? 12.18 C5 PG4 D 350 G 236 ASP C 89 ASP.? 13.45 C5 PG4 D 350 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -57.88 0.79 18.76 -56.46 0.67 21.52 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -58.19 -3.49 30.72 -58.73 -3.38 32.77 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG D 42 ARG.? 20.81 C4 PG4 C 350 G 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 G 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -33.94 3.86 75.82 -34.45 4.46 72.82 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -31.01 0.13 64.24 -30.68 -1.79 63.45 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 42 ARG~? 19.93 C3 PG4 B 350 H 163 TYR A 91 TYR~? 12.90 C4 PG4 B 350 H 236 ASP A 89 ASP~? 13.93 C4 PG4 B 350 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 7.49 56.88 46.72 6.71 54.94 44.43 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 3.23 49.01 40.90 3.18 50.90 38.82 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 10.16 45.65 42.38 11.05 44.28 40.99 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG C 42 ARG.? 19.15 C5 PG4 D 350 H 163 TYR C 91 TYR~? 12.18 C5 PG4 D 350 H 236 ASP C 89 ASP.? 13.45 C5 PG4 D 350 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -57.88 0.79 18.76 -56.46 0.67 21.52 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -58.19 -3.49 30.72 -58.73 -3.38 32.77 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG D 42 ARG.? 20.81 C4 PG4 C 350 H 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 H 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -33.94 3.86 75.82 -34.45 4.46 72.82 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -31.01 0.13 64.24 -30.68 -1.79 63.45 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 91 TYR~? 12.90 C4 PG4 B 350 E 236 ASP A 89 ASP~? 13.93 C4 PG4 B 350 G 110 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 3.23 49.01 40.90 3.18 50.90 38.82 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 10.16 45.65 42.38 11.05 44.28 40.99 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR C 91 TYR~? 12.18 C5 PG4 D 350 E 236 ASP C 89 ASP.? 13.45 C5 PG4 D 350 G 110 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -57.88 0.79 18.76 -56.46 0.67 21.52 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 E 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 G 110 ARG D 42 ARG.? 20.81 C4 PG4 C 350 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -33.94 3.86 75.82 -34.45 4.46 72.82 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 91 TYR~? 12.90 C4 PG4 B 350 F 236 ASP A 89 ASP~? 13.93 C4 PG4 B 350 H 110 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 3.23 49.01 40.90 3.18 50.90 38.82 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 10.16 45.65 42.38 11.05 44.28 40.99 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR C 91 TYR~? 12.18 C5 PG4 D 350 F 236 ASP C 89 ASP.? 13.45 C5 PG4 D 350 H 110 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -58.19 -3.49 30.72 -58.73 -3.38 32.77 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -57.88 0.79 18.76 -56.46 0.67 21.52 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR D 91 TYR~? 13.46 C4 PG4 C 350 F 236 ASP D 89 ASP.? 16.35 C5 PG4 C 350 H 110 ARG D 42 ARG.? 20.81 C4 PG4 C 350 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -33.94 3.86 75.82 -34.45 4.46 72.82 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 131 ASP^? 9.75 C6 PG4 B 350 A 147 THR A 111 THR.? -3.96 C5 PG4 B 350s A 294 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -0.72 42.17 33.63 1.22 41.72 34.46 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 131 ASP^? 9.75 C6 PG4 B 350 A 147 THR A 111 THR.? -3.96 C5 PG4 B 350s A 294 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -0.72 42.17 33.63 1.22 41.72 34.46 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 147 THR A 242 THR.? 14.16 O1 PG4 B 350 A 294 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -3.11 49.78 15.72 -2.58 47.68 15.65 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 147 THR A 242 THR.? 14.16 O1 PG4 B 350 A 294 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -3.11 49.78 15.72 -2.58 47.68 15.65 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 5 3 # 5 A 49 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 147 THR B 242 THR.? 14.01 C2 PG4 A 350 A 294 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 6 3 # 6 A 49 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 147 THR B 242 THR.? 14.01 C2 PG4 A 350 A 294 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 7 3 # 7 A 49 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 147 THR B 242 THR.? 14.01 C2 PG4 A 350 A 294 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 8 3 # 8 A 49 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 147 THR A 307 THR.? 14.46 O2 PO4 A 349 A 294 ASP A 311 ASP~? 22.72 O2 PO4 A 349 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.91 74.69 22.42 -8.63 75.73 21.66 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -4.84 83.29 26.02 -4.08 84.26 24.26 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 9 3 # 9 A 49 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 147 THR B 111 THR.? -3.92 C5 PG4 A 350s A 294 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 0.40 27.07 22.40 -0.62 25.51 23.42 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.89 27.93 21.89 -8.77 26.98 22.40 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 10 3 # 10 A 49 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 147 THR B 111 THR.? -3.92 C5 PG4 A 350s A 294 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 0.40 27.07 22.40 -0.62 25.51 23.42 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.89 27.93 21.89 -8.77 26.98 22.40 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 11 3 # 11 A 49 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 147 THR B 242 THR.? 14.01 C2 PG4 A 350 A 294 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 12 3 # 12 A 49 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 147 THR B 242 THR.? 14.01 C2 PG4 A 350 A 294 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 13 3 # 13 A 49 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 147 THR B 242 THR.? 14.01 C2 PG4 A 350 A 294 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 14 3 # 14 A 49 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 147 THR A 242 THR.? 14.16 O1 PG4 B 350 A 294 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -3.11 49.78 15.72 -2.58 47.68 15.65 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 15 3 # 15 A 49 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 147 THR A 242 THR.? 14.16 O1 PG4 B 350 A 294 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -3.11 49.78 15.72 -2.58 47.68 15.65 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 16 3 # 16 A 49 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 147 THR B 307 THR.? 14.53 O3 PO4 B 349 A 294 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -4.70 32.82 -11.47 -3.25 33.55 -12.93 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 17 3 # 17 A 49 ASP C 131 ASP^? 9.91 O2 PG4 D 350 A 147 THR C 111 THR.? -3.86 C3 PG4 D 350s A 294 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -47.70 3.36 37.51 -49.56 2.24 37.49 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 18 3 # 18 A 49 ASP C 131 ASP^? 9.91 O2 PG4 D 350 A 147 THR C 111 THR.? -3.86 C3 PG4 D 350s A 294 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -47.70 3.36 37.51 -49.56 2.24 37.49 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 19 3 # 19 A 49 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 147 THR C 242 THR.? 14.00 O5 PG4 D 350 A 294 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -47.88 22.66 41.54 -48.06 21.40 43.36 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 20 3 # 20 A 49 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 147 THR C 242 THR.? 14.00 O5 PG4 D 350 A 294 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -47.88 22.66 41.54 -48.06 21.40 43.36 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 21 3 # 21 A 49 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 147 THR C 242 THR.? 14.00 O5 PG4 D 350 A 294 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -47.88 22.66 41.54 -48.06 21.40 43.36 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 22 3 # 22 A 49 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 147 THR D 242 THR.? 14.33 O2 PG4 C 350 A 294 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -43.74 23.47 47.95 -43.28 22.17 46.24 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 23 3 # 23 A 49 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 147 THR D 242 THR.? 14.33 O2 PG4 C 350 A 294 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -43.74 23.47 47.95 -43.28 22.17 46.24 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 24 3 # 24 A 49 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 147 THR D 242 THR.? 14.33 O2 PG4 C 350 A 294 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -43.74 23.47 47.95 -43.28 22.17 46.24 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 25 3 # 25 A 49 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 147 THR C 307 THR.? 14.50 O4 PO4 C 349 A 294 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -47.35 31.27 17.04 -45.92 32.81 16.45 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 26 3 # 26 A 49 ASP D 131 ASP^? 9.77 C6 PG4 C 350 A 147 THR D 111 THR.? 4.22 C6 PG4 C 350 A 294 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -40.95 5.28 55.14 -39.04 4.37 55.56 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 27 3 # 27 A 49 ASP D 131 ASP^? 9.77 C6 PG4 C 350 A 147 THR D 111 THR.? 4.22 C6 PG4 C 350 A 294 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -40.95 5.28 55.14 -39.04 4.37 55.56 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 28 3 # 28 A 49 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 147 THR D 242 THR.? 14.33 O2 PG4 C 350 A 294 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -43.74 23.47 47.95 -43.28 22.17 46.24 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 29 3 # 29 A 49 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 147 THR D 242 THR.? 14.33 O2 PG4 C 350 A 294 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -43.74 23.47 47.95 -43.28 22.17 46.24 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -41.09 30.11 59.34 -39.33 28.92 59.24 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 30 3 # 30 A 49 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 147 THR D 242 THR.? 14.33 O2 PG4 C 350 A 294 ASP D 208 ASP~? 8.41 C6 PG4 D 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -43.74 23.47 47.95 -43.28 22.17 46.24 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -48.63 14.68 39.02 -49.06 15.01 36.96 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 31 3 # 31 A 49 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 147 THR C 242 THR.? 14.00 O5 PG4 D 350 A 294 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -47.88 22.66 41.54 -48.06 21.40 43.36 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 32 3 # 32 A 49 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 147 THR C 242 THR.? 14.00 O5 PG4 D 350 A 294 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -47.88 22.66 41.54 -48.06 21.40 43.36 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 33 3 # 33 A 49 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 147 THR D 307 THR.? 14.52 O2 PO4 D 349 A 294 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -45.94 35.31 71.02 -47.61 36.72 71.34 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -43.35 38.70 79.64 -42.93 40.74 79.14 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 33 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 256 GLU A 15 GLU.? 17.86 C3 PG4 B 350 A 329 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 1.74 60.96 43.57 3.36 61.47 42.28 coo 30.54 71.65 32.58 31.73 72.26 30.92 7.25 58.10 39.87 8.59 56.71 39.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 311 ASP~? 22.72 O2 PO4 A 349 A 256 GLU A 312 GLU~? 22.67 O2 PO4 A 349 A 329 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.84 83.29 26.02 -4.08 84.26 24.26 coo 30.54 71.65 32.58 31.73 72.26 30.92 -11.55 82.77 24.82 -13.13 83.67 25.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 311 ASP~? 22.86 O3 PO4 B 349 A 256 GLU B 312 GLU~? 22.88 O3 PO4 B 349 A 329 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 30.54 71.65 32.58 31.73 72.26 30.92 -0.30 29.09 -19.54 1.27 27.97 -20.48 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 256 GLU C 15 GLU.? 17.45 C5 PG4 D 350 A 329 ASP C 90 ASP~? 15.56 C5 PG4 D 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 30.54 71.65 32.58 31.73 72.26 30.92 -57.75 5.96 21.41 -58.79 5.43 23.18 coo 37.87 70.12 31.80 36.61 69.74 30.15 -56.94 -1.99 25.63 -56.96 0.10 25.89 ULMN 3 1qho_c04 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP C 311 ASP~? 22.87 O4 PO4 C 349 A 256 GLU C 312 GLU~? 22.95 O4 PO4 C 349 A 329 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 28.46 69.88 26.74 30.40 70.70 26.53 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 30.54 71.65 32.58 31.73 72.26 30.92 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1qho_c04 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 256 GLU D 15 GLU.? 19.32 C4 PG4 C 350 A 329 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 30.54 71.65 32.58 31.73 72.26 30.92 -33.73 9.80 72.63 -32.07 9.73 71.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 -33.15 1.70 68.90 -33.50 3.76 68.48 ULMN 3 1qho_c04 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP D 311 ASP~? 22.85 O2 PO4 D 349 A 256 GLU D 312 GLU~? 22.27 O2 PO4 D 349 A 329 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.35 38.70 79.64 -42.93 40.74 79.14 coo 30.54 71.65 32.58 31.73 72.26 30.92 -50.13 39.19 79.01 -51.63 38.45 80.28 coo 37.87 70.12 31.80 36.61 69.74 30.15 -51.05 35.32 70.59 -50.24 33.36 70.95 1qho_c04 source 1qho ALPHA-AMYLASE : 7 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 140 ASP.? 7.37 O2 PG4 A 350 A 261 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 329 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 34.02 79.89 42.60 34.73 78.01 41.86 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 140 ASP.? 7.37 O2 PG4 A 350 A 261 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 329 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 34.02 79.89 42.60 34.73 78.01 41.86 0.40 27.07 22.40 -0.62 25.51 23.42 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 140 ASP.? 7.37 O2 PG4 A 350 A 261 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 329 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 34.02 79.89 42.60 34.73 78.01 41.86 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 140 ASP.? 7.37 O2 PG4 A 350 A 261 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 329 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 34.02 79.89 42.60 34.73 78.01 41.86 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 140 ASP.? 7.99 O2 PG4 B 350 A 261 ASP A 131 ASP^? 9.75 C6 PG4 B 350 A 329 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 8.40 47.76 23.89 8.35 49.33 25.35 coo 34.02 79.89 42.60 34.73 78.01 41.86 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 140 ASP.? 7.99 O2 PG4 B 350 A 261 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 329 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 8.40 47.76 23.89 8.35 49.33 25.35 coo 34.02 79.89 42.60 34.73 78.01 41.86 -1.16 62.88 18.52 0.68 62.16 19.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 140 ASP.? 7.99 O2 PG4 B 350 A 261 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 329 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 8.40 47.76 23.89 8.35 49.33 25.35 coo 34.02 79.89 42.60 34.73 78.01 41.86 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 140 ASP.? 7.99 O2 PG4 B 350 A 261 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 329 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 8.40 47.76 23.89 8.35 49.33 25.35 coo 34.02 79.89 42.60 34.73 78.01 41.86 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP C 140 ASP.? 7.74 C2 PG4 C 350 A 261 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 329 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 34.02 79.89 42.60 34.73 78.01 41.86 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1qho_c05 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP C 140 ASP.? 7.74 C2 PG4 C 350 A 261 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 329 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 34.02 79.89 42.60 34.73 78.01 41.86 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 1qho_c05 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP C 140 ASP.? 7.74 C2 PG4 C 350 A 261 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 329 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 34.02 79.89 42.60 34.73 78.01 41.86 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 37.87 70.12 31.80 36.61 69.74 30.15 -41.61 16.40 51.56 -41.24 17.22 53.47 1qho_c05 source 1qho ALPHA-AMYLASE : 11 hits 1qho_c05 naa= 3 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 64 SER~? 26.25 O3 PG4 B 350 A 207 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 235 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 15.54 46.73 17.13 17.06 48.44 16.17 1.46 56.04 50.07 2.12 55.38 52.31 coo 23.60 50.31 20.82 21.66 50.51 20.06 1.74 60.96 43.57 3.36 61.47 42.28 coo 20.17 51.16 17.08 18.31 50.28 17.44 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER A 64 SER~? 26.25 O3 PG4 B 350 A 207 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 235 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 15.54 46.73 17.13 17.06 48.44 16.17 1.46 56.04 50.07 2.12 55.38 52.31 coo 23.60 50.31 20.82 21.66 50.51 20.06 8.08 50.44 43.84 7.48 51.26 41.98 coo 20.17 51.16 17.08 18.31 50.28 17.44 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER A 241 SER.? 9.98 O3 PO4 A 349 A 207 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 235 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 15.54 46.73 17.13 17.06 48.44 16.17 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 23.60 50.31 20.82 21.66 50.51 20.06 -1.16 62.88 18.52 0.68 62.16 19.33 coo 20.17 51.16 17.08 18.31 50.28 17.44 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 4 3 # 4 A 80 SER B 64 SER~? 26.98 C5 PG4 A 350 A 207 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 235 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 15.54 46.73 17.13 17.06 48.44 16.17 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 23.60 50.31 20.82 21.66 50.51 20.06 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 20.17 51.16 17.08 18.31 50.28 17.44 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 5 3 # 5 A 80 SER B 241 SER.? 10.02 O1 PO4 B 349 A 207 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 235 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 15.54 46.73 17.13 17.06 48.44 16.17 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 23.60 50.31 20.82 21.66 50.51 20.06 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 20.17 51.16 17.08 18.31 50.28 17.44 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 6 3 # 6 A 80 SER C 64 SER~? 25.88 C5 PG4 D 350 A 207 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 235 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 15.54 46.73 17.13 17.06 48.44 16.17 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 23.60 50.31 20.82 21.66 50.51 20.06 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 20.17 51.16 17.08 18.31 50.28 17.44 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 7 3 # 7 A 80 SER C 241 SER.? 9.97 O3 PO4 C 349 A 207 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 235 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 15.54 46.73 17.13 17.06 48.44 16.17 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 23.60 50.31 20.82 21.66 50.51 20.06 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 20.17 51.16 17.08 18.31 50.28 17.44 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 8 3 # 8 A 80 SER D 64 SER~? 27.50 C6 PG4 C 350 A 207 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 235 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 15.54 46.73 17.13 17.06 48.44 16.17 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 23.60 50.31 20.82 21.66 50.51 20.06 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 20.17 51.16 17.08 18.31 50.28 17.44 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 9 3 # 9 A 80 SER D 241 SER.? 10.08 O3 PO4 D 349 A 207 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 235 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 15.54 46.73 17.13 17.06 48.44 16.17 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 23.60 50.31 20.82 21.66 50.51 20.06 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 20.17 51.16 17.08 18.31 50.28 17.44 -38.74 26.41 54.26 -37.48 24.84 54.87 1qj4_c00 source 1qj4 HYDROXYNITRILE LYASE : 9 hits 1qj4_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA B 308 ALA.? 11.34 O3 PO4 B 349 B 148 HIS B 309 HIS.? 14.09 O3 PO4 B 349 B 163 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -4.57 29.17 -10.27 -4.28 28.71 -8.84 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA C 308 ALA.? 11.16 O4 PO4 C 349 B 148 HIS C 309 HIS.? 14.15 O4 PO4 C 349 B 163 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -47.63 27.77 15.40 -47.50 26.46 16.16 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -52.33 29.51 16.61 -52.04 31.11 17.93 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA D 308 ALA.? 11.28 O2 PO4 D 349 B 148 HIS D 309 HIS.? 14.00 O2 PO4 D 349 B 163 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -45.31 32.26 73.28 -45.38 30.82 72.81 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -40.87 34.22 71.66 -41.37 35.58 70.15 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -43.35 38.70 79.64 -42.93 40.74 79.14 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c01 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 262 ALA.? 14.15 O4 PO4 A 349 H 148 HIS A 260 HIS^? 11.64 O4 PO4 A 349 H 163 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -3.81 73.23 18.07 -4.57 74.45 18.58 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -1.16 62.88 18.52 0.68 62.16 19.33 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c07 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 646 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 741 SER B 64 SER~? 26.98 C5 PG4 A 350 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 741 SER A 143 SER.? 14.48 C2 PG4 A 350 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -18.44 40.75 9.72 -20.35 39.92 10.87 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 741 SER B 235 SER.? 9.35 O4 PO4 B 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -6.73 42.81 4.19 -8.03 43.03 2.17 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 741 SER C 64 SER~? 25.88 C5 PG4 D 350 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1qrz_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 646 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 741 SER D 64 SER~? 27.50 C6 PG4 C 350 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1qrz_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 741 SER C 143 SER.? 14.49 C2 PG4 C 350 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -31.83 24.72 51.20 -29.72 23.61 51.01 ULMN 3 1qrz_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 741 SER D 235 SER.? 9.32 O4 PO4 D 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -44.15 28.59 53.58 -43.17 30.60 54.60 1qrz_c12 source 1qrz PLASMINOGEN : 7 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 741 SER A 64 SER~? 26.25 O3 PG4 B 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 3.61 55.89 43.73 3.10 55.52 45.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 8.08 50.44 43.84 7.48 51.26 41.98 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 646 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 741 SER B 64 SER~? 26.98 C5 PG4 A 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 741 SER B 235 SER.? 9.35 O4 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -6.73 42.81 4.19 -8.03 43.03 2.17 ULMN 3 1qrz_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 741 SER C 64 SER~? 25.88 C5 PG4 D 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1qrz_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 646 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 741 SER D 64 SER~? 27.50 C6 PG4 C 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -40.29 0.73 76.87 -39.79 -1.23 78.23 1qrz_c13 source 1qrz PLASMINOGEN : 5 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 C 741 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 3.61 55.89 43.73 3.10 55.52 45.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 8.08 50.44 43.84 7.48 51.26 41.98 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 646 ASP B 90 ASP~? 17.21 C5 PG4 A 350 C 741 SER B 64 SER~? 26.98 C5 PG4 A 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 C 741 SER A 143 SER.? 14.48 C2 PG4 A 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -18.44 40.75 9.72 -20.35 39.92 10.87 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 C 741 SER B 235 SER.? 9.35 O4 PO4 B 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -6.73 42.81 4.19 -8.03 43.03 2.17 ULMN 3 1qrz_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 C 741 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1qrz_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS D 14 HIS.? 21.26 C4 PG4 C 350 C 646 ASP D 90 ASP~? 17.03 C4 PG4 C 350 C 741 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1qrz_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 C 741 SER C 143 SER.? 14.49 C2 PG4 C 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -31.83 24.72 51.20 -29.72 23.61 51.01 ULMN 3 1qrz_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 C 741 SER D 235 SER.? 9.32 O4 PO4 D 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -44.15 28.59 53.58 -43.17 30.60 54.60 1qrz_c14 source 1qrz PLASMINOGEN : 8 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 D 741 SER A 64 SER~? 26.25 O3 PG4 B 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 3.61 55.89 43.73 3.10 55.52 45.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 8.08 50.44 43.84 7.48 51.26 41.98 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS B 14 HIS.? 21.30 C5 PG4 A 350 D 646 ASP B 90 ASP~? 17.21 C5 PG4 A 350 D 741 SER B 64 SER~? 26.98 C5 PG4 A 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 741 SER A 143 SER.? 14.48 C2 PG4 A 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -18.44 40.75 9.72 -20.35 39.92 10.87 ULMN 3 1qrz_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 238 HIS.? 10.82 O1 PO4 B 349 D 646 ASP A 208 ASP~? 8.51 C3 PG4 A 350 D 741 SER B 235 SER.? 9.35 O4 PO4 B 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -6.73 42.81 4.19 -8.03 43.03 2.17 ULMN 3 1qrz_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 D 741 SER C 64 SER~? 25.88 C5 PG4 D 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1qrz_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS D 14 HIS.? 21.26 C4 PG4 C 350 D 646 ASP D 90 ASP~? 17.03 C4 PG4 C 350 D 741 SER D 64 SER~? 27.50 C6 PG4 C 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1qrz_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 741 SER C 143 SER.? 14.49 C2 PG4 C 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -31.83 24.72 51.20 -29.72 23.61 51.01 ULMN 3 1qrz_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 D 646 ASP C 208 ASP~? 8.73 O2 PG4 C 350 D 741 SER D 235 SER.? 9.32 O4 PO4 D 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -44.15 28.59 53.58 -43.17 30.60 54.60 1qrz_c15 source 1qrz PLASMINOGEN : 8 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 646 ASP A 131 ASP^? 9.75 C6 PG4 B 350 A 739 GLY A 192 GLY~? 8.82 O1 PO4 A 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -8.03 41.96 35.37 -6.75 41.25 36.93 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -13.34 54.92 29.80 -13.05 54.30 30.24 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 646 ASP B 140 ASP.? 7.99 O2 PG4 B 350 A 739 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -18.83 7.68 26.86 -20.89 7.78 26.56 8.40 47.76 23.89 8.35 49.33 25.35 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 646 ASP B 140 ASP.? 7.99 O2 PG4 B 350 A 739 GLY A 234 GLY.? 7.10 O3 PO4 A 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -18.83 7.68 26.86 -20.89 7.78 26.56 8.40 47.76 23.89 8.35 49.33 25.35 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -4.72 55.63 18.83 -5.29 56.17 18.78 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY A 302 GLY^? 15.79 O4 PO4 A 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -1.16 62.88 18.52 0.68 62.16 19.33 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -16.13 68.37 12.01 -15.71 67.65 12.00 ULMN 3 1qrz_c20 PLASMINOGEN user 5 3 # 5 A 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 646 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 739 GLY A 232 GLY.? 6.13 O1 PO4 A 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -12.09 74.10 21.91 -11.23 73.05 23.55 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -11.48 56.85 19.86 -11.43 56.72 20.67 ULMN 3 1qrz_c20 PLASMINOGEN user 6 3 # 6 A 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 646 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 739 GLY A 327 GLY~? 22.81 O4 PO4 A 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -12.09 74.10 21.91 -11.23 73.05 23.55 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -13.96 74.24 5.41 -13.80 73.71 6.02 ULMN 3 1qrz_c20 PLASMINOGEN user 7 3 # 7 A 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo -20.72 2.99 34.37 -21.94 1.82 35.61 6.94 67.18 14.08 7.86 68.38 12.63 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -1.16 62.88 18.52 0.68 62.16 19.33 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1qrz_c20 PLASMINOGEN user 8 3 # 8 A 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 A 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 739 GLY B 296 GLY.? 24.39 O4 PO4 A 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 6.94 67.18 14.08 7.86 68.38 12.63 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -1.16 62.88 18.52 0.68 62.16 19.33 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 7.61 58.29 3.60 6.91 57.85 3.79 ULMN 3 1qrz_c20 PLASMINOGEN user 9 3 # 9 A 603 HIS A 309 HIS.? 13.93 O2 PO4 A 349 A 646 ASP A 311 ASP~? 22.72 O2 PO4 A 349 A 739 GLY A 54 GLY~? 16.02 O2 PO4 A 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -1.71 74.54 24.02 -2.03 74.32 21.96 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -4.84 83.29 26.02 -4.08 84.26 24.26 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -4.86 72.57 36.81 -5.02 71.91 37.27 ULMN 3 1qrz_c20 PLASMINOGEN user 10 3 # 10 A 603 HIS A 309 HIS.? 13.93 O2 PO4 A 349 A 646 ASP A 332 ASP~? 12.07 O2 PO4 A 349 A 739 GLY A 54 GLY~? 16.02 O2 PO4 A 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -1.71 74.54 24.02 -2.03 74.32 21.96 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -12.09 74.10 21.91 -11.23 73.05 23.55 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -4.86 72.57 36.81 -5.02 71.91 37.27 ULMN 3 1qrz_c20 PLASMINOGEN user 11 3 # 11 A 603 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 646 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 739 GLY B 25 GLY~? 12.55 O3 PO4 B 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -1.91 21.39 6.65 -1.94 22.01 6.12 ULMN 3 1qrz_c20 PLASMINOGEN user 12 3 # 12 A 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 646 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 739 GLY B 192 GLY~? 8.75 O2 PO4 B 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -18.83 7.68 26.86 -20.89 7.78 26.56 0.40 27.07 22.40 -0.62 25.51 23.42 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 4.63 30.70 8.46 4.46 30.28 9.17 ULMN 3 1qrz_c20 PLASMINOGEN user 13 3 # 13 A 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY B 302 GLY^? 15.90 O4 PO4 B 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 3.38 45.56 -8.81 3.08 45.63 -8.02 ULMN 3 1qrz_c20 PLASMINOGEN user 14 3 # 14 A 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 646 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 739 GLY B 232 GLY.? 6.11 O2 PO4 B 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -18.83 7.68 26.86 -20.89 7.78 26.56 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 1.39 39.60 4.72 1.45 38.82 4.98 ULMN 3 1qrz_c20 PLASMINOGEN user 15 3 # 15 A 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 646 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 739 GLY B 327 GLY~? 22.81 O4 PO4 B 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -18.83 7.68 26.86 -20.89 7.78 26.56 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -0.28 50.53 -15.18 -0.27 49.97 -14.57 ULMN 3 1qrz_c20 PLASMINOGEN user 16 3 # 16 A 603 HIS B 266 HIS.? 18.54 O4 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1qrz_c20 PLASMINOGEN user 17 3 # 17 A 603 HIS B 266 HIS.? 18.54 O4 PO4 B 349 A 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 739 GLY A 296 GLY.? 24.68 O4 PO4 B 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -19.90 53.09 2.71 -19.14 53.04 3.04 ULMN 3 1qrz_c20 PLASMINOGEN user 18 3 # 18 A 603 HIS B 309 HIS.? 14.09 O3 PO4 B 349 A 646 ASP B 311 ASP~? 22.86 O3 PO4 B 349 A 739 GLY B 54 GLY~? 16.02 O3 PO4 B 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.04 19.25 -6.91 -1.76 19.09 -6.14 ULMN 3 1qrz_c20 PLASMINOGEN user 19 3 # 19 A 603 HIS B 309 HIS.? 14.09 O3 PO4 B 349 A 646 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 739 GLY B 54 GLY~? 16.02 O3 PO4 B 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -2.04 19.25 -6.91 -1.76 19.09 -6.14 ULMN 3 1qrz_c20 PLASMINOGEN user 20 3 # 20 A 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 739 GLY C 25 GLY~? 12.45 O4 PO4 C 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -45.25 10.31 21.73 -45.31 11.13 21.82 ULMN 3 1qrz_c20 PLASMINOGEN user 21 3 # 21 A 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 739 GLY C 108 GLY.? 11.29 O3 PG4 D 350 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -43.60 7.14 31.15 -44.12 6.54 31.35 ULMN 3 1qrz_c20 PLASMINOGEN user 22 3 # 22 A 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 646 ASP C 131 ASP^? 9.91 O2 PG4 D 350 A 739 GLY C 192 GLY~? 8.67 O2 PO4 C 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -40.29 2.77 35.99 -41.53 1.06 35.77 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.38 15.60 28.56 -37.54 14.80 28.74 ULMN 3 1qrz_c20 PLASMINOGEN user 23 3 # 23 A 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY C 302 GLY^? 15.82 O1 PO4 C 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -38.20 38.03 27.59 -38.48 37.54 28.20 ULMN 3 1qrz_c20 PLASMINOGEN user 24 3 # 24 A 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 646 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 739 GLY C 232 GLY.? 6.26 O2 PO4 C 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -42.20 32.39 17.40 -42.88 30.35 17.40 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -40.24 24.30 32.80 -40.26 23.59 32.39 ULMN 3 1qrz_c20 PLASMINOGEN user 25 3 # 25 A 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 646 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 739 GLY C 327 GLY~? 22.90 O1 PO4 C 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -42.20 32.39 17.40 -42.88 30.35 17.40 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -41.66 46.37 26.74 -41.71 45.54 26.84 ULMN 3 1qrz_c20 PLASMINOGEN user 26 3 # 26 A 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -60.48 31.92 28.90 -61.75 33.58 29.06 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1qrz_c20 PLASMINOGEN user 27 3 # 27 A 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 A 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 739 GLY D 296 GLY.? 24.56 O1 PO4 C 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -60.48 31.92 28.90 -61.75 33.58 29.06 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -60.88 35.38 42.47 -60.11 35.04 42.67 ULMN 3 1qrz_c20 PLASMINOGEN user 28 3 # 28 A 603 HIS C 309 HIS.? 14.15 O4 PO4 C 349 A 646 ASP C 311 ASP~? 22.87 O4 PO4 C 349 A 739 GLY C 54 GLY~? 15.97 O4 PO4 C 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -52.33 29.51 16.61 -52.04 31.11 17.93 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -50.03 32.79 8.00 -51.02 34.70 8.05 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -48.31 18.40 10.87 -47.94 17.71 11.21 ULMN 3 1qrz_c20 PLASMINOGEN user 29 3 # 29 A 603 HIS C 309 HIS.? 14.15 O4 PO4 C 349 A 646 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 739 GLY C 54 GLY~? 15.97 O4 PO4 C 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -52.33 29.51 16.61 -52.04 31.11 17.93 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -42.20 32.39 17.40 -42.88 30.35 17.40 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -48.31 18.40 10.87 -47.94 17.71 11.21 ULMN 3 1qrz_c20 PLASMINOGEN user 30 3 # 30 A 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 646 ASP D 131 ASP^? 9.77 C6 PG4 C 350 A 739 GLY D 192 GLY~? 8.57 O1 PO4 D 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -48.29 3.79 55.93 -46.95 2.25 56.44 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -52.91 16.56 61.94 -52.62 15.79 61.81 ULMN 3 1qrz_c20 PLASMINOGEN user 31 3 # 31 A 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY D 302 GLY^? 15.79 O4 PO4 D 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -55.83 38.84 59.83 -55.49 38.30 59.29 ULMN 3 1qrz_c20 PLASMINOGEN user 32 3 # 32 A 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 646 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 739 GLY D 232 GLY.? 6.31 O1 PO4 D 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -51.05 35.32 70.59 -50.24 33.36 70.95 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -51.56 25.17 56.57 -51.51 24.50 57.04 ULMN 3 1qrz_c20 PLASMINOGEN user 33 3 # 33 A 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 646 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 739 GLY D 327 GLY~? 22.67 O4 PO4 D 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -51.05 35.32 70.59 -50.24 33.36 70.95 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -53.52 47.46 59.28 -53.40 46.64 59.37 ULMN 3 1qrz_c20 PLASMINOGEN user 34 3 # 34 A 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -32.64 35.78 59.13 -31.61 37.59 58.96 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1qrz_c20 PLASMINOGEN user 35 3 # 35 A 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 A 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 739 GLY C 296 GLY.? 24.74 O4 PO4 D 349 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -32.64 35.78 59.13 -31.61 37.59 58.96 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -32.91 37.54 44.99 -33.65 37.14 44.90 1qrz_c20 source 1qrz PLASMINOGEN : 35 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 739 GLY A 25 GLY~? 12.48 O2 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 3.61 55.89 43.73 3.10 55.52 45.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 8.08 50.44 43.84 7.48 51.26 41.98 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -5.57 58.65 37.18 -5.59 59.05 36.47 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 739 GLY A 108 GLY.? 11.36 O3 PG4 B 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 3.61 55.89 43.73 3.10 55.52 45.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 8.08 50.44 43.84 7.48 51.26 41.98 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -5.80 48.81 34.39 -5.17 48.42 34.72 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 646 ASP A 131 ASP^? 9.75 C6 PG4 B 350 B 739 GLY A 192 GLY~? 8.82 O1 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -8.03 41.96 35.37 -6.75 41.25 36.93 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -13.34 54.92 29.80 -13.05 54.30 30.24 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 739 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 739 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1qrz_c21 PLASMINOGEN user 6 3 # 6 B 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY A 302 GLY^? 15.79 O4 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -1.16 62.88 18.52 0.68 62.16 19.33 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -16.13 68.37 12.01 -15.71 67.65 12.00 ULMN 3 1qrz_c21 PLASMINOGEN user 7 3 # 7 B 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -1.16 62.88 18.52 0.68 62.16 19.33 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1qrz_c21 PLASMINOGEN user 8 3 # 8 B 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -1.16 62.88 18.52 0.68 62.16 19.33 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1qrz_c21 PLASMINOGEN user 9 3 # 9 B 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 6.94 67.18 14.08 7.86 68.38 12.63 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -1.16 62.88 18.52 0.68 62.16 19.33 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1qrz_c21 PLASMINOGEN user 10 3 # 10 B 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 6.94 67.18 14.08 7.86 68.38 12.63 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -1.16 62.88 18.52 0.68 62.16 19.33 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1qrz_c21 PLASMINOGEN user 11 3 # 11 B 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 B 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 739 GLY B 296 GLY.? 24.39 O4 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 6.94 67.18 14.08 7.86 68.38 12.63 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -1.16 62.88 18.52 0.68 62.16 19.33 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 7.61 58.29 3.60 6.91 57.85 3.79 ULMN 3 1qrz_c21 PLASMINOGEN user 12 3 # 12 B 603 HIS A 309 HIS.? 13.93 O2 PO4 A 349 B 646 ASP A 311 ASP~? 22.72 O2 PO4 A 349 B 739 GLY A 54 GLY~? 16.02 O2 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -1.71 74.54 24.02 -2.03 74.32 21.96 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -4.84 83.29 26.02 -4.08 84.26 24.26 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -4.86 72.57 36.81 -5.02 71.91 37.27 ULMN 3 1qrz_c21 PLASMINOGEN user 13 3 # 13 B 603 HIS A 309 HIS.? 13.93 O2 PO4 A 349 B 646 ASP A 332 ASP~? 12.07 O2 PO4 A 349 B 739 GLY A 54 GLY~? 16.02 O2 PO4 A 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -1.71 74.54 24.02 -2.03 74.32 21.96 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -12.09 74.10 21.91 -11.23 73.05 23.55 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -4.86 72.57 36.81 -5.02 71.91 37.27 ULMN 3 1qrz_c21 PLASMINOGEN user 14 3 # 14 B 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 646 ASP B 131 ASP^? 9.09 C8 PG4 A 350 B 739 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 0.40 27.07 22.40 -0.62 25.51 23.42 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1qrz_c21 PLASMINOGEN user 15 3 # 15 B 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 646 ASP B 131 ASP^? 9.09 C8 PG4 A 350 B 739 GLY B 192 GLY~? 8.75 O2 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 0.40 27.07 22.40 -0.62 25.51 23.42 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 4.63 30.70 8.46 4.46 30.28 9.17 ULMN 3 1qrz_c21 PLASMINOGEN user 16 3 # 16 B 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 646 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 739 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1qrz_c21 PLASMINOGEN user 17 3 # 17 B 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 646 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 739 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1qrz_c21 PLASMINOGEN user 18 3 # 18 B 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1qrz_c21 PLASMINOGEN user 19 3 # 19 B 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 293 GLY.? 20.64 O4 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -15.25 51.43 -1.86 -14.91 51.02 -1.25 ULMN 3 1qrz_c21 PLASMINOGEN user 20 3 # 20 B 603 HIS B 266 HIS.? 18.54 O4 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1qrz_c21 PLASMINOGEN user 21 3 # 21 B 603 HIS B 266 HIS.? 18.54 O4 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1qrz_c21 PLASMINOGEN user 22 3 # 22 B 603 HIS B 266 HIS.? 18.54 O4 PO4 B 349 B 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 739 GLY A 296 GLY.? 24.68 O4 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -19.90 53.09 2.71 -19.14 53.04 3.04 ULMN 3 1qrz_c21 PLASMINOGEN user 23 3 # 23 B 603 HIS B 309 HIS.? 14.09 O3 PO4 B 349 B 646 ASP B 311 ASP~? 22.86 O3 PO4 B 349 B 739 GLY B 54 GLY~? 16.02 O3 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -2.04 19.25 -6.91 -1.76 19.09 -6.14 ULMN 3 1qrz_c21 PLASMINOGEN user 24 3 # 24 B 603 HIS B 309 HIS.? 14.09 O3 PO4 B 349 B 646 ASP B 332 ASP~? 12.13 O3 PO4 B 349 B 739 GLY B 54 GLY~? 16.02 O3 PO4 B 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -2.04 19.25 -6.91 -1.76 19.09 -6.14 ULMN 3 1qrz_c21 PLASMINOGEN user 25 3 # 25 B 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 739 GLY C 25 GLY~? 12.45 O4 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -45.25 10.31 21.73 -45.31 11.13 21.82 ULMN 3 1qrz_c21 PLASMINOGEN user 26 3 # 26 B 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 739 GLY C 108 GLY.? 11.29 O3 PG4 D 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -43.60 7.14 31.15 -44.12 6.54 31.35 ULMN 3 1qrz_c21 PLASMINOGEN user 27 3 # 27 B 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 646 ASP C 131 ASP^? 9.91 O2 PG4 D 350 B 739 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.29 2.77 35.99 -41.53 1.06 35.77 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1qrz_c21 PLASMINOGEN user 28 3 # 28 B 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 646 ASP C 131 ASP^? 9.91 O2 PG4 D 350 B 739 GLY C 192 GLY~? 8.67 O2 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.29 2.77 35.99 -41.53 1.06 35.77 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.38 15.60 28.56 -37.54 14.80 28.74 ULMN 3 1qrz_c21 PLASMINOGEN user 29 3 # 29 B 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 739 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1qrz_c21 PLASMINOGEN user 30 3 # 30 B 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 739 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1qrz_c21 PLASMINOGEN user 31 3 # 31 B 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -52.52 37.57 39.17 -53.18 37.10 39.11 ULMN 3 1qrz_c21 PLASMINOGEN user 32 3 # 32 B 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1qrz_c21 PLASMINOGEN user 33 3 # 33 B 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -60.48 31.92 28.90 -61.75 33.58 29.06 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1qrz_c21 PLASMINOGEN user 34 3 # 34 B 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -60.48 31.92 28.90 -61.75 33.58 29.06 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -52.52 37.57 39.17 -53.18 37.10 39.11 ULMN 3 1qrz_c21 PLASMINOGEN user 35 3 # 35 B 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -60.48 31.92 28.90 -61.75 33.58 29.06 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1qrz_c21 PLASMINOGEN user 36 3 # 36 B 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 B 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 739 GLY D 296 GLY.? 24.56 O1 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -60.48 31.92 28.90 -61.75 33.58 29.06 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -60.88 35.38 42.47 -60.11 35.04 42.67 ULMN 3 1qrz_c21 PLASMINOGEN user 37 3 # 37 B 603 HIS C 309 HIS.? 14.15 O4 PO4 C 349 B 646 ASP C 311 ASP~? 22.87 O4 PO4 C 349 B 739 GLY C 54 GLY~? 15.97 O4 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -52.33 29.51 16.61 -52.04 31.11 17.93 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -50.03 32.79 8.00 -51.02 34.70 8.05 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -48.31 18.40 10.87 -47.94 17.71 11.21 ULMN 3 1qrz_c21 PLASMINOGEN user 38 3 # 38 B 603 HIS C 309 HIS.? 14.15 O4 PO4 C 349 B 646 ASP C 332 ASP~? 12.18 O4 PO4 C 349 B 739 GLY C 54 GLY~? 15.97 O4 PO4 C 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -52.33 29.51 16.61 -52.04 31.11 17.93 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -42.20 32.39 17.40 -42.88 30.35 17.40 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -48.31 18.40 10.87 -47.94 17.71 11.21 ULMN 3 1qrz_c21 PLASMINOGEN user 39 3 # 39 B 603 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 646 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 739 GLY D 108 GLY.? 11.50 C6 PG4 C 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -46.34 8.93 60.42 -45.67 8.48 60.39 ULMN 3 1qrz_c21 PLASMINOGEN user 40 3 # 40 B 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 646 ASP D 131 ASP^? 9.77 C6 PG4 C 350 B 739 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -48.29 3.79 55.93 -46.95 2.25 56.44 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1qrz_c21 PLASMINOGEN user 41 3 # 41 B 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 646 ASP D 131 ASP^? 9.77 C6 PG4 C 350 B 739 GLY D 192 GLY~? 8.57 O1 PO4 D 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -48.29 3.79 55.93 -46.95 2.25 56.44 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -52.91 16.56 61.94 -52.62 15.79 61.81 ULMN 3 1qrz_c21 PLASMINOGEN user 42 3 # 42 B 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 646 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 739 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1qrz_c21 PLASMINOGEN user 43 3 # 43 B 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1qrz_c21 PLASMINOGEN user 44 3 # 44 B 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1qrz_c21 PLASMINOGEN user 45 3 # 45 B 603 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY D 189 GLY~? 8.43 O1 PO4 D 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -49.90 16.88 57.52 -50.61 16.53 57.79 ULMN 3 1qrz_c21 PLASMINOGEN user 46 3 # 46 B 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1qrz_c21 PLASMINOGEN user 47 3 # 47 B 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1qrz_c21 PLASMINOGEN user 48 3 # 48 B 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -32.64 35.78 59.13 -31.61 37.59 58.96 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1qrz_c21 PLASMINOGEN user 49 3 # 49 B 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -32.64 35.78 59.13 -31.61 37.59 58.96 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1qrz_c21 PLASMINOGEN user 50 3 # 50 B 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 B 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -32.64 35.78 59.13 -31.61 37.59 58.96 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.76 39.68 49.36 -37.98 38.91 49.39 1qrz_c21 source 1qrz PLASMINOGEN : 50 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 C 739 GLY A 25 GLY~? 12.48 O2 PO4 A 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 3.61 55.89 43.73 3.10 55.52 45.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 8.08 50.44 43.84 7.48 51.26 41.98 coo 7.82 1.25 3.03 7.30 1.31 3.65 -5.57 58.65 37.18 -5.59 59.05 36.47 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 C 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 C 739 GLY A 108 GLY.? 11.36 O3 PG4 B 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 3.61 55.89 43.73 3.10 55.52 45.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 8.08 50.44 43.84 7.48 51.26 41.98 coo 7.82 1.25 3.03 7.30 1.31 3.65 -5.80 48.81 34.39 -5.17 48.42 34.72 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 646 ASP A 131 ASP^? 9.75 C6 PG4 B 350 C 739 GLY A 192 GLY~? 8.82 O1 PO4 A 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -8.03 41.96 35.37 -6.75 41.25 36.93 coo 7.82 1.25 3.03 7.30 1.31 3.65 -13.34 54.92 29.80 -13.05 54.30 30.24 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 C 739 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 7.82 1.25 3.03 7.30 1.31 3.65 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1qrz_c22 PLASMINOGEN user 5 3 # 5 C 603 HIS A 110 HIS.? 5.77 C3 PG4 B 350 C 646 ASP A 203 ASP~? 10.68 C3 PG4 B 350 C 739 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 7.82 1.25 3.03 7.30 1.31 3.65 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1qrz_c22 PLASMINOGEN user 6 3 # 6 C 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 C 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 739 GLY A 302 GLY^? 15.79 O4 PO4 A 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -1.16 62.88 18.52 0.68 62.16 19.33 coo 7.82 1.25 3.03 7.30 1.31 3.65 -16.13 68.37 12.01 -15.71 67.65 12.00 ULMN 3 1qrz_c22 PLASMINOGEN user 7 3 # 7 C 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 C 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -1.16 62.88 18.52 0.68 62.16 19.33 coo 7.82 1.25 3.03 7.30 1.31 3.65 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1qrz_c22 PLASMINOGEN user 8 3 # 8 C 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 C 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 739 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 6.94 67.18 14.08 7.86 68.38 12.63 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -1.16 62.88 18.52 0.68 62.16 19.33 coo 7.82 1.25 3.03 7.30 1.31 3.65 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1qrz_c22 PLASMINOGEN user 9 3 # 9 C 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 C 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 6.94 67.18 14.08 7.86 68.38 12.63 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -1.16 62.88 18.52 0.68 62.16 19.33 coo 7.82 1.25 3.03 7.30 1.31 3.65 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1qrz_c22 PLASMINOGEN user 10 3 # 10 C 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 C 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 739 GLY B 296 GLY.? 24.39 O4 PO4 A 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 6.94 67.18 14.08 7.86 68.38 12.63 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -1.16 62.88 18.52 0.68 62.16 19.33 coo 7.82 1.25 3.03 7.30 1.31 3.65 7.61 58.29 3.60 6.91 57.85 3.79 ULMN 3 1qrz_c22 PLASMINOGEN user 11 3 # 11 C 603 HIS A 309 HIS.? 13.93 O2 PO4 A 349 C 646 ASP A 311 ASP~? 22.72 O2 PO4 A 349 C 739 GLY A 54 GLY~? 16.02 O2 PO4 A 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -4.84 83.29 26.02 -4.08 84.26 24.26 coo 7.82 1.25 3.03 7.30 1.31 3.65 -4.86 72.57 36.81 -5.02 71.91 37.27 ULMN 3 1qrz_c22 PLASMINOGEN user 12 3 # 12 C 603 HIS A 309 HIS.? 13.93 O2 PO4 A 349 C 646 ASP A 332 ASP~? 12.07 O2 PO4 A 349 C 739 GLY A 54 GLY~? 16.02 O2 PO4 A 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 7.82 1.25 3.03 7.30 1.31 3.65 -4.86 72.57 36.81 -5.02 71.91 37.27 ULMN 3 1qrz_c22 PLASMINOGEN user 13 3 # 13 C 603 HIS B 14 HIS.? 21.30 C5 PG4 A 350 C 646 ASP B 90 ASP~? 17.21 C5 PG4 A 350 C 739 GLY B 25 GLY~? 12.55 O3 PO4 B 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 7.82 1.25 3.03 7.30 1.31 3.65 -1.91 21.39 6.65 -1.94 22.01 6.12 ULMN 3 1qrz_c22 PLASMINOGEN user 14 3 # 14 C 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 646 ASP B 131 ASP^? 9.09 C8 PG4 A 350 C 739 GLY B 192 GLY~? 8.75 O2 PO4 B 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 0.40 27.07 22.40 -0.62 25.51 23.42 coo 7.82 1.25 3.03 7.30 1.31 3.65 4.63 30.70 8.46 4.46 30.28 9.17 ULMN 3 1qrz_c22 PLASMINOGEN user 15 3 # 15 C 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 C 646 ASP B 203 ASP~? 9.89 C4 PG4 A 350 C 739 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 7.82 1.25 3.03 7.30 1.31 3.65 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1qrz_c22 PLASMINOGEN user 16 3 # 16 C 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 C 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 739 GLY B 302 GLY^? 15.90 O4 PO4 B 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 7.82 1.25 3.03 7.30 1.31 3.65 3.38 45.56 -8.81 3.08 45.63 -8.02 ULMN 3 1qrz_c22 PLASMINOGEN user 17 3 # 17 C 603 HIS B 266 HIS.? 18.54 O4 PO4 B 349 C 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 739 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 7.82 1.25 3.03 7.30 1.31 3.65 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1qrz_c22 PLASMINOGEN user 18 3 # 18 C 603 HIS B 266 HIS.? 18.54 O4 PO4 B 349 C 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 739 GLY A 296 GLY.? 24.68 O4 PO4 B 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 7.82 1.25 3.03 7.30 1.31 3.65 -19.90 53.09 2.71 -19.14 53.04 3.04 ULMN 3 1qrz_c22 PLASMINOGEN user 19 3 # 19 C 603 HIS B 309 HIS.? 14.09 O3 PO4 B 349 C 646 ASP B 311 ASP~? 22.86 O3 PO4 B 349 C 739 GLY B 54 GLY~? 16.02 O3 PO4 B 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 7.82 1.25 3.03 7.30 1.31 3.65 -2.04 19.25 -6.91 -1.76 19.09 -6.14 ULMN 3 1qrz_c22 PLASMINOGEN user 20 3 # 20 C 603 HIS B 309 HIS.? 14.09 O3 PO4 B 349 C 646 ASP B 332 ASP~? 12.13 O3 PO4 B 349 C 739 GLY B 54 GLY~? 16.02 O3 PO4 B 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 7.82 1.25 3.03 7.30 1.31 3.65 -2.04 19.25 -6.91 -1.76 19.09 -6.14 ULMN 3 1qrz_c22 PLASMINOGEN user 21 3 # 21 C 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 C 739 GLY C 25 GLY~? 12.45 O4 PO4 C 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 7.82 1.25 3.03 7.30 1.31 3.65 -45.25 10.31 21.73 -45.31 11.13 21.82 ULMN 3 1qrz_c22 PLASMINOGEN user 22 3 # 22 C 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 C 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 C 739 GLY C 108 GLY.? 11.29 O3 PG4 D 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 7.82 1.25 3.03 7.30 1.31 3.65 -43.60 7.14 31.15 -44.12 6.54 31.35 ULMN 3 1qrz_c22 PLASMINOGEN user 23 3 # 23 C 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 646 ASP C 131 ASP^? 9.91 O2 PG4 D 350 C 739 GLY C 192 GLY~? 8.67 O2 PO4 C 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -40.29 2.77 35.99 -41.53 1.06 35.77 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.38 15.60 28.56 -37.54 14.80 28.74 ULMN 3 1qrz_c22 PLASMINOGEN user 24 3 # 24 C 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 C 739 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 7.82 1.25 3.03 7.30 1.31 3.65 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1qrz_c22 PLASMINOGEN user 25 3 # 25 C 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 C 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 C 739 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 7.82 1.25 3.03 7.30 1.31 3.65 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1qrz_c22 PLASMINOGEN user 26 3 # 26 C 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 C 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 739 GLY C 302 GLY^? 15.82 O1 PO4 C 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.82 1.25 3.03 7.30 1.31 3.65 -38.20 38.03 27.59 -38.48 37.54 28.20 ULMN 3 1qrz_c22 PLASMINOGEN user 27 3 # 27 C 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 C 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.82 1.25 3.03 7.30 1.31 3.65 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1qrz_c22 PLASMINOGEN user 28 3 # 28 C 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 C 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 739 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -60.48 31.92 28.90 -61.75 33.58 29.06 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.82 1.25 3.03 7.30 1.31 3.65 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1qrz_c22 PLASMINOGEN user 29 3 # 29 C 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 C 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -60.48 31.92 28.90 -61.75 33.58 29.06 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.82 1.25 3.03 7.30 1.31 3.65 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1qrz_c22 PLASMINOGEN user 30 3 # 30 C 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 C 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 739 GLY D 296 GLY.? 24.56 O1 PO4 C 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -60.48 31.92 28.90 -61.75 33.58 29.06 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.82 1.25 3.03 7.30 1.31 3.65 -60.88 35.38 42.47 -60.11 35.04 42.67 ULMN 3 1qrz_c22 PLASMINOGEN user 31 3 # 31 C 603 HIS C 309 HIS.? 14.15 O4 PO4 C 349 C 646 ASP C 311 ASP~? 22.87 O4 PO4 C 349 C 739 GLY C 54 GLY~? 15.97 O4 PO4 C 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 7.82 1.25 3.03 7.30 1.31 3.65 -48.31 18.40 10.87 -47.94 17.71 11.21 ULMN 3 1qrz_c22 PLASMINOGEN user 32 3 # 32 C 603 HIS C 309 HIS.? 14.15 O4 PO4 C 349 C 646 ASP C 332 ASP~? 12.18 O4 PO4 C 349 C 739 GLY C 54 GLY~? 15.97 O4 PO4 C 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 7.82 1.25 3.03 7.30 1.31 3.65 -48.31 18.40 10.87 -47.94 17.71 11.21 ULMN 3 1qrz_c22 PLASMINOGEN user 33 3 # 33 C 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 646 ASP D 131 ASP^? 9.77 C6 PG4 C 350 C 739 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 7.82 1.25 3.03 7.30 1.31 3.65 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1qrz_c22 PLASMINOGEN user 34 3 # 34 C 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 646 ASP D 131 ASP^? 9.77 C6 PG4 C 350 C 739 GLY D 192 GLY~? 8.57 O1 PO4 D 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -48.29 3.79 55.93 -46.95 2.25 56.44 coo 7.82 1.25 3.03 7.30 1.31 3.65 -52.91 16.56 61.94 -52.62 15.79 61.81 ULMN 3 1qrz_c22 PLASMINOGEN user 35 3 # 35 C 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 C 646 ASP D 203 ASP~? 10.40 O3 PG4 C 350 C 739 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 7.82 1.25 3.03 7.30 1.31 3.65 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1qrz_c22 PLASMINOGEN user 36 3 # 36 C 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1qrz_c22 PLASMINOGEN user 37 3 # 37 C 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY D 302 GLY^? 15.79 O4 PO4 D 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 7.82 1.25 3.03 7.30 1.31 3.65 -55.83 38.84 59.83 -55.49 38.30 59.29 ULMN 3 1qrz_c22 PLASMINOGEN user 38 3 # 38 C 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -32.64 35.78 59.13 -31.61 37.59 58.96 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 7.82 1.25 3.03 7.30 1.31 3.65 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1qrz_c22 PLASMINOGEN user 39 3 # 39 C 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -32.64 35.78 59.13 -31.61 37.59 58.96 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1qrz_c22 PLASMINOGEN user 40 3 # 40 C 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 C 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 739 GLY C 296 GLY.? 24.74 O4 PO4 D 349 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -32.64 35.78 59.13 -31.61 37.59 58.96 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 7.82 1.25 3.03 7.30 1.31 3.65 -32.91 37.54 44.99 -33.65 37.14 44.90 1qrz_c22 source 1qrz PLASMINOGEN : 40 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 D 739 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 3.61 55.89 43.73 3.10 55.52 45.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 8.08 50.44 43.84 7.48 51.26 41.98 coo -45.82 1.31 41.67 -46.38 1.39 42.31 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 D 739 GLY A 25 GLY~? 12.48 O2 PO4 A 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 3.61 55.89 43.73 3.10 55.52 45.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 8.08 50.44 43.84 7.48 51.26 41.98 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -5.57 58.65 37.18 -5.59 59.05 36.47 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS A 14 HIS.? 20.33 C3 PG4 B 350 D 646 ASP A 90 ASP~? 15.98 C4 PG4 B 350 D 739 GLY A 108 GLY.? 11.36 O3 PG4 B 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 3.61 55.89 43.73 3.10 55.52 45.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 8.08 50.44 43.84 7.48 51.26 41.98 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -5.80 48.81 34.39 -5.17 48.42 34.72 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY A 302 GLY^? 15.79 O4 PO4 A 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -1.16 62.88 18.52 0.68 62.16 19.33 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -16.13 68.37 12.01 -15.71 67.65 12.00 ULMN 3 1qrz_c23 PLASMINOGEN user 5 3 # 5 D 603 HIS A 260 HIS^? 11.64 O4 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -4.97 68.88 15.23 -3.05 69.59 14.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -1.16 62.88 18.52 0.68 62.16 19.33 coo -45.82 1.31 41.67 -46.38 1.39 42.31 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1qrz_c23 PLASMINOGEN user 6 3 # 6 D 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 6.94 67.18 14.08 7.86 68.38 12.63 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -1.16 62.88 18.52 0.68 62.16 19.33 coo -45.82 1.31 41.67 -46.38 1.39 42.31 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1qrz_c23 PLASMINOGEN user 7 3 # 7 D 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 6.94 67.18 14.08 7.86 68.38 12.63 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -1.16 62.88 18.52 0.68 62.16 19.33 coo -45.82 1.31 41.67 -46.38 1.39 42.31 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1qrz_c23 PLASMINOGEN user 8 3 # 8 D 603 HIS A 266 HIS.? 18.54 O4 PO4 A 349 D 646 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 739 GLY B 296 GLY.? 24.39 O4 PO4 A 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 6.94 67.18 14.08 7.86 68.38 12.63 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -1.16 62.88 18.52 0.68 62.16 19.33 coo -45.82 1.31 41.67 -46.38 1.39 42.31 7.61 58.29 3.60 6.91 57.85 3.79 ULMN 3 1qrz_c23 PLASMINOGEN user 9 3 # 9 D 603 HIS A 309 HIS.? 13.93 O2 PO4 A 349 D 646 ASP A 311 ASP~? 22.72 O2 PO4 A 349 D 739 GLY A 54 GLY~? 16.02 O2 PO4 A 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -1.71 74.54 24.02 -2.03 74.32 21.96 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -4.84 83.29 26.02 -4.08 84.26 24.26 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -4.86 72.57 36.81 -5.02 71.91 37.27 ULMN 3 1qrz_c23 PLASMINOGEN user 10 3 # 10 D 603 HIS A 309 HIS.? 13.93 O2 PO4 A 349 D 646 ASP A 332 ASP~? 12.07 O2 PO4 A 349 D 739 GLY A 54 GLY~? 16.02 O2 PO4 A 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -1.71 74.54 24.02 -2.03 74.32 21.96 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -12.09 74.10 21.91 -11.23 73.05 23.55 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -4.86 72.57 36.81 -5.02 71.91 37.27 ULMN 3 1qrz_c23 PLASMINOGEN user 11 3 # 11 D 603 HIS B 14 HIS.? 21.30 C5 PG4 A 350 D 646 ASP B 90 ASP~? 17.21 C5 PG4 A 350 D 739 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1qrz_c23 PLASMINOGEN user 12 3 # 12 D 603 HIS B 14 HIS.? 21.30 C5 PG4 A 350 D 646 ASP B 90 ASP~? 17.21 C5 PG4 A 350 D 739 GLY B 25 GLY~? 12.55 O3 PO4 B 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -1.91 21.39 6.65 -1.94 22.01 6.12 ULMN 3 1qrz_c23 PLASMINOGEN user 13 3 # 13 D 603 HIS B 110 HIS.? 5.25 C4 PG4 A 350 D 646 ASP B 131 ASP^? 9.09 C8 PG4 A 350 D 739 GLY B 192 GLY~? 8.75 O2 PO4 B 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 0.40 27.07 22.40 -0.62 25.51 23.42 coo -45.82 1.31 41.67 -46.38 1.39 42.31 4.63 30.70 8.46 4.46 30.28 9.17 ULMN 3 1qrz_c23 PLASMINOGEN user 14 3 # 14 D 603 HIS B 260 HIS^? 11.70 O4 PO4 B 349 D 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 739 GLY B 302 GLY^? 15.90 O4 PO4 B 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -45.82 1.31 41.67 -46.38 1.39 42.31 3.38 45.56 -8.81 3.08 45.63 -8.02 ULMN 3 1qrz_c23 PLASMINOGEN user 15 3 # 15 D 603 HIS B 266 HIS.? 18.54 O4 PO4 B 349 D 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 739 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1qrz_c23 PLASMINOGEN user 16 3 # 16 D 603 HIS B 266 HIS.? 18.54 O4 PO4 B 349 D 646 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 739 GLY A 296 GLY.? 24.68 O4 PO4 B 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -18.71 40.64 -3.93 -20.02 41.58 -5.29 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -19.90 53.09 2.71 -19.14 53.04 3.04 ULMN 3 1qrz_c23 PLASMINOGEN user 17 3 # 17 D 603 HIS B 309 HIS.? 14.09 O3 PO4 B 349 D 646 ASP B 311 ASP~? 22.86 O3 PO4 B 349 D 739 GLY B 54 GLY~? 16.02 O3 PO4 B 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -2.04 19.25 -6.91 -1.76 19.09 -6.14 ULMN 3 1qrz_c23 PLASMINOGEN user 18 3 # 18 D 603 HIS B 309 HIS.? 14.09 O3 PO4 B 349 D 646 ASP B 332 ASP~? 12.13 O3 PO4 B 349 D 739 GLY B 54 GLY~? 16.02 O3 PO4 B 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -2.04 19.25 -6.91 -1.76 19.09 -6.14 ULMN 3 1qrz_c23 PLASMINOGEN user 19 3 # 19 D 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 D 739 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1qrz_c23 PLASMINOGEN user 20 3 # 20 D 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 D 739 GLY C 25 GLY~? 12.45 O4 PO4 C 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -45.25 10.31 21.73 -45.31 11.13 21.82 ULMN 3 1qrz_c23 PLASMINOGEN user 21 3 # 21 D 603 HIS C 14 HIS.? 19.64 C5 PG4 D 350 D 646 ASP C 90 ASP~? 15.56 C5 PG4 D 350 D 739 GLY C 108 GLY.? 11.29 O3 PG4 D 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -43.60 7.14 31.15 -44.12 6.54 31.35 ULMN 3 1qrz_c23 PLASMINOGEN user 22 3 # 22 D 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 D 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 D 739 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1qrz_c23 PLASMINOGEN user 23 3 # 23 D 603 HIS C 110 HIS.? 5.63 C6 PG4 D 350 D 646 ASP C 203 ASP~? 10.24 C6 PG4 D 350 D 739 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1qrz_c23 PLASMINOGEN user 24 3 # 24 D 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY C 302 GLY^? 15.82 O1 PO4 C 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -38.20 38.03 27.59 -38.48 37.54 28.20 ULMN 3 1qrz_c23 PLASMINOGEN user 25 3 # 25 D 603 HIS C 260 HIS^? 11.63 O1 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -48.83 33.87 26.09 -50.85 34.38 25.82 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1qrz_c23 PLASMINOGEN user 26 3 # 26 D 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -60.48 31.92 28.90 -61.75 33.58 29.06 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1qrz_c23 PLASMINOGEN user 27 3 # 27 D 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -60.48 31.92 28.90 -61.75 33.58 29.06 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1qrz_c23 PLASMINOGEN user 28 3 # 28 D 603 HIS C 266 HIS.? 18.53 O1 PO4 C 349 D 646 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 739 GLY D 296 GLY.? 24.56 O1 PO4 C 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -60.48 31.92 28.90 -61.75 33.58 29.06 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -60.88 35.38 42.47 -60.11 35.04 42.67 ULMN 3 1qrz_c23 PLASMINOGEN user 29 3 # 29 D 603 HIS C 309 HIS.? 14.15 O4 PO4 C 349 D 646 ASP C 311 ASP~? 22.87 O4 PO4 C 349 D 739 GLY C 54 GLY~? 15.97 O4 PO4 C 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -52.33 29.51 16.61 -52.04 31.11 17.93 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -50.03 32.79 8.00 -51.02 34.70 8.05 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -48.31 18.40 10.87 -47.94 17.71 11.21 ULMN 3 1qrz_c23 PLASMINOGEN user 30 3 # 30 D 603 HIS C 309 HIS.? 14.15 O4 PO4 C 349 D 646 ASP C 332 ASP~? 12.18 O4 PO4 C 349 D 739 GLY C 54 GLY~? 15.97 O4 PO4 C 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -52.33 29.51 16.61 -52.04 31.11 17.93 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -42.20 32.39 17.40 -42.88 30.35 17.40 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -48.31 18.40 10.87 -47.94 17.71 11.21 ULMN 3 1qrz_c23 PLASMINOGEN user 31 3 # 31 D 603 HIS D 14 HIS.? 21.26 C4 PG4 C 350 D 646 ASP D 90 ASP~? 17.03 C4 PG4 C 350 D 739 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1qrz_c23 PLASMINOGEN user 32 3 # 32 D 603 HIS D 14 HIS.? 21.26 C4 PG4 C 350 D 646 ASP D 90 ASP~? 17.03 C4 PG4 C 350 D 739 GLY D 25 GLY~? 13.17 O2 PO4 D 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -46.02 12.94 70.06 -45.99 13.73 69.92 ULMN 3 1qrz_c23 PLASMINOGEN user 33 3 # 33 D 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 646 ASP D 131 ASP^? 9.77 C6 PG4 C 350 D 739 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -48.29 3.79 55.93 -46.95 2.25 56.44 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1qrz_c23 PLASMINOGEN user 34 3 # 34 D 603 HIS D 110 HIS.? 5.57 O3 PG4 C 350 D 646 ASP D 131 ASP^? 9.77 C6 PG4 C 350 D 739 GLY D 192 GLY~? 8.57 O1 PO4 D 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -48.29 3.79 55.93 -46.95 2.25 56.44 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -52.91 16.56 61.94 -52.62 15.79 61.81 ULMN 3 1qrz_c23 PLASMINOGEN user 35 3 # 35 D 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1qrz_c23 PLASMINOGEN user 36 3 # 36 D 603 HIS D 260 HIS^? 11.65 O4 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY D 302 GLY^? 15.79 O4 PO4 D 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -44.73 36.67 61.75 -42.79 37.49 61.80 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -55.83 38.84 59.83 -55.49 38.30 59.29 ULMN 3 1qrz_c23 PLASMINOGEN user 37 3 # 37 D 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -32.64 35.78 59.13 -31.61 37.59 58.96 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1qrz_c23 PLASMINOGEN user 38 3 # 38 D 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -32.64 35.78 59.13 -31.61 37.59 58.96 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1qrz_c23 PLASMINOGEN user 39 3 # 39 D 603 HIS D 266 HIS.? 18.55 O4 PO4 D 349 D 646 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 739 GLY C 296 GLY.? 24.74 O4 PO4 D 349 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -32.64 35.78 59.13 -31.61 37.59 58.96 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -32.91 37.54 44.99 -33.65 37.14 44.90 1qrz_c23 source 1qrz PLASMINOGEN : 39 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 209 PHE~? -4.26 C3 PG4 A 350s A 201 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 227 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 23.39 49.81 32.16 21.33 51.68 32.26 -10.72 37.17 18.24 -10.31 34.51 17.57 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 12.68 46.83 36.69 18.26 48.67 34.51 1.49 32.28 22.12 4.07 30.52 27.68 1qz9_c02 source 1qz9 KYNURENINASE : 1 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 140 ASP.? 7.37 O2 PG4 A 350 A 186 ASN A 138 ASN.? -6.13 O2 PG4 A 350s A 260 ALA C 175 ALA~? 17.02 O2 PG4 A 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 11.43 26.53 7.41 13.01 27.56 8.43 -17.89 33.84 23.48 -17.76 31.89 24.26 coo 21.53 26.33 6.96 20.26 25.69 7.52 -28.16 28.46 20.32 -29.18 29.57 20.45 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 140 ASP.? 7.37 O2 PG4 A 350 A 186 ASN A 138 ASN.? -6.13 O2 PG4 A 350s A 260 ALA C 176 ALA~? 15.03 O2 PG4 A 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 11.43 26.53 7.41 13.01 27.56 8.43 -17.89 33.84 23.48 -17.76 31.89 24.26 coo 21.53 26.33 6.96 20.26 25.69 7.52 -25.95 28.73 23.42 -26.39 28.45 24.83 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 186 ASN A 267 ASN.? 11.93 O4 PO4 A 349 A 260 ALA B 294 ALA~? 16.64 O4 PO4 A 349 coo 11.81 33.10 11.71 13.07 31.45 11.40 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.43 26.53 7.41 13.01 27.56 8.43 4.37 61.77 16.42 3.54 60.20 17.57 coo 21.53 26.33 6.96 20.26 25.69 7.52 3.51 61.12 8.27 2.59 60.51 9.32 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 186 ASN A 270 ASN.? 15.06 O3 PO4 A 349 A 260 ALA B 294 ALA~? 16.64 O4 PO4 A 349 coo 11.81 33.10 11.71 13.07 31.45 11.40 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.43 26.53 7.41 13.01 27.56 8.43 7.80 59.00 17.23 7.36 57.24 18.34 coo 21.53 26.33 6.96 20.26 25.69 7.52 3.51 61.12 8.27 2.59 60.51 9.32 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 186 ASN B 269 ASN.? 10.41 O1 PO4 B 349 A 260 ALA A 142 ALA.? 12.14 C2 PG4 A 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.43 26.53 7.41 13.01 27.56 8.43 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 21.53 26.33 6.96 20.26 25.69 7.52 -16.20 40.87 12.81 -15.80 42.33 13.02 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 186 ASN B 270 ASN.? 15.02 O1 PO4 B 349 A 260 ALA A 142 ALA.? 12.14 C2 PG4 A 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.43 26.53 7.41 13.01 27.56 8.43 -17.98 39.50 4.84 -17.14 38.86 6.70 coo 21.53 26.33 6.96 20.26 25.69 7.52 -16.20 40.87 12.81 -15.80 42.33 13.02 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 186 ASN B 270 ASN.? 15.02 O1 PO4 B 349 A 260 ALA A 294 ALA.? 16.82 O4 PO4 B 349 coo 11.81 33.10 11.71 13.07 31.45 11.40 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.43 26.53 7.41 13.01 27.56 8.43 -17.98 39.50 4.84 -17.14 38.86 6.70 coo 21.53 26.33 6.96 20.26 25.69 7.52 -15.59 48.24 0.20 -14.45 47.45 0.82 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 8 3 # 8 A 10 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 186 ASN C 267 ASN.? 11.87 O1 PO4 C 349 A 260 ALA D 142 ALA.? 12.20 O5 PG4 D 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.43 26.53 7.41 13.01 27.56 8.43 -56.89 27.38 32.00 -55.68 25.71 32.54 coo 21.53 26.33 6.96 20.26 25.69 7.52 -57.25 19.43 40.27 -56.72 20.25 41.44 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 9 3 # 9 A 10 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 186 ASN C 267 ASN.? 11.87 O1 PO4 C 349 A 260 ALA D 294 ALA~? 16.73 O1 PO4 C 349 coo 11.81 33.10 11.71 13.07 31.45 11.40 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.43 26.53 7.41 13.01 27.56 8.43 -56.89 27.38 32.00 -55.68 25.71 32.54 coo 21.53 26.33 6.96 20.26 25.69 7.52 -56.74 34.00 37.04 -55.63 32.95 36.83 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 10 3 # 10 A 10 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 186 ASN C 269 ASN.? 10.45 O3 PO4 C 349 A 260 ALA D 142 ALA.? 12.20 O5 PG4 D 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.43 26.53 7.41 13.01 27.56 8.43 -57.17 21.55 31.51 -55.49 20.56 30.60 coo 21.53 26.33 6.96 20.26 25.69 7.52 -57.25 19.43 40.27 -56.72 20.25 41.44 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 11 3 # 11 A 10 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 186 ASN C 270 ASN.? 15.22 O3 PO4 C 349 A 260 ALA D 142 ALA.? 12.20 O5 PG4 D 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.43 26.53 7.41 13.01 27.56 8.43 -59.71 24.81 33.93 -59.02 22.97 34.76 coo 21.53 26.33 6.96 20.26 25.69 7.52 -57.25 19.43 40.27 -56.72 20.25 41.44 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 12 3 # 12 A 10 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 186 ASN C 270 ASN.? 15.22 O3 PO4 C 349 A 260 ALA D 294 ALA~? 16.73 O1 PO4 C 349 coo 11.81 33.10 11.71 13.07 31.45 11.40 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.43 26.53 7.41 13.01 27.56 8.43 -59.71 24.81 33.93 -59.02 22.97 34.76 coo 21.53 26.33 6.96 20.26 25.69 7.52 -56.74 34.00 37.04 -55.63 32.95 36.83 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 13 3 # 13 A 10 ASP C 226 ASP.? 11.40 C1 PG4 A 350 A 186 ASN A 138 ASN.? -6.13 O2 PG4 A 350s A 260 ALA C 175 ALA~? 17.02 O2 PG4 A 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 11.43 26.53 7.41 13.01 27.56 8.43 -17.89 33.84 23.48 -17.76 31.89 24.26 coo 21.53 26.33 6.96 20.26 25.69 7.52 -28.16 28.46 20.32 -29.18 29.57 20.45 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 14 3 # 14 A 10 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 186 ASN D 267 ASN.? 11.74 O3 PO4 D 349 A 260 ALA C 142 ALA.? 12.35 C2 PG4 C 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.43 26.53 7.41 13.01 27.56 8.43 -35.75 30.56 56.76 -36.75 28.68 56.44 coo 21.53 26.33 6.96 20.26 25.69 7.52 -33.86 22.03 49.44 -34.51 22.67 48.24 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 15 3 # 15 A 10 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 186 ASN D 267 ASN.? 11.74 O3 PO4 D 349 A 260 ALA C 294 ALA~? 16.90 O4 PO4 D 349 coo 11.81 33.10 11.71 13.07 31.45 11.40 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.43 26.53 7.41 13.01 27.56 8.43 -35.75 30.56 56.76 -36.75 28.68 56.44 coo 21.53 26.33 6.96 20.26 25.69 7.52 -36.72 36.26 50.70 -37.65 35.11 51.01 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 16 3 # 16 A 10 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 186 ASN D 269 ASN.? 10.24 O3 PO4 D 349 A 260 ALA C 142 ALA.? 12.35 C2 PG4 C 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.43 26.53 7.41 13.01 27.56 8.43 -34.61 24.72 58.03 -36.14 23.70 59.12 coo 21.53 26.33 6.96 20.26 25.69 7.52 -33.86 22.03 49.44 -34.51 22.67 48.24 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 17 3 # 17 A 10 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 186 ASN D 270 ASN.? 14.75 O3 PO4 D 349 A 260 ALA C 142 ALA.? 12.35 C2 PG4 C 350 coo 11.81 33.10 11.71 13.07 31.45 11.40 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.43 26.53 7.41 13.01 27.56 8.43 -32.60 27.92 55.07 -33.22 25.92 54.63 coo 21.53 26.33 6.96 20.26 25.69 7.52 -33.86 22.03 49.44 -34.51 22.67 48.24 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 18 3 # 18 A 10 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 186 ASN D 270 ASN.? 14.75 O3 PO4 D 349 A 260 ALA C 294 ALA~? 16.90 O4 PO4 D 349 coo 11.81 33.10 11.71 13.07 31.45 11.40 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.43 26.53 7.41 13.01 27.56 8.43 -32.60 27.92 55.07 -33.22 25.92 54.63 coo 21.53 26.33 6.96 20.26 25.69 7.52 -36.72 36.26 50.70 -37.65 35.11 51.01 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 18 hits 1r4f_c00 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS B 321 HIS~? 21.63 O4 PO4 B 349 A 41 LYS B 316 LYS~? 24.20 O3 PO4 B 349 A 119 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -8.21 43.10 -17.57 -9.89 44.30 -17.19 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -2.04 35.41 -19.34 2.27 31.66 -22.14 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS C 321 HIS~? 21.29 O1 PO4 C 349 A 41 LYS C 316 LYS~? 23.27 O4 PO4 C 349 A 119 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -50.23 42.88 20.64 -51.67 43.34 22.10 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -44.69 38.73 13.31 -40.21 38.10 9.89 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -48.83 33.87 26.09 -50.85 34.38 25.82 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 2 hits 1rbn_c01 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 610 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 661 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 75.99 81.56 1.86 73.91 81.34 2.28 -1.16 62.88 18.52 0.68 62.16 19.33 coo 71.04 78.84 0.46 71.54 76.90 1.02 1.50 56.90 17.79 2.83 56.38 19.33 coo 75.40 81.38 12.06 74.88 79.42 12.63 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 610 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 661 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 75.99 81.56 1.86 73.91 81.34 2.28 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 71.04 78.84 0.46 71.54 76.90 1.02 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 75.40 81.38 12.06 74.88 79.42 12.63 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 3 3 # 3 A 608 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 610 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 661 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 75.99 81.56 1.86 73.91 81.34 2.28 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 71.04 78.84 0.46 71.54 76.90 1.02 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 75.40 81.38 12.06 74.88 79.42 12.63 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 4 3 # 4 A 608 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 610 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 661 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 75.99 81.56 1.86 73.91 81.34 2.28 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 71.04 78.84 0.46 71.54 76.90 1.02 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 75.40 81.38 12.06 74.88 79.42 12.63 -32.64 35.78 59.13 -31.61 37.59 58.96 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 610 HIS A 238 HIS.? 10.67 O3 PO4 A 349 C 661 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -1.16 62.88 18.52 0.68 62.16 19.33 coo -16.56 83.18 53.03 -16.33 85.18 53.60 1.50 56.90 17.79 2.83 56.38 19.33 coo -8.38 80.78 62.24 -7.53 82.67 62.02 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 610 HIS B 238 HIS.? 10.82 O1 PO4 B 349 C 661 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 3 3 # 3 C 608 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 610 HIS C 238 HIS.? 10.74 O3 PO4 C 349 C 661 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 4 3 # 4 C 608 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 610 HIS D 238 HIS.? 10.72 O3 PO4 D 349 C 661 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -32.64 35.78 59.13 -31.61 37.59 58.96 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 84 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 140 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 3.61 55.89 43.73 3.10 55.52 45.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 8.08 50.44 43.84 7.48 51.26 41.98 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 84 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 140 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 3.61 55.89 43.73 3.10 55.52 45.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 8.08 50.44 43.84 7.48 51.26 41.98 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 84 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 140 GLY A 25 GLY~? 12.48 O2 PO4 A 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 3.61 55.89 43.73 3.10 55.52 45.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 8.08 50.44 43.84 7.48 51.26 41.98 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -5.57 58.65 37.18 -5.59 59.05 36.47 ULMN 3 1rgq_c01 NS4A PEPTIDE user 4 3 # 4 B 60 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 84 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 140 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 3.61 55.89 43.73 3.10 55.52 45.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 8.08 50.44 43.84 7.48 51.26 41.98 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1rgq_c01 NS4A PEPTIDE user 5 3 # 5 B 60 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 84 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 140 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 1rgq_c01 NS4A PEPTIDE user 6 3 # 6 B 60 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 84 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 140 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 1.50 56.90 17.79 2.83 56.38 19.33 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1rgq_c01 NS4A PEPTIDE user 7 3 # 7 B 60 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 84 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 140 GLY A 302 GLY^? 15.79 O4 PO4 A 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -16.13 68.37 12.01 -15.71 67.65 12.00 ULMN 3 1rgq_c01 NS4A PEPTIDE user 8 3 # 8 B 60 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 84 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 140 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1rgq_c01 NS4A PEPTIDE user 9 3 # 9 B 60 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 84 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 140 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1rgq_c01 NS4A PEPTIDE user 10 3 # 10 B 60 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 84 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 140 GLY B 25 GLY~? 12.55 O3 PO4 B 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -1.91 21.39 6.65 -1.94 22.01 6.12 ULMN 3 1rgq_c01 NS4A PEPTIDE user 11 3 # 11 B 60 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 84 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 140 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1rgq_c01 NS4A PEPTIDE user 12 3 # 12 B 60 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 84 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 140 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1rgq_c01 NS4A PEPTIDE user 13 3 # 13 B 60 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 84 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 140 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1rgq_c01 NS4A PEPTIDE user 14 3 # 14 B 60 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 84 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 140 GLY B 302 GLY^? 15.90 O4 PO4 B 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 3.38 45.56 -8.81 3.08 45.63 -8.02 ULMN 3 1rgq_c01 NS4A PEPTIDE user 15 3 # 15 B 60 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 84 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 140 GLY C 19 GLY.? 15.83 O4 PO4 C 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -56.32 12.91 20.05 -55.54 13.23 19.94 ULMN 3 1rgq_c01 NS4A PEPTIDE user 16 3 # 16 B 60 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 84 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 140 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1rgq_c01 NS4A PEPTIDE user 17 3 # 17 B 60 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 84 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 140 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1rgq_c01 NS4A PEPTIDE user 18 3 # 18 B 60 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 84 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 140 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1rgq_c01 NS4A PEPTIDE user 19 3 # 19 B 60 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 84 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 140 GLY C 302 GLY^? 15.82 O1 PO4 C 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -38.20 38.03 27.59 -38.48 37.54 28.20 ULMN 3 1rgq_c01 NS4A PEPTIDE user 20 3 # 20 B 60 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 84 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 140 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 1rgq_c01 NS4A PEPTIDE user 21 3 # 21 B 60 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 84 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 140 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1rgq_c01 NS4A PEPTIDE user 22 3 # 22 B 60 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 84 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 140 GLY D 25 GLY~? 13.17 O2 PO4 D 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -46.02 12.94 70.06 -45.99 13.73 69.92 ULMN 3 1rgq_c01 NS4A PEPTIDE user 23 3 # 23 B 60 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 84 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 140 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1rgq_c01 NS4A PEPTIDE user 24 3 # 24 B 60 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 84 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 140 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1rgq_c01 NS4A PEPTIDE user 25 3 # 25 B 60 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 84 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 140 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1rgq_c01 NS4A PEPTIDE user 26 3 # 26 B 60 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 84 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 140 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1rgq_c01 NS4A PEPTIDE user 27 3 # 27 B 60 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 84 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 140 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1rgq_c01 NS4A PEPTIDE user 28 3 # 28 B 60 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 84 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 140 GLY D 302 GLY^? 15.79 O4 PO4 D 349 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -55.83 38.84 59.83 -55.49 38.30 59.29 1rgq_c01 source 1rgq NS4A PEPTIDE : 28 hits 1rgq_c01 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 215 GLU~? 13.07 C2 PG4 A 350 A 288 HIS C 229 HIS^? 14.09 O2 PO4 C 349 A 329 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 29.27 18.78 14.99 27.16 18.62 14.76 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 49.52 10.06 10.36 50.99 9.65 8.92 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU B 135 GLU.? -3.99 O5 PG4 B 350s A 288 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 329 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 29.27 18.78 14.99 27.16 18.62 14.76 2.30 38.46 22.67 1.14 39.98 23.57 coo 49.52 10.06 10.36 50.99 9.65 8.92 11.38 38.70 0.79 12.71 38.99 -0.80 coo 57.80 12.92 13.83 53.77 8.42 12.15 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU B 286 GLU~? 20.04 O4 PO4 B 349 A 288 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 329 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 29.27 18.78 14.99 27.16 18.62 14.76 0.48 53.28 -2.68 0.79 53.94 -4.67 coo 49.52 10.06 10.36 50.99 9.65 8.92 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 57.80 12.92 13.83 53.77 8.42 12.15 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU D 135 GLU.? -4.27 C8 PG4 D 350s A 288 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 329 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 29.27 18.78 14.99 27.16 18.62 14.76 -50.80 9.98 46.92 -49.80 10.03 45.07 coo 49.52 10.06 10.36 50.99 9.65 8.92 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 57.80 12.92 13.83 53.77 8.42 12.15 -68.08 25.33 66.69 -67.75 19.10 66.60 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 4 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 215 GLU~? 13.07 C2 PG4 A 350 B 288 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 329 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -41.72 25.46 27.54 -45.65 24.70 30.33 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 286 GLU~? 19.74 O4 PO4 A 349 B 288 HIS B 260 HIS^? 11.70 O4 PO4 B 349 B 329 LYS B 165 LYS~? -2.78 O4 PO4 B 349s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -13.11 61.08 5.26 -13.84 62.85 4.34 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 0.37 36.49 0.17 -3.63 37.66 2.73 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU B 135 GLU.? -3.99 O5 PG4 B 350s B 288 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 329 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 2.30 38.46 22.67 1.14 39.98 23.57 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 11.38 38.70 0.79 12.71 38.99 -0.80 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU B 286 GLU~? 20.04 O4 PO4 B 349 B 288 HIS A 260 HIS^? 11.64 O4 PO4 A 349 B 329 LYS A 165 LYS~? -2.78 O4 PO4 A 349s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 0.48 53.28 -2.68 0.79 53.94 -4.67 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -10.69 61.92 21.86 -6.45 59.75 20.54 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU C 286 GLU~? 19.95 O1 PO4 C 349 B 288 HIS D 260 HIS^? 11.65 O4 PO4 D 349 B 329 LYS D 165 LYS~? -2.89 O4 PO4 D 349s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -40.61 39.13 37.58 -40.31 41.01 36.65 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -50.59 27.20 61.67 -46.47 26.50 58.89 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU D 135 GLU.? -4.27 C8 PG4 D 350s B 288 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 329 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -50.80 9.98 46.92 -49.80 10.03 45.07 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -68.08 25.33 66.69 -67.75 19.10 66.60 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU D 286 GLU~? 19.90 O4 PO4 D 349 B 288 HIS C 260 HIS^? 11.63 O1 PO4 C 349 B 329 LYS C 165 LYS~? -2.77 O1 PO4 C 349s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -53.47 38.80 49.84 -54.10 40.73 50.49 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -41.72 25.46 27.54 -45.65 24.70 30.33 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 7 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 195 SER A 64 SER~? 26.25 O3 PG4 B 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 3.61 55.89 43.73 3.10 55.52 45.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 1.74 60.96 43.57 3.36 61.47 42.28 coo -2.83 25.96 36.71 -4.77 27.03 37.63 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 195 SER A 64 SER~? 26.25 O3 PG4 B 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 3.61 55.89 43.73 3.10 55.52 45.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 8.08 50.44 43.84 7.48 51.26 41.98 coo -2.83 25.96 36.71 -4.77 27.03 37.63 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 195 SER A 241 SER.? 9.98 O3 PO4 A 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 1.50 56.90 17.79 2.83 56.38 19.33 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -1.16 62.88 18.52 0.68 62.16 19.33 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -0.69 52.51 16.88 -2.72 53.79 17.21 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 102 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 195 SER B 64 SER~? 26.98 C5 PG4 A 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -7.40 13.29 5.68 -9.25 14.12 5.01 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 3 # 5 B 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 195 SER B 241 SER.? 10.02 O1 PO4 B 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -9.21 42.20 9.74 -7.29 41.83 8.32 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 3 # 6 B 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 102 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 195 SER C 64 SER~? 25.88 C5 PG4 D 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -52.23 5.22 16.50 -53.97 6.36 17.05 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 7 3 # 7 B 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 195 SER C 64 SER~? 25.88 C5 PG4 D 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 8 3 # 8 B 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 195 SER C 241 SER.? 9.97 O3 PO4 C 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -50.53 22.77 38.79 -48.65 23.56 37.48 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 9 3 # 9 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 195 SER D 64 SER~? 27.50 C6 PG4 C 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -39.78 8.95 76.71 -38.11 10.21 76.27 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 10 3 # 10 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 195 SER D 64 SER~? 27.50 C6 PG4 C 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 11 3 # 11 B 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 195 SER D 241 SER.? 10.08 O3 PO4 D 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -41.15 24.23 50.62 -43.08 24.97 51.88 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 11 hits 1rtf_c03 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 193 GLY A 16 GLY.? 15.23 O3 PO4 A 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 3.61 55.89 43.73 3.10 55.52 45.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 8.08 50.44 43.84 7.48 51.26 41.98 coo -6.81 22.81 34.74 -6.42 23.54 34.62 2.07 60.33 37.29 2.12 60.80 37.90 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 193 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 3.61 55.89 43.73 3.10 55.52 45.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 8.08 50.44 43.84 7.48 51.26 41.98 coo -6.81 22.81 34.74 -6.42 23.54 34.62 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 193 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 3.61 55.89 43.73 3.10 55.52 45.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 8.08 50.44 43.84 7.48 51.26 41.98 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 193 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 3.61 55.89 43.73 3.10 55.52 45.73 coo -0.27 31.24 43.51 -1.49 29.62 42.98 8.08 50.44 43.84 7.48 51.26 41.98 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 3 # 5 B 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 102 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 193 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -6.81 22.81 34.74 -6.42 23.54 34.62 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 3 # 6 B 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 102 ASP A 203 ASP~? 10.68 C3 PG4 B 350 B 193 GLY A 86 GLY.? 5.00 C4 PG4 B 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -6.81 22.81 34.74 -6.42 23.54 34.62 4.72 44.66 33.63 5.12 45.31 34.00 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 7 3 # 7 B 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 102 ASP B 208 ASP~? 8.88 C3 PG4 B 350 B 193 GLY A 86 GLY.? 5.00 C4 PG4 B 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -6.81 22.81 34.74 -6.42 23.54 34.62 4.72 44.66 33.63 5.12 45.31 34.00 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 8 3 # 8 B 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 B 102 ASP B 208 ASP~? 8.88 C3 PG4 B 350 B 193 GLY A 108 GLY.? 11.36 O3 PG4 B 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -1.26 45.53 28.70 -1.92 46.50 26.97 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -5.80 48.81 34.39 -5.17 48.42 34.72 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 9 3 # 9 B 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 193 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 1.50 56.90 17.79 2.83 56.38 19.33 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -1.16 62.88 18.52 0.68 62.16 19.33 coo -6.81 22.81 34.74 -6.42 23.54 34.62 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 10 3 # 10 B 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 193 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 1.50 56.90 17.79 2.83 56.38 19.33 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -1.16 62.88 18.52 0.68 62.16 19.33 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 11 3 # 11 B 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 193 GLY B 16 GLY.? 15.34 O3 PO4 B 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -8.99 19.43 5.14 -8.92 18.73 4.81 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 12 3 # 12 B 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 193 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 13 3 # 13 B 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 193 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 14 3 # 14 B 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 B 193 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.26 14.51 16.36 -14.11 16.10 14.94 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 15 3 # 15 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 16 3 # 16 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 17 3 # 17 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 B 193 GLY B 108 GLY.? 11.44 C5 PG4 A 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -1.45 26.58 15.61 -2.07 26.26 16.03 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 18 3 # 18 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 193 GLY B 84 GLY.? 7.18 C3 PG4 A 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -14.58 29.73 14.21 -14.80 28.98 14.10 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 19 3 # 19 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 20 3 # 20 B 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 B 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -6.85 32.28 17.79 -6.48 33.98 16.61 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 21 3 # 21 B 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 193 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 22 3 # 22 B 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 193 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 23 3 # 23 B 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 193 GLY C 16 GLY.? 15.48 O4 PO4 C 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -52.98 9.90 20.86 -53.06 9.69 20.11 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 24 3 # 24 B 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 193 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 25 3 # 25 B 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 B 193 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 26 3 # 26 B 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 193 GLY C 84 GLY.? 7.31 O4 PG4 D 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -56.51 10.28 34.21 -56.90 9.83 33.65 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 27 3 # 27 B 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 193 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 28 3 # 28 B 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 B 193 GLY C 86 GLY.? 4.20 C5 PG4 D 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -53.55 4.02 36.09 -53.97 4.11 35.35 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 29 3 # 29 B 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 102 ASP D 208 ASP~? 8.41 C6 PG4 D 350 B 193 GLY C 86 GLY.? 4.20 C5 PG4 D 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -53.55 4.02 36.09 -53.97 4.11 35.35 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 30 3 # 30 B 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 B 102 ASP D 208 ASP~? 8.41 C6 PG4 D 350 B 193 GLY C 108 GLY.? 11.29 O3 PG4 D 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -48.06 9.35 37.56 -47.54 11.38 37.75 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -43.60 7.14 31.15 -44.12 6.54 31.35 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 31 3 # 31 B 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 193 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 32 3 # 32 B 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 193 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -53.20 24.10 34.96 -54.25 22.32 34.57 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 33 3 # 33 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 193 GLY D 16 GLY.? 16.14 O2 PO4 D 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -38.65 13.48 72.21 -38.70 13.32 72.96 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 34 3 # 34 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 193 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 35 3 # 35 B 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 B 193 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -33.15 1.70 68.90 -33.50 3.76 68.48 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 36 3 # 36 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 37 3 # 37 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 38 3 # 38 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 39 3 # 39 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 B 193 GLY D 108 GLY.? 11.50 C6 PG4 C 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -46.34 8.93 60.42 -45.67 8.48 60.39 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 40 3 # 40 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 41 3 # 41 B 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 B 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 B 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -41.52 11.20 54.17 -42.16 13.10 53.55 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 42 3 # 42 B 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 193 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 43 3 # 43 B 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 193 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -38.74 26.41 54.26 -37.48 24.84 54.87 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -40.50 35.55 47.63 -40.37 36.37 47.40 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 43 hits 1rtf_c06 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS B 321 HIS~? 21.63 O4 PO4 B 349 62 GLU B 325 GLU~? 19.47 O4 PO4 B 349 101 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 13.91 26.31 13.70 14.98 27.08 12.06 -8.21 43.10 -17.57 -9.89 44.30 -17.19 coo 9.15 26.32 13.85 8.75 28.20 13.02 -7.86 48.35 -14.01 -8.88 47.03 -12.75 coo 7.90 34.31 7.89 9.24 33.73 9.42 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 2 3 # 2 41 HIS C 321 HIS~? 21.29 O1 PO4 C 349 62 GLU C 325 GLU~? 19.31 O1 PO4 C 349 101 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 13.91 26.31 13.70 14.98 27.08 12.06 -50.23 42.88 20.64 -51.67 43.34 22.10 coo 9.15 26.32 13.85 8.75 28.20 13.02 -49.52 44.21 26.45 -50.31 42.24 26.60 coo 7.90 34.31 7.89 9.24 33.73 9.42 -48.83 33.87 26.09 -50.85 34.38 25.82 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 3 3 # 3 41 HIS D 321 HIS~? 21.61 O4 PO4 D 349 62 GLU D 325 GLU~? 19.00 O4 PO4 D 349 101 HIS D 260 HIS^? 11.65 O4 PO4 D 349 coo 13.91 26.31 13.70 14.98 27.08 12.06 -44.81 46.75 66.01 -43.36 47.24 64.57 coo 9.15 26.32 13.85 8.75 28.20 13.02 -45.65 46.55 59.76 -44.68 44.67 59.92 coo 7.90 34.31 7.89 9.24 33.73 9.42 -44.73 36.67 61.75 -42.79 37.49 61.80 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 3 hits 1rtu_c00 naa= 3 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 3 # 1 A 104 ILE A 80 ILE.? 15.35 C3 PG4 B 350 A 106 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 142 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo -15.54 60.72 29.56 -16.71 61.53 30.10 0.88 54.97 37.41 1.44 55.29 38.70 coo -17.00 64.03 23.46 -18.21 65.65 22.90 3.61 55.89 43.73 3.10 55.52 45.73 coo -17.05 67.91 26.85 -18.66 66.47 26.76 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 3 # 2 A 104 ILE B 80 ILE.? 16.18 C4 PG4 A 350 A 106 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 142 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -8.04 20.62 10.30 -8.33 19.20 10.24 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 3 3 # 3 A 104 ILE C 80 ILE.? 14.76 C5 PG4 D 350 A 106 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 142 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -50.92 7.07 25.05 -51.42 6.14 24.06 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 4 3 # 4 A 104 ILE D 80 ILE.? 15.99 C4 PG4 C 350 A 106 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 142 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -39.71 10.08 67.97 -39.29 9.25 69.05 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -39.78 8.95 76.71 -38.11 10.21 76.27 1s3i_c00 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 4 hits 1s3i_c00 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 41 ASP.? 20.10 O2 PO4 A 349 64 HIS A 14 HIS.? 20.33 C3 PG4 B 350 221 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 1.74 60.96 43.57 3.36 61.47 42.28 coo 78.27 67.69 61.83 79.58 67.76 60.19 3.61 55.89 43.73 3.10 55.52 45.73 coo 83.63 66.07 58.16 81.31 66.75 57.98 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 90 ASP~? 15.98 C4 PG4 B 350 64 HIS A 14 HIS.? 20.33 C3 PG4 B 350 221 SER A 64 SER~? 26.25 O3 PG4 B 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 8.08 50.44 43.84 7.48 51.26 41.98 coo 78.27 67.69 61.83 79.58 67.76 60.19 3.61 55.89 43.73 3.10 55.52 45.73 coo 83.63 66.07 58.16 81.31 66.75 57.98 1.46 56.04 50.07 2.12 55.38 52.31 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP A 160 ASP.? 8.60 O4 PO4 A 349 64 HIS A 238 HIS.? 10.67 O3 PO4 A 349 221 SER A 241 SER.? 9.98 O3 PO4 A 349 coo 80.16 73.25 62.48 80.01 71.25 61.82 -1.16 62.88 18.52 0.68 62.16 19.33 coo 78.27 67.69 61.83 79.58 67.76 60.19 1.50 56.90 17.79 2.83 56.38 19.33 coo 83.63 66.07 58.16 81.31 66.75 57.98 -0.69 52.51 16.88 -2.72 53.79 17.21 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP B 41 ASP.? 20.21 O3 PO4 B 349 64 HIS B 14 HIS.? 21.30 C5 PG4 A 350 221 SER B 64 SER~? 26.98 C5 PG4 A 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 78.27 67.69 61.83 79.58 67.76 60.19 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 83.63 66.07 58.16 81.31 66.75 57.98 -6.23 8.13 11.77 -6.66 5.89 12.66 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP B 160 ASP.? 8.62 O4 PO4 B 349 64 HIS B 238 HIS.? 10.82 O1 PO4 B 349 221 SER B 241 SER.? 10.02 O1 PO4 B 349 coo 80.16 73.25 62.48 80.01 71.25 61.82 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 78.27 67.69 61.83 79.58 67.76 60.19 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 83.63 66.07 58.16 81.31 66.75 57.98 -9.21 42.20 9.74 -7.29 41.83 8.32 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP C 41 ASP.? 20.22 O4 PO4 C 349 64 HIS C 14 HIS.? 19.64 C5 PG4 D 350 221 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 78.27 67.69 61.83 79.58 67.76 60.19 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 83.63 66.07 58.16 81.31 66.75 57.98 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP C 90 ASP~? 15.56 C5 PG4 D 350 64 HIS C 14 HIS.? 19.64 C5 PG4 D 350 221 SER C 64 SER~? 25.88 C5 PG4 D 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 78.27 67.69 61.83 79.58 67.76 60.19 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 83.63 66.07 58.16 81.31 66.75 57.98 -51.01 -2.63 16.81 -51.42 -4.86 15.97 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 8 3 # 8 32 ASP C 160 ASP.? 8.57 O1 PO4 C 349 64 HIS C 238 HIS.? 10.74 O3 PO4 C 349 221 SER C 241 SER.? 9.97 O3 PO4 C 349 coo 80.16 73.25 62.48 80.01 71.25 61.82 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 78.27 67.69 61.83 79.58 67.76 60.19 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 83.63 66.07 58.16 81.31 66.75 57.98 -50.53 22.77 38.79 -48.65 23.56 37.48 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 9 3 # 9 32 ASP D 41 ASP.? 20.92 O2 PO4 D 349 64 HIS D 14 HIS.? 21.26 C4 PG4 C 350 221 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 78.27 67.69 61.83 79.58 67.76 60.19 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 83.63 66.07 58.16 81.31 66.75 57.98 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 10 3 # 10 32 ASP D 90 ASP~? 17.03 C4 PG4 C 350 64 HIS D 14 HIS.? 21.26 C4 PG4 C 350 221 SER D 64 SER~? 27.50 C6 PG4 C 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 78.27 67.69 61.83 79.58 67.76 60.19 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 83.63 66.07 58.16 81.31 66.75 57.98 -40.29 0.73 76.87 -39.79 -1.23 78.23 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 11 3 # 11 32 ASP D 160 ASP.? 8.58 O4 PO4 D 349 64 HIS D 238 HIS.? 10.72 O3 PO4 D 349 221 SER D 241 SER.? 10.08 O3 PO4 D 349 coo 80.16 73.25 62.48 80.01 71.25 61.82 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 78.27 67.69 61.83 79.58 67.76 60.19 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 83.63 66.07 58.16 81.31 66.75 57.98 -41.15 24.23 50.62 -43.08 24.97 51.88 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 11 hits 1sca_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 203 ASP~? 10.68 C3 PG4 B 350 64 HIS A 110 HIS.? 5.77 C3 PG4 B 350 155 ASN A 107 ASN^? 9.64 C5 PG4 B 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 78.27 67.69 61.83 79.58 67.76 60.19 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 80.34 61.88 52.75 81.25 63.19 54.35 -5.73 45.70 37.96 -3.97 45.35 36.84 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 208 ASP~? 8.51 C3 PG4 A 350 64 HIS B 110 HIS.? 5.25 C4 PG4 A 350 155 ASN A 138 ASN.? -6.13 O2 PG4 A 350s coo 80.16 73.25 62.48 80.01 71.25 61.82 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 78.27 67.69 61.83 79.58 67.76 60.19 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 80.34 61.88 52.75 81.25 63.19 54.35 -17.89 33.84 23.48 -17.76 31.89 24.26 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP A 208 ASP~? 8.51 C3 PG4 A 350 64 HIS B 110 HIS.? 5.25 C4 PG4 A 350 155 ASN B 107 ASN^? 9.43 C5 PG4 A 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 78.27 67.69 61.83 79.58 67.76 60.19 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 80.34 61.88 52.75 81.25 63.19 54.35 -1.39 23.50 19.22 -3.25 24.51 19.38 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP B 203 ASP~? 9.89 C4 PG4 A 350 64 HIS B 110 HIS.? 5.25 C4 PG4 A 350 155 ASN B 107 ASN^? 9.43 C5 PG4 A 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 78.27 67.69 61.83 79.58 67.76 60.19 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 80.34 61.88 52.75 81.25 63.19 54.35 -1.39 23.50 19.22 -3.25 24.51 19.38 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP B 208 ASP~? 8.88 C3 PG4 B 350 64 HIS A 110 HIS.? 5.77 C3 PG4 B 350 155 ASN A 107 ASN^? 9.64 C5 PG4 B 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 78.27 67.69 61.83 79.58 67.76 60.19 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 80.34 61.88 52.75 81.25 63.19 54.35 -5.73 45.70 37.96 -3.97 45.35 36.84 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP B 208 ASP~? 8.88 C3 PG4 B 350 64 HIS A 110 HIS.? 5.77 C3 PG4 B 350 155 ASN B 138 ASN.? -6.40 C1 PG4 B 350s coo 80.16 73.25 62.48 80.01 71.25 61.82 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 78.27 67.69 61.83 79.58 67.76 60.19 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 80.34 61.88 52.75 81.25 63.19 54.35 10.62 41.15 26.22 11.12 39.95 27.93 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP C 203 ASP~? 10.24 C6 PG4 D 350 64 HIS C 110 HIS.? 5.63 C6 PG4 D 350 155 ASN C 107 ASN^? 9.61 C3 PG4 D 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 78.27 67.69 61.83 79.58 67.76 60.19 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 80.34 61.88 52.75 81.25 63.19 54.35 -42.97 2.46 31.63 -44.77 2.90 32.68 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 8 3 # 8 32 ASP C 208 ASP~? 8.73 O2 PG4 C 350 64 HIS D 110 HIS.? 5.57 O3 PG4 C 350 155 ASN D 107 ASN^? 9.34 C6 PG4 C 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 78.27 67.69 61.83 79.58 67.76 60.19 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 80.34 61.88 52.75 81.25 63.19 54.35 -46.02 4.22 60.61 -44.32 4.89 59.53 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 9 3 # 9 32 ASP D 203 ASP~? 10.40 O3 PG4 C 350 64 HIS D 110 HIS.? 5.57 O3 PG4 C 350 155 ASN D 107 ASN^? 9.34 C6 PG4 C 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 78.27 67.69 61.83 79.58 67.76 60.19 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 80.34 61.88 52.75 81.25 63.19 54.35 -46.02 4.22 60.61 -44.32 4.89 59.53 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 10 3 # 10 32 ASP D 208 ASP~? 8.41 C6 PG4 D 350 64 HIS C 110 HIS.? 5.63 C6 PG4 D 350 155 ASN C 107 ASN^? 9.61 C3 PG4 D 350 coo 80.16 73.25 62.48 80.01 71.25 61.82 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 78.27 67.69 61.83 79.58 67.76 60.19 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 80.34 61.88 52.75 81.25 63.19 54.35 -42.97 2.46 31.63 -44.77 2.90 32.68 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 11 3 # 11 32 ASP D 208 ASP~? 8.41 C6 PG4 D 350 64 HIS C 110 HIS.? 5.63 C6 PG4 D 350 155 ASN D 138 ASN.? -6.36 C7 PG4 D 350s coo 80.16 73.25 62.48 80.01 71.25 61.82 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 78.27 67.69 61.83 79.58 67.76 60.19 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 80.34 61.88 52.75 81.25 63.19 54.35 -59.25 7.10 43.19 -59.38 4.97 43.35 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 11 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 41 ASP.? 20.10 O2 PO4 A 349 595 GLU A 94 GLU~? 21.51 O3 PG4 B 350 713 TYR A 91 TYR~? 12.90 C4 PG4 B 350 coo 5.64 2.82 38.49 4.59 4.19 37.25 1.74 60.96 43.57 3.36 61.47 42.28 coo 4.35 13.73 37.63 3.39 12.18 36.55 2.26 51.25 46.83 2.00 52.68 48.40 coo 3.76 10.25 31.38 3.16 9.87 34.10 3.23 49.01 40.90 3.18 50.90 38.82 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP B 41 ASP.? 20.21 O3 PO4 B 349 595 GLU B 94 GLU~? 22.11 C5 PG4 A 350 713 TYR B 91 TYR~? 13.43 C5 PG4 A 350 coo 5.64 2.82 38.49 4.59 4.19 37.25 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 4.35 13.73 37.63 3.39 12.18 36.55 -7.91 12.10 15.72 -7.33 10.19 14.89 coo 3.76 10.25 31.38 3.16 9.87 34.10 -9.83 18.57 16.69 -10.13 20.18 14.41 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP C 41 ASP.? 20.22 O4 PO4 C 349 595 GLU C 94 GLU~? 21.12 C5 PG4 D 350 713 TYR C 91 TYR~? 12.18 C5 PG4 D 350 coo 5.64 2.82 38.49 4.59 4.19 37.25 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 4.35 13.73 37.63 3.39 12.18 36.55 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo 3.76 10.25 31.38 3.16 9.87 34.10 -52.07 0.67 28.08 -52.42 3.42 27.72 1sll_c00 source 1sll SIALIDASE L : 3 hits 1sll_c00 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 335 ARG~? 17.04 O2 PO4 A 349 A 89 HIS A 309 HIS.? 13.93 O2 PO4 A 349 A 119 ASN A 306 ASN^? 8.27 O2 PO4 A 349 coo 28.44 23.52 73.95 30.13 24.84 76.11 -10.94 77.02 25.36 -8.46 78.77 25.78 coo 21.34 20.13 69.47 22.14 19.11 71.12 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 19.69 29.00 71.61 19.80 26.98 72.20 -7.02 69.82 22.14 -6.25 69.91 24.11 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG B 335 ARG~? 17.10 O3 PO4 B 349 A 89 HIS B 309 HIS.? 14.09 O3 PO4 B 349 A 119 ASN B 306 ASN^? 8.17 O3 PO4 B 349 coo 28.44 23.52 73.95 30.13 24.84 76.11 -0.53 29.97 -13.85 -3.08 28.75 -15.03 coo 21.34 20.13 69.47 22.14 19.11 71.12 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo 19.69 29.00 71.61 19.80 26.98 72.20 -3.96 34.28 -6.86 -4.36 32.22 -6.36 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 A 87 ARG C 335 ARG~? 16.94 O4 PO4 C 349 A 89 HIS C 309 HIS.? 14.15 O4 PO4 C 349 A 119 ASN C 306 ASN^? 8.19 O4 PO4 C 349 coo 28.44 23.52 73.95 30.13 24.84 76.11 -43.40 31.02 13.21 -46.07 30.90 11.67 coo 21.34 20.13 69.47 22.14 19.11 71.12 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 19.69 29.00 71.61 19.80 26.98 72.20 -46.37 29.17 21.30 -46.92 27.39 20.25 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 A 87 ARG D 335 ARG~? 17.05 O2 PO4 D 349 A 89 HIS D 309 HIS.? 14.00 O2 PO4 D 349 A 119 ASN D 306 ASN^? 8.15 O2 PO4 D 349 coo 28.44 23.52 73.95 30.13 24.84 76.11 -49.77 35.01 75.03 -47.14 35.61 76.51 coo 21.34 20.13 69.47 22.14 19.11 71.12 -40.87 34.22 71.66 -41.37 35.58 70.15 coo 19.69 29.00 71.61 19.80 26.98 72.20 -46.44 32.39 67.16 -45.73 30.88 68.47 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 4 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG B 335 ARG~? 17.10 O3 PO4 B 349 B 89 HIS B 309 HIS.? 14.09 O3 PO4 B 349 B 119 ASN B 306 ASN^? 8.17 O3 PO4 B 349 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -0.53 29.97 -13.85 -3.08 28.75 -15.03 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -3.96 34.28 -6.86 -4.36 32.22 -6.36 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG C 335 ARG~? 16.94 O4 PO4 C 349 B 89 HIS C 309 HIS.? 14.15 O4 PO4 C 349 B 119 ASN C 306 ASN^? 8.19 O4 PO4 C 349 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -43.40 31.02 13.21 -46.07 30.90 11.67 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -52.33 29.51 16.61 -52.04 31.11 17.93 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -46.37 29.17 21.30 -46.92 27.39 20.25 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 2 hits 1smn_c01 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 16 GLY.? 15.23 O3 PO4 A 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 3.61 55.89 43.73 3.10 55.52 45.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 8.08 50.44 43.84 7.48 51.26 41.98 coo 14.52 29.10 10.01 15.08 29.66 10.19 2.07 60.33 37.29 2.12 60.80 37.90 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 3.61 55.89 43.73 3.10 55.52 45.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 8.08 50.44 43.84 7.48 51.26 41.98 coo 14.52 29.10 10.01 15.08 29.66 10.19 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 3.61 55.89 43.73 3.10 55.52 45.73 coo 19.67 30.58 22.61 18.30 29.87 21.17 8.08 50.44 43.84 7.48 51.26 41.98 coo 14.52 29.10 10.01 15.08 29.66 10.19 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 102 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 193 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 19.67 30.58 22.61 18.30 29.87 21.17 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 14.52 29.10 10.01 15.08 29.66 10.19 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 102 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 193 GLY A 86 GLY.? 5.00 C4 PG4 B 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 19.67 30.58 22.61 18.30 29.87 21.17 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 14.52 29.10 10.01 15.08 29.66 10.19 4.72 44.66 33.63 5.12 45.31 34.00 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 102 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 193 GLY A 86 GLY.? 5.00 C4 PG4 B 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 19.67 30.58 22.61 18.30 29.87 21.17 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 14.52 29.10 10.01 15.08 29.66 10.19 4.72 44.66 33.63 5.12 45.31 34.00 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 7 3 # 7 A 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 102 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 193 GLY A 108 GLY.? 11.36 O3 PG4 B 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 19.67 30.58 22.61 18.30 29.87 21.17 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 14.52 29.10 10.01 15.08 29.66 10.19 -5.80 48.81 34.39 -5.17 48.42 34.72 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 8 3 # 8 A 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 193 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 1.50 56.90 17.79 2.83 56.38 19.33 coo 19.67 30.58 22.61 18.30 29.87 21.17 -1.16 62.88 18.52 0.68 62.16 19.33 coo 14.52 29.10 10.01 15.08 29.66 10.19 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 9 3 # 9 A 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 193 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 1.50 56.90 17.79 2.83 56.38 19.33 coo 19.67 30.58 22.61 18.30 29.87 21.17 -1.16 62.88 18.52 0.68 62.16 19.33 coo 14.52 29.10 10.01 15.08 29.66 10.19 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 10 3 # 10 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 16 GLY.? 15.34 O3 PO4 B 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 19.67 30.58 22.61 18.30 29.87 21.17 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 14.52 29.10 10.01 15.08 29.66 10.19 -8.99 19.43 5.14 -8.92 18.73 4.81 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 11 3 # 11 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 19.67 30.58 22.61 18.30 29.87 21.17 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 14.52 29.10 10.01 15.08 29.66 10.19 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 12 3 # 12 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 19.67 30.58 22.61 18.30 29.87 21.17 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 14.52 29.10 10.01 15.08 29.66 10.19 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 13 3 # 13 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.67 30.58 22.61 18.30 29.87 21.17 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 14.52 29.10 10.01 15.08 29.66 10.19 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 14 3 # 14 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.67 30.58 22.61 18.30 29.87 21.17 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 14.52 29.10 10.01 15.08 29.66 10.19 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 15 3 # 15 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 193 GLY B 108 GLY.? 11.44 C5 PG4 A 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.67 30.58 22.61 18.30 29.87 21.17 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 14.52 29.10 10.01 15.08 29.66 10.19 -1.45 26.58 15.61 -2.07 26.26 16.03 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 16 3 # 16 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 193 GLY B 84 GLY.? 7.18 C3 PG4 A 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.67 30.58 22.61 18.30 29.87 21.17 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 14.52 29.10 10.01 15.08 29.66 10.19 -14.58 29.73 14.21 -14.80 28.98 14.10 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 17 3 # 17 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.67 30.58 22.61 18.30 29.87 21.17 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 14.52 29.10 10.01 15.08 29.66 10.19 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 18 3 # 18 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.67 30.58 22.61 18.30 29.87 21.17 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 14.52 29.10 10.01 15.08 29.66 10.19 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 19 3 # 19 A 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 193 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 19.67 30.58 22.61 18.30 29.87 21.17 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 14.52 29.10 10.01 15.08 29.66 10.19 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 20 3 # 20 A 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 193 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 19.67 30.58 22.61 18.30 29.87 21.17 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 14.52 29.10 10.01 15.08 29.66 10.19 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 21 3 # 21 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 193 GLY C 16 GLY.? 15.48 O4 PO4 C 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 19.67 30.58 22.61 18.30 29.87 21.17 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 14.52 29.10 10.01 15.08 29.66 10.19 -52.98 9.90 20.86 -53.06 9.69 20.11 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 22 3 # 22 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 193 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 19.67 30.58 22.61 18.30 29.87 21.17 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 14.52 29.10 10.01 15.08 29.66 10.19 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 23 3 # 23 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 193 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 19.67 30.58 22.61 18.30 29.87 21.17 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 14.52 29.10 10.01 15.08 29.66 10.19 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 24 3 # 24 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 193 GLY C 84 GLY.? 7.31 O4 PG4 D 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 19.67 30.58 22.61 18.30 29.87 21.17 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 14.52 29.10 10.01 15.08 29.66 10.19 -56.51 10.28 34.21 -56.90 9.83 33.65 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 25 3 # 25 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 193 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 19.67 30.58 22.61 18.30 29.87 21.17 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 14.52 29.10 10.01 15.08 29.66 10.19 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 26 3 # 26 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 193 GLY C 86 GLY.? 4.20 C5 PG4 D 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 19.67 30.58 22.61 18.30 29.87 21.17 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 14.52 29.10 10.01 15.08 29.66 10.19 -53.55 4.02 36.09 -53.97 4.11 35.35 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 27 3 # 27 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 193 GLY C 86 GLY.? 4.20 C5 PG4 D 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 19.67 30.58 22.61 18.30 29.87 21.17 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 14.52 29.10 10.01 15.08 29.66 10.19 -53.55 4.02 36.09 -53.97 4.11 35.35 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 28 3 # 28 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 193 GLY C 108 GLY.? 11.29 O3 PG4 D 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 19.67 30.58 22.61 18.30 29.87 21.17 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 14.52 29.10 10.01 15.08 29.66 10.19 -43.60 7.14 31.15 -44.12 6.54 31.35 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 29 3 # 29 A 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 193 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 19.67 30.58 22.61 18.30 29.87 21.17 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 14.52 29.10 10.01 15.08 29.66 10.19 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 30 3 # 30 A 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 193 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 19.67 30.58 22.61 18.30 29.87 21.17 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 14.52 29.10 10.01 15.08 29.66 10.19 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 31 3 # 31 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 16 GLY.? 16.14 O2 PO4 D 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 19.67 30.58 22.61 18.30 29.87 21.17 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 14.52 29.10 10.01 15.08 29.66 10.19 -38.65 13.48 72.21 -38.70 13.32 72.96 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 32 3 # 32 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 19.67 30.58 22.61 18.30 29.87 21.17 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 14.52 29.10 10.01 15.08 29.66 10.19 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 33 3 # 33 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 15.02 29.17 19.44 15.63 29.96 17.60 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 19.67 30.58 22.61 18.30 29.87 21.17 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 14.52 29.10 10.01 15.08 29.66 10.19 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 34 3 # 34 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.67 30.58 22.61 18.30 29.87 21.17 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 14.52 29.10 10.01 15.08 29.66 10.19 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 35 3 # 35 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.67 30.58 22.61 18.30 29.87 21.17 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 14.52 29.10 10.01 15.08 29.66 10.19 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 36 3 # 36 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.67 30.58 22.61 18.30 29.87 21.17 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 14.52 29.10 10.01 15.08 29.66 10.19 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 37 3 # 37 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 108 GLY.? 11.50 C6 PG4 C 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.67 30.58 22.61 18.30 29.87 21.17 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 14.52 29.10 10.01 15.08 29.66 10.19 -46.34 8.93 60.42 -45.67 8.48 60.39 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 38 3 # 38 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.67 30.58 22.61 18.30 29.87 21.17 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 14.52 29.10 10.01 15.08 29.66 10.19 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 39 3 # 39 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.67 30.58 22.61 18.30 29.87 21.17 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 14.52 29.10 10.01 15.08 29.66 10.19 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 40 3 # 40 A 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 193 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo 15.02 29.17 19.44 15.63 29.96 17.60 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 19.67 30.58 22.61 18.30 29.87 21.17 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 14.52 29.10 10.01 15.08 29.66 10.19 -31.32 27.31 48.44 -30.80 26.72 48.62 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 40 hits 1ssx_c02 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP B 131 ASP^? 9.09 C8 PG4 A 350 E 168 LYS B 134 LYS.? 7.94 O5 PG4 B 350 E 201 THR B 111 THR.? -3.92 C5 PG4 A 350s coo 5.36 16.20 22.10 3.88 17.00 23.31 0.40 27.07 22.40 -0.62 25.51 23.42 coo 5.06 22.32 18.11 1.02 22.08 22.74 1.49 32.28 22.12 4.07 30.52 27.68 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -6.89 27.93 21.89 -8.77 26.98 22.40 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 1 hits 1stc_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 80 GLU A 15 GLU.? 17.86 C3 PG4 B 350 B 223 ARG A 206 ARG~? -3.21 O4 PG4 A 350s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 3.61 55.89 43.73 3.10 55.52 45.73 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 7.25 58.10 39.87 8.59 56.71 39.00 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -5.76 36.17 21.40 -8.07 34.21 22.04 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 321 HIS~? 22.96 O4 PO4 A 349 B 80 GLU A 317 GLU~? 25.40 O4 PO4 A 349 B 223 ARG B 147 ARG~? 21.77 C2 PG4 B 350 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -5.72 80.36 11.81 -5.04 82.32 12.10 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -6.54 84.03 15.10 -5.06 85.44 15.56 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 11.90 56.41 10.58 13.26 57.05 13.30 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 80 GLU B 15 GLU.? 19.82 C3 PG4 A 350 B 223 ARG B 206 ARG~? -3.06 O4 PG4 B 350s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -13.67 16.25 7.60 -15.45 16.94 8.51 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -2.22 41.47 25.55 0.33 41.32 27.30 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 80 GLU B 15 GLU.? 19.82 C3 PG4 A 350 B 223 ARG C 220 ARG~? 11.31 O1 PG4 C 350 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -13.67 16.25 7.60 -15.45 16.94 8.51 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -25.78 14.58 38.60 -28.17 14.03 40.55 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 80 GLU B 94 GLU~? 22.11 C5 PG4 A 350 B 223 ARG B 206 ARG~? -3.06 O4 PG4 B 350s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -7.91 12.10 15.72 -7.33 10.19 14.89 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -2.22 41.47 25.55 0.33 41.32 27.30 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 80 GLU B 94 GLU~? 22.11 C5 PG4 A 350 B 223 ARG C 57 ARG.? 17.31 O4 PO4 C 349 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -9.44 13.73 10.71 -8.61 11.98 11.53 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -7.91 12.10 15.72 -7.33 10.19 14.89 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -40.16 11.74 13.21 -37.69 10.86 14.87 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 7 3 # 7 B 8 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 80 GLU C 15 GLU.? 17.45 C5 PG4 D 350 B 223 ARG C 206 ARG~? -3.06 O3 PG4 C 350s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -57.75 5.96 21.41 -58.79 5.43 23.18 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -42.81 10.68 48.87 -40.18 9.57 50.03 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 8 3 # 8 B 8 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 80 GLU C 94 GLU~? 21.12 C5 PG4 D 350 B 223 ARG C 206 ARG~? -3.06 O3 PG4 C 350s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -53.35 2.03 20.79 -52.66 0.23 19.95 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -51.22 -2.72 22.56 -51.13 -3.21 20.49 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -42.81 10.68 48.87 -40.18 9.57 50.03 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 9 3 # 9 B 8 HIS C 321 HIS~? 21.29 O1 PO4 C 349 B 80 GLU C 325 GLU~? 19.31 O1 PO4 C 349 B 223 ARG A 147 ARG~? 21.89 C2 PG4 A 350 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -50.23 42.88 20.64 -51.67 43.34 22.10 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -49.52 44.21 26.45 -50.31 42.24 26.60 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -23.00 46.39 6.22 -24.32 43.65 5.76 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 10 3 # 10 B 8 HIS C 321 HIS~? 21.29 O1 PO4 C 349 B 80 GLU C 325 GLU~? 19.31 O1 PO4 C 349 B 223 ARG A 152 ARG^? 23.60 O1 PO4 A 349 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -50.23 42.88 20.64 -51.67 43.34 22.10 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -49.52 44.21 26.45 -50.31 42.24 26.60 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -26.26 60.60 13.36 -28.56 61.89 11.76 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 11 3 # 11 B 8 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 80 GLU D 15 GLU.? 19.32 C4 PG4 C 350 B 223 ARG D 206 ARG~? -3.23 O2 PG4 D 350s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -33.73 9.80 72.63 -32.07 9.73 71.31 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -46.64 9.92 42.41 -48.92 7.98 41.78 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 12 3 # 12 B 8 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 80 GLU D 94 GLU~? 22.39 C6 PG4 C 350 B 223 ARG D 206 ARG~? -3.23 O2 PG4 D 350s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -37.83 5.64 73.04 -38.41 3.86 73.97 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -39.10 0.33 71.21 -39.59 -0.04 73.26 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -46.64 9.92 42.41 -48.92 7.98 41.78 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 12 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 212 GLY~? 9.07 O1 PG4 A 350 B 17 GLN A 216 GLN~? 7.36 O1 PG4 A 350 B 140 GLU A 215 GLU~? 13.07 C2 PG4 A 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 -15.16 41.65 16.73 -14.78 42.24 17.11 coo 63.76 11.90 7.93 65.18 13.07 6.77 -19.93 41.08 21.62 -18.69 39.99 22.97 coo 66.44 19.00 7.38 67.69 17.67 8.37 -19.69 43.42 15.07 -19.36 42.01 13.60 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY A 212 GLY~? 9.07 O1 PG4 A 350 B 17 GLN A 252 GLN~? 20.06 C2 PG4 A 350 B 140 GLU A 215 GLU~? 13.07 C2 PG4 A 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 -15.16 41.65 16.73 -14.78 42.24 17.11 coo 63.76 11.90 7.93 65.18 13.07 6.77 -19.54 48.29 10.12 -18.57 48.04 8.22 coo 66.44 19.00 7.38 67.69 17.67 8.37 -19.69 43.42 15.07 -19.36 42.01 13.60 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY A 250 GLY~? 14.78 O1 PG4 A 350 B 17 GLN A 216 GLN~? 7.36 O1 PG4 A 350 B 140 GLU A 215 GLU~? 13.07 C2 PG4 A 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 -16.12 46.96 14.05 -16.23 47.66 13.72 coo 63.76 11.90 7.93 65.18 13.07 6.77 -19.93 41.08 21.62 -18.69 39.99 22.97 coo 66.44 19.00 7.38 67.69 17.67 8.37 -19.69 43.42 15.07 -19.36 42.01 13.60 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY B 212 GLY~? 9.26 O1 PG4 B 350 B 17 GLN B 216 GLN~? 7.61 O1 PG4 B 350 B 140 GLU B 215 GLU~? 13.59 C2 PG4 B 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 6.02 46.22 18.32 5.64 45.65 17.83 coo 63.76 11.90 7.93 65.18 13.07 6.77 11.42 42.35 19.15 10.50 41.03 20.54 coo 66.44 19.00 7.38 67.69 17.67 8.37 10.14 48.09 15.50 9.78 49.78 16.69 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 5 3 # 5 A 261 GLY B 212 GLY~? 9.26 O1 PG4 B 350 B 17 GLN B 252 GLN~? 20.40 C2 PG4 B 350 B 140 GLU B 215 GLU~? 13.59 C2 PG4 B 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 6.02 46.22 18.32 5.64 45.65 17.83 coo 63.76 11.90 7.93 65.18 13.07 6.77 8.85 51.73 9.90 7.57 53.45 9.91 coo 66.44 19.00 7.38 67.69 17.67 8.37 10.14 48.09 15.50 9.78 49.78 16.69 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 6 3 # 6 A 261 GLY B 250 GLY~? 14.99 O1 PG4 B 350 B 17 GLN B 216 GLN~? 7.61 O1 PG4 B 350 B 140 GLU B 215 GLU~? 13.59 C2 PG4 B 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 6.04 47.81 12.44 6.05 48.05 11.67 coo 63.76 11.90 7.93 65.18 13.07 6.77 11.42 42.35 19.15 10.50 41.03 20.54 coo 66.44 19.00 7.38 67.69 17.67 8.37 10.14 48.09 15.50 9.78 49.78 16.69 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 7 3 # 7 A 261 GLY C 212 GLY~? 9.26 C2 PG4 C 350 B 17 GLN C 216 GLN~? 7.49 O1 PG4 C 350 B 140 GLU C 215 GLU~? 13.26 C2 PG4 C 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 -34.69 19.16 46.59 -35.10 19.11 45.88 coo 63.76 11.90 7.93 65.18 13.07 6.77 -29.55 15.50 43.86 -30.62 13.67 44.21 coo 66.44 19.00 7.38 67.69 17.67 8.37 -30.56 22.29 45.75 -30.82 22.67 47.79 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 8 3 # 8 A 261 GLY C 212 GLY~? 9.26 C2 PG4 C 350 B 17 GLN C 252 GLN~? 20.11 C2 PG4 C 350 B 140 GLU C 215 GLU~? 13.26 C2 PG4 C 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 -34.69 19.16 46.59 -35.10 19.11 45.88 coo 63.76 11.90 7.93 65.18 13.07 6.77 -31.89 28.94 44.68 -33.00 30.08 46.12 coo 66.44 19.00 7.38 67.69 17.67 8.37 -30.56 22.29 45.75 -30.82 22.67 47.79 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 9 3 # 9 A 261 GLY C 250 GLY~? 15.20 C2 PG4 C 350 B 17 GLN C 216 GLN~? 7.49 O1 PG4 C 350 B 140 GLU C 215 GLU~? 13.26 C2 PG4 C 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 -34.85 24.44 43.72 -34.85 25.15 43.35 coo 63.76 11.90 7.93 65.18 13.07 6.77 -29.55 15.50 43.86 -30.62 13.67 44.21 coo 66.44 19.00 7.38 67.69 17.67 8.37 -30.56 22.29 45.75 -30.82 22.67 47.79 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 10 3 # 10 A 261 GLY D 212 GLY~? 8.60 O5 PG4 D 350 B 17 GLN D 216 GLN~? 6.81 O5 PG4 D 350 B 140 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 -55.90 16.99 43.52 -55.53 17.14 44.23 coo 63.76 11.90 7.93 65.18 13.07 6.77 -60.48 13.07 46.91 -59.29 11.30 46.96 coo 66.44 19.00 7.38 67.69 17.67 8.37 -60.56 19.61 44.11 -60.32 19.66 42.03 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 11 3 # 11 A 261 GLY D 212 GLY~? 8.60 O5 PG4 D 350 B 17 GLN D 252 GLN~? 19.62 O5 PG4 D 350 B 140 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 -55.90 16.99 43.52 -55.53 17.14 44.23 coo 63.76 11.90 7.93 65.18 13.07 6.77 -60.59 26.35 44.25 -59.32 27.46 42.92 coo 66.44 19.00 7.38 67.69 17.67 8.37 -60.56 19.61 44.11 -60.32 19.66 42.03 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 12 3 # 12 A 261 GLY D 250 GLY~? 14.38 O5 PG4 D 350 B 17 GLN D 216 GLN~? 6.81 O5 PG4 D 350 B 140 GLU D 215 GLU~? 12.92 O5 PG4 D 350 coo 61.49 19.86 5.96 61.52 19.46 5.16 -56.76 22.61 45.76 -56.89 23.34 46.02 coo 63.76 11.90 7.93 65.18 13.07 6.77 -60.48 13.07 46.91 -59.29 11.30 46.96 coo 66.44 19.00 7.38 67.69 17.67 8.37 -60.56 19.61 44.11 -60.32 19.66 42.03 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 12 hits 1t4c_c02 naa= 3 ULMN 3 1tah_c00 LIPASE user 1 3 # 1 B 87 SER A 64 SER~? 26.25 O3 PG4 B 350 B 263 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 285 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 1.46 56.04 50.07 2.12 55.38 52.31 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 1.74 60.96 43.57 3.36 61.47 42.28 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1tah_c00 LIPASE user 2 3 # 2 B 87 SER A 241 SER.? 9.98 O3 PO4 A 349 B 263 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 285 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -1.16 62.88 18.52 0.68 62.16 19.33 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1tah_c00 LIPASE user 3 3 # 3 B 87 SER B 64 SER~? 26.98 C5 PG4 A 350 B 263 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 285 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1tah_c00 LIPASE user 4 3 # 4 B 87 SER B 241 SER.? 10.02 O1 PO4 B 349 B 263 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 285 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1tah_c00 LIPASE user 5 3 # 5 B 87 SER C 64 SER~? 25.88 C5 PG4 D 350 B 263 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 285 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1tah_c00 LIPASE user 6 3 # 6 B 87 SER C 241 SER.? 9.97 O3 PO4 C 349 B 263 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 285 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1tah_c00 LIPASE user 7 3 # 7 B 87 SER D 64 SER~? 27.50 C6 PG4 C 350 B 263 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 285 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1tah_c00 LIPASE user 8 3 # 8 B 87 SER D 241 SER.? 10.08 O3 PO4 D 349 B 263 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 285 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -38.74 26.41 54.26 -37.48 24.84 54.87 1tah_c00 source 1tah LIPASE : 8 hits 1tah_c00 naa= 3 ULMN 3 1tah_c01 LIPASE user 1 3 # 1 A 87 SER A 64 SER~? 26.25 O3 PG4 B 350 A 263 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 285 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 1.46 56.04 50.07 2.12 55.38 52.31 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 1.74 60.96 43.57 3.36 61.47 42.28 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1tah_c01 LIPASE user 2 3 # 2 A 87 SER A 241 SER.? 9.98 O3 PO4 A 349 A 263 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 285 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -1.16 62.88 18.52 0.68 62.16 19.33 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1tah_c01 LIPASE user 3 3 # 3 A 87 SER B 64 SER~? 26.98 C5 PG4 A 350 A 263 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 285 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1tah_c01 LIPASE user 4 3 # 4 A 87 SER B 241 SER.? 10.02 O1 PO4 B 349 A 263 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 285 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1tah_c01 LIPASE user 5 3 # 5 A 87 SER C 64 SER~? 25.88 C5 PG4 D 350 A 263 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 285 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1tah_c01 LIPASE user 6 3 # 6 A 87 SER C 241 SER.? 9.97 O3 PO4 C 349 A 263 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 285 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1tah_c01 LIPASE user 7 3 # 7 A 87 SER D 64 SER~? 27.50 C6 PG4 C 350 A 263 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 285 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1tah_c01 LIPASE user 8 3 # 8 A 87 SER D 241 SER.? 10.08 O3 PO4 D 349 A 263 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 285 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -38.74 26.41 54.26 -37.48 24.84 54.87 1tah_c01 source 1tah LIPASE : 8 hits 1tah_c01 naa= 3 ULMN 3 1tah_c02 LIPASE user 1 3 # 1 C 87 SER A 64 SER~? 26.25 O3 PG4 B 350 C 263 ASP A 41 ASP.? 20.10 O2 PO4 A 349 C 285 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 1.46 56.04 50.07 2.12 55.38 52.31 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 1.74 60.96 43.57 3.36 61.47 42.28 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1tah_c02 LIPASE user 2 3 # 2 C 87 SER A 241 SER.? 9.98 O3 PO4 A 349 C 263 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 285 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -0.69 52.51 16.88 -2.72 53.79 17.21 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -1.16 62.88 18.52 0.68 62.16 19.33 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1tah_c02 LIPASE user 3 3 # 3 C 87 SER B 64 SER~? 26.98 C5 PG4 A 350 C 263 ASP B 41 ASP.? 20.21 O3 PO4 B 349 C 285 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -6.23 8.13 11.77 -6.66 5.89 12.66 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -7.40 13.29 5.68 -9.25 14.12 5.01 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1tah_c02 LIPASE user 4 3 # 4 C 87 SER B 241 SER.? 10.02 O1 PO4 B 349 C 263 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 285 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -9.21 42.20 9.74 -7.29 41.83 8.32 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1tah_c02 LIPASE user 5 3 # 5 C 87 SER C 64 SER~? 25.88 C5 PG4 D 350 C 263 ASP C 41 ASP.? 20.22 O4 PO4 C 349 C 285 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -52.23 5.22 16.50 -53.97 6.36 17.05 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1tah_c02 LIPASE user 6 3 # 6 C 87 SER C 241 SER.? 9.97 O3 PO4 C 349 C 263 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 285 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -50.53 22.77 38.79 -48.65 23.56 37.48 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1tah_c02 LIPASE user 7 3 # 7 C 87 SER D 64 SER~? 27.50 C6 PG4 C 350 C 263 ASP D 41 ASP.? 20.92 O2 PO4 D 349 C 285 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -39.78 8.95 76.71 -38.11 10.21 76.27 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1tah_c02 LIPASE user 8 3 # 8 C 87 SER D 241 SER.? 10.08 O3 PO4 D 349 C 263 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 285 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -41.15 24.23 50.62 -43.08 24.97 51.88 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -38.74 26.41 54.26 -37.48 24.84 54.87 1tah_c02 source 1tah LIPASE : 8 hits 1tah_c02 naa= 3 ULMN 3 1tah_c03 LIPASE user 1 3 # 1 D 87 SER A 64 SER~? 26.25 O3 PG4 B 350 D 263 ASP A 41 ASP.? 20.10 O2 PO4 A 349 D 285 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 1.46 56.04 50.07 2.12 55.38 52.31 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 1.74 60.96 43.57 3.36 61.47 42.28 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1tah_c03 LIPASE user 2 3 # 2 D 87 SER A 241 SER.? 9.98 O3 PO4 A 349 D 263 ASP A 160 ASP.? 8.60 O4 PO4 A 349 D 285 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -0.69 52.51 16.88 -2.72 53.79 17.21 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -1.16 62.88 18.52 0.68 62.16 19.33 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1tah_c03 LIPASE user 3 3 # 3 D 87 SER B 64 SER~? 26.98 C5 PG4 A 350 D 263 ASP B 41 ASP.? 20.21 O3 PO4 B 349 D 285 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -6.23 8.13 11.77 -6.66 5.89 12.66 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -7.40 13.29 5.68 -9.25 14.12 5.01 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1tah_c03 LIPASE user 4 3 # 4 D 87 SER B 241 SER.? 10.02 O1 PO4 B 349 D 263 ASP B 160 ASP.? 8.62 O4 PO4 B 349 D 285 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -9.21 42.20 9.74 -7.29 41.83 8.32 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1tah_c03 LIPASE user 5 3 # 5 D 87 SER C 64 SER~? 25.88 C5 PG4 D 350 D 263 ASP C 41 ASP.? 20.22 O4 PO4 C 349 D 285 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -52.23 5.22 16.50 -53.97 6.36 17.05 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1tah_c03 LIPASE user 6 3 # 6 D 87 SER C 241 SER.? 9.97 O3 PO4 C 349 D 263 ASP C 160 ASP.? 8.57 O1 PO4 C 349 D 285 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -50.53 22.77 38.79 -48.65 23.56 37.48 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1tah_c03 LIPASE user 7 3 # 7 D 87 SER D 64 SER~? 27.50 C6 PG4 C 350 D 263 ASP D 41 ASP.? 20.92 O2 PO4 D 349 D 285 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -39.78 8.95 76.71 -38.11 10.21 76.27 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1tah_c03 LIPASE user 8 3 # 8 D 87 SER D 241 SER.? 10.08 O3 PO4 D 349 D 263 ASP D 160 ASP.? 8.58 O4 PO4 D 349 D 285 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -41.15 24.23 50.62 -43.08 24.97 51.88 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -38.74 26.41 54.26 -37.48 24.84 54.87 1tah_c03 source 1tah LIPASE : 8 hits 1tah_c03 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 142 ALA.? 12.14 C2 PG4 A 350 A 251 GLY A 212 GLY~? 9.07 O1 PG4 A 350 A 252 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -16.20 40.87 12.81 -15.80 42.33 13.02 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -15.16 41.65 16.73 -14.78 42.24 17.11 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA A 187 ALA.? 10.63 O1 PO4 A 349 A 251 GLY A 199 GLY.? 14.09 O1 PG4 A 350 A 252 ASP A 198 ASP.? 17.22 O1 PO4 A 349 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -15.70 52.98 26.26 -15.60 52.72 27.75 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -17.17 48.70 27.51 -16.96 48.00 27.99 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -20.04 48.14 30.81 -21.28 49.70 29.91 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA A 201 ALA~? 12.43 O1 PG4 A 350 A 251 GLY A 189 GLY~? 8.76 O1 PO4 A 349 A 252 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -10.23 47.67 26.68 -9.44 47.25 27.90 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA A 338 ALA~? 14.94 O1 PO4 A 349 A 251 GLY A 337 GLY~? 17.24 O2 PO4 A 349 A 252 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -19.69 73.64 23.95 -19.01 73.56 23.47 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 5 3 # 5 A 250 ALA B 142 ALA.? 12.37 C2 PG4 B 350 A 251 GLY B 212 GLY~? 9.26 O1 PG4 B 350 A 252 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 6.73 50.30 18.21 6.20 49.71 16.95 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 6.02 46.22 18.32 5.64 45.65 17.83 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 6 3 # 6 A 250 ALA B 187 ALA.? 10.53 O2 PO4 B 349 A 251 GLY B 199 GLY.? 13.71 O1 PG4 B 350 A 252 ASP B 198 ASP.? 14.38 O1 PG4 B 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 6.84 34.76 9.15 6.94 33.32 9.66 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 8.71 34.57 13.67 8.56 34.17 14.43 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 11.89 31.57 14.26 12.37 32.72 16.00 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 7 3 # 7 A 250 ALA B 201 ALA~? 11.68 O5 PG4 A 350 A 251 GLY B 189 GLY~? 8.50 O2 PO4 B 349 A 252 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 1.77 34.76 14.91 1.15 33.57 15.58 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 1.22 33.78 11.00 2.03 33.50 11.09 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 8 3 # 8 A 250 ALA B 338 ALA~? 14.85 O2 PO4 B 349 A 251 GLY B 337 GLY~? 16.94 O3 PO4 B 349 A 252 ASP B 339 ASP~? 20.98 O2 PO4 B 349 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 8.09 33.07 -11.69 7.39 33.52 -11.68 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 12.36 37.42 -12.59 13.93 36.17 -11.84 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 9 3 # 9 A 250 ALA C 142 ALA.? 12.35 C2 PG4 C 350 A 251 GLY C 212 GLY~? 9.26 C2 PG4 C 350 A 252 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -33.86 22.03 49.44 -34.51 22.67 48.24 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -34.69 19.16 46.59 -35.10 19.11 45.88 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 10 3 # 10 A 250 ALA C 187 ALA.? 10.66 O2 PO4 C 349 A 251 GLY C 199 GLY.? 14.01 O1 PG4 C 350 A 252 ASP C 198 ASP.? 14.11 O1 PG4 C 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -34.89 17.65 31.97 -34.86 16.31 31.26 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -32.88 14.56 34.60 -33.00 13.70 34.89 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -29.82 11.85 32.90 -29.50 11.63 35.01 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 11 3 # 11 A 250 ALA C 201 ALA~? 12.26 O1 PG4 C 350 A 251 GLY C 189 GLY~? 8.64 O2 PO4 C 349 A 252 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -39.60 13.45 36.30 -40.20 12.08 36.02 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -40.49 15.78 32.96 -39.70 15.56 32.71 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 12 3 # 12 A 250 ALA C 338 ALA~? 14.81 O2 PO4 C 349 A 251 GLY C 337 GLY~? 17.12 O2 PO4 C 349 A 252 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -34.47 31.36 16.09 -35.14 31.66 16.46 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 13 3 # 13 A 250 ALA D 187 ALA.? 10.52 O1 PO4 D 349 A 251 GLY D 199 GLY.? 13.68 O5 PG4 D 350 A 252 ASP D 198 ASP.? 14.02 O5 PG4 D 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -55.68 17.82 58.37 -55.49 16.55 59.17 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -57.03 13.69 56.19 -56.77 12.88 56.00 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -59.61 10.87 58.41 -59.89 10.18 56.43 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 14 3 # 14 A 250 ALA D 201 ALA~? 12.42 C7 PG4 C 350 A 251 GLY D 189 GLY~? 8.43 O1 PO4 D 349 A 252 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -50.29 13.95 54.51 -49.45 12.81 55.00 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 15 3 # 15 A 250 ALA D 338 ALA~? 15.02 O1 PO4 D 349 A 251 GLY D 337 GLY~? 16.88 O2 PO4 D 349 A 252 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -59.57 33.12 68.34 -59.94 31.78 67.75 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -58.47 33.44 71.99 -57.91 33.83 71.55 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -63.02 36.35 69.71 -64.42 35.04 70.68 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 15 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 142 ALA.? 12.14 C2 PG4 A 350 B 251 GLY A 212 GLY~? 9.07 O1 PG4 A 350 B 252 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -16.20 40.87 12.81 -15.80 42.33 13.02 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -15.16 41.65 16.73 -14.78 42.24 17.11 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA A 187 ALA.? 10.63 O1 PO4 A 349 B 251 GLY A 199 GLY.? 14.09 O1 PG4 A 350 B 252 ASP A 198 ASP.? 17.22 O1 PO4 A 349 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -15.70 52.98 26.26 -15.60 52.72 27.75 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -17.17 48.70 27.51 -16.96 48.00 27.99 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -20.04 48.14 30.81 -21.28 49.70 29.91 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA A 201 ALA~? 12.43 O1 PG4 A 350 B 251 GLY A 189 GLY~? 8.76 O1 PO4 A 349 B 252 ASP A 203 ASP~? 10.68 C3 PG4 B 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -10.23 47.67 26.68 -9.44 47.25 27.90 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -4.78 48.60 23.67 -4.98 49.09 25.71 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA A 338 ALA~? 14.94 O1 PO4 A 349 B 251 GLY A 337 GLY~? 17.24 O2 PO4 A 349 B 252 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -19.69 73.64 23.95 -19.01 73.56 23.47 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 5 3 # 5 B 250 ALA B 142 ALA.? 12.37 C2 PG4 B 350 B 251 GLY B 212 GLY~? 9.26 O1 PG4 B 350 B 252 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 6.73 50.30 18.21 6.20 49.71 16.95 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 6.02 46.22 18.32 5.64 45.65 17.83 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 6 3 # 6 B 250 ALA B 187 ALA.? 10.53 O2 PO4 B 349 B 251 GLY B 199 GLY.? 13.71 O1 PG4 B 350 B 252 ASP B 198 ASP.? 14.38 O1 PG4 B 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 6.84 34.76 9.15 6.94 33.32 9.66 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 8.71 34.57 13.67 8.56 34.17 14.43 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 11.89 31.57 14.26 12.37 32.72 16.00 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 7 3 # 7 B 250 ALA B 201 ALA~? 11.68 O5 PG4 A 350 B 251 GLY B 189 GLY~? 8.50 O2 PO4 B 349 B 252 ASP B 203 ASP~? 9.89 C4 PG4 A 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 1.77 34.76 14.91 1.15 33.57 15.58 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 1.22 33.78 11.00 2.03 33.50 11.09 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -4.02 37.06 13.77 -3.95 34.93 13.81 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 8 3 # 8 B 250 ALA B 338 ALA~? 14.85 O2 PO4 B 349 B 251 GLY B 337 GLY~? 16.94 O3 PO4 B 349 B 252 ASP B 339 ASP~? 20.98 O2 PO4 B 349 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 8.09 33.07 -11.69 7.39 33.52 -11.68 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 12.36 37.42 -12.59 13.93 36.17 -11.84 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 9 3 # 9 B 250 ALA C 142 ALA.? 12.35 C2 PG4 C 350 B 251 GLY C 212 GLY~? 9.26 C2 PG4 C 350 B 252 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -33.86 22.03 49.44 -34.51 22.67 48.24 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -34.69 19.16 46.59 -35.10 19.11 45.88 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 10 3 # 10 B 250 ALA C 187 ALA.? 10.66 O2 PO4 C 349 B 251 GLY C 199 GLY.? 14.01 O1 PG4 C 350 B 252 ASP C 198 ASP.? 14.11 O1 PG4 C 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -34.89 17.65 31.97 -34.86 16.31 31.26 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -32.88 14.56 34.60 -33.00 13.70 34.89 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -29.82 11.85 32.90 -29.50 11.63 35.01 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 11 3 # 11 B 250 ALA C 201 ALA~? 12.26 O1 PG4 C 350 B 251 GLY C 189 GLY~? 8.64 O2 PO4 C 349 B 252 ASP C 203 ASP~? 10.24 C6 PG4 D 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -39.60 13.45 36.30 -40.20 12.08 36.02 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -40.49 15.78 32.96 -39.70 15.56 32.71 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -45.27 15.71 37.60 -45.14 14.14 36.20 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 12 3 # 12 B 250 ALA C 338 ALA~? 14.81 O2 PO4 C 349 B 251 GLY C 337 GLY~? 17.12 O2 PO4 C 349 B 252 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -34.47 31.36 16.09 -35.14 31.66 16.46 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 13 3 # 13 B 250 ALA D 187 ALA.? 10.52 O1 PO4 D 349 B 251 GLY D 199 GLY.? 13.68 O5 PG4 D 350 B 252 ASP D 198 ASP.? 14.02 O5 PG4 D 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -55.68 17.82 58.37 -55.49 16.55 59.17 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -57.03 13.69 56.19 -56.77 12.88 56.00 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -59.61 10.87 58.41 -59.89 10.18 56.43 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 14 3 # 14 B 250 ALA D 201 ALA~? 12.42 C7 PG4 C 350 B 251 GLY D 189 GLY~? 8.43 O1 PO4 D 349 B 252 ASP D 203 ASP~? 10.40 O3 PG4 C 350 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -50.29 13.95 54.51 -49.45 12.81 55.00 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -45.07 16.93 52.92 -45.16 15.64 54.59 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 15 3 # 15 B 250 ALA D 338 ALA~? 15.02 O1 PO4 D 349 B 251 GLY D 337 GLY~? 16.88 O2 PO4 D 349 B 252 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -59.57 33.12 68.34 -59.94 31.78 67.75 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -58.47 33.44 71.99 -57.91 33.83 71.55 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -63.02 36.35 69.71 -64.42 35.04 70.68 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 15 hits 1tz3_c03 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 196 GLU~? 14.14 O1 PO4 A 349 A 126 LYS A 184 LYS^? 18.49 O1 PO4 A 349 A 171 ALA A 187 ALA.? 10.63 O1 PO4 A 349 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -15.70 52.98 26.26 -15.60 52.72 27.75 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU B 196 GLU~? 13.82 O2 PO4 B 349 A 126 LYS B 184 LYS^? 17.27 O2 PO4 B 349 A 171 ALA B 187 ALA.? 10.53 O2 PO4 B 349 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 10.06 30.74 8.04 11.63 30.24 6.70 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 15.36 36.70 4.47 15.17 34.16 8.91 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 6.84 34.76 9.15 6.94 33.32 9.66 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU C 70 GLU~? 32.89 O4 PO4 C 349 A 126 LYS C 72 LYS~? 33.77 C3 PG4 D 350 A 171 ALA C 67 ALA~? 28.90 C5 PG4 D 350 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -43.64 -5.35 8.13 -45.41 -4.88 7.08 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -38.31 -4.87 13.60 -38.37 -10.28 12.47 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -48.28 -5.14 12.94 -49.46 -4.26 12.54 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU C 70 GLU~? 32.89 O4 PO4 C 349 A 126 LYS C 72 LYS~? 33.77 C3 PG4 D 350 A 171 ALA C 68 ALA~? 26.31 O3 PG4 D 350 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -43.64 -5.35 8.13 -45.41 -4.88 7.08 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -38.31 -4.87 13.60 -38.37 -10.28 12.47 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -45.24 -3.04 14.02 -45.15 -2.24 15.32 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU C 196 GLU~? 13.61 O2 PO4 C 349 A 126 LYS C 184 LYS^? 18.13 O2 PO4 C 349 A 171 ALA C 187 ALA.? 10.66 O2 PO4 C 349 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -34.89 17.65 31.97 -34.86 16.31 31.26 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 A 46 GLU D 196 GLU~? 13.48 O1 PO4 D 349 A 126 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 171 ALA D 187 ALA.? 10.52 O1 PO4 D 349 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -55.68 17.82 58.37 -55.49 16.55 59.17 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 6 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 196 GLU~? 14.14 O1 PO4 A 349 B 126 LYS A 184 LYS^? 18.49 O1 PO4 A 349 B 171 ALA A 187 ALA.? 10.63 O1 PO4 A 349 coo 20.47 87.42 16.54 20.16 87.17 14.45 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 24.73 94.37 14.59 21.08 89.84 11.98 -24.93 56.02 24.66 -24.65 51.60 28.30 coo 24.38 86.32 12.71 22.88 86.54 12.71 -15.70 52.98 26.26 -15.60 52.72 27.75 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU B 196 GLU~? 13.82 O2 PO4 B 349 B 126 LYS B 184 LYS^? 17.27 O2 PO4 B 349 B 171 ALA B 187 ALA.? 10.53 O2 PO4 B 349 coo 20.47 87.42 16.54 20.16 87.17 14.45 10.06 30.74 8.04 11.63 30.24 6.70 coo 24.73 94.37 14.59 21.08 89.84 11.98 15.36 36.70 4.47 15.17 34.16 8.91 coo 24.38 86.32 12.71 22.88 86.54 12.71 6.84 34.76 9.15 6.94 33.32 9.66 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU C 70 GLU~? 32.89 O4 PO4 C 349 B 126 LYS C 72 LYS~? 33.77 C3 PG4 D 350 B 171 ALA C 67 ALA~? 28.90 C5 PG4 D 350 coo 20.47 87.42 16.54 20.16 87.17 14.45 -43.64 -5.35 8.13 -45.41 -4.88 7.08 coo 24.73 94.37 14.59 21.08 89.84 11.98 -38.31 -4.87 13.60 -38.37 -10.28 12.47 coo 24.38 86.32 12.71 22.88 86.54 12.71 -48.28 -5.14 12.94 -49.46 -4.26 12.54 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU C 70 GLU~? 32.89 O4 PO4 C 349 B 126 LYS C 72 LYS~? 33.77 C3 PG4 D 350 B 171 ALA C 68 ALA~? 26.31 O3 PG4 D 350 coo 20.47 87.42 16.54 20.16 87.17 14.45 -43.64 -5.35 8.13 -45.41 -4.88 7.08 coo 24.73 94.37 14.59 21.08 89.84 11.98 -38.31 -4.87 13.60 -38.37 -10.28 12.47 coo 24.38 86.32 12.71 22.88 86.54 12.71 -45.24 -3.04 14.02 -45.15 -2.24 15.32 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU C 196 GLU~? 13.61 O2 PO4 C 349 B 126 LYS C 184 LYS^? 18.13 O2 PO4 C 349 B 171 ALA C 187 ALA.? 10.66 O2 PO4 C 349 coo 20.47 87.42 16.54 20.16 87.17 14.45 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 24.73 94.37 14.59 21.08 89.84 11.98 -26.52 22.11 29.66 -26.07 16.73 31.07 coo 24.38 86.32 12.71 22.88 86.54 12.71 -34.89 17.65 31.97 -34.86 16.31 31.26 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 B 46 GLU D 196 GLU~? 13.48 O1 PO4 D 349 B 126 LYS D 184 LYS^? 18.69 O1 PO4 D 349 B 171 ALA D 187 ALA.? 10.52 O1 PO4 D 349 coo 20.47 87.42 16.54 20.16 87.17 14.45 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 24.73 94.37 14.59 21.08 89.84 11.98 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 24.38 86.32 12.71 22.88 86.54 12.71 -55.68 17.82 58.37 -55.49 16.55 59.17 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 6 hits 1uf7_c01 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 14 HIS.? 20.33 C3 PG4 B 350 89 GLU A 15 GLU.? 17.86 C3 PG4 B 350 243 ASN A 107 ASN^? 9.64 C5 PG4 B 350 coo 5.83 15.74 17.38 6.41 17.70 17.86 3.61 55.89 43.73 3.10 55.52 45.73 coo 3.11 16.19 13.44 4.96 17.09 13.42 7.25 58.10 39.87 8.59 56.71 39.00 coo 0.53 21.81 31.33 1.05 20.47 29.70 -5.73 45.70 37.96 -3.97 45.35 36.84 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS B 14 HIS.? 21.30 C5 PG4 A 350 89 GLU B 15 GLU.? 19.82 C3 PG4 A 350 243 ASN B 107 ASN^? 9.43 C5 PG4 A 350 coo 5.83 15.74 17.38 6.41 17.70 17.86 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 3.11 16.19 13.44 4.96 17.09 13.42 -13.67 16.25 7.60 -15.45 16.94 8.51 coo 0.53 21.81 31.33 1.05 20.47 29.70 -1.39 23.50 19.22 -3.25 24.51 19.38 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS C 14 HIS.? 19.64 C5 PG4 D 350 89 GLU C 15 GLU.? 17.45 C5 PG4 D 350 243 ASN C 107 ASN^? 9.61 C3 PG4 D 350 coo 5.83 15.74 17.38 6.41 17.70 17.86 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 3.11 16.19 13.44 4.96 17.09 13.42 -57.75 5.96 21.41 -58.79 5.43 23.18 coo 0.53 21.81 31.33 1.05 20.47 29.70 -42.97 2.46 31.63 -44.77 2.90 32.68 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS D 14 HIS.? 21.26 C4 PG4 C 350 89 GLU D 15 GLU.? 19.32 C4 PG4 C 350 243 ASN D 107 ASN^? 9.34 C6 PG4 C 350 coo 5.83 15.74 17.38 6.41 17.70 17.86 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 3.11 16.19 13.44 4.96 17.09 13.42 -33.73 9.80 72.63 -32.07 9.73 71.31 coo 0.53 21.81 31.33 1.05 20.47 29.70 -46.02 4.22 60.61 -44.32 4.89 59.53 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 4 hits 1ula_c00 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 41 ASP.? 20.10 O2 PO4 A 349 255 GLU A 15 GLU.? 17.86 C3 PG4 B 350 329 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.74 60.96 43.57 3.36 61.47 42.28 coo 52.57 37.12 10.17 53.37 35.95 11.75 7.25 58.10 39.87 8.59 56.71 39.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 311 ASP~? 22.86 O3 PO4 B 349 255 GLU B 312 GLU~? 22.88 O3 PO4 B 349 329 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -7.01 27.41 -19.12 -7.82 28.98 -20.32 coo 52.57 37.12 10.17 53.37 35.95 11.75 -0.30 29.09 -19.54 1.27 27.97 -20.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP C 311 ASP~? 22.87 O4 PO4 C 349 255 GLU C 312 GLU~? 22.95 O4 PO4 C 349 329 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -50.03 32.79 8.00 -51.02 34.70 8.05 coo 52.57 37.12 10.17 53.37 35.95 11.75 -43.40 34.54 8.60 -41.92 34.59 7.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP D 311 ASP~? 22.85 O2 PO4 D 349 255 GLU D 312 GLU~? 22.27 O2 PO4 D 349 329 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -43.35 38.70 79.64 -42.93 40.74 79.14 coo 52.57 37.12 10.17 53.37 35.95 11.75 -50.13 39.19 79.01 -51.63 38.45 80.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -51.05 35.32 70.59 -50.24 33.36 70.95 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 4 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 41 ASP.? 20.10 O2 PO4 A 349 218 GLU A 135 GLU.? -3.98 O1 PG4 A 350s 329 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.74 60.96 43.57 3.36 61.47 42.28 coo 70.09 11.71 8.46 70.56 12.89 6.77 -10.19 39.37 24.45 -9.09 38.16 23.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 41 ASP.? 20.10 O2 PO4 A 349 218 GLU B 215 GLU~? 13.59 C2 PG4 B 350 329 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.74 60.96 43.57 3.36 61.47 42.28 coo 70.09 11.71 8.46 70.56 12.89 6.77 10.14 48.09 15.50 9.78 49.78 16.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 332 ASP~? 12.07 O2 PO4 A 349 218 GLU A 215 GLU~? 13.07 C2 PG4 A 350 329 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP C 332 ASP~? 12.18 O4 PO4 C 349 218 GLU C 215 GLU~? 13.26 C2 PG4 C 350 329 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 70.09 11.71 8.46 70.56 12.89 6.77 -30.56 22.29 45.75 -30.82 22.67 47.79 coo 59.16 37.82 13.95 57.63 37.03 15.12 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP D 332 ASP~? 12.02 O2 PO4 D 349 218 GLU D 215 GLU~? 12.92 O5 PG4 D 350 329 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 70.09 11.71 8.46 70.56 12.89 6.77 -60.56 19.61 44.11 -60.32 19.66 42.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 -63.02 36.35 69.71 -64.42 35.04 70.68 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 5 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 140 ASP.? 7.37 O2 PG4 A 350 242 GLU C 171 GLU~? 12.90 O2 PO4 C 349 329 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 30.42 34.74 5.00 29.09 35.09 3.38 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 208 ASP~? 8.51 C3 PG4 A 350 242 GLU B 196 GLU~? 13.82 O2 PO4 B 349 329 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 30.42 34.74 5.00 29.09 35.09 3.38 10.06 30.74 8.04 11.63 30.24 6.70 coo 59.16 37.82 13.95 57.63 37.03 15.12 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 208 ASP~? 8.51 C3 PG4 A 350 242 GLU B 215 GLU~? 13.59 C2 PG4 B 350 329 ASP A 140 ASP.? 7.37 O2 PG4 A 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 30.42 34.74 5.00 29.09 35.09 3.38 10.14 48.09 15.50 9.78 49.78 16.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -17.33 36.17 16.29 -18.45 34.60 17.12 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 332 ASP~? 12.07 O2 PO4 A 349 242 GLU A 280 GLU~? 22.33 O4 PO4 A 349 329 ASP A 339 ASP~? 20.53 O1 PO4 A 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.09 74.10 21.91 -11.23 73.05 23.55 coo 30.42 34.74 5.00 29.09 35.09 3.38 -2.67 65.99 2.80 -3.14 64.76 1.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 -24.08 73.03 20.51 -24.61 72.81 22.55 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 208 ASP~? 8.88 C3 PG4 B 350 242 GLU A 196 GLU~? 14.14 O1 PO4 A 349 329 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 -18.66 54.90 30.43 -20.55 55.76 30.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 208 ASP~? 8.88 C3 PG4 B 350 242 GLU A 215 GLU~? 13.07 C2 PG4 A 350 329 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.69 43.42 15.07 -19.36 42.01 13.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 332 ASP~? 12.13 O3 PO4 B 349 242 GLU B 196 GLU~? 13.82 O2 PO4 B 349 329 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 10.06 30.74 8.04 11.63 30.24 6.70 coo 59.16 37.82 13.95 57.63 37.03 15.12 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 332 ASP~? 12.13 O3 PO4 B 349 242 GLU B 280 GLU~? 22.45 O4 PO4 B 349 329 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 -10.91 53.12 -6.46 -10.34 55.07 -5.90 coo 59.16 37.82 13.95 57.63 37.03 15.12 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 332 ASP~? 12.13 O3 PO4 B 349 242 GLU B 286 GLU~? 20.04 O4 PO4 B 349 329 ASP B 311 ASP~? 22.86 O3 PO4 B 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 0.48 53.28 -2.68 0.79 53.94 -4.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -7.01 27.41 -19.12 -7.82 28.98 -20.32 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP C 208 ASP~? 8.73 O2 PG4 C 350 242 GLU D 196 GLU~? 13.48 O1 PO4 D 349 329 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 30.42 34.74 5.00 29.09 35.09 3.38 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP C 208 ASP~? 8.73 O2 PG4 C 350 242 GLU D 215 GLU~? 12.92 O5 PG4 D 350 329 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 30.42 34.74 5.00 29.09 35.09 3.38 -60.56 19.61 44.11 -60.32 19.66 42.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 -31.75 16.85 51.07 -30.38 15.61 52.00 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP C 332 ASP~? 12.18 O4 PO4 C 349 242 GLU C 33 GLU.? 18.98 O2 PO4 C 349 329 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 30.42 34.74 5.00 29.09 35.09 3.38 -31.39 13.53 17.11 -31.33 14.10 15.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP C 332 ASP~? 12.18 O4 PO4 C 349 242 GLU C 196 GLU~? 13.61 O2 PO4 C 349 329 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 30.42 34.74 5.00 29.09 35.09 3.38 -32.17 15.85 27.58 -30.80 16.36 26.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP C 332 ASP~? 12.18 O4 PO4 C 349 242 GLU C 280 GLU~? 22.63 O1 PO4 C 349 329 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 30.42 34.74 5.00 29.09 35.09 3.38 -51.90 42.15 35.36 -51.16 43.57 36.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP C 332 ASP~? 12.18 O4 PO4 C 349 242 GLU C 280 GLU~? 22.63 O1 PO4 C 349 329 ASP C 339 ASP~? 17.02 O2 PG4 A 350 coo 49.16 35.16 15.19 51.08 34.43 15.65 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 30.42 34.74 5.00 29.09 35.09 3.38 -51.90 42.15 35.36 -51.16 43.57 36.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 -30.42 35.10 18.03 -29.05 33.77 17.12 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP C 332 ASP~? 12.18 O4 PO4 C 349 242 GLU C 286 GLU~? 19.95 O1 PO4 C 349 329 ASP C 311 ASP~? 22.87 O4 PO4 C 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 30.42 34.74 5.00 29.09 35.09 3.38 -40.61 39.13 37.58 -40.31 41.01 36.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 -50.03 32.79 8.00 -51.02 34.70 8.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP D 332 ASP~? 12.02 O2 PO4 D 349 242 GLU D 33 GLU.? 17.94 O1 PO4 D 349 329 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 30.42 34.74 5.00 29.09 35.09 3.38 -60.02 15.53 71.55 -61.82 16.61 71.53 coo 59.16 37.82 13.95 57.63 37.03 15.12 -43.35 38.70 79.64 -42.93 40.74 79.14 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP D 332 ASP~? 12.02 O2 PO4 D 349 242 GLU D 196 GLU~? 13.48 O1 PO4 D 349 329 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 30.42 34.74 5.00 29.09 35.09 3.38 -58.16 15.98 62.44 -59.80 16.71 63.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 -43.35 38.70 79.64 -42.93 40.74 79.14 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP D 332 ASP~? 12.02 O2 PO4 D 349 242 GLU D 280 GLU~? 22.63 O4 PO4 D 349 329 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 30.42 34.74 5.00 29.09 35.09 3.38 -42.78 43.78 51.37 -43.64 44.83 49.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 -43.35 38.70 79.64 -42.93 40.74 79.14 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP D 332 ASP~? 12.02 O2 PO4 D 349 242 GLU D 280 GLU~? 22.63 O4 PO4 D 349 329 ASP D 339 ASP~? 21.27 O1 PO4 D 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 30.42 34.74 5.00 29.09 35.09 3.38 -42.78 43.78 51.37 -43.64 44.83 49.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 -63.02 36.35 69.71 -64.42 35.04 70.68 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP D 332 ASP~? 12.02 O2 PO4 D 349 242 GLU D 286 GLU~? 19.90 O4 PO4 D 349 329 ASP D 311 ASP~? 22.85 O2 PO4 D 349 coo 49.16 35.16 15.19 51.08 34.43 15.65 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 30.42 34.74 5.00 29.09 35.09 3.38 -53.47 38.80 49.84 -54.10 40.73 50.49 coo 59.16 37.82 13.95 57.63 37.03 15.12 -43.35 38.70 79.64 -42.93 40.74 79.14 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 21 hits 1uok_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN D 270 ASN.? 14.75 O3 PO4 D 349 457 GLY D 240 GLY.? 13.57 O2 PG4 C 350 459 GLU C 215 GLU~? 13.26 C2 PG4 C 350 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -32.60 27.92 55.07 -33.22 25.92 54.63 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -37.41 23.92 50.12 -38.01 24.41 50.36 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -30.56 22.29 45.75 -30.82 22.67 47.79 1vom_c00 source 1vom MYOSIN : 1 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 285 TYR~? 11.91 O4 PO4 A 349 A 317 GLU A 286 GLU~? 19.74 O4 PO4 A 349 A 365 ARG A 249 ARG~? 17.61 O4 PO4 B 349 coo 1.77 6.56 57.05 3.05 7.44 59.37 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 3.06 2.85 52.79 4.83 3.89 53.24 -13.11 61.08 5.26 -13.84 62.85 4.34 coo 3.82 17.09 49.56 4.09 14.32 50.84 -12.58 47.35 8.37 -11.42 49.74 6.78 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR A 313 TYR~? 26.58 O2 PO4 A 349 A 317 GLU A 317 GLU~? 25.40 O4 PO4 A 349 A 365 ARG A 335 ARG~? 17.04 O2 PO4 A 349 coo 1.77 6.56 57.05 3.05 7.44 59.37 -7.13 87.01 20.69 -6.82 88.46 18.34 coo 3.06 2.85 52.79 4.83 3.89 53.24 -6.54 84.03 15.10 -5.06 85.44 15.56 coo 3.82 17.09 49.56 4.09 14.32 50.84 -10.94 77.02 25.36 -8.46 78.77 25.78 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR B 285 TYR~? 12.05 O4 PO4 B 349 A 317 GLU B 286 GLU~? 20.04 O4 PO4 B 349 A 365 ARG B 249 ARG~? 17.39 O4 PO4 A 349 coo 1.77 6.56 57.05 3.05 7.44 59.37 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 3.06 2.85 52.79 4.83 3.89 53.24 0.48 53.28 -2.68 0.79 53.94 -4.67 coo 3.82 17.09 49.56 4.09 14.32 50.84 1.78 52.94 11.29 0.18 53.87 8.84 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR C 285 TYR~? 11.99 O1 PO4 C 349 A 317 GLU C 286 GLU~? 19.95 O1 PO4 C 349 A 365 ARG C 249 ARG~? 17.71 O4 PO4 D 349 coo 1.77 6.56 57.05 3.05 7.44 59.37 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 3.06 2.85 52.79 4.83 3.89 53.24 -40.61 39.13 37.58 -40.31 41.01 36.65 coo 3.82 17.09 49.56 4.09 14.32 50.84 -38.85 28.76 46.96 -40.48 31.26 46.10 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR D 285 TYR~? 12.08 O4 PO4 D 349 A 317 GLU D 286 GLU~? 19.90 O4 PO4 D 349 A 365 ARG D 249 ARG~? 17.54 O1 PO4 C 349 coo 1.77 6.56 57.05 3.05 7.44 59.37 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 3.06 2.85 52.79 4.83 3.89 53.24 -53.47 38.80 49.84 -54.10 40.73 50.49 coo 3.82 17.09 49.56 4.09 14.32 50.84 -53.61 27.06 41.90 -52.49 29.90 42.42 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR D 313 TYR~? 26.83 O2 PO4 D 349 A 317 GLU D 317 GLU~? 25.08 O4 PO4 D 349 A 365 ARG D 335 ARG~? 17.05 O2 PO4 D 349 coo 1.77 6.56 57.05 3.05 7.44 59.37 -45.78 44.87 79.28 -45.52 47.64 79.09 coo 3.06 2.85 52.79 4.83 3.89 53.24 -45.36 46.85 72.91 -43.76 47.38 74.18 coo 3.82 17.09 49.56 4.09 14.32 50.84 -49.77 35.01 75.03 -47.14 35.61 76.51 1vzx_c02 source 1vzx 2.04.01.0087 : 6 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 285 TYR~? 11.91 O4 PO4 A 349 B1317 GLU A 286 GLU~? 19.74 O4 PO4 A 349 B1365 ARG A 249 ARG~? 17.61 O4 PO4 B 349 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -13.11 61.08 5.26 -13.84 62.85 4.34 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -12.58 47.35 8.37 -11.42 49.74 6.78 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR A 313 TYR~? 26.58 O2 PO4 A 349 B1317 GLU A 317 GLU~? 25.40 O4 PO4 A 349 B1365 ARG A 335 ARG~? 17.04 O2 PO4 A 349 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -7.13 87.01 20.69 -6.82 88.46 18.34 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -6.54 84.03 15.10 -5.06 85.44 15.56 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -10.94 77.02 25.36 -8.46 78.77 25.78 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR B 285 TYR~? 12.05 O4 PO4 B 349 B1317 GLU B 286 GLU~? 20.04 O4 PO4 B 349 B1365 ARG B 249 ARG~? 17.39 O4 PO4 A 349 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 0.48 53.28 -2.68 0.79 53.94 -4.67 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 1.78 52.94 11.29 0.18 53.87 8.84 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR C 285 TYR~? 11.99 O1 PO4 C 349 B1317 GLU C 286 GLU~? 19.95 O1 PO4 C 349 B1365 ARG C 249 ARG~? 17.71 O4 PO4 D 349 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -40.61 39.13 37.58 -40.31 41.01 36.65 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -38.85 28.76 46.96 -40.48 31.26 46.10 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR D 285 TYR~? 12.08 O4 PO4 D 349 B1317 GLU D 286 GLU~? 19.90 O4 PO4 D 349 B1365 ARG D 249 ARG~? 17.54 O1 PO4 C 349 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -53.47 38.80 49.84 -54.10 40.73 50.49 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -53.61 27.06 41.90 -52.49 29.90 42.42 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR D 313 TYR~? 26.83 O2 PO4 D 349 B1317 GLU D 317 GLU~? 25.08 O4 PO4 D 349 B1365 ARG D 335 ARG~? 17.05 O2 PO4 D 349 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -45.78 44.87 79.28 -45.52 47.64 79.09 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -45.36 46.85 72.91 -43.76 47.38 74.18 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -49.77 35.01 75.03 -47.14 35.61 76.51 1vzx_c03 source 1vzx 2.04.01.0087 : 6 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 91 TYR~? 12.90 C4 PG4 B 350 A 40 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 103 LEU A 12 LEU^? 17.63 O3 PG4 B 350 coo 12.09 16.13 10.57 11.28 18.80 10.73 3.23 49.01 40.90 3.18 50.90 38.82 coo 7.55 25.51 14.34 9.65 25.73 14.24 1.74 60.96 43.57 3.36 61.47 42.28 coo 11.83 18.73 16.99 10.99 19.71 15.26 -1.87 53.48 42.74 -0.15 52.44 43.53 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 221 TYR~? 17.25 O1 PG4 A 350 A 40 ASP A 226 ASP.? 25.19 O1 PO4 A 349 A 103 LEU A 228 LEU^? 17.30 O1 PO4 A 349 coo 12.09 16.13 10.57 11.28 18.80 10.73 -24.98 48.97 24.49 -23.82 47.69 26.70 coo 7.55 25.51 14.34 9.65 25.73 14.24 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 11.83 18.73 16.99 10.99 19.71 15.26 -23.36 54.36 19.49 -24.64 52.65 19.78 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 285 TYR~? 11.91 O4 PO4 A 349 A 40 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 103 LEU A 236 LEU.? 13.48 O4 PO4 A 349 coo 12.09 16.13 10.57 11.28 18.80 10.73 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 7.55 25.51 14.34 9.65 25.73 14.24 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.83 18.73 16.99 10.99 19.71 15.26 -4.08 56.51 10.90 -5.57 54.97 10.53 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR A 285 TYR~? 11.91 O4 PO4 A 349 A 40 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 103 LEU A 237 LEU.? 12.58 O4 PO4 A 349 coo 12.09 16.13 10.57 11.28 18.80 10.73 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 7.55 25.51 14.34 9.65 25.73 14.24 -1.16 62.88 18.52 0.68 62.16 19.33 coo 11.83 18.73 16.99 10.99 19.71 15.26 -0.58 60.53 12.48 -1.70 61.73 11.03 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 91 TYR~? 13.43 C5 PG4 A 350 A 40 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 103 LEU B 12 LEU^? 17.91 C5 PG4 A 350 coo 12.09 16.13 10.57 11.28 18.80 10.73 -9.83 18.57 16.69 -10.13 20.18 14.41 coo 7.55 25.51 14.34 9.65 25.73 14.24 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 11.83 18.73 16.99 10.99 19.71 15.26 -4.23 16.40 12.91 -5.95 15.65 14.04 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR B 221 TYR~? 17.66 O1 PG4 B 350 A 40 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 103 LEU B 228 LEU^? 17.34 O2 PO4 B 349 coo 12.09 16.13 10.57 11.28 18.80 10.73 16.24 38.44 11.23 15.50 36.34 12.94 coo 7.55 25.51 14.34 9.65 25.73 14.24 20.38 42.79 0.27 22.43 42.38 0.23 coo 11.83 18.73 16.99 10.99 19.71 15.26 13.29 42.11 5.44 14.87 42.28 6.94 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR B 285 TYR~? 12.05 O4 PO4 B 349 A 40 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 103 LEU B 236 LEU.? 13.69 O4 PO4 B 349 coo 12.09 16.13 10.57 11.28 18.80 10.73 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 7.55 25.51 14.34 9.65 25.73 14.24 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 11.83 18.73 16.99 10.99 19.71 15.26 -7.17 47.64 4.03 -5.58 48.63 5.14 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR C 91 TYR~? 12.18 C5 PG4 D 350 A 40 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 103 LEU C 12 LEU^? 17.34 C5 PG4 D 350 coo 12.09 16.13 10.57 11.28 18.80 10.73 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 7.55 25.51 14.34 9.65 25.73 14.24 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 11.83 18.73 16.99 10.99 19.71 15.26 -47.60 2.29 22.79 -49.16 0.88 23.31 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR C 221 TYR~? 17.74 O1 PG4 C 350 A 40 ASP C 226 ASP.? 11.40 C1 PG4 A 350 A 103 LEU C 228 LEU^? 17.42 O2 PO4 C 349 coo 12.09 16.13 10.57 11.28 18.80 10.73 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 7.55 25.51 14.34 9.65 25.73 14.24 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 11.83 18.73 16.99 10.99 19.71 15.26 -28.14 25.24 34.24 -26.56 24.10 35.24 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR C 285 TYR~? 11.99 O1 PO4 C 349 A 40 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 103 LEU C 236 LEU.? 13.51 O1 PO4 C 349 coo 12.09 16.13 10.57 11.28 18.80 10.73 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 7.55 25.51 14.34 9.65 25.73 14.24 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.83 18.73 16.99 10.99 19.71 15.26 -48.29 30.43 38.79 -46.56 30.05 40.04 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR C 285 TYR~? 11.99 O1 PO4 C 349 A 40 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 103 LEU C 237 LEU.? 12.76 O1 PO4 C 349 coo 12.09 16.13 10.57 11.28 18.80 10.73 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 7.55 25.51 14.34 9.65 25.73 14.24 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 11.83 18.73 16.99 10.99 19.71 15.26 -52.35 30.84 34.89 -51.55 32.85 34.62 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR D 91 TYR~? 13.46 C4 PG4 C 350 A 40 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 103 LEU D 12 LEU^? 18.47 C6 PG4 C 350 coo 12.09 16.13 10.57 11.28 18.80 10.73 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 7.55 25.51 14.34 9.65 25.73 14.24 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 11.83 18.73 16.99 10.99 19.71 15.26 -43.02 5.08 69.98 -41.32 3.75 69.83 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 13 3 # 13 A 16 TYR D 221 TYR~? 17.09 O5 PG4 D 350 A 40 ASP D 226 ASP.? 25.08 O1 PO4 D 349 A 103 LEU D 228 LEU^? 17.38 O1 PO4 D 349 coo 12.09 16.13 10.57 11.28 18.80 10.73 -65.63 16.43 54.69 -64.60 13.90 55.16 coo 7.55 25.51 14.34 9.65 25.73 14.24 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 11.83 18.73 16.99 10.99 19.71 15.26 -63.69 23.65 55.09 -64.88 21.99 54.32 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 14 3 # 14 A 16 TYR D 285 TYR~? 12.08 O4 PO4 D 349 A 40 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 103 LEU D 236 LEU.? 13.82 O4 PO4 D 349 coo 12.09 16.13 10.57 11.28 18.80 10.73 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 7.55 25.51 14.34 9.65 25.73 14.24 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 11.83 18.73 16.99 10.99 19.71 15.26 -44.49 31.48 49.70 -46.09 30.95 48.36 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 14 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 91 TYR~? 12.90 C4 PG4 B 350 B 40 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 103 LEU A 12 LEU^? 17.63 O3 PG4 B 350 coo 14.25 20.09 37.35 13.48 17.40 37.38 3.23 49.01 40.90 3.18 50.90 38.82 coo 9.39 10.77 34.53 11.50 10.63 34.41 1.74 60.96 43.57 3.36 61.47 42.28 coo 12.89 17.60 31.13 12.34 16.51 32.90 -1.87 53.48 42.74 -0.15 52.44 43.53 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 221 TYR~? 17.25 O1 PG4 A 350 B 40 ASP A 226 ASP.? 25.19 O1 PO4 A 349 B 103 LEU A 228 LEU^? 17.30 O1 PO4 A 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -24.98 48.97 24.49 -23.82 47.69 26.70 coo 9.39 10.77 34.53 11.50 10.63 34.41 -31.23 58.08 18.66 -33.23 57.82 19.18 coo 12.89 17.60 31.13 12.34 16.51 32.90 -23.36 54.36 19.49 -24.64 52.65 19.78 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 285 TYR~? 11.91 O4 PO4 A 349 B 40 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 103 LEU A 236 LEU.? 13.48 O4 PO4 A 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 9.39 10.77 34.53 11.50 10.63 34.41 -1.16 62.88 18.52 0.68 62.16 19.33 coo 12.89 17.60 31.13 12.34 16.51 32.90 -4.08 56.51 10.90 -5.57 54.97 10.53 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR A 285 TYR~? 11.91 O4 PO4 A 349 B 40 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 103 LEU A 237 LEU.? 12.58 O4 PO4 A 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 9.39 10.77 34.53 11.50 10.63 34.41 -1.16 62.88 18.52 0.68 62.16 19.33 coo 12.89 17.60 31.13 12.34 16.51 32.90 -0.58 60.53 12.48 -1.70 61.73 11.03 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 91 TYR~? 13.43 C5 PG4 A 350 B 40 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 103 LEU B 12 LEU^? 17.91 C5 PG4 A 350 coo 14.25 20.09 37.35 13.48 17.40 37.38 -9.83 18.57 16.69 -10.13 20.18 14.41 coo 9.39 10.77 34.53 11.50 10.63 34.41 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 12.89 17.60 31.13 12.34 16.51 32.90 -4.23 16.40 12.91 -5.95 15.65 14.04 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR B 221 TYR~? 17.66 O1 PG4 B 350 B 40 ASP B 226 ASP.? 24.90 O2 PO4 B 349 B 103 LEU B 228 LEU^? 17.34 O2 PO4 B 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 16.24 38.44 11.23 15.50 36.34 12.94 coo 9.39 10.77 34.53 11.50 10.63 34.41 20.38 42.79 0.27 22.43 42.38 0.23 coo 12.89 17.60 31.13 12.34 16.51 32.90 13.29 42.11 5.44 14.87 42.28 6.94 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR B 285 TYR~? 12.05 O4 PO4 B 349 B 40 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 103 LEU B 236 LEU.? 13.69 O4 PO4 B 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 9.39 10.77 34.53 11.50 10.63 34.41 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 12.89 17.60 31.13 12.34 16.51 32.90 -7.17 47.64 4.03 -5.58 48.63 5.14 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR C 91 TYR~? 12.18 C5 PG4 D 350 B 40 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 103 LEU C 12 LEU^? 17.34 C5 PG4 D 350 coo 14.25 20.09 37.35 13.48 17.40 37.38 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 9.39 10.77 34.53 11.50 10.63 34.41 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 12.89 17.60 31.13 12.34 16.51 32.90 -47.60 2.29 22.79 -49.16 0.88 23.31 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR C 221 TYR~? 17.74 O1 PG4 C 350 B 40 ASP C 226 ASP.? 11.40 C1 PG4 A 350 B 103 LEU C 228 LEU^? 17.42 O2 PO4 C 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 9.39 10.77 34.53 11.50 10.63 34.41 -21.22 29.31 30.63 -19.17 29.03 30.27 coo 12.89 17.60 31.13 12.34 16.51 32.90 -28.14 25.24 34.24 -26.56 24.10 35.24 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR C 285 TYR~? 11.99 O1 PO4 C 349 B 40 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 103 LEU C 236 LEU.? 13.51 O1 PO4 C 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 9.39 10.77 34.53 11.50 10.63 34.41 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 12.89 17.60 31.13 12.34 16.51 32.90 -48.29 30.43 38.79 -46.56 30.05 40.04 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR C 285 TYR~? 11.99 O1 PO4 C 349 B 40 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 103 LEU C 237 LEU.? 12.76 O1 PO4 C 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 9.39 10.77 34.53 11.50 10.63 34.41 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 12.89 17.60 31.13 12.34 16.51 32.90 -52.35 30.84 34.89 -51.55 32.85 34.62 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 12 3 # 12 B 16 TYR D 91 TYR~? 13.46 C4 PG4 C 350 B 40 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 103 LEU D 12 LEU^? 18.47 C6 PG4 C 350 coo 14.25 20.09 37.35 13.48 17.40 37.38 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 9.39 10.77 34.53 11.50 10.63 34.41 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 12.89 17.60 31.13 12.34 16.51 32.90 -43.02 5.08 69.98 -41.32 3.75 69.83 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 13 3 # 13 B 16 TYR D 221 TYR~? 17.09 O5 PG4 D 350 B 40 ASP D 198 ASP.? 14.02 O5 PG4 D 350 B 103 LEU D 186 LEU^? 14.08 O1 PO4 D 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -65.63 16.43 54.69 -64.60 13.90 55.16 coo 9.39 10.77 34.53 11.50 10.63 34.41 -59.61 10.87 58.41 -59.89 10.18 56.43 coo 12.89 17.60 31.13 12.34 16.51 32.90 -59.43 19.81 56.19 -61.37 19.42 55.27 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 14 3 # 14 B 16 TYR D 221 TYR~? 17.09 O5 PG4 D 350 B 40 ASP D 226 ASP.? 25.08 O1 PO4 D 349 B 103 LEU D 228 LEU^? 17.38 O1 PO4 D 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -65.63 16.43 54.69 -64.60 13.90 55.16 coo 9.39 10.77 34.53 11.50 10.63 34.41 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 12.89 17.60 31.13 12.34 16.51 32.90 -63.69 23.65 55.09 -64.88 21.99 54.32 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 15 3 # 15 B 16 TYR D 285 TYR~? 12.08 O4 PO4 D 349 B 40 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 103 LEU D 236 LEU.? 13.82 O4 PO4 D 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 9.39 10.77 34.53 11.50 10.63 34.41 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 12.89 17.60 31.13 12.34 16.51 32.90 -44.49 31.48 49.70 -46.09 30.95 48.36 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 16 3 # 16 B 16 TYR D 285 TYR~? 12.08 O4 PO4 D 349 B 40 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 103 LEU D 237 LEU.? 12.72 O4 PO4 D 349 coo 14.25 20.09 37.35 13.48 17.40 37.38 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 9.39 10.77 34.53 11.50 10.63 34.41 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 12.89 17.60 31.13 12.34 16.51 32.90 -40.74 32.88 53.53 -41.84 34.75 53.48 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 16 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 169 ASP B 140 ASP.? 7.99 O2 PG4 B 350 A 288 GLU B 215 GLU~? 13.59 C2 PG4 B 350 coo 67.72 35.99 30.87 69.77 36.13 31.33 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 73.17 30.66 22.56 72.87 30.30 20.46 8.40 47.76 23.89 8.35 49.33 25.35 coo 74.06 28.51 15.92 73.77 29.56 17.73 10.14 48.09 15.50 9.78 49.78 16.69 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 169 ASP A 140 ASP.? 7.37 O2 PG4 A 350 A 288 GLU A 215 GLU~? 13.07 C2 PG4 A 350 coo 67.72 35.99 30.87 69.77 36.13 31.33 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 73.17 30.66 22.56 72.87 30.30 20.46 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 74.06 28.51 15.92 73.77 29.56 17.73 -19.69 43.42 15.07 -19.36 42.01 13.60 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 169 ASP C 140 ASP.? 7.74 C2 PG4 C 350 A 288 GLU C 215 GLU~? 13.26 C2 PG4 C 350 coo 67.72 35.99 30.87 69.77 36.13 31.33 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 73.17 30.66 22.56 72.87 30.30 20.46 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 74.06 28.51 15.92 73.77 29.56 17.73 -30.56 22.29 45.75 -30.82 22.67 47.79 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 3 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 22 GLY~? 12.04 O3 PO4 A 349 B 419 GLY A 25 GLY~? 12.48 O2 PO4 A 349 B 420 ALA A 27 ALA~? 7.49 O2 PO4 A 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -0.44 58.79 35.05 -0.39 59.06 34.34 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -5.57 58.65 37.18 -5.59 59.05 36.47 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -8.59 61.44 33.66 -8.54 60.49 32.47 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY A 79 GLY.? 14.13 O3 PO4 A 349 B 419 GLY A 25 GLY~? 12.48 O2 PO4 A 349 B 420 ALA A 27 ALA~? 7.49 O2 PO4 A 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -3.85 55.21 37.72 -3.17 54.79 37.80 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -5.57 58.65 37.18 -5.59 59.05 36.47 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -8.59 61.44 33.66 -8.54 60.49 32.47 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY A 189 GLY~? 8.76 O1 PO4 A 349 B 419 GLY A 192 GLY~? 8.82 O1 PO4 A 349 B 420 ALA A 187 ALA.? 10.63 O1 PO4 A 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -15.70 52.98 26.26 -15.60 52.72 27.75 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY A 192 GLY~? 8.82 O1 PO4 A 349 B 419 GLY A 189 GLY~? 8.76 O1 PO4 A 349 B 420 ALA A 201 ALA~? 12.43 O1 PG4 A 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -13.34 54.92 29.80 -13.05 54.30 30.24 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -9.96 51.69 26.75 -10.72 51.67 27.15 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -10.23 47.67 26.68 -9.44 47.25 27.90 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 183 GLY A 250 GLY~? 14.78 O1 PG4 A 350 B 419 GLY A 212 GLY~? 9.07 O1 PG4 A 350 B 420 ALA A 142 ALA.? 12.14 C2 PG4 A 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -16.12 46.96 14.05 -16.23 47.66 13.72 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -15.16 41.65 16.73 -14.78 42.24 17.11 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -16.20 40.87 12.81 -15.80 42.33 13.02 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 183 GLY A 250 GLY~? 14.78 O1 PG4 A 350 B 419 GLY A 212 GLY~? 9.07 O1 PG4 A 350 B 420 ALA A 210 ALA~? 10.48 O1 PG4 A 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -16.12 46.96 14.05 -16.23 47.66 13.72 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -15.16 41.65 16.73 -14.78 42.24 17.11 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -10.24 43.30 17.86 -8.96 44.01 17.47 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 183 GLY A 250 GLY~? 14.78 O1 PG4 A 350 B 419 GLY A 212 GLY~? 9.07 O1 PG4 A 350 B 420 ALA A 213 ALA~? 7.64 O1 PG4 A 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -16.12 46.96 14.05 -16.23 47.66 13.72 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -15.16 41.65 16.73 -14.78 42.24 17.11 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -14.74 43.07 20.23 -13.44 43.27 20.98 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 183 GLY A 292 GLY.? 19.56 O4 PO4 B 349 B 419 GLY A 291 GLY~? 18.10 O4 PO4 B 349 B 420 ALA A 289 ALA~? 18.02 O4 PO4 A 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -11.67 52.51 -1.16 -12.33 52.16 -0.84 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -11.93 50.92 2.28 -12.21 51.53 1.80 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -13.20 54.19 6.57 -13.87 55.41 7.14 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 183 GLY A 292 GLY.? 19.56 O4 PO4 B 349 B 419 GLY A 291 GLY~? 18.10 O4 PO4 B 349 B 420 ALA A 294 ALA.? 16.82 O4 PO4 B 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -11.67 52.51 -1.16 -12.33 52.16 -0.84 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -11.93 50.92 2.28 -12.21 51.53 1.80 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -15.59 48.24 0.20 -14.45 47.45 0.82 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 10 3 # 10 A 183 GLY A 292 GLY.? 19.56 O4 PO4 B 349 B 419 GLY A 293 GLY.? 20.64 O4 PO4 B 349 B 420 ALA A 294 ALA.? 16.82 O4 PO4 B 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -11.67 52.51 -1.16 -12.33 52.16 -0.84 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -15.25 51.43 -1.86 -14.91 51.02 -1.25 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -15.59 48.24 0.20 -14.45 47.45 0.82 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 11 3 # 11 A 183 GLY A 293 GLY.? 20.64 O4 PO4 B 349 B 419 GLY A 291 GLY~? 18.10 O4 PO4 B 349 B 420 ALA A 289 ALA~? 18.02 O4 PO4 A 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -15.25 51.43 -1.86 -14.91 51.02 -1.25 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -11.93 50.92 2.28 -12.21 51.53 1.80 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -13.20 54.19 6.57 -13.87 55.41 7.14 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 12 3 # 12 A 183 GLY B 22 GLY~? 12.30 O3 PO4 B 349 B 419 GLY B 25 GLY~? 12.55 O3 PO4 B 349 B 420 ALA B 27 ALA~? 7.73 O3 PO4 B 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -6.99 22.32 6.03 -7.16 22.99 5.70 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -1.91 21.39 6.65 -1.94 22.01 6.12 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 0.57 24.81 3.25 0.35 26.08 4.04 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 13 3 # 13 A 183 GLY B 79 GLY.? 14.35 O1 PO4 B 349 B 419 GLY B 25 GLY~? 12.55 O3 PO4 B 349 B 420 ALA B 27 ALA~? 7.73 O3 PO4 B 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -1.91 21.39 6.65 -1.94 22.01 6.12 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 0.57 24.81 3.25 0.35 26.08 4.04 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 14 3 # 14 A 183 GLY B 189 GLY~? 8.50 O2 PO4 B 349 B 419 GLY B 192 GLY~? 8.75 O2 PO4 B 349 B 420 ALA B 187 ALA.? 10.53 O2 PO4 B 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 1.22 33.78 11.00 2.03 33.50 11.09 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 4.63 30.70 8.46 4.46 30.28 9.17 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 6.84 34.76 9.15 6.94 33.32 9.66 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 15 3 # 15 A 183 GLY B 192 GLY~? 8.75 O2 PO4 B 349 B 419 GLY B 189 GLY~? 8.50 O2 PO4 B 349 B 420 ALA B 201 ALA~? 11.68 O5 PG4 A 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 4.63 30.70 8.46 4.46 30.28 9.17 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 1.22 33.78 11.00 2.03 33.50 11.09 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 1.77 34.76 14.91 1.15 33.57 15.58 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 16 3 # 16 A 183 GLY B 250 GLY~? 14.99 O1 PG4 B 350 B 419 GLY B 212 GLY~? 9.26 O1 PG4 B 350 B 420 ALA B 142 ALA.? 12.37 C2 PG4 B 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 6.04 47.81 12.44 6.05 48.05 11.67 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 6.02 46.22 18.32 5.64 45.65 17.83 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 6.73 50.30 18.21 6.20 49.71 16.95 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 17 3 # 17 A 183 GLY B 250 GLY~? 14.99 O1 PG4 B 350 B 419 GLY B 212 GLY~? 9.26 O1 PG4 B 350 B 420 ALA B 210 ALA~? 10.64 O1 PG4 B 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 6.04 47.81 12.44 6.05 48.05 11.67 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 6.02 46.22 18.32 5.64 45.65 17.83 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 1.12 44.24 17.53 -0.27 44.37 16.85 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 18 3 # 18 A 183 GLY B 250 GLY~? 14.99 O1 PG4 B 350 B 419 GLY B 212 GLY~? 9.26 O1 PG4 B 350 B 420 ALA B 213 ALA~? 7.87 O1 PG4 B 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 6.04 47.81 12.44 6.05 48.05 11.67 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 6.02 46.22 18.32 5.64 45.65 17.83 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 5.93 42.50 17.57 4.67 41.60 17.62 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 19 3 # 19 A 183 GLY B 292 GLY~? 19.29 O4 PO4 A 349 B 419 GLY B 291 GLY~? 17.91 O4 PO4 A 349 B 420 ALA B 289 ALA~? 18.00 O4 PO4 B 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -1.18 60.93 4.48 -0.44 60.76 4.75 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -0.11 58.00 6.65 0.09 58.36 5.91 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 1.46 53.29 4.26 2.07 52.48 3.12 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 20 3 # 20 A 183 GLY B 292 GLY~? 19.29 O4 PO4 A 349 B 419 GLY B 291 GLY~? 17.91 O4 PO4 A 349 B 420 ALA B 294 ALA~? 16.64 O4 PO4 A 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -1.18 60.93 4.48 -0.44 60.76 4.75 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -0.11 58.00 6.65 0.09 58.36 5.91 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 3.51 61.12 8.27 2.59 60.51 9.32 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 21 3 # 21 A 183 GLY B 292 GLY~? 19.29 O4 PO4 A 349 B 419 GLY B 293 GLY~? 20.43 O4 PO4 A 349 B 420 ALA B 294 ALA~? 16.64 O4 PO4 A 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -1.18 60.93 4.48 -0.44 60.76 4.75 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 2.42 62.24 4.78 2.23 61.74 5.37 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 3.51 61.12 8.27 2.59 60.51 9.32 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 22 3 # 22 A 183 GLY B 293 GLY~? 20.43 O4 PO4 A 349 B 419 GLY B 291 GLY~? 17.91 O4 PO4 A 349 B 420 ALA B 289 ALA~? 18.00 O4 PO4 B 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 2.42 62.24 4.78 2.23 61.74 5.37 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -0.11 58.00 6.65 0.09 58.36 5.91 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 1.46 53.29 4.26 2.07 52.48 3.12 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 23 3 # 23 A 183 GLY C 22 GLY~? 12.31 O3 PO4 C 349 B 419 GLY C 25 GLY~? 12.45 O4 PO4 C 349 B 420 ALA C 27 ALA~? 7.42 O4 PO4 C 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -50.31 11.35 23.15 -50.44 12.07 23.41 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -45.25 10.31 21.73 -45.31 11.13 21.82 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -43.00 15.18 21.21 -42.97 15.63 22.69 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 24 3 # 24 A 183 GLY C 79 GLY.? 14.41 O3 PO4 C 349 B 419 GLY C 25 GLY~? 12.45 O4 PO4 C 349 B 420 ALA C 27 ALA~? 7.42 O4 PO4 C 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -46.35 7.57 24.19 -46.94 7.17 24.58 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -45.25 10.31 21.73 -45.31 11.13 21.82 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -43.00 15.18 21.21 -42.97 15.63 22.69 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 25 3 # 25 A 183 GLY C 189 GLY~? 8.64 O2 PO4 C 349 B 419 GLY C 192 GLY~? 8.67 O2 PO4 C 349 B 420 ALA C 187 ALA.? 10.66 O2 PO4 C 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -40.49 15.78 32.96 -39.70 15.56 32.71 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -34.89 17.65 31.97 -34.86 16.31 31.26 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 26 3 # 26 A 183 GLY C 192 GLY~? 8.67 O2 PO4 C 349 B 419 GLY C 189 GLY~? 8.64 O2 PO4 C 349 B 420 ALA C 201 ALA~? 12.26 O1 PG4 C 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -37.38 15.60 28.56 -37.54 14.80 28.74 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -40.49 15.78 32.96 -39.70 15.56 32.71 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -39.60 13.45 36.30 -40.20 12.08 36.02 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 27 3 # 27 A 183 GLY C 250 GLY~? 15.20 C2 PG4 C 350 B 419 GLY C 212 GLY~? 9.26 C2 PG4 C 350 B 420 ALA C 142 ALA.? 12.35 C2 PG4 C 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -34.85 24.44 43.72 -34.85 25.15 43.35 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -34.69 19.16 46.59 -35.10 19.11 45.88 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -33.86 22.03 49.44 -34.51 22.67 48.24 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 28 3 # 28 A 183 GLY C 250 GLY~? 15.20 C2 PG4 C 350 B 419 GLY C 212 GLY~? 9.26 C2 PG4 C 350 B 420 ALA C 210 ALA~? 10.91 O1 PG4 C 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -34.85 24.44 43.72 -34.85 25.15 43.35 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -34.69 19.16 46.59 -35.10 19.11 45.88 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -39.73 18.40 44.95 -41.09 18.98 44.68 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 29 3 # 29 A 183 GLY C 250 GLY~? 15.20 C2 PG4 C 350 B 419 GLY C 212 GLY~? 9.26 C2 PG4 C 350 B 420 ALA C 213 ALA~? 8.04 O1 PG4 C 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -34.85 24.44 43.72 -34.85 25.15 43.35 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -34.69 19.16 46.59 -35.10 19.11 45.88 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -34.93 17.01 43.45 -36.20 16.37 42.93 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 30 3 # 30 A 183 GLY C 292 GLY~? 19.56 O4 PO4 D 349 B 419 GLY C 291 GLY~? 18.24 O4 PO4 D 349 B 420 ALA C 289 ALA~? 18.06 O1 PO4 C 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -41.43 39.15 48.42 -40.69 38.80 48.44 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -40.50 35.55 47.63 -40.37 36.37 47.40 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -39.41 34.12 42.48 -38.86 34.40 41.06 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 31 3 # 31 A 183 GLY C 292 GLY~? 19.56 O4 PO4 D 349 B 419 GLY C 291 GLY~? 18.24 O4 PO4 D 349 B 420 ALA C 294 ALA~? 16.90 O4 PO4 D 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -41.43 39.15 48.42 -40.69 38.80 48.44 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -40.50 35.55 47.63 -40.37 36.37 47.40 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -36.72 36.26 50.70 -37.65 35.11 51.01 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 32 3 # 32 A 183 GLY C 292 GLY~? 19.56 O4 PO4 D 349 B 419 GLY C 293 GLY~? 20.66 O4 PO4 D 349 B 420 ALA C 294 ALA~? 16.90 O4 PO4 D 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -41.43 39.15 48.42 -40.69 38.80 48.44 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -37.76 39.68 49.36 -37.98 38.91 49.39 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -36.72 36.26 50.70 -37.65 35.11 51.01 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 33 3 # 33 A 183 GLY C 293 GLY~? 20.66 O4 PO4 D 349 B 419 GLY C 291 GLY~? 18.24 O4 PO4 D 349 B 420 ALA C 289 ALA~? 18.06 O1 PO4 C 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -37.76 39.68 49.36 -37.98 38.91 49.39 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -40.50 35.55 47.63 -40.37 36.37 47.40 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -39.41 34.12 42.48 -38.86 34.40 41.06 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 34 3 # 34 A 183 GLY D 22 GLY~? 12.96 O2 PO4 D 349 B 419 GLY D 25 GLY~? 13.17 O2 PO4 D 349 B 420 ALA D 27 ALA~? 8.25 O2 PO4 D 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -40.91 14.48 69.44 -40.82 15.16 69.11 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -46.02 12.94 70.06 -45.99 13.73 69.92 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -48.66 17.60 69.69 -48.49 17.70 68.18 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 35 3 # 35 A 183 GLY D 79 GLY.? 15.17 O2 PO4 D 349 B 419 GLY D 25 GLY~? 13.17 O2 PO4 D 349 B 420 ALA D 27 ALA~? 8.25 O2 PO4 D 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -44.38 10.12 68.07 -43.71 9.75 67.85 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -46.02 12.94 70.06 -45.99 13.73 69.92 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -48.66 17.60 69.69 -48.49 17.70 68.18 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 36 3 # 36 A 183 GLY D 189 GLY~? 8.43 O1 PO4 D 349 B 419 GLY D 192 GLY~? 8.57 O1 PO4 D 349 B 420 ALA D 187 ALA.? 10.52 O1 PO4 D 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -55.68 17.82 58.37 -55.49 16.55 59.17 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 37 3 # 37 A 183 GLY D 192 GLY~? 8.57 O1 PO4 D 349 B 419 GLY D 189 GLY~? 8.43 O1 PO4 D 349 B 420 ALA D 201 ALA~? 12.42 C7 PG4 C 350 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -52.91 16.56 61.94 -52.62 15.79 61.81 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -49.90 16.88 57.52 -50.61 16.53 57.79 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -50.29 13.95 54.51 -49.45 12.81 55.00 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 38 3 # 38 A 183 GLY D 292 GLY~? 19.43 O1 PO4 C 349 B 419 GLY D 291 GLY~? 17.95 O1 PO4 C 349 B 420 ALA D 289 ALA~? 18.27 O4 PO4 D 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -52.52 37.57 39.17 -53.18 37.10 39.11 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -52.94 33.94 40.24 -53.21 34.73 40.40 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -53.96 33.09 45.60 -54.57 33.53 46.91 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 39 3 # 39 A 183 GLY D 292 GLY~? 19.43 O1 PO4 C 349 B 419 GLY D 291 GLY~? 17.95 O1 PO4 C 349 B 420 ALA D 294 ALA~? 16.73 O1 PO4 C 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -52.52 37.57 39.17 -53.18 37.10 39.11 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -52.94 33.94 40.24 -53.21 34.73 40.40 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -56.74 34.00 37.04 -55.63 32.95 36.83 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 40 3 # 40 A 183 GLY D 292 GLY~? 19.43 O1 PO4 C 349 B 419 GLY D 293 GLY~? 20.58 O1 PO4 C 349 B 420 ALA D 294 ALA~? 16.73 O1 PO4 C 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -52.52 37.57 39.17 -53.18 37.10 39.11 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -56.17 37.64 38.05 -55.87 36.92 38.12 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -56.74 34.00 37.04 -55.63 32.95 36.83 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 41 3 # 41 A 183 GLY D 293 GLY~? 20.58 O1 PO4 C 349 B 419 GLY D 291 GLY~? 17.95 O1 PO4 C 349 B 420 ALA D 289 ALA~? 18.27 O4 PO4 D 349 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -56.17 37.64 38.05 -55.87 36.92 38.12 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -52.94 33.94 40.24 -53.21 34.73 40.40 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -53.96 33.09 45.60 -54.57 33.53 46.91 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 41 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 27 ALA~? 7.49 O2 PO4 A 349 B 182 GLY A 16 GLY.? 15.23 O3 PO4 A 349 B 183 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -8.59 61.44 33.66 -8.54 60.49 32.47 coo 41.93-102.35-126.87 41.52-101.89-126.30 2.07 60.33 37.29 2.12 60.80 37.90 coo 38.37-101.99-128.11 38.63-102.24-127.37 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 27 ALA~? 7.49 O2 PO4 A 349 B 182 GLY A 22 GLY~? 12.04 O3 PO4 A 349 B 183 GLY A 25 GLY~? 12.48 O2 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -8.59 61.44 33.66 -8.54 60.49 32.47 coo 41.93-102.35-126.87 41.52-101.89-126.30 -0.44 58.79 35.05 -0.39 59.06 34.34 coo 38.37-101.99-128.11 38.63-102.24-127.37 -5.57 58.65 37.18 -5.59 59.05 36.47 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA A 27 ALA~? 7.49 O2 PO4 A 349 B 182 GLY A 22 GLY~? 12.04 O3 PO4 A 349 B 183 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -8.59 61.44 33.66 -8.54 60.49 32.47 coo 41.93-102.35-126.87 41.52-101.89-126.30 -0.44 58.79 35.05 -0.39 59.06 34.34 coo 38.37-101.99-128.11 38.63-102.24-127.37 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA A 27 ALA~? 7.49 O2 PO4 A 349 B 182 GLY A 79 GLY.? 14.13 O3 PO4 A 349 B 183 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -8.59 61.44 33.66 -8.54 60.49 32.47 coo 41.93-102.35-126.87 41.52-101.89-126.30 -3.85 55.21 37.72 -3.17 54.79 37.80 coo 38.37-101.99-128.11 38.63-102.24-127.37 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA A 27 ALA~? 7.49 O2 PO4 A 349 B 182 GLY A 79 GLY.? 14.13 O3 PO4 A 349 B 183 GLY A 25 GLY~? 12.48 O2 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -8.59 61.44 33.66 -8.54 60.49 32.47 coo 41.93-102.35-126.87 41.52-101.89-126.30 -3.85 55.21 37.72 -3.17 54.79 37.80 coo 38.37-101.99-128.11 38.63-102.24-127.37 -5.57 58.65 37.18 -5.59 59.05 36.47 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA A 81 ALA.? 10.40 C3 PG4 B 350 B 182 GLY A 16 GLY.? 15.23 O3 PO4 A 349 B 183 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 1.29 52.42 33.85 0.45 52.31 32.60 coo 41.93-102.35-126.87 41.52-101.89-126.30 2.07 60.33 37.29 2.12 60.80 37.90 coo 38.37-101.99-128.11 38.63-102.24-127.37 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA A 81 ALA.? 10.40 C3 PG4 B 350 B 182 GLY A 25 GLY~? 12.48 O2 PO4 A 349 B 183 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 1.29 52.42 33.85 0.45 52.31 32.60 coo 41.93-102.35-126.87 41.52-101.89-126.30 -5.57 58.65 37.18 -5.59 59.05 36.47 coo 38.37-101.99-128.11 38.63-102.24-127.37 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 420 ALA A 81 ALA.? 10.40 C3 PG4 B 350 B 182 GLY A 25 GLY~? 12.48 O2 PO4 A 349 B 183 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 1.29 52.42 33.85 0.45 52.31 32.60 coo 41.93-102.35-126.87 41.52-101.89-126.30 -5.57 58.65 37.18 -5.59 59.05 36.47 coo 38.37-101.99-128.11 38.63-102.24-127.37 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 420 ALA A 81 ALA.? 10.40 C3 PG4 B 350 B 182 GLY A 85 GLY.? 5.88 O2 PG4 B 350 B 183 GLY A 86 GLY.? 5.00 C4 PG4 B 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 1.29 52.42 33.85 0.45 52.31 32.60 coo 41.93-102.35-126.87 41.52-101.89-126.30 7.14 46.81 31.62 6.42 46.78 31.19 coo 38.37-101.99-128.11 38.63-102.24-127.37 4.72 44.66 33.63 5.12 45.31 34.00 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 10 3 # 10 A 420 ALA A 81 ALA.? 10.40 C3 PG4 B 350 B 182 GLY A 86 GLY.? 5.00 C4 PG4 B 350 B 183 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 1.29 52.42 33.85 0.45 52.31 32.60 coo 41.93-102.35-126.87 41.52-101.89-126.30 4.72 44.66 33.63 5.12 45.31 34.00 coo 38.37-101.99-128.11 38.63-102.24-127.37 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 11 3 # 11 A 420 ALA A 289 ALA~? 18.02 O4 PO4 A 349 B 182 GLY A 292 GLY.? 19.56 O4 PO4 B 349 B 183 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -13.20 54.19 6.57 -13.87 55.41 7.14 coo 41.93-102.35-126.87 41.52-101.89-126.30 -11.67 52.51 -1.16 -12.33 52.16 -0.84 coo 38.37-101.99-128.11 38.63-102.24-127.37 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 12 3 # 12 A 420 ALA A 289 ALA~? 18.02 O4 PO4 A 349 B 182 GLY A 292 GLY.? 19.56 O4 PO4 B 349 B 183 GLY A 293 GLY.? 20.64 O4 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -13.20 54.19 6.57 -13.87 55.41 7.14 coo 41.93-102.35-126.87 41.52-101.89-126.30 -11.67 52.51 -1.16 -12.33 52.16 -0.84 coo 38.37-101.99-128.11 38.63-102.24-127.37 -15.25 51.43 -1.86 -14.91 51.02 -1.25 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 13 3 # 13 A 420 ALA A 289 ALA~? 18.02 O4 PO4 A 349 B 182 GLY A 293 GLY.? 20.64 O4 PO4 B 349 B 183 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -13.20 54.19 6.57 -13.87 55.41 7.14 coo 41.93-102.35-126.87 41.52-101.89-126.30 -15.25 51.43 -1.86 -14.91 51.02 -1.25 coo 38.37-101.99-128.11 38.63-102.24-127.37 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 14 3 # 14 A 420 ALA A 289 ALA~? 18.02 O4 PO4 A 349 B 182 GLY A 293 GLY.? 20.64 O4 PO4 B 349 B 183 GLY A 292 GLY.? 19.56 O4 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -13.20 54.19 6.57 -13.87 55.41 7.14 coo 41.93-102.35-126.87 41.52-101.89-126.30 -15.25 51.43 -1.86 -14.91 51.02 -1.25 coo 38.37-101.99-128.11 38.63-102.24-127.37 -11.67 52.51 -1.16 -12.33 52.16 -0.84 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 15 3 # 15 A 420 ALA B 27 ALA~? 7.73 O3 PO4 B 349 B 182 GLY B 16 GLY.? 15.34 O3 PO4 B 349 B 183 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 0.57 24.81 3.25 0.35 26.08 4.04 coo 41.93-102.35-126.87 41.52-101.89-126.30 -8.99 19.43 5.14 -8.92 18.73 4.81 coo 38.37-101.99-128.11 38.63-102.24-127.37 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 16 3 # 16 A 420 ALA B 27 ALA~? 7.73 O3 PO4 B 349 B 182 GLY B 22 GLY~? 12.30 O3 PO4 B 349 B 183 GLY B 25 GLY~? 12.55 O3 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 0.57 24.81 3.25 0.35 26.08 4.04 coo 41.93-102.35-126.87 41.52-101.89-126.30 -6.99 22.32 6.03 -7.16 22.99 5.70 coo 38.37-101.99-128.11 38.63-102.24-127.37 -1.91 21.39 6.65 -1.94 22.01 6.12 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 17 3 # 17 A 420 ALA B 27 ALA~? 7.73 O3 PO4 B 349 B 182 GLY B 22 GLY~? 12.30 O3 PO4 B 349 B 183 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 0.57 24.81 3.25 0.35 26.08 4.04 coo 41.93-102.35-126.87 41.52-101.89-126.30 -6.99 22.32 6.03 -7.16 22.99 5.70 coo 38.37-101.99-128.11 38.63-102.24-127.37 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 18 3 # 18 A 420 ALA B 27 ALA~? 7.73 O3 PO4 B 349 B 182 GLY B 79 GLY.? 14.35 O1 PO4 B 349 B 183 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 0.57 24.81 3.25 0.35 26.08 4.04 coo 41.93-102.35-126.87 41.52-101.89-126.30 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 38.37-101.99-128.11 38.63-102.24-127.37 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 19 3 # 19 A 420 ALA B 27 ALA~? 7.73 O3 PO4 B 349 B 182 GLY B 79 GLY.? 14.35 O1 PO4 B 349 B 183 GLY B 25 GLY~? 12.55 O3 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 0.57 24.81 3.25 0.35 26.08 4.04 coo 41.93-102.35-126.87 41.52-101.89-126.30 -3.33 21.12 10.10 -3.98 20.99 10.55 coo 38.37-101.99-128.11 38.63-102.24-127.37 -1.91 21.39 6.65 -1.94 22.01 6.12 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 20 3 # 20 A 420 ALA B 81 ALA.? 10.90 C4 PG4 A 350 B 182 GLY B 16 GLY.? 15.34 O3 PO4 B 349 B 183 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -9.22 24.44 12.09 -8.53 25.77 12.01 coo 41.93-102.35-126.87 41.52-101.89-126.30 -8.99 19.43 5.14 -8.92 18.73 4.81 coo 38.37-101.99-128.11 38.63-102.24-127.37 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 21 3 # 21 A 420 ALA B 81 ALA.? 10.90 C4 PG4 A 350 B 182 GLY B 19 GLY.? 15.74 O3 PO4 B 349 B 183 GLY B 16 GLY.? 15.34 O3 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -9.22 24.44 12.09 -8.53 25.77 12.01 coo 41.93-102.35-126.87 41.52-101.89-126.30 -12.10 20.39 1.89 -11.31 20.65 1.71 coo 38.37-101.99-128.11 38.63-102.24-127.37 -8.99 19.43 5.14 -8.92 18.73 4.81 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 22 3 # 22 A 420 ALA B 81 ALA.? 10.90 C4 PG4 A 350 B 182 GLY B 25 GLY~? 12.55 O3 PO4 B 349 B 183 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -9.22 24.44 12.09 -8.53 25.77 12.01 coo 41.93-102.35-126.87 41.52-101.89-126.30 -1.91 21.39 6.65 -1.94 22.01 6.12 coo 38.37-101.99-128.11 38.63-102.24-127.37 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 23 3 # 23 A 420 ALA B 81 ALA.? 10.90 C4 PG4 A 350 B 182 GLY B 25 GLY~? 12.55 O3 PO4 B 349 B 183 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -9.22 24.44 12.09 -8.53 25.77 12.01 coo 41.93-102.35-126.87 41.52-101.89-126.30 -1.91 21.39 6.65 -1.94 22.01 6.12 coo 38.37-101.99-128.11 38.63-102.24-127.37 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 24 3 # 24 A 420 ALA B 81 ALA.? 10.90 C4 PG4 A 350 B 182 GLY B 84 GLY.? 7.18 C3 PG4 A 350 B 183 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -9.22 24.44 12.09 -8.53 25.77 12.01 coo 41.93-102.35-126.87 41.52-101.89-126.30 -14.58 29.73 14.21 -14.80 28.98 14.10 coo 38.37-101.99-128.11 38.63-102.24-127.37 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 25 3 # 25 A 420 ALA B 81 ALA.? 10.90 C4 PG4 A 350 B 182 GLY B 85 GLY.? 7.55 C3 PG4 A 350 B 183 GLY B 84 GLY.? 7.18 C3 PG4 A 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -9.22 24.44 12.09 -8.53 25.77 12.01 coo 41.93-102.35-126.87 41.52-101.89-126.30 -15.17 26.80 16.60 -14.44 26.95 16.65 coo 38.37-101.99-128.11 38.63-102.24-127.37 -14.58 29.73 14.21 -14.80 28.98 14.10 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 26 3 # 26 A 420 ALA B 81 ALA.? 10.90 C4 PG4 A 350 B 182 GLY B 85 GLY.? 7.55 C3 PG4 A 350 B 183 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -9.22 24.44 12.09 -8.53 25.77 12.01 coo 41.93-102.35-126.87 41.52-101.89-126.30 -15.17 26.80 16.60 -14.44 26.95 16.65 coo 38.37-101.99-128.11 38.63-102.24-127.37 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 27 3 # 27 A 420 ALA B 81 ALA.? 10.90 C4 PG4 A 350 B 182 GLY B 86 GLY.? 6.11 C4 PG4 A 350 B 183 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -9.22 24.44 12.09 -8.53 25.77 12.01 coo 41.93-102.35-126.87 41.52-101.89-126.30 -12.50 26.48 19.35 -12.60 26.05 18.67 coo 38.37-101.99-128.11 38.63-102.24-127.37 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 28 3 # 28 A 420 ALA B 289 ALA~? 18.00 O4 PO4 B 349 B 182 GLY B 292 GLY~? 19.29 O4 PO4 A 349 B 183 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 1.46 53.29 4.26 2.07 52.48 3.12 coo 41.93-102.35-126.87 41.52-101.89-126.30 -1.18 60.93 4.48 -0.44 60.76 4.75 coo 38.37-101.99-128.11 38.63-102.24-127.37 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 29 3 # 29 A 420 ALA B 289 ALA~? 18.00 O4 PO4 B 349 B 182 GLY B 292 GLY~? 19.29 O4 PO4 A 349 B 183 GLY B 293 GLY~? 20.43 O4 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 1.46 53.29 4.26 2.07 52.48 3.12 coo 41.93-102.35-126.87 41.52-101.89-126.30 -1.18 60.93 4.48 -0.44 60.76 4.75 coo 38.37-101.99-128.11 38.63-102.24-127.37 2.42 62.24 4.78 2.23 61.74 5.37 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 30 3 # 30 A 420 ALA B 289 ALA~? 18.00 O4 PO4 B 349 B 182 GLY B 293 GLY~? 20.43 O4 PO4 A 349 B 183 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 1.46 53.29 4.26 2.07 52.48 3.12 coo 41.93-102.35-126.87 41.52-101.89-126.30 2.42 62.24 4.78 2.23 61.74 5.37 coo 38.37-101.99-128.11 38.63-102.24-127.37 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 31 3 # 31 A 420 ALA B 289 ALA~? 18.00 O4 PO4 B 349 B 182 GLY B 293 GLY~? 20.43 O4 PO4 A 349 B 183 GLY B 292 GLY~? 19.29 O4 PO4 A 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 1.46 53.29 4.26 2.07 52.48 3.12 coo 41.93-102.35-126.87 41.52-101.89-126.30 2.42 62.24 4.78 2.23 61.74 5.37 coo 38.37-101.99-128.11 38.63-102.24-127.37 -1.18 60.93 4.48 -0.44 60.76 4.75 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 32 3 # 32 A 420 ALA C 27 ALA~? 7.42 O4 PO4 C 349 B 182 GLY C 16 GLY.? 15.48 O4 PO4 C 349 B 183 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -43.00 15.18 21.21 -42.97 15.63 22.69 coo 41.93-102.35-126.87 41.52-101.89-126.30 -52.98 9.90 20.86 -53.06 9.69 20.11 coo 38.37-101.99-128.11 38.63-102.24-127.37 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 33 3 # 33 A 420 ALA C 27 ALA~? 7.42 O4 PO4 C 349 B 182 GLY C 22 GLY~? 12.31 O3 PO4 C 349 B 183 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -43.00 15.18 21.21 -42.97 15.63 22.69 coo 41.93-102.35-126.87 41.52-101.89-126.30 -50.31 11.35 23.15 -50.44 12.07 23.41 coo 38.37-101.99-128.11 38.63-102.24-127.37 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 34 3 # 34 A 420 ALA C 27 ALA~? 7.42 O4 PO4 C 349 B 182 GLY C 79 GLY.? 14.41 O3 PO4 C 349 B 183 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -43.00 15.18 21.21 -42.97 15.63 22.69 coo 41.93-102.35-126.87 41.52-101.89-126.30 -46.35 7.57 24.19 -46.94 7.17 24.58 coo 38.37-101.99-128.11 38.63-102.24-127.37 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 35 3 # 35 A 420 ALA C 81 ALA.? 9.82 C5 PG4 D 350 B 182 GLY C 16 GLY.? 15.48 O4 PO4 C 349 B 183 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -51.31 8.31 29.27 -50.61 9.39 30.07 coo 41.93-102.35-126.87 41.52-101.89-126.30 -52.98 9.90 20.86 -53.06 9.69 20.11 coo 38.37-101.99-128.11 38.63-102.24-127.37 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 36 3 # 36 A 420 ALA C 81 ALA.? 9.82 C5 PG4 D 350 B 182 GLY C 25 GLY~? 12.45 O4 PO4 C 349 B 183 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -51.31 8.31 29.27 -50.61 9.39 30.07 coo 41.93-102.35-126.87 41.52-101.89-126.30 -45.25 10.31 21.73 -45.31 11.13 21.82 coo 38.37-101.99-128.11 38.63-102.24-127.37 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 37 3 # 37 A 420 ALA C 81 ALA.? 9.82 C5 PG4 D 350 B 182 GLY C 25 GLY~? 12.45 O4 PO4 C 349 B 183 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -51.31 8.31 29.27 -50.61 9.39 30.07 coo 41.93-102.35-126.87 41.52-101.89-126.30 -45.25 10.31 21.73 -45.31 11.13 21.82 coo 38.37-101.99-128.11 38.63-102.24-127.37 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 38 3 # 38 A 420 ALA C 81 ALA.? 9.82 C5 PG4 D 350 B 182 GLY C 84 GLY.? 7.31 O4 PG4 D 350 B 183 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -51.31 8.31 29.27 -50.61 9.39 30.07 coo 41.93-102.35-126.87 41.52-101.89-126.30 -56.51 10.28 34.21 -56.90 9.83 33.65 coo 38.37-101.99-128.11 38.63-102.24-127.37 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 39 3 # 39 A 420 ALA C 81 ALA.? 9.82 C5 PG4 D 350 B 182 GLY C 85 GLY.? 5.52 C5 PG4 D 350 B 183 GLY C 84 GLY.? 7.31 O4 PG4 D 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -51.31 8.31 29.27 -50.61 9.39 30.07 coo 41.93-102.35-126.87 41.52-101.89-126.30 -56.18 6.72 35.54 -55.45 7.13 35.50 coo 38.37-101.99-128.11 38.63-102.24-127.37 -56.51 10.28 34.21 -56.90 9.83 33.65 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 40 3 # 40 A 420 ALA C 81 ALA.? 9.82 C5 PG4 D 350 B 182 GLY C 85 GLY.? 5.52 C5 PG4 D 350 B 183 GLY C 86 GLY.? 4.20 C5 PG4 D 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -51.31 8.31 29.27 -50.61 9.39 30.07 coo 41.93-102.35-126.87 41.52-101.89-126.30 -56.18 6.72 35.54 -55.45 7.13 35.50 coo 38.37-101.99-128.11 38.63-102.24-127.37 -53.55 4.02 36.09 -53.97 4.11 35.35 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 41 3 # 41 A 420 ALA C 81 ALA.? 9.82 C5 PG4 D 350 B 182 GLY C 86 GLY.? 4.20 C5 PG4 D 350 B 183 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -51.31 8.31 29.27 -50.61 9.39 30.07 coo 41.93-102.35-126.87 41.52-101.89-126.30 -53.55 4.02 36.09 -53.97 4.11 35.35 coo 38.37-101.99-128.11 38.63-102.24-127.37 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 42 3 # 42 A 420 ALA C 289 ALA~? 18.06 O1 PO4 C 349 B 182 GLY C 292 GLY~? 19.56 O4 PO4 D 349 B 183 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -39.41 34.12 42.48 -38.86 34.40 41.06 coo 41.93-102.35-126.87 41.52-101.89-126.30 -41.43 39.15 48.42 -40.69 38.80 48.44 coo 38.37-101.99-128.11 38.63-102.24-127.37 -40.50 35.55 47.63 -40.37 36.37 47.40 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 43 3 # 43 A 420 ALA C 289 ALA~? 18.06 O1 PO4 C 349 B 182 GLY C 292 GLY~? 19.56 O4 PO4 D 349 B 183 GLY C 293 GLY~? 20.66 O4 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -39.41 34.12 42.48 -38.86 34.40 41.06 coo 41.93-102.35-126.87 41.52-101.89-126.30 -41.43 39.15 48.42 -40.69 38.80 48.44 coo 38.37-101.99-128.11 38.63-102.24-127.37 -37.76 39.68 49.36 -37.98 38.91 49.39 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 44 3 # 44 A 420 ALA C 289 ALA~? 18.06 O1 PO4 C 349 B 182 GLY C 293 GLY~? 20.66 O4 PO4 D 349 B 183 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -39.41 34.12 42.48 -38.86 34.40 41.06 coo 41.93-102.35-126.87 41.52-101.89-126.30 -37.76 39.68 49.36 -37.98 38.91 49.39 coo 38.37-101.99-128.11 38.63-102.24-127.37 -40.50 35.55 47.63 -40.37 36.37 47.40 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 45 3 # 45 A 420 ALA C 289 ALA~? 18.06 O1 PO4 C 349 B 182 GLY C 293 GLY~? 20.66 O4 PO4 D 349 B 183 GLY C 292 GLY~? 19.56 O4 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -39.41 34.12 42.48 -38.86 34.40 41.06 coo 41.93-102.35-126.87 41.52-101.89-126.30 -37.76 39.68 49.36 -37.98 38.91 49.39 coo 38.37-101.99-128.11 38.63-102.24-127.37 -41.43 39.15 48.42 -40.69 38.80 48.44 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 46 3 # 46 A 420 ALA D 27 ALA~? 8.25 O2 PO4 D 349 B 182 GLY D 16 GLY.? 16.14 O2 PO4 D 349 B 183 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -48.66 17.60 69.69 -48.49 17.70 68.18 coo 41.93-102.35-126.87 41.52-101.89-126.30 -38.65 13.48 72.21 -38.70 13.32 72.96 coo 38.37-101.99-128.11 38.63-102.24-127.37 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 47 3 # 47 A 420 ALA D 27 ALA~? 8.25 O2 PO4 D 349 B 182 GLY D 22 GLY~? 12.96 O2 PO4 D 349 B 183 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -48.66 17.60 69.69 -48.49 17.70 68.18 coo 41.93-102.35-126.87 41.52-101.89-126.30 -40.91 14.48 69.44 -40.82 15.16 69.11 coo 38.37-101.99-128.11 38.63-102.24-127.37 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 48 3 # 48 A 420 ALA D 27 ALA~? 8.25 O2 PO4 D 349 B 182 GLY D 79 GLY.? 15.17 O2 PO4 D 349 B 183 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -48.66 17.60 69.69 -48.49 17.70 68.18 coo 41.93-102.35-126.87 41.52-101.89-126.30 -44.38 10.12 68.07 -43.71 9.75 67.85 coo 38.37-101.99-128.11 38.63-102.24-127.37 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 49 3 # 49 A 420 ALA D 81 ALA.? 10.80 C4 PG4 C 350 B 182 GLY D 16 GLY.? 16.14 O2 PO4 D 349 B 183 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -38.71 11.15 63.83 -39.53 11.94 62.83 coo 41.93-102.35-126.87 41.52-101.89-126.30 -38.65 13.48 72.21 -38.70 13.32 72.96 coo 38.37-101.99-128.11 38.63-102.24-127.37 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 50 3 # 50 A 420 ALA D 81 ALA.? 10.80 C4 PG4 C 350 B 182 GLY D 19 GLY.? 16.61 O2 PO4 D 349 B 183 GLY D 16 GLY.? 16.14 O2 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -38.71 11.15 63.83 -39.53 11.94 62.83 coo 41.93-102.35-126.87 41.52-101.89-126.30 -35.71 16.74 73.26 -36.52 17.01 73.21 coo 38.37-101.99-128.11 38.63-102.24-127.37 -38.65 13.48 72.21 -38.70 13.32 72.96 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 51 3 # 51 A 420 ALA D 81 ALA.? 10.80 C4 PG4 C 350 B 182 GLY D 25 GLY~? 13.17 O2 PO4 D 349 B 183 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -38.71 11.15 63.83 -39.53 11.94 62.83 coo 41.93-102.35-126.87 41.52-101.89-126.30 -46.02 12.94 70.06 -45.99 13.73 69.92 coo 38.37-101.99-128.11 38.63-102.24-127.37 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 52 3 # 52 A 420 ALA D 81 ALA.? 10.80 C4 PG4 C 350 B 182 GLY D 25 GLY~? 13.17 O2 PO4 D 349 B 183 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -38.71 11.15 63.83 -39.53 11.94 62.83 coo 41.93-102.35-126.87 41.52-101.89-126.30 -46.02 12.94 70.06 -45.99 13.73 69.92 coo 38.37-101.99-128.11 38.63-102.24-127.37 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 53 3 # 53 A 420 ALA D 81 ALA.? 10.80 C4 PG4 C 350 B 182 GLY D 84 GLY.? 9.62 C4 PG4 C 350 B 183 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -38.71 11.15 63.83 -39.53 11.94 62.83 coo 41.93-102.35-126.87 41.52-101.89-126.30 -31.98 13.03 59.70 -32.24 12.70 60.41 coo 38.37-101.99-128.11 38.63-102.24-127.37 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 54 3 # 54 A 420 ALA D 81 ALA.? 10.80 C4 PG4 C 350 B 182 GLY D 85 GLY.? 8.05 C4 PG4 C 350 B 183 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -38.71 11.15 63.83 -39.53 11.94 62.83 coo 41.93-102.35-126.87 41.52-101.89-126.30 -32.50 9.26 59.23 -33.13 9.72 58.90 coo 38.37-101.99-128.11 38.63-102.24-127.37 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 55 3 # 55 A 420 ALA D 81 ALA.? 10.80 C4 PG4 C 350 B 182 GLY D 85 GLY.? 8.05 C4 PG4 C 350 B 183 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -38.71 11.15 63.83 -39.53 11.94 62.83 coo 41.93-102.35-126.87 41.52-101.89-126.30 -32.50 9.26 59.23 -33.13 9.72 58.90 coo 38.37-101.99-128.11 38.63-102.24-127.37 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 56 3 # 56 A 420 ALA D 81 ALA.? 10.80 C4 PG4 C 350 B 182 GLY D 86 GLY.? 5.93 C4 PG4 C 350 B 183 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 38.36-101.47-135.52 39.62-101.29-136.35 -38.71 11.15 63.83 -39.53 11.94 62.83 coo 41.93-102.35-126.87 41.52-101.89-126.30 -35.09 6.83 57.80 -34.85 6.87 58.64 coo 38.37-101.99-128.11 38.63-102.24-127.37 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 57 3 # 57 A 420 ALA D 289 ALA~? 18.27 O4 PO4 D 349 B 182 GLY D 292 GLY~? 19.43 O1 PO4 C 349 B 183 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -53.96 33.09 45.60 -54.57 33.53 46.91 coo 41.93-102.35-126.87 41.52-101.89-126.30 -52.52 37.57 39.17 -53.18 37.10 39.11 coo 38.37-101.99-128.11 38.63-102.24-127.37 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 58 3 # 58 A 420 ALA D 289 ALA~? 18.27 O4 PO4 D 349 B 182 GLY D 292 GLY~? 19.43 O1 PO4 C 349 B 183 GLY D 293 GLY~? 20.58 O1 PO4 C 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -53.96 33.09 45.60 -54.57 33.53 46.91 coo 41.93-102.35-126.87 41.52-101.89-126.30 -52.52 37.57 39.17 -53.18 37.10 39.11 coo 38.37-101.99-128.11 38.63-102.24-127.37 -56.17 37.64 38.05 -55.87 36.92 38.12 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 59 3 # 59 A 420 ALA D 289 ALA~? 18.27 O4 PO4 D 349 B 182 GLY D 293 GLY~? 20.58 O1 PO4 C 349 B 183 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -53.96 33.09 45.60 -54.57 33.53 46.91 coo 41.93-102.35-126.87 41.52-101.89-126.30 -56.17 37.64 38.05 -55.87 36.92 38.12 coo 38.37-101.99-128.11 38.63-102.24-127.37 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 60 3 # 60 A 420 ALA D 289 ALA~? 18.27 O4 PO4 D 349 B 182 GLY D 293 GLY~? 20.58 O1 PO4 C 349 B 183 GLY D 292 GLY~? 19.43 O1 PO4 C 349 coo 38.36-101.47-135.52 39.62-101.29-136.35 -53.96 33.09 45.60 -54.57 33.53 46.91 coo 41.93-102.35-126.87 41.52-101.89-126.30 -56.17 37.64 38.05 -55.87 36.92 38.12 coo 38.37-101.99-128.11 38.63-102.24-127.37 -52.52 37.57 39.17 -53.18 37.10 39.11 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 60 hits 1xny_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 289 ALA~? 18.02 O4 PO4 A 349 B 126 ARG A 249 ARG~? 17.61 O4 PO4 B 349 B 138 GLU A 286 GLU~? 19.74 O4 PO4 A 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 -13.20 54.19 6.57 -13.87 55.41 7.14 coo 2.45 5.53 11.28 3.59 7.56 13.29 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 6.10 2.00 25.24 6.12 1.84 23.13 -13.11 61.08 5.26 -13.84 62.85 4.34 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 314 ALA~? 21.11 O2 PO4 A 349 B 126 ARG A 335 ARG~? 17.04 O2 PO4 A 349 B 138 GLU A 317 GLU~? 25.40 O4 PO4 A 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 -5.48 82.54 20.34 -4.13 82.23 20.99 coo 2.45 5.53 11.28 3.59 7.56 13.29 -10.94 77.02 25.36 -8.46 78.77 25.78 coo 6.10 2.00 25.24 6.12 1.84 23.13 -6.54 84.03 15.10 -5.06 85.44 15.56 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA A 338 ALA~? 14.94 O1 PO4 A 349 B 126 ARG A 179 ARG~? 21.90 O1 PO4 A 349 B 138 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 2.45 5.53 11.28 3.59 7.56 13.29 -29.50 69.96 21.84 -27.37 70.37 19.60 coo 6.10 2.00 25.24 6.12 1.84 23.13 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA B 201 ALA~? 11.68 O5 PG4 A 350 B 126 ARG B 133 ARG.? 8.50 C4 PG4 A 350 B 138 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 1.77 34.76 14.91 1.15 33.57 15.58 coo 2.45 5.53 11.28 3.59 7.56 13.29 -3.22 31.42 16.60 -5.11 31.22 14.14 coo 6.10 2.00 25.24 6.12 1.84 23.13 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA B 289 ALA~? 18.00 O4 PO4 B 349 B 126 ARG B 249 ARG~? 17.39 O4 PO4 A 349 B 138 GLU B 286 GLU~? 20.04 O4 PO4 B 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 1.46 53.29 4.26 2.07 52.48 3.12 coo 2.45 5.53 11.28 3.59 7.56 13.29 1.78 52.94 11.29 0.18 53.87 8.84 coo 6.10 2.00 25.24 6.12 1.84 23.13 0.48 53.28 -2.68 0.79 53.94 -4.67 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA B 338 ALA~? 14.85 O2 PO4 B 349 B 126 ARG B 179 ARG~? 22.83 O2 PO4 B 349 B 138 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 2.45 5.53 11.28 3.59 7.56 13.29 17.17 37.45 -10.17 16.17 40.20 -11.05 coo 6.10 2.00 25.24 6.12 1.84 23.13 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 B 124 ALA C 34 ALA.? 19.28 O2 PO4 C 349 B 126 ARG C 8 ARG.? 30.39 O4 PO4 C 349 B 138 GLU C 33 GLU.? 18.98 O2 PO4 C 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 -33.62 7.75 17.77 -34.37 7.21 18.99 coo 2.45 5.53 11.28 3.59 7.56 13.29 -34.38 -0.74 13.28 -32.98 -3.36 14.17 coo 6.10 2.00 25.24 6.12 1.84 23.13 -31.39 13.53 17.11 -31.33 14.10 15.04 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 B 124 ALA C 289 ALA~? 18.06 O1 PO4 C 349 B 126 ARG C 249 ARG~? 17.71 O4 PO4 D 349 B 138 GLU C 286 GLU~? 19.95 O1 PO4 C 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 -39.41 34.12 42.48 -38.86 34.40 41.06 coo 2.45 5.53 11.28 3.59 7.56 13.29 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 6.10 2.00 25.24 6.12 1.84 23.13 -40.61 39.13 37.58 -40.31 41.01 36.65 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 B 124 ALA C 338 ALA~? 14.81 O2 PO4 C 349 B 126 ARG C 179 ARG~? 14.85 O2 PG4 A 350 B 138 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 2.45 5.53 11.28 3.59 7.56 13.29 -24.98 33.12 21.00 -27.25 35.17 20.85 coo 6.10 2.00 25.24 6.12 1.84 23.13 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 B 124 ALA D 34 ALA.? 19.39 O1 PO4 D 349 B 126 ARG D 8 ARG.? 29.91 O2 PO4 D 349 B 138 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 -57.94 9.74 72.19 -56.97 9.11 71.19 coo 2.45 5.53 11.28 3.59 7.56 13.29 -57.65 0.93 76.64 -57.42 1.44 79.66 coo 6.10 2.00 25.24 6.12 1.84 23.13 -60.02 15.53 71.55 -61.82 16.61 71.53 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 B 124 ALA D 289 ALA~? 18.27 O4 PO4 D 349 B 126 ARG D 249 ARG~? 17.54 O1 PO4 C 349 B 138 GLU D 286 GLU~? 19.90 O4 PO4 D 349 coo 2.11 4.00 19.31 3.14 4.86 19.99 -53.96 33.09 45.60 -54.57 33.53 46.91 coo 2.45 5.53 11.28 3.59 7.56 13.29 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 6.10 2.00 25.24 6.12 1.84 23.13 -53.47 38.80 49.84 -54.10 40.73 50.49 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 289 ALA~? 18.02 O4 PO4 A 349 C 126 ARG A 249 ARG~? 17.61 O4 PO4 B 349 C 138 GLU A 286 GLU~? 19.74 O4 PO4 A 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -13.20 54.19 6.57 -13.87 55.41 7.14 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -13.11 61.08 5.26 -13.84 62.85 4.34 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 314 ALA~? 21.11 O2 PO4 A 349 C 126 ARG A 335 ARG~? 17.04 O2 PO4 A 349 C 138 GLU A 317 GLU~? 25.40 O4 PO4 A 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -5.48 82.54 20.34 -4.13 82.23 20.99 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -10.94 77.02 25.36 -8.46 78.77 25.78 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -6.54 84.03 15.10 -5.06 85.44 15.56 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA A 338 ALA~? 14.94 O1 PO4 A 349 C 126 ARG A 179 ARG~? 21.90 O1 PO4 A 349 C 138 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -20.17 70.54 21.81 -20.31 69.17 22.47 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -29.50 69.96 21.84 -27.37 70.37 19.60 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA B 289 ALA~? 18.00 O4 PO4 B 349 C 126 ARG B 249 ARG~? 17.39 O4 PO4 A 349 C 138 GLU B 286 GLU~? 20.04 O4 PO4 B 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 1.46 53.29 4.26 2.07 52.48 3.12 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 1.78 52.94 11.29 0.18 53.87 8.84 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 0.48 53.28 -2.68 0.79 53.94 -4.67 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA B 338 ALA~? 14.85 O2 PO4 B 349 C 126 ARG B 179 ARG~? 22.83 O2 PO4 B 349 C 138 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 8.76 36.08 -9.47 9.09 35.86 -8.00 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 17.17 37.45 -10.17 16.17 40.20 -11.05 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA C 34 ALA.? 19.28 O2 PO4 C 349 C 126 ARG C 8 ARG.? 30.39 O4 PO4 C 349 C 138 GLU C 33 GLU.? 18.98 O2 PO4 C 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -33.62 7.75 17.77 -34.37 7.21 18.99 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -34.38 -0.74 13.28 -32.98 -3.36 14.17 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -31.39 13.53 17.11 -31.33 14.10 15.04 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 C 124 ALA C 289 ALA~? 18.06 O1 PO4 C 349 C 126 ARG C 249 ARG~? 17.71 O4 PO4 D 349 C 138 GLU C 286 GLU~? 19.95 O1 PO4 C 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -39.41 34.12 42.48 -38.86 34.40 41.06 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -40.61 39.13 37.58 -40.31 41.01 36.65 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 C 124 ALA C 338 ALA~? 14.81 O2 PO4 C 349 C 126 ARG C 179 ARG~? 14.85 O2 PG4 A 350 C 138 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -33.54 31.76 19.76 -33.13 30.53 20.58 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -24.98 33.12 21.00 -27.25 35.17 20.85 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 C 124 ALA D 34 ALA.? 19.39 O1 PO4 D 349 C 126 ARG D 8 ARG.? 29.91 O2 PO4 D 349 C 138 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -57.94 9.74 72.19 -56.97 9.11 71.19 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -57.65 0.93 76.64 -57.42 1.44 79.66 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -60.02 15.53 71.55 -61.82 16.61 71.53 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 C 124 ALA D 289 ALA~? 18.27 O4 PO4 D 349 C 126 ARG D 249 ARG~? 17.54 O1 PO4 C 349 C 138 GLU D 286 GLU~? 19.90 O4 PO4 D 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -53.96 33.09 45.60 -54.57 33.53 46.91 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -53.61 27.06 41.90 -52.49 29.90 42.42 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -53.47 38.80 49.84 -54.10 40.73 50.49 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 C 124 ALA D 314 ALA~? 21.06 O2 PO4 D 349 C 126 ARG D 335 ARG~? 17.05 O2 PO4 D 349 C 138 GLU D 317 GLU~? 25.08 O4 PO4 D 349 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -44.47 42.22 75.35 -43.13 41.48 75.40 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -49.77 35.01 75.03 -47.14 35.61 76.51 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -45.36 46.85 72.91 -43.76 47.38 74.18 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 289 ALA~? 18.02 O4 PO4 A 349 D 126 ARG A 249 ARG~? 17.61 O4 PO4 B 349 D 138 GLU A 286 GLU~? 19.74 O4 PO4 A 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -13.20 54.19 6.57 -13.87 55.41 7.14 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 6.23 0.50 57.10 5.93 0.72 59.19 -13.11 61.08 5.26 -13.84 62.85 4.34 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 314 ALA~? 21.11 O2 PO4 A 349 D 126 ARG A 335 ARG~? 17.04 O2 PO4 A 349 D 138 GLU A 317 GLU~? 25.40 O4 PO4 A 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -5.48 82.54 20.34 -4.13 82.23 20.99 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -10.94 77.02 25.36 -8.46 78.77 25.78 coo 6.23 0.50 57.10 5.93 0.72 59.19 -6.54 84.03 15.10 -5.06 85.44 15.56 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA A 315 ALA~? 17.77 O2 PO4 A 349 D 126 ARG A 335 ARG~? 17.04 O2 PO4 A 349 D 138 GLU A 317 GLU~? 25.40 O4 PO4 A 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -7.94 79.62 20.68 -8.62 79.20 21.97 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -10.94 77.02 25.36 -8.46 78.77 25.78 coo 6.23 0.50 57.10 5.93 0.72 59.19 -6.54 84.03 15.10 -5.06 85.44 15.56 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA A 338 ALA~? 14.94 O1 PO4 A 349 D 126 ARG A 179 ARG~? 21.90 O1 PO4 A 349 D 138 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -20.17 70.54 21.81 -20.31 69.17 22.47 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -29.50 69.96 21.84 -27.37 70.37 19.60 coo 6.23 0.50 57.10 5.93 0.72 59.19 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA B 201 ALA~? 11.68 O5 PG4 A 350 D 126 ARG B 133 ARG.? 8.50 C4 PG4 A 350 D 138 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 1.77 34.76 14.91 1.15 33.57 15.58 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -3.22 31.42 16.60 -5.11 31.22 14.14 coo 6.23 0.50 57.10 5.93 0.72 59.19 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA B 289 ALA~? 18.00 O4 PO4 B 349 D 126 ARG B 249 ARG~? 17.39 O4 PO4 A 349 D 138 GLU B 286 GLU~? 20.04 O4 PO4 B 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 1.46 53.29 4.26 2.07 52.48 3.12 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 1.78 52.94 11.29 0.18 53.87 8.84 coo 6.23 0.50 57.10 5.93 0.72 59.19 0.48 53.28 -2.68 0.79 53.94 -4.67 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 D 124 ALA B 338 ALA~? 14.85 O2 PO4 B 349 D 126 ARG B 179 ARG~? 22.83 O2 PO4 B 349 D 138 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 8.76 36.08 -9.47 9.09 35.86 -8.00 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 17.17 37.45 -10.17 16.17 40.20 -11.05 coo 6.23 0.50 57.10 5.93 0.72 59.19 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 D 124 ALA C 34 ALA.? 19.28 O2 PO4 C 349 D 126 ARG C 8 ARG.? 30.39 O4 PO4 C 349 D 138 GLU C 33 GLU.? 18.98 O2 PO4 C 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -33.62 7.75 17.77 -34.37 7.21 18.99 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -34.38 -0.74 13.28 -32.98 -3.36 14.17 coo 6.23 0.50 57.10 5.93 0.72 59.19 -31.39 13.53 17.11 -31.33 14.10 15.04 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 D 124 ALA C 289 ALA~? 18.06 O1 PO4 C 349 D 126 ARG C 249 ARG~? 17.71 O4 PO4 D 349 D 138 GLU C 286 GLU~? 19.95 O1 PO4 C 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -39.41 34.12 42.48 -38.86 34.40 41.06 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 6.23 0.50 57.10 5.93 0.72 59.19 -40.61 39.13 37.58 -40.31 41.01 36.65 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 D 124 ALA C 338 ALA~? 14.81 O2 PO4 C 349 D 126 ARG C 179 ARG~? 14.85 O2 PG4 A 350 D 138 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -33.54 31.76 19.76 -33.13 30.53 20.58 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -24.98 33.12 21.00 -27.25 35.17 20.85 coo 6.23 0.50 57.10 5.93 0.72 59.19 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 D 124 ALA D 34 ALA.? 19.39 O1 PO4 D 349 D 126 ARG D 8 ARG.? 29.91 O2 PO4 D 349 D 138 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -57.94 9.74 72.19 -56.97 9.11 71.19 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -57.65 0.93 76.64 -57.42 1.44 79.66 coo 6.23 0.50 57.10 5.93 0.72 59.19 -60.02 15.53 71.55 -61.82 16.61 71.53 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 D 124 ALA D 289 ALA~? 18.27 O4 PO4 D 349 D 126 ARG D 249 ARG~? 17.54 O1 PO4 C 349 D 138 GLU D 286 GLU~? 19.90 O4 PO4 D 349 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -53.96 33.09 45.60 -54.57 33.53 46.91 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 6.23 0.50 57.10 5.93 0.72 59.19 -53.47 38.80 49.84 -54.10 40.73 50.49 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 12 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 289 ALA~? 18.02 O4 PO4 A 349 E 126 ARG A 249 ARG~? 17.61 O4 PO4 B 349 E 138 GLU A 286 GLU~? 19.74 O4 PO4 A 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -13.20 54.19 6.57 -13.87 55.41 7.14 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -13.11 61.08 5.26 -13.84 62.85 4.34 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 294 ALA.? 16.82 O4 PO4 B 349 E 126 ARG A 249 ARG~? 17.61 O4 PO4 B 349 E 138 GLU B 280 GLU~? 22.45 O4 PO4 B 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -15.59 48.24 0.20 -14.45 47.45 0.82 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -10.91 53.12 -6.46 -10.34 55.07 -5.90 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA A 314 ALA~? 21.11 O2 PO4 A 349 E 126 ARG A 335 ARG~? 17.04 O2 PO4 A 349 E 138 GLU A 317 GLU~? 25.40 O4 PO4 A 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -5.48 82.54 20.34 -4.13 82.23 20.99 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -10.94 77.02 25.36 -8.46 78.77 25.78 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -6.54 84.03 15.10 -5.06 85.44 15.56 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA A 315 ALA~? 17.77 O2 PO4 A 349 E 126 ARG A 335 ARG~? 17.04 O2 PO4 A 349 E 138 GLU A 317 GLU~? 25.40 O4 PO4 A 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -7.94 79.62 20.68 -8.62 79.20 21.97 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -10.94 77.02 25.36 -8.46 78.77 25.78 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -6.54 84.03 15.10 -5.06 85.44 15.56 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA A 338 ALA~? 14.94 O1 PO4 A 349 E 126 ARG A 179 ARG~? 21.90 O1 PO4 A 349 E 138 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -20.17 70.54 21.81 -20.31 69.17 22.47 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -29.50 69.96 21.84 -27.37 70.37 19.60 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA B 201 ALA~? 11.68 O5 PG4 A 350 E 126 ARG B 133 ARG.? 8.50 C4 PG4 A 350 E 138 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 1.77 34.76 14.91 1.15 33.57 15.58 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -3.22 31.42 16.60 -5.11 31.22 14.14 coo -8.67 12.22 56.54 -8.68 12.09 58.65 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 E 124 ALA B 289 ALA~? 18.00 O4 PO4 B 349 E 126 ARG B 249 ARG~? 17.39 O4 PO4 A 349 E 138 GLU B 286 GLU~? 20.04 O4 PO4 B 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 1.46 53.29 4.26 2.07 52.48 3.12 coo -3.02 12.00 70.07 -1.94 13.84 67.82 1.78 52.94 11.29 0.18 53.87 8.84 coo -8.67 12.22 56.54 -8.68 12.09 58.65 0.48 53.28 -2.68 0.79 53.94 -4.67 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 E 124 ALA B 338 ALA~? 14.85 O2 PO4 B 349 E 126 ARG B 179 ARG~? 22.83 O2 PO4 B 349 E 138 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 8.76 36.08 -9.47 9.09 35.86 -8.00 coo -3.02 12.00 70.07 -1.94 13.84 67.82 17.17 37.45 -10.17 16.17 40.20 -11.05 coo -8.67 12.22 56.54 -8.68 12.09 58.65 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 E 124 ALA C 34 ALA.? 19.28 O2 PO4 C 349 E 126 ARG C 8 ARG.? 30.39 O4 PO4 C 349 E 138 GLU C 33 GLU.? 18.98 O2 PO4 C 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -33.62 7.75 17.77 -34.37 7.21 18.99 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -34.38 -0.74 13.28 -32.98 -3.36 14.17 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -31.39 13.53 17.11 -31.33 14.10 15.04 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 E 124 ALA C 289 ALA~? 18.06 O1 PO4 C 349 E 126 ARG C 249 ARG~? 17.71 O4 PO4 D 349 E 138 GLU C 286 GLU~? 19.95 O1 PO4 C 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -39.41 34.12 42.48 -38.86 34.40 41.06 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -40.61 39.13 37.58 -40.31 41.01 36.65 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 E 124 ALA C 338 ALA~? 14.81 O2 PO4 C 349 E 126 ARG C 179 ARG~? 14.85 O2 PG4 A 350 E 138 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -33.54 31.76 19.76 -33.13 30.53 20.58 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -24.98 33.12 21.00 -27.25 35.17 20.85 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 E 124 ALA D 34 ALA.? 19.39 O1 PO4 D 349 E 126 ARG D 8 ARG.? 29.91 O2 PO4 D 349 E 138 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -57.94 9.74 72.19 -56.97 9.11 71.19 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -57.65 0.93 76.64 -57.42 1.44 79.66 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -60.02 15.53 71.55 -61.82 16.61 71.53 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 E 124 ALA D 289 ALA~? 18.27 O4 PO4 D 349 E 126 ARG D 249 ARG~? 17.54 O1 PO4 C 349 E 138 GLU D 286 GLU~? 19.90 O4 PO4 D 349 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -53.96 33.09 45.60 -54.57 33.53 46.91 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -53.61 27.06 41.90 -52.49 29.90 42.42 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -53.47 38.80 49.84 -54.10 40.73 50.49 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 13 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 289 ALA~? 18.02 O4 PO4 A 349 F 126 ARG A 249 ARG~? 17.61 O4 PO4 B 349 F 138 GLU A 286 GLU~? 19.74 O4 PO4 A 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -13.20 54.19 6.57 -13.87 55.41 7.14 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -12.58 47.35 8.37 -11.42 49.74 6.78 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -13.11 61.08 5.26 -13.84 62.85 4.34 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 314 ALA~? 21.11 O2 PO4 A 349 F 126 ARG A 335 ARG~? 17.04 O2 PO4 A 349 F 138 GLU A 317 GLU~? 25.40 O4 PO4 A 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -5.48 82.54 20.34 -4.13 82.23 20.99 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -10.94 77.02 25.36 -8.46 78.77 25.78 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -6.54 84.03 15.10 -5.06 85.44 15.56 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA A 338 ALA~? 14.94 O1 PO4 A 349 F 126 ARG A 179 ARG~? 21.90 O1 PO4 A 349 F 138 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -20.17 70.54 21.81 -20.31 69.17 22.47 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -29.50 69.96 21.84 -27.37 70.37 19.60 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA B 289 ALA~? 18.00 O4 PO4 B 349 F 126 ARG B 249 ARG~? 17.39 O4 PO4 A 349 F 138 GLU B 286 GLU~? 20.04 O4 PO4 B 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 1.46 53.29 4.26 2.07 52.48 3.12 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 1.78 52.94 11.29 0.18 53.87 8.84 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 0.48 53.28 -2.68 0.79 53.94 -4.67 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA B 338 ALA~? 14.85 O2 PO4 B 349 F 126 ARG B 179 ARG~? 22.83 O2 PO4 B 349 F 138 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 8.76 36.08 -9.47 9.09 35.86 -8.00 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 17.17 37.45 -10.17 16.17 40.20 -11.05 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA C 34 ALA.? 19.28 O2 PO4 C 349 F 126 ARG C 8 ARG.? 30.39 O4 PO4 C 349 F 138 GLU C 33 GLU.? 18.98 O2 PO4 C 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -33.62 7.75 17.77 -34.37 7.21 18.99 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -34.38 -0.74 13.28 -32.98 -3.36 14.17 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -31.39 13.53 17.11 -31.33 14.10 15.04 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 F 124 ALA C 289 ALA~? 18.06 O1 PO4 C 349 F 126 ARG C 249 ARG~? 17.71 O4 PO4 D 349 F 138 GLU C 286 GLU~? 19.95 O1 PO4 C 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -39.41 34.12 42.48 -38.86 34.40 41.06 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -40.61 39.13 37.58 -40.31 41.01 36.65 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 F 124 ALA C 338 ALA~? 14.81 O2 PO4 C 349 F 126 ARG C 179 ARG~? 14.85 O2 PG4 A 350 F 138 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -33.54 31.76 19.76 -33.13 30.53 20.58 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -24.98 33.12 21.00 -27.25 35.17 20.85 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 F 124 ALA D 34 ALA.? 19.39 O1 PO4 D 349 F 126 ARG D 8 ARG.? 29.91 O2 PO4 D 349 F 138 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -57.94 9.74 72.19 -56.97 9.11 71.19 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -57.65 0.93 76.64 -57.42 1.44 79.66 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -60.02 15.53 71.55 -61.82 16.61 71.53 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 F 124 ALA D 289 ALA~? 18.27 O4 PO4 D 349 F 126 ARG D 249 ARG~? 17.54 O1 PO4 C 349 F 138 GLU D 286 GLU~? 19.90 O4 PO4 D 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -53.96 33.09 45.60 -54.57 33.53 46.91 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -53.61 27.06 41.90 -52.49 29.90 42.42 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -53.47 38.80 49.84 -54.10 40.73 50.49 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 F 124 ALA D 314 ALA~? 21.06 O2 PO4 D 349 F 126 ARG D 335 ARG~? 17.05 O2 PO4 D 349 F 138 GLU D 317 GLU~? 25.08 O4 PO4 D 349 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -44.47 42.22 75.35 -43.13 41.48 75.40 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -49.77 35.01 75.03 -47.14 35.61 76.51 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -45.36 46.85 72.91 -43.76 47.38 74.18 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 11 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 25 GLY~? 12.48 O2 PO4 A 349 B 175 ARG A 57 ARG.? 17.32 O2 PO4 A 349 B 242 TYR A 31 TYR~? 9.01 O2 PO4 A 349 coo 99.45 58.28 3.33 99.57 58.61 4.10 -5.57 58.65 37.18 -5.59 59.05 36.47 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -11.38 65.24 41.83 -13.84 63.42 41.14 coo 100.93 69.04 4.38 99.52 68.48 2.09 -13.67 63.12 32.54 -12.97 64.78 30.45 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY B 25 GLY~? 12.55 O3 PO4 B 349 B 175 ARG B 57 ARG.? 17.74 O3 PO4 B 349 B 242 TYR B 31 TYR~? 9.45 O3 PO4 B 349 coo 99.45 58.28 3.33 99.57 58.61 4.10 -1.91 21.39 6.65 -1.94 22.01 6.12 coo 106.37 63.53 0.89 108.02 63.40 -1.62 5.49 16.86 0.47 7.09 17.94 2.86 coo 100.93 69.04 4.38 99.52 68.48 2.09 5.43 26.32 0.91 4.29 27.88 -1.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY B 54 GLY~? 16.02 O3 PO4 B 349 B 175 ARG B 57 ARG.? 17.74 O3 PO4 B 349 B 242 TYR B 58 TYR.? 25.36 O3 PO4 B 349 coo 99.45 58.28 3.33 99.57 58.61 4.10 -2.04 19.25 -6.91 -1.76 19.09 -6.14 coo 106.37 63.53 0.89 108.02 63.40 -1.62 5.49 16.86 0.47 7.09 17.94 2.86 coo 100.93 69.04 4.38 99.52 68.48 2.09 4.06 9.43 -1.88 2.81 7.26 -0.64 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY C 25 GLY~? 12.45 O4 PO4 C 349 B 175 ARG C 57 ARG.? 17.31 O4 PO4 C 349 B 242 TYR C 31 TYR~? 9.00 O4 PO4 C 349 coo 99.45 58.28 3.33 99.57 58.61 4.10 -45.25 10.31 21.73 -45.31 11.13 21.82 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -40.16 11.74 13.21 -37.69 10.86 14.87 coo 100.93 69.04 4.38 99.52 68.48 2.09 -38.22 17.89 20.09 -39.26 20.46 19.95 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY D 25 GLY~? 13.17 O2 PO4 D 349 B 175 ARG D 57 ARG.? 17.88 O2 PO4 D 349 B 242 TYR D 31 TYR~? 9.28 O2 PO4 D 349 coo 99.45 58.28 3.33 99.57 58.61 4.10 -46.02 12.94 70.06 -45.99 13.73 69.92 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -53.05 14.45 77.65 -54.84 13.45 75.34 coo 100.93 69.04 4.38 99.52 68.48 2.09 -53.52 20.07 70.01 -52.37 22.61 69.97 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 5 hits 1xva_c03 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS D 177 LYS~? 20.36 O1 PO4 D 349 A 74 LYS D 184 LYS^? 18.69 O1 PO4 D 349 A 165 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 18.28 7.83 36.39 22.82 8.75 39.52 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 14.16 13.09 37.03 20.00 12.44 37.49 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 22.22 16.06 48.76 23.94 15.33 49.78 -60.02 15.53 71.55 -61.82 16.61 71.53 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS D 177 LYS~? 20.36 O1 PO4 D 349 B 74 LYS D 184 LYS^? 18.69 O1 PO4 D 349 B 165 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 13.51 0.92 76.10 12.98 6.13 74.68 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 21.39 11.56 68.52 20.24 13.13 67.73 -60.02 15.53 71.55 -61.82 16.61 71.53 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS D 184 LYS^? 18.69 O1 PO4 D 349 B 74 LYS D 177 LYS~? 20.36 O1 PO4 D 349 B 165 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 13.51 0.92 76.10 12.98 6.13 74.68 -64.76 21.00 60.32 -64.61 15.17 58.23 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -68.08 25.33 66.69 -67.75 19.10 66.60 coo 21.39 11.56 68.52 20.24 13.13 67.73 -60.02 15.53 71.55 -61.82 16.61 71.53 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1ylu_c01 naa= 3 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 1 3 # 1 146 SER A 64 SER~? 26.25 O3 PG4 B 350 338 ASP A 41 ASP.? 20.10 O2 PO4 A 349 397 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 1.46 56.04 50.07 2.12 55.38 52.31 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 1.74 60.96 43.57 3.36 61.47 42.28 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 2 3 # 2 146 SER A 241 SER.? 9.98 O3 PO4 A 349 338 ASP A 160 ASP.? 8.60 O4 PO4 A 349 397 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -1.16 62.88 18.52 0.68 62.16 19.33 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 3 3 # 3 146 SER B 64 SER~? 26.98 C5 PG4 A 350 338 ASP B 41 ASP.? 20.21 O3 PO4 B 349 397 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 4 3 # 4 146 SER B 241 SER.? 10.02 O1 PO4 B 349 338 ASP B 160 ASP.? 8.62 O4 PO4 B 349 397 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 5 3 # 5 146 SER C 64 SER~? 25.88 C5 PG4 D 350 338 ASP C 41 ASP.? 20.22 O4 PO4 C 349 397 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 6 3 # 6 146 SER C 241 SER.? 9.97 O3 PO4 C 349 338 ASP C 160 ASP.? 8.57 O1 PO4 C 349 397 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 7 3 # 7 146 SER D 64 SER~? 27.50 C6 PG4 C 350 338 ASP D 41 ASP.? 20.92 O2 PO4 D 349 397 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 8 3 # 8 146 SER D 241 SER.? 10.08 O3 PO4 D 349 338 ASP D 160 ASP.? 8.58 O4 PO4 D 349 397 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -38.74 26.41 54.26 -37.48 24.84 54.87 1ysc_c01 source 1ysc SERINE CARBOXYPEPTIDASE (CPY, CPD-Y, OR PROTEI: 8 hits 1ysc_c01 naa= 3 ULMN 3 1zoi_c00 ESTERASE user 1 3 # 1 A 97 SER A 64 SER~? 26.25 O3 PG4 B 350 A 227 ASP A 41 ASP.? 20.10 O2 PO4 A 349 A 256 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 64.84 24.93 59.62 66.28 24.42 57.72 1.46 56.04 50.07 2.12 55.38 52.31 coo 73.80 27.56 60.96 72.24 26.45 60.08 1.74 60.96 43.57 3.36 61.47 42.28 coo 70.86 23.63 59.28 68.91 24.23 58.80 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1zoi_c00 ESTERASE user 2 3 # 2 A 97 SER A 64 SER~? 26.25 O3 PG4 B 350 A 227 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 256 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 64.84 24.93 59.62 66.28 24.42 57.72 1.46 56.04 50.07 2.12 55.38 52.31 coo 73.80 27.56 60.96 72.24 26.45 60.08 8.08 50.44 43.84 7.48 51.26 41.98 coo 70.86 23.63 59.28 68.91 24.23 58.80 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1zoi_c00 ESTERASE user 3 3 # 3 A 97 SER A 241 SER.? 9.98 O3 PO4 A 349 A 227 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 256 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 64.84 24.93 59.62 66.28 24.42 57.72 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 73.80 27.56 60.96 72.24 26.45 60.08 -1.16 62.88 18.52 0.68 62.16 19.33 coo 70.86 23.63 59.28 68.91 24.23 58.80 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1zoi_c00 ESTERASE user 4 3 # 4 A 97 SER B 64 SER~? 26.98 C5 PG4 A 350 A 227 ASP B 41 ASP.? 20.21 O3 PO4 B 349 A 256 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 64.84 24.93 59.62 66.28 24.42 57.72 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 73.80 27.56 60.96 72.24 26.45 60.08 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 70.86 23.63 59.28 68.91 24.23 58.80 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1zoi_c00 ESTERASE user 5 3 # 5 A 97 SER B 241 SER.? 10.02 O1 PO4 B 349 A 227 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 256 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 64.84 24.93 59.62 66.28 24.42 57.72 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 73.80 27.56 60.96 72.24 26.45 60.08 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 70.86 23.63 59.28 68.91 24.23 58.80 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1zoi_c00 ESTERASE user 6 3 # 6 A 97 SER C 64 SER~? 25.88 C5 PG4 D 350 A 227 ASP C 41 ASP.? 20.22 O4 PO4 C 349 A 256 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 64.84 24.93 59.62 66.28 24.42 57.72 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 73.80 27.56 60.96 72.24 26.45 60.08 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 70.86 23.63 59.28 68.91 24.23 58.80 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1zoi_c00 ESTERASE user 7 3 # 7 A 97 SER C 241 SER.? 9.97 O3 PO4 C 349 A 227 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 256 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 64.84 24.93 59.62 66.28 24.42 57.72 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 73.80 27.56 60.96 72.24 26.45 60.08 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 70.86 23.63 59.28 68.91 24.23 58.80 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1zoi_c00 ESTERASE user 8 3 # 8 A 97 SER D 64 SER~? 27.50 C6 PG4 C 350 A 227 ASP D 41 ASP.? 20.92 O2 PO4 D 349 A 256 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 64.84 24.93 59.62 66.28 24.42 57.72 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 73.80 27.56 60.96 72.24 26.45 60.08 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 70.86 23.63 59.28 68.91 24.23 58.80 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1zoi_c00 ESTERASE user 9 3 # 9 A 97 SER D 241 SER.? 10.08 O3 PO4 D 349 A 227 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 256 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 64.84 24.93 59.62 66.28 24.42 57.72 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 73.80 27.56 60.96 72.24 26.45 60.08 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 70.86 23.63 59.28 68.91 24.23 58.80 -38.74 26.41 54.26 -37.48 24.84 54.87 1zoi_c00 source 1zoi ESTERASE : 9 hits 1zoi_c00 naa= 3 ULMN 3 1zoi_c01 ESTERASE user 1 3 # 1 B 97 SER A 64 SER~? 26.25 O3 PG4 B 350 B 227 ASP A 41 ASP.? 20.10 O2 PO4 A 349 B 256 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 1.46 56.04 50.07 2.12 55.38 52.31 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 1.74 60.96 43.57 3.36 61.47 42.28 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1zoi_c01 ESTERASE user 2 3 # 2 B 97 SER A 64 SER~? 26.25 O3 PG4 B 350 B 227 ASP A 90 ASP~? 15.98 C4 PG4 B 350 B 256 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 1.46 56.04 50.07 2.12 55.38 52.31 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 8.08 50.44 43.84 7.48 51.26 41.98 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1zoi_c01 ESTERASE user 3 3 # 3 B 97 SER A 241 SER.? 9.98 O3 PO4 A 349 B 227 ASP A 160 ASP.? 8.60 O4 PO4 A 349 B 256 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -1.16 62.88 18.52 0.68 62.16 19.33 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1zoi_c01 ESTERASE user 4 3 # 4 B 97 SER B 64 SER~? 26.98 C5 PG4 A 350 B 227 ASP B 41 ASP.? 20.21 O3 PO4 B 349 B 256 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1zoi_c01 ESTERASE user 5 3 # 5 B 97 SER B 241 SER.? 10.02 O1 PO4 B 349 B 227 ASP B 160 ASP.? 8.62 O4 PO4 B 349 B 256 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1zoi_c01 ESTERASE user 6 3 # 6 B 97 SER C 64 SER~? 25.88 C5 PG4 D 350 B 227 ASP C 41 ASP.? 20.22 O4 PO4 C 349 B 256 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1zoi_c01 ESTERASE user 7 3 # 7 B 97 SER C 241 SER.? 9.97 O3 PO4 C 349 B 227 ASP C 160 ASP.? 8.57 O1 PO4 C 349 B 256 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1zoi_c01 ESTERASE user 8 3 # 8 B 97 SER D 64 SER~? 27.50 C6 PG4 C 350 B 227 ASP D 41 ASP.? 20.92 O2 PO4 D 349 B 256 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1zoi_c01 ESTERASE user 9 3 # 9 B 97 SER D 241 SER.? 10.08 O3 PO4 D 349 B 227 ASP D 160 ASP.? 8.58 O4 PO4 D 349 B 256 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -38.74 26.41 54.26 -37.48 24.84 54.87 1zoi_c01 source 1zoi ESTERASE : 9 hits 1zoi_c01 naa= 3 ULMN 3 1zoi_c02 ESTERASE user 1 3 # 1 C 97 SER A 64 SER~? 26.25 O3 PG4 B 350 C 227 ASP A 41 ASP.? 20.10 O2 PO4 A 349 C 256 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 1.46 56.04 50.07 2.12 55.38 52.31 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 1.74 60.96 43.57 3.36 61.47 42.28 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1zoi_c02 ESTERASE user 2 3 # 2 C 97 SER A 64 SER~? 26.25 O3 PG4 B 350 C 227 ASP A 90 ASP~? 15.98 C4 PG4 B 350 C 256 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 1.46 56.04 50.07 2.12 55.38 52.31 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 8.08 50.44 43.84 7.48 51.26 41.98 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 1zoi_c02 ESTERASE user 3 3 # 3 C 97 SER A 241 SER.? 9.98 O3 PO4 A 349 C 227 ASP A 160 ASP.? 8.60 O4 PO4 A 349 C 256 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -1.16 62.88 18.52 0.68 62.16 19.33 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 1zoi_c02 ESTERASE user 4 3 # 4 C 97 SER B 64 SER~? 26.98 C5 PG4 A 350 C 227 ASP B 41 ASP.? 20.21 O3 PO4 B 349 C 256 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 1zoi_c02 ESTERASE user 5 3 # 5 C 97 SER B 241 SER.? 10.02 O1 PO4 B 349 C 227 ASP B 160 ASP.? 8.62 O4 PO4 B 349 C 256 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 1zoi_c02 ESTERASE user 6 3 # 6 C 97 SER C 64 SER~? 25.88 C5 PG4 D 350 C 227 ASP C 41 ASP.? 20.22 O4 PO4 C 349 C 256 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 1zoi_c02 ESTERASE user 7 3 # 7 C 97 SER C 241 SER.? 9.97 O3 PO4 C 349 C 227 ASP C 160 ASP.? 8.57 O1 PO4 C 349 C 256 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 1zoi_c02 ESTERASE user 8 3 # 8 C 97 SER D 64 SER~? 27.50 C6 PG4 C 350 C 227 ASP D 41 ASP.? 20.92 O2 PO4 D 349 C 256 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 1zoi_c02 ESTERASE user 9 3 # 9 C 97 SER D 241 SER.? 10.08 O3 PO4 D 349 C 227 ASP D 160 ASP.? 8.58 O4 PO4 D 349 C 256 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -38.74 26.41 54.26 -37.48 24.84 54.87 1zoi_c02 source 1zoi ESTERASE : 9 hits 1zoi_c02 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 371 LYS B 134 LYS.? 7.94 O5 PG4 B 350 A 407 THR B 111 THR.? -3.92 C5 PG4 A 350s coo -5.17 31.09 15.73 -7.07 31.12 16.73 0.40 27.07 22.40 -0.62 25.51 23.42 coo -4.43 30.92 22.89 -6.61 31.91 19.71 1.49 32.28 22.12 4.07 30.52 27.68 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -6.89 27.93 21.89 -8.77 26.98 22.40 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 371 LYS B 316 LYS~? 24.20 O3 PO4 B 349 A 407 THR B 307 THR.? 14.53 O3 PO4 B 349 coo -5.17 31.09 15.73 -7.07 31.12 16.73 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -2.04 35.41 -19.34 2.27 31.66 -22.14 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -4.70 32.82 -11.47 -3.25 33.55 -12.93 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 371 LYS B 316 LYS~? 24.20 O3 PO4 B 349 A 407 THR B 331 THR^? 16.37 O4 PO4 B 349 coo -5.17 31.09 15.73 -7.07 31.12 16.73 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -2.04 35.41 -19.34 2.27 31.66 -22.14 coo -8.38 36.02 19.06 -8.83 34.10 19.89 2.36 38.24 -13.00 4.20 37.08 -13.10 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 371 LYS C 316 LYS~? 23.27 O4 PO4 C 349 A 407 THR C 307 THR.? 14.50 O4 PO4 C 349 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -42.20 32.39 17.40 -42.88 30.35 17.40 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -44.69 38.73 13.31 -40.21 38.10 9.89 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -47.35 31.27 17.04 -45.92 32.81 16.45 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 371 LYS C 316 LYS~? 23.27 O4 PO4 C 349 A 407 THR C 331 THR^? 16.46 O1 PO4 C 349 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -42.20 32.39 17.40 -42.88 30.35 17.40 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -44.69 38.73 13.31 -40.21 38.10 9.89 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -39.89 36.19 19.34 -38.09 35.37 18.43 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 6 3 # 6 A 369 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 371 LYS D 316 LYS~? 24.37 O2 PO4 D 349 A 407 THR D 307 THR.? 14.52 O2 PO4 D 349 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -51.05 35.32 70.59 -50.24 33.36 70.95 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -49.65 42.56 73.75 -53.64 42.38 78.67 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -45.94 35.31 71.02 -47.61 36.72 71.34 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 7 3 # 7 A 369 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 371 LYS D 316 LYS~? 24.37 O2 PO4 D 349 A 407 THR D 331 THR^? 16.33 O4 PO4 D 349 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -51.05 35.32 70.59 -50.24 33.36 70.95 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -49.65 42.56 73.75 -53.64 42.38 78.67 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -53.87 38.43 68.16 -55.50 37.55 69.29 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 7 hits 1zrz_c02 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 92 TRP~? 12.30 C5 PG4 B 350 223 ASP A 90 ASP~? 15.98 C4 PG4 B 350 258 ALA A 81 ALA.? 10.40 C3 PG4 B 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 5.76 43.52 43.23 2.80 41.26 41.96 coo 127.91 41.73 23.55 129.18 40.35 24.44 8.08 50.44 43.84 7.48 51.26 41.98 coo 141.00 37.49 25.74 139.80 37.53 24.78 1.29 52.42 33.85 0.45 52.31 32.60 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP A 92 TRP~? 12.30 C5 PG4 B 350 223 ASP A 90 ASP~? 15.98 C4 PG4 B 350 258 ALA A 98 ALA~? 20.83 C5 PG4 B 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 5.76 43.52 43.23 2.80 41.26 41.96 coo 127.91 41.73 23.55 129.18 40.35 24.44 8.08 50.44 43.84 7.48 51.26 41.98 coo 141.00 37.49 25.74 139.80 37.53 24.78 -4.80 48.00 50.25 -4.93 48.51 48.79 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 3 # 3 142 TRP A 92 TRP~? 12.30 C5 PG4 B 350 223 ASP A 118 ASP~? 17.27 C5 PG4 B 350 258 ALA A 98 ALA~? 20.83 C5 PG4 B 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 5.76 43.52 43.23 2.80 41.26 41.96 coo 127.91 41.73 23.55 129.18 40.35 24.44 0.76 36.83 47.04 2.33 35.40 47.32 coo 141.00 37.49 25.74 139.80 37.53 24.78 -4.80 48.00 50.25 -4.93 48.51 48.79 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 4 3 # 4 142 TRP A 130 TRP^? 16.11 O1 PG4 A 350 223 ASP A 198 ASP.? 17.22 O1 PO4 A 349 258 ALA A 137 ALA.? 5.46 O1 PG4 A 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 -12.75 44.26 36.25 -14.22 47.86 35.68 coo 127.91 41.73 23.55 129.18 40.35 24.44 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 141.00 37.49 25.74 139.80 37.53 24.78 -15.24 36.07 26.36 -15.96 35.31 27.49 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 5 3 # 5 142 TRP B 92 TRP~? 12.54 C5 PG4 A 350 223 ASP B 90 ASP~? 17.21 C5 PG4 A 350 258 ALA B 81 ALA.? 10.90 C4 PG4 A 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 -11.95 17.23 22.74 -9.16 19.51 24.31 coo 127.91 41.73 23.55 129.18 40.35 24.44 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 141.00 37.49 25.74 139.80 37.53 24.78 -9.22 24.44 12.09 -8.53 25.77 12.01 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 6 3 # 6 142 TRP B 92 TRP~? 12.54 C5 PG4 A 350 223 ASP B 90 ASP~? 17.21 C5 PG4 A 350 258 ALA B 98 ALA~? 20.95 C5 PG4 A 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 -11.95 17.23 22.74 -9.16 19.51 24.31 coo 127.91 41.73 23.55 129.18 40.35 24.44 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 141.00 37.49 25.74 139.80 37.53 24.78 -0.63 10.86 19.74 -0.63 12.19 18.99 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 7 3 # 7 142 TRP B 92 TRP~? 12.54 C5 PG4 A 350 223 ASP B 118 ASP~? 16.08 C6 PG4 A 350 258 ALA B 98 ALA~? 20.95 C5 PG4 A 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 -11.95 17.23 22.74 -9.16 19.51 24.31 coo 127.91 41.73 23.55 129.18 40.35 24.44 -7.43 16.06 29.70 -8.95 16.74 31.02 coo 141.00 37.49 25.74 139.80 37.53 24.78 -0.63 10.86 19.74 -0.63 12.19 18.99 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 8 3 # 8 142 TRP B 130 TRP^? 14.98 O5 PG4 B 350 223 ASP B 198 ASP.? 14.38 O1 PG4 B 350 258 ALA B 137 ALA.? 5.32 O1 PG4 B 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 5.35 26.39 20.25 6.70 26.34 16.54 coo 127.91 41.73 23.55 129.18 40.35 24.44 11.89 31.57 14.26 12.37 32.72 16.00 coo 141.00 37.49 25.74 139.80 37.53 24.78 7.80 37.88 25.36 8.67 37.02 26.26 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 9 3 # 9 142 TRP C 92 TRP~? 12.27 C3 PG4 D 350 223 ASP C 118 ASP~? 17.28 C3 PG4 D 350 258 ALA C 98 ALA~? 20.93 C3 PG4 D 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 -53.62 -4.70 31.38 -50.46 -4.47 33.71 coo 127.91 41.73 23.55 129.18 40.35 24.44 -47.97 -10.84 34.12 -49.33 -12.17 35.08 coo 141.00 37.49 25.74 139.80 37.53 24.78 -43.76 -6.51 22.55 -43.80 -5.04 22.97 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 10 3 # 10 142 TRP C 130 TRP^? 16.08 O1 PG4 C 350 223 ASP C 198 ASP.? 14.11 O1 PG4 C 350 258 ALA C 137 ALA.? 4.99 O1 PG4 C 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 -35.90 3.97 33.18 -35.19 6.75 30.48 coo 127.91 41.73 23.55 129.18 40.35 24.44 -29.82 11.85 32.90 -29.50 11.63 35.01 coo 141.00 37.49 25.74 139.80 37.53 24.78 -32.98 8.36 45.57 -32.22 7.01 45.61 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 11 3 # 11 142 TRP C 130 TRP^? 16.08 O1 PG4 C 350 223 ASP C 198 ASP.? 14.11 O1 PG4 C 350 258 ALA C 204 ALA~? 8.41 C1 PG4 D 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 -35.90 3.97 33.18 -35.19 6.75 30.48 coo 127.91 41.73 23.55 129.18 40.35 24.44 -29.82 11.85 32.90 -29.50 11.63 35.01 coo 141.00 37.49 25.74 139.80 37.53 24.78 -43.72 12.08 40.27 -43.19 10.95 39.41 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 12 3 # 12 142 TRP C 181 TRP.? 10.24 C1 PG4 A 350 223 ASP C 343 ASP~? 16.17 O1 PG4 A 350 258 ALA A 213 ALA~? 7.64 O1 PG4 A 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 -23.22 31.17 24.81 -20.89 33.85 26.48 coo 127.91 41.73 23.55 129.18 40.35 24.44 -29.47 38.91 22.93 -28.30 38.51 21.17 coo 141.00 37.49 25.74 139.80 37.53 24.78 -14.74 43.07 20.23 -13.44 43.27 20.98 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 13 3 # 13 142 TRP D 92 TRP~? 12.49 C6 PG4 C 350 223 ASP D 118 ASP~? 17.29 C6 PG4 C 350 258 ALA D 98 ALA~? 21.08 C6 PG4 C 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 -35.51 -1.29 62.69 -38.42 -1.60 60.06 coo 127.91 41.73 23.55 129.18 40.35 24.44 -39.99 -8.60 59.76 -38.31 -9.56 58.92 coo 141.00 37.49 25.74 139.80 37.53 24.78 -46.21 -4.06 70.08 -46.37 -2.63 69.56 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 14 3 # 14 142 TRP D 130 TRP^? 15.64 O5 PG4 D 350 223 ASP D 198 ASP.? 14.02 O5 PG4 D 350 258 ALA D 137 ALA.? -5.14 O5 PG4 D 350s coo 128.40 33.01 26.67 128.12 36.28 28.81 -53.23 4.77 58.11 -54.46 7.60 60.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 -59.61 10.87 58.41 -59.89 10.18 56.43 coo 141.00 37.49 25.74 139.80 37.53 24.78 -56.06 6.67 46.20 -56.71 5.27 46.46 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 15 3 # 15 142 TRP D 130 TRP^? 15.64 O5 PG4 D 350 223 ASP D 198 ASP.? 14.02 O5 PG4 D 350 258 ALA D 204 ALA~? 8.16 C7 PG4 C 350 coo 128.40 33.01 26.67 128.12 36.28 28.81 -53.23 4.77 58.11 -54.46 7.60 60.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 -59.61 10.87 58.41 -59.89 10.18 56.43 coo 141.00 37.49 25.74 139.80 37.53 24.78 -45.88 12.76 50.82 -46.11 11.67 51.84 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 15 hits 2aat_c01 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 48 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 77 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 13.04 30.41 72.50 12.95 30.65 70.36 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 12.77 23.50 68.33 13.58 25.42 68.49 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 7.53 29.84 65.06 12.29 29.41 67.79 1.49 32.28 22.12 4.07 30.52 27.68 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 2 3 # 2 A 43 ASP B 226 ASP.? 24.90 O2 PO4 B 349 A 48 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 77 LYS B 177 LYS~? 21.19 O2 PO4 B 349 coo 13.04 30.41 72.50 12.95 30.65 70.36 20.38 42.79 0.27 22.43 42.38 0.23 coo 12.77 23.50 68.33 13.58 25.42 68.49 11.38 38.70 0.79 12.71 38.99 -0.80 coo 7.53 29.84 65.06 12.29 29.41 67.79 18.35 34.41 -3.27 19.41 29.18 0.25 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 3 3 # 3 A 43 ASP D 226 ASP.? 25.08 O1 PO4 D 349 A 48 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 77 LYS D 177 LYS~? 20.36 O1 PO4 D 349 coo 13.04 30.41 72.50 12.95 30.65 70.36 -71.26 26.87 58.29 -73.26 26.34 58.61 coo 12.77 23.50 68.33 13.58 25.42 68.49 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 7.53 29.84 65.06 12.29 29.41 67.79 -68.08 25.33 66.69 -67.75 19.10 66.60 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 3 hits 2acu_c01 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 140 ASP.? 7.37 O2 PG4 A 350 231 ASP B 90 ASP~? 17.21 C5 PG4 A 350 294 ASP A 208 ASP~? 8.51 C3 PG4 A 350 coo 27.89 102.52 14.98 29.35 101.92 13.57 -17.33 36.17 16.29 -18.45 34.60 17.12 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 33.16 106.80 7.72 33.34 104.87 6.92 -7.49 37.13 15.29 -7.97 36.07 13.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 140 ASP.? 7.99 O2 PG4 B 350 231 ASP A 41 ASP.? 20.10 O2 PO4 A 349 294 ASP B 208 ASP~? 8.88 C3 PG4 B 350 coo 27.89 102.52 14.98 29.35 101.92 13.57 8.40 47.76 23.89 8.35 49.33 25.35 coo 14.74 93.05 -1.00 14.30 94.22 0.73 1.74 60.96 43.57 3.36 61.47 42.28 coo 33.16 106.80 7.72 33.34 104.87 6.92 -1.20 47.44 23.46 -1.05 49.37 24.33 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 208 ASP~? 8.88 C3 PG4 B 350 231 ASP A 41 ASP.? 20.10 O2 PO4 A 349 294 ASP B 140 ASP.? 7.99 O2 PG4 B 350 coo 27.89 102.52 14.98 29.35 101.92 13.57 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 14.74 93.05 -1.00 14.30 94.22 0.73 1.74 60.96 43.57 3.36 61.47 42.28 coo 33.16 106.80 7.72 33.34 104.87 6.92 8.40 47.76 23.89 8.35 49.33 25.35 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP C 140 ASP.? 7.74 C2 PG4 C 350 231 ASP D 89 ASP.? 16.35 C5 PG4 C 350 294 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -31.01 0.13 64.24 -30.68 -1.79 63.45 coo 33.16 106.80 7.72 33.34 104.87 6.92 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP C 140 ASP.? 7.74 C2 PG4 C 350 231 ASP D 90 ASP~? 17.03 C4 PG4 C 350 294 ASP C 208 ASP~? 8.73 O2 PG4 C 350 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.75 16.85 51.07 -30.38 15.61 52.00 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 33.16 106.80 7.72 33.34 104.87 6.92 -41.61 16.40 51.56 -41.24 17.22 53.47 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP C 208 ASP~? 8.73 O2 PG4 C 350 231 ASP D 90 ASP~? 17.03 C4 PG4 C 350 294 ASP C 140 ASP.? 7.74 C2 PG4 C 350 coo 27.89 102.52 14.98 29.35 101.92 13.57 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 33.16 106.80 7.72 33.34 104.87 6.92 -31.75 16.85 51.07 -30.38 15.61 52.00 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 6 hits 2amg_c06 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 173 HIS~? 15.17 O1 PO4 A 349 B 163 ALA A 176 ALA~? 18.28 O1 PO4 A 349 B 182 SER A 183 SER^? 16.92 O1 PO4 A 349 coo 30.42 1.98 4.36 29.07 0.41 4.68 -22.96 60.49 26.07 -24.34 59.43 27.24 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -27.00 64.71 23.01 -26.51 63.43 22.36 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -27.51 58.57 23.48 -25.56 60.04 23.47 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS A 229 HIS^? 14.13 O1 PO4 A 349 B 163 ALA A 176 ALA~? 18.28 O1 PO4 A 349 B 182 SER A 183 SER^? 16.92 O1 PO4 A 349 coo 30.42 1.98 4.36 29.07 0.41 4.68 -21.69 59.77 21.49 -23.21 61.13 21.02 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -27.00 64.71 23.01 -26.51 63.43 22.36 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -27.51 58.57 23.48 -25.56 60.04 23.47 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS A 238 HIS.? 10.67 O3 PO4 A 349 B 163 ALA B 142 ALA.? 12.37 C2 PG4 B 350 B 182 SER B 143 SER.? 15.37 C2 PG4 B 350 coo 30.42 1.98 4.36 29.07 0.41 4.68 1.50 56.90 17.79 2.83 56.38 19.33 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 6.73 50.30 18.21 6.20 49.71 16.95 coo 24.00 -0.17 2.07 24.51 1.00 0.04 8.40 53.62 17.31 10.72 53.32 17.95 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS A 272 HIS.? 19.95 O3 PO4 A 349 B 163 ALA B 145 ALA~? 16.87 C2 PG4 B 350 B 182 SER B 143 SER.? 15.37 C2 PG4 B 350 coo 30.42 1.98 4.36 29.07 0.41 4.68 11.10 60.27 13.77 10.40 58.32 14.13 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 12.65 52.19 14.23 13.11 51.44 15.47 coo 24.00 -0.17 2.07 24.51 1.00 0.04 8.40 53.62 17.31 10.72 53.32 17.95 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 5 3 # 5 B 46 HIS B 173 HIS~? 15.15 O2 PO4 B 349 B 163 ALA B 176 ALA~? 18.30 O2 PO4 B 349 B 182 SER B 183 SER^? 16.79 O2 PO4 B 349 coo 30.42 1.98 4.36 29.07 0.41 4.68 13.23 34.15 0.64 14.88 33.23 1.56 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 16.22 37.28 -4.66 15.77 38.11 -3.49 coo 24.00 -0.17 2.07 24.51 1.00 0.04 17.47 37.56 1.42 15.35 37.17 0.22 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 6 3 # 6 B 46 HIS B 229 HIS^? 14.08 O2 PO4 B 349 B 163 ALA B 176 ALA~? 18.30 O2 PO4 B 349 B 182 SER B 183 SER^? 16.79 O2 PO4 B 349 coo 30.42 1.98 4.36 29.07 0.41 4.68 11.38 38.70 0.79 12.71 38.99 -0.80 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 16.22 37.28 -4.66 15.77 38.11 -3.49 coo 24.00 -0.17 2.07 24.51 1.00 0.04 17.47 37.56 1.42 15.35 37.17 0.22 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 7 3 # 7 B 46 HIS B 238 HIS.? 10.82 O1 PO4 B 349 B 163 ALA A 142 ALA.? 12.14 C2 PG4 A 350 B 182 SER A 143 SER.? 14.48 C2 PG4 A 350 coo 30.42 1.98 4.36 29.07 0.41 4.68 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -16.20 40.87 12.81 -15.80 42.33 13.02 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -18.44 40.75 9.72 -20.35 39.92 10.87 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 8 3 # 8 B 46 HIS B 272 HIS.? 20.00 O1 PO4 B 349 B 163 ALA A 145 ALA~? 16.33 C2 PG4 A 350 B 182 SER A 143 SER.? 14.48 C2 PG4 A 350 coo 30.42 1.98 4.36 29.07 0.41 4.68 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -22.82 43.66 11.21 -22.96 42.60 12.30 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -18.44 40.75 9.72 -20.35 39.92 10.87 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 9 3 # 9 B 46 HIS C 173 HIS~? 15.03 O2 PO4 C 349 B 163 ALA C 176 ALA~? 15.03 O2 PG4 A 350 B 182 SER C 183 SER^? 16.83 O2 PO4 C 349 coo 30.42 1.98 4.36 29.07 0.41 4.68 -28.98 23.20 25.42 -27.39 21.83 25.46 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -25.95 28.73 23.42 -26.39 28.45 24.83 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -24.45 24.87 27.97 -26.59 25.58 27.05 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 10 3 # 10 B 46 HIS C 229 HIS^? 14.09 O2 PO4 C 349 B 163 ALA C 176 ALA~? 15.03 O2 PG4 A 350 B 182 SER C 183 SER^? 16.83 O2 PO4 C 349 coo 30.42 1.98 4.36 29.07 0.41 4.68 -30.48 26.35 28.68 -29.26 27.76 27.72 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -25.95 28.73 23.42 -26.39 28.45 24.83 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -24.45 24.87 27.97 -26.59 25.58 27.05 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 11 3 # 11 B 46 HIS C 238 HIS.? 10.74 O3 PO4 C 349 B 163 ALA D 142 ALA.? 12.20 O5 PG4 D 350 B 182 SER D 143 SER.? 14.73 O4 PG4 D 350 coo 30.42 1.98 4.36 29.07 0.41 4.68 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -57.25 19.43 40.27 -56.72 20.25 41.44 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -59.66 21.71 38.39 -61.59 20.24 38.67 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 12 3 # 12 B 46 HIS C 272 HIS.? 20.13 O1 PO4 C 349 B 163 ALA D 145 ALA~? 16.03 O5 PG4 D 350 B 182 SER D 143 SER.? 14.73 O4 PG4 D 350 coo 30.42 1.98 4.36 29.07 0.41 4.68 -63.70 27.74 35.03 -62.68 26.43 36.32 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -63.78 22.48 41.65 -63.83 20.96 41.65 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -59.66 21.71 38.39 -61.59 20.24 38.67 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 13 3 # 13 B 46 HIS D 173 HIS~? 14.91 O1 PO4 D 349 B 163 ALA D 176 ALA~? 18.20 O1 PO4 D 349 B 182 SER D 183 SER^? 16.97 O1 PO4 D 349 coo 30.42 1.98 4.36 29.07 0.41 4.68 -62.51 23.18 64.17 -63.84 21.56 64.29 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -66.56 28.54 65.37 -66.10 28.17 63.98 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -67.39 23.51 61.42 -65.47 24.80 62.18 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 14 3 # 14 B 46 HIS D 229 HIS^? 14.18 O1 PO4 D 349 B 163 ALA D 176 ALA~? 18.20 O1 PO4 D 349 B 182 SER D 183 SER^? 16.97 O1 PO4 D 349 coo 30.42 1.98 4.36 29.07 0.41 4.68 -61.67 25.88 60.45 -63.21 27.00 61.32 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -66.56 28.54 65.37 -66.10 28.17 63.98 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -67.39 23.51 61.42 -65.47 24.80 62.18 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 15 3 # 15 B 46 HIS D 238 HIS.? 10.72 O3 PO4 D 349 B 163 ALA C 142 ALA.? 12.35 C2 PG4 C 350 B 182 SER C 143 SER.? 14.49 C2 PG4 C 350 coo 30.42 1.98 4.36 29.07 0.41 4.68 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -33.86 22.03 49.44 -34.51 22.67 48.24 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -31.83 24.72 51.20 -29.72 23.61 51.01 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 16 3 # 16 B 46 HIS D 272 HIS.? 19.84 O3 PO4 D 349 B 163 ALA C 145 ALA~? 16.35 C2 PG4 C 350 B 182 SER C 143 SER.? 14.49 C2 PG4 C 350 coo 30.42 1.98 4.36 29.07 0.41 4.68 -29.12 31.20 53.56 -30.01 29.84 52.23 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -27.83 25.92 47.63 -27.40 24.47 47.83 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -31.83 24.72 51.20 -29.72 23.61 51.01 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 16 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG C 152 ARG^? 15.32 O1 PG4 A 350 C 161 ASP A 198 ASP.? 17.22 O1 PO4 A 349 C 174 TYR A 221 TYR~? 17.25 O1 PG4 A 350 coo 2.84 19.43 40.34 1.59 20.35 37.65 -26.55 34.01 32.08 -24.98 36.67 32.18 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -20.04 48.14 30.81 -21.28 49.70 29.91 coo 5.94 13.28 27.17 3.53 13.05 28.58 -24.98 48.97 24.49 -23.82 47.69 26.70 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c10 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 171 GLU~? 12.95 O2 PO4 A 349 A 156 GLU A 231 GLU.? 5.77 O1 PO4 A 349 A 194 ASN A 306 ASN^? 8.27 O2 PO4 A 349 coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 67.47 20.07 1.34 65.99 20.06 2.88 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 67.44 25.26 13.91 67.54 23.65 15.28 -7.02 69.82 22.14 -6.25 69.91 24.11 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU B 171 GLU~? 12.87 O3 PO4 B 349 A 156 GLU B 231 GLU.? 5.72 O2 PO4 B 349 A 194 ASN B 306 ASN^? 8.17 O3 PO4 B 349 coo 74.14 15.91 8.55 72.08 15.36 8.63 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 67.47 20.07 1.34 65.99 20.06 2.88 3.23 35.71 5.73 3.00 33.97 6.89 coo 67.44 25.26 13.91 67.54 23.65 15.28 -3.96 34.28 -6.86 -4.36 32.22 -6.36 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU C 171 GLU~? 12.90 O2 PO4 C 349 A 156 GLU C 231 GLU.? 5.70 O2 PO4 C 349 A 194 ASN C 306 ASN^? 8.19 O4 PO4 C 349 coo 74.14 15.91 8.55 72.08 15.36 8.63 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 67.47 20.07 1.34 65.99 20.06 2.88 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 67.44 25.26 13.91 67.54 23.65 15.28 -46.37 29.17 21.30 -46.92 27.39 20.25 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU D 171 GLU~? 12.87 O2 PO4 D 349 A 156 GLU D 231 GLU.? 5.62 O1 PO4 D 349 A 194 ASN D 306 ASN^? 8.15 O2 PO4 D 349 coo 74.14 15.91 8.55 72.08 15.36 8.63 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 67.47 20.07 1.34 65.99 20.06 2.88 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 67.44 25.26 13.91 67.54 23.65 15.28 -46.44 32.39 67.16 -45.73 30.88 68.47 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU D 312 GLU~? 22.27 O2 PO4 D 349 A 156 GLU D 317 GLU~? 25.08 O4 PO4 D 349 A 194 ASN D 306 ASN^? 8.15 O2 PO4 D 349 coo 74.14 15.91 8.55 72.08 15.36 8.63 -50.13 39.19 79.01 -51.63 38.45 80.28 coo 67.47 20.07 1.34 65.99 20.06 2.88 -45.36 46.85 72.91 -43.76 47.38 74.18 coo 67.44 25.26 13.91 67.54 23.65 15.28 -46.44 32.39 67.16 -45.73 30.88 68.47 2dbt_c00 source 2dbt CHITINASE C : 5 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 171 GLU~? 12.95 O2 PO4 A 349 B 156 GLU A 231 GLU.? 5.77 O1 PO4 A 349 B 194 ASN A 306 ASN^? 8.27 O2 PO4 A 349 coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 54.43 67.89 19.82 55.62 67.90 18.07 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 49.79 70.75 7.78 50.10 68.90 6.86 -7.02 69.82 22.14 -6.25 69.91 24.11 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU B 171 GLU~? 12.87 O3 PO4 B 349 B 156 GLU B 231 GLU.? 5.72 O2 PO4 B 349 B 194 ASN B 306 ASN^? 8.17 O3 PO4 B 349 coo 45.64 63.11 17.20 47.48 62.43 16.45 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 54.43 67.89 19.82 55.62 67.90 18.07 3.23 35.71 5.73 3.00 33.97 6.89 coo 49.79 70.75 7.78 50.10 68.90 6.86 -3.96 34.28 -6.86 -4.36 32.22 -6.36 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU C 171 GLU~? 12.90 O2 PO4 C 349 B 156 GLU C 231 GLU.? 5.70 O2 PO4 C 349 B 194 ASN C 306 ASN^? 8.19 O4 PO4 C 349 coo 45.64 63.11 17.20 47.48 62.43 16.45 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 54.43 67.89 19.82 55.62 67.90 18.07 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 49.79 70.75 7.78 50.10 68.90 6.86 -46.37 29.17 21.30 -46.92 27.39 20.25 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU D 171 GLU~? 12.87 O2 PO4 D 349 B 156 GLU D 231 GLU.? 5.62 O1 PO4 D 349 B 194 ASN D 306 ASN^? 8.15 O2 PO4 D 349 coo 45.64 63.11 17.20 47.48 62.43 16.45 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 54.43 67.89 19.82 55.62 67.90 18.07 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 49.79 70.75 7.78 50.10 68.90 6.86 -46.44 32.39 67.16 -45.73 30.88 68.47 2dbt_c01 source 2dbt CHITINASE C : 4 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 171 GLU~? 12.95 O2 PO4 A 349 C 156 GLU A 231 GLU.? 5.77 O1 PO4 A 349 C 194 ASN A 306 ASN^? 8.27 O2 PO4 A 349 coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.15 67.55 26.15 -17.92 68.63 27.78 coo 44.75 23.09 5.51 46.77 22.91 6.12 -12.78 56.62 24.13 -12.11 55.65 25.89 coo 49.75 21.00 18.12 50.45 23.02 18.26 -7.02 69.82 22.14 -6.25 69.91 24.11 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU B 171 GLU~? 12.87 O3 PO4 B 349 C 156 GLU B 231 GLU.? 5.72 O2 PO4 B 349 C 194 ASN B 306 ASN^? 8.17 O3 PO4 B 349 coo 41.23 29.31 13.28 43.03 29.85 12.29 6.59 31.85 -5.28 7.53 30.11 -6.08 coo 44.75 23.09 5.51 46.77 22.91 6.12 3.23 35.71 5.73 3.00 33.97 6.89 coo 49.75 21.00 18.12 50.45 23.02 18.26 -3.96 34.28 -6.86 -4.36 32.22 -6.36 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU C 171 GLU~? 12.90 O2 PO4 C 349 C 156 GLU C 231 GLU.? 5.70 O2 PO4 C 349 C 194 ASN C 306 ASN^? 8.19 O4 PO4 C 349 coo 41.23 29.31 13.28 43.03 29.85 12.29 -35.81 26.11 19.98 -35.09 25.51 18.09 coo 44.75 23.09 5.51 46.77 22.91 6.12 -38.62 20.97 30.45 -38.95 18.93 30.05 coo 49.75 21.00 18.12 50.45 23.02 18.26 -46.37 29.17 21.30 -46.92 27.39 20.25 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU D 171 GLU~? 12.87 O2 PO4 D 349 C 156 GLU D 231 GLU.? 5.62 O1 PO4 D 349 C 194 ASN D 306 ASN^? 8.15 O2 PO4 D 349 coo 41.23 29.31 13.28 43.03 29.85 12.29 -56.37 27.70 69.07 -57.02 27.32 71.04 coo 44.75 23.09 5.51 46.77 22.91 6.12 -52.72 21.86 59.42 -51.91 19.95 59.86 coo 49.75 21.00 18.12 50.45 23.02 18.26 -46.44 32.39 67.16 -45.73 30.88 68.47 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU D 312 GLU~? 22.27 O2 PO4 D 349 C 156 GLU D 317 GLU~? 25.08 O4 PO4 D 349 C 194 ASN D 306 ASN^? 8.15 O2 PO4 D 349 coo 41.23 29.31 13.28 43.03 29.85 12.29 -50.13 39.19 79.01 -51.63 38.45 80.28 coo 44.75 23.09 5.51 46.77 22.91 6.12 -45.36 46.85 72.91 -43.76 47.38 74.18 coo 49.75 21.00 18.12 50.45 23.02 18.26 -46.44 32.39 67.16 -45.73 30.88 68.47 2dbt_c02 source 2dbt CHITINASE C : 5 hits 2dbt_c02 naa= 3 ULMN 3 2esd_c00 1.02.01.0009 user 1 3 # 1 A 154 ASN B 224 ASN~? 23.43 O1 PG4 B 350 A 250 ALA B 146 ALA~? 18.33 O1 PG4 B 350 A 284 CYH B 151 CYH.? 20.90 O2 PO4 B 349 coo -98.31 19.25 26.95 -99.27 21.10 26.57 22.11 40.26 9.14 23.14 40.57 10.98 coo -102.90 29.72 23.02 -103.69 28.50 23.43 12.70 49.96 11.14 11.60 48.99 10.76 coo -98.59 26.45 29.50 -99.24 25.73 26.84 17.77 46.72 3.80 16.28 45.67 5.92 ULMN 3 2esd_c00 1.02.01.0009 user 2 3 # 2 A 154 ASN C 224 ASN~? 19.07 C6 PG4 A 350 A 250 ALA C 146 ALA~? 18.27 C2 PG4 C 350 A 284 CYH C 151 CYH.? 19.97 C1 PG4 A 350 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -19.05 21.33 34.82 -18.35 20.29 36.53 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -28.22 26.62 43.87 -29.46 26.35 43.06 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -23.43 29.67 36.17 -24.68 27.35 36.97 ULMN 3 2esd_c00 1.02.01.0009 user 3 3 # 3 A 154 ASN D 224 ASN.? 21.91 O5 PG4 D 350 A 250 ALA D 146 ALA~? 17.62 O5 PG4 D 350 A 284 CYH D 151 CYH.? 21.19 O1 PO4 D 349 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -71.47 18.11 55.17 -71.73 16.64 53.65 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -63.80 23.77 45.26 -62.60 23.75 46.23 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -68.87 26.89 52.59 -67.21 24.68 51.99 2esd_c00 source 2esd 1.02.01.0009 : 3 hits 2esd_c00 naa= 3 ULMN 3 2esd_c01 1.02.01.0009 user 1 3 # 1 B 154 ASN B 224 ASN~? 23.43 O1 PG4 B 350 B 250 ALA B 146 ALA~? 18.33 O1 PG4 B 350 B 284 CYH B 151 CYH.? 20.90 O2 PO4 B 349 coo -116.62 58.12 2.11 -116.17 56.24 3.01 22.11 40.26 9.14 23.14 40.57 10.98 coo -114.20 47.61 7.65 -114.88 48.80 8.33 12.70 49.96 11.14 11.60 48.99 10.76 coo -118.73 50.90 1.30 -116.61 51.76 2.87 17.77 46.72 3.80 16.28 45.67 5.92 ULMN 3 2esd_c01 1.02.01.0009 user 2 3 # 2 B 154 ASN C 224 ASN~? 19.07 C6 PG4 A 350 B 250 ALA C 146 ALA~? 18.27 C2 PG4 C 350 B 284 CYH C 151 CYH.? 19.97 C1 PG4 A 350 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -19.05 21.33 34.82 -18.35 20.29 36.53 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -28.22 26.62 43.87 -29.46 26.35 43.06 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -23.43 29.67 36.17 -24.68 27.35 36.97 ULMN 3 2esd_c01 1.02.01.0009 user 3 3 # 3 B 154 ASN D 224 ASN.? 21.91 O5 PG4 D 350 B 250 ALA D 146 ALA~? 17.62 O5 PG4 D 350 B 284 CYH D 151 CYH.? 21.19 O1 PO4 D 349 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -71.47 18.11 55.17 -71.73 16.64 53.65 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -63.80 23.77 45.26 -62.60 23.75 46.23 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -68.87 26.89 52.59 -67.21 24.68 51.99 2esd_c01 source 2esd 1.02.01.0009 : 3 hits 2esd_c01 naa= 3 ULMN 3 2esd_c02 1.02.01.0009 user 1 3 # 1 C 154 ASN B 224 ASN~? 23.43 O1 PG4 B 350 C 250 ALA B 146 ALA~? 18.33 O1 PG4 B 350 C 284 CYH B 151 CYH.? 20.90 O2 PO4 B 349 coo -155.36 18.42 28.93 -154.49 20.30 29.39 22.11 40.26 9.14 23.14 40.57 10.98 coo -150.95 29.02 32.87 -150.10 27.86 32.40 12.70 49.96 11.14 11.60 48.99 10.76 coo -155.22 25.64 26.33 -154.78 25.20 29.09 17.77 46.72 3.80 16.28 45.67 5.92 ULMN 3 2esd_c02 1.02.01.0009 user 2 3 # 2 C 154 ASN C 224 ASN~? 19.07 C6 PG4 A 350 C 250 ALA C 146 ALA~? 18.27 C2 PG4 C 350 C 284 CYH C 151 CYH.? 19.97 C1 PG4 A 350 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -19.05 21.33 34.82 -18.35 20.29 36.53 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -28.22 26.62 43.87 -29.46 26.35 43.06 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -23.43 29.67 36.17 -24.68 27.35 36.97 ULMN 3 2esd_c02 1.02.01.0009 user 3 3 # 3 C 154 ASN D 224 ASN.? 21.91 O5 PG4 D 350 C 250 ALA D 146 ALA~? 17.62 O5 PG4 D 350 C 284 CYH D 151 CYH.? 21.19 O1 PO4 D 349 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -71.47 18.11 55.17 -71.73 16.64 53.65 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -63.80 23.77 45.26 -62.60 23.75 46.23 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -68.87 26.89 52.59 -67.21 24.68 51.99 2esd_c02 source 2esd 1.02.01.0009 : 3 hits 2esd_c02 naa= 3 ULMN 3 2esd_c03 1.02.01.0009 user 1 3 # 1 D 154 ASN B 224 ASN~? 23.43 O1 PG4 B 350 D 250 ALA B 146 ALA~? 18.33 O1 PG4 B 350 D 284 CYH B 151 CYH.? 20.90 O2 PO4 B 349 coo -138.05 57.23 54.59 -137.96 55.47 53.43 22.11 40.26 9.14 23.14 40.57 10.98 coo -139.97 46.71 48.80 -139.25 47.90 48.19 12.70 49.96 11.14 11.60 48.99 10.76 coo -135.22 50.13 55.22 -137.25 50.94 53.65 17.77 46.72 3.80 16.28 45.67 5.92 ULMN 3 2esd_c03 1.02.01.0009 user 2 3 # 2 D 154 ASN C 224 ASN~? 19.07 C6 PG4 A 350 D 250 ALA C 146 ALA~? 18.27 C2 PG4 C 350 D 284 CYH C 151 CYH.? 19.97 C1 PG4 A 350 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -19.05 21.33 34.82 -18.35 20.29 36.53 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -28.22 26.62 43.87 -29.46 26.35 43.06 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -23.43 29.67 36.17 -24.68 27.35 36.97 ULMN 3 2esd_c03 1.02.01.0009 user 3 3 # 3 D 154 ASN D 224 ASN.? 21.91 O5 PG4 D 350 D 250 ALA D 146 ALA~? 17.62 O5 PG4 D 350 D 284 CYH D 151 CYH.? 21.19 O1 PO4 D 349 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -71.47 18.11 55.17 -71.73 16.64 53.65 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -63.80 23.77 45.26 -62.60 23.75 46.23 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -68.87 26.89 52.59 -67.21 24.68 51.99 2esd_c03 source 2esd 1.02.01.0009 : 3 hits 2esd_c03 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS B 321 HIS~? 21.63 O4 PO4 B 349 A 341 GLU B 325 GLU~? 19.47 O4 PO4 B 349 A 356 HIS B 260 HIS^? 11.70 O4 PO4 B 349 coo 121.00 36.37 19.26 121.57 38.37 19.56 -8.21 43.10 -17.57 -9.89 44.30 -17.19 coo 125.72 32.70 19.75 124.44 34.16 18.84 -7.86 48.35 -14.01 -8.88 47.03 -12.75 coo 124.34 41.73 25.55 123.79 42.60 23.72 -6.90 40.83 -7.07 -8.88 40.92 -7.74 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS C 321 HIS~? 21.29 O1 PO4 C 349 A 341 GLU C 325 GLU~? 19.31 O1 PO4 C 349 A 356 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 121.00 36.37 19.26 121.57 38.37 19.56 -50.23 42.88 20.64 -51.67 43.34 22.10 coo 125.72 32.70 19.75 124.44 34.16 18.84 -49.52 44.21 26.45 -50.31 42.24 26.60 coo 124.34 41.73 25.55 123.79 42.60 23.72 -48.83 33.87 26.09 -50.85 34.38 25.82 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 2 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS C 321 HIS~? 21.29 O1 PO4 C 349 B 341 GLU C 325 GLU~? 19.31 O1 PO4 C 349 B 356 HIS C 260 HIS^? 11.63 O1 PO4 C 349 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -50.23 42.88 20.64 -51.67 43.34 22.10 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -49.52 44.21 26.45 -50.31 42.24 26.60 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -48.83 33.87 26.09 -50.85 34.38 25.82 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 1 hits 2isd_c01 naa= 3 ULMN 3 2lip_c00 LIPASE user 1 3 # 1 87 SER A 64 SER~? 26.25 O3 PG4 B 350 264 ASP A 41 ASP.? 20.10 O2 PO4 A 349 286 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 10.47 25.91 18.67 10.67 27.13 20.84 1.46 56.04 50.07 2.12 55.38 52.31 coo 2.34 22.49 22.56 3.80 23.95 22.00 1.74 60.96 43.57 3.36 61.47 42.28 coo 7.10 24.11 23.40 8.18 25.09 21.87 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 2lip_c00 LIPASE user 2 3 # 2 87 SER A 64 SER~? 26.25 O3 PG4 B 350 264 ASP A 90 ASP~? 15.98 C4 PG4 B 350 286 HIS A 14 HIS.? 20.33 C3 PG4 B 350 coo 10.47 25.91 18.67 10.67 27.13 20.84 1.46 56.04 50.07 2.12 55.38 52.31 coo 2.34 22.49 22.56 3.80 23.95 22.00 8.08 50.44 43.84 7.48 51.26 41.98 coo 7.10 24.11 23.40 8.18 25.09 21.87 3.61 55.89 43.73 3.10 55.52 45.73 ULMN 3 2lip_c00 LIPASE user 3 3 # 3 87 SER A 241 SER.? 9.98 O3 PO4 A 349 264 ASP A 160 ASP.? 8.60 O4 PO4 A 349 286 HIS A 238 HIS.? 10.67 O3 PO4 A 349 coo 10.47 25.91 18.67 10.67 27.13 20.84 -0.69 52.51 16.88 -2.72 53.79 17.21 coo 2.34 22.49 22.56 3.80 23.95 22.00 -1.16 62.88 18.52 0.68 62.16 19.33 coo 7.10 24.11 23.40 8.18 25.09 21.87 1.50 56.90 17.79 2.83 56.38 19.33 ULMN 3 2lip_c00 LIPASE user 4 3 # 4 87 SER B 64 SER~? 26.98 C5 PG4 A 350 264 ASP B 41 ASP.? 20.21 O3 PO4 B 349 286 HIS B 14 HIS.? 21.30 C5 PG4 A 350 coo 10.47 25.91 18.67 10.67 27.13 20.84 -6.23 8.13 11.77 -6.66 5.89 12.66 coo 2.34 22.49 22.56 3.80 23.95 22.00 -7.40 13.29 5.68 -9.25 14.12 5.01 coo 7.10 24.11 23.40 8.18 25.09 21.87 -9.44 13.73 10.71 -8.61 11.98 11.53 ULMN 3 2lip_c00 LIPASE user 5 3 # 5 87 SER B 241 SER.? 10.02 O1 PO4 B 349 264 ASP B 160 ASP.? 8.62 O4 PO4 B 349 286 HIS B 238 HIS.? 10.82 O1 PO4 B 349 coo 10.47 25.91 18.67 10.67 27.13 20.84 -9.21 42.20 9.74 -7.29 41.83 8.32 coo 2.34 22.49 22.56 3.80 23.95 22.00 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 7.10 24.11 23.40 8.18 25.09 21.87 -11.67 40.20 5.98 -12.62 38.67 7.06 ULMN 3 2lip_c00 LIPASE user 6 3 # 6 87 SER C 64 SER~? 25.88 C5 PG4 D 350 264 ASP C 41 ASP.? 20.22 O4 PO4 C 349 286 HIS C 14 HIS.? 19.64 C5 PG4 D 350 coo 10.47 25.91 18.67 10.67 27.13 20.84 -51.01 -2.63 16.81 -51.42 -4.86 15.97 coo 2.34 22.49 22.56 3.80 23.95 22.00 -52.23 5.22 16.50 -53.97 6.36 17.05 coo 7.10 24.11 23.40 8.18 25.09 21.87 -53.35 2.03 20.79 -52.66 0.23 19.95 ULMN 3 2lip_c00 LIPASE user 7 3 # 7 87 SER C 241 SER.? 9.97 O3 PO4 C 349 264 ASP C 160 ASP.? 8.57 O1 PO4 C 349 286 HIS C 238 HIS.? 10.74 O3 PO4 C 349 coo 10.47 25.91 18.67 10.67 27.13 20.84 -50.53 22.77 38.79 -48.65 23.56 37.48 coo 2.34 22.49 22.56 3.80 23.95 22.00 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 7.10 24.11 23.40 8.18 25.09 21.87 -53.20 24.10 34.96 -54.25 22.32 34.57 ULMN 3 2lip_c00 LIPASE user 8 3 # 8 87 SER D 64 SER~? 27.50 C6 PG4 C 350 264 ASP D 41 ASP.? 20.92 O2 PO4 D 349 286 HIS D 14 HIS.? 21.26 C4 PG4 C 350 coo 10.47 25.91 18.67 10.67 27.13 20.84 -40.29 0.73 76.87 -39.79 -1.23 78.23 coo 2.34 22.49 22.56 3.80 23.95 22.00 -39.78 8.95 76.71 -38.11 10.21 76.27 coo 7.10 24.11 23.40 8.18 25.09 21.87 -37.83 5.64 73.04 -38.41 3.86 73.97 ULMN 3 2lip_c00 LIPASE user 9 3 # 9 87 SER D 241 SER.? 10.08 O3 PO4 D 349 264 ASP D 160 ASP.? 8.58 O4 PO4 D 349 286 HIS D 238 HIS.? 10.72 O3 PO4 D 349 coo 10.47 25.91 18.67 10.67 27.13 20.84 -41.15 24.23 50.62 -43.08 24.97 51.88 coo 2.34 22.49 22.56 3.80 23.95 22.00 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 7.10 24.11 23.40 8.18 25.09 21.87 -38.74 26.41 54.26 -37.48 24.84 54.87 2lip_c00 source 2lip LIPASE : 9 hits 2lip_c00 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 16 GLY.? 15.23 O3 PO4 A 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 3.61 55.89 43.73 3.10 55.52 45.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 8.08 50.44 43.84 7.48 51.26 41.98 coo 14.54 28.99 9.76 15.06 29.59 10.02 2.07 60.33 37.29 2.12 60.80 37.90 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 19 GLY.? 15.80 O3 PO4 A 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 3.61 55.89 43.73 3.10 55.52 45.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 8.08 50.44 43.84 7.48 51.26 41.98 coo 14.54 28.99 9.76 15.06 29.59 10.02 5.02 63.13 35.09 4.17 63.25 34.97 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 22 GLY~? 12.04 O3 PO4 A 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 3.61 55.89 43.73 3.10 55.52 45.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 8.08 50.44 43.84 7.48 51.26 41.98 coo 14.54 28.99 9.76 15.06 29.59 10.02 -0.44 58.79 35.05 -0.39 59.06 34.34 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 102 ASP A 90 ASP~? 15.98 C4 PG4 B 350 A 193 GLY A 79 GLY.? 14.13 O3 PO4 A 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 3.61 55.89 43.73 3.10 55.52 45.73 coo 19.64 30.69 22.61 18.18 29.94 21.25 8.08 50.44 43.84 7.48 51.26 41.98 coo 14.54 28.99 9.76 15.06 29.59 10.02 -3.85 55.21 37.72 -3.17 54.79 37.80 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 102 ASP A 203 ASP~? 10.68 C3 PG4 B 350 A 193 GLY A 85 GLY.? 5.88 O2 PG4 B 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 19.64 30.69 22.61 18.18 29.94 21.25 -4.78 48.60 23.67 -4.98 49.09 25.71 coo 14.54 28.99 9.76 15.06 29.59 10.02 7.14 46.81 31.62 6.42 46.78 31.19 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 102 ASP B 208 ASP~? 8.88 C3 PG4 B 350 A 193 GLY A 108 GLY.? 11.36 O3 PG4 B 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 19.64 30.69 22.61 18.18 29.94 21.25 -1.20 47.44 23.46 -1.05 49.37 24.33 coo 14.54 28.99 9.76 15.06 29.59 10.02 -5.80 48.81 34.39 -5.17 48.42 34.72 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 7 3 # 7 A 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 193 GLY B 144 GLY~? 17.74 C2 PG4 B 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 1.50 56.90 17.79 2.83 56.38 19.33 coo 19.64 30.69 22.61 18.18 29.94 21.25 -1.16 62.88 18.52 0.68 62.16 19.33 coo 14.54 28.99 9.76 15.06 29.59 10.02 9.02 53.30 13.55 9.55 53.11 14.13 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 8 3 # 8 A 57 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 102 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 193 GLY B 291 GLY~? 17.91 O4 PO4 A 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 1.50 56.90 17.79 2.83 56.38 19.33 coo 19.64 30.69 22.61 18.18 29.94 21.25 -1.16 62.88 18.52 0.68 62.16 19.33 coo 14.54 28.99 9.76 15.06 29.59 10.02 -0.11 58.00 6.65 0.09 58.36 5.91 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 9 3 # 9 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 16 GLY.? 15.34 O3 PO4 B 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 19.64 30.69 22.61 18.18 29.94 21.25 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 14.54 28.99 9.76 15.06 29.59 10.02 -8.99 19.43 5.14 -8.92 18.73 4.81 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 10 3 # 10 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 19 GLY.? 15.74 O3 PO4 B 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 19.64 30.69 22.61 18.18 29.94 21.25 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 14.54 28.99 9.76 15.06 29.59 10.02 -12.10 20.39 1.89 -11.31 20.65 1.71 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 11 3 # 11 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 22 GLY~? 12.30 O3 PO4 B 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 19.64 30.69 22.61 18.18 29.94 21.25 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 14.54 28.99 9.76 15.06 29.59 10.02 -6.99 22.32 6.03 -7.16 22.99 5.70 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 12 3 # 12 A 57 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 102 ASP B 90 ASP~? 17.21 C5 PG4 A 350 A 193 GLY B 79 GLY.? 14.35 O1 PO4 B 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 19.64 30.69 22.61 18.18 29.94 21.25 -14.26 14.51 16.36 -14.11 16.10 14.94 coo 14.54 28.99 9.76 15.06 29.59 10.02 -3.33 21.12 10.10 -3.98 20.99 10.55 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 13 3 # 13 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.64 30.69 22.61 18.18 29.94 21.25 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 14.54 28.99 9.76 15.06 29.59 10.02 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 14 3 # 14 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.64 30.69 22.61 18.18 29.94 21.25 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 14.54 28.99 9.76 15.06 29.59 10.02 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 15 3 # 15 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP A 208 ASP~? 8.51 C3 PG4 A 350 A 193 GLY B 108 GLY.? 11.44 C5 PG4 A 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.64 30.69 22.61 18.18 29.94 21.25 -7.49 37.13 15.29 -7.97 36.07 13.51 coo 14.54 28.99 9.76 15.06 29.59 10.02 -1.45 26.58 15.61 -2.07 26.26 16.03 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 16 3 # 16 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 193 GLY B 84 GLY.? 7.18 C3 PG4 A 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.64 30.69 22.61 18.18 29.94 21.25 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 14.54 28.99 9.76 15.06 29.59 10.02 -14.58 29.73 14.21 -14.80 28.98 14.10 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 17 3 # 17 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 193 GLY B 85 GLY.? 7.55 C3 PG4 A 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.64 30.69 22.61 18.18 29.94 21.25 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 14.54 28.99 9.76 15.06 29.59 10.02 -15.17 26.80 16.60 -14.44 26.95 16.65 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 18 3 # 18 A 57 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 102 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 193 GLY B 86 GLY.? 6.11 C4 PG4 A 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 19.64 30.69 22.61 18.18 29.94 21.25 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 14.54 28.99 9.76 15.06 29.59 10.02 -12.50 26.48 19.35 -12.60 26.05 18.67 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 19 3 # 19 A 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 193 GLY A 144 GLY~? 17.41 C2 PG4 A 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 19.64 30.69 22.61 18.18 29.94 21.25 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 14.54 28.99 9.76 15.06 29.59 10.02 -19.62 44.35 9.26 -20.00 43.77 9.68 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 20 3 # 20 A 57 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 102 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 193 GLY A 291 GLY~? 18.10 O4 PO4 B 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 19.64 30.69 22.61 18.18 29.94 21.25 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo 14.54 28.99 9.76 15.06 29.59 10.02 -11.93 50.92 2.28 -12.21 51.53 1.80 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 21 3 # 21 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 193 GLY C 16 GLY.? 15.48 O4 PO4 C 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 19.64 30.69 22.61 18.18 29.94 21.25 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 14.54 28.99 9.76 15.06 29.59 10.02 -52.98 9.90 20.86 -53.06 9.69 20.11 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 22 3 # 22 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 193 GLY C 22 GLY~? 12.31 O3 PO4 C 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 19.64 30.69 22.61 18.18 29.94 21.25 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 14.54 28.99 9.76 15.06 29.59 10.02 -50.31 11.35 23.15 -50.44 12.07 23.41 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 23 3 # 23 A 57 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 102 ASP C 90 ASP~? 15.56 C5 PG4 D 350 A 193 GLY C 79 GLY.? 14.41 O3 PO4 C 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 19.64 30.69 22.61 18.18 29.94 21.25 -56.94 -1.99 25.63 -56.96 0.10 25.89 coo 14.54 28.99 9.76 15.06 29.59 10.02 -46.35 7.57 24.19 -46.94 7.17 24.58 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 24 3 # 24 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 193 GLY C 84 GLY.? 7.31 O4 PG4 D 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 19.64 30.69 22.61 18.18 29.94 21.25 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 14.54 28.99 9.76 15.06 29.59 10.02 -56.51 10.28 34.21 -56.90 9.83 33.65 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 25 3 # 25 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP C 203 ASP~? 10.24 C6 PG4 D 350 A 193 GLY C 85 GLY.? 5.52 C5 PG4 D 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 19.64 30.69 22.61 18.18 29.94 21.25 -45.27 15.71 37.60 -45.14 14.14 36.20 coo 14.54 28.99 9.76 15.06 29.59 10.02 -56.18 6.72 35.54 -55.45 7.13 35.50 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 26 3 # 26 A 57 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 102 ASP D 208 ASP~? 8.41 C6 PG4 D 350 A 193 GLY C 108 GLY.? 11.29 O3 PG4 D 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 19.64 30.69 22.61 18.18 29.94 21.25 -48.63 14.68 39.02 -49.06 15.01 36.96 coo 14.54 28.99 9.76 15.06 29.59 10.02 -43.60 7.14 31.15 -44.12 6.54 31.35 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 27 3 # 27 A 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 193 GLY D 144 GLY~? 17.47 O5 PG4 D 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 19.64 30.69 22.61 18.18 29.94 21.25 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 14.54 28.99 9.76 15.06 29.59 10.02 -60.61 24.47 40.88 -61.01 23.76 40.72 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 28 3 # 28 A 57 HIS C 238 HIS.? 10.74 O3 PO4 C 349 A 102 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 193 GLY D 291 GLY~? 17.95 O1 PO4 C 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 19.64 30.69 22.61 18.18 29.94 21.25 -51.44 27.30 29.48 -53.03 25.88 29.75 coo 14.54 28.99 9.76 15.06 29.59 10.02 -52.94 33.94 40.24 -53.21 34.73 40.40 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 29 3 # 29 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 16 GLY.? 16.14 O2 PO4 D 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 19.64 30.69 22.61 18.18 29.94 21.25 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 14.54 28.99 9.76 15.06 29.59 10.02 -38.65 13.48 72.21 -38.70 13.32 72.96 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 30 3 # 30 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 19 GLY.? 16.61 O2 PO4 D 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 19.64 30.69 22.61 18.18 29.94 21.25 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 14.54 28.99 9.76 15.06 29.59 10.02 -35.71 16.74 73.26 -36.52 17.01 73.21 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 31 3 # 31 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 22 GLY~? 12.96 O2 PO4 D 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 19.64 30.69 22.61 18.18 29.94 21.25 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 14.54 28.99 9.76 15.06 29.59 10.02 -40.91 14.48 69.44 -40.82 15.16 69.11 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 32 3 # 32 A 57 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 102 ASP D 90 ASP~? 17.03 C4 PG4 C 350 A 193 GLY D 79 GLY.? 15.17 O2 PO4 D 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 19.64 30.69 22.61 18.18 29.94 21.25 -33.15 1.70 68.90 -33.50 3.76 68.48 coo 14.54 28.99 9.76 15.06 29.59 10.02 -44.38 10.12 68.07 -43.71 9.75 67.85 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 33 3 # 33 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.64 30.69 22.61 18.18 29.94 21.25 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 14.54 28.99 9.76 15.06 29.59 10.02 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 34 3 # 34 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 85 GLY.? 8.05 C4 PG4 C 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.64 30.69 22.61 18.18 29.94 21.25 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 14.54 28.99 9.76 15.06 29.59 10.02 -32.50 9.26 59.23 -33.13 9.72 58.90 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 35 3 # 35 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.64 30.69 22.61 18.18 29.94 21.25 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 14.54 28.99 9.76 15.06 29.59 10.02 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 36 3 # 36 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP C 208 ASP~? 8.73 O2 PG4 C 350 A 193 GLY D 108 GLY.? 11.50 C6 PG4 C 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.64 30.69 22.61 18.18 29.94 21.25 -41.61 16.40 51.56 -41.24 17.22 53.47 coo 14.54 28.99 9.76 15.06 29.59 10.02 -46.34 8.93 60.42 -45.67 8.48 60.39 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 37 3 # 37 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 193 GLY D 84 GLY.? 9.62 C4 PG4 C 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.64 30.69 22.61 18.18 29.94 21.25 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 14.54 28.99 9.76 15.06 29.59 10.02 -31.98 13.03 59.70 -32.24 12.70 60.41 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 38 3 # 38 A 57 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 102 ASP D 203 ASP~? 10.40 O3 PG4 C 350 A 193 GLY D 86 GLY.? 5.93 C4 PG4 C 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 19.64 30.69 22.61 18.18 29.94 21.25 -45.07 16.93 52.92 -45.16 15.64 54.59 coo 14.54 28.99 9.76 15.06 29.59 10.02 -35.09 6.83 57.80 -34.85 6.87 58.64 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 39 3 # 39 A 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 193 GLY C 144 GLY~? 17.44 C2 PG4 C 350 coo 14.96 29.22 19.55 15.62 29.93 17.67 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 19.64 30.69 22.61 18.18 29.94 21.25 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 14.54 28.99 9.76 15.06 29.59 10.02 -31.32 27.31 48.44 -30.80 26.72 48.62 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 40 3 # 40 A 57 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 102 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 193 GLY C 291 GLY~? 18.24 O4 PO4 D 349 coo 14.96 29.22 19.55 15.62 29.93 17.67 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 19.64 30.69 22.61 18.18 29.94 21.25 -41.09 30.11 59.34 -39.33 28.92 59.24 coo 14.54 28.99 9.76 15.06 29.59 10.02 -40.50 35.55 47.63 -40.37 36.37 47.40 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 40 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 209 PHE~? -4.26 C3 PG4 A 350s A 263 ASP B 203 ASP~? 9.89 C4 PG4 A 350 A 292 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 51.51 50.32 16.39 52.13 49.68 13.75 -10.72 37.17 18.24 -10.31 34.51 17.57 coo 54.43 44.82 23.74 55.21 45.06 21.80 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 63.95 45.30 16.71 59.11 49.15 16.05 1.49 32.28 22.12 4.07 30.52 27.68 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 209 PHE~? -4.26 C3 PG4 A 350s B 263 ASP B 203 ASP~? 9.89 C4 PG4 A 350 B 292 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 49.99 26.05 6.28 51.46 26.87 8.49 -10.72 37.17 18.24 -10.31 34.51 17.57 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 60.53 31.67 0.97 57.79 27.51 3.63 1.49 32.28 22.12 4.07 30.52 27.68 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 209 PHE~? -4.26 C3 PG4 A 350s C 263 ASP B 203 ASP~? 9.89 C4 PG4 A 350 C 292 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -10.72 37.17 18.24 -10.31 34.51 17.57 coo 19.84 12.02 9.33 18.68 11.23 7.75 -4.02 37.06 13.77 -3.95 34.93 13.81 coo 12.82 3.49 4.98 17.80 5.59 1.90 1.49 32.28 22.12 4.07 30.52 27.68 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c05 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP B 131 ASP^? 9.09 C8 PG4 A 350 A 151 LYS B 134 LYS.? 7.94 O5 PG4 B 350 A 186 THR B 111 THR.? -3.92 C5 PG4 A 350s coo 41.42 17.90 44.98 43.39 18.36 45.61 0.40 27.07 22.40 -0.62 25.51 23.42 coo 45.75 16.58 39.61 47.43 18.26 45.54 1.49 32.28 22.12 4.07 30.52 27.68 coo 45.88 23.02 44.72 46.99 21.16 44.68 -6.89 27.93 21.89 -8.77 26.98 22.40 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 151 LYS B 316 LYS~? 24.20 O3 PO4 B 349 A 186 THR B 307 THR.? 14.53 O3 PO4 B 349 coo 41.42 17.90 44.98 43.39 18.36 45.61 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 45.75 16.58 39.61 47.43 18.26 45.54 -2.04 35.41 -19.34 2.27 31.66 -22.14 coo 45.88 23.02 44.72 46.99 21.16 44.68 -4.70 32.82 -11.47 -3.25 33.55 -12.93 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 332 ASP~? 12.13 O3 PO4 B 349 A 151 LYS B 316 LYS~? 24.20 O3 PO4 B 349 A 186 THR B 331 THR^? 16.37 O4 PO4 B 349 coo 41.42 17.90 44.98 43.39 18.36 45.61 0.44 34.01 -11.76 -0.11 32.57 -10.33 coo 45.75 16.58 39.61 47.43 18.26 45.54 -2.04 35.41 -19.34 2.27 31.66 -22.14 coo 45.88 23.02 44.72 46.99 21.16 44.68 2.36 38.24 -13.00 4.20 37.08 -13.10 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 151 LYS C 316 LYS~? 23.27 O4 PO4 C 349 A 186 THR C 307 THR.? 14.50 O4 PO4 C 349 coo 41.42 17.90 44.98 43.39 18.36 45.61 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 45.75 16.58 39.61 47.43 18.26 45.54 -44.69 38.73 13.31 -40.21 38.10 9.89 coo 45.88 23.02 44.72 46.99 21.16 44.68 -47.35 31.27 17.04 -45.92 32.81 16.45 ULMN 3 2phk_c02 MC-PEPTIDE user 5 3 # 5 A 149 ASP C 332 ASP~? 12.18 O4 PO4 C 349 A 151 LYS C 316 LYS~? 23.27 O4 PO4 C 349 A 186 THR C 331 THR^? 16.46 O1 PO4 C 349 coo 41.42 17.90 44.98 43.39 18.36 45.61 -42.20 32.39 17.40 -42.88 30.35 17.40 coo 45.75 16.58 39.61 47.43 18.26 45.54 -44.69 38.73 13.31 -40.21 38.10 9.89 coo 45.88 23.02 44.72 46.99 21.16 44.68 -39.89 36.19 19.34 -38.09 35.37 18.43 ULMN 3 2phk_c02 MC-PEPTIDE user 6 3 # 6 A 149 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 151 LYS D 316 LYS~? 24.37 O2 PO4 D 349 A 186 THR D 307 THR.? 14.52 O2 PO4 D 349 coo 41.42 17.90 44.98 43.39 18.36 45.61 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 45.75 16.58 39.61 47.43 18.26 45.54 -49.65 42.56 73.75 -53.64 42.38 78.67 coo 45.88 23.02 44.72 46.99 21.16 44.68 -45.94 35.31 71.02 -47.61 36.72 71.34 ULMN 3 2phk_c02 MC-PEPTIDE user 7 3 # 7 A 149 ASP D 332 ASP~? 12.02 O2 PO4 D 349 A 151 LYS D 316 LYS~? 24.37 O2 PO4 D 349 A 186 THR D 331 THR^? 16.33 O4 PO4 D 349 coo 41.42 17.90 44.98 43.39 18.36 45.61 -51.05 35.32 70.59 -50.24 33.36 70.95 coo 45.75 16.58 39.61 47.43 18.26 45.54 -49.65 42.56 73.75 -53.64 42.38 78.67 coo 45.88 23.02 44.72 46.99 21.16 44.68 -53.87 38.43 68.16 -55.50 37.55 69.29 2phk_c02 source 2phk MC-PEPTIDE : 7 hits 2phk_c02 naa= 3 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 1 3 # 1 10 ASN A 43 ASN~? 22.73 O3 PO4 A 349 20 HIS A 14 HIS.? 20.33 C3 PG4 B 350 93 ASP A 90 ASP~? 15.98 C4 PG4 B 350 coo 45.21 45.27 48.24 46.79 44.92 46.88 6.86 62.77 42.72 8.12 61.14 42.12 coo 47.05 39.55 45.24 48.99 39.30 44.46 3.61 55.89 43.73 3.10 55.52 45.73 coo 46.96 34.22 47.29 47.91 35.95 46.52 8.08 50.44 43.84 7.48 51.26 41.98 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 2 3 # 2 10 ASN A 270 ASN.? 15.06 O3 PO4 A 349 20 HIS A 238 HIS.? 10.67 O3 PO4 A 349 93 ASP A 160 ASP.? 8.60 O4 PO4 A 349 coo 45.21 45.27 48.24 46.79 44.92 46.88 7.80 59.00 17.23 7.36 57.24 18.34 coo 47.05 39.55 45.24 48.99 39.30 44.46 1.50 56.90 17.79 2.83 56.38 19.33 coo 46.96 34.22 47.29 47.91 35.95 46.52 -1.16 62.88 18.52 0.68 62.16 19.33 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 3 3 # 3 10 ASN B 43 ASN.? 23.10 O3 PO4 B 349 20 HIS B 14 HIS.? 21.30 C5 PG4 A 350 93 ASP B 90 ASP~? 17.21 C5 PG4 A 350 coo 45.21 45.27 48.24 46.79 44.92 46.88 -12.52 12.59 3.86 -14.07 13.20 5.18 coo 47.05 39.55 45.24 48.99 39.30 44.46 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 46.96 34.22 47.29 47.91 35.95 46.52 -14.26 14.51 16.36 -14.11 16.10 14.94 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 4 3 # 4 10 ASN B 270 ASN.? 15.02 O1 PO4 B 349 20 HIS B 238 HIS.? 10.82 O1 PO4 B 349 93 ASP B 160 ASP.? 8.62 O4 PO4 B 349 coo 45.21 45.27 48.24 46.79 44.92 46.88 -17.98 39.50 4.84 -17.14 38.86 6.70 coo 47.05 39.55 45.24 48.99 39.30 44.46 -11.67 40.20 5.98 -12.62 38.67 7.06 coo 46.96 34.22 47.29 47.91 35.95 46.52 -9.63 38.59 -0.09 -11.16 37.62 1.09 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 5 3 # 5 10 ASN C 43 ASN.? 22.72 C5 PG4 D 350 20 HIS C 14 HIS.? 19.64 C5 PG4 D 350 93 ASP C 90 ASP~? 15.56 C5 PG4 D 350 coo 45.21 45.27 48.24 46.79 44.92 46.88 -57.74 6.14 16.07 -58.97 5.36 17.64 coo 47.05 39.55 45.24 48.99 39.30 44.46 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 46.96 34.22 47.29 47.91 35.95 46.52 -56.94 -1.99 25.63 -56.96 0.10 25.89 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 6 3 # 6 10 ASN C 270 ASN.? 15.22 O3 PO4 C 349 20 HIS C 238 HIS.? 10.74 O3 PO4 C 349 93 ASP C 160 ASP.? 8.57 O1 PO4 C 349 coo 45.21 45.27 48.24 46.79 44.92 46.88 -59.71 24.81 33.93 -59.02 22.97 34.76 coo 47.05 39.55 45.24 48.99 39.30 44.46 -53.20 24.10 34.96 -54.25 22.32 34.57 coo 46.96 34.22 47.29 47.91 35.95 46.52 -51.44 27.30 29.48 -53.03 25.88 29.75 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 7 3 # 7 10 ASN D 43 ASN.? 23.87 O2 PO4 D 349 20 HIS D 14 HIS.? 21.26 C4 PG4 C 350 93 ASP D 90 ASP~? 17.03 C4 PG4 C 350 coo 45.21 45.27 48.24 46.79 44.92 46.88 -34.60 10.60 78.03 -33.00 10.04 76.71 coo 47.05 39.55 45.24 48.99 39.30 44.46 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 46.96 34.22 47.29 47.91 35.95 46.52 -33.15 1.70 68.90 -33.50 3.76 68.48 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 8 3 # 8 10 ASN D 270 ASN.? 14.75 O3 PO4 D 349 20 HIS D 238 HIS.? 10.72 O3 PO4 D 349 93 ASP D 160 ASP.? 8.58 O4 PO4 D 349 coo 45.21 45.27 48.24 46.79 44.92 46.88 -32.60 27.92 55.07 -33.22 25.92 54.63 coo 47.05 39.55 45.24 48.99 39.30 44.46 -38.74 26.41 54.26 -37.48 24.84 54.87 coo 46.96 34.22 47.29 47.91 35.95 46.52 -41.09 30.11 59.34 -39.33 28.92 59.24 2pth_c00 source 2pth PEPTIDYL-TRNA HYDROLASE : 8 hits 2pth_c00 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 160 ASP.? 8.60 O4 PO4 A 349 166 GLY A 22 GLY~? 12.04 O3 PO4 A 349 169 GLU A 15 GLU.? 17.86 C3 PG4 B 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.16 62.88 18.52 0.68 62.16 19.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -0.44 58.79 35.05 -0.39 59.06 34.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 7.25 58.10 39.87 8.59 56.71 39.00 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 160 ASP.? 8.60 O4 PO4 A 349 166 GLY B 212 GLY~? 9.26 O1 PG4 B 350 169 GLU B 135 GLU.? -3.99 O5 PG4 B 350s coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.16 62.88 18.52 0.68 62.16 19.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 6.02 46.22 18.32 5.64 45.65 17.83 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.30 38.46 22.67 1.14 39.98 23.57 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 160 ASP.? 8.60 O4 PO4 A 349 166 GLY B 296 GLY.? 24.39 O4 PO4 A 349 169 GLU B 286 GLU~? 20.04 O4 PO4 B 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.16 62.88 18.52 0.68 62.16 19.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 7.61 58.29 3.60 6.91 57.85 3.79 coo -16.67 7.89 2.78 -17.65 6.56 1.49 0.48 53.28 -2.68 0.79 53.94 -4.67 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 203 ASP~? 10.68 C3 PG4 B 350 166 GLY B 234 GLY.? 7.16 O1 PO4 B 349 169 GLU B 231 GLU.? 5.72 O2 PO4 B 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.78 48.60 23.67 -4.98 49.09 25.71 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -5.34 40.16 6.49 -4.85 40.15 5.88 coo -16.67 7.89 2.78 -17.65 6.56 1.49 3.23 35.71 5.73 3.00 33.97 6.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 208 ASP~? 8.51 C3 PG4 A 350 166 GLY A 189 GLY~? 8.76 O1 PO4 A 349 169 GLU A 196 GLU~? 14.14 O1 PO4 A 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -9.96 51.69 26.75 -10.72 51.67 27.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -18.66 54.90 30.43 -20.55 55.76 30.68 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 208 ASP~? 8.51 C3 PG4 A 350 166 GLY A 291 GLY~? 18.10 O4 PO4 B 349 169 GLU A 286 GLU~? 19.74 O4 PO4 A 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -11.93 50.92 2.28 -12.21 51.53 1.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.11 61.08 5.26 -13.84 62.85 4.34 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 208 ASP~? 8.51 C3 PG4 A 350 166 GLY B 22 GLY~? 12.30 O3 PO4 B 349 169 GLU B 15 GLU.? 19.82 C3 PG4 A 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -6.99 22.32 6.03 -7.16 22.99 5.70 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.67 16.25 7.60 -15.45 16.94 8.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP A 208 ASP~? 8.51 C3 PG4 A 350 166 GLY B 79 GLY.? 14.35 O1 PO4 B 349 169 GLU B 15 GLU.? 19.82 C3 PG4 A 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.33 21.12 10.10 -3.98 20.99 10.55 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.67 16.25 7.60 -15.45 16.94 8.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP A 208 ASP~? 8.51 C3 PG4 A 350 166 GLY B 79 GLY.? 14.35 O1 PO4 B 349 169 GLU B 94 GLU~? 22.11 C5 PG4 A 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.33 21.12 10.10 -3.98 20.99 10.55 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.91 12.10 15.72 -7.33 10.19 14.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP A 208 ASP~? 8.51 C3 PG4 A 350 166 GLY B 164 GLY~? -3.62 O3 PO4 B 349s 169 GLU B 171 GLU~? 12.87 O3 PO4 B 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.49 37.13 15.29 -7.97 36.07 13.51 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.30 33.64 -1.77 -1.48 34.26 -1.32 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.59 31.85 -5.28 7.53 30.11 -6.08 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP A 226 ASP.? 25.19 O1 PO4 A 349 166 GLY C 327 GLY~? 22.90 O1 PO4 C 349 169 GLU C 325 GLU~? 19.31 O1 PO4 C 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -31.23 58.08 18.66 -33.23 57.82 19.18 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -41.66 46.37 26.74 -41.71 45.54 26.84 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -49.52 44.21 26.45 -50.31 42.24 26.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP B 131 ASP^? 9.09 C8 PG4 A 350 166 GLY B 22 GLY~? 12.30 O3 PO4 B 349 169 GLU B 15 GLU.? 19.82 C3 PG4 A 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 0.40 27.07 22.40 -0.62 25.51 23.42 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -6.99 22.32 6.03 -7.16 22.99 5.70 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.67 16.25 7.60 -15.45 16.94 8.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP B 140 ASP.? 7.99 O2 PG4 B 350 166 GLY A 79 GLY.? 14.13 O3 PO4 A 349 169 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 8.40 47.76 23.89 8.35 49.33 25.35 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.85 55.21 37.72 -3.17 54.79 37.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP B 160 ASP.? 8.62 O4 PO4 B 349 166 GLY A 212 GLY~? 9.07 O1 PG4 A 350 169 GLU A 135 GLU.? -3.98 O1 PG4 A 350s coo 8.28 6.87 1.62 10.08 5.77 1.34 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -15.16 41.65 16.73 -14.78 42.24 17.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -10.19 39.37 24.45 -9.09 38.16 23.13 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP B 160 ASP.? 8.62 O4 PO4 B 349 166 GLY A 296 GLY.? 24.68 O4 PO4 B 349 169 GLU A 286 GLU~? 19.74 O4 PO4 A 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -19.90 53.09 2.71 -19.14 53.04 3.04 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.11 61.08 5.26 -13.84 62.85 4.34 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP B 160 ASP.? 8.62 O4 PO4 B 349 166 GLY B 22 GLY~? 12.30 O3 PO4 B 349 169 GLU B 15 GLU.? 19.82 C3 PG4 A 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -6.99 22.32 6.03 -7.16 22.99 5.70 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.67 16.25 7.60 -15.45 16.94 8.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP B 203 ASP~? 9.89 C4 PG4 A 350 166 GLY A 234 GLY.? 7.10 O3 PO4 A 349 169 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -4.72 55.63 18.83 -5.29 56.17 18.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP B 203 ASP~? 9.89 C4 PG4 A 350 166 GLY A 291 GLY~? 18.10 O4 PO4 B 349 169 GLU B 280 GLU~? 22.45 O4 PO4 B 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -11.93 50.92 2.28 -12.21 51.53 1.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -10.91 53.12 -6.46 -10.34 55.07 -5.90 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP B 203 ASP~? 9.89 C4 PG4 A 350 166 GLY B 22 GLY~? 12.30 O3 PO4 B 349 169 GLU B 15 GLU.? 19.82 C3 PG4 A 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -6.99 22.32 6.03 -7.16 22.99 5.70 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.67 16.25 7.60 -15.45 16.94 8.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP B 203 ASP~? 9.89 C4 PG4 A 350 166 GLY B 79 GLY.? 14.35 O1 PO4 B 349 169 GLU B 15 GLU.? 19.82 C3 PG4 A 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.33 21.12 10.10 -3.98 20.99 10.55 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.67 16.25 7.60 -15.45 16.94 8.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP B 203 ASP~? 9.89 C4 PG4 A 350 166 GLY B 79 GLY.? 14.35 O1 PO4 B 349 169 GLU B 94 GLU~? 22.11 C5 PG4 A 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.02 37.06 13.77 -3.95 34.93 13.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.33 21.12 10.10 -3.98 20.99 10.55 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.91 12.10 15.72 -7.33 10.19 14.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP B 208 ASP~? 8.88 C3 PG4 B 350 166 GLY A 79 GLY.? 14.13 O3 PO4 A 349 169 GLU A 94 GLU~? 21.51 O3 PG4 B 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.85 55.21 37.72 -3.17 54.79 37.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 2.26 51.25 46.83 2.00 52.68 48.40 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP B 208 ASP~? 8.88 C3 PG4 B 350 166 GLY A 164 GLY~? -3.53 O2 PO4 A 349s 169 GLU A 171 GLU~? 12.95 O2 PO4 A 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -8.93 64.61 23.96 -8.76 64.08 23.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -17.15 67.55 26.15 -17.92 68.63 27.78 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 24 3 # 24 141 ASP B 208 ASP~? 8.88 C3 PG4 B 350 166 GLY B 189 GLY~? 8.50 O2 PO4 B 349 169 GLU B 196 GLU~? 13.82 O2 PO4 B 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.22 33.78 11.00 2.03 33.50 11.09 coo -16.67 7.89 2.78 -17.65 6.56 1.49 10.06 30.74 8.04 11.63 30.24 6.70 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 25 3 # 25 141 ASP B 208 ASP~? 8.88 C3 PG4 B 350 166 GLY B 291 GLY~? 17.91 O4 PO4 A 349 169 GLU B 286 GLU~? 20.04 O4 PO4 B 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.20 47.44 23.46 -1.05 49.37 24.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -0.11 58.00 6.65 0.09 58.36 5.91 coo -16.67 7.89 2.78 -17.65 6.56 1.49 0.48 53.28 -2.68 0.79 53.94 -4.67 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 26 3 # 26 141 ASP B 339 ASP~? 20.98 O2 PO4 B 349 166 GLY B 327 GLY~? 22.81 O4 PO4 B 349 169 GLU B 325 GLU~? 19.47 O4 PO4 B 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 12.36 37.42 -12.59 13.93 36.17 -11.84 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -0.28 50.53 -15.18 -0.27 49.97 -14.57 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.86 48.35 -14.01 -8.88 47.03 -12.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 27 3 # 27 141 ASP C 160 ASP.? 8.57 O1 PO4 C 349 166 GLY C 22 GLY~? 12.31 O3 PO4 C 349 169 GLU C 15 GLU.? 17.45 C5 PG4 D 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -50.31 11.35 23.15 -50.44 12.07 23.41 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -57.75 5.96 21.41 -58.79 5.43 23.18 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 28 3 # 28 141 ASP C 160 ASP.? 8.57 O1 PO4 C 349 166 GLY D 212 GLY~? 8.60 O5 PG4 D 350 169 GLU D 135 GLU.? -4.27 C8 PG4 D 350s coo 8.28 6.87 1.62 10.08 5.77 1.34 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -55.90 16.99 43.52 -55.53 17.14 44.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -50.80 9.98 46.92 -49.80 10.03 45.07 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 29 3 # 29 141 ASP C 160 ASP.? 8.57 O1 PO4 C 349 166 GLY D 296 GLY.? 24.56 O1 PO4 C 349 169 GLU D 286 GLU~? 19.90 O4 PO4 D 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -60.88 35.38 42.47 -60.11 35.04 42.67 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -53.47 38.80 49.84 -54.10 40.73 50.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 30 3 # 30 141 ASP C 203 ASP~? 10.24 C6 PG4 D 350 166 GLY D 234 GLY.? 7.11 O3 PO4 D 349 169 GLU D 231 GLU.? 5.62 O1 PO4 D 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -45.27 15.71 37.60 -45.14 14.14 36.20 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -44.87 24.99 54.53 -45.43 25.38 54.91 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -52.72 21.86 59.42 -51.91 19.95 59.86 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 31 3 # 31 141 ASP C 208 ASP~? 8.73 O2 PG4 C 350 166 GLY C 189 GLY~? 8.64 O2 PO4 C 349 169 GLU C 196 GLU~? 13.61 O2 PO4 C 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -40.49 15.78 32.96 -39.70 15.56 32.71 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -32.17 15.85 27.58 -30.80 16.36 26.07 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 32 3 # 32 141 ASP C 208 ASP~? 8.73 O2 PG4 C 350 166 GLY C 291 GLY~? 18.24 O4 PO4 D 349 169 GLU C 286 GLU~? 19.95 O1 PO4 C 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -40.50 35.55 47.63 -40.37 36.37 47.40 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -40.61 39.13 37.58 -40.31 41.01 36.65 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 33 3 # 33 141 ASP C 208 ASP~? 8.73 O2 PG4 C 350 166 GLY D 22 GLY~? 12.96 O2 PO4 D 349 169 GLU D 15 GLU.? 19.32 C4 PG4 C 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -40.91 14.48 69.44 -40.82 15.16 69.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -33.73 9.80 72.63 -32.07 9.73 71.31 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 34 3 # 34 141 ASP C 208 ASP~? 8.73 O2 PG4 C 350 166 GLY D 79 GLY.? 15.17 O2 PO4 D 349 169 GLU D 15 GLU.? 19.32 C4 PG4 C 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -44.38 10.12 68.07 -43.71 9.75 67.85 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -33.73 9.80 72.63 -32.07 9.73 71.31 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 35 3 # 35 141 ASP C 208 ASP~? 8.73 O2 PG4 C 350 166 GLY D 79 GLY.? 15.17 O2 PO4 D 349 169 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -44.38 10.12 68.07 -43.71 9.75 67.85 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 36 3 # 36 141 ASP C 208 ASP~? 8.73 O2 PG4 C 350 166 GLY D 164 GLY~? -3.57 O2 PO4 D 349s 169 GLU D 171 GLU~? 12.87 O2 PO4 D 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.61 16.40 51.56 -41.24 17.22 53.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -48.53 27.34 64.89 -48.44 27.44 64.12 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -56.37 27.70 69.07 -57.02 27.32 71.04 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 37 3 # 37 141 ASP C 343 ASP~? 16.17 O1 PG4 A 350 166 GLY A 199 GLY.? 14.09 O1 PG4 A 350 169 GLU A 231 GLU.? 5.77 O1 PO4 A 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.47 38.91 22.93 -28.30 38.51 21.17 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -17.17 48.70 27.51 -16.96 48.00 27.99 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.78 56.62 24.13 -12.11 55.65 25.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 38 3 # 38 141 ASP D 160 ASP.? 8.58 O4 PO4 D 349 166 GLY C 212 GLY~? 9.26 C2 PG4 C 350 169 GLU C 135 GLU.? -3.67 O1 PG4 C 350s coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -34.69 19.16 46.59 -35.10 19.11 45.88 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -38.59 10.74 44.23 -39.39 10.87 46.20 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 39 3 # 39 141 ASP D 160 ASP.? 8.58 O4 PO4 D 349 166 GLY C 296 GLY.? 24.74 O4 PO4 D 349 169 GLU C 286 GLU~? 19.95 O1 PO4 C 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -32.91 37.54 44.99 -33.65 37.14 44.90 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -40.61 39.13 37.58 -40.31 41.01 36.65 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 40 3 # 40 141 ASP D 160 ASP.? 8.58 O4 PO4 D 349 166 GLY D 22 GLY~? 12.96 O2 PO4 D 349 169 GLU D 15 GLU.? 19.32 C4 PG4 C 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -40.91 14.48 69.44 -40.82 15.16 69.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -33.73 9.80 72.63 -32.07 9.73 71.31 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 41 3 # 41 141 ASP D 198 ASP.? 14.02 O5 PG4 D 350 166 GLY D 79 GLY.? 15.17 O2 PO4 D 349 169 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -59.61 10.87 58.41 -59.89 10.18 56.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -44.38 10.12 68.07 -43.71 9.75 67.85 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 42 3 # 42 141 ASP D 203 ASP~? 10.40 O3 PG4 C 350 166 GLY C 234 GLY.? 6.98 O3 PO4 C 349 169 GLU C 231 GLU.? 5.70 O2 PO4 C 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -46.93 23.60 34.75 -46.44 24.03 34.33 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -38.62 20.97 30.45 -38.95 18.93 30.05 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 43 3 # 43 141 ASP D 203 ASP~? 10.40 O3 PG4 C 350 166 GLY C 291 GLY~? 18.24 O4 PO4 D 349 169 GLU D 280 GLU~? 22.63 O4 PO4 D 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -40.50 35.55 47.63 -40.37 36.37 47.40 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -42.78 43.78 51.37 -43.64 44.83 49.74 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 44 3 # 44 141 ASP D 203 ASP~? 10.40 O3 PG4 C 350 166 GLY D 22 GLY~? 12.96 O2 PO4 D 349 169 GLU D 15 GLU.? 19.32 C4 PG4 C 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -40.91 14.48 69.44 -40.82 15.16 69.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -33.73 9.80 72.63 -32.07 9.73 71.31 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 45 3 # 45 141 ASP D 203 ASP~? 10.40 O3 PG4 C 350 166 GLY D 79 GLY.? 15.17 O2 PO4 D 349 169 GLU D 15 GLU.? 19.32 C4 PG4 C 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -44.38 10.12 68.07 -43.71 9.75 67.85 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -33.73 9.80 72.63 -32.07 9.73 71.31 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 46 3 # 46 141 ASP D 203 ASP~? 10.40 O3 PG4 C 350 166 GLY D 79 GLY.? 15.17 O2 PO4 D 349 169 GLU D 94 GLU~? 22.39 C6 PG4 C 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -44.38 10.12 68.07 -43.71 9.75 67.85 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.10 0.33 71.21 -39.59 -0.04 73.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 47 3 # 47 141 ASP D 203 ASP~? 10.40 O3 PG4 C 350 166 GLY D 197 GLY~? 16.72 O1 PO4 D 349 169 GLU D 33 GLU.? 17.94 O1 PO4 D 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -45.07 16.93 52.92 -45.16 15.64 54.59 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -57.74 9.98 62.39 -57.72 10.62 61.86 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -60.02 15.53 71.55 -61.82 16.61 71.53 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 48 3 # 48 141 ASP D 208 ASP~? 8.41 C6 PG4 D 350 166 GLY C 79 GLY.? 14.41 O3 PO4 C 349 169 GLU C 94 GLU~? 21.12 C5 PG4 D 350 coo 8.28 6.87 1.62 10.08 5.77 1.34 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -46.35 7.57 24.19 -46.94 7.17 24.58 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -51.22 -2.72 22.56 -51.13 -3.21 20.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 49 3 # 49 141 ASP D 208 ASP~? 8.41 C6 PG4 D 350 166 GLY C 164 GLY~? -3.64 O4 PO4 C 349s 169 GLU C 171 GLU~? 12.90 O2 PO4 C 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -43.65 24.97 24.30 -43.77 25.11 25.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -35.81 26.11 19.98 -35.09 25.51 18.09 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 50 3 # 50 141 ASP D 208 ASP~? 8.41 C6 PG4 D 350 166 GLY D 189 GLY~? 8.43 O1 PO4 D 349 169 GLU D 196 GLU~? 13.48 O1 PO4 D 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -49.90 16.88 57.52 -50.61 16.53 57.79 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -58.16 15.98 62.44 -59.80 16.71 63.55 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 51 3 # 51 141 ASP D 208 ASP~? 8.41 C6 PG4 D 350 166 GLY D 291 GLY~? 17.95 O1 PO4 C 349 169 GLU D 286 GLU~? 19.90 O4 PO4 D 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -48.63 14.68 39.02 -49.06 15.01 36.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -52.94 33.94 40.24 -53.21 34.73 40.40 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -53.47 38.80 49.84 -54.10 40.73 50.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 52 3 # 52 141 ASP D 226 ASP.? 25.08 O1 PO4 D 349 166 GLY D 302 GLY^? 15.79 O4 PO4 D 349 169 GLU D 286 GLU~? 19.90 O4 PO4 D 349 coo 8.28 6.87 1.62 10.08 5.77 1.34 -71.26 26.87 58.29 -73.26 26.34 58.61 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -55.83 38.84 59.83 -55.49 38.30 59.29 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -53.47 38.80 49.84 -54.10 40.73 50.49 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 52 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 91 TYR~? 12.90 C4 PG4 B 350 A 172 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 267 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 26.78 20.44 0.03 28.51 18.26 0.09 3.23 49.01 40.90 3.18 50.90 38.82 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 3.61 55.89 43.73 3.10 55.52 45.73 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 91 TYR~? 13.43 C5 PG4 A 350 A 172 HIS B 14 HIS.? 21.30 C5 PG4 A 350 A 267 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 26.78 20.44 0.03 28.51 18.26 0.09 -9.83 18.57 16.69 -10.13 20.18 14.41 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR C 91 TYR~? 12.18 C5 PG4 D 350 A 172 HIS C 14 HIS.? 19.64 C5 PG4 D 350 A 267 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 26.78 20.44 0.03 28.51 18.26 0.09 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 A 169 TYR D 91 TYR~? 13.46 C4 PG4 C 350 A 172 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 267 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 26.78 20.44 0.03 28.51 18.26 0.09 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -39.78 8.95 76.71 -38.11 10.21 76.27 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 91 TYR~? 12.90 C4 PG4 B 350 B 172 HIS A 14 HIS.? 20.33 C3 PG4 B 350 B 267 ASP A 41 ASP.? 20.10 O2 PO4 A 349 coo 44.86 1.98 33.27 42.75 1.12 31.67 3.23 49.01 40.90 3.18 50.90 38.82 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 3.61 55.89 43.73 3.10 55.52 45.73 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 1.74 60.96 43.57 3.36 61.47 42.28 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 91 TYR~? 13.43 C5 PG4 A 350 B 172 HIS B 14 HIS.? 21.30 C5 PG4 A 350 B 267 ASP B 41 ASP.? 20.21 O3 PO4 B 349 coo 44.86 1.98 33.27 42.75 1.12 31.67 -9.83 18.57 16.69 -10.13 20.18 14.41 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -9.44 13.73 10.71 -8.61 11.98 11.53 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -7.40 13.29 5.68 -9.25 14.12 5.01 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR C 91 TYR~? 12.18 C5 PG4 D 350 B 172 HIS C 14 HIS.? 19.64 C5 PG4 D 350 B 267 ASP C 41 ASP.? 20.22 O4 PO4 C 349 coo 44.86 1.98 33.27 42.75 1.12 31.67 -52.07 0.67 28.08 -52.42 3.42 27.72 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -53.35 2.03 20.79 -52.66 0.23 19.95 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -52.23 5.22 16.50 -53.97 6.36 17.05 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 B 169 TYR D 91 TYR~? 13.46 C4 PG4 C 350 B 172 HIS D 14 HIS.? 21.26 C4 PG4 C 350 B 267 ASP D 41 ASP.? 20.92 O2 PO4 D 349 coo 44.86 1.98 33.27 42.75 1.12 31.67 -37.64 3.76 65.52 -37.58 6.56 65.66 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -39.78 8.95 76.71 -38.11 10.21 76.27 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c01 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR B 221 TYR~? 17.66 O1 PG4 B 350 A 214 ASP B 198 ASP.? 14.38 O1 PG4 B 350 A 256 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 16.24 38.44 11.23 15.50 36.34 12.94 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 11.89 31.57 14.26 12.37 32.72 16.00 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 1.49 32.28 22.12 4.07 30.52 27.68 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 1 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR B 221 TYR~? 17.66 O1 PG4 B 350 B 214 ASP B 198 ASP.? 14.38 O1 PG4 B 350 B 256 LYS B 134 LYS.? 7.94 O5 PG4 B 350 coo -32.67 22.74 10.17 -32.85 23.98 7.70 16.24 38.44 11.23 15.50 36.34 12.94 coo -26.88 17.61 16.89 -26.08 17.11 15.00 11.89 31.57 14.26 12.37 32.72 16.00 coo -16.04 12.06 11.09 -17.97 10.54 5.71 1.49 32.28 22.12 4.07 30.52 27.68 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 1 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG B 153 ARG^? 21.71 O2 PO4 B 349 A 130 SER B 183 SER^? 16.79 O2 PO4 B 349 A 159 LYS B 223 LYS~? 20.96 O1 PG4 B 350 coo 18.35 45.84 20.99 16.20 47.83 21.89 12.56 47.43 6.76 13.42 50.26 5.86 coo 15.14 43.67 10.77 15.61 44.43 13.04 17.47 37.56 1.42 15.35 37.17 0.22 coo 11.57 48.49 22.18 13.51 49.99 17.21 21.08 44.90 9.51 21.11 48.16 14.97 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG C 153 ARG^? 21.82 O2 PO4 C 349 A 130 SER C 183 SER^? 16.83 O2 PO4 C 349 A 159 LYS C 223 LYS~? 21.04 C2 PG4 C 350 coo 18.35 45.84 20.99 16.20 47.83 21.89 -28.52 27.96 39.05 -27.50 30.55 40.41 coo 15.14 43.67 10.77 15.61 44.43 13.04 -24.45 24.87 27.97 -26.59 25.58 27.05 coo 11.57 48.49 22.18 13.51 49.99 17.21 -19.98 24.16 38.56 -19.29 22.78 44.77 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c00 naa= 3 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 1 3 # 1 83 GLN A 264 GLN.? 9.90 O4 PO4 A 349 94 HIS A 272 HIS.? 19.95 O3 PO4 A 349 96 HIS A 266 HIS.? 18.54 O4 PO4 A 349 coo 12.06 13.83 19.61 9.96 13.82 20.00 1.25 68.04 18.04 0.43 66.37 19.03 coo 15.69 26.32 19.80 17.39 27.17 20.68 11.10 60.27 13.77 10.40 58.32 14.13 coo 14.38 20.59 22.16 12.49 20.21 21.35 6.94 67.18 14.08 7.86 68.38 12.63 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 2 3 # 2 83 GLN B 264 GLN.? 10.00 O4 PO4 B 349 94 HIS B 272 HIS.? 20.00 O1 PO4 B 349 96 HIS B 266 HIS.? 18.54 O4 PO4 B 349 coo 12.06 13.83 19.61 9.96 13.82 20.00 -12.69 37.44 -4.88 -11.52 36.95 -3.20 coo 15.69 26.32 19.80 17.39 27.17 20.68 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 14.38 20.59 22.16 12.49 20.21 21.35 -18.71 40.64 -3.93 -20.02 41.58 -5.29 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 3 3 # 3 83 GLN C 264 GLN.? 9.92 O1 PO4 C 349 94 HIS C 272 HIS.? 20.13 O1 PO4 C 349 96 HIS C 266 HIS.? 18.53 O1 PO4 C 349 coo 12.06 13.83 19.61 9.96 13.82 20.00 -54.76 30.03 25.62 -53.57 28.46 26.44 coo 15.69 26.32 19.80 17.39 27.17 20.68 -63.70 27.74 35.03 -62.68 26.43 36.32 coo 14.38 20.59 22.16 12.49 20.21 21.35 -60.48 31.92 28.90 -61.75 33.58 29.06 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 4 3 # 4 83 GLN D 264 GLN.? 9.80 O4 PO4 D 349 94 HIS D 272 HIS.? 19.84 O3 PO4 D 349 96 HIS D 266 HIS.? 18.55 O4 PO4 D 349 coo 12.06 13.83 19.61 9.96 13.82 20.00 -38.31 33.76 62.74 -39.26 31.90 62.31 coo 15.69 26.32 19.80 17.39 27.17 20.68 -29.12 31.20 53.56 -30.01 29.84 52.23 coo 14.38 20.59 22.16 12.49 20.21 21.35 -32.64 35.78 59.13 -31.61 37.59 58.96 5fit_c00 source 5fit FRAGILE HISTIDINE TRIAD PROTEIN : 4 hits 5fit_c00 naa= 3 ULMN 3 7atj_c00 PEROXIDASE C1A user 1 3 # 1 A 38 ARG A 42 ARG~? 19.93 C3 PG4 B 350 A 42 HIS A 14 HIS.? 20.33 C3 PG4 B 350 A 70 ASN A 43 ASN~? 22.73 O3 PO4 A 349 coo 1.39 6.34 11.43 0.09 6.19 8.61 7.49 56.88 46.72 6.71 54.94 44.43 coo 5.40 8.25 8.15 4.09 6.62 7.93 3.61 55.89 43.73 3.10 55.52 45.73 coo 1.54 10.80 4.23 3.44 10.57 5.15 6.86 62.77 42.72 8.12 61.14 42.12 ULMN 3 7atj_c00 PEROXIDASE C1A user 2 3 # 2 A 38 ARG A 147 ARG~? 21.89 C2 PG4 A 350 A 42 HIS B 272 HIS.? 20.00 O1 PO4 B 349 A 70 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo 1.39 6.34 11.43 0.09 6.19 8.61 -23.00 46.39 6.22 -24.32 43.65 5.76 coo 5.40 8.25 8.15 4.09 6.62 7.93 -21.96 42.12 3.17 -20.97 42.39 5.00 coo 1.54 10.80 4.23 3.44 10.57 5.15 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 3 7atj_c00 PEROXIDASE C1A user 3 3 # 3 A 38 ARG B 147 ARG~? 21.77 C2 PG4 B 350 A 42 HIS A 272 HIS.? 19.95 O3 PO4 A 349 A 70 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo 1.39 6.34 11.43 0.09 6.19 8.61 11.90 56.41 10.58 13.26 57.05 13.30 coo 5.40 8.25 8.15 4.09 6.62 7.93 11.10 60.27 13.77 10.40 58.32 14.13 coo 1.54 10.80 4.23 3.44 10.57 5.15 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 3 7atj_c00 PEROXIDASE C1A user 4 3 # 4 A 38 ARG C 147 ARG~? 21.64 C2 PG4 C 350 A 42 HIS D 272 HIS.? 19.84 O3 PO4 D 349 A 70 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo 1.39 6.34 11.43 0.09 6.19 8.61 -28.57 31.49 48.25 -26.95 30.26 50.59 coo 5.40 8.25 8.15 4.09 6.62 7.93 -29.12 31.20 53.56 -30.01 29.84 52.23 coo 1.54 10.80 4.23 3.44 10.57 5.15 -32.60 27.92 55.07 -33.22 25.92 54.63 ULMN 3 7atj_c00 PEROXIDASE C1A user 5 3 # 5 A 38 ARG D 42 ARG.? 20.81 C4 PG4 C 350 A 42 HIS D 14 HIS.? 21.26 C4 PG4 C 350 A 70 ASN D 43 ASN.? 23.87 O2 PO4 D 349 coo 1.39 6.34 11.43 0.09 6.19 8.61 -33.94 3.86 75.82 -34.45 4.46 72.82 coo 5.40 8.25 8.15 4.09 6.62 7.93 -37.83 5.64 73.04 -38.41 3.86 73.97 coo 1.54 10.80 4.23 3.44 10.57 5.15 -34.60 10.60 78.03 -33.00 10.04 76.71 ULMN 3 7atj_c00 PEROXIDASE C1A user 6 3 # 6 A 38 ARG D 147 ARG~? 21.65 O5 PG4 D 350 A 42 HIS C 272 HIS.? 20.13 O1 PO4 C 349 A 70 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo 1.39 6.34 11.43 0.09 6.19 8.61 -64.41 28.02 40.25 -65.44 25.99 38.16 coo 5.40 8.25 8.15 4.09 6.62 7.93 -63.70 27.74 35.03 -62.68 26.43 36.32 coo 1.54 10.80 4.23 3.44 10.57 5.15 -59.71 24.81 33.93 -59.02 22.97 34.76 7atj_c00 source 7atj PEROXIDASE C1A : 6 hits 7atj_c00 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 99 GLY A 268 GLY.? 11.90 O3 PO4 A 349 A 125 ASN A 269 ASN.? 10.42 O3 PO4 A 349 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -1.16 62.88 18.52 0.68 62.16 19.33 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 4.47 63.40 20.71 4.75 62.80 20.25 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 5.56 58.73 21.48 4.09 58.66 22.99 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP A 160 ASP.? 8.60 O4 PO4 A 349 A 99 GLY A 268 GLY.? 11.90 O3 PO4 A 349 A 125 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -1.16 62.88 18.52 0.68 62.16 19.33 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 4.47 63.40 20.71 4.75 62.80 20.25 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 3 3 # 3 A 81 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 99 GLY B 268 GLY.? 11.97 O4 PO4 B 349 A 125 ASN B 269 ASN.? 10.41 O1 PO4 B 349 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -14.82 35.55 0.64 -15.06 36.08 1.20 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -15.16 35.63 5.50 -13.49 34.32 5.66 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 4 3 # 4 A 81 ASP B 160 ASP.? 8.62 O4 PO4 B 349 A 99 GLY B 268 GLY.? 11.97 O4 PO4 B 349 A 125 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -9.63 38.59 -0.09 -11.16 37.62 1.09 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -14.82 35.55 0.64 -15.06 36.08 1.20 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 5 3 # 5 A 81 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 99 GLY C 268 GLY.? 12.08 O1 PO4 C 349 A 125 ASN C 269 ASN.? 10.45 O3 PO4 C 349 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -56.98 24.93 28.04 -57.19 24.96 28.84 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -57.17 21.55 31.51 -55.49 20.56 30.60 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 6 3 # 6 A 81 ASP C 160 ASP.? 8.57 O1 PO4 C 349 A 99 GLY C 268 GLY.? 12.08 O1 PO4 C 349 A 125 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -51.44 27.30 29.48 -53.03 25.88 29.75 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -56.98 24.93 28.04 -57.19 24.96 28.84 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -59.71 24.81 33.93 -59.02 22.97 34.76 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 7 3 # 7 A 81 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 99 GLY D 268 GLY.? 11.79 O3 PO4 D 349 A 125 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -35.40 28.55 60.91 -35.17 28.48 60.14 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -34.61 24.72 58.03 -36.14 23.70 59.12 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 8 3 # 8 A 81 ASP D 160 ASP.? 8.58 O4 PO4 D 349 A 99 GLY D 268 GLY.? 11.79 O3 PO4 D 349 A 125 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -41.09 30.11 59.34 -39.33 28.92 59.24 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -35.40 28.55 60.91 -35.17 28.48 60.14 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -32.60 27.92 55.07 -33.22 25.92 54.63 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 8 hits 1hkd_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 6 ASN.? 25.67 O1 PO4 A 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -21.75 54.08 45.77 -21.38 52.05 45.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 43 ASN~? 22.73 O3 PO4 A 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 6.86 62.77 42.72 8.12 61.14 42.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 107 ASN^? 9.64 C5 PG4 B 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -5.73 45.70 37.96 -3.97 45.35 36.84 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 115 ASN.? 12.42 C7 PG4 B 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -5.76 34.35 38.60 -7.85 34.22 38.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 120 ASN~? 17.71 C6 PG4 B 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.35 35.53 45.32 -8.38 34.93 45.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 138 ASN.? -6.13 O2 PG4 A 350s coo 5.80 63.03 55.85 5.52 65.03 56.45 -17.89 33.84 23.48 -17.76 31.89 24.26 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 224 ASN.? 23.11 O1 PG4 A 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.46 49.91 23.23 -32.31 47.94 23.27 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN A 269 ASN.? 10.42 O3 PO4 A 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 5.56 58.73 21.48 4.09 58.66 22.99 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN A 270 ASN.? 15.06 O3 PO4 A 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 7.80 59.00 17.23 7.36 57.24 18.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN A 306 ASN^? 8.27 O2 PO4 A 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.02 69.82 22.14 -6.25 69.91 24.11 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN A 348 ASN.? 22.55 O4 PO4 A 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -23.78 64.03 8.33 -22.91 62.83 6.81 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 43 ASN.? 23.10 O3 PO4 B 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -12.52 12.59 3.86 -14.07 13.20 5.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 107 ASN^? 9.43 C5 PG4 A 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -1.39 23.50 19.22 -3.25 24.51 19.38 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN B 115 ASN.? 11.03 C8 PG4 A 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -1.59 25.02 30.59 0.45 25.64 30.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 120 ASN~? 15.18 C8 PG4 A 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -0.30 18.23 31.33 0.39 20.12 30.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN B 138 ASN.? -6.40 C1 PG4 B 350s coo 5.80 63.03 55.85 5.52 65.03 56.45 10.62 41.15 26.22 11.12 39.95 27.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN B 224 ASN~? 23.43 O1 PG4 B 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 22.11 40.26 9.14 23.14 40.57 10.98 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN B 267 ASN.? 11.96 O4 PO4 B 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -15.10 40.08 1.51 -14.03 39.29 3.16 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN B 269 ASN.? 10.41 O1 PO4 B 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -15.16 35.63 5.50 -13.49 34.32 5.66 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN B 270 ASN.? 15.02 O1 PO4 B 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -17.98 39.50 4.84 -17.14 38.86 6.70 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN B 306 ASN^? 8.17 O3 PO4 B 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -3.96 34.28 -6.86 -4.36 32.22 -6.36 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN B 348 ASN.? 22.58 O4 PO4 B 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 11.22 50.80 -5.88 10.43 52.38 -4.70 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN C 6 ASN.? 25.68 O2 PO4 C 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -27.75 3.03 19.30 -28.08 2.22 21.26 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN C 43 ASN.? 22.72 C5 PG4 D 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -57.74 6.14 16.07 -58.97 5.36 17.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN C 107 ASN^? 9.61 C3 PG4 D 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -42.97 2.46 31.63 -44.77 2.90 32.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN C 115 ASN.? 12.48 C8 PG4 C 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -41.39 -4.75 40.31 -39.45 -3.87 40.40 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN C 120 ASN~? 16.10 C3 PG4 D 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -40.48 -9.89 35.46 -40.04 -7.95 36.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN C 138 ASN.? 6.71 C1 PG4 C 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -29.85 10.06 48.10 -29.27 8.04 48.24 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN C 224 ASN~? 19.07 C6 PG4 A 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.05 21.33 34.82 -18.35 20.29 36.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN C 267 ASN.? 11.87 O1 PO4 C 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -56.89 27.38 32.00 -55.68 25.71 32.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN C 269 ASN.? 10.45 O3 PO4 C 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -57.17 21.55 31.51 -55.49 20.56 30.60 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 33 1 # 33 A 461 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -59.71 24.81 33.93 -59.02 22.97 34.76 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 34 1 # 34 A 461 ASN C 306 ASN^? 8.19 O4 PO4 C 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.37 29.17 21.30 -46.92 27.39 20.25 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 35 1 # 35 A 461 ASN C 348 ASN.? 21.93 O1 PG4 A 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -30.06 39.54 32.39 -31.15 40.21 34.08 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 36 1 # 36 A 461 ASN D 43 ASN.? 23.87 O2 PO4 D 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -34.60 10.60 78.03 -33.00 10.04 76.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 37 1 # 37 A 461 ASN D 107 ASN^? 9.34 C6 PG4 C 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.02 4.22 60.61 -44.32 4.89 59.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 38 1 # 38 A 461 ASN D 115 ASN.? 10.82 O1 PG4 D 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -45.89 -3.64 52.14 -47.96 -3.26 51.75 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 39 1 # 39 A 461 ASN D 120 ASN~? 15.59 O4 PG4 C 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.79 -8.62 56.97 -47.29 -6.96 55.79 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 40 1 # 40 A 461 ASN D 138 ASN.? -6.36 C7 PG4 D 350s coo 5.80 63.03 55.85 5.52 65.03 56.45 -59.25 7.10 43.19 -59.38 4.97 43.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 41 1 # 41 A 461 ASN D 224 ASN.? 21.91 O5 PG4 D 350 coo 5.80 63.03 55.85 5.52 65.03 56.45 -71.47 18.11 55.17 -71.73 16.64 53.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 42 1 # 42 A 461 ASN D 267 ASN.? 11.74 O3 PO4 D 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -35.75 30.56 56.76 -36.75 28.68 56.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 43 1 # 43 A 461 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -34.61 24.72 58.03 -36.14 23.70 59.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 44 1 # 44 A 461 ASN D 270 ASN.? 14.75 O3 PO4 D 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -32.60 27.92 55.07 -33.22 25.92 54.63 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 45 1 # 45 A 461 ASN D 306 ASN^? 8.15 O2 PO4 D 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.44 32.39 67.16 -45.73 30.88 68.47 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 46 1 # 46 A 461 ASN D 348 ASN.? 22.67 O4 PO4 D 349 coo 5.80 63.03 55.85 5.52 65.03 56.45 -64.04 38.36 54.66 -63.28 38.86 52.74 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 46 hits 1kbk_p00 naa= 1 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS A 110 HIS.? 5.77 C3 PG4 B 350 A 76 ASN A 107 ASN^? 9.64 C5 PG4 B 350 A 81 ASP A 131 ASP^? 9.75 C6 PG4 B 350 coo 4.09 43.69 67.89 2.45 42.40 68.10 -1.26 45.53 28.70 -1.92 46.50 26.97 coo 4.75 48.17 75.81 4.99 47.30 77.74 -5.73 45.70 37.96 -3.97 45.35 36.84 coo 0.57 50.41 73.18 0.46 48.28 73.56 -8.03 41.96 35.37 -6.75 41.25 36.93 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS A 260 HIS^? 11.64 O4 PO4 A 349 A 76 ASN A 306 ASN^? 8.27 O2 PO4 A 349 A 81 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 4.09 43.69 67.89 2.45 42.40 68.10 -4.97 68.88 15.23 -3.05 69.59 14.77 coo 4.75 48.17 75.81 4.99 47.30 77.74 -7.02 69.82 22.14 -6.25 69.91 24.11 coo 0.57 50.41 73.18 0.46 48.28 73.56 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 3 3 # 3 A 26 HIS A 309 HIS.? 13.93 O2 PO4 A 349 A 76 ASN A 306 ASN^? 8.27 O2 PO4 A 349 A 81 ASP A 332 ASP~? 12.07 O2 PO4 A 349 coo 4.09 43.69 67.89 2.45 42.40 68.10 -1.71 74.54 24.02 -2.03 74.32 21.96 coo 4.75 48.17 75.81 4.99 47.30 77.74 -7.02 69.82 22.14 -6.25 69.91 24.11 coo 0.57 50.41 73.18 0.46 48.28 73.56 -12.09 74.10 21.91 -11.23 73.05 23.55 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 4 3 # 4 A 26 HIS B 110 HIS.? 5.25 C4 PG4 A 350 A 76 ASN B 107 ASN^? 9.43 C5 PG4 A 350 A 81 ASP B 131 ASP^? 9.09 C8 PG4 A 350 coo 4.09 43.69 67.89 2.45 42.40 68.10 -6.85 32.28 17.79 -6.48 33.98 16.61 coo 4.75 48.17 75.81 4.99 47.30 77.74 -1.39 23.50 19.22 -3.25 24.51 19.38 coo 0.57 50.41 73.18 0.46 48.28 73.56 0.40 27.07 22.40 -0.62 25.51 23.42 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 5 3 # 5 A 26 HIS B 260 HIS^? 11.70 O4 PO4 B 349 A 76 ASN B 306 ASN^? 8.17 O3 PO4 B 349 A 81 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 4.09 43.69 67.89 2.45 42.40 68.10 -6.90 40.83 -7.07 -8.88 40.92 -7.74 coo 4.75 48.17 75.81 4.99 47.30 77.74 -3.96 34.28 -6.86 -4.36 32.22 -6.36 coo 0.57 50.41 73.18 0.46 48.28 73.56 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 6 3 # 6 A 26 HIS B 309 HIS.? 14.09 O3 PO4 B 349 A 76 ASN B 306 ASN^? 8.17 O3 PO4 B 349 A 81 ASP B 332 ASP~? 12.13 O3 PO4 B 349 coo 4.09 43.69 67.89 2.45 42.40 68.10 -9.40 30.81 -10.60 -9.30 32.90 -10.77 coo 4.75 48.17 75.81 4.99 47.30 77.74 -3.96 34.28 -6.86 -4.36 32.22 -6.36 coo 0.57 50.41 73.18 0.46 48.28 73.56 0.44 34.01 -11.76 -0.11 32.57 -10.33 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 7 3 # 7 A 26 HIS C 110 HIS.? 5.63 C6 PG4 D 350 A 76 ASN C 107 ASN^? 9.61 C3 PG4 D 350 A 81 ASP C 131 ASP^? 9.91 O2 PG4 D 350 coo 4.09 43.69 67.89 2.45 42.40 68.10 -48.06 9.35 37.56 -47.54 11.38 37.75 coo 4.75 48.17 75.81 4.99 47.30 77.74 -42.97 2.46 31.63 -44.77 2.90 32.68 coo 0.57 50.41 73.18 0.46 48.28 73.56 -40.29 2.77 35.99 -41.53 1.06 35.77 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 8 3 # 8 A 26 HIS C 260 HIS^? 11.63 O1 PO4 C 349 A 76 ASN C 306 ASN^? 8.19 O4 PO4 C 349 A 81 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 4.09 43.69 67.89 2.45 42.40 68.10 -48.83 33.87 26.09 -50.85 34.38 25.82 coo 4.75 48.17 75.81 4.99 47.30 77.74 -46.37 29.17 21.30 -46.92 27.39 20.25 coo 0.57 50.41 73.18 0.46 48.28 73.56 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 9 3 # 9 A 26 HIS C 309 HIS.? 14.15 O4 PO4 C 349 A 76 ASN C 306 ASN^? 8.19 O4 PO4 C 349 A 81 ASP C 332 ASP~? 12.18 O4 PO4 C 349 coo 4.09 43.69 67.89 2.45 42.40 68.10 -52.33 29.51 16.61 -52.04 31.11 17.93 coo 4.75 48.17 75.81 4.99 47.30 77.74 -46.37 29.17 21.30 -46.92 27.39 20.25 coo 0.57 50.41 73.18 0.46 48.28 73.56 -42.20 32.39 17.40 -42.88 30.35 17.40 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 10 3 # 10 A 26 HIS D 110 HIS.? 5.57 O3 PG4 C 350 A 76 ASN D 107 ASN^? 9.34 C6 PG4 C 350 A 81 ASP D 131 ASP^? 9.77 C6 PG4 C 350 coo 4.09 43.69 67.89 2.45 42.40 68.10 -41.52 11.20 54.17 -42.16 13.10 53.55 coo 4.75 48.17 75.81 4.99 47.30 77.74 -46.02 4.22 60.61 -44.32 4.89 59.53 coo 0.57 50.41 73.18 0.46 48.28 73.56 -48.29 3.79 55.93 -46.95 2.25 56.44 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 11 3 # 11 A 26 HIS D 260 HIS^? 11.65 O4 PO4 D 349 A 76 ASN D 306 ASN^? 8.15 O2 PO4 D 349 A 81 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 4.09 43.69 67.89 2.45 42.40 68.10 -44.73 36.67 61.75 -42.79 37.49 61.80 coo 4.75 48.17 75.81 4.99 47.30 77.74 -46.44 32.39 67.16 -45.73 30.88 68.47 coo 0.57 50.41 73.18 0.46 48.28 73.56 -51.05 35.32 70.59 -50.24 33.36 70.95 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 12 3 # 12 A 26 HIS D 309 HIS.? 14.00 O2 PO4 D 349 A 76 ASN D 306 ASN^? 8.15 O2 PO4 D 349 A 81 ASP D 332 ASP~? 12.02 O2 PO4 D 349 coo 4.09 43.69 67.89 2.45 42.40 68.10 -40.87 34.22 71.66 -41.37 35.58 70.15 coo 4.75 48.17 75.81 4.99 47.30 77.74 -46.44 32.39 67.16 -45.73 30.88 68.47 coo 0.57 50.41 73.18 0.46 48.28 73.56 -51.05 35.32 70.59 -50.24 33.36 70.95 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 12 hits 2c3x_p00 naa= 3 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 57 ARG.? 17.32 O2 PO4 A 349 A 188 TYR A 31 TYR~? 9.01 O2 PO4 A 349 A 190 SER A 32 SER~? 16.30 O1 PO4 A 349 coo 37.69 7.64 13.51 38.82 8.84 16.11 -11.38 65.24 41.83 -13.84 63.42 41.14 coo 47.14 12.10 13.73 48.75 12.33 16.01 -13.67 63.12 32.54 -12.97 64.78 30.45 coo 43.77 6.93 15.46 45.49 7.21 17.11 -15.10 60.37 37.70 -14.96 58.56 39.27 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG B 57 ARG.? 17.74 O3 PO4 B 349 A 188 TYR B 31 TYR~? 9.45 O3 PO4 B 349 A 190 SER B 32 SER~? 16.44 O2 PO4 B 349 coo 37.69 7.64 13.51 38.82 8.84 16.11 5.49 16.86 0.47 7.09 17.94 2.86 coo 47.14 12.10 13.73 48.75 12.33 16.01 5.43 26.32 0.91 4.29 27.88 -1.11 coo 43.77 6.93 15.46 45.49 7.21 17.11 7.81 22.14 4.70 7.84 21.04 6.86 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG C 57 ARG.? 17.31 O4 PO4 C 349 A 188 TYR C 31 TYR~? 9.00 O4 PO4 C 349 A 190 SER C 32 SER~? 16.11 O2 PO4 C 349 coo 37.69 7.64 13.51 38.82 8.84 16.11 -40.16 11.74 13.21 -37.69 10.86 14.87 coo 47.14 12.10 13.73 48.75 12.33 16.01 -38.22 17.89 20.09 -39.26 20.46 19.95 coo 43.77 6.93 15.46 45.49 7.21 17.11 -36.01 12.35 19.07 -35.78 10.06 19.77 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG D 57 ARG.? 17.88 O2 PO4 D 349 A 188 TYR D 31 TYR~? 9.28 O2 PO4 D 349 A 190 SER D 32 SER~? 16.14 O1 PO4 D 349 coo 37.69 7.64 13.51 38.82 8.84 16.11 -53.05 14.45 77.65 -54.84 13.45 75.34 coo 47.14 12.10 13.73 48.75 12.33 16.01 -53.52 20.07 70.01 -52.37 22.61 69.97 coo 43.77 6.93 15.46 45.49 7.21 17.11 -55.51 14.46 71.00 -55.42 12.11 70.52 2p3i_p00 source 2p3i VP4 : 4 hits 2p3i_p00 naa= 3 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 267 ASN.? 11.93 O4 PO4 A 349 A 460 GLY A 268 GLY.? 11.90 O3 PO4 A 349 A 461 ASN A 269 ASN.? 10.42 O3 PO4 A 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 4.37 61.77 16.42 3.54 60.20 17.57 coo 19.48 94.04 5.03 19.26 94.00 5.78 4.47 63.40 20.71 4.75 62.80 20.25 coo 20.23 95.69 9.16 21.55 97.37 9.20 5.56 58.73 21.48 4.09 58.66 22.99 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 269 ASN.? 10.42 O3 PO4 A 349 A 460 GLY A 268 GLY.? 11.90 O3 PO4 A 349 A 461 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 5.56 58.73 21.48 4.09 58.66 22.99 coo 19.48 94.04 5.03 19.26 94.00 5.78 4.47 63.40 20.71 4.75 62.80 20.25 coo 20.23 95.69 9.16 21.55 97.37 9.20 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN A 270 ASN.? 15.06 O3 PO4 A 349 A 460 GLY A 268 GLY.? 11.90 O3 PO4 A 349 A 461 ASN A 267 ASN.? 11.93 O4 PO4 A 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 7.80 59.00 17.23 7.36 57.24 18.34 coo 19.48 94.04 5.03 19.26 94.00 5.78 4.47 63.40 20.71 4.75 62.80 20.25 coo 20.23 95.69 9.16 21.55 97.37 9.20 4.37 61.77 16.42 3.54 60.20 17.57 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN A 270 ASN.? 15.06 O3 PO4 A 349 A 460 GLY A 268 GLY.? 11.90 O3 PO4 A 349 A 461 ASN A 269 ASN.? 10.42 O3 PO4 A 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 7.80 59.00 17.23 7.36 57.24 18.34 coo 19.48 94.04 5.03 19.26 94.00 5.78 4.47 63.40 20.71 4.75 62.80 20.25 coo 20.23 95.69 9.16 21.55 97.37 9.20 5.56 58.73 21.48 4.09 58.66 22.99 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 5 3 # 5 A 459 ASN B 267 ASN.? 11.96 O4 PO4 B 349 A 460 GLY B 268 GLY.? 11.97 O4 PO4 B 349 A 461 ASN B 269 ASN.? 10.41 O1 PO4 B 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -15.10 40.08 1.51 -14.03 39.29 3.16 coo 19.48 94.04 5.03 19.26 94.00 5.78 -14.82 35.55 0.64 -15.06 36.08 1.20 coo 20.23 95.69 9.16 21.55 97.37 9.20 -15.16 35.63 5.50 -13.49 34.32 5.66 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 6 3 # 6 A 459 ASN B 269 ASN.? 10.41 O1 PO4 B 349 A 460 GLY B 268 GLY.? 11.97 O4 PO4 B 349 A 461 ASN B 267 ASN.? 11.96 O4 PO4 B 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 19.48 94.04 5.03 19.26 94.00 5.78 -14.82 35.55 0.64 -15.06 36.08 1.20 coo 20.23 95.69 9.16 21.55 97.37 9.20 -15.10 40.08 1.51 -14.03 39.29 3.16 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 7 3 # 7 A 459 ASN B 270 ASN.? 15.02 O1 PO4 B 349 A 460 GLY B 268 GLY.? 11.97 O4 PO4 B 349 A 461 ASN B 267 ASN.? 11.96 O4 PO4 B 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -17.98 39.50 4.84 -17.14 38.86 6.70 coo 19.48 94.04 5.03 19.26 94.00 5.78 -14.82 35.55 0.64 -15.06 36.08 1.20 coo 20.23 95.69 9.16 21.55 97.37 9.20 -15.10 40.08 1.51 -14.03 39.29 3.16 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 8 3 # 8 A 459 ASN B 270 ASN.? 15.02 O1 PO4 B 349 A 460 GLY B 268 GLY.? 11.97 O4 PO4 B 349 A 461 ASN B 269 ASN.? 10.41 O1 PO4 B 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -17.98 39.50 4.84 -17.14 38.86 6.70 coo 19.48 94.04 5.03 19.26 94.00 5.78 -14.82 35.55 0.64 -15.06 36.08 1.20 coo 20.23 95.69 9.16 21.55 97.37 9.20 -15.16 35.63 5.50 -13.49 34.32 5.66 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 9 3 # 9 A 459 ASN C 267 ASN.? 11.87 O1 PO4 C 349 A 460 GLY C 268 GLY.? 12.08 O1 PO4 C 349 A 461 ASN C 269 ASN.? 10.45 O3 PO4 C 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -56.89 27.38 32.00 -55.68 25.71 32.54 coo 19.48 94.04 5.03 19.26 94.00 5.78 -56.98 24.93 28.04 -57.19 24.96 28.84 coo 20.23 95.69 9.16 21.55 97.37 9.20 -57.17 21.55 31.51 -55.49 20.56 30.60 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 10 3 # 10 A 459 ASN C 267 ASN.? 11.87 O1 PO4 C 349 A 460 GLY C 268 GLY.? 12.08 O1 PO4 C 349 A 461 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -56.89 27.38 32.00 -55.68 25.71 32.54 coo 19.48 94.04 5.03 19.26 94.00 5.78 -56.98 24.93 28.04 -57.19 24.96 28.84 coo 20.23 95.69 9.16 21.55 97.37 9.20 -59.71 24.81 33.93 -59.02 22.97 34.76 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 11 3 # 11 A 459 ASN C 269 ASN.? 10.45 O3 PO4 C 349 A 460 GLY C 268 GLY.? 12.08 O1 PO4 C 349 A 461 ASN C 267 ASN.? 11.87 O1 PO4 C 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -57.17 21.55 31.51 -55.49 20.56 30.60 coo 19.48 94.04 5.03 19.26 94.00 5.78 -56.98 24.93 28.04 -57.19 24.96 28.84 coo 20.23 95.69 9.16 21.55 97.37 9.20 -56.89 27.38 32.00 -55.68 25.71 32.54 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 12 3 # 12 A 459 ASN C 269 ASN.? 10.45 O3 PO4 C 349 A 460 GLY C 268 GLY.? 12.08 O1 PO4 C 349 A 461 ASN C 270 ASN.? 15.22 O3 PO4 C 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -57.17 21.55 31.51 -55.49 20.56 30.60 coo 19.48 94.04 5.03 19.26 94.00 5.78 -56.98 24.93 28.04 -57.19 24.96 28.84 coo 20.23 95.69 9.16 21.55 97.37 9.20 -59.71 24.81 33.93 -59.02 22.97 34.76 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 13 3 # 13 A 459 ASN C 270 ASN.? 15.22 O3 PO4 C 349 A 460 GLY C 268 GLY.? 12.08 O1 PO4 C 349 A 461 ASN C 267 ASN.? 11.87 O1 PO4 C 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -59.71 24.81 33.93 -59.02 22.97 34.76 coo 19.48 94.04 5.03 19.26 94.00 5.78 -56.98 24.93 28.04 -57.19 24.96 28.84 coo 20.23 95.69 9.16 21.55 97.37 9.20 -56.89 27.38 32.00 -55.68 25.71 32.54 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 14 3 # 14 A 459 ASN C 270 ASN.? 15.22 O3 PO4 C 349 A 460 GLY C 268 GLY.? 12.08 O1 PO4 C 349 A 461 ASN C 269 ASN.? 10.45 O3 PO4 C 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -59.71 24.81 33.93 -59.02 22.97 34.76 coo 19.48 94.04 5.03 19.26 94.00 5.78 -56.98 24.93 28.04 -57.19 24.96 28.84 coo 20.23 95.69 9.16 21.55 97.37 9.20 -57.17 21.55 31.51 -55.49 20.56 30.60 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 15 3 # 15 A 459 ASN D 267 ASN.? 11.74 O3 PO4 D 349 A 460 GLY D 268 GLY.? 11.79 O3 PO4 D 349 A 461 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -35.75 30.56 56.76 -36.75 28.68 56.44 coo 19.48 94.04 5.03 19.26 94.00 5.78 -35.40 28.55 60.91 -35.17 28.48 60.14 coo 20.23 95.69 9.16 21.55 97.37 9.20 -34.61 24.72 58.03 -36.14 23.70 59.12 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 16 3 # 16 A 459 ASN D 269 ASN.? 10.24 O3 PO4 D 349 A 460 GLY D 268 GLY.? 11.79 O3 PO4 D 349 A 461 ASN D 267 ASN.? 11.74 O3 PO4 D 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -34.61 24.72 58.03 -36.14 23.70 59.12 coo 19.48 94.04 5.03 19.26 94.00 5.78 -35.40 28.55 60.91 -35.17 28.48 60.14 coo 20.23 95.69 9.16 21.55 97.37 9.20 -35.75 30.56 56.76 -36.75 28.68 56.44 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 17 3 # 17 A 459 ASN D 270 ASN.? 14.75 O3 PO4 D 349 A 460 GLY D 268 GLY.? 11.79 O3 PO4 D 349 A 461 ASN D 267 ASN.? 11.74 O3 PO4 D 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -32.60 27.92 55.07 -33.22 25.92 54.63 coo 19.48 94.04 5.03 19.26 94.00 5.78 -35.40 28.55 60.91 -35.17 28.48 60.14 coo 20.23 95.69 9.16 21.55 97.37 9.20 -35.75 30.56 56.76 -36.75 28.68 56.44 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 18 3 # 18 A 459 ASN D 270 ASN.? 14.75 O3 PO4 D 349 A 460 GLY D 268 GLY.? 11.79 O3 PO4 D 349 A 461 ASN D 269 ASN.? 10.24 O3 PO4 D 349 coo 15.00 94.38 6.97 13.00 93.59 6.99 -32.60 27.92 55.07 -33.22 25.92 54.63 coo 19.48 94.04 5.03 19.26 94.00 5.78 -35.40 28.55 60.91 -35.17 28.48 60.14 coo 20.23 95.69 9.16 21.55 97.37 9.20 -34.61 24.72 58.03 -36.14 23.70 59.12 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 18 hits 2qv4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN B 269 ASN.? 10.41 O1 PO4 B 349 A 384 ASN B 43 ASN.? 23.10 O3 PO4 B 349 A 385 GLU B 15 GLU.? 19.82 C3 PG4 A 350 coo 22.28 63.17 110.61 22.47 65.06 111.53 -15.16 35.63 5.50 -13.49 34.32 5.66 coo 7.06 50.07 96.17 8.50 48.54 96.31 -12.52 12.59 3.86 -14.07 13.20 5.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 -13.67 16.25 7.60 -15.45 16.94 8.51 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN D 269 ASN.? 10.24 O3 PO4 D 349 A 384 ASN D 43 ASN.? 23.87 O2 PO4 D 349 A 385 GLU D 15 GLU.? 19.32 C4 PG4 C 350 coo 22.28 63.17 110.61 22.47 65.06 111.53 -34.61 24.72 58.03 -36.14 23.70 59.12 coo 7.06 50.07 96.17 8.50 48.54 96.31 -34.60 10.60 78.03 -33.00 10.04 76.71 coo 11.59 49.83 99.41 10.92 47.97 100.16 -33.73 9.80 72.63 -32.07 9.73 71.31 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 2 hits 2v3r_p00 naa= 3 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 1 3 # 1 A 82 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 166 SER A 169 SER~? 7.69 O1 PO4 A 349 A 168 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -16.90 61.69 22.73 -15.84 59.83 21.54 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 2 3 # 2 A 82 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 166 SER A 183 SER^? 16.92 O1 PO4 A 349 A 168 HIS A 229 HIS^? 14.13 O1 PO4 A 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -27.51 58.57 23.48 -25.56 60.04 23.47 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -21.69 59.77 21.49 -23.21 61.13 21.02 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 3 3 # 3 A 82 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 166 SER A 169 SER~? 7.69 O1 PO4 A 349 A 168 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -21.69 59.77 21.49 -23.21 61.13 21.02 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -16.90 61.69 22.73 -15.84 59.83 21.54 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 4 3 # 4 A 82 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 166 SER A 183 SER^? 16.92 O1 PO4 A 349 A 168 HIS A 173 HIS~? 15.17 O1 PO4 A 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -21.69 59.77 21.49 -23.21 61.13 21.02 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -27.51 58.57 23.48 -25.56 60.04 23.47 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -22.96 60.49 26.07 -24.34 59.43 27.24 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 5 3 # 5 A 82 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 166 SER B 169 SER~? 7.42 O2 PO4 B 349 A 168 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 13.23 34.15 0.64 14.88 33.23 1.56 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 6.64 36.52 -0.21 5.42 37.80 1.47 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 6 3 # 6 A 82 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 166 SER B 183 SER^? 16.79 O2 PO4 B 349 A 168 HIS B 229 HIS^? 14.08 O2 PO4 B 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 13.23 34.15 0.64 14.88 33.23 1.56 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 17.47 37.56 1.42 15.35 37.17 0.22 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 11.38 38.70 0.79 12.71 38.99 -0.80 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 7 3 # 7 A 82 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 166 SER B 169 SER~? 7.42 O2 PO4 B 349 A 168 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 11.38 38.70 0.79 12.71 38.99 -0.80 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 6.64 36.52 -0.21 5.42 37.80 1.47 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 8 3 # 8 A 82 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 166 SER B 183 SER^? 16.79 O2 PO4 B 349 A 168 HIS B 173 HIS~? 15.15 O2 PO4 B 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 11.38 38.70 0.79 12.71 38.99 -0.80 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 17.47 37.56 1.42 15.35 37.17 0.22 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 13.23 34.15 0.64 14.88 33.23 1.56 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 9 3 # 9 A 82 HIS C 173 HIS~? 15.03 O2 PO4 C 349 A 166 SER C 169 SER~? 7.39 O2 PO4 C 349 A 168 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -28.98 23.20 25.42 -27.39 21.83 25.46 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -35.40 25.65 26.78 -36.52 25.32 28.91 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 10 3 # 10 A 82 HIS C 173 HIS~? 15.03 O2 PO4 C 349 A 166 SER C 183 SER^? 16.83 O2 PO4 C 349 A 168 HIS C 229 HIS^? 14.09 O2 PO4 C 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -28.98 23.20 25.42 -27.39 21.83 25.46 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -24.45 24.87 27.97 -26.59 25.58 27.05 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -30.48 26.35 28.68 -29.26 27.76 27.72 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 11 3 # 11 A 82 HIS C 229 HIS^? 14.09 O2 PO4 C 349 A 166 SER C 169 SER~? 7.39 O2 PO4 C 349 A 168 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -30.48 26.35 28.68 -29.26 27.76 27.72 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -35.40 25.65 26.78 -36.52 25.32 28.91 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 12 3 # 12 A 82 HIS C 229 HIS^? 14.09 O2 PO4 C 349 A 166 SER C 183 SER^? 16.83 O2 PO4 C 349 A 168 HIS C 173 HIS~? 15.03 O2 PO4 C 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -30.48 26.35 28.68 -29.26 27.76 27.72 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -24.45 24.87 27.97 -26.59 25.58 27.05 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -28.98 23.20 25.42 -27.39 21.83 25.46 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 13 3 # 13 A 82 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 166 SER D 169 SER~? 7.40 O1 PO4 D 349 A 168 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -62.51 23.18 64.17 -63.84 21.56 64.29 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -56.61 26.42 62.40 -55.41 26.04 60.30 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 14 3 # 14 A 82 HIS D 173 HIS~? 14.91 O1 PO4 D 349 A 166 SER D 183 SER^? 16.97 O1 PO4 D 349 A 168 HIS D 229 HIS^? 14.18 O1 PO4 D 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -62.51 23.18 64.17 -63.84 21.56 64.29 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -67.39 23.51 61.42 -65.47 24.80 62.18 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -61.67 25.88 60.45 -63.21 27.00 61.32 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 15 3 # 15 A 82 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 166 SER D 169 SER~? 7.40 O1 PO4 D 349 A 168 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -61.67 25.88 60.45 -63.21 27.00 61.32 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -56.61 26.42 62.40 -55.41 26.04 60.30 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -62.51 23.18 64.17 -63.84 21.56 64.29 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 16 3 # 16 A 82 HIS D 229 HIS^? 14.18 O1 PO4 D 349 A 166 SER D 183 SER^? 16.97 O1 PO4 D 349 A 168 HIS D 173 HIS~? 14.91 O1 PO4 D 349 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -61.67 25.88 60.45 -63.21 27.00 61.32 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -67.39 23.51 61.42 -65.47 24.80 62.18 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -62.51 23.18 64.17 -63.84 21.56 64.29 2vmg_p00 source 2vmg FIBRONECTIN TYPE III DOMAIN PROTEIN : 16 hits 2vmg_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 152 ARG^? 23.60 O1 PO4 A 349 B 6 THR A 254 THR.? 20.09 O1 PO4 A 349 B 8 THR A 297 THR.? 24.89 O4 PO4 A 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -26.26 60.60 13.36 -28.56 61.89 11.76 coo 36.11 13.64 95.03 34.54 14.86 95.91 -21.73 56.84 10.14 -23.52 56.47 11.25 coo 32.72 8.05 92.39 31.25 9.11 91.35 -18.58 56.61 2.58 -18.64 58.07 0.99 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 153 ARG^? 21.78 O1 PO4 A 349 B 6 THR A 254 THR.? 20.09 O1 PO4 A 349 B 8 THR A 297 THR.? 24.89 O4 PO4 A 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -23.08 51.89 14.34 -24.46 52.07 11.57 coo 36.11 13.64 95.03 34.54 14.86 95.91 -21.73 56.84 10.14 -23.52 56.47 11.25 coo 32.72 8.05 92.39 31.25 9.11 91.35 -18.58 56.61 2.58 -18.64 58.07 0.99 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG A 249 ARG~? 17.61 O4 PO4 B 349 B 6 THR B 242 THR.? 14.01 C2 PG4 A 350 B 8 THR A 242 THR.? 14.16 O1 PG4 B 350 coo 40.52 16.08 100.90 37.97 16.41 102.60 -12.58 47.35 8.37 -11.42 49.74 6.78 coo 36.11 13.64 95.03 34.54 14.86 95.91 -6.70 44.34 11.61 -7.01 44.85 13.75 coo 32.72 8.05 92.39 31.25 9.11 91.35 -3.11 49.78 15.72 -2.58 47.68 15.65 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG A 261 ARG^? 7.73 O2 PO4 A 349 B 6 THR A 307 THR.? 14.46 O2 PO4 A 349 B 8 THR A 331 THR^? 16.62 O4 PO4 A 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -1.53 69.75 22.21 -1.72 66.84 23.28 coo 36.11 13.64 95.03 34.54 14.86 95.91 -6.91 74.69 22.42 -8.63 75.73 21.66 coo 32.72 8.05 92.39 31.25 9.11 91.35 -14.62 74.37 17.81 -16.32 74.55 19.19 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG A 283 ARG~? 22.10 O4 PO4 A 349 B 6 THR A 287 THR~? 22.00 O4 PO4 A 349 B 8 THR A 297 THR.? 24.89 O4 PO4 A 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -6.83 62.59 -0.10 -4.11 61.39 0.92 coo 36.11 13.64 95.03 34.54 14.86 95.91 -10.13 56.48 2.76 -8.53 56.78 1.32 coo 32.72 8.05 92.39 31.25 9.11 91.35 -18.58 56.61 2.58 -18.64 58.07 0.99 ULMN 3 1b01_d00 GENE REGULATION/DNA user 6 3 # 6 B 4 ARG A 283 ARG~? 22.10 O4 PO4 A 349 B 6 THR B 287 THR~? 22.03 O4 PO4 A 349 B 8 THR B 297 THR.? 24.99 O4 PO4 B 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -6.83 62.59 -0.10 -4.11 61.39 0.92 coo 36.11 13.64 95.03 34.54 14.86 95.91 -2.38 56.31 1.67 -4.17 57.52 1.30 coo 32.72 8.05 92.39 31.25 9.11 91.35 5.93 57.44 0.32 5.53 58.59 -1.46 ULMN 3 1b01_d00 GENE REGULATION/DNA user 7 3 # 7 B 4 ARG B 30 ARG~? 9.80 O3 PO4 B 349 B 6 THR B 53 THR~? 15.65 O3 PO4 B 349 B 8 THR B 17 THR.? 17.41 O3 PO4 B 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 1.86 25.26 -2.23 -1.04 24.22 -2.87 coo 36.11 13.64 95.03 34.54 14.86 95.91 -4.39 18.47 -3.98 -3.17 17.71 -2.38 coo 32.72 8.05 92.39 31.25 9.11 91.35 -7.05 17.62 2.38 -5.89 15.78 2.29 ULMN 3 1b01_d00 GENE REGULATION/DNA user 8 3 # 8 B 4 ARG B 30 ARG~? 9.80 O3 PO4 B 349 B 6 THR B 53 THR~? 15.65 O3 PO4 B 349 B 8 THR B 18 THR.? 18.49 O3 PO4 B 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 1.86 25.26 -2.23 -1.04 24.22 -2.87 coo 36.11 13.64 95.03 34.54 14.86 95.91 -4.39 18.47 -3.98 -3.17 17.71 -2.38 coo 32.72 8.05 92.39 31.25 9.11 91.35 -9.76 18.26 -0.25 -10.26 16.26 -0.91 ULMN 3 1b01_d00 GENE REGULATION/DNA user 9 3 # 9 B 4 ARG B 152 ARG^? 23.80 O2 PO4 B 349 B 6 THR B 254 THR.? 20.12 O2 PO4 B 349 B 8 THR B 297 THR.? 24.99 O4 PO4 B 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 14.94 46.89 -2.30 16.61 48.81 -4.04 coo 36.11 13.64 95.03 34.54 14.86 95.91 10.14 50.29 1.40 12.13 49.53 1.68 coo 32.72 8.05 92.39 31.25 9.11 91.35 5.93 57.44 0.32 5.53 58.59 -1.46 ULMN 3 1b01_d00 GENE REGULATION/DNA user 10 3 # 10 B 4 ARG B 153 ARG^? 21.71 O2 PO4 B 349 B 6 THR B 254 THR.? 20.12 O2 PO4 B 349 B 8 THR B 297 THR.? 24.99 O4 PO4 B 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 12.56 47.43 6.76 13.42 50.26 5.86 coo 36.11 13.64 95.03 34.54 14.86 95.91 10.14 50.29 1.40 12.13 49.53 1.68 coo 32.72 8.05 92.39 31.25 9.11 91.35 5.93 57.44 0.32 5.53 58.59 -1.46 ULMN 3 1b01_d00 GENE REGULATION/DNA user 11 3 # 11 B 4 ARG B 335 ARG~? 17.10 O3 PO4 B 349 B 6 THR B 331 THR^? 16.37 O4 PO4 B 349 B 8 THR B 322 THR~? 16.35 O4 PO4 B 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -0.53 29.97 -13.85 -3.08 28.75 -15.03 coo 36.11 13.64 95.03 34.54 14.86 95.91 2.36 38.24 -13.00 4.20 37.08 -13.10 coo 32.72 8.05 92.39 31.25 9.11 91.35 -4.35 43.84 -14.76 -4.06 42.63 -12.99 ULMN 3 1b01_d00 GENE REGULATION/DNA user 12 3 # 12 B 4 ARG C 152 ARG^? 15.32 O1 PG4 A 350 B 6 THR C 254 THR.? 20.37 O2 PO4 C 349 B 8 THR C 297 THR.? 24.78 O1 PO4 C 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -26.55 34.01 32.08 -24.98 36.67 32.18 coo 36.11 13.64 95.03 34.54 14.86 95.91 -30.89 33.85 37.59 -28.87 33.18 37.19 coo 32.72 8.05 92.39 31.25 9.11 91.35 -34.87 39.45 42.36 -35.27 41.56 42.05 ULMN 3 1b01_d00 GENE REGULATION/DNA user 13 3 # 13 B 4 ARG C 153 ARG^? 21.82 O2 PO4 C 349 B 6 THR C 254 THR.? 20.37 O2 PO4 C 349 B 8 THR C 297 THR.? 24.78 O1 PO4 C 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -28.52 27.96 39.05 -27.50 30.55 40.41 coo 36.11 13.64 95.03 34.54 14.86 95.91 -30.89 33.85 37.59 -28.87 33.18 37.19 coo 32.72 8.05 92.39 31.25 9.11 91.35 -34.87 39.45 42.36 -35.27 41.56 42.05 ULMN 3 1b01_d00 GENE REGULATION/DNA user 14 3 # 14 B 4 ARG C 249 ARG~? 17.71 O4 PO4 D 349 B 6 THR D 242 THR.? 14.33 O2 PG4 C 350 B 8 THR C 242 THR.? 14.00 O5 PG4 D 350 coo 40.52 16.08 100.90 37.97 16.41 102.60 -38.85 28.76 46.96 -40.48 31.26 46.10 coo 36.11 13.64 95.03 34.54 14.86 95.91 -43.74 23.47 47.95 -43.28 22.17 46.24 coo 32.72 8.05 92.39 31.25 9.11 91.35 -47.88 22.66 41.54 -48.06 21.40 43.36 ULMN 3 1b01_d00 GENE REGULATION/DNA user 15 3 # 15 B 4 ARG C 283 ARG~? 24.80 O1 PO4 C 349 B 6 THR C 287 THR~? 22.18 O1 PO4 C 349 B 8 THR C 297 THR.? 24.78 O1 PO4 C 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -47.36 43.82 38.18 -45.87 46.48 37.65 coo 36.11 13.64 95.03 34.54 14.86 95.91 -43.08 38.07 43.05 -44.80 39.16 43.76 coo 32.72 8.05 92.39 31.25 9.11 91.35 -34.87 39.45 42.36 -35.27 41.56 42.05 ULMN 3 1b01_d00 GENE REGULATION/DNA user 16 3 # 16 B 4 ARG C 283 ARG~? 24.80 O1 PO4 C 349 B 6 THR D 287 THR~? 22.05 O1 PO4 C 349 B 8 THR D 297 THR.? 24.69 O4 PO4 D 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -47.36 43.82 38.18 -45.87 46.48 37.65 coo 36.11 13.64 95.03 34.54 14.86 95.91 -50.86 37.45 44.52 -49.17 38.53 43.62 coo 32.72 8.05 92.39 31.25 9.11 91.35 -59.18 37.67 45.00 -59.08 39.85 45.29 ULMN 3 1b01_d00 GENE REGULATION/DNA user 17 3 # 17 B 4 ARG D 30 ARG~? 11.31 O2 PO4 D 349 B 6 THR D 53 THR~? 16.59 O2 PO4 D 349 B 8 THR D 17 THR.? 18.04 O2 PO4 D 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -49.79 21.88 72.70 -47.47 22.25 74.75 coo 36.11 13.64 95.03 34.54 14.86 95.91 -43.53 19.74 79.32 -44.41 17.86 78.69 coo 32.72 8.05 92.39 31.25 9.11 91.35 -40.66 14.38 75.33 -41.73 13.09 76.71 ULMN 3 1b01_d00 GENE REGULATION/DNA user 18 3 # 18 B 4 ARG D 30 ARG~? 11.31 O2 PO4 D 349 B 6 THR D 53 THR~? 16.59 O2 PO4 D 349 B 8 THR D 18 THR.? 19.18 O2 PO4 D 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -49.79 21.88 72.70 -47.47 22.25 74.75 coo 36.11 13.64 95.03 34.54 14.86 95.91 -43.53 19.74 79.32 -44.41 17.86 78.69 coo 32.72 8.05 92.39 31.25 9.11 91.35 -38.03 16.95 76.32 -37.64 16.25 78.33 ULMN 3 1b01_d00 GENE REGULATION/DNA user 19 3 # 19 B 4 ARG D 152 ARG^? 23.56 O1 PO4 D 349 B 6 THR D 254 THR.? 20.33 O1 PO4 D 349 B 8 THR D 297 THR.? 24.69 O4 PO4 D 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -66.62 32.34 56.11 -68.43 34.76 55.54 coo 36.11 13.64 95.03 34.54 14.86 95.91 -62.28 32.28 50.56 -64.11 31.32 51.19 coo 32.72 8.05 92.39 31.25 9.11 91.35 -59.18 37.67 45.00 -59.08 39.85 45.29 ULMN 3 1b01_d00 GENE REGULATION/DNA user 20 3 # 20 B 4 ARG D 153 ARG^? 21.95 O1 PO4 D 349 B 6 THR D 254 THR.? 20.33 O1 PO4 D 349 B 8 THR D 297 THR.? 24.69 O4 PO4 D 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -63.61 25.82 49.88 -65.26 27.93 48.32 coo 36.11 13.64 95.03 34.54 14.86 95.91 -62.28 32.28 50.56 -64.11 31.32 51.19 coo 32.72 8.05 92.39 31.25 9.11 91.35 -59.18 37.67 45.00 -59.08 39.85 45.29 ULMN 3 1b01_d00 GENE REGULATION/DNA user 21 3 # 21 B 4 ARG D 249 ARG~? 17.54 O1 PO4 C 349 B 6 THR C 242 THR.? 14.00 O5 PG4 D 350 B 8 THR D 242 THR.? 14.33 O2 PG4 C 350 coo 40.52 16.08 100.90 37.97 16.41 102.60 -53.61 27.06 41.90 -52.49 29.90 42.42 coo 36.11 13.64 95.03 34.54 14.86 95.91 -47.88 22.66 41.54 -48.06 21.40 43.36 coo 32.72 8.05 92.39 31.25 9.11 91.35 -43.74 23.47 47.95 -43.28 22.17 46.24 ULMN 3 1b01_d00 GENE REGULATION/DNA user 22 3 # 22 B 4 ARG D 261 ARG^? 8.01 O2 PO4 D 349 B 6 THR D 307 THR.? 14.52 O2 PO4 D 349 B 8 THR D 331 THR^? 16.33 O4 PO4 D 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -41.02 32.36 67.18 -41.18 29.51 65.99 coo 36.11 13.64 95.03 34.54 14.86 95.91 -45.94 35.31 71.02 -47.61 36.72 71.34 coo 32.72 8.05 92.39 31.25 9.11 91.35 -53.87 38.43 68.16 -55.50 37.55 69.29 ULMN 3 1b01_d00 GENE REGULATION/DNA user 23 3 # 23 B 4 ARG D 335 ARG~? 17.05 O2 PO4 D 349 B 6 THR D 331 THR^? 16.33 O4 PO4 D 349 B 8 THR D 322 THR~? 16.37 O4 PO4 D 349 coo 40.52 16.08 100.90 37.97 16.41 102.60 -49.77 35.01 75.03 -47.14 35.61 76.51 coo 36.11 13.64 95.03 34.54 14.86 95.91 -53.87 38.43 68.16 -55.50 37.55 69.29 coo 32.72 8.05 92.39 31.25 9.11 91.35 -48.40 44.20 64.00 -48.20 42.05 63.93 1b01_d00 source 1b01 GENE REGULATION/DNA : 23 hits 1b01_d00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 47 GLN.? 24.33 O2 PO4 A 349 A 11 ASN A 43 ASN~? 22.73 O3 PO4 A 349 A 13 ARG A 42 ARG~? 19.93 C3 PG4 B 350 coo 33.45 2.10 7.21 34.51 1.09 5.67 3.48 69.09 46.55 4.95 68.93 45.01 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 6.86 62.77 42.72 8.12 61.14 42.12 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 7.49 56.88 46.72 6.71 54.94 44.43 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN B 47 GLN.? 24.31 O3 PO4 B 349 A 11 ASN B 43 ASN.? 23.10 O3 PO4 B 349 A 13 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 33.45 2.10 7.21 34.51 1.09 5.67 -8.08 8.65 -2.04 -9.77 9.95 -2.10 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -12.52 12.59 3.86 -14.07 13.20 5.18 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 3 3 # 3 A 9 GLN C 47 GLN.? 24.24 O4 PO4 C 349 A 11 ASN C 43 ASN.? 22.72 C5 PG4 D 350 A 13 ARG C 42 ARG.? 19.15 C5 PG4 D 350 coo 33.45 2.10 7.21 34.51 1.09 5.67 -54.88 7.34 8.33 -56.28 8.33 9.60 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -57.74 6.14 16.07 -58.97 5.36 17.64 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -57.88 0.79 18.76 -56.46 0.67 21.52 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 4 3 # 4 A 9 GLN D 47 GLN.? 25.10 O2 PO4 D 349 A 11 ASN D 43 ASN.? 23.87 O2 PO4 D 349 A 13 ARG D 42 ARG.? 20.81 C4 PG4 C 350 coo 33.45 2.10 7.21 34.51 1.09 5.67 -39.01 12.13 85.26 -37.55 12.91 83.92 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -34.60 10.60 78.03 -33.00 10.04 76.71 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -33.94 3.86 75.82 -34.45 4.46 72.82 1bdv_d00 source 1bdv GENE REGULATION/DNA : 4 hits 1bdv_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 58 TYR.? 25.18 O2 PO4 A 349 I 306 VAL A 37 VAL^? 24.38 O2 PO4 A 349 I 308 VAL A 39 VAL^? 19.47 O2 PO4 A 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -9.28 69.56 48.22 -7.53 68.84 50.27 coo 23.55 29.53 9.81 23.15 27.39 10.24 -10.54 60.80 48.63 -11.67 59.30 49.81 coo 16.43 30.18 9.35 15.05 30.67 11.01 -4.17 60.70 45.26 -4.09 62.11 43.58 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 71 TYR~? 28.56 O2 PO4 A 349 I 306 VAL A 37 VAL^? 24.38 O2 PO4 A 349 I 308 VAL A 9 VAL^? 20.83 O2 PO4 A 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -7.92 60.98 53.46 -6.24 63.13 54.07 coo 23.55 29.53 9.81 23.15 27.39 10.24 -10.54 60.80 48.63 -11.67 59.30 49.81 coo 16.43 30.18 9.35 15.05 30.67 11.01 -11.47 55.92 45.78 -11.78 55.77 43.58 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 71 TYR~? 28.56 O2 PO4 A 349 I 306 VAL A 62 VAL^? 26.07 O2 PO4 A 349 I 308 VAL A 65 VAL~? 23.07 C5 PG4 B 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 -7.92 60.98 53.46 -6.24 63.13 54.07 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.40 61.48 50.13 -2.19 60.54 51.02 coo 16.43 30.18 9.35 15.05 30.67 11.01 -1.56 53.74 50.33 -2.25 51.85 49.39 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 221 TYR~? 17.25 O1 PG4 A 350 I 306 VAL A 218 VAL~? 16.35 O1 PG4 A 350 I 308 VAL A 214 VAL~? 12.61 O1 PG4 A 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 -24.98 48.97 24.49 -23.82 47.69 26.70 coo 23.55 29.53 9.81 23.15 27.39 10.24 -21.92 48.09 19.23 -21.19 49.38 17.59 coo 16.43 30.18 9.35 15.05 30.67 11.01 -15.88 46.48 18.88 -14.78 48.25 18.14 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 285 TYR~? 11.91 O4 PO4 A 349 I 306 VAL A 157 VAL^? 9.08 O4 PO4 A 349 I 308 VAL A 259 VAL^? 6.77 O4 PO4 A 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 -10.29 59.91 15.62 -11.02 59.40 13.59 coo 16.43 30.18 9.35 15.05 30.67 11.01 -9.53 65.57 17.14 -10.11 64.98 19.16 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 285 TYR~? 11.91 O4 PO4 A 349 I 306 VAL A 257 VAL^? 11.93 O4 PO4 A 349 I 308 VAL A 154 VAL^? 14.34 O1 PO4 A 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 -15.09 63.65 14.33 -16.33 64.65 15.84 coo 16.43 30.18 9.35 15.05 30.67 11.01 -19.92 58.46 15.79 -20.55 60.55 15.94 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 285 TYR~? 11.91 O4 PO4 A 349 I 306 VAL A 257 VAL^? 11.93 O4 PO4 A 349 I 308 VAL A 259 VAL^? 6.77 O4 PO4 A 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 -15.09 63.65 14.33 -16.33 64.65 15.84 coo 16.43 30.18 9.35 15.05 30.67 11.01 -9.53 65.57 17.14 -10.11 64.98 19.16 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR A 285 TYR~? 11.91 O4 PO4 A 349 I 306 VAL A 257 VAL^? 11.93 O4 PO4 A 349 I 308 VAL A 301 VAL^? 17.78 O4 PO4 A 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 -15.09 63.65 14.33 -16.33 64.65 15.84 coo 16.43 30.18 9.35 15.05 30.67 11.01 -18.00 66.05 9.67 -19.62 64.86 10.59 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR A 285 TYR~? 11.91 O4 PO4 A 349 I 306 VAL A 288 VAL~? 18.20 O4 PO4 A 349 I 308 VAL B 288 VAL~? 18.27 O4 PO4 B 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 -9.54 53.93 5.52 -8.09 53.54 7.10 coo 16.43 30.18 9.35 15.05 30.67 11.01 -2.25 54.01 4.75 -3.47 52.31 5.55 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR A 285 TYR~? 11.91 O4 PO4 A 349 I 306 VAL A 300 VAL^? 15.53 O4 PO4 A 349 I 308 VAL A 298 VAL.? 19.62 O4 PO4 A 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.78 59.29 10.05 -7.08 58.89 12.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 -15.17 63.56 8.91 -13.08 63.77 9.45 coo 16.43 30.18 9.35 15.05 30.67 11.01 -17.96 57.92 6.10 -17.80 56.48 7.73 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR B 71 TYR~? 28.79 O3 PO4 B 349 I 306 VAL B 37 VAL^? 24.95 O3 PO4 B 349 I 308 VAL B 9 VAL^? 21.20 O3 PO4 B 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.73 5.71 7.80 2.32 4.41 5.78 coo 23.55 29.53 9.81 23.15 27.39 10.24 5.64 10.63 7.00 6.78 10.02 8.81 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.72 14.59 11.17 5.55 16.77 10.88 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR B 71 TYR~? 28.79 O3 PO4 B 349 I 306 VAL B 39 VAL^? 19.76 O3 PO4 B 349 I 308 VAL B 9 VAL^? 21.20 O3 PO4 B 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.73 5.71 7.80 2.32 4.41 5.78 coo 23.55 29.53 9.81 23.15 27.39 10.24 -1.23 12.85 6.36 -1.63 14.16 4.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.72 14.59 11.17 5.55 16.77 10.88 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR B 71 TYR~? 28.79 O3 PO4 B 349 I 306 VAL B 39 VAL^? 19.76 O3 PO4 B 349 I 308 VAL B 65 VAL~? 23.45 C5 PG4 A 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.73 5.71 7.80 2.32 4.41 5.78 coo 23.55 29.53 9.81 23.15 27.39 10.24 -1.23 12.85 6.36 -1.63 14.16 4.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 -3.39 8.81 14.19 -3.01 10.28 15.80 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR B 71 TYR~? 28.79 O3 PO4 B 349 I 306 VAL B 62 VAL^? 26.22 O3 PO4 B 349 I 308 VAL B 65 VAL~? 23.45 C5 PG4 A 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.73 5.71 7.80 2.32 4.41 5.78 coo 23.55 29.53 9.81 23.15 27.39 10.24 -4.09 7.34 6.50 -2.18 7.08 7.56 coo 16.43 30.18 9.35 15.05 30.67 11.01 -3.39 8.81 14.19 -3.01 10.28 15.80 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR B 221 TYR~? 17.66 O1 PG4 B 350 I 306 VAL B 218 VAL~? 16.52 O1 PG4 B 350 I 308 VAL B 214 VAL~? 12.79 O1 PG4 B 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.24 38.44 11.23 15.50 36.34 12.94 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.36 43.27 11.59 11.17 44.49 10.20 coo 16.43 30.18 9.35 15.05 30.67 11.01 6.59 43.24 13.89 5.24 43.57 12.16 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR B 285 TYR~? 12.05 O4 PO4 B 349 I 306 VAL B 157 VAL^? 9.26 O4 PO4 B 349 I 308 VAL B 259 VAL^? 6.80 O4 PO4 B 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.64 43.07 1.09 -0.09 45.22 0.98 coo 16.43 30.18 9.35 15.05 30.67 11.01 -1.79 40.17 -4.12 -0.77 38.44 -3.21 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR B 285 TYR~? 12.05 O4 PO4 B 349 I 306 VAL B 257 VAL^? 11.93 O4 PO4 B 349 I 308 VAL B 154 VAL^? 14.29 O2 PO4 B 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.36 44.02 -3.53 4.67 42.51 -4.44 coo 16.43 30.18 9.35 15.05 30.67 11.01 8.87 44.32 1.16 9.42 43.74 -0.89 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR B 285 TYR~? 12.05 O4 PO4 B 349 I 306 VAL B 257 VAL^? 11.93 O4 PO4 B 349 I 308 VAL B 259 VAL^? 6.80 O4 PO4 B 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.36 44.02 -3.53 4.67 42.51 -4.44 coo 16.43 30.18 9.35 15.05 30.67 11.01 -1.79 40.17 -4.12 -0.77 38.44 -3.21 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR B 285 TYR~? 12.05 O4 PO4 B 349 I 306 VAL B 257 VAL^? 11.93 O4 PO4 B 349 I 308 VAL B 301 VAL^? 17.67 O4 PO4 B 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 23.55 29.53 9.81 23.15 27.39 10.24 3.36 44.02 -3.53 4.67 42.51 -4.44 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.31 48.32 -7.12 7.12 47.80 -5.95 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR B 285 TYR~? 12.05 O4 PO4 B 349 I 306 VAL B 288 VAL~? 18.27 O4 PO4 B 349 I 308 VAL A 288 VAL~? 18.20 O4 PO4 A 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 23.55 29.53 9.81 23.15 27.39 10.24 -2.25 54.01 4.75 -3.47 52.31 5.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 -9.54 53.93 5.52 -8.09 53.54 7.10 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR B 285 TYR~? 12.05 O4 PO4 B 349 I 306 VAL B 288 VAL~? 18.27 O4 PO4 B 349 I 308 VAL B 298 VAL.? 19.75 O4 PO4 B 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 23.55 29.53 9.81 23.15 27.39 10.24 -2.25 54.01 4.75 -3.47 52.31 5.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.62 53.65 0.04 5.78 52.39 1.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR B 285 TYR~? 12.05 O4 PO4 B 349 I 306 VAL B 300 VAL^? 15.66 O4 PO4 B 349 I 308 VAL B 298 VAL.? 19.75 O4 PO4 B 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -2.93 48.39 0.67 -4.25 46.17 1.73 coo 23.55 29.53 9.81 23.15 27.39 10.24 2.68 49.37 -4.57 0.60 48.61 -4.34 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.62 53.65 0.04 5.78 52.39 1.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 23 3 # 23 I 303 TYR C 58 TYR.? 25.51 O4 PO4 C 349 I 306 VAL C 37 VAL^? 24.48 O4 PO4 C 349 I 308 VAL C 39 VAL^? 19.66 O4 PO4 C 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -41.92 7.88 6.18 -42.73 5.30 5.53 coo 23.55 29.53 9.81 23.15 27.39 10.24 -39.64 2.94 12.76 -38.34 1.23 13.31 coo 16.43 30.18 9.35 15.05 30.67 11.01 -46.22 4.52 15.35 -46.75 6.68 15.27 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 24 3 # 24 I 303 TYR C 71 TYR~? 28.61 O4 PO4 C 349 I 306 VAL C 37 VAL^? 24.48 O4 PO4 C 349 I 308 VAL C 9 VAL^? 21.06 O4 PO4 C 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -42.04 -1.21 10.11 -44.02 -0.84 8.15 coo 23.55 29.53 9.81 23.15 27.39 10.24 -39.64 2.94 12.76 -38.34 1.23 13.31 coo 16.43 30.18 9.35 15.05 30.67 11.01 -38.24 2.44 18.29 -38.08 4.09 19.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 25 3 # 25 I 303 TYR C 71 TYR~? 28.61 O4 PO4 C 349 I 306 VAL C 39 VAL^? 19.66 O4 PO4 C 349 I 308 VAL C 9 VAL^? 21.06 O4 PO4 C 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -42.04 -1.21 10.11 -44.02 -0.84 8.15 coo 23.55 29.53 9.81 23.15 27.39 10.24 -46.22 4.52 15.35 -46.75 6.68 15.27 coo 16.43 30.18 9.35 15.05 30.67 11.01 -38.24 2.44 18.29 -38.08 4.09 19.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 26 3 # 26 I 303 TYR C 71 TYR~? 28.61 O4 PO4 C 349 I 306 VAL C 39 VAL^? 19.66 O4 PO4 C 349 I 308 VAL C 65 VAL~? 23.11 O3 PG4 D 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 -42.04 -1.21 10.11 -44.02 -0.84 8.15 coo 23.55 29.53 9.81 23.15 27.39 10.24 -46.22 4.52 15.35 -46.75 6.68 15.27 coo 16.43 30.18 9.35 15.05 30.67 11.01 -47.67 -3.95 18.13 -46.71 -4.12 20.13 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 27 3 # 27 I 303 TYR C 71 TYR~? 28.61 O4 PO4 C 349 I 306 VAL C 62 VAL^? 26.14 O4 PO4 C 349 I 308 VAL C 65 VAL~? 23.11 O3 PG4 D 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 -42.04 -1.21 10.11 -44.02 -0.84 8.15 coo 23.55 29.53 9.81 23.15 27.39 10.24 -49.89 0.65 12.30 -47.93 -0.40 12.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 -47.67 -3.95 18.13 -46.71 -4.12 20.13 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 28 3 # 28 I 303 TYR C 221 TYR~? 17.74 O1 PG4 C 350 I 306 VAL C 218 VAL~? 16.70 O1 PG4 C 350 I 308 VAL C 214 VAL~? 12.97 O1 PG4 C 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 -25.26 18.68 35.52 -25.91 16.01 35.07 coo 23.55 29.53 9.81 23.15 27.39 10.24 -28.78 21.64 39.37 -29.76 23.61 39.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 -34.46 20.17 41.38 -35.85 21.63 40.54 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 29 3 # 29 I 303 TYR C 285 TYR~? 11.99 O1 PO4 C 349 I 306 VAL C 157 VAL^? 9.13 O1 PO4 C 349 I 308 VAL C 259 VAL^? 6.85 O1 PO4 C 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 23.55 29.53 9.81 23.15 27.39 10.24 -42.25 29.38 32.85 -41.62 30.80 34.41 coo 16.43 30.18 9.35 15.05 30.67 11.01 -43.65 31.25 27.31 -42.81 29.35 26.64 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 30 3 # 30 I 303 TYR C 285 TYR~? 11.99 O1 PO4 C 349 I 306 VAL C 257 VAL^? 11.92 O1 PO4 C 349 I 308 VAL C 154 VAL^? 14.37 O2 PO4 C 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 23.55 29.53 9.81 23.15 27.39 10.24 -38.24 33.29 30.17 -37.13 32.83 28.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 -32.52 29.91 33.17 -32.16 31.09 31.36 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 31 3 # 31 I 303 TYR C 285 TYR~? 11.99 O1 PO4 C 349 I 306 VAL C 257 VAL^? 11.92 O1 PO4 C 349 I 308 VAL C 259 VAL^? 6.85 O1 PO4 C 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 23.55 29.53 9.81 23.15 27.39 10.24 -38.24 33.29 30.17 -37.13 32.83 28.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 -43.65 31.25 27.31 -42.81 29.35 26.64 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 32 3 # 32 I 303 TYR C 285 TYR~? 11.99 O1 PO4 C 349 I 306 VAL C 257 VAL^? 11.92 O1 PO4 C 349 I 308 VAL C 301 VAL^? 17.68 O1 PO4 C 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 23.55 29.53 9.81 23.15 27.39 10.24 -38.24 33.29 30.17 -37.13 32.83 28.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 -35.98 38.72 30.59 -34.20 37.47 30.93 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 33 3 # 33 I 303 TYR C 285 TYR~? 11.99 O1 PO4 C 349 I 306 VAL C 288 VAL~? 18.26 O1 PO4 C 349 I 308 VAL D 288 VAL~? 18.36 O4 PO4 D 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 23.55 29.53 9.81 23.15 27.39 10.24 -43.10 34.31 43.52 -44.38 32.62 42.93 coo 16.43 30.18 9.35 15.05 30.67 11.01 -50.33 33.67 44.53 -48.79 32.32 45.36 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 34 3 # 34 I 303 TYR C 285 TYR~? 11.99 O1 PO4 C 349 I 306 VAL C 300 VAL^? 15.63 O1 PO4 C 349 I 308 VAL C 298 VAL.? 19.56 O1 PO4 C 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -44.26 33.47 36.56 -45.76 31.25 35.74 coo 23.55 29.53 9.81 23.15 27.39 10.24 -38.52 37.72 33.24 -40.61 37.11 32.94 coo 16.43 30.18 9.35 15.05 30.67 11.01 -35.30 37.20 39.31 -35.06 35.05 39.43 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 35 3 # 35 I 303 TYR D 58 TYR.? 26.59 O2 PO4 D 349 I 306 VAL D 37 VAL^? 25.31 O2 PO4 D 349 I 308 VAL D 39 VAL^? 20.55 O2 PO4 D 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -51.78 11.22 85.17 -50.35 9.07 86.25 coo 23.55 29.53 9.81 23.15 27.39 10.24 -52.60 5.52 78.47 -53.72 3.72 77.80 coo 16.43 30.18 9.35 15.05 30.67 11.01 -45.86 7.68 76.93 -45.57 9.85 76.93 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 36 3 # 36 I 303 TYR D 71 TYR~? 29.61 O2 PO4 D 349 I 306 VAL D 37 VAL^? 25.31 O2 PO4 D 349 I 308 VAL D 9 VAL^? 21.30 O1 PO4 D 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -50.15 1.87 82.02 -48.64 2.61 84.24 coo 23.55 29.53 9.81 23.15 27.39 10.24 -52.60 5.52 78.47 -53.72 3.72 77.80 coo 16.43 30.18 9.35 15.05 30.67 11.01 -52.94 4.87 72.79 -52.92 6.53 71.33 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 37 3 # 37 I 303 TYR D 71 TYR~? 29.61 O2 PO4 D 349 I 306 VAL D 39 VAL^? 20.55 O2 PO4 D 349 I 308 VAL D 9 VAL^? 21.30 O1 PO4 D 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -50.15 1.87 82.02 -48.64 2.61 84.24 coo 23.55 29.53 9.81 23.15 27.39 10.24 -45.86 7.68 76.93 -45.57 9.85 76.93 coo 16.43 30.18 9.35 15.05 30.67 11.01 -52.94 4.87 72.79 -52.92 6.53 71.33 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 38 3 # 38 I 303 TYR D 71 TYR~? 29.61 O2 PO4 D 349 I 306 VAL D 39 VAL^? 20.55 O2 PO4 D 349 I 308 VAL D 65 VAL~? 23.69 C6 PG4 C 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 -50.15 1.87 82.02 -48.64 2.61 84.24 coo 23.55 29.53 9.81 23.15 27.39 10.24 -45.86 7.68 76.93 -45.57 9.85 76.93 coo 16.43 30.18 9.35 15.05 30.67 11.01 -43.26 -0.78 75.00 -43.89 -1.12 72.88 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 39 3 # 39 I 303 TYR D 71 TYR~? 29.61 O2 PO4 D 349 I 306 VAL D 62 VAL^? 27.03 O2 PO4 D 349 I 308 VAL D 65 VAL~? 23.69 C6 PG4 C 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 -50.15 1.87 82.02 -48.64 2.61 84.24 coo 23.55 29.53 9.81 23.15 27.39 10.24 -42.47 4.23 80.79 -44.30 3.05 80.40 coo 16.43 30.18 9.35 15.05 30.67 11.01 -43.26 -0.78 75.00 -43.89 -1.12 72.88 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 40 3 # 40 I 303 TYR D 221 TYR~? 17.09 O5 PG4 D 350 I 306 VAL D 218 VAL~? 15.85 O5 PG4 D 350 I 308 VAL D 214 VAL~? 12.32 O5 PG4 D 350 coo 26.18 35.24 6.87 24.33 35.18 8.97 -65.63 16.43 54.69 -64.60 13.90 55.16 coo 23.55 29.53 9.81 23.15 27.39 10.24 -62.39 19.57 50.41 -61.63 21.62 50.24 coo 16.43 30.18 9.35 15.05 30.67 11.01 -56.46 18.75 48.71 -55.37 20.55 49.32 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 41 3 # 41 I 303 TYR D 285 TYR~? 12.08 O4 PO4 D 349 I 306 VAL D 157 VAL^? 9.28 O4 PO4 D 349 I 308 VAL D 259 VAL^? 6.76 O4 PO4 D 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -50.44 30.40 55.81 -51.22 31.67 54.16 coo 16.43 30.18 9.35 15.05 30.67 11.01 -49.33 33.04 60.99 -49.94 31.16 61.96 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 42 3 # 42 I 303 TYR D 285 TYR~? 12.08 O4 PO4 D 349 I 306 VAL D 257 VAL^? 11.87 O4 PO4 D 349 I 308 VAL D 154 VAL^? 14.44 O1 PO4 D 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -55.02 33.77 57.95 -56.15 33.38 59.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 -60.15 29.21 55.46 -60.68 30.49 57.13 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 43 3 # 43 I 303 TYR D 285 TYR~? 12.08 O4 PO4 D 349 I 306 VAL D 257 VAL^? 11.87 O4 PO4 D 349 I 308 VAL D 259 VAL^? 6.76 O4 PO4 D 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -55.02 33.77 57.95 -56.15 33.38 59.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 -49.33 33.04 60.99 -49.94 31.16 61.96 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 44 3 # 44 I 303 TYR D 285 TYR~? 12.08 O4 PO4 D 349 I 306 VAL D 257 VAL^? 11.87 O4 PO4 D 349 I 308 VAL D 301 VAL^? 17.62 O4 PO4 D 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -55.02 33.77 57.95 -56.15 33.38 59.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 -57.99 38.81 56.72 -59.53 37.22 56.68 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 45 3 # 45 I 303 TYR D 285 TYR~? 12.08 O4 PO4 D 349 I 306 VAL D 288 VAL~? 18.36 O4 PO4 D 349 I 308 VAL C 288 VAL~? 18.26 O1 PO4 C 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -50.33 33.67 44.53 -48.79 32.32 45.36 coo 16.43 30.18 9.35 15.05 30.67 11.01 -43.10 34.31 43.52 -44.38 32.62 42.93 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 46 3 # 46 I 303 TYR D 285 TYR~? 12.08 O4 PO4 D 349 I 306 VAL D 300 VAL^? 15.59 O4 PO4 D 349 I 308 VAL D 298 VAL.? 19.71 O4 PO4 D 349 coo 26.18 35.24 6.87 24.33 35.18 8.97 -49.07 33.98 51.47 -47.27 32.17 52.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -55.34 37.70 54.18 -53.19 37.46 54.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 -58.45 35.90 48.29 -58.34 33.74 48.36 1cqt_d00 source 1cqt GENE REGULATION/DNA : 46 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 136 PRO.? -5.72 O1 PG4 A 350s A 272 LEU A 139 LEU.? -3.83 O1 PG4 A 350s A 276 ARG A 206 ARG~? -3.21 O4 PG4 A 350s coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -14.35 41.81 25.59 -13.46 39.99 26.56 coo 10.97 0.43 16.73 11.31 2.11 18.06 -14.21 37.82 20.63 -14.15 39.67 21.77 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -5.76 36.17 21.40 -8.07 34.21 22.04 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 150 PRO.? 25.92 O1 PG4 A 350 A 272 LEU A 149 LEU~? 20.90 O1 PG4 A 350 A 276 ARG A 147 ARG~? 21.89 C2 PG4 A 350 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -31.81 51.05 14.27 -30.20 51.53 12.78 coo 10.97 0.43 16.73 11.31 2.11 18.06 -27.09 49.45 14.10 -26.48 47.95 15.59 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -23.00 46.39 6.22 -24.32 43.65 5.76 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO A 246 PRO~? 14.77 O1 PG4 A 350 A 272 LEU A 245 LEU~? 17.12 O4 PO4 A 349 A 276 ARG B 249 ARG~? 17.39 O4 PO4 A 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -8.63 47.58 15.89 -10.02 48.19 14.22 coo 10.97 0.43 16.73 11.31 2.11 18.06 -7.51 49.49 11.77 -7.66 48.60 9.78 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 1.78 52.94 11.29 0.18 53.87 8.84 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO A 246 PRO~? 14.77 O1 PG4 A 350 A 272 LEU B 245 LEU~? 17.05 O4 PO4 A 349 A 276 ARG B 249 ARG~? 17.39 O4 PO4 A 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -8.63 47.58 15.89 -10.02 48.19 14.22 coo 10.97 0.43 16.73 11.31 2.11 18.06 -2.99 48.72 10.67 -3.02 50.87 10.99 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 1.78 52.94 11.29 0.18 53.87 8.84 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO A 276 PRO.? 16.98 O4 PO4 A 349 A 272 LEU A 237 LEU.? 12.58 O4 PO4 A 349 A 276 ARG B 249 ARG~? 17.39 O4 PO4 A 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 0.28 63.95 7.56 0.41 65.99 8.51 coo 10.97 0.43 16.73 11.31 2.11 18.06 -0.58 60.53 12.48 -1.70 61.73 11.03 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 1.78 52.94 11.29 0.18 53.87 8.84 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO A 276 PRO.? 16.98 O4 PO4 A 349 A 272 LEU A 284 LEU~? 16.66 O4 PO4 A 349 A 276 ARG A 283 ARG~? 22.10 O4 PO4 A 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 0.28 63.95 7.56 0.41 65.99 8.51 coo 10.97 0.43 16.73 11.31 2.11 18.06 -5.32 59.56 6.11 -3.97 58.07 6.92 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -6.83 62.59 -0.10 -4.11 61.39 0.92 ULMN 3 1emh_d00 HYDROLASE/DNA user 7 3 # 7 A 271 PRO B 136 PRO.? -5.90 O1 PG4 B 350s A 272 LEU B 139 LEU.? -3.88 O1 PG4 B 350s A 276 ARG B 206 ARG~? -3.06 O4 PG4 B 350s coo 16.45 -2.42 17.59 14.58 -2.74 16.47 6.08 37.13 19.78 5.60 36.57 21.90 coo 10.97 0.43 16.73 11.31 2.11 18.06 5.82 42.83 22.92 5.79 41.39 21.29 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -2.22 41.47 25.55 0.33 41.32 27.30 ULMN 3 1emh_d00 HYDROLASE/DNA user 8 3 # 8 A 271 PRO B 150 PRO.? 25.91 O2 PO4 B 349 A 272 LEU B 149 LEU~? 21.21 O1 PG4 B 350 A 276 ARG B 147 ARG~? 21.77 C2 PG4 B 350 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 20.95 48.24 6.63 19.29 49.62 5.97 coo 10.97 0.43 16.73 11.31 2.11 18.06 16.58 48.64 8.60 16.30 47.40 10.36 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 11.90 56.41 10.58 13.26 57.05 13.30 ULMN 3 1emh_d00 HYDROLASE/DNA user 9 3 # 9 A 271 PRO B 246 PRO~? 14.86 O1 PG4 B 350 A 272 LEU A 245 LEU~? 17.12 O4 PO4 A 349 A 276 ARG A 249 ARG~? 17.61 O4 PO4 B 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -0.94 45.15 13.15 0.10 46.84 12.06 coo 10.97 0.43 16.73 11.31 2.11 18.06 -7.51 49.49 11.77 -7.66 48.60 9.78 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -12.58 47.35 8.37 -11.42 49.74 6.78 ULMN 3 1emh_d00 HYDROLASE/DNA user 10 3 # 10 A 271 PRO B 246 PRO~? 14.86 O1 PG4 B 350 A 272 LEU B 245 LEU~? 17.05 O4 PO4 A 349 A 276 ARG A 249 ARG~? 17.61 O4 PO4 B 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -0.94 45.15 13.15 0.10 46.84 12.06 coo 10.97 0.43 16.73 11.31 2.11 18.06 -2.99 48.72 10.67 -3.02 50.87 10.99 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -12.58 47.35 8.37 -11.42 49.74 6.78 ULMN 3 1emh_d00 HYDROLASE/DNA user 11 3 # 11 A 271 PRO B 276 PRO.? 17.04 O4 PO4 B 349 A 272 LEU B 237 LEU.? 12.67 O4 PO4 B 349 A 276 ARG A 249 ARG~? 17.61 O4 PO4 B 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -12.52 48.72 -3.03 -13.02 47.31 -4.74 coo 10.97 0.43 16.73 11.31 2.11 18.06 -10.81 44.71 1.03 -10.07 45.97 -0.56 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -12.58 47.35 8.37 -11.42 49.74 6.78 ULMN 3 1emh_d00 HYDROLASE/DNA user 12 3 # 12 A 271 PRO C 136 PRO.? -5.79 O1 PG4 C 350s A 272 LEU C 139 LEU.? -4.28 O1 PG4 C 350s A 276 ARG C 206 ARG~? -3.06 O3 PG4 C 350s coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -34.81 11.84 41.25 -35.27 9.89 42.27 coo 10.97 0.43 16.73 11.31 2.11 18.06 -34.72 13.62 47.48 -34.93 13.62 45.32 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -42.81 10.68 48.87 -40.18 9.57 50.03 ULMN 3 1emh_d00 HYDROLASE/DNA user 13 3 # 13 A 271 PRO C 150 PRO.? 19.10 C1 PG4 A 350 A 272 LEU C 149 LEU~? 21.32 C2 PG4 C 350 A 276 ARG C 147 ARG~? 21.64 C2 PG4 C 350 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -19.94 28.72 39.08 -21.62 30.09 39.68 coo 10.97 0.43 16.73 11.31 2.11 18.06 -24.26 27.54 40.96 -24.59 25.42 41.35 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -28.57 31.49 48.25 -26.95 30.26 50.59 ULMN 3 1emh_d00 HYDROLASE/DNA user 14 3 # 14 A 271 PRO C 246 PRO~? 15.09 O1 PG4 C 350 A 272 LEU C 245 LEU~? 17.13 O1 PO4 C 349 A 276 ARG D 249 ARG~? 17.54 O1 PO4 C 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -41.91 22.10 42.73 -40.89 24.05 43.13 coo 10.97 0.43 16.73 11.31 2.11 18.06 -43.87 26.31 43.72 -43.76 27.54 45.51 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -53.61 27.06 41.90 -52.49 29.90 42.42 ULMN 3 1emh_d00 HYDROLASE/DNA user 15 3 # 15 A 271 PRO C 246 PRO~? 15.09 O1 PG4 C 350 A 272 LEU D 245 LEU~? 17.15 O3 PO4 C 349 A 276 ARG D 249 ARG~? 17.54 O1 PO4 C 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -41.91 22.10 42.73 -40.89 24.05 43.13 coo 10.97 0.43 16.73 11.31 2.11 18.06 -48.34 26.20 45.37 -48.61 26.96 43.37 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -53.61 27.06 41.90 -52.49 29.90 42.42 ULMN 3 1emh_d00 HYDROLASE/DNA user 16 3 # 16 A 271 PRO C 274 PRO.? 18.34 O1 PO4 C 349 A 272 LEU C 237 LEU.? 12.76 O1 PO4 C 349 A 276 ARG D 249 ARG~? 17.54 O1 PO4 C 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -59.60 34.57 34.09 -58.99 32.79 32.87 coo 10.97 0.43 16.73 11.31 2.11 18.06 -52.35 30.84 34.89 -51.55 32.85 34.62 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -53.61 27.06 41.90 -52.49 29.90 42.42 ULMN 3 1emh_d00 HYDROLASE/DNA user 17 3 # 17 A 271 PRO C 276 PRO.? 16.94 O1 PO4 C 349 A 272 LEU C 237 LEU.? 12.76 O1 PO4 C 349 A 276 ARG D 249 ARG~? 17.54 O1 PO4 C 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -53.83 36.49 34.85 -54.49 36.81 32.72 coo 10.97 0.43 16.73 11.31 2.11 18.06 -52.35 30.84 34.89 -51.55 32.85 34.62 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -53.61 27.06 41.90 -52.49 29.90 42.42 ULMN 3 1emh_d00 HYDROLASE/DNA user 18 3 # 18 A 271 PRO C 276 PRO.? 16.94 O1 PO4 C 349 A 272 LEU C 284 LEU~? 16.67 O1 PO4 C 349 A 276 ARG C 283 ARG~? 24.80 O1 PO4 C 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -53.83 36.49 34.85 -54.49 36.81 32.72 coo 10.97 0.43 16.73 11.31 2.11 18.06 -48.03 36.26 38.78 -49.00 34.50 39.64 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -47.36 43.82 38.18 -45.87 46.48 37.65 ULMN 3 1emh_d00 HYDROLASE/DNA user 19 3 # 19 A 271 PRO D 136 PRO.? -5.88 O5 PG4 D 350s A 272 LEU D 139 LEU.? -3.47 O5 PG4 D 350s A 276 ARG D 206 ARG~? -3.23 O2 PG4 D 350s coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -54.71 11.03 50.01 -54.10 9.08 49.12 coo 10.97 0.43 16.73 11.31 2.11 18.06 -55.20 11.62 43.43 -55.10 11.98 45.55 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -46.64 9.92 42.41 -48.92 7.98 41.78 ULMN 3 1emh_d00 HYDROLASE/DNA user 20 3 # 20 A 271 PRO D 150 PRO.? 25.13 O5 PG4 D 350 A 272 LEU D 149 LEU~? 20.41 O5 PG4 D 350 A 276 ARG D 147 ARG~? 21.65 O5 PG4 D 350 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -72.07 24.78 50.12 -70.84 26.40 49.20 coo 10.97 0.43 16.73 11.31 2.11 18.06 -67.67 24.38 48.14 -67.04 22.30 48.02 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -64.41 28.02 40.25 -65.44 25.99 38.16 ULMN 3 1emh_d00 HYDROLASE/DNA user 21 3 # 21 A 271 PRO D 246 PRO~? 14.70 O5 PG4 D 350 A 272 LEU C 245 LEU~? 17.13 O1 PO4 C 349 A 276 ARG C 249 ARG~? 17.71 O4 PO4 D 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -49.35 21.79 46.76 -50.81 23.45 46.27 coo 10.97 0.43 16.73 11.31 2.11 18.06 -43.87 26.31 43.72 -43.76 27.54 45.51 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -38.85 28.76 46.96 -40.48 31.26 46.10 ULMN 3 1emh_d00 HYDROLASE/DNA user 22 3 # 22 A 271 PRO D 246 PRO~? 14.70 O5 PG4 D 350 A 272 LEU D 245 LEU~? 17.15 O3 PO4 C 349 A 276 ARG C 249 ARG~? 17.71 O4 PO4 D 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -49.35 21.79 46.76 -50.81 23.45 46.27 coo 10.97 0.43 16.73 11.31 2.11 18.06 -48.34 26.20 45.37 -48.61 26.96 43.37 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -38.85 28.76 46.96 -40.48 31.26 46.10 ULMN 3 1emh_d00 HYDROLASE/DNA user 23 3 # 23 A 271 PRO D 276 PRO.? 17.06 O4 PO4 D 349 A 272 LEU D 237 LEU.? 12.72 O4 PO4 D 349 A 276 ARG C 249 ARG~? 17.71 O4 PO4 D 349 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -39.84 38.70 52.62 -39.45 39.40 54.73 coo 10.97 0.43 16.73 11.31 2.11 18.06 -40.74 32.88 53.53 -41.84 34.75 53.48 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -38.85 28.76 46.96 -40.48 31.26 46.10 1emh_d00 source 1emh HYDROLASE/DNA : 23 hits 1emh_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG B 133 ARG.? 8.50 C4 PG4 A 350 C 71 LYS B 134 LYS.? 7.94 O5 PG4 B 350 C 72 VAL B 132 VAL.? 12.49 C8 PG4 A 350 coo 23.89 33.54 29.21 26.59 34.86 28.68 -3.22 31.42 16.60 -5.11 31.22 14.14 coo 25.82 26.89 29.68 23.33 22.98 25.84 1.49 32.28 22.12 4.07 30.52 27.68 coo 28.86 29.08 30.37 28.04 31.02 29.93 2.43 28.48 18.14 2.79 27.81 16.06 1hwt_d00 source 1hwt GENE REGULATION/DNA : 1 hits 1hwt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 182 ARG.? 27.04 O1 PO4 A 349 E 41 TYR A 225 TYR.? 21.13 O1 PO4 A 349 E 83 ARG B 42 ARG.? 20.99 C5 PG4 A 350 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -34.46 56.29 23.08 -34.82 53.96 21.09 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -13.08 10.76 9.81 -13.21 13.36 11.51 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG A 182 ARG.? 27.04 O1 PO4 A 349 E 41 TYR A 225 TYR.? 21.13 O1 PO4 A 349 E 83 ARG D 206 ARG~? -3.23 O2 PG4 D 350s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -34.46 56.29 23.08 -34.82 53.96 21.09 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -46.64 9.92 42.41 -48.92 7.98 41.78 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG A 182 ARG.? 27.04 O1 PO4 A 349 E 41 TYR A 225 TYR.? 21.13 O1 PO4 A 349 E 83 ARG D 261 ARG^? 8.01 O2 PO4 D 349 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -34.46 56.29 23.08 -34.82 53.96 21.09 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -28.82 53.90 23.23 -28.73 53.13 25.91 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -41.02 32.36 67.18 -41.18 29.51 65.99 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG B 8 ARG.? 30.97 O3 PO4 B 349 E 41 TYR B 71 TYR~? 28.79 O3 PO4 B 349 E 83 ARG A 147 ARG~? 21.89 C2 PG4 A 350 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 10.20 9.25 11.13 12.17 8.18 13.25 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 3.73 5.71 7.80 2.32 4.41 5.78 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -23.00 46.39 6.22 -24.32 43.65 5.76 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG B 8 ARG.? 30.97 O3 PO4 B 349 E 41 TYR B 71 TYR~? 28.79 O3 PO4 B 349 E 83 ARG A 220 ARG~? 15.84 O1 PG4 A 350 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 10.20 9.25 11.13 12.17 8.18 13.25 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 3.73 5.71 7.80 2.32 4.41 5.78 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -23.72 43.89 25.49 -25.14 44.23 28.23 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 6 3 # 6 E 40 ARG B 8 ARG.? 30.97 O3 PO4 B 349 E 41 TYR B 71 TYR~? 28.79 O3 PO4 B 349 E 83 ARG C 153 ARG^? 21.82 O2 PO4 C 349 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 10.20 9.25 11.13 12.17 8.18 13.25 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 3.73 5.71 7.80 2.32 4.41 5.78 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -28.52 27.96 39.05 -27.50 30.55 40.41 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 7 3 # 7 E 40 ARG B 57 ARG.? 17.74 O3 PO4 B 349 E 41 TYR B 58 TYR.? 25.36 O3 PO4 B 349 E 83 ARG C 30 ARG~? 10.19 O4 PO4 C 349 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 5.49 16.86 0.47 7.09 17.94 2.86 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 4.06 9.43 -1.88 2.81 7.26 -0.64 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -42.41 19.48 17.74 -45.10 19.59 16.14 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 8 3 # 8 E 40 ARG B 182 ARG.? 25.41 O2 PO4 B 349 E 41 TYR B 225 TYR~? 21.07 O2 PO4 B 349 E 83 ARG A 30 ARG~? 10.33 O2 PO4 A 349 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 24.54 38.99 2.73 24.16 37.16 5.19 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 19.22 39.10 5.74 19.70 36.67 7.05 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -9.85 66.58 32.39 -7.32 68.13 33.36 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 9 3 # 9 E 40 ARG C 8 ARG.? 30.39 O4 PO4 C 349 E 41 TYR C 71 TYR~? 28.61 O4 PO4 C 349 E 83 ARG D 147 ARG~? 21.65 O5 PG4 D 350 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -34.38 -0.74 13.28 -32.98 -3.36 14.17 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -42.04 -1.21 10.11 -44.02 -0.84 8.15 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -64.41 28.02 40.25 -65.44 25.99 38.16 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 10 3 # 10 E 40 ARG C 8 ARG.? 30.39 O4 PO4 C 349 E 41 TYR C 71 TYR~? 28.61 O4 PO4 C 349 E 83 ARG D 220 ARG~? 10.23 O5 PG4 D 350 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -34.38 -0.74 13.28 -32.98 -3.36 14.17 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -42.04 -1.21 10.11 -44.02 -0.84 8.15 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -64.10 12.09 51.59 -61.65 11.18 49.96 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 11 3 # 11 E 40 ARG C 57 ARG.? 17.31 O4 PO4 C 349 E 41 TYR C 56 TYR.? 20.70 O4 PO4 C 349 E 83 ARG B 206 ARG~? -3.06 O4 PG4 B 350s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -40.16 11.74 13.21 -37.69 10.86 14.87 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -41.24 17.60 7.53 -40.11 17.22 5.03 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -2.22 41.47 25.55 0.33 41.32 27.30 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 12 3 # 12 E 40 ARG C 57 ARG.? 17.31 O4 PO4 C 349 E 41 TYR C 56 TYR.? 20.70 O4 PO4 C 349 E 83 ARG B 335 ARG~? 17.10 O3 PO4 B 349 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -40.16 11.74 13.21 -37.69 10.86 14.87 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -41.24 17.60 7.53 -40.11 17.22 5.03 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -0.53 29.97 -13.85 -3.08 28.75 -15.03 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 13 3 # 13 E 40 ARG C 57 ARG.? 17.31 O4 PO4 C 349 E 41 TYR C 58 TYR.? 25.51 O4 PO4 C 349 E 83 ARG B 335 ARG~? 17.10 O3 PO4 B 349 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -40.16 11.74 13.21 -37.69 10.86 14.87 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -41.92 7.88 6.18 -42.73 5.30 5.53 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -0.53 29.97 -13.85 -3.08 28.75 -15.03 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 14 3 # 14 E 40 ARG D 8 ARG.? 29.91 O2 PO4 D 349 E 41 TYR D 71 TYR~? 29.61 O2 PO4 D 349 E 83 ARG C 147 ARG~? 21.64 C2 PG4 C 350 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -57.65 0.93 76.64 -57.42 1.44 79.66 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -50.15 1.87 82.02 -48.64 2.61 84.24 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -28.57 31.49 48.25 -26.95 30.26 50.59 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 15 3 # 15 E 40 ARG D 8 ARG.? 29.91 O2 PO4 D 349 E 41 TYR D 71 TYR~? 29.61 O2 PO4 D 349 E 83 ARG C 220 ARG~? 11.31 O1 PG4 C 350 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -57.65 0.93 76.64 -57.42 1.44 79.66 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -50.15 1.87 82.02 -48.64 2.61 84.24 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -25.78 14.58 38.60 -28.17 14.03 40.55 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 16 3 # 16 E 40 ARG D 57 ARG.? 17.88 O2 PO4 D 349 E 41 TYR D 56 TYR.? 20.92 O2 PO4 D 349 E 83 ARG C 283 ARG~? 24.80 O1 PO4 C 349 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -53.05 14.45 77.65 -54.84 13.45 75.34 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -51.59 21.66 83.26 -50.28 23.43 84.94 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -47.36 43.82 38.18 -45.87 46.48 37.65 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 17 3 # 17 E 40 ARG D 182 ARG.? 26.89 O1 PO4 D 349 E 41 TYR D 225 TYR.? 21.05 O1 PO4 D 349 E 83 ARG C 30 ARG~? 10.19 O4 PO4 C 349 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -74.46 22.20 60.05 -74.88 21.98 57.01 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -68.84 20.67 57.80 -68.69 18.14 58.96 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -42.41 19.48 17.74 -45.10 19.59 16.14 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 17 hits 1id3_d00 naa= 3 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 1 4 # 1 G 5 LYS B 177 LYS~? 21.19 O2 PO4 B 349 G 13 LYS B 165 LYS~? -2.78 O4 PO4 B 349s G 42 ARG B 147 ARG~? 21.77 C2 PG4 B 350 G 77 ARG C 182 ARG.? 12.42 C6 PG4 A 350 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 18.35 34.41 -3.27 19.41 29.18 0.25 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 0.37 36.49 0.17 -3.63 37.66 2.73 coo 39.46 58.80 1.48 39.21 55.92 0.43 11.90 56.41 10.58 13.26 57.05 13.30 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -17.19 25.58 29.52 -16.27 25.77 32.47 1kx5_d03 source 1kx5 STRUCTURAL PROTEIN/DNA : 1 hits 1kx5_d03 naa= 4 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 458 GLU B 317 GLU~? 25.52 O4 PO4 B 349 A 461 LYS B 316 LYS~? 24.20 O3 PO4 B 349 A 462 ALA B 315 ALA~? 17.89 O3 PO4 B 349 A 466 ARG B 335 ARG~? 17.10 O3 PO4 B 349 coo 36.22 34.04 93.46 35.20 35.01 95.03 -6.27 36.67 -22.50 -8.15 36.31 -23.40 coo 29.92 31.01 94.11 31.45 36.50 96.08 -2.04 35.41 -19.34 2.27 31.66 -22.14 coo 28.62 33.12 91.21 29.52 33.84 90.21 -4.15 33.50 -16.84 -3.20 32.43 -16.31 coo 25.27 34.07 87.35 27.76 35.81 87.05 -0.53 29.97 -13.85 -3.08 28.75 -15.03 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 458 GLU D 317 GLU~? 25.08 O4 PO4 D 349 A 461 LYS D 316 LYS~? 24.37 O2 PO4 D 349 A 462 ALA D 315 ALA~? 17.83 O2 PO4 D 349 A 466 ARG D 335 ARG~? 17.05 O2 PO4 D 349 coo 36.22 34.04 93.46 35.20 35.01 95.03 -45.36 46.85 72.91 -43.76 47.38 74.18 coo 29.92 31.01 94.11 31.45 36.50 96.08 -49.65 42.56 73.75 -53.64 42.38 78.67 coo 28.62 33.12 91.21 29.52 33.84 90.21 -46.93 39.91 73.63 -47.63 38.72 74.27 coo 25.27 34.07 87.35 27.76 35.81 87.05 -49.77 35.01 75.03 -47.14 35.61 76.51 1lat_d00 source 1lat TRANSCRIPTION/DNA : 2 hits 1lat_d00 naa= 4 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS B 134 LYS.? 7.94 O5 PG4 B 350 A 564 VAL B 132 VAL.? 12.49 C8 PG4 A 350 A 568 ARG B 133 ARG.? 8.50 C4 PG4 A 350 coo -6.60 80.79 55.64 -8.55 79.48 61.01 1.49 32.28 22.12 4.07 30.52 27.68 coo -9.25 78.14 55.31 -11.11 77.94 56.39 2.43 28.48 18.14 2.79 27.81 16.06 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -3.22 31.42 16.60 -5.11 31.22 14.14 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 1 hits 1r4i_d00 naa= 3 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 48 SER~? 23.12 O2 PO4 A 349 E 5 VAL A 59 VAL.? 21.23 O2 PO4 A 349 E 7 ARG A 57 ARG.? 17.32 O2 PO4 A 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -1.95 71.28 45.67 -3.37 73.11 44.99 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -8.09 65.75 46.79 -8.58 63.95 45.59 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -11.38 65.24 41.83 -13.84 63.42 41.14 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 167 SER~? 5.73 O2 PO4 A 349 E 5 VAL A 334 VAL~? 10.92 O2 PO4 A 349 E 7 ARG A 335 ARG~? 17.04 O2 PO4 A 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -13.33 64.08 26.14 -11.49 64.89 27.48 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -14.44 71.14 26.18 -12.87 69.84 27.10 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -10.94 77.02 25.36 -8.46 78.77 25.78 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER A 169 SER~? 7.69 O1 PO4 A 349 E 5 VAL A 154 VAL^? 14.34 O1 PO4 A 349 E 7 ARG A 152 ARG^? 23.60 O1 PO4 A 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -16.90 61.69 22.73 -15.84 59.83 21.54 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -19.92 58.46 15.79 -20.55 60.55 15.94 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -26.26 60.60 13.36 -28.56 61.89 11.76 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER A 251 SER~? 15.16 O1 PO4 A 349 E 5 VAL A 154 VAL^? 14.34 O1 PO4 A 349 E 7 ARG A 152 ARG^? 23.60 O1 PO4 A 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -18.37 49.97 14.50 -17.17 52.05 14.58 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -19.92 58.46 15.79 -20.55 60.55 15.94 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -26.26 60.60 13.36 -28.56 61.89 11.76 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER B 48 SER~? 23.24 O3 PO4 B 349 E 5 VAL B 59 VAL.? 21.50 O3 PO4 B 349 E 7 ARG B 57 ARG.? 17.74 O3 PO4 B 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -2.83 10.14 -3.94 -1.62 10.85 -5.92 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 2.94 11.31 1.64 3.15 12.85 3.20 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 5.49 16.86 0.47 7.09 17.94 2.86 ULMN 3 2bsq_d00 TRANSCRIPTION user 6 3 # 6 E 3 SER B 167 SER~? 5.62 O3 PO4 B 349 E 5 VAL B 334 VAL~? 11.07 O3 PO4 B 349 E 7 ARG B 335 ARG~? 17.10 O3 PO4 B 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 3.34 32.15 -1.39 1.57 30.56 -1.62 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 3.84 30.88 -8.42 2.54 29.99 -6.87 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -0.53 29.97 -13.85 -3.08 28.75 -15.03 ULMN 3 2bsq_d00 TRANSCRIPTION user 7 3 # 7 E 3 SER B 241 SER.? 10.02 O1 PO4 B 349 E 5 VAL A 207 VAL~? 11.72 O5 PG4 A 350 E 7 ARG A 206 ARG~? -3.21 O4 PG4 A 350s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -9.21 42.20 9.74 -7.29 41.83 8.32 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -5.50 41.37 16.73 -3.80 41.96 15.41 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -5.76 36.17 21.40 -8.07 34.21 22.04 ULMN 3 2bsq_d00 TRANSCRIPTION user 8 3 # 8 E 3 SER C 48 SER~? 23.03 O4 PO4 C 349 E 5 VAL C 59 VAL.? 21.21 O4 PO4 C 349 E 7 ARG C 57 ARG.? 17.31 O4 PO4 C 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -49.92 9.94 6.78 -48.92 11.89 5.74 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -43.16 6.87 10.20 -42.52 6.96 12.30 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -40.16 11.74 13.21 -37.69 10.86 14.87 ULMN 3 2bsq_d00 TRANSCRIPTION user 9 3 # 9 E 3 SER C 167 SER~? 5.88 O4 PO4 C 349 E 5 VAL C 334 VAL~? 11.08 O4 PO4 C 349 E 7 ARG C 335 ARG~? 16.94 O4 PO4 C 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -38.98 23.58 23.13 -40.74 22.64 21.84 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -38.89 27.67 17.32 -40.16 25.95 17.84 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -43.40 31.02 13.21 -46.07 30.90 11.67 ULMN 3 2bsq_d00 TRANSCRIPTION user 10 3 # 10 E 3 SER C 241 SER.? 9.97 O3 PO4 C 349 E 5 VAL D 207 VAL~? 11.87 C8 PG4 D 350 E 7 ARG D 206 ARG~? -3.23 O2 PG4 D 350s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -50.53 22.77 38.79 -48.65 23.56 37.48 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -46.49 16.85 42.81 -44.78 18.15 42.19 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -46.64 9.92 42.41 -48.92 7.98 41.78 ULMN 3 2bsq_d00 TRANSCRIPTION user 11 3 # 11 E 3 SER D 48 SER~? 24.33 O2 PO4 D 349 E 5 VAL D 59 VAL.? 22.31 O2 PO4 D 349 E 7 ARG D 57 ARG.? 17.88 O2 PO4 D 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -44.50 14.01 85.56 -45.98 15.75 86.37 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -50.11 10.00 81.42 -50.34 9.94 79.23 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -53.05 14.45 77.65 -54.84 13.45 75.34 ULMN 3 2bsq_d00 TRANSCRIPTION user 12 3 # 12 E 3 SER D 167 SER~? 5.79 O2 PO4 D 349 E 5 VAL D 334 VAL~? 11.04 O2 PO4 D 349 E 7 ARG D 335 ARG~? 17.05 O2 PO4 D 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -52.83 25.44 66.27 -50.98 24.93 67.73 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -53.73 30.33 71.44 -52.25 28.75 71.16 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -49.77 35.01 75.03 -47.14 35.61 76.51 ULMN 3 2bsq_d00 TRANSCRIPTION user 13 3 # 13 E 3 SER D 169 SER~? 7.40 O1 PO4 D 349 E 5 VAL D 154 VAL^? 14.44 O1 PO4 D 349 E 7 ARG D 152 ARG^? 23.56 O1 PO4 D 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -56.61 26.42 62.40 -55.41 26.04 60.30 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -60.15 29.21 55.46 -60.68 30.49 57.13 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -66.62 32.34 56.11 -68.43 34.76 55.54 ULMN 3 2bsq_d00 TRANSCRIPTION user 14 3 # 14 E 3 SER D 241 SER.? 10.08 O3 PO4 D 349 E 5 VAL C 207 VAL~? 11.82 O2 PG4 C 350 E 7 ARG C 206 ARG~? -3.06 O3 PG4 C 350s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -41.15 24.23 50.62 -43.08 24.97 51.88 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -44.09 17.39 47.51 -46.00 18.49 47.81 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -42.81 10.68 48.87 -40.18 9.57 50.03 ULMN 3 2bsq_d00 TRANSCRIPTION user 15 3 # 15 E 3 SER D 251 SER~? 15.21 O1 PO4 D 349 E 5 VAL D 154 VAL^? 14.44 O1 PO4 D 349 E 7 ARG D 152 ARG^? 23.56 O1 PO4 D 349 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -58.95 24.32 48.36 -57.66 25.69 49.92 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -60.15 29.21 55.46 -60.68 30.49 57.13 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -66.62 32.34 56.11 -68.43 34.76 55.54 2bsq_d00 source 2bsq TRANSCRIPTION : 15 hits 2bsq_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG D 179 ARG~? 21.69 O1 PO4 D 349 A 32 LYS D 177 LYS~? 20.36 O1 PO4 D 349 A 46 ARG D 152 ARG^? 23.56 O1 PO4 D 349 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -67.72 32.24 67.66 -66.56 34.95 66.77 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -68.08 25.33 66.69 -67.75 19.10 66.60 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -66.62 32.34 56.11 -68.43 34.76 55.54 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 1 hits 2ky8_d00 naa= 3 ULMN 4 2q2t_d00 LIGASE/DNA user 1 4 # 1 A 48 ARG B 206 ARG~? -3.06 O4 PG4 B 350s A 249 THR B 148 THR~? 22.53 C2 PG4 B 350 A 285 ARG B 249 ARG~? 17.39 O4 PO4 A 349 A 286 PHE B 295 PHE.? 17.77 O4 PO4 A 349 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -2.22 41.47 25.55 0.33 41.32 27.30 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 16.43 53.30 9.96 17.05 53.80 11.98 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 1.78 52.94 11.29 0.18 53.87 8.84 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 4.44 56.76 8.32 3.13 56.55 10.76 ULMN 4 2q2t_d00 LIGASE/DNA user 2 4 # 2 A 48 ARG B 206 ARG~? -3.06 O4 PG4 B 350s A 249 THR B 254 THR.? 20.12 O2 PO4 B 349 A 285 ARG B 249 ARG~? 17.39 O4 PO4 A 349 A 286 PHE B 295 PHE.? 17.77 O4 PO4 A 349 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -2.22 41.47 25.55 0.33 41.32 27.30 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 10.14 50.29 1.40 12.13 49.53 1.68 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 1.78 52.94 11.29 0.18 53.87 8.84 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 4.44 56.76 8.32 3.13 56.55 10.76 ULMN 4 2q2t_d00 LIGASE/DNA user 3 4 # 3 A 48 ARG C 206 ARG~? -3.06 O3 PG4 C 350s A 249 THR C 148 THR~? 21.31 C2 PG4 C 350 A 285 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 286 PHE C 295 PHE.? 18.04 O4 PO4 D 349 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -42.81 10.68 48.87 -40.18 9.57 50.03 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -24.12 29.68 45.29 -24.09 28.16 46.88 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -35.98 33.23 47.56 -37.26 31.40 49.20 ULMN 4 2q2t_d00 LIGASE/DNA user 4 4 # 4 A 48 ARG C 206 ARG~? -3.06 O3 PG4 C 350s A 249 THR C 254 THR.? 20.37 O2 PO4 C 349 A 285 ARG C 249 ARG~? 17.71 O4 PO4 D 349 A 286 PHE C 295 PHE.? 18.04 O4 PO4 D 349 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -42.81 10.68 48.87 -40.18 9.57 50.03 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -30.89 33.85 37.59 -28.87 33.18 37.19 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -38.85 28.76 46.96 -40.48 31.26 46.10 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -35.98 33.23 47.56 -37.26 31.40 49.20 2q2t_d00 source 2q2t LIGASE/DNA : 4 hits 2q2t_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 143 SER.? 14.48 C2 PG4 A 350 B 37 ASN B 270 ASN.? 15.02 O1 PO4 B 349 B 45 THR B 159 THR.? 9.69 O4 PO4 B 349 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -18.44 40.75 9.72 -20.35 39.92 10.87 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -17.98 39.50 4.84 -17.14 38.86 6.70 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -7.46 42.26 -1.59 -7.39 42.02 -3.73 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER B 143 SER.? 15.37 C2 PG4 B 350 B 37 ASN A 270 ASN.? 15.06 O3 PO4 A 349 B 45 THR A 20 THR.? 13.58 O3 PO4 A 349 coo -19.49 41.97 71.08 -17.37 40.80 71.17 8.40 53.62 17.31 10.72 53.32 17.95 coo -23.05 39.62 69.74 -22.86 39.59 67.61 7.80 59.00 17.23 7.36 57.24 18.34 coo -30.87 34.84 80.57 -28.94 34.51 81.49 3.89 61.16 32.01 5.74 61.19 30.84 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER B 143 SER.? 15.37 C2 PG4 B 350 B 37 ASN A 270 ASN.? 15.06 O3 PO4 A 349 B 45 THR A 159 THR.? 9.59 O4 PO4 A 349 coo -19.49 41.97 71.08 -17.37 40.80 71.17 8.40 53.62 17.31 10.72 53.32 17.95 coo -23.05 39.62 69.74 -22.86 39.59 67.61 7.80 59.00 17.23 7.36 57.24 18.34 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -3.74 63.20 14.86 -4.14 65.31 14.68 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER C 143 SER.? 14.49 C2 PG4 C 350 B 37 ASN D 270 ASN.? 14.75 O3 PO4 D 349 B 45 THR D 159 THR.? 9.84 O4 PO4 D 349 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -31.83 24.72 51.20 -29.72 23.61 51.01 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -32.60 27.92 55.07 -33.22 25.92 54.63 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -43.83 33.07 57.34 -43.96 34.77 58.72 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER D 143 SER.? 14.73 O4 PG4 D 350 B 37 ASN C 270 ASN.? 15.22 O3 PO4 C 349 B 45 THR C 20 THR.? 14.12 O3 PO4 C 349 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -59.66 21.71 38.39 -61.59 20.24 38.67 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -59.71 24.81 33.93 -59.02 22.97 34.76 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -55.27 14.55 23.34 -57.23 15.15 23.98 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER D 143 SER.? 14.73 O4 PG4 D 350 B 37 ASN C 270 ASN.? 15.22 O3 PO4 C 349 B 45 THR C 159 THR.? 9.76 O1 PO4 C 349 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -59.66 21.71 38.39 -61.59 20.24 38.67 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -59.71 24.81 33.93 -59.02 22.97 34.76 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -49.22 30.92 31.00 -49.22 32.37 29.42 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 6 hits 2z3x_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 143 SER.? 14.48 C2 PG4 A 350 A 20 HIS B 238 HIS.? 10.82 O1 PO4 B 349 A 22 LEU B 236 LEU.? 13.69 O4 PO4 B 349 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -18.44 40.75 9.72 -20.35 39.92 10.87 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -11.67 40.20 5.98 -12.62 38.67 7.06 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -7.17 47.64 4.03 -5.58 48.63 5.14 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER A 169 SER~? 7.69 O1 PO4 A 349 A 20 HIS A 173 HIS~? 15.17 O1 PO4 A 349 A 22 LEU A 178 LEU~? 22.13 O1 PO4 A 349 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -16.90 61.69 22.73 -15.84 59.83 21.54 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -22.96 60.49 26.07 -24.34 59.43 27.24 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -28.30 68.43 27.18 -28.52 70.33 28.19 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER A 183 SER^? 16.92 O1 PO4 A 349 A 20 HIS A 229 HIS^? 14.13 O1 PO4 A 349 A 22 LEU A 155 LEU^? 11.40 O1 PO4 A 349 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -27.51 58.57 23.48 -25.56 60.04 23.47 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -21.69 59.77 21.49 -23.21 61.13 21.02 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -15.63 56.55 15.39 -13.97 55.19 15.86 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER B 143 SER.? 15.37 C2 PG4 B 350 A 20 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 22 LEU A 236 LEU.? 13.48 O4 PO4 A 349 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 8.40 53.62 17.31 10.72 53.32 17.95 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 1.50 56.90 17.79 2.83 56.38 19.33 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -4.08 56.51 10.90 -5.57 54.97 10.53 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 18 SER B 143 SER.? 15.37 C2 PG4 B 350 A 20 HIS A 238 HIS.? 10.67 O3 PO4 A 349 A 22 LEU A 237 LEU.? 12.58 O4 PO4 A 349 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 8.40 53.62 17.31 10.72 53.32 17.95 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 1.50 56.90 17.79 2.83 56.38 19.33 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -0.58 60.53 12.48 -1.70 61.73 11.03 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 18 SER B 169 SER~? 7.42 O2 PO4 B 349 A 20 HIS B 173 HIS~? 15.15 O2 PO4 B 349 A 22 LEU B 178 LEU~? 21.93 O2 PO4 B 349 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 6.64 36.52 -0.21 5.42 37.80 1.47 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 13.23 34.15 0.64 14.88 33.23 1.56 coo -14.55 2.62 13.63 -14.94 2.66 11.50 17.63 32.43 -7.64 17.72 30.88 -9.17 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 A 18 SER B 183 SER^? 16.79 O2 PO4 B 349 A 20 HIS B 229 HIS^? 14.08 O2 PO4 B 349 A 22 LEU B 155 LEU^? 11.29 O2 PO4 B 349 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 17.47 37.56 1.42 15.35 37.17 0.22 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 11.38 38.70 0.79 12.71 38.99 -0.80 coo -14.55 2.62 13.63 -14.94 2.66 11.50 4.77 44.58 3.50 3.24 44.09 4.98 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 A 18 SER C 143 SER.? 14.49 C2 PG4 C 350 A 20 HIS D 238 HIS.? 10.72 O3 PO4 D 349 A 22 LEU D 236 LEU.? 13.82 O4 PO4 D 349